data_1afh_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1afh _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.585 ' CG1' ' HB3' ' A' ' 40' ' ' ALA . 5.3 tp . . . . . 0 N--CA 1.507 2.407 0 CA-C-O 121.916 0.865 . . . . 0.0 111.579 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 5' ' ' GLY . 1.2 t -156.39 80.19 0.97 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.782 -1.199 . . . . 0.0 110.632 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 11.4 t 66.08 -57.88 0.35 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 3' ' ' SER . . . -44.07 -53.45 6.53 Favored Glycine 0 N--CA 1.505 3.279 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.466 ' CG ' ' HA ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -81.49 -25.76 35.73 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.514 -0.992 . . . . 0.0 110.482 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 37.6 t -56.07 -41.18 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.47 ' HA ' ' CD1' ' A' ' 11' ' ' ILE . . . -68.42 -39.58 81.54 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.0 p -71.9 -20.84 61.72 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.339 -0.851 . . . . 0.0 109.94 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.73 -49.1 11.61 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.508 -0.745 . . . . 0.0 110.573 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.47 ' CD1' ' HA ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -84.31 -16.7 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.209 -0.932 . . . . 0.0 110.488 -179.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.497 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -46.82 -53.98 22.64 Favored Pre-proline 0 N--CA 1.501 2.099 0 O-C-N 121.369 -0.832 . . . . 0.0 109.867 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 27.5 Cg_endo -63.38 -23.1 71.75 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 121.945 1.763 . . . . 0.0 110.585 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.2 m -88.58 -6.52 57.49 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 118.655 -0.688 . . . . 0.0 112.714 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.55 ' O ' ' CB ' ' A' ' 19' ' ' ARG . 1.0 OUTLIER -48.56 -47.07 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-N 118.62 0.646 . . . . 0.0 109.686 -178.096 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.462 ' O ' ' N ' ' A' ' 21' ' ' GLN . 85.2 p -52.81 -63.55 1.11 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.119 -0.988 . . . . 0.0 109.38 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.534 ' CD2' HG12 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -59.5 -59.74 4.97 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.683 -0.636 . . . . 0.0 110.295 179.674 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.82 -27.59 60.24 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.289 -0.882 . . . . 0.0 111.039 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.55 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 16.1 ttm-85 -94.02 11.31 30.19 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.306 -0.872 . . . . 0.0 110.899 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.22 30.12 63.32 Favored Glycine 0 N--CA 1.506 3.307 0 O-C-N 120.784 -1.198 . . . . 0.0 111.33 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 16' ' ' SER . 69.4 mt-30 -140.79 48.49 1.71 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.335 -1.097 . . . . 0.0 109.461 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -165.28 -52.23 0.02 OUTLIER Glycine 0 N--CA 1.502 3.072 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.3 p 70.87 -47.6 0.65 Allowed 'General case' 0 N--CA 1.51 2.564 0 O-C-N 121.81 -0.818 . . . . 0.0 111.501 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.59 132.11 10.82 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.15 148.83 91.24 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 C-N-CA 122.366 2.044 . . . . 0.0 110.766 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.1 p -104.19 156.14 18.14 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.285 -0.884 . . . . 0.0 109.749 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.34 -47.44 85.86 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.49 -0.756 . . . . 0.0 109.133 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.01 -36.43 93.45 Favored Glycine 0 N--CA 1.501 2.977 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.444 ' O ' HG22 ' A' ' 33' ' ' VAL . 3.9 t -62.38 -59.11 5.45 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 91.5 m -63.65 -36.43 83.81 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 120.184 -0.606 . . . . 0.0 112.15 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.4 m -66.81 -48.18 69.74 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 123.726 0.641 . . . . 0.0 109.753 176.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.36 -53.74 37.18 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.507 HG11 HG22 ' A' ' 77' ' ' VAL . 11.6 t -62.23 -48.33 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.609 -0.936 . . . . 0.0 110.361 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -23.89 63.48 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.988 -1.07 . . . . 0.0 109.66 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.427 ' HA ' ' OD1' ' A' ' 38' ' ' ASN . 21.4 p -73.63 -34.54 65.06 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.301 -0.874 . . . . 0.0 108.818 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.498 HD22 ' HA ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER -67.2 -31.8 72.43 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.495 -0.753 . . . . 0.0 109.861 179.073 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.463 ' HB2' HG12 ' A' ' 77' ' ' VAL . 2.4 t-20 -64.6 -50.23 67.99 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.395 -0.816 . . . . 0.0 110.575 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.427 ' OD1' ' HA ' ' A' ' 35' ' ' SER . 3.8 p-10 -68.76 -27.07 65.58 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.211 -0.93 . . . . 0.0 109.964 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.11 -46.11 12.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.667 -0.646 . . . . 0.0 110.004 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.585 ' HB3' ' CG1' ' A' ' 2' ' ' ILE . . . -88.97 95.99 10.54 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.199 -0.938 . . . . 0.0 109.679 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.539 ' HG2' ' NH1' ' A' ' 46' ' ' ARG . 42.1 mtm180 -152.3 23.74 0.63 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.398 -0.814 . . . . 0.0 110.595 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -128.26 33.95 4.64 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.024 -1.048 . . . . 0.0 110.462 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 47' ' ' ARG . 53.2 m 67.73 -61.78 0.36 Allowed 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.443 -0.786 . . . . 0.0 109.601 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 42' ' ' THR . . . -55.93 -57.8 10.58 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.632 -0.667 . . . . 0.0 109.713 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -71.1 -35.06 71.67 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.582 ' HG3' ' CE2' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -67.38 -58.9 3.94 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 122.001 -0.437 . . . . 0.0 110.271 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 43' ' ' THR . 80.2 mtt180 -60.6 -43.71 97.12 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.04 -45.71 61.4 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.292 -0.88 . . . . 0.0 108.662 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.6 -49.49 62.86 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.667 ' SG ' HG23 ' A' ' 87' ' ' THR . 0.0 OUTLIER -55.68 -39.87 71.54 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.498 -0.751 . . . . 0.0 112.359 179.266 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.605 ' N ' ' SG ' ' A' ' 89' ' ' CYS . 2.2 t30 -63.44 -56.87 12.72 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.677 177.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 53.7 t -63.93 -26.7 68.71 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.773 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.0 mt -63.42 -51.31 66.28 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 124.183 0.927 . . . . 0.0 109.285 175.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.435 ' HE3' ' HA ' ' A' ' 51' ' ' ASN . 0.4 OUTLIER -55.86 -40.75 73.35 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.19 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.402 ' N ' ' HG2' ' A' ' 54' ' ' LYS . 5.3 m120 -66.48 -46.8 75.09 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.97 -46.02 91.08 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.493 ' HA ' ' HG ' ' A' ' 63' ' ' LEU . . . -61.42 -58.52 7.85 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.27 66.9 6.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.352 -0.843 . . . . 0.0 109.153 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.6 -36.59 0.09 OUTLIER Glycine 0 N--CA 1.498 2.813 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.0 t -51.91 136.4 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.651 -0.911 . . . . 0.0 110.087 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.62 102.0 0.3 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.592 -0.692 . . . . 0.0 109.629 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.28 42.11 19.65 Favored Glycine 0 N--CA 1.5 2.934 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.493 ' HG ' ' HA ' ' A' ' 57' ' ' ALA . 3.3 tm? -64.02 122.72 17.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.463 -1.022 . . . . 0.0 110.251 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -97.57 83.94 3.32 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -36.24 -53.08 0.82 Allowed 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.89 -0.506 . . . . 0.0 111.506 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -51.71 -50.96 41.14 Favored Glycine 0 N--CA 1.504 3.201 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -67.2 -53.28 31.68 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.694 -0.886 . . . . 0.0 108.949 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.404 ' O ' ' CD ' ' A' ' 72' ' ' PRO . . . -54.03 -32.77 55.41 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 122.038 -0.414 . . . . 0.0 111.235 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.3 -48.19 8.72 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.196 -0.94 . . . . 0.0 110.299 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.462 ' HA ' ' HZ2' ' A' ' 74' ' ' LYS . 1.9 t -65.4 -27.98 68.93 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.326 -0.859 . . . . 0.0 110.967 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.534 HG12 ' CD2' ' A' ' 17' ' ' TYR . 55.8 mt -58.48 -65.17 2.09 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.253 -0.904 . . . . 0.0 110.451 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.495 ' HB3' HG13 ' A' ' 33' ' ' VAL . 9.5 Cg_endo -53.75 -52.1 9.28 Favored 'Trans proline' 0 N--CA 1.482 0.828 0 C-N-CA 122.217 1.945 . . . . 0.0 110.838 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.7 p -44.63 -70.62 0.1 Allowed 'General case' 0 N--CA 1.504 2.232 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.317 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.462 ' HZ2' ' HA ' ' A' ' 70' ' ' SER . 1.1 mppt? -64.06 -39.37 93.92 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.972 -0.455 . . . . 0.0 111.106 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 1.1 m -47.5 -35.14 8.34 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.502 -0.749 . . . . 0.0 111.505 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 135.16 46.69 0.09 OUTLIER Glycine 0 N--CA 1.496 2.658 0 O-C-N 124.655 1.222 . . . . 0.0 110.05 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.507 HG22 HG11 ' A' ' 33' ' ' VAL . 59.8 t -119.13 86.33 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.31 -1.112 . . . . 0.0 110.071 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.1 m -75.92 62.49 1.6 Allowed 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.433 ' CG1' ' HD2' ' A' ' 46' ' ' ARG . 8.9 tt -111.14 142.98 27.43 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.373 -0.83 . . . . 0.0 109.287 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.418 ' HD2' ' CG1' ' A' ' 79' ' ' ILE . 11.4 Cg_endo -53.37 -39.2 82.33 Favored 'Trans proline' 0 N--CA 1.485 0.973 0 C-N-CA 122.873 2.382 . . . . 0.0 112.942 -177.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.582 ' CE2' ' HG3' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -96.63 159.94 14.66 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.661 -1.275 . . . . 0.0 111.144 -179.572 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.437 ' C ' HD13 ' A' ' 83' ' ' ILE . 1.3 m -96.11 -170.25 2.08 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.437 HD13 ' C ' ' A' ' 82' ' ' THR . 2.0 mp -120.65 92.68 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.154 -0.967 . . . . 0.0 108.48 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.3 p -142.83 172.29 12.9 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.574 -0.704 . . . . 0.0 110.292 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.6 p -59.69 -50.14 75.01 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.698 -0.626 . . . . 0.0 109.546 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 38.8 m -84.96 48.54 1.58 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.761 -0.587 . . . . 0.0 110.559 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.667 HG23 ' SG ' ' A' ' 50' ' ' CYS . 22.2 m -74.6 117.25 16.21 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.055 -1.028 . . . . 0.0 108.569 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -83.21 136.36 34.44 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.332 -0.855 . . . . 0.0 110.968 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.605 ' SG ' ' N ' ' A' ' 51' ' ' ASN . 58.6 m -117.08 56.04 0.82 Allowed 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.286 176.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.67 -38.7 0.47 Allowed 'General case' 0 N--CA 1.497 1.925 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.227 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.32 2.76 48.4 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.317 -0.864 . . . . 0.0 111.199 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.549 HG12 ' CD2' ' A' ' 81' ' ' TYR . 17.1 t -105.82 136.17 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 120.889 -1.132 . . . . 0.0 110.007 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.5 m120 . . . . . 0 N--CA 1.494 1.772 0 O-C-N 121.289 -0.882 . . . . 0.0 108.738 179.153 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.557 ' HB ' ' NE2' ' A' ' 6' ' ' GLN . 1.2 pp . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.3 t -90.18 174.56 7.55 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.002 -1.061 . . . . 0.0 111.215 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.9 t -62.23 -25.83 68.03 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.672 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.63 -46.39 94.08 Favored Glycine 0 N--CA 1.5 2.93 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.557 ' NE2' ' HB ' ' A' ' 2' ' ' ILE . 1.2 pt20 -78.03 -35.27 49.99 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.327 -1.102 . . . . 0.0 109.719 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.458 ' N ' ' HG3' ' A' ' 6' ' ' GLN . 95.9 t -59.74 -47.41 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.532 ' HA ' ' CD1' ' A' ' 11' ' ' ILE . . . -69.98 -35.05 74.12 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 72.4 m -70.59 -21.16 62.7 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.139 -0.976 . . . . 0.0 109.92 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.55 -41.94 12.39 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.384 -0.822 . . . . 0.0 111.128 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.532 ' CD1' ' HA ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -83.28 -17.81 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 120.813 -1.179 . . . . 0.0 110.307 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.514 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -48.05 -52.97 36.66 Favored Pre-proline 0 N--CA 1.502 2.13 0 O-C-N 121.249 -0.907 . . . . 0.0 109.596 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 17.8 Cg_endo -61.68 -25.03 78.49 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 121.899 1.732 . . . . 0.0 110.011 178.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.6 m -88.39 -1.67 58.17 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.501 ' O ' ' CB ' ' A' ' 19' ' ' ARG . 0.5 OUTLIER -55.39 -50.79 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.505 ' O ' ' N ' ' A' ' 21' ' ' GLN . 5.8 m -54.1 -53.17 56.83 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.292 -0.88 . . . . 0.0 108.797 178.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.476 ' CD1' HD13 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -59.97 -65.33 0.7 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.127 -0.983 . . . . 0.0 110.042 179.053 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.406 ' N ' HD13 ' A' ' 71' ' ' ILE . . . -55.08 -34.0 63.26 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.606 -0.684 . . . . 0.0 110.97 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.501 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 1.7 ttm-85 -80.35 5.58 14.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.718 -0.614 . . . . 0.0 111.539 -178.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.72 23.68 45.35 Favored Glycine 0 N--CA 1.504 3.226 0 O-C-N 120.618 -1.301 . . . . 0.0 111.803 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 16' ' ' SER . 6.3 mm-40 -141.22 59.76 1.51 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.18 -1.188 . . . . 0.0 109.515 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.61 -58.99 0.02 OUTLIER Glycine 0 N--CA 1.503 3.12 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.7 p 74.42 -51.34 0.68 Allowed 'General case' 0 N--CA 1.511 2.596 0 O-C-N 122.054 -0.674 . . . . 0.0 111.479 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.78 139.99 14.66 Favored Glycine 0 N--CA 1.501 2.981 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.634 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 27.3 Cg_endo -61.9 121.77 9.99 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 122.173 1.915 . . . . 0.0 110.238 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 p -75.96 152.95 36.91 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.201 -0.937 . . . . 0.0 110.313 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.01 -51.91 66.1 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.363 -0.835 . . . . 0.0 108.828 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.19 -36.63 91.21 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.434 ' HA ' ' HG2' ' A' ' 13' ' ' PRO . 7.3 t -63.98 -53.95 42.03 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.634 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 93.4 m -67.52 -39.27 85.09 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 118.635 -0.698 . . . . 0.0 111.389 -177.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.0 t -65.62 -47.9 74.08 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 124.19 0.931 . . . . 0.0 109.5 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.31 -53.09 48.5 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.541 HG11 HG23 ' A' ' 77' ' ' VAL . 12.5 t -63.36 -50.63 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.382 -1.069 . . . . 0.0 110.072 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.469 ' O ' ' CB ' ' A' ' 38' ' ' ASN . 7.1 ttp180 -56.24 -35.63 67.6 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 m -73.92 -43.69 57.5 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.465 HD22 ' HA ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -64.4 -44.89 89.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.752 -0.593 . . . . 0.0 109.663 179.628 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.497 ' HB3' HG11 ' A' ' 77' ' ' VAL . 7.3 m-80 -80.8 -28.9 36.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -0.904 . . . . 0.0 110.509 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 8.7 t30 -63.6 -35.19 79.69 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.7 -38.23 29.26 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.532 ' N ' HG23 ' A' ' 2' ' ' ILE . . . -83.17 93.5 7.66 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.503 -0.748 . . . . 0.0 110.651 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.452 ' HA ' ' HD3' ' A' ' 46' ' ' ARG . 43.3 mtt180 -143.0 9.18 1.7 Allowed 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.95 -1.094 . . . . 0.0 110.584 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 58.0 m -87.53 -65.74 0.98 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.223 -0.923 . . . . 0.0 110.337 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 m 160.15 -56.98 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.86 -47.64 70.79 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.544 ' HB3' ' CG1' ' A' ' 2' ' ' ILE . 18.2 m-20 -68.58 -49.92 55.69 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.452 ' HD3' ' HA ' ' A' ' 41' ' ' ARG . 22.2 mtm180 -62.47 -46.27 89.27 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.526 -0.734 . . . . 0.0 110.46 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -59.06 -46.29 88.63 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.378 -0.826 . . . . 0.0 108.879 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.56 -39.68 91.95 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.507 ' HB1' HD13 ' A' ' 2' ' ' ILE . . . -57.24 -51.13 70.6 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.46 ' SG ' ' N ' ' A' ' 89' ' ' CYS . 19.1 t -58.05 -38.11 75.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.809 -0.557 . . . . 0.0 110.866 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -63.7 -63.21 1.23 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 123.711 0.632 . . . . 0.0 109.305 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 8.6 t -53.7 -33.92 57.09 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.336 -0.852 . . . . 0.0 112.036 176.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.476 HD23 HG21 ' A' ' 83' ' ' ILE . 25.1 mt -61.81 -44.83 96.07 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 114.961 -1.018 . . . . 0.0 108.821 176.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.516 ' HD2' ' SG ' ' A' ' 89' ' ' CYS . 3.3 tttp -56.77 -42.96 80.32 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.639 -0.663 . . . . 0.0 109.269 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -55.89 -44.94 78.65 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.764 -0.585 . . . . 0.0 109.73 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.476 ' O ' HG22 ' A' ' 60' ' ' VAL . . . -76.63 -53.98 7.29 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.567 -0.708 . . . . 0.0 109.565 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.446 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -52.36 -55.31 22.46 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.536 -0.728 . . . . 0.0 109.679 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -87.95 62.18 6.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.288 -0.883 . . . . 0.0 108.74 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.98 -34.14 0.07 OUTLIER Glycine 0 N--CA 1.498 2.787 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 56' ' ' ALA . 24.3 t -47.54 133.78 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.672 -0.899 . . . . 0.0 109.86 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.41 97.93 0.1 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.706 -0.621 . . . . 0.0 110.191 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.59 73.37 0.61 Allowed Glycine 0 N--CA 1.5 2.928 0 N-CA-C 110.014 -1.235 . . . . 0.0 110.014 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 1.7 pt? -102.5 159.28 15.57 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.346 -1.091 . . . . 0.0 110.713 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -116.26 114.71 24.76 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -49.57 -53.3 24.49 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.753 -0.592 . . . . 0.0 110.423 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.76 -45.35 85.85 Favored Glycine 0 N--CA 1.5 2.904 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -62.37 -55.33 28.95 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.728 -0.866 . . . . 0.0 109.474 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.452 ' O ' ' CD ' ' A' ' 72' ' ' PRO . . . -58.36 -33.04 69.12 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.921 -0.487 . . . . 0.0 110.76 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.61 -51.15 8.52 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.217 -0.927 . . . . 0.0 110.215 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.3 t -60.62 -31.13 70.33 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.543 -0.723 . . . . 0.0 110.738 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.482 ' HB ' ' CD ' ' A' ' 72' ' ' PRO . 51.6 mt -56.94 -69.63 0.43 Allowed Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.518 -0.739 . . . . 0.0 111.072 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.482 ' CD ' ' HB ' ' A' ' 71' ' ' ILE . 17.7 Cg_endo -56.06 -52.56 7.03 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 122.485 2.123 . . . . 0.0 111.762 -178.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.4 t -49.36 -69.5 0.11 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.78 -0.575 . . . . 0.0 110.521 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -63.56 -35.83 81.8 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 122.107 -0.37 . . . . 0.0 111.166 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -48.66 -35.98 14.98 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.398 -0.814 . . . . 0.0 111.419 -178.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 133.92 50.14 0.08 OUTLIER Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.541 HG23 HG11 ' A' ' 33' ' ' VAL . 2.4 t -119.52 110.99 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.423 -1.045 . . . . 0.0 109.951 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 83.8 p -81.32 68.24 7.56 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.296 -0.878 . . . . 0.0 108.918 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.499 HG12 ' CE2' ' A' ' 81' ' ' TYR . 0.7 OUTLIER -133.92 134.26 23.0 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.589 -0.694 . . . . 0.0 109.739 -178.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.413 ' HD2' HG13 ' A' ' 79' ' ' ILE . 47.3 Cg_endo -67.11 -35.37 25.43 Favored 'Trans proline' 0 N--CA 1.486 1.048 0 C-N-CA 122.958 2.439 . . . . 0.0 113.278 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.499 ' CE2' HG12 ' A' ' 79' ' ' ILE . 54.8 p90 -80.54 132.26 35.64 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.698 -1.251 . . . . 0.0 110.755 -178.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.55 154.51 20.28 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.468 0.651 . . . . 0.0 110.38 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.476 HG21 HD23 ' A' ' 53' ' ' LEU . 1.9 mp -98.33 83.16 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 121.41 0.624 . . . . 0.0 109.739 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 99.8 p -128.99 171.26 12.52 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.116 -0.99 . . . . 0.0 110.07 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.446 ' HA ' ' HB3' ' A' ' 57' ' ' ALA . 1.7 m -58.37 101.14 0.07 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.335 -0.853 . . . . 0.0 109.375 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.406 ' HA ' ' CG ' ' A' ' 54' ' ' LYS . 34.2 t 60.36 60.53 2.0 Allowed 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 121.493 0.663 . . . . 0.0 109.513 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 56.0 m -63.8 -69.23 0.29 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.434 -0.791 . . . . 0.0 110.684 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -150.87 -72.46 0.16 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.061 -1.024 . . . . 0.0 110.149 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.516 ' SG ' ' HD2' ' A' ' 54' ' ' LYS . 38.5 m 58.82 55.01 4.83 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-O 121.621 0.724 . . . . 0.0 111.626 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 97.6 p -162.75 -42.35 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 114.427 -1.261 . . . . 0.0 109.705 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -100.17 12.43 37.02 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.458 -0.777 . . . . 0.0 109.719 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.473 HG21 ' HB3' ' A' ' 81' ' ' TYR . 85.7 t -79.54 117.14 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.268 -0.895 . . . . 0.0 109.659 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.936 0 CA-C-O 117.267 -1.349 . . . . 0.0 109.542 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.599 HD13 ' HB1' ' A' ' 49' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.3 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.2 t -119.05 -173.3 2.47 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.527 -1.358 . . . . 0.0 110.632 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.493 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 1.9 t -52.2 -28.16 17.34 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 177.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -57.23 -51.75 55.67 Favored Glycine 0 N--CA 1.501 2.987 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.479 ' HG3' ' N ' ' A' ' 7' ' ' VAL . 3.1 pt20 -89.33 -34.16 16.65 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.387 -1.067 . . . . 0.0 109.666 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.493 ' HB ' ' HA ' ' A' ' 4' ' ' CYS . 40.7 t -56.16 -37.74 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.32 -37.7 68.86 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.7 p -77.15 -22.11 53.04 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.011 -1.056 . . . . 0.0 110.02 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.63 -48.86 23.98 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.473 -0.767 . . . . 0.0 110.29 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -83.98 -16.02 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 O-C-N 121.13 -0.981 . . . . 0.0 110.812 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.498 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -45.61 -54.78 14.27 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.455 -0.778 . . . . 0.0 109.759 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.631 ' HG2' ' SG ' ' A' ' 29' ' ' CYS . 19.2 Cg_endo -62.0 -24.76 77.09 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.186 1.924 . . . . 0.0 110.565 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.614 ' SG ' HG22 ' A' ' 71' ' ' ILE . 72.1 m -86.61 -16.81 35.57 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 178.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.429 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -47.58 -24.53 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.904 -0.497 . . . . 0.0 111.255 -177.462 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.423 ' HA ' ' NH2' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -91.21 -61.93 1.55 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.017 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.454 ' CD2' HG12 ' A' ' 71' ' ' ILE . 1.1 t80 -55.19 -57.42 11.87 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 14' ' ' CYS . . . -52.36 -32.38 38.15 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-O 121.42 0.629 . . . . 0.0 110.144 178.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.469 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 9.3 tmm_? -90.01 7.9 35.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.798 -0.564 . . . . 0.0 110.86 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.18 9.31 59.45 Favored Glycine 0 N--CA 1.502 3.075 0 O-C-N 120.713 -1.242 . . . . 0.0 111.976 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 16' ' ' SER . 5.5 tp60 -114.75 81.91 1.64 Allowed 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 118.768 1.284 . . . . 0.0 109.699 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 157.48 -148.95 19.26 Favored Glycine 0 N--CA 1.5 2.905 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.3 t -175.24 -45.71 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.596 -0.943 . . . . 0.0 109.918 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -97.84 141.75 15.76 Favored Glycine 0 N--CA 1.499 2.886 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.551 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 27.9 Cg_endo -62.31 121.91 10.11 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 122.362 2.041 . . . . 0.0 111.051 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.5 t -60.77 134.62 57.27 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.548 -0.72 . . . . 0.0 110.045 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.91 -52.9 37.53 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.65 -0.656 . . . . 0.0 110.109 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -52.76 -45.93 60.27 Favored Glycine 0 N--CA 1.502 3.06 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.631 ' SG ' ' HG2' ' A' ' 13' ' ' PRO . 1.1 m -60.02 -43.84 95.02 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.016 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.551 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 3.6 m -63.56 -57.33 10.47 Favored 'General case' 0 C--O 1.201 -1.473 0 CA-C-O 117.556 -1.211 . . . . 0.0 109.574 -176.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.3 t -65.79 -39.78 91.28 Favored 'General case' 0 N--CA 1.505 2.296 0 CA-C-N 118.804 0.729 . . . . 0.0 110.683 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -57.98 -44.78 94.38 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.565 ' CG1' HG22 ' A' ' 77' ' ' VAL . 5.3 t -84.06 -46.41 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.425 -1.044 . . . . 0.0 110.169 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -54.62 -35.06 63.02 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.491 -0.756 . . . . 0.0 109.14 179.676 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 90.9 p -78.49 -44.42 24.56 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.306 -0.871 . . . . 0.0 110.027 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.437 ' C ' HD13 ' A' ' 36' ' ' LEU . 0.4 OUTLIER -52.67 -35.82 55.91 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.513 -0.742 . . . . 0.0 109.665 179.786 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.455 ' HB2' HG12 ' A' ' 77' ' ' VAL . 4.3 t-20 -62.39 -26.21 68.35 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.259 -0.9 . . . . 0.0 109.917 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -91.65 -40.56 11.23 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.317 -0.864 . . . . 0.0 108.98 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.06 -36.44 69.58 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.572 ' HB1' HG12 ' A' ' 2' ' ' ILE . . . -91.51 -131.21 0.11 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.873 -0.517 . . . . 0.0 109.926 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.1 mtt-85 56.95 38.92 29.67 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.294 -0.879 . . . . 0.0 110.064 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.409 ' O ' ' HB ' ' A' ' 43' ' ' THR . 9.0 t -136.1 19.02 3.2 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.822 -0.549 . . . . 0.0 109.867 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.702 ' HA ' ' C ' ' A' ' 93' ' ' ASN . 99.5 m 78.17 -60.73 0.4 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.755 -0.591 . . . . 0.0 110.327 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.51 -55.67 32.06 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.445 -0.785 . . . . 0.0 110.613 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.41 ' HB3' HG13 ' A' ' 2' ' ' ILE . 54.5 m-20 -67.44 -37.14 82.54 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.575 -0.703 . . . . 0.0 110.889 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.497 ' HD2' HD12 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -67.5 -57.08 7.14 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.879 -1.138 . . . . 0.0 110.778 -179.145 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -55.31 -44.17 75.56 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.226 -0.921 . . . . 0.0 109.419 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.46 -45.76 80.72 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.599 ' HB1' HD13 ' A' ' 2' ' ' ILE 0.27 . . -61.59 -52.87 62.61 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.4 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.471 ' C ' ' SG ' ' A' ' 89' ' ' CYS . 44.7 t -54.84 -34.26 62.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.996 -1.065 . . . . 0.0 111.809 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -68.92 -59.5 3.02 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 123.676 0.61 . . . . 0.0 109.988 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.5 t -61.73 -33.36 73.91 Favored 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.526 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.448 HD21 HG13 ' A' ' 83' ' ' ILE . 17.8 mt -67.65 -51.39 50.45 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.636 176.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -59.04 -38.92 80.48 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -61.13 -53.43 57.1 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 122.077 -0.39 . . . . 0.0 110.381 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.29 -44.42 52.77 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.286 -0.884 . . . . 0.0 110.357 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.57 -44.31 76.75 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.526 -0.734 . . . . 0.0 110.112 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.54 68.66 2.88 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.321 -0.862 . . . . 0.0 109.379 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 149.13 -12.21 1.06 Allowed Glycine 0 N--CA 1.5 2.933 0 C-N-CA 120.117 -1.039 . . . . 0.0 111.719 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.3 t -40.09 -60.33 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.566 0 CA-C-N 118.962 1.381 . . . . 0.0 110.776 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.0 m 160.45 77.9 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.512 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.54 -65.21 3.45 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 107.456 -2.257 . . . . 0.0 107.456 -177.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 8.4 tt 68.99 138.13 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 121.821 0.82 . . . . 0.0 111.413 177.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.401 ' O ' ' N ' ' A' ' 67' ' ' ASN . 17.3 m120 -121.38 92.26 3.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.427 -0.796 . . . . 0.0 109.192 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.46 -41.4 4.3 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.764 -0.585 . . . . 0.0 110.07 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -53.11 -32.18 42.38 Favored Glycine 0 N--CA 1.502 3.076 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 64' ' ' ASN . 83.1 m-20 -97.49 -53.49 3.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.788 -0.831 . . . . 0.0 108.95 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -54.69 -32.42 59.37 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.871 -0.518 . . . . 0.0 111.221 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.422 ' CB ' ' HB ' ' A' ' 82' ' ' THR . . . -86.7 -44.01 12.14 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.232 -0.917 . . . . 0.0 109.534 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 65.5 m -64.05 -39.36 93.91 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.677 -0.639 . . . . 0.0 111.139 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.614 HG22 ' SG ' ' A' ' 14' ' ' CYS . 68.5 mt -51.18 -64.35 1.43 Allowed Pre-proline 0 N--CA 1.499 2.008 0 O-C-N 121.628 -0.67 . . . . 0.0 111.479 -178.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.47 ' CB ' HG13 ' A' ' 33' ' ' VAL . 36.8 Cg_endo -59.56 -50.14 8.82 Favored 'Trans proline' 0 N--CA 1.48 0.678 0 C-N-CA 121.85 1.7 . . . . 0.0 110.549 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.7 t -55.82 -60.74 3.03 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.843 -0.536 . . . . 0.0 110.186 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -63.04 -40.01 96.44 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 122.04 -0.413 . . . . 0.0 110.317 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 1.2 m -49.86 -37.59 31.64 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.377 -0.827 . . . . 0.0 111.176 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 136.21 55.99 0.06 OUTLIER Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 176.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.565 HG22 ' CG1' ' A' ' 33' ' ' VAL . 37.4 t -132.07 114.36 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.515 -0.991 . . . . 0.0 110.139 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.2 m -82.57 56.53 3.36 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.467 -0.77 . . . . 0.0 109.215 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.497 HD12 ' HD2' ' A' ' 46' ' ' ARG . 2.1 tt -117.49 125.51 28.06 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.433 -0.792 . . . . 0.0 109.581 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -64.46 -37.13 40.33 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 122.786 2.324 . . . . 0.0 111.79 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.488 ' C ' ' CD1' ' A' ' 81' ' ' TYR . 0.8 OUTLIER -77.83 138.83 39.17 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.995 -1.066 . . . . 0.0 109.76 -179.396 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.422 ' HB ' ' CB ' ' A' ' 69' ' ' ALA . 30.0 p -107.79 168.21 9.42 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.499 -0.751 . . . . 0.0 110.327 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.454 ' N ' ' CD1' ' A' ' 83' ' ' ILE . 1.2 mp -84.6 58.31 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.9 m -136.49 40.4 2.61 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.541 -0.725 . . . . 0.0 109.149 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 87' ' ' THR . 66.9 p 39.72 -115.69 0.2 Allowed 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -178.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.1 m 62.75 -60.87 0.13 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.389 -0.819 . . . . 0.0 111.416 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 85' ' ' THR . 3.7 t -75.76 158.61 32.01 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.247 -0.908 . . . . 0.0 111.181 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -104.52 6.72 34.93 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.476 -0.765 . . . . 0.0 110.418 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.471 ' SG ' ' C ' ' A' ' 50' ' ' CYS . 3.9 m 52.42 49.27 20.82 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.933 -0.479 . . . . 0.0 111.611 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.7 t -111.05 -37.85 5.24 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.981 -178.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -138.71 36.68 2.2 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.486 -0.759 . . . . 0.0 109.507 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.4 p -98.78 11.86 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 O-C-N 121.323 -0.861 . . . . 0.0 110.464 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.702 ' C ' ' HA ' ' A' ' 43' ' ' THR . 27.6 m-20 . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 117.186 -1.388 . . . . 0.0 108.78 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.522 HG23 ' HB3' ' A' ' 45' ' ' ASP . 10.6 tp . . . . . 0 N--CA 1.506 2.351 0 CA-C-O 122.092 0.948 . . . . 0.0 111.655 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.6 t -144.59 59.74 1.33 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.72 -1.237 . . . . 0.0 110.521 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.3 t 67.3 -52.5 0.48 Allowed 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -47.32 -48.91 20.69 Favored Glycine 0 N--CA 1.506 3.321 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 177.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.411 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -82.46 -31.05 29.63 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.422 -1.046 . . . . 0.0 110.479 179.531 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.401 ' N ' ' CD ' ' A' ' 6' ' ' GLN . 1.7 t -60.72 -46.15 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.446 ' HA ' HG13 ' A' ' 11' ' ' ILE . . . -72.64 -26.33 61.62 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.9 m -68.57 -20.37 64.52 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.323 -0.861 . . . . 0.0 110.34 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -98.24 -36.42 10.03 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.248 -0.908 . . . . 0.0 110.477 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.446 HG13 ' HA ' ' A' ' 8' ' ' ALA . 2.6 pp -80.0 -31.7 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.378 -0.826 . . . . 0.0 110.541 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.51 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -46.76 -50.89 41.3 Favored Pre-proline 0 N--CA 1.501 2.107 0 O-C-N 121.45 -0.782 . . . . 0.0 109.897 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 19.3 Cg_endo -63.08 -13.02 32.76 Favored 'Trans proline' 0 CA--C 1.548 1.178 0 C-N-CA 122.23 1.953 . . . . 0.0 111.412 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.2 m -125.45 24.06 7.37 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 175.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 16' ' ' SER . 0.3 OUTLIER -60.06 -50.16 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 118.684 0.674 . . . . 0.0 111.019 177.18 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 21' ' ' GLN . 1.5 m -67.58 -45.73 74.69 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.251 -0.906 . . . . 0.0 109.726 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.521 ' CE2' HG12 ' A' ' 71' ' ' ILE . 1.2 t80 -58.69 -48.5 80.9 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.38 -28.98 66.66 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.592 -0.692 . . . . 0.0 109.375 178.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.433 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 9.9 ttm180 -75.34 -18.24 60.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.653 -0.654 . . . . 0.0 109.864 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.46 20.83 11.34 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.42 ' O ' ' HB3' ' A' ' 16' ' ' SER . 26.7 tt0 -123.06 82.34 1.98 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 158.88 -153.75 24.86 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.4 t 170.17 60.45 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.795 -0.827 . . . . 0.0 109.233 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 160.06 123.12 0.68 Allowed Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.547 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 32.0 Cg_endo -63.1 124.8 14.57 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 122.571 2.18 . . . . 0.0 110.918 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.2 p -77.36 154.43 32.79 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.484 -0.76 . . . . 0.0 109.612 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.31 -57.76 10.88 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.461 -0.775 . . . . 0.0 110.245 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -53.94 -37.96 59.2 Favored Glycine 0 N--CA 1.501 3.011 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.487 ' HA ' ' HG2' ' A' ' 13' ' ' PRO . 6.4 t -66.63 -73.24 0.14 Allowed 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.749 177.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.547 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 0.5 OUTLIER -44.81 -41.52 7.06 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.238 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.8 t -73.15 -52.03 15.68 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.414 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.21 -41.24 96.62 Favored Glycine 0 N--CA 1.5 2.913 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.527 ' HA ' HD21 ' A' ' 36' ' ' LEU . 57.7 t -72.54 -50.23 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.339 -1.094 . . . . 0.0 109.85 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -62.1 -23.04 66.29 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.5 -0.75 . . . . 0.0 110.351 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 57.6 p -88.4 -42.3 12.26 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.314 -0.866 . . . . 0.0 109.373 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.527 HD21 ' HA ' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -52.24 -32.89 39.04 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.322 -0.861 . . . . 0.0 109.344 178.794 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -74.78 -8.56 56.81 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.932 -0.48 . . . . 0.0 111.168 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -105.44 -26.95 11.72 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.501 -1.375 . . . . 0.0 110.855 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.41 -13.86 61.98 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.287 -0.883 . . . . 0.0 110.219 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.635 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . . . -163.1 139.54 7.23 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.51 -0.743 . . . . 0.0 110.297 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.448 ' HA ' ' HD3' ' A' ' 46' ' ' ARG . 4.4 mtm180 -172.62 51.32 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.228 -0.92 . . . . 0.0 110.613 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.596 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.9 OUTLIER -133.6 57.99 1.79 Allowed 'General case' 0 N--CA 1.508 2.466 0 O-C-N 120.987 -1.07 . . . . 0.0 109.979 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.545 ' CB ' ' HA ' ' A' ' 93' ' ' ASN . 12.6 t 54.66 -53.8 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.105 0 C-N-CA 123.988 0.915 . . . . 0.0 111.775 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.596 ' N ' ' O ' ' A' ' 42' ' ' THR . . . -61.37 -51.86 67.03 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.635 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 6.3 m-20 -66.87 -42.86 84.91 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.486 ' HD2' HG13 ' A' ' 79' ' ' ILE . 1.0 OUTLIER -62.01 -48.35 80.7 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.411 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.553 ' HA ' ' SG ' ' A' ' 50' ' ' CYS . 72.0 mtt180 -67.43 -37.13 82.53 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.247 -0.908 . . . . 0.0 109.213 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.47 -50.21 74.54 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 177.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.74 -42.65 97.77 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.553 ' SG ' ' HA ' ' A' ' 47' ' ' ARG . 4.3 p -66.23 -33.15 75.1 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.591 -0.693 . . . . 0.0 110.509 -177.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.5 ' N ' ' SG ' ' A' ' 50' ' ' CYS . 1.7 t30 -62.93 -54.15 43.0 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 124.06 0.85 . . . . 0.0 109.334 176.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 18.6 t -68.41 -38.79 81.59 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 119.166 -1.014 . . . . 0.0 111.314 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.4 mt -56.03 -41.97 75.81 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 124.377 1.048 . . . . 0.0 108.619 176.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.417 ' HG2' ' HB ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -58.61 -50.22 74.61 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.109 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -59.34 -41.51 89.34 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.78 -55.86 8.72 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.477 -0.764 . . . . 0.0 109.403 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.59 -47.67 73.05 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.586 -0.696 . . . . 0.0 110.297 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.11 7.34 7.64 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.319 -0.863 . . . . 0.0 110.726 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -132.99 7.52 5.14 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 t -79.73 133.92 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.128 -1.219 . . . . 0.0 109.382 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.8 p -65.57 94.21 0.18 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.514 -0.741 . . . . 0.0 109.284 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 112.93 -78.52 0.25 Allowed Glycine 0 N--CA 1.497 2.715 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 16.7 tp 69.12 134.43 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 122.2 1.0 . . . . 0.0 111.316 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.417 ' HB3' ' HB2' ' A' ' 67' ' ' ASN . 6.8 t-20 -135.84 106.09 6.37 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.0 -57.82 8.35 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.623 -0.673 . . . . 0.0 111.463 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.45 -47.69 68.22 Favored Glycine 0 N--CA 1.504 3.18 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.417 ' HB2' ' HB3' ' A' ' 64' ' ' ASN . 1.8 m-20 -69.84 -58.94 3.28 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.625 -0.926 . . . . 0.0 110.25 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.449 ' O ' ' CD ' ' A' ' 72' ' ' PRO . . . -57.35 -32.4 66.72 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.474 -0.766 . . . . 0.0 112.273 -178.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.46 -52.57 7.88 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.879 -1.138 . . . . 0.0 110.189 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 90.6 p -68.3 -34.25 75.81 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.653 -0.654 . . . . 0.0 111.122 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.521 HG12 ' CE2' ' A' ' 17' ' ' TYR . 28.1 mt -47.83 -65.33 0.77 Allowed Pre-proline 0 N--CA 1.503 2.215 0 O-C-N 121.516 -0.74 . . . . 0.0 110.357 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.487 ' HB3' HG12 ' A' ' 33' ' ' VAL . 28.3 Cg_endo -61.65 -50.23 5.8 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 122.218 1.945 . . . . 0.0 110.557 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 40.6 t -51.52 -60.84 2.7 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.828 -0.545 . . . . 0.0 110.151 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.437 ' NZ ' ' O ' ' A' ' 74' ' ' LYS . 3.2 tptp -64.36 -41.28 96.81 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.721 -0.612 . . . . 0.0 110.1 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -48.16 -50.44 28.9 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 120.019 -0.673 . . . . 0.0 111.707 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.61 46.99 0.01 OUTLIER Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 176.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.491 HG23 HG13 ' A' ' 33' ' ' VAL . 53.5 t -129.23 125.65 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.643 -0.916 . . . . 0.0 110.106 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.5 t -112.45 81.0 1.4 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.486 HG13 ' HD2' ' A' ' 46' ' ' ARG . 11.1 tt -121.3 137.38 26.76 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.652 -0.655 . . . . 0.0 109.27 -178.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.409 ' HD2' HG13 ' A' ' 79' ' ' ILE . 50.9 Cg_exo -52.75 -41.74 67.66 Favored 'Trans proline' 0 N--CA 1.483 0.889 0 C-N-CA 122.785 2.324 . . . . 0.0 113.114 -178.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.417 ' HB3' HG22 ' A' ' 92' ' ' VAL . 5.9 p90 -93.6 147.91 22.57 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 120.626 -1.296 . . . . 0.0 110.824 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -84.1 152.91 24.05 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.598 -0.688 . . . . 0.0 109.503 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.0 mp -85.38 93.74 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.487 -0.758 . . . . 0.0 109.951 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.9 p -170.89 -175.65 1.82 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.417 -0.802 . . . . 0.0 109.827 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.417 HG21 ' CD2' ' A' ' 63' ' ' LEU . 0.6 OUTLIER -62.88 -28.91 70.36 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.807 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 32.9 m -83.93 45.76 1.12 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.527 -0.733 . . . . 0.0 109.819 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.417 ' HB ' ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -77.01 139.0 39.94 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.341 -0.849 . . . . 0.0 109.977 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -95.4 134.63 37.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.449 -0.782 . . . . 0.0 109.872 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 94.5 m -143.47 53.57 1.33 Allowed 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.675 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 89.7 p -159.15 -48.48 0.06 Allowed 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.732 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -113.41 21.16 15.46 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.417 HG22 ' HB3' ' A' ' 81' ' ' TYR . 3.3 p -101.9 129.99 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-O 121.638 0.733 . . . . 0.0 109.794 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.545 ' HA ' ' CB ' ' A' ' 43' ' ' THR . 72.4 m-20 . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 116.506 -1.711 . . . . 0.0 108.969 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.545 HG22 ' HB3' ' A' ' 45' ' ' ASP . 3.5 tp . . . . . 0 N--CA 1.5 2.032 0 CA-C-O 121.757 0.789 . . . . 0.0 109.82 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.1 t -115.81 169.54 9.14 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.244 -0.91 . . . . 0.0 109.994 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 26.5 t -62.33 -33.64 75.09 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.665 -0.814 . . . . 0.0 112.65 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -50.56 -51.09 33.92 Favored Glycine 0 N--CA 1.502 3.062 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.24 -36.05 54.94 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.279 -1.13 . . . . 0.0 110.308 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.421 HG22 ' HA ' ' A' ' 49' ' ' ALA . 83.2 t -56.52 -46.66 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.74 -35.59 72.74 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.6 t -69.0 -21.86 64.12 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.272 -0.893 . . . . 0.0 109.825 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.28 -27.93 21.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.509 -0.744 . . . . 0.0 109.018 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.415 HD13 HG22 ' A' ' 83' ' ' ILE . 1.2 tp -79.5 -40.63 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.356 -0.84 . . . . 0.0 110.023 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.492 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -44.26 -51.46 19.23 Favored Pre-proline 0 N--CA 1.504 2.225 0 O-C-N 121.646 -0.659 . . . . 0.0 110.977 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 32.9 Cg_endo -65.79 -28.17 51.47 Favored 'Trans proline' 0 N--CA 1.483 0.911 0 C-N-CA 122.281 1.987 . . . . 0.0 110.592 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.685 ' SG ' HG22 ' A' ' 71' ' ' ILE . 1.3 m -101.28 16.79 24.39 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 177.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.523 HD11 HG11 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -65.79 -51.1 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.507 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.1 p -59.76 -57.79 11.38 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.324 -0.86 . . . . 0.0 109.302 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.641 ' CD1' HD13 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -55.3 -54.45 43.38 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' A' ' 64' ' ' ASN . . . -65.11 -25.37 67.74 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.416 -0.802 . . . . 0.0 110.003 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.474 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 10.5 ttp180 -79.02 -26.03 43.23 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.319 -0.863 . . . . 0.0 110.006 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 148.32 -12.95 1.23 Allowed Glycine 0 N--CA 1.5 2.916 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.9 mp0 -82.53 64.38 7.15 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.923 -1.34 . . . . 0.0 108.875 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.518 ' HA2' ' CD1' ' A' ' 17' ' ' TYR . . . -76.34 75.69 1.56 Allowed Glycine 0 N--CA 1.5 2.904 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.62 36.05 0.06 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.717 -0.873 . . . . 0.0 110.05 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 178.11 78.78 0.06 OUTLIER Glycine 0 N--CA 1.499 2.836 0 C-N-CA 120.075 -1.059 . . . . 0.0 110.51 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -59.91 131.88 41.94 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 122.17 1.913 . . . . 0.0 109.928 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.1 t -90.06 120.17 31.03 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.268 -0.895 . . . . 0.0 110.602 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.87 -45.2 74.56 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.38 -46.0 87.93 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.5 t -54.07 -42.28 69.11 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.301 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 80.4 m -61.76 -47.6 84.47 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.926 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.1 t -65.19 -40.55 94.38 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 124.259 0.974 . . . . 0.0 110.906 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.25 -57.07 12.43 Favored Glycine 0 N--CA 1.5 2.908 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.567 HG13 ' CB ' ' A' ' 72' ' ' PRO . 16.4 t -62.94 -46.54 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.488 -1.007 . . . . 0.0 109.442 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.564 ' N ' HG23 ' A' ' 77' ' ' VAL . 0.5 OUTLIER -54.54 -31.08 55.76 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.694 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.7 m -78.86 -44.09 23.62 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -56.86 -43.7 81.45 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.632 -0.668 . . . . 0.0 109.995 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.545 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 51.3 t30 -74.72 -35.48 62.69 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.167 -0.958 . . . . 0.0 109.912 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -63.83 -37.72 88.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.039 -1.038 . . . . 0.0 108.395 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.29 -43.53 13.65 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.786 -0.571 . . . . 0.0 110.617 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.471 ' CB ' HG12 ' A' ' 2' ' ' ILE . . . -103.9 111.44 23.97 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.06 -1.025 . . . . 0.0 111.441 -178.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.545 ' HG3' ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -157.84 26.48 0.27 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.781 -0.575 . . . . 0.0 110.0 179.044 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.64 34.7 4.62 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.127 -0.983 . . . . 0.0 109.624 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.427 ' OG1' ' HA ' ' A' ' 93' ' ' ASN . 27.9 m 70.09 -66.08 0.29 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.562 -0.711 . . . . 0.0 109.924 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.91 -57.06 10.5 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.707 -0.62 . . . . 0.0 110.677 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.545 ' HB3' HG22 ' A' ' 2' ' ' ILE . 6.5 m-20 -67.2 -36.89 82.67 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.463 ' NH1' HG12 ' A' ' 79' ' ' ILE . 5.6 mmm180 -67.95 -39.45 83.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.629 -0.669 . . . . 0.0 109.684 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.82 -41.89 87.9 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.428 -0.795 . . . . 0.0 108.995 178.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.42 -46.49 86.34 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.433 ' HB1' HD13 ' A' ' 2' ' ' ILE . . . -64.14 -41.58 97.14 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 50.0 t -66.31 -35.83 81.39 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.613 -0.68 . . . . 0.0 110.569 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -66.54 -55.76 14.0 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 124.152 0.908 . . . . 0.0 109.813 176.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.403 ' SG ' ' HB ' ' A' ' 7' ' ' VAL . 42.1 t -61.63 -35.7 78.66 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.862 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.486 HD21 HG21 ' A' ' 83' ' ' ILE . 12.1 mt -61.15 -53.19 60.15 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 124.336 1.022 . . . . 0.0 109.011 176.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.476 ' NZ ' ' O ' ' A' ' 85' ' ' THR . 43.8 tttp -55.82 -37.64 68.94 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.78 -29.77 69.05 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.532 -0.73 . . . . 0.0 110.817 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.448 ' O ' HG21 ' A' ' 60' ' ' VAL . . . -94.96 -49.3 5.62 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.271 -0.893 . . . . 0.0 110.378 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.435 ' HA ' HD11 ' A' ' 63' ' ' LEU . . . -53.65 -49.59 67.59 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.36 -0.838 . . . . 0.0 109.522 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.462 ' HB3' ' HG1' ' A' ' 85' ' ' THR . . . -73.46 67.05 1.02 Allowed 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 61' ' ' SER . . . 165.16 -22.87 0.14 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.523 HG11 HD11 ' A' ' 15' ' ' ILE . 24.7 t -64.52 69.85 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 121.29 -1.124 . . . . 0.0 109.942 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 59' ' ' GLY . 43.3 m 54.38 -102.68 0.15 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.222 -0.924 . . . . 0.0 110.022 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -100.0 -29.11 6.99 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.435 HD11 ' HA ' ' A' ' 57' ' ' ALA . 21.7 tp 63.54 99.98 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.807 -0.82 . . . . 0.0 111.047 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.558 ' N ' ' O ' ' A' ' 18' ' ' ALA . 12.2 m-80 -98.62 95.43 7.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.205 -0.934 . . . . 0.0 108.643 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -49.31 -50.44 39.38 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.734 -0.604 . . . . 0.0 111.042 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.07 -32.7 50.2 Favored Glycine 0 N--CA 1.505 3.261 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -82.87 -48.98 10.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.52 -0.988 . . . . 0.0 109.435 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.25 -21.42 63.91 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.687 -0.633 . . . . 0.0 111.408 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.44 -41.35 12.13 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.011 -1.056 . . . . 0.0 110.253 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 76.6 p -68.99 -45.39 70.71 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.499 -0.751 . . . . 0.0 110.954 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.685 HG22 ' SG ' ' A' ' 14' ' ' CYS . 44.0 mt -47.95 -64.55 1.03 Allowed Pre-proline 0 N--CA 1.503 2.208 0 O-C-N 121.647 -0.658 . . . . 0.0 111.589 -178.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.567 ' CB ' HG13 ' A' ' 33' ' ' VAL . 28.4 Cg_endo -59.27 -48.87 12.28 Favored 'Trans proline' 0 N--CA 1.48 0.677 0 C-N-CA 121.745 1.63 . . . . 0.0 110.566 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.1 m -49.45 -68.96 0.13 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -33.59 75.62 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -47.78 -35.43 9.99 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.794 -0.566 . . . . 0.0 110.453 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 124.74 54.4 0.18 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.011 -2.036 . . . . 0.0 108.011 177.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.564 HG23 ' N ' ' A' ' 34' ' ' ARG . 85.2 t -111.09 -48.57 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.205 -178.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.7 m 68.33 33.59 4.15 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.677 -0.639 . . . . 0.0 110.149 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.614 HG12 ' CD1' ' A' ' 81' ' ' TYR . 9.7 tt -95.78 121.35 61.44 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.059 -1.026 . . . . 0.0 109.06 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 79' ' ' ILE . 16.2 Cg_exo -65.31 56.6 0.31 Allowed 'Trans proline' 0 CA--C 1.55 1.294 0 C-N-CA 122.51 2.14 . . . . 0.0 112.711 -178.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.614 ' CD1' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -178.54 152.31 0.64 Allowed 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.332 -0.855 . . . . 0.0 110.271 177.443 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.6 p -108.64 171.37 7.46 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.65 0.738 . . . . 0.0 110.592 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.486 HG21 HD21 ' A' ' 53' ' ' LEU . 2.0 mp -104.44 67.12 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 122.012 0.911 . . . . 0.0 108.702 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.419 ' O ' ' CB ' ' A' ' 85' ' ' THR . 86.2 p -98.37 -18.39 18.33 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.494 -0.754 . . . . 0.0 110.627 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.476 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . 0.5 OUTLIER 81.04 -16.44 0.65 Allowed 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.781 -0.574 . . . . 0.0 110.995 -179.282 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.9 m -76.17 -21.88 56.02 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.017 -1.052 . . . . 0.0 109.013 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -47.74 145.8 2.61 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.621 0.724 . . . . 0.0 111.1 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -88.93 -13.23 39.5 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.995 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 54.6 m 52.87 51.25 16.29 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.465 0.65 . . . . 0.0 111.291 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.96 -42.64 0.27 Allowed 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.552 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.8 31.74 4.83 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.3 p -109.48 118.84 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.768 -0.582 . . . . 0.0 109.462 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.427 ' HA ' ' OG1' ' A' ' 43' ' ' THR . 2.9 p-10 . . . . . 0 N--CA 1.497 1.912 0 CA-C-O 114.6 -2.619 . . . . 0.0 110.17 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.47 HD12 ' HB1' ' A' ' 49' ' ' ALA . 4.2 tp . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 121.899 0.857 . . . . 0.0 109.828 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.8 t -135.17 172.61 12.76 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.314 -0.867 . . . . 0.0 110.205 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.8 t -67.86 -20.78 65.17 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -56.7 -54.48 36.12 Favored Glycine 0 N--CA 1.504 3.176 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.401 ' NE2' ' HB3' ' A' ' 36' ' ' LEU . 8.4 tt0 -67.66 -40.65 84.48 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.456 -1.026 . . . . 0.0 108.516 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 77.5 t -53.78 -44.91 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.87 -35.95 75.09 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.7 t -69.39 -22.2 63.73 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.44 -0.788 . . . . 0.0 109.241 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.51 ' C ' ' HD2' ' A' ' 13' ' ' PRO . . . -98.05 -25.43 14.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.51 -0.744 . . . . 0.0 109.236 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.8 tp -78.77 -42.31 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.218 -0.926 . . . . 0.0 110.072 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.503 ' HB2' ' HD3' ' A' ' 13' ' ' PRO . . . -46.43 -51.16 36.92 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.588 -0.695 . . . . 0.0 110.432 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.51 ' HD2' ' C ' ' A' ' 10' ' ' ALA . 11.2 Cg_exo -67.26 -28.76 39.7 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.136 1.891 . . . . 0.0 110.992 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.553 ' SG ' HG22 ' A' ' 71' ' ' ILE . 1.3 m -103.07 14.38 31.99 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 178.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.461 ' O ' ' CB ' ' A' ' 19' ' ' ARG . 0.4 OUTLIER -74.16 -44.5 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -178.474 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.1 p -65.74 -56.84 9.89 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.619 ' CG ' HD13 ' A' ' 71' ' ' ILE . 0.5 OUTLIER -54.82 -55.35 31.12 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.579 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 64' ' ' ASN . . . -60.01 -32.05 70.51 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.313 -0.867 . . . . 0.0 109.439 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.461 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 11.9 ttt180 -78.42 -5.89 53.69 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.647 -0.658 . . . . 0.0 110.623 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.56 -12.43 39.21 Favored Glycine 0 N--CA 1.501 3.025 0 O-C-N 120.666 -1.272 . . . . 0.0 111.412 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -105.06 81.38 1.72 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.136 -1.214 . . . . 0.0 109.333 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -146.44 -177.03 20.76 Favored Glycine 0 N--CA 1.499 2.838 0 C-N-CA 119.686 -1.245 . . . . 0.0 111.356 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -176.38 49.98 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.13 136.93 3.73 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 108.504 -1.839 . . . . 0.0 108.504 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -60.98 130.22 31.84 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 122.158 1.905 . . . . 0.0 111.136 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.1 t -74.04 123.81 25.07 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.507 -0.746 . . . . 0.0 109.718 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.51 -46.43 73.5 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.502 -0.749 . . . . 0.0 109.879 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.1 -48.3 86.57 Favored Glycine 0 N--CA 1.503 3.164 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.442 ' O ' HG21 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -58.74 -55.19 38.24 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.095 178.328 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 96.2 m -58.76 -27.17 64.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 124.027 0.829 . . . . 0.0 112.033 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.2 m -74.23 -47.7 33.6 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 123.825 0.703 . . . . 0.0 109.296 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.43 ' HA3' ' HB1' ' A' ' 10' ' ' ALA . . . -65.0 -28.26 73.29 Favored Glycine 0 N--CA 1.5 2.953 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.613 ' CG1' HG23 ' A' ' 77' ' ' VAL . 21.2 t -81.91 -48.22 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.269 -1.136 . . . . 0.0 108.762 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.423 ' HA ' HG21 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -61.9 -25.78 67.77 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.358 -0.839 . . . . 0.0 109.05 179.071 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 79.6 p -74.0 -46.38 44.03 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.514 HD21 ' HA ' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -63.24 -30.86 71.93 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.671 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.549 ' HB2' HG12 ' A' ' 77' ' ' VAL . 3.1 t-20 -63.39 -36.17 82.84 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.025 -1.047 . . . . 0.0 110.215 179.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -90.38 -36.33 14.68 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.463 -0.773 . . . . 0.0 110.099 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.26 -18.48 25.56 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.538 -0.727 . . . . 0.0 111.076 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.628 ' HA ' ' CB ' ' A' ' 45' ' ' ASP . . . -123.56 110.49 15.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.011 -1.055 . . . . 0.0 110.508 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -163.32 -20.19 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.411 -0.806 . . . . 0.0 112.081 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 44' ' ' ALA . 89.7 m -78.28 50.02 0.88 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.648 -1.283 . . . . 0.0 110.292 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.515 HG21 ' HA ' ' A' ' 93' ' ' ASN . 97.9 m 62.4 -64.6 0.09 Allowed 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.846 -0.534 . . . . 0.0 110.015 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 42' ' ' THR . . . -48.45 -57.29 6.32 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 122.067 -0.396 . . . . 0.0 110.419 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.628 ' CB ' ' HA ' ' A' ' 40' ' ' ALA . 3.1 m-20 -55.26 -45.45 76.09 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.525 HH11 ' HB2' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -57.51 -55.23 37.52 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.738 178.825 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -59.92 -44.14 94.48 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.15 -50.88 71.39 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.535 -0.728 . . . . 0.0 109.317 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.47 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -63.56 -55.27 25.11 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.413 ' HA ' ' HB2' ' A' ' 53' ' ' LEU . 3.7 t -48.63 -39.42 24.03 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 174.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.419 ' N ' ' SG ' ' A' ' 89' ' ' CYS . 2.8 t30 -60.35 -53.09 61.81 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 176.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.6 t -68.54 -32.26 72.07 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 119.766 -0.774 . . . . 0.0 111.598 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.413 ' HB2' ' HA ' ' A' ' 50' ' ' CYS . 13.6 mt -63.0 -57.56 10.29 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.072 178.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.468 ' NZ ' ' O ' ' A' ' 85' ' ' THR . 54.7 tttp -54.73 -39.4 68.21 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -54.51 -50.75 67.1 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.465 ' O ' HG22 ' A' ' 60' ' ' VAL . . . -72.03 -44.17 63.82 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.507 -0.746 . . . . 0.0 109.205 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.5 ' HA ' ' CD1' ' A' ' 63' ' ' LEU . . . -54.88 -37.79 66.73 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.629 -0.669 . . . . 0.0 110.297 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.89 8.03 21.83 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.237 -0.914 . . . . 0.0 110.43 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -140.3 11.56 3.02 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 56' ' ' ALA . 3.8 t -79.04 -28.01 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.234 -1.157 . . . . 0.0 109.937 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 77.25 113.26 0.07 Allowed 'General case' 0 N--CA 1.506 2.369 0 CA-C-O 121.275 0.559 . . . . 0.0 109.946 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.48 34.22 87.1 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.5 ' CD1' ' HA ' ' A' ' 57' ' ' ALA . 10.0 tt -64.68 121.86 15.5 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.463 -1.022 . . . . 0.0 110.406 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 18' ' ' ALA . 10.7 m-80 -97.09 90.05 5.02 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -44.28 -48.47 9.5 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.912 -0.492 . . . . 0.0 110.494 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -50.68 -40.52 40.92 Favored Glycine 0 N--CA 1.502 3.07 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -76.46 -56.4 4.66 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.703 -0.88 . . . . 0.0 109.344 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.44 -24.7 63.74 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.906 -0.496 . . . . 0.0 111.769 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.01 -47.48 7.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.956 -1.09 . . . . 0.0 110.419 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 t -64.54 -31.27 72.42 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.445 -0.784 . . . . 0.0 111.056 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.619 HD13 ' CG ' ' A' ' 17' ' ' TYR . 78.0 mt -60.43 -70.38 0.44 Allowed Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 121.204 -0.935 . . . . 0.0 111.007 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.601 ' CB ' HG13 ' A' ' 33' ' ' VAL . 38.0 Cg_endo -60.07 -51.67 5.33 Favored 'Trans proline' 0 N--CA 1.484 0.944 0 C-N-CA 122.328 2.019 . . . . 0.0 112.077 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.2 p -51.45 -63.67 1.06 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.692 -0.63 . . . . 0.0 110.487 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.7 mmtt -63.11 -42.33 99.53 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 122.15 -0.343 . . . . 0.0 110.604 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 71' ' ' ILE . 0.4 OUTLIER -47.36 -55.22 9.27 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.506 -0.746 . . . . 0.0 112.12 -177.502 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 164.9 50.97 0.02 OUTLIER Glycine 0 N--CA 1.496 2.653 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.613 HG23 ' CG1' ' A' ' 33' ' ' VAL . 46.8 t -130.85 93.59 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.756 -0.85 . . . . 0.0 110.323 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 56.7 p -70.1 66.44 0.27 Allowed 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.6 0.714 . . . . 0.0 110.365 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.591 HG12 ' CE1' ' A' ' 81' ' ' TYR . 0.4 OUTLIER -124.94 120.36 25.49 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.173 -0.954 . . . . 0.0 108.79 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.91 -27.5 74.76 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 C-N-CA 122.955 2.436 . . . . 0.0 113.679 -177.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.591 ' CE1' HG12 ' A' ' 79' ' ' ILE . 12.9 p90 -89.59 130.12 35.94 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.794 -1.191 . . . . 0.0 111.063 -178.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.1 p -102.68 155.51 18.26 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.738 0.78 . . . . 0.0 110.655 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.502 ' N ' HD13 ' A' ' 83' ' ' ILE . 2.0 mp -86.92 85.21 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.402 ' O ' ' N ' ' A' ' 86' ' ' SER . 59.5 p -114.39 13.79 17.8 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.526 -0.734 . . . . 0.0 111.866 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.468 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . 86.0 m 68.78 -56.82 0.52 Allowed 'General case' 0 N--CA 1.51 2.567 0 O-C-N 121.211 -0.93 . . . . 0.0 108.86 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 84' ' ' SER . 42.0 m -68.43 -25.6 65.1 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.289 -0.882 . . . . 0.0 109.167 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.439 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . 94.4 m -38.48 140.92 0.29 Allowed 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 121.362 0.601 . . . . 0.0 110.697 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -85.3 139.9 31.24 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.594 -0.691 . . . . 0.0 110.56 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 51' ' ' ASN . 0.5 OUTLIER -122.73 56.26 1.15 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.934 0.873 . . . . 0.0 110.61 176.448 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.1 m -151.34 -41.15 0.12 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.092 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.06 -1.09 37.8 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.264 -0.897 . . . . 0.0 110.311 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.9 t -73.26 136.51 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 O-C-N 121.049 -1.032 . . . . 0.0 109.714 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.515 ' HA ' HG21 ' A' ' 43' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 114.0 -2.905 . . . . 0.0 110.05 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.64 ' CD1' ' HB3' ' A' ' 49' ' ' ALA . 1.3 pp . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.413 ' O ' ' HG3' ' A' ' 6' ' ' GLN . 27.7 t -96.13 -167.73 1.63 Allowed 'General case' 0 N--CA 1.503 2.211 0 O-C-N 120.894 -1.129 . . . . 0.0 111.199 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 33.5 t -74.96 -29.05 60.81 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -54.5 -50.57 56.46 Favored Glycine 0 N--CA 1.504 3.226 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 177.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.42 ' HG3' ' N ' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -66.67 -34.93 78.95 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.486 -1.009 . . . . 0.0 109.415 179.111 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.513 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 61.6 t -59.05 -38.27 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 177.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.41 ' HA ' HG13 ' A' ' 11' ' ' ILE . . . -68.97 -34.84 75.97 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.56 -16.36 63.84 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.531 -0.731 . . . . 0.0 109.573 178.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.534 ' CB ' HG23 ' A' ' 33' ' ' VAL . . . -94.11 -31.84 14.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.505 -0.747 . . . . 0.0 110.145 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.466 HD13 ' N ' ' A' ' 12' ' ' ALA . 2.4 pp -95.18 -30.79 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.31 -0.869 . . . . 0.0 111.443 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.466 ' N ' HD13 ' A' ' 11' ' ' ILE . . . -50.87 -52.84 53.69 Favored Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.133 -0.979 . . . . 0.0 110.449 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.465 ' HD3' ' HB1' ' A' ' 12' ' ' ALA . 71.5 Cg_endo -73.46 -10.05 23.48 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.405 2.07 . . . . 0.0 111.019 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.561 ' SG ' ' HB3' ' A' ' 25' ' ' PRO . 15.6 m -124.61 21.0 8.56 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.452 ' CD1' HG11 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -67.04 -50.69 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.548 -179.129 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.436 ' HA ' ' HB3' ' A' ' 19' ' ' ARG . 20.2 m -62.48 -46.91 86.34 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.278 -0.889 . . . . 0.0 110.091 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.537 ' CD2' HG12 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -59.31 -56.14 25.92 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 64' ' ' ASN . . . -57.96 -28.21 64.13 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.436 ' HB3' ' HA ' ' A' ' 16' ' ' SER . 0.0 OUTLIER -75.09 -5.21 42.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.904 -0.497 . . . . 0.0 110.568 179.153 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.04 -5.73 27.2 Favored Glycine 0 N--CA 1.5 2.953 0 O-C-N 120.599 -1.313 . . . . 0.0 111.846 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.46 97.52 3.71 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 118.991 1.395 . . . . 0.0 110.091 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.421 ' HA3' ' CB ' ' A' ' 17' ' ' TYR . . . -153.54 -66.28 0.01 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.7 t 58.65 43.64 18.62 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.507 -0.996 . . . . 0.0 109.037 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 132.37 95.31 0.61 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 107.977 -2.049 . . . . 0.0 107.977 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.561 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 17.1 Cg_exo -59.95 -78.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 122.381 2.054 . . . . 0.0 111.089 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 25' ' ' PRO . 10.8 t 161.83 149.79 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.581 -0.7 . . . . 0.0 109.635 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.35 -36.69 78.6 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.93 -45.01 87.41 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.413 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 35.3 t -64.63 -52.42 57.54 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.655 -1.218 . . . . 0.0 109.638 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 83.4 m -59.18 -46.94 87.08 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.5 m -68.89 -50.12 52.37 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 124.119 0.887 . . . . 0.0 110.468 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.55 -54.76 33.82 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.578 HG11 ' CG2' ' A' ' 77' ' ' VAL . 38.3 t -60.61 -47.27 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.972 -0.722 . . . . 0.0 109.241 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.491 ' O ' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -56.34 -31.2 63.51 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.41 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.1 m -80.23 -55.12 5.14 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.778 -0.576 . . . . 0.0 109.647 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.483 ' CG ' ' HA ' ' A' ' 33' ' ' VAL . 1.7 pp -58.37 -42.46 87.05 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.254 -0.904 . . . . 0.0 109.133 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.461 ' HB3' HG11 ' A' ' 77' ' ' VAL . 18.4 m120 -70.92 -20.14 62.51 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.449 -0.782 . . . . 0.0 109.194 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 34' ' ' ARG . 52.1 t30 -67.69 -37.52 82.4 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.15 -24.87 30.02 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.96 -0.462 . . . . 0.0 110.89 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.486 ' N ' HG23 ' A' ' 2' ' ' ILE . . . -82.46 86.88 6.68 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.117 -0.99 . . . . 0.0 110.104 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.593 ' HA ' ' NE ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -152.55 38.19 0.54 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.121 -0.987 . . . . 0.0 110.314 -179.713 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.472 ' O ' ' N ' ' A' ' 44' ' ' ALA . 12.4 p -139.08 35.57 2.12 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 120.935 -1.103 . . . . 0.0 110.805 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.446 HG21 ' HB3' ' A' ' 93' ' ' ASN . 1.1 p 65.19 -60.92 0.24 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.424 -0.798 . . . . 0.0 109.6 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 42' ' ' THR . . . -58.72 -58.16 9.83 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.5 ' O ' HD13 ' A' ' 2' ' ' ILE . 21.8 m-20 -66.1 -45.21 82.01 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.835 0.826 . . . . 0.0 108.83 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.593 ' NE ' ' HA ' ' A' ' 41' ' ' ARG . 1.8 tpp180 -59.63 -57.63 12.1 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.752 -0.593 . . . . 0.0 110.95 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 -61.6 -38.69 88.54 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.282 -0.886 . . . . 0.0 109.986 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.13 -50.79 70.11 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.64 ' HB3' ' CD1' ' A' ' 2' ' ' ILE . . . -62.4 -46.68 87.49 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.489 ' C ' ' SG ' ' A' ' 89' ' ' CYS . 42.9 t -55.12 -42.19 72.66 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.998 -0.439 . . . . 0.0 111.05 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -67.69 -60.45 2.53 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 124.117 0.885 . . . . 0.0 110.206 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.513 ' SG ' ' HB ' ' A' ' 7' ' ' VAL . 10.8 t -55.36 -29.33 58.2 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.05 178.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.487 HD21 HG13 ' A' ' 83' ' ' ILE . 15.8 mt -70.44 -50.65 36.14 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.13 175.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.5 tttm -56.67 -41.03 76.56 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -56.34 -46.19 80.05 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.05 -41.01 62.42 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.558 -0.714 . . . . 0.0 109.238 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.474 ' HA ' HD11 ' A' ' 63' ' ' LEU . . . -52.92 -43.74 66.47 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.664 -0.647 . . . . 0.0 109.963 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -90.05 18.2 6.09 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.293 -0.879 . . . . 0.0 110.133 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -127.95 -31.48 0.69 Allowed Glycine 0 N--CA 1.501 2.969 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.452 HG11 ' CD1' ' A' ' 15' ' ' ILE . 7.6 t -52.87 135.34 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.54 -0.977 . . . . 0.0 110.272 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.7 t -64.12 107.68 1.35 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.596 -0.69 . . . . 0.0 109.191 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.93 50.09 43.47 Favored Glycine 0 N--CA 1.499 2.88 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.474 HD11 ' HA ' ' A' ' 57' ' ' ALA . 4.0 tp -61.41 126.31 26.89 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.369 -1.077 . . . . 0.0 110.372 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 18' ' ' ALA . 2.0 m-80 -103.48 93.48 4.97 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -41.49 -46.21 3.42 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.853 -0.53 . . . . 0.0 110.691 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.06 -31.34 48.27 Favored Glycine 0 N--CA 1.502 3.064 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -94.59 -49.5 5.61 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.464 -1.021 . . . . 0.0 109.257 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.414 ' HB3' ' CG2' ' A' ' 83' ' ' ILE . . . -57.88 -34.26 69.59 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.702 -0.624 . . . . 0.0 111.049 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.493 ' HA ' ' HB ' ' A' ' 82' ' ' THR . . . -83.79 -47.76 10.79 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.945 -1.097 . . . . 0.0 109.934 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.6 p -68.66 -36.78 78.99 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.537 -0.727 . . . . 0.0 110.984 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.537 HG12 ' CD2' ' A' ' 17' ' ' TYR . 22.4 mt -46.07 -62.44 1.84 Allowed Pre-proline 0 N--CA 1.504 2.271 0 O-C-N 121.436 -0.79 . . . . 0.0 110.584 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 71' ' ' ILE . 37.9 Cg_endo -62.35 -52.62 2.45 Favored 'Trans proline' 0 C--N 1.321 -0.869 0 C-N-CA 121.907 1.738 . . . . 0.0 110.048 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.6 m -52.46 -60.81 2.78 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.518 -0.739 . . . . 0.0 110.183 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -61.41 -44.65 96.78 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -47.56 -32.78 5.74 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.554 -0.716 . . . . 0.0 111.264 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.407 ' O ' ' CD ' ' A' ' 34' ' ' ARG . . . 126.55 41.47 0.32 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 177.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.578 ' CG2' HG11 ' A' ' 33' ' ' VAL . 12.8 t -92.43 -32.95 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -1.121 . . . . 0.0 110.851 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.8 m 45.25 58.82 3.87 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.536 -0.728 . . . . 0.0 109.435 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.557 ' CG1' HH11 ' A' ' 46' ' ' ARG . 0.2 OUTLIER -140.8 136.71 16.51 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.443 -0.786 . . . . 0.0 109.449 -178.683 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -58.76 -43.97 39.92 Favored 'Trans proline' 0 C--N 1.318 -1.054 0 C-N-CA 122.842 2.361 . . . . 0.0 112.184 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.47 ' CD1' ' HG3' ' A' ' 46' ' ' ARG . 42.7 p90 -79.7 134.28 36.39 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 122.026 0.917 . . . . 0.0 109.988 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.493 ' HB ' ' HA ' ' A' ' 69' ' ' ALA . 32.4 p -123.21 -175.84 3.28 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.363 0.601 . . . . 0.0 109.916 -178.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.555 ' N ' ' CD1' ' A' ' 83' ' ' ILE . 0.3 OUTLIER -84.48 59.27 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 178.553 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.6 p -102.2 136.13 42.57 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.972 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.9 p -61.66 -56.01 24.41 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.514 -0.741 . . . . 0.0 109.014 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 55.9 p -93.32 53.53 1.93 Allowed 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.491 ' CG2' ' SG ' ' A' ' 89' ' ' CYS . 2.4 t -75.7 -170.96 1.42 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.518 -0.739 . . . . 0.0 110.867 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.407 ' N ' HG22 ' A' ' 87' ' ' THR . 22.8 t70 -83.13 -71.74 0.48 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.305 -0.872 . . . . 0.0 109.99 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.491 ' SG ' ' CG2' ' A' ' 87' ' ' THR . 85.1 m 52.19 51.52 16.16 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.274 0.559 . . . . 0.0 112.228 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.2 t -170.12 -49.24 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.492 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -99.54 -22.2 15.58 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.527 -0.733 . . . . 0.0 110.865 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.518 HG11 ' HG2' ' A' ' 46' ' ' ARG . 21.5 t -59.09 138.32 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.001 -1.062 . . . . 0.0 110.065 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.446 ' HB3' HG21 ' A' ' 43' ' ' THR . 61.8 m-20 . . . . . 0 N--CA 1.496 1.852 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.579 HD12 ' HB1' ' A' ' 49' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 121.988 0.899 . . . . 0.0 109.272 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.0 t -146.97 171.22 15.58 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.224 -0.922 . . . . 0.0 110.846 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -56.4 -35.96 68.37 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -58.52 -42.11 95.79 Favored Glycine 0 N--CA 1.502 3.037 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 175.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.472 ' CG ' ' HB2' ' A' ' 36' ' ' LEU . 0.8 OUTLIER -79.83 -41.43 26.39 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.574 -0.956 . . . . 0.0 109.168 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 77.0 t -56.33 -42.44 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.66 -36.27 75.9 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.2 t -69.35 -21.24 63.83 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.315 -0.866 . . . . 0.0 108.973 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.49 -52.26 14.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.437 -0.789 . . . . 0.0 110.651 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.425 HD12 ' N ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -80.54 -20.21 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 121.184 -0.948 . . . . 0.0 110.978 -178.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.456 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -45.5 -55.36 12.28 Favored Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 121.262 -0.899 . . . . 0.0 110.385 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 64.4 Cg_endo -70.49 -21.95 29.39 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.251 1.968 . . . . 0.0 110.994 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.544 ' SG ' ' CG2' ' A' ' 71' ' ' ILE . 1.1 m -111.73 27.99 9.16 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.464 ' O ' ' CB ' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -63.24 -44.92 99.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 177.208 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.413 ' O ' ' N ' ' A' ' 21' ' ' GLN . 0.4 OUTLIER -61.72 -53.83 50.72 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.392 -0.817 . . . . 0.0 108.807 178.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.544 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 0.5 OUTLIER -53.77 -60.66 3.02 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.662 -0.648 . . . . 0.0 109.566 178.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.555 ' N ' HD13 ' A' ' 71' ' ' ILE . . . -60.1 -31.92 70.49 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.612 -0.68 . . . . 0.0 111.084 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.464 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 9.5 tmm_? -83.84 18.49 1.99 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.453 -0.779 . . . . 0.0 111.602 -178.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.49 14.65 75.65 Favored Glycine 0 N--CA 1.503 3.137 0 O-C-N 120.541 -1.349 . . . . 0.0 112.032 178.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.544 ' O ' ' HA ' ' A' ' 17' ' ' TYR . 1.6 mm-40 -124.8 -176.7 3.61 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.113 -1.228 . . . . 0.0 109.92 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.08 -62.1 0.54 Allowed Glycine 0 N--CA 1.504 3.171 0 O-C-N 121.096 -1.003 . . . . 0.0 110.992 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 76.16 -51.82 0.61 Allowed 'General case' 0 N--CA 1.508 2.461 0 O-C-N 121.557 -0.967 . . . . 0.0 110.372 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.5 134.28 12.46 Favored Glycine 0 N--CA 1.501 2.974 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.38 134.3 47.64 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 122.394 2.063 . . . . 0.0 111.017 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 t -79.93 134.56 36.28 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.299 -0.875 . . . . 0.0 109.407 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.28 -50.11 72.32 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.367 -0.833 . . . . 0.0 109.112 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.26 -46.17 94.76 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.5 t -56.79 -39.68 74.54 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.994 178.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 82.0 m -71.22 -44.81 64.62 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.597 -175.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 46.7 t -65.65 -40.01 92.0 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 124.048 0.842 . . . . 0.0 109.916 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.76 -60.3 6.29 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.535 ' HA ' ' CG ' ' A' ' 36' ' ' LEU . 17.3 t -59.38 -47.85 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.581 -0.952 . . . . 0.0 110.946 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.476 ' HA ' HG23 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -57.94 -26.87 62.81 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.237 -0.914 . . . . 0.0 109.537 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.0 m -86.12 -51.07 6.54 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.394 -0.816 . . . . 0.0 109.697 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.535 ' CG ' ' HA ' ' A' ' 33' ' ' VAL . 2.7 pp -60.69 -49.2 78.47 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.676 -0.64 . . . . 0.0 110.51 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.505 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . 2.6 m-80 -66.83 -32.55 73.9 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.1 -1.0 . . . . 0.0 108.696 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.455 ' HA ' ' HD2' ' A' ' 41' ' ' ARG . 10.0 t30 -63.79 -38.96 93.07 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.48 -30.37 71.4 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.485 ' HA ' ' CB ' ' A' ' 45' ' ' ASP . . . -94.16 88.46 5.63 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.508 -0.745 . . . . 0.0 109.82 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.455 ' HD2' ' HA ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -143.1 20.49 1.93 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.937 -1.102 . . . . 0.0 111.922 -179.653 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.4 m -115.55 31.96 6.38 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.817 -1.177 . . . . 0.0 109.939 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.462 HG21 ' HA ' ' A' ' 93' ' ' ASN . 58.0 m 69.63 -61.54 0.44 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.456 -0.777 . . . . 0.0 109.297 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.24 -45.56 72.38 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.485 ' CB ' ' HA ' ' A' ' 40' ' ' ALA . 8.9 m-20 -73.44 -39.69 64.78 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.462 ' HG3' ' CE1' ' A' ' 81' ' ' TYR . 0.3 OUTLIER -65.14 -47.13 78.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.901 -0.499 . . . . 0.0 111.552 -178.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.402 ' NE ' ' O ' ' A' ' 90' ' ' SER . 51.9 mtt180 -65.49 -40.67 93.34 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.009 -1.057 . . . . 0.0 109.517 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.89 -43.19 99.36 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.579 ' HB1' HD12 ' A' ' 2' ' ' ILE 0.268 . . -65.15 -49.69 68.88 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.234 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.495 ' C ' ' SG ' ' A' ' 89' ' ' CYS . 50.2 t -55.26 -40.73 71.3 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.289 -0.882 . . . . 0.0 110.126 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.499 ' O ' ' HG3' ' A' ' 54' ' ' LYS . 1.8 t30 -62.69 -53.41 54.87 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 124.035 0.834 . . . . 0.0 110.481 177.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.9 t -72.2 -20.01 61.64 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.817 -1.153 . . . . 0.0 111.609 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.461 HD11 ' CG1' ' A' ' 83' ' ' ILE . 18.1 mt -68.85 -57.86 4.98 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 124.092 0.87 . . . . 0.0 109.012 175.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -57.17 -28.79 63.11 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.436 ' OD1' ' NZ ' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -73.63 -45.33 53.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.688 -0.632 . . . . 0.0 109.569 178.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.98 -49.84 47.6 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.418 -0.801 . . . . 0.0 109.75 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.412 ' O ' HD12 ' A' ' 63' ' ' LEU . . . -59.74 -62.23 2.03 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.439 -0.788 . . . . 0.0 109.334 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.529 ' HA ' HD12 ' A' ' 63' ' ' LEU . . . -70.75 77.28 0.61 Allowed 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.73 -16.21 0.94 Allowed Glycine 0 N--CA 1.497 2.749 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.433 HG11 HD12 ' A' ' 15' ' ' ILE . 0.9 OUTLIER -47.7 -58.58 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 CA-C-N 118.54 1.17 . . . . 0.0 110.477 -179.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 m 162.79 -62.74 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.513 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -128.28 46.97 1.05 Allowed Glycine 0 N--CA 1.498 2.784 0 N-CA-C 107.462 -2.255 . . . . 0.0 107.462 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.529 HD12 ' HA ' ' A' ' 58' ' ' ALA . 2.5 pt? -50.54 129.48 22.36 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.883 0.849 . . . . 0.0 111.431 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.452 ' CB ' ' HB2' ' A' ' 67' ' ' ASN . 1.6 m-80 -109.27 103.14 12.04 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -36.06 -57.48 0.7 Allowed 'General case' 0 N--CA 1.506 2.349 0 O-C-N 122.028 -0.42 . . . . 0.0 111.775 -178.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.23 -52.41 44.34 Favored Glycine 0 N--CA 1.502 3.074 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.452 ' HB2' ' CB ' ' A' ' 64' ' ' ASN . 2.9 m120 -54.9 -45.39 74.71 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.669 -0.9 . . . . 0.0 110.626 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.431 ' O ' ' HD2' ' A' ' 72' ' ' PRO . . . -55.45 -55.42 31.97 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.783 -0.573 . . . . 0.0 110.252 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.517 ' HB3' HG21 ' A' ' 82' ' ' THR . . . -70.66 -36.98 73.65 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.476 -0.765 . . . . 0.0 110.784 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.487 ' OG ' ' NZ ' ' A' ' 74' ' ' LYS . 4.5 t -62.12 -28.07 69.37 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.361 -0.837 . . . . 0.0 111.087 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.555 HD13 ' N ' ' A' ' 18' ' ' ALA . 38.4 mt -61.36 -69.67 0.55 Allowed Pre-proline 0 N--CA 1.502 2.15 0 O-C-N 121.243 -0.911 . . . . 0.0 111.442 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.505 ' CD ' ' HB ' ' A' ' 71' ' ' ILE . 19.5 Cg_endo -58.81 -50.27 9.54 Favored 'Trans proline' 0 N--CA 1.481 0.787 0 C-N-CA 122.141 1.894 . . . . 0.0 110.929 -178.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.0 m -48.51 -70.91 0.08 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 122.099 -0.376 . . . . 0.0 110.478 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.487 ' NZ ' ' OG ' ' A' ' 70' ' ' SER . 27.9 mtmm -60.33 -43.14 96.68 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-N 116.965 -0.107 . . . . 0.0 110.746 -178.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 1.5 m -45.48 -35.98 4.17 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.823 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 34' ' ' ARG . . . 122.37 49.88 0.24 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 175.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.505 ' CG1' ' HB3' ' A' ' 37' ' ' ASN . 90.6 t -90.07 -27.66 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 C-N-CA 118.365 -1.334 . . . . 0.0 112.029 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 77' ' ' VAL . 24.9 p 65.47 16.75 10.67 Favored 'General case' 0 N--CA 1.51 2.56 0 O-C-N 121.103 -0.998 . . . . 0.0 110.564 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.493 ' HB ' HG11 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -89.06 124.75 64.26 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.008 -1.058 . . . . 0.0 108.504 179.341 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.23 -35.86 60.72 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 122.519 2.146 . . . . 0.0 112.214 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.462 ' CE1' ' HG3' ' A' ' 46' ' ' ARG . 17.9 p90 -82.65 142.15 31.93 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.098 -1.001 . . . . 0.0 110.515 -179.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.517 HG21 ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -96.38 150.65 20.35 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.489 -0.757 . . . . 0.0 110.633 -178.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.461 ' CG1' HD11 ' A' ' 53' ' ' LEU . 4.4 mp -99.71 128.91 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.428 -0.795 . . . . 0.0 109.196 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 62.4 p -150.61 -85.3 0.08 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.236 -0.915 . . . . 0.0 110.379 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.8 p -152.62 -61.11 0.15 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.588 -0.695 . . . . 0.0 109.486 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.6 t -109.5 59.83 0.6 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.617 -0.677 . . . . 0.0 110.088 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.5 m -75.28 164.5 26.38 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.345 -0.847 . . . . 0.0 109.116 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -83.83 80.19 9.23 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.95 -1.094 . . . . 0.0 110.172 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.495 ' SG ' ' C ' ' A' ' 50' ' ' CYS . 14.9 m -82.55 53.31 2.3 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.119 176.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.402 ' O ' ' NE ' ' A' ' 47' ' ' ARG . 41.4 t -144.98 -50.66 0.26 Allowed 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.024 -177.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -99.5 -23.82 14.97 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.331 -0.855 . . . . 0.0 110.414 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.2 t -49.54 142.09 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 O-C-N 121.402 -0.811 . . . . 0.0 111.038 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.462 ' HA ' HG21 ' A' ' 43' ' ' THR . 33.4 m-80 . . . . . 0 N--CA 1.5 2.073 0 CA-C-O 117.039 -1.458 . . . . 0.0 109.134 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.5 ' CD1' ' HB1' ' A' ' 40' ' ' ALA . 3.0 tp . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 121.723 0.773 . . . . 0.0 109.569 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.6 p -125.95 177.75 6.15 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.156 -0.965 . . . . 0.0 110.198 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.459 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 70.5 m -56.97 -19.17 16.67 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 119.879 -0.728 . . . . 0.0 112.467 177.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.58 -43.44 99.28 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -85.68 -35.04 21.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.432 -1.04 . . . . 0.0 108.824 178.603 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.459 ' HB ' ' HA ' ' A' ' 4' ' ' CYS . 58.7 t -54.7 -43.22 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.09 -37.68 61.45 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.484 ' HB2' ' HA ' ' A' ' 6' ' ' GLN . 69.0 m -69.61 -21.09 63.61 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.221 -0.924 . . . . 0.0 109.806 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 6' ' ' GLN . . . -85.65 -30.29 23.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.428 -0.795 . . . . 0.0 109.629 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.439 HD13 ' N ' ' A' ' 12' ' ' ALA . 2.4 pp -96.57 -26.71 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.463 -0.773 . . . . 0.0 110.813 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.504 ' HB2' ' HD3' ' A' ' 13' ' ' PRO . . . -49.33 -53.45 39.66 Favored Pre-proline 0 N--CA 1.504 2.244 0 O-C-N 121.207 -0.933 . . . . 0.0 110.783 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.504 ' HD3' ' HB2' ' A' ' 12' ' ' ALA . 73.4 Cg_endo -72.78 -9.6 23.98 Favored 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 122.29 1.993 . . . . 0.0 110.969 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.7 m -117.41 6.33 12.62 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.525 ' O ' ' CB ' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -58.09 -50.43 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 118.109 0.413 . . . . 0.0 110.632 -178.606 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.414 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -61.2 -63.49 1.27 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.952 -1.092 . . . . 0.0 109.618 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.51 ' CD2' HG12 ' A' ' 71' ' ' ILE . 1.1 t80 -51.66 -58.8 5.33 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.644 -0.66 . . . . 0.0 109.922 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' A' ' 64' ' ' ASN . . . -57.22 -29.25 63.59 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.603 -0.686 . . . . 0.0 110.556 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.525 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 9.1 tmm_? -89.93 8.67 31.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.368 -0.833 . . . . 0.0 110.944 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.28 1.1 44.32 Favored Glycine 0 N--CA 1.503 3.123 0 O-C-N 120.714 -1.241 . . . . 0.0 111.922 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -117.59 72.12 0.83 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.014 -1.286 . . . . 0.0 110.115 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.72 174.61 45.82 Favored Glycine 0 N--CA 1.498 2.793 0 C-N-CA 120.197 -1.001 . . . . 0.0 110.826 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.9 p -151.23 -60.8 0.18 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -97.83 126.77 8.99 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.642 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 37.1 Cg_endo -62.49 125.45 16.23 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 C-N-CA 122.393 2.062 . . . . 0.0 111.008 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.3 t -76.57 159.89 29.92 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.418 -0.801 . . . . 0.0 110.99 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.57 -41.44 76.92 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.644 -0.66 . . . . 0.0 110.552 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.62 -48.46 77.35 Favored Glycine 0 N--CA 1.503 3.127 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.55 ' SG ' ' CG2' ' A' ' 71' ' ' ILE . 42.4 t -58.3 -43.0 87.88 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.661 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.642 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 88.2 m -73.69 -35.18 65.15 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.154 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 61.9 m -71.81 -40.7 68.99 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 124.533 1.146 . . . . 0.0 109.725 175.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.33 -51.75 57.29 Favored Glycine 0 N--CA 1.5 2.953 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.61 HG13 ' CB ' ' A' ' 72' ' ' PRO . 47.4 t -69.3 -45.69 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.441 -1.035 . . . . 0.0 109.125 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.555 ' HA ' ' CG1' ' A' ' 77' ' ' VAL . 2.4 tpt180 -54.15 -28.42 39.89 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.4 m -73.76 -44.0 57.38 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER -61.32 -33.94 74.43 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.409 -0.807 . . . . 0.0 109.771 179.338 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.465 ' HB2' ' CG1' ' A' ' 77' ' ' VAL . 0.6 OUTLIER -59.69 -32.68 70.72 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.299 -0.876 . . . . 0.0 110.015 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -88.71 -33.51 17.5 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.526 -0.734 . . . . 0.0 109.415 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.11 -32.29 22.87 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.506 -0.746 . . . . 0.0 110.878 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.559 ' HA ' ' CB ' ' A' ' 45' ' ' ASP . . . -111.47 101.52 9.94 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.169 -0.957 . . . . 0.0 110.474 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.511 ' CZ ' ' HB3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -161.06 20.27 0.12 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.402 -0.811 . . . . 0.0 111.692 179.59 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 44' ' ' ALA . 5.8 m -116.87 35.31 4.67 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.848 -1.158 . . . . 0.0 109.384 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 44.6 m 67.95 -59.82 0.42 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.595 -0.691 . . . . 0.0 109.649 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 42' ' ' THR . . . -57.35 -54.63 44.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.551 -0.718 . . . . 0.0 109.179 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.559 ' CB ' ' HA ' ' A' ' 40' ' ' ALA . 8.3 m-20 -55.61 -44.04 76.65 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.707 0.765 . . . . 0.0 109.199 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.44 ' NH1' HG13 ' A' ' 79' ' ' ILE . 0.5 OUTLIER -67.39 -47.12 71.25 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.978 -178.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -60.84 -48.58 81.16 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.5 -48.72 80.53 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.777 -0.577 . . . . 0.0 109.498 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.442 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -57.16 -46.37 82.8 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.459 ' SG ' HG23 ' A' ' 87' ' ' THR . 0.1 OUTLIER -63.86 -38.81 92.48 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.112 -0.368 . . . . 0.0 110.872 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.44 ' N ' ' SG ' ' A' ' 89' ' ' CYS . 2.2 t30 -60.01 -57.38 13.1 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 123.869 0.731 . . . . 0.0 109.701 176.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 12.9 t -66.76 -31.08 71.49 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.357 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.485 HD21 HG21 ' A' ' 83' ' ' ILE . 15.1 mt -64.01 -44.47 92.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 123.902 0.751 . . . . 0.0 109.446 175.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -58.54 -41.18 84.98 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -64.18 -54.01 40.35 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.74 -43.39 90.2 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.643 -0.661 . . . . 0.0 109.608 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.463 ' HA ' HD11 ' A' ' 63' ' ' LEU . . . -60.55 -51.9 67.44 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.87 64.86 1.33 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 61' ' ' SER . . . 167.88 -22.48 0.1 Allowed Glycine 0 N--CA 1.499 2.879 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.202 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.474 HG11 ' CD1' ' A' ' 15' ' ' ILE . 6.5 t -64.9 62.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 CA-C-N 118.699 1.25 . . . . 0.0 110.595 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 59' ' ' GLY . 67.9 m 36.02 57.32 0.99 Allowed 'General case' 0 N--CA 1.507 2.409 0 O-C-N 121.309 -0.869 . . . . 0.0 111.888 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.76 57.81 3.69 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.463 HD11 ' HA ' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -56.94 132.04 51.51 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.677 -0.896 . . . . 0.0 110.463 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 18' ' ' ALA . 1.8 m-80 -96.7 89.78 5.06 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -39.54 -45.87 1.65 Allowed 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.907 -0.495 . . . . 0.0 111.021 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -51.7 -38.16 43.93 Favored Glycine 0 N--CA 1.503 3.136 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -83.7 -55.5 4.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.635 -0.921 . . . . 0.0 108.913 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 83' ' ' ILE . . . -55.72 -25.21 39.16 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.826 -0.546 . . . . 0.0 111.932 -178.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.25 -49.27 6.82 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.949 -1.094 . . . . 0.0 109.818 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.04 -32.37 72.68 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.47 -0.769 . . . . 0.0 110.409 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.55 ' CG2' ' SG ' ' A' ' 29' ' ' CYS . 30.8 mt -52.07 -61.51 4.32 Favored Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 121.643 -0.66 . . . . 0.0 110.528 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.61 ' CB ' HG13 ' A' ' 33' ' ' VAL . 38.4 Cg_endo -61.88 -57.08 0.58 Allowed 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 122.028 1.819 . . . . 0.0 110.465 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.9 t -44.35 -63.64 0.84 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 120.681 0.277 . . . . 0.0 110.38 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -63.61 -39.1 93.52 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 122.034 -0.416 . . . . 0.0 109.982 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.593 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 0.8 OUTLIER -48.01 -35.04 10.28 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.823 -0.751 . . . . 0.0 112.092 -178.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.422 ' O ' ' HD2' ' A' ' 34' ' ' ARG . . . 137.7 44.53 0.08 OUTLIER Glycine 0 N--CA 1.496 2.659 0 C-N-CA 119.243 -1.456 . . . . 0.0 111.339 176.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.555 ' CG1' ' HA ' ' A' ' 34' ' ' ARG . 16.1 m -135.34 129.76 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 120.828 -1.395 . . . . 0.0 111.021 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.1 p -99.97 78.38 2.1 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.557 HD13 ' CE2' ' A' ' 81' ' ' TYR . 11.0 tt -132.38 128.41 21.14 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.514 -0.741 . . . . 0.0 109.723 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.77 -45.33 41.76 Favored 'Trans proline' 0 N--CA 1.484 0.936 0 C-N-CA 123.28 2.653 . . . . 0.0 112.736 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.557 ' CE2' HD13 ' A' ' 79' ' ' ILE . 26.5 p90 -81.7 143.28 31.98 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.938 -1.101 . . . . 0.0 109.911 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 69.5 p -98.67 166.49 11.3 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.908 0.861 . . . . 0.0 110.692 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.485 HG21 HD21 ' A' ' 53' ' ' LEU . 1.5 mp -90.16 63.81 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 82.4 p -161.49 170.34 20.13 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.022 -1.049 . . . . 0.0 110.701 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.5 p -60.71 -30.0 69.69 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.575 -0.703 . . . . 0.0 109.748 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.0 t -82.49 79.74 8.84 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.459 HG23 ' SG ' ' A' ' 50' ' ' CYS . 0.6 OUTLIER -162.63 149.15 12.87 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.842 -179.37 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -91.77 154.65 18.79 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 122.18 0.991 . . . . 0.0 112.329 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 51' ' ' ASN . 1.2 m -137.03 53.4 1.89 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.142 176.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 95.8 p -159.3 -51.42 0.06 Allowed 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.355 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.0 mmm-85 -97.1 -6.78 34.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.223 -0.923 . . . . 0.0 109.245 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.1 t -70.48 119.73 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.391 -0.818 . . . . 0.0 109.231 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 1.7 p30 . . . . . 0 N--CA 1.497 1.915 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.46 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.519 HG22 ' HB1' ' A' ' 49' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.0 t -118.19 167.19 11.73 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.305 -0.872 . . . . 0.0 111.504 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -63.94 -35.98 82.44 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -56.39 -51.49 55.88 Favored Glycine 0 N--CA 1.503 3.122 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 177.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.23 -41.87 84.95 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.455 -1.026 . . . . 0.0 109.087 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.8 t -54.8 -46.14 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.36 -36.38 74.15 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.3 t -68.83 -20.53 64.3 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.318 -0.864 . . . . 0.0 110.099 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.39 -41.65 9.29 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.316 -0.865 . . . . 0.0 109.862 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.5 pp -79.98 -33.79 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.214 -0.929 . . . . 0.0 111.099 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.505 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -46.95 -51.76 37.69 Favored Pre-proline 0 N--CA 1.504 2.229 0 O-C-N 121.213 -0.929 . . . . 0.0 110.417 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 33.5 Cg_endo -65.89 -15.65 49.74 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.163 1.909 . . . . 0.0 110.831 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.61 ' SG ' HG22 ' A' ' 71' ' ' ILE . 1.3 m -114.14 18.94 16.8 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 176.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.406 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -62.72 -49.58 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-N 118.16 0.437 . . . . 0.0 110.473 178.047 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.4 p -68.88 -49.27 59.66 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.429 -0.794 . . . . 0.0 109.323 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.568 ' CG ' HD13 ' A' ' 71' ' ' ILE . 0.4 OUTLIER -55.42 -54.3 45.46 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.084 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 64' ' ' ASN . . . -60.69 -27.99 68.28 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.406 ' HB3' ' O ' ' A' ' 15' ' ' ILE . 1.3 tpt180 -82.46 -13.24 57.06 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.864 -0.522 . . . . 0.0 109.953 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.24 14.3 42.36 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -118.16 78.18 1.23 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.251 -1.146 . . . . 0.0 109.527 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 177.15 -151.68 11.33 Favored Glycine 0 N--CA 1.5 2.918 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.6 p -168.88 -58.71 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.632 -0.923 . . . . 0.0 109.511 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.74 145.98 17.95 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.64 152.09 82.74 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 C-N-CA 122.536 2.158 . . . . 0.0 110.356 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.4 p -102.18 146.79 27.46 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.311 -0.868 . . . . 0.0 110.431 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.95 -47.08 71.67 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.793 -0.567 . . . . 0.0 110.848 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.79 -41.31 95.92 Favored Glycine 0 N--CA 1.502 3.037 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.1 t -61.64 -55.98 24.8 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.405 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.6 -39.59 94.25 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.735 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.7 m -67.18 -50.76 59.83 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 123.932 0.77 . . . . 0.0 110.24 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.43 -47.33 91.67 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.514 ' HA ' HD21 ' A' ' 36' ' ' LEU . 59.2 t -67.86 -53.07 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.773 -0.839 . . . . 0.0 110.891 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 76' ' ' GLY . 0.4 OUTLIER -56.04 -21.19 20.26 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.175 -0.953 . . . . 0.0 110.295 -179.569 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.8 p -81.32 -43.8 18.57 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.402 -0.811 . . . . 0.0 109.523 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.517 ' HB2' HD13 ' A' ' 2' ' ' ILE . 0.6 OUTLIER -55.85 -36.01 67.07 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.891 -0.506 . . . . 0.0 110.646 -179.411 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 76' ' ' GLY . 31.9 t30 -56.44 -49.55 74.24 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.323 -0.861 . . . . 0.0 109.821 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -81.36 -29.39 34.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.604 -0.685 . . . . 0.0 109.776 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.2 -26.9 68.34 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.697 -0.627 . . . . 0.0 110.451 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.504 ' CB ' ' CG1' ' A' ' 2' ' ' ILE . . . -139.92 -110.79 0.15 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.091 -1.005 . . . . 0.0 111.109 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.442 ' CB ' ' CZ ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 64.5 32.23 11.87 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.403 -0.811 . . . . 0.0 111.082 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.461 ' O ' ' HB ' ' A' ' 43' ' ' THR . 14.9 t -128.57 17.54 6.39 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 120.829 -1.169 . . . . 0.0 111.382 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.589 ' HA ' ' C ' ' A' ' 93' ' ' ASN . 86.5 m 84.8 -67.76 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.696 -0.627 . . . . 0.0 109.799 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.49 -61.43 2.02 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.302 -0.874 . . . . 0.0 109.708 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.491 ' HB3' ' HB ' ' A' ' 2' ' ' ILE . 1.0 OUTLIER -70.28 -36.55 74.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.682 -0.636 . . . . 0.0 109.367 179.321 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.455 ' NH1' ' HD2' ' A' ' 80' ' ' PRO . 5.8 mtm180 -59.28 -53.12 61.89 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.436 -0.79 . . . . 0.0 110.249 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.463 ' NH1' ' HA ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -54.12 -47.48 71.81 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.473 -0.767 . . . . 0.0 109.337 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.91 -41.38 87.08 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.519 ' HB1' HG22 ' A' ' 2' ' ' ILE . . . -58.28 -48.32 80.83 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.498 ' C ' ' SG ' ' A' ' 89' ' ' CYS . 0.8 OUTLIER -55.4 -33.66 63.7 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.498 178.566 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.444 ' N ' ' SG ' ' A' ' 89' ' ' CYS . 1.3 t30 -65.56 -61.98 1.78 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.035 0.445 . . . . 0.0 110.056 177.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.6 t -63.49 -33.58 75.88 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.253 -0.979 . . . . 0.0 111.342 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.458 HD23 HG21 ' A' ' 83' ' ' ILE . 20.8 mt -68.4 -57.82 5.29 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.373 178.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 24.6 tttp -57.9 -36.2 72.1 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.465 -0.772 . . . . 0.0 109.354 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.84 -39.05 87.63 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.474 -0.766 . . . . 0.0 110.606 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.443 ' O ' HG22 ' A' ' 60' ' ' VAL . . . -94.39 -53.43 3.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.235 -0.916 . . . . 0.0 110.009 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.536 ' HB2' ' HA ' ' A' ' 84' ' ' SER . . . -60.09 -53.74 54.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.484 -0.76 . . . . 0.0 109.702 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 54' ' ' LYS . . . -80.79 63.18 5.1 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.52 -32.43 0.06 OUTLIER Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 56' ' ' ALA . 24.4 t -47.23 148.67 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 121.68 -0.894 . . . . 0.0 110.199 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.8 m -64.29 90.85 0.07 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.576 -0.702 . . . . 0.0 110.123 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.99 64.89 1.69 Allowed Glycine 0 N--CA 1.499 2.854 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.522 HD13 ' HB2' ' A' ' 84' ' ' SER . 3.0 tm? -74.68 118.73 17.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.667 -0.902 . . . . 0.0 109.791 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.524 ' N ' ' O ' ' A' ' 18' ' ' ALA . 11.7 m120 -94.52 85.36 4.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.891 . . . . 0.0 108.726 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.453 ' HA ' ' HB2' ' A' ' 84' ' ' SER . . . -48.31 -37.95 17.74 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.858 -0.526 . . . . 0.0 110.719 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -53.97 -38.71 60.97 Favored Glycine 0 N--CA 1.502 3.099 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -89.7 -45.38 9.36 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.478 -1.013 . . . . 0.0 109.961 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.458 ' HB1' ' CB ' ' A' ' 18' ' ' ALA . . . -71.74 -20.34 61.91 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.594 -0.691 . . . . 0.0 111.946 -178.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.23 -40.95 10.16 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.867 -1.146 . . . . 0.0 110.244 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 92.5 p -71.17 -43.27 67.8 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.57 -0.706 . . . . 0.0 110.847 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.61 HG22 ' SG ' ' A' ' 14' ' ' CYS . 87.0 mt -50.63 -64.59 1.23 Allowed Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.485 -0.76 . . . . 0.0 110.89 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.511 ' CA ' HG13 ' A' ' 33' ' ' VAL . 30.7 Cg_endo -59.74 -52.52 4.37 Favored 'Trans proline' 0 C--N 1.326 -0.636 0 C-N-CA 121.868 1.712 . . . . 0.0 110.773 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.2 t -38.5 -68.07 0.18 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 122.271 -0.268 . . . . 0.0 110.62 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.4 pttt -70.38 -32.45 70.11 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.551 -0.718 . . . . 0.0 109.888 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.4 ' HB2' ' HA ' ' A' ' 72' ' ' PRO . 1.1 m -49.72 -47.57 50.49 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.27 -0.893 . . . . 0.0 111.985 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 34' ' ' ARG . . . 169.03 47.03 0.03 OUTLIER Glycine 0 N--CA 1.5 2.927 0 C-N-CA 118.365 -1.874 . . . . 0.0 111.527 175.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.42 HG13 ' HB2' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -150.65 91.04 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.191 -1.182 . . . . 0.0 110.353 179.323 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.6 t -80.18 77.78 6.89 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.509 HD11 ' CZ ' ' A' ' 81' ' ' TYR . 3.3 pt -130.98 135.68 27.71 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.6 -0.687 . . . . 0.0 110.306 -178.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . 0.455 ' HD2' ' NH1' ' A' ' 46' ' ' ARG . 77.4 Cg_exo -49.19 -43.2 37.86 Favored 'Trans proline' 0 N--CA 1.483 0.908 0 C-N-CA 122.682 2.255 . . . . 0.0 111.533 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.509 ' CZ ' HD11 ' A' ' 79' ' ' ILE . 1.5 p90 -81.03 143.98 32.11 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.06 -1.025 . . . . 0.0 109.41 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.7 p -100.4 165.75 11.3 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.213 -0.929 . . . . 0.0 109.849 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.458 HG21 HD23 ' A' ' 53' ' ' LEU . 1.5 mp -89.93 62.91 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.536 ' HA ' ' HB2' ' A' ' 57' ' ' ALA . 80.5 p -158.68 -106.68 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.362 -0.836 . . . . 0.0 109.808 -178.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.5 p -122.4 -24.71 4.94 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.96 -1.088 . . . . 0.0 109.792 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.2 p -74.12 64.24 1.04 Allowed 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.423 HG21 ' HB2' ' A' ' 81' ' ' TYR . 13.1 m -162.43 128.71 3.53 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -125.73 138.46 53.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.244 -0.91 . . . . 0.0 110.762 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.498 ' SG ' ' C ' ' A' ' 50' ' ' CYS . 89.4 m -90.9 57.89 3.65 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.267 -0.973 . . . . 0.0 111.473 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.3 t -155.42 -42.34 0.08 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.865 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.8 mtm-85 -99.68 -37.01 9.29 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.28 -0.888 . . . . 0.0 110.332 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.495 HG22 ' HB3' ' A' ' 81' ' ' TYR . 1.2 t -60.69 158.74 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 121.451 -0.78 . . . . 0.0 111.254 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.589 ' C ' ' HA ' ' A' ' 43' ' ' THR . 58.9 m-80 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 176.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.592 HG22 ' HB3' ' A' ' 45' ' ' ASP . 10.4 tp . . . . . 0 N--CA 1.503 2.194 0 CA-C-O 121.803 0.811 . . . . 0.0 111.714 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.4 t -123.16 -74.88 0.6 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.134 -0.979 . . . . 0.0 109.931 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.7 t -151.51 -46.31 0.11 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -53.47 -44.11 66.84 Favored Glycine 0 N--CA 1.506 3.302 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 177.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.52 -41.99 23.26 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.304 -1.115 . . . . 0.0 108.452 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 91.5 t -54.1 -44.13 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.454 ' HA ' ' CG1' ' A' ' 11' ' ' ILE . . . -69.12 -34.82 75.65 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.8 m -71.37 -20.12 62.19 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.513 -0.742 . . . . 0.0 109.608 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.57 -35.45 10.61 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.275 -0.89 . . . . 0.0 109.923 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.454 ' CG1' ' HA ' ' A' ' 8' ' ' ALA . 2.6 pp -79.94 -33.61 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.254 -0.904 . . . . 0.0 110.54 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.502 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -47.85 -51.67 45.05 Favored Pre-proline 0 N--CA 1.503 2.187 0 O-C-N 121.28 -0.888 . . . . 0.0 110.206 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 31.0 Cg_endo -65.21 -12.22 33.77 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.238 1.959 . . . . 0.0 110.938 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.427 ' HB3' HD11 ' A' ' 71' ' ' ILE . 2.7 m -121.85 17.33 11.01 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 176.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.446 ' O ' ' CB ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -62.73 -50.1 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 121.381 -0.128 . . . . 0.0 110.802 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 21' ' ' GLN . 18.7 m -57.46 -46.84 83.19 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.338 -0.851 . . . . 0.0 109.33 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.517 ' CD2' HG12 ' A' ' 71' ' ' ILE . 0.9 OUTLIER -61.26 -62.0 2.15 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.787 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.486 ' N ' HD12 ' A' ' 71' ' ' ILE . . . -55.78 -35.46 66.28 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.153 -0.967 . . . . 0.0 110.436 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.46 ' HB2' ' CG1' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -73.85 -1.69 20.54 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.587 -0.696 . . . . 0.0 111.3 -179.151 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.88 21.24 47.39 Favored Glycine 0 N--CA 1.501 3.009 0 O-C-N 120.678 -1.264 . . . . 0.0 110.902 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 16' ' ' SER . 34.3 mm-40 -140.41 50.01 1.7 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.201 -1.176 . . . . 0.0 109.612 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -150.38 -64.75 0.01 OUTLIER Glycine 0 N--CA 1.501 2.975 0 O-C-N 121.019 -1.051 . . . . 0.0 110.833 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 71.8 -58.02 0.6 Allowed 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.642 -0.916 . . . . 0.0 109.485 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.59 112.06 3.64 Favored Glycine 0 N--CA 1.498 2.779 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.75 173.63 12.36 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 122.611 2.207 . . . . 0.0 110.751 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.1 p -110.25 134.93 51.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.57 -0.706 . . . . 0.0 109.362 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -45.99 -54.77 7.8 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.776 -0.578 . . . . 0.0 110.887 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.97 -39.43 89.29 Favored Glycine 0 N--CA 1.503 3.103 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 44.1 t -63.55 -49.48 73.31 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 118.764 -1.174 . . . . 0.0 109.828 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.422 ' HA ' ' HB3' ' A' ' 75' ' ' CYS . 68.2 m -69.07 -42.99 75.47 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.483 -176.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.494 ' O ' ' HG2' ' A' ' 34' ' ' ARG . 72.5 p -68.31 -47.26 68.03 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 124.355 1.034 . . . . 0.0 110.012 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -53.91 -55.19 27.01 Favored Glycine 0 N--CA 1.498 2.782 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.473 ' HA ' ' HG ' ' A' ' 36' ' ' LEU . 17.4 t -63.81 -44.59 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.486 -1.008 . . . . 0.0 110.257 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 31' ' ' SER . 7.8 ptm180 -57.71 -22.61 47.38 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.111 -0.993 . . . . 0.0 109.694 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.1 t -92.65 -55.14 3.49 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.3 -0.875 . . . . 0.0 109.461 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.473 ' HG ' ' HA ' ' A' ' 33' ' ' VAL . 3.5 pp -58.25 -28.43 64.89 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.497 -0.752 . . . . 0.0 110.89 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.488 ' CB ' HG11 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -64.85 -42.69 94.69 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.945 -1.097 . . . . 0.0 108.719 179.523 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -63.5 -29.2 70.51 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.93 8.83 35.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.679 -0.638 . . . . 0.0 110.102 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.508 ' CB ' ' HB ' ' A' ' 2' ' ' ILE . . . -166.91 51.5 0.07 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.763 -1.21 . . . . 0.0 111.454 -179.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.463 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 2.3 mpt_? -135.27 44.7 2.55 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.527 -0.733 . . . . 0.0 109.596 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.421 ' O ' ' OG1' ' A' ' 43' ' ' THR . 6.7 m -95.38 -45.96 6.91 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.344 -0.847 . . . . 0.0 109.278 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 42' ' ' THR . 1.4 m 160.52 -51.48 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.453 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.73 -45.81 84.91 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 177.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.592 ' HB3' HG22 ' A' ' 2' ' ' ILE . 3.1 m-20 -63.69 -50.93 67.27 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.575 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.407 ' HD3' ' HG3' ' A' ' 41' ' ' ARG . 8.9 mtm180 -59.94 -39.07 84.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.738 -0.601 . . . . 0.0 109.792 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.431 ' NH1' ' HG2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -62.2 -44.45 96.56 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.227 -0.92 . . . . 0.0 108.957 179.165 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.55 -46.62 75.5 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.539 ' HB1' ' CG1' ' A' ' 2' ' ' ILE 0.252 . . -61.45 -55.36 32.18 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.865 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.537 ' C ' ' SG ' ' A' ' 89' ' ' CYS . 12.0 t -48.23 -36.86 14.69 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 174.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -58.55 -56.33 23.48 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 42.3 t -70.06 -31.12 68.57 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 118.388 -1.325 . . . . 0.0 111.621 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.52 HD23 HG21 ' A' ' 83' ' ' ILE . 75.5 mt -58.83 -48.61 80.72 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 124.101 0.876 . . . . 0.0 109.598 176.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.573 ' HD3' ' SG ' ' A' ' 89' ' ' CYS . 7.5 mtpp -61.12 -38.25 85.67 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -65.71 -47.49 75.2 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.822 -0.548 . . . . 0.0 109.706 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.79 -44.75 63.46 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.416 -0.803 . . . . 0.0 109.977 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.53 -55.36 29.94 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.74 62.56 1.08 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.392 -0.818 . . . . 0.0 108.912 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 61' ' ' SER . . . -179.75 -28.91 0.05 OUTLIER Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.46 ' CG1' ' HB2' ' A' ' 19' ' ' ARG . 74.5 t -65.92 53.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.507 0 O-C-N 121.254 -1.145 . . . . 0.0 110.992 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 59' ' ' GLY . 56.5 p 49.12 -138.11 0.92 Allowed 'General case' 0 N--CA 1.504 2.244 0 O-C-N 120.6 -1.312 . . . . 0.0 110.093 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.96 71.65 2.82 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 108.496 -1.842 . . . . 0.0 108.496 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 1.8 pp -63.13 158.96 18.47 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 122.01 -0.7 . . . . 0.0 110.582 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -106.62 107.87 19.09 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.36 -55.22 4.21 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.743 -0.598 . . . . 0.0 110.152 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -57.69 -41.9 94.02 Favored Glycine 0 N--CA 1.498 2.799 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 3.2 m120 -60.31 -57.5 12.51 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.313 -1.11 . . . . 0.0 109.309 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.424 ' O ' ' HD2' ' A' ' 72' ' ' PRO . . . -58.71 -41.19 85.75 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.788 -0.57 . . . . 0.0 110.173 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.471 ' HB1' ' HB ' ' A' ' 82' ' ' THR . . . -71.64 -46.01 60.33 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.313 -0.867 . . . . 0.0 110.235 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 94.1 p -61.16 -36.25 79.31 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.623 -0.673 . . . . 0.0 110.802 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.517 HG12 ' CD2' ' A' ' 17' ' ' TYR . 18.7 mt -47.83 -74.23 0.08 OUTLIER Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 121.611 -0.681 . . . . 0.0 111.364 -178.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.519 ' HG3' ' CG1' ' A' ' 83' ' ' ILE . 28.6 Cg_endo -58.82 -49.75 10.78 Favored 'Trans proline' 0 N--CA 1.481 0.779 0 C-N-CA 121.681 1.587 . . . . 0.0 111.499 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.4 p -51.66 -68.71 0.15 Allowed 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.525 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.4 pttt -64.25 -37.95 89.29 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.621 -0.674 . . . . 0.0 110.973 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 30' ' ' CYS . 1.7 m -47.11 -35.54 7.22 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.325 -0.859 . . . . 0.0 111.888 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.79 40.84 0.16 Allowed Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 177.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.488 HG11 ' CB ' ' A' ' 37' ' ' ASN . 4.0 t -131.16 106.89 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.521 -0.988 . . . . 0.0 109.313 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.53 73.4 0.75 Allowed 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.691 0.758 . . . . 0.0 109.716 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.48 HD12 ' HB2' ' A' ' 72' ' ' PRO . 0.8 OUTLIER -121.66 109.49 34.31 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.296 -0.877 . . . . 0.0 109.319 179.735 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.14 -23.58 45.45 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 123.105 2.537 . . . . 0.0 112.618 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.45 ' C ' ' CD1' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -82.43 171.13 14.51 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.378 -0.826 . . . . 0.0 109.922 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.471 ' HB ' ' HB1' ' A' ' 69' ' ' ALA . 51.9 p -122.81 164.67 17.94 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.118 -0.989 . . . . 0.0 110.137 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.52 HG21 HD23 ' A' ' 53' ' ' LEU . 5.3 mm -93.24 40.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.88 162.41 15.85 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.384 0.611 . . . . 0.0 110.032 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 68.6 p -62.03 -33.17 73.88 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.5 p -70.22 64.95 0.26 Allowed 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.648 0.737 . . . . 0.0 109.439 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.6 m -168.08 155.22 8.01 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.345 -0.847 . . . . 0.0 109.0 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -132.95 152.91 51.86 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.002 -1.061 . . . . 0.0 111.285 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.573 ' SG ' ' HD3' ' A' ' 54' ' ' LYS . 4.2 m -94.82 60.89 2.52 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.409 178.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 37.2 p -135.62 -51.5 0.74 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.551 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -98.78 5.91 47.22 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.647 -0.658 . . . . 0.0 110.792 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 94.3 t -82.84 106.33 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 120.997 -1.064 . . . . 0.0 108.785 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.8 m120 . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 117.053 -1.451 . . . . 0.0 109.32 -179.752 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.493 HG12 ' CA ' ' A' ' 40' ' ' ALA . 5.1 tp . . . . . 0 N--CA 1.509 2.48 0 CA-C-O 121.666 0.745 . . . . 0.0 111.37 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 5' ' ' GLY . 23.4 t -124.08 66.9 1.05 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.023 -1.048 . . . . 0.0 109.485 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.0 t 62.8 -56.29 0.16 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 3' ' ' SER . . . -49.6 -43.91 37.3 Favored Glycine 0 N--CA 1.506 3.312 0 CA-C-N 119.458 1.026 . . . . 0.0 110.556 177.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.473 ' NE2' ' HB3' ' A' ' 36' ' ' LEU . 0.4 OUTLIER -78.99 -39.73 33.43 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.414 -1.051 . . . . 0.0 108.856 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 56.6 t -55.24 -46.6 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.64 -31.31 65.01 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.435 ' HB2' ' HA ' ' A' ' 6' ' ' GLN . 58.6 m -68.35 -22.12 64.69 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.132 -0.98 . . . . 0.0 109.463 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.77 -29.71 14.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.515 -0.741 . . . . 0.0 109.071 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 tp -82.83 -41.0 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.514 -0.741 . . . . 0.0 110.527 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.493 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -42.42 -52.06 10.64 Favored Pre-proline 0 N--CA 1.504 2.268 0 O-C-N 121.757 -0.589 . . . . 0.0 111.399 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 36.9 Cg_endo -64.23 -23.76 66.01 Favored 'Trans proline' 0 N--CA 1.484 0.923 0 C-N-CA 121.977 1.785 . . . . 0.0 110.386 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.588 ' SG ' HG22 ' A' ' 71' ' ' ILE . 1.4 m -109.36 19.37 19.43 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 176.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 16' ' ' SER . 0.4 OUTLIER -66.07 -50.24 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.86 177.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.426 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 51.4 p -55.73 -50.94 69.0 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.39 -0.818 . . . . 0.0 108.875 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.422 ' CG ' HD13 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -57.29 -57.76 11.19 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.393 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' A' ' 64' ' ' ASN . . . -67.76 -5.99 18.92 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.58 -0.7 . . . . 0.0 110.172 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.8 ttt-85 -100.05 -18.01 17.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.406 -0.809 . . . . 0.0 109.999 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 133.8 -20.82 4.04 Favored Glycine 0 N--CA 1.503 3.108 0 O-C-N 120.859 -1.151 . . . . 0.0 111.577 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -123.01 92.46 3.71 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.03 -1.277 . . . . 0.0 110.463 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 17' ' ' TYR . . . -156.12 -60.18 0.01 OUTLIER Glycine 0 N--CA 1.504 3.176 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.3 p 73.91 -62.65 0.46 Allowed 'General case' 0 N--CA 1.507 2.409 0 O-C-N 122.061 -0.67 . . . . 0.0 111.278 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -114.82 139.44 15.59 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 110.476 -1.049 . . . . 0.0 110.476 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.01 173.14 9.77 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 122.552 2.168 . . . . 0.0 110.911 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 69.3 p -124.48 149.6 46.66 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.303 -0.873 . . . . 0.0 110.321 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.38 -45.62 69.32 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.608 -0.683 . . . . 0.0 110.115 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.16 -39.06 97.16 Favored Glycine 0 N--CA 1.5 2.931 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 40.2 t -66.43 -45.57 79.41 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 119.016 -1.074 . . . . 0.0 110.589 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 88.7 m -71.36 -38.49 71.57 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.343 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.6 p -68.7 -39.81 80.32 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 124.166 0.916 . . . . 0.0 109.668 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.41 -52.98 38.78 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.533 HG13 ' CB ' ' A' ' 72' ' ' PRO . 43.2 t -62.5 -44.88 99.73 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.367 -1.079 . . . . 0.0 109.134 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.579 ' HA ' ' CG1' ' A' ' 77' ' ' VAL . 6.4 tpm_? -54.78 -32.39 60.01 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.5 m -75.17 -45.89 37.77 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 40' ' ' ALA . 0.4 OUTLIER -62.99 -39.68 95.48 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.482 -0.761 . . . . 0.0 110.062 179.602 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -60.42 -42.35 95.86 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.326 -0.859 . . . . 0.0 109.684 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -64.1 -44.39 92.42 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.513 -0.742 . . . . 0.0 109.004 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.42 ' HB1' ' HB ' ' A' ' 2' ' ' ILE . . . -75.94 -50.3 15.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.777 -0.577 . . . . 0.0 110.349 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 36' ' ' LEU . . . -74.35 59.43 0.79 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.058 -1.026 . . . . 0.0 109.792 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.486 ' HA ' ' HD3' ' A' ' 46' ' ' ARG . 7.0 mtt-85 -147.94 18.48 1.12 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.036 -1.04 . . . . 0.0 111.082 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.453 ' O ' ' HB ' ' A' ' 43' ' ' THR . 9.9 t -111.26 28.14 9.01 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.116 -0.99 . . . . 0.0 109.652 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.504 ' CG2' ' HB3' ' A' ' 93' ' ' ASN . 46.3 m 70.95 -61.77 0.47 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.76 -0.588 . . . . 0.0 110.127 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.48 -60.12 3.61 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.786 -0.571 . . . . 0.0 111.118 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -72.54 -28.93 63.15 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.586 -0.696 . . . . 0.0 110.775 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.486 ' HD3' ' HA ' ' A' ' 41' ' ' ARG . 7.6 mmm-85 -53.13 -51.75 60.93 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.396 -0.815 . . . . 0.0 109.47 179.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.519 ' HD2' ' HB2' ' A' ' 93' ' ' ASN . 1.0 OUTLIER -62.12 -51.62 67.17 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.411 -0.805 . . . . 0.0 110.361 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.83 -44.74 90.95 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.63 -0.669 . . . . 0.0 109.733 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.52 -47.67 85.14 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.435 ' C ' ' SG ' ' A' ' 89' ' ' CYS . 37.9 t -59.37 -38.48 80.59 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.018 177.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -64.46 -54.16 36.85 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 123.772 0.67 . . . . 0.0 109.596 176.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . 0.429 ' HA ' ' ND2' ' A' ' 55' ' ' ASN . 39.3 t -63.65 -31.04 72.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.896 -1.127 . . . . 0.0 110.566 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.476 HD12 HG12 ' A' ' 83' ' ' ILE . 26.3 mt -63.67 -46.56 85.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 124.365 1.041 . . . . 0.0 109.008 175.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -55.04 -49.93 70.36 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.429 ' ND2' ' HA ' ' A' ' 52' ' ' CYS . 1.3 p30 -65.66 -33.61 76.3 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.247 -0.908 . . . . 0.0 109.489 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.423 ' O ' HG22 ' A' ' 60' ' ' VAL . . . -66.92 -56.78 8.75 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.327 -0.858 . . . . 0.0 108.743 178.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.62 -56.9 15.74 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.572 -0.705 . . . . 0.0 109.167 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.9 66.45 1.15 Allowed 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.17 -28.05 0.1 OUTLIER Glycine 0 N--CA 1.501 3.014 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -178.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 56' ' ' ALA . 2.8 t -46.92 -21.92 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.736 -0.861 . . . . 0.0 111.06 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.6 m 74.8 83.45 0.1 Allowed 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.82 36.82 7.61 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.474 HD11 ' O ' ' A' ' 84' ' ' SER . 3.7 pp -56.02 138.87 48.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.661 -0.905 . . . . 0.0 110.22 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 18' ' ' ALA . 1.6 m-80 -109.25 88.27 2.69 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -48.28 -41.8 28.93 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.654 -0.654 . . . . 0.0 109.983 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -52.3 -47.23 56.47 Favored Glycine 0 N--CA 1.501 2.999 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 30.7 m-20 -82.14 -50.2 9.3 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.568 -0.96 . . . . 0.0 109.262 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.422 ' O ' ' CD ' ' A' ' 72' ' ' PRO . . . -51.2 -43.0 61.27 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.996 -0.44 . . . . 0.0 111.987 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.75 -45.95 19.98 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.141 -0.975 . . . . 0.0 110.217 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.4 m -61.92 -43.47 98.78 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.618 -0.676 . . . . 0.0 110.619 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.588 HG22 ' SG ' ' A' ' 14' ' ' CYS . 44.0 mt -42.58 -64.3 0.74 Allowed Pre-proline 0 N--CA 1.504 2.273 0 O-C-N 121.864 -0.522 . . . . 0.0 111.109 -179.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.533 ' CB ' HG13 ' A' ' 33' ' ' VAL . 46.0 Cg_endo -62.69 -60.33 0.19 Allowed 'Trans proline' 0 C--N 1.322 -0.816 0 C-N-CA 122.124 1.882 . . . . 0.0 110.682 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.4 m -45.2 -61.22 1.74 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.942 -0.474 . . . . 0.0 109.919 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.87 -39.98 95.46 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 1.2 m -50.11 -34.66 22.75 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.826 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.415 ' O ' ' HD2' ' A' ' 34' ' ' ARG . . . 135.36 46.62 0.09 OUTLIER Glycine 0 N--CA 1.494 2.553 0 C-N-CA 119.584 -1.293 . . . . 0.0 111.344 175.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.579 ' CG1' ' HA ' ' A' ' 34' ' ' ARG . 16.4 m -135.57 126.47 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 CA-C-N 118.776 1.288 . . . . 0.0 111.084 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.3 p -99.92 70.96 1.63 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.366 0.603 . . . . 0.0 109.707 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 tp -92.97 138.24 23.41 Favored Pre-proline 0 N--CA 1.505 2.31 0 O-C-N 121.213 -0.929 . . . . 0.0 109.456 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -59.49 -44.81 29.85 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 122.38 2.053 . . . . 0.0 111.555 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -94.6 135.98 35.43 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.014 -1.054 . . . . 0.0 110.906 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.1 m -91.91 163.12 14.14 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.476 HG12 HD12 ' A' ' 53' ' ' LEU . 4.5 mp -121.27 118.18 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.819 -1.175 . . . . 0.0 110.99 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.474 ' O ' HD11 ' A' ' 63' ' ' LEU . 2.5 t -123.47 -72.19 0.69 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 98.2 m -133.13 -69.32 0.56 Allowed 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.8 m -113.43 -24.46 9.29 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.444 HG23 ' N ' ' A' ' 88' ' ' ASP . 54.6 m 54.63 -100.18 0.1 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.801 -0.562 . . . . 0.0 110.806 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.444 ' N ' HG23 ' A' ' 87' ' ' THR . 20.7 t0 -157.97 -70.74 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.272 -0.893 . . . . 0.0 110.062 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.435 ' SG ' ' C ' ' A' ' 50' ' ' CYS . 14.0 m 58.92 50.99 7.74 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 121.339 0.59 . . . . 0.0 111.645 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.2 t -161.37 -38.15 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.282 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -94.16 9.26 38.57 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.684 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.9 t -109.0 139.49 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.519 ' HB2' ' HD2' ' A' ' 47' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.499 2.007 0 O-C-N 121.556 -0.715 . . . . 0.0 109.635 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.501 HD11 ' HB2' ' A' ' 36' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.502 2.148 0 CA-C-O 121.716 0.77 . . . . 0.0 109.167 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.6 t -152.06 82.35 1.26 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.675 -1.265 . . . . 0.0 111.168 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.4 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 2.6 t 66.43 -59.85 0.34 Allowed 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 177.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -46.01 -58.51 5.57 Favored Glycine 0 N--CA 1.506 3.366 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 178.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -78.49 -34.11 47.72 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.54 -0.976 . . . . 0.0 108.93 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.43 HG11 ' CD2' ' A' ' 53' ' ' LEU . 8.3 t -53.39 -39.93 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.421 ' HA ' ' CD1' ' A' ' 11' ' ' ILE . . . -68.81 -35.23 76.75 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.1 p -71.75 -21.37 61.75 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.431 -0.793 . . . . 0.0 109.778 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.1 -46.74 13.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.525 -0.734 . . . . 0.0 110.429 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.421 ' CD1' ' HA ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -79.96 -25.63 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 O-C-N 121.09 -1.006 . . . . 0.0 110.984 -178.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.458 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -47.45 -55.02 17.98 Favored Pre-proline 0 N--CA 1.502 2.15 0 O-C-N 121.132 -0.98 . . . . 0.0 110.1 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 57.8 Cg_endo -70.9 -26.71 21.89 Favored 'Trans proline' 0 C--N 1.322 -0.84 0 C-N-CA 122.106 1.871 . . . . 0.0 110.555 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.603 ' SG ' HG23 ' A' ' 71' ' ' ILE . 1.1 m -97.4 15.46 22.99 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.744 -0.783 . . . . 0.0 112.442 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.445 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 0.4 OUTLIER -63.19 -45.03 99.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.712 179.082 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.404 ' OG ' ' N ' ' A' ' 17' ' ' TYR . 39.1 p -65.26 -59.29 4.22 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.343 -0.848 . . . . 0.0 109.549 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.404 ' N ' ' OG ' ' A' ' 16' ' ' SER . 1.5 t80 -53.82 -56.08 20.78 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.76 -33.38 68.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.577 -0.702 . . . . 0.0 110.036 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.445 ' HB3' ' O ' ' A' ' 15' ' ' ILE . 24.2 ttm180 -76.7 -32.39 57.83 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.562 -0.711 . . . . 0.0 109.838 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.24 -20.81 3.16 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -85.48 77.24 9.93 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.305 -1.115 . . . . 0.0 109.352 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.7 -158.08 28.77 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.15 -43.74 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.676 -0.896 . . . . 0.0 109.089 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -102.14 141.24 15.2 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.683 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 27.0 Cg_endo -61.03 127.98 23.92 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 121.945 1.763 . . . . 0.0 110.894 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.7 t -62.33 142.16 57.93 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.704 -0.622 . . . . 0.0 110.134 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.52 -61.04 2.57 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.608 -0.682 . . . . 0.0 109.805 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.57 -41.06 80.62 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.527 ' SG ' ' CG2' ' A' ' 71' ' ' ILE . 42.8 t -57.56 -49.36 76.62 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.859 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.683 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 24.9 m -60.5 -34.8 74.59 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 120.674 0.273 . . . . 0.0 110.687 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.9 t -68.75 -50.86 47.13 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.102 175.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.59 -38.26 95.55 Favored Glycine 0 N--CA 1.501 3.013 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.5 HG12 ' HA ' ' A' ' 72' ' ' PRO . 12.8 t -83.57 -52.68 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.403 -1.057 . . . . 0.0 110.707 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.524 ' HA ' ' CG1' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -57.77 -18.23 20.37 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.472 -0.768 . . . . 0.0 110.861 -179.685 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 89.9 p -94.97 -40.69 9.54 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.223 -0.923 . . . . 0.0 109.278 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.501 ' HB2' HD11 ' A' ' 2' ' ' ILE . 0.8 OUTLIER -54.15 -35.89 62.74 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.052 -1.03 . . . . 0.0 109.675 179.265 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.33 -19.2 64.41 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.44 -0.788 . . . . 0.0 109.668 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -87.44 -27.62 22.6 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.46 -30.3 18.4 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.652 -0.655 . . . . 0.0 110.385 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.473 ' HB1' HG12 ' A' ' 2' ' ' ILE . . . -84.41 -148.27 0.1 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.299 -0.876 . . . . 0.0 110.744 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 69.43 23.15 6.19 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.25 -0.906 . . . . 0.0 111.055 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.439 ' O ' ' HB ' ' A' ' 43' ' ' THR . 6.3 t -123.77 15.44 9.41 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.998 -1.064 . . . . 0.0 110.533 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 85.4 m 76.7 -66.94 0.23 Allowed 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.22 -0.925 . . . . 0.0 109.973 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.99 -58.51 6.29 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.213 0.53 . . . . 0.0 110.509 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.467 ' HB3' HG21 ' A' ' 2' ' ' ILE . 24.8 m-20 -70.77 -33.01 70.33 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.453 -0.779 . . . . 0.0 109.184 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.588 ' HG3' ' CE1' ' A' ' 81' ' ' TYR . 0.2 OUTLIER -56.32 -54.8 41.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.543 -0.723 . . . . 0.0 109.858 179.621 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -68.26 -43.0 78.76 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.492 -0.755 . . . . 0.0 109.574 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.36 -48.41 74.29 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.407 ' HB1' HG13 ' A' ' 2' ' ' ILE . . . -66.23 -49.4 67.35 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.476 ' SG ' ' O ' ' A' ' 88' ' ' ASP . 1.6 t -56.53 -41.14 76.26 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -57.61 -58.3 8.94 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 124.231 0.957 . . . . 0.0 110.285 177.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 48.6 t -67.91 -34.35 76.45 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 118.724 -1.19 . . . . 0.0 111.749 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.572 HD23 HD11 ' A' ' 83' ' ' ILE . 15.3 mt -59.22 -41.46 88.71 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.525 175.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.7 ttmt -64.63 -38.58 91.49 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -54.85 -36.27 64.88 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.43 -55.84 4.76 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.521 ' HB3' HG21 ' A' ' 83' ' ' ILE . . . -56.26 -36.02 68.09 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.309 -0.869 . . . . 0.0 110.814 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -93.04 17.02 11.46 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.34 -0.85 . . . . 0.0 110.856 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -143.68 -25.63 0.15 Allowed Glycine 0 N--CA 1.507 3.374 0 O-C-N 121.061 -1.024 . . . . 0.0 111.631 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.8 t -55.53 123.91 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.199 -1.177 . . . . 0.0 110.46 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.8 t -64.67 114.61 4.54 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.563 -0.711 . . . . 0.0 109.611 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 63' ' ' LEU . . . 103.1 -49.94 0.93 Allowed Glycine 0 N--CA 1.499 2.849 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 57' ' ' ALA . 3.4 tm? 19.86 100.65 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.764 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.406 ' O ' ' N ' ' A' ' 67' ' ' ASN . 1.0 OUTLIER -97.32 87.52 4.17 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.475 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -38.61 -45.85 1.13 Allowed 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.605 -0.684 . . . . 0.0 111.192 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.41 -35.36 55.91 Favored Glycine 0 N--CA 1.504 3.19 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 64' ' ' ASN . 7.0 m-20 -89.57 -46.58 8.56 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.776 -0.838 . . . . 0.0 109.063 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.514 ' HB2' ' HB ' ' A' ' 83' ' ' ILE . . . -51.24 -49.85 60.32 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.95 -0.469 . . . . 0.0 110.347 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.77 -26.8 60.83 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.333 -0.855 . . . . 0.0 109.835 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.9 m -68.83 -36.89 78.74 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.379 -0.825 . . . . 0.0 110.698 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.603 HG23 ' SG ' ' A' ' 14' ' ' CYS . 10.6 mt -53.45 -61.93 4.34 Favored Pre-proline 0 N--CA 1.5 2.034 0 O-C-N 121.675 -0.641 . . . . 0.0 110.465 -179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.5 ' HA ' HG12 ' A' ' 33' ' ' VAL . 28.3 Cg_endo -61.26 -60.96 0.19 Allowed 'Trans proline' 0 C--N 1.323 -0.785 0 C-N-CA 121.794 1.663 . . . . 0.0 111.032 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 77.7 p -46.77 -64.09 0.86 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.966 -0.459 . . . . 0.0 111.057 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -62.67 -44.69 95.62 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 119.571 -0.252 . . . . 0.0 111.346 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 1.6 m -46.88 -43.99 19.26 Favored 'General case' 0 N--CA 1.506 2.335 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.673 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 146.86 50.44 0.03 OUTLIER Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.186 -1.483 . . . . 0.0 111.52 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.524 ' CG1' ' HA ' ' A' ' 34' ' ' ARG . 32.9 m -135.07 136.46 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-N 119.243 1.521 . . . . 0.0 111.064 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.3 p -106.82 62.65 0.63 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.504 HG12 ' CE1' ' A' ' 81' ' ' TYR . 3.2 tp -116.64 126.24 27.7 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.426 -0.796 . . . . 0.0 109.354 -179.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.97 -38.11 93.41 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 C-N-CA 122.662 2.241 . . . . 0.0 112.083 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.588 ' CE1' ' HG3' ' A' ' 46' ' ' ARG . 14.0 p90 -90.27 113.99 25.93 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.879 -1.138 . . . . 0.0 109.941 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.5 ' C ' HD12 ' A' ' 83' ' ' ILE . 81.9 p -113.71 -135.55 0.36 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.532 -0.73 . . . . 0.0 109.119 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.572 HD11 HD23 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -123.51 51.59 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.111 -0.993 . . . . 0.0 108.648 -179.53 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.7 p -89.45 9.83 24.96 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.858 -0.526 . . . . 0.0 111.794 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.5 m 72.07 -59.89 0.54 Allowed 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.285 -0.884 . . . . 0.0 110.104 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.7 p -73.14 -58.08 3.56 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.1 m 31.58 -144.63 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.941 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.996 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.476 ' O ' ' SG ' ' A' ' 50' ' ' CYS . 31.6 t70 -155.51 142.55 19.16 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.609 -1.307 . . . . 0.0 110.58 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.2 m -137.06 54.69 1.85 Allowed 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.964 0.888 . . . . 0.0 110.421 176.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.0 t -164.08 -51.52 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.58 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.27 26.06 6.32 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.575 HG23 ' HB3' ' A' ' 81' ' ' TYR . 5.0 p -110.32 15.75 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.82 -0.55 . . . . 0.0 110.842 -178.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 1.9 p-10 . . . . . 0 N--CA 1.505 2.291 0 CA-C-O 115.308 -2.282 . . . . 0.0 111.078 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.507 ' CD1' ' HB3' ' A' ' 49' ' ' ALA . 2.9 tp . . . . . 0 N--CA 1.509 2.479 0 CA-C-O 121.735 0.778 . . . . 0.0 111.74 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.7 t -95.72 152.9 18.05 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.996 -1.065 . . . . 0.0 110.279 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.411 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 13.0 t -53.63 -27.69 28.49 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 115.407 -0.815 . . . . 0.0 113.113 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.34 -55.85 27.79 Favored Glycine 0 N--CA 1.502 3.034 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 176.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.473 ' HG3' ' N ' ' A' ' 7' ' ' VAL . 5.5 pt20 -71.39 -34.99 70.9 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.209 -1.171 . . . . 0.0 109.442 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.493 ' CG1' ' HG ' ' A' ' 53' ' ' LEU . 37.6 t -56.62 -49.16 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.492 ' HA ' ' CD1' ' A' ' 11' ' ' ILE . . . -70.09 -34.29 72.95 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 t -73.03 -22.26 60.67 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.116 -0.99 . . . . 0.0 110.149 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.21 -43.73 23.27 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.298 -0.876 . . . . 0.0 110.427 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.492 ' CD1' ' HA ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -85.59 -16.73 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.038 -1.039 . . . . 0.0 110.413 -179.691 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.47 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -48.62 -54.98 21.89 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.38 -0.825 . . . . 0.0 110.167 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 41.4 Cg_endo -67.56 -22.84 43.91 Favored 'Trans proline' 0 N--CA 1.481 0.763 0 C-N-CA 122.142 1.894 . . . . 0.0 110.585 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.754 ' SG ' HG23 ' A' ' 71' ' ' ILE . 10.6 m -102.28 11.7 37.76 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.607 178.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.518 ' O ' ' CB ' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -59.94 -39.54 80.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.049 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.68 -57.97 5.46 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.59 -0.694 . . . . 0.0 109.558 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.565 ' CD1' ' HA2' ' A' ' 22' ' ' GLY . 0.9 OUTLIER -58.37 -57.21 13.93 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.62 -0.675 . . . . 0.0 109.272 179.594 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.31 -22.98 21.1 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.335 -0.853 . . . . 0.0 109.916 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.518 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 9.2 tmm_? -95.19 0.02 53.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.619 -0.676 . . . . 0.0 110.75 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 123.16 -17.86 7.95 Favored Glycine 0 N--CA 1.501 2.988 0 O-C-N 120.339 -1.475 . . . . 0.0 112.166 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -83.06 69.48 9.85 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-N 119.084 1.442 . . . . 0.0 109.476 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.565 ' HA2' ' CD1' ' A' ' 17' ' ' TYR . . . -74.05 77.19 1.0 Allowed Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.2 p -101.25 -37.06 8.68 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.68 -0.894 . . . . 0.0 109.755 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 172.97 131.64 1.41 Allowed Glycine 0 N--CA 1.501 3.021 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -60.72 119.02 5.96 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 C-N-CA 122.272 1.982 . . . . 0.0 110.442 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.25 135.38 48.92 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.377 -0.827 . . . . 0.0 110.707 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.68 -48.87 71.86 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.783 -0.573 . . . . 0.0 109.587 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.95 -43.75 92.81 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 30.5 t -60.1 -46.52 89.31 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.53 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 96.5 m -64.63 -39.32 93.5 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.283 -177.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.77 -42.24 77.7 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 124.462 1.101 . . . . 0.0 110.031 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.36 -53.94 37.6 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.564 ' CG1' HG23 ' A' ' 77' ' ' VAL . 2.8 t -68.6 -44.83 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.572 -0.957 . . . . 0.0 109.21 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.432 ' HD2' ' O ' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -53.23 -35.71 60.24 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.956 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.4 m -73.53 -48.31 34.07 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -59.77 -34.13 72.59 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.736 -1.227 . . . . 0.0 107.938 177.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.435 ' HB2' HG12 ' A' ' 77' ' ' VAL . 66.0 t30 -52.28 -42.87 64.09 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.601 -0.687 . . . . 0.0 110.212 178.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -93.12 -24.06 18.4 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.18 -0.95 . . . . 0.0 110.703 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.464 ' O ' ' HB ' ' A' ' 2' ' ' ILE . . . -106.63 33.85 3.7 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.956 -1.09 . . . . 0.0 110.372 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.464 ' HB1' HD11 ' A' ' 2' ' ' ILE . . . -168.62 85.78 0.18 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.165 -0.959 . . . . 0.0 110.669 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.467 ' HA ' ' CD ' ' A' ' 46' ' ' ARG . 15.2 mtt180 -158.86 24.31 0.22 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.204 -0.935 . . . . 0.0 111.028 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.419 ' O ' ' HB ' ' A' ' 43' ' ' THR . 8.9 m -110.82 42.16 1.66 Allowed 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.973 -1.079 . . . . 0.0 110.796 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.49 HG21 ' HB3' ' A' ' 93' ' ' ASN . 52.0 m 68.8 -65.72 0.27 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.158 -0.964 . . . . 0.0 109.469 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 42' ' ' THR . . . -56.82 -51.9 67.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.902 -0.499 . . . . 0.0 109.731 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.465 ' HB3' HG23 ' A' ' 2' ' ' ILE . 12.6 m-20 -58.42 -48.61 80.12 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.273 0.558 . . . . 0.0 109.797 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.467 ' CD ' ' HA ' ' A' ' 41' ' ' ARG . 13.5 mtm180 -67.39 -48.66 66.74 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.943 -0.473 . . . . 0.0 111.145 -178.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -63.39 -50.86 68.22 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.081 -1.012 . . . . 0.0 109.145 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.97 -47.7 77.16 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.507 ' HB3' ' CD1' ' A' ' 2' ' ' ILE . . . -63.7 -44.06 94.76 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.538 -0.726 . . . . 0.0 109.186 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.574 ' O ' ' SG ' ' A' ' 89' ' ' CYS . 38.4 t -57.39 -39.03 75.24 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 120.364 -0.534 . . . . 0.0 109.736 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -61.37 -56.12 23.94 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 124.03 0.832 . . . . 0.0 109.788 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 8.4 t -64.26 -35.16 79.94 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.544 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.493 ' HG ' ' CG1' ' A' ' 7' ' ' VAL . 8.0 mt -63.39 -44.47 94.61 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.061 176.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -59.67 -40.62 88.41 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -56.11 -47.23 78.46 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.65 -47.16 42.05 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.87 -41.66 64.52 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.59 -0.694 . . . . 0.0 110.136 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.98 1.53 39.35 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.541 -0.724 . . . . 0.0 110.199 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -125.63 9.48 7.68 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.405 ' O ' ' CB ' ' A' ' 61' ' ' SER . 4.9 t -73.58 -5.69 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.579 -0.953 . . . . 0.0 110.07 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER 76.59 -71.03 0.12 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.34 -0.85 . . . . 0.0 109.598 179.777 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 19' ' ' ARG . . . -109.48 59.33 0.36 Allowed Glycine 0 N--CA 1.499 2.859 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.547 HD13 ' HA ' ' A' ' 84' ' ' SER . 1.4 tm? -54.79 117.99 3.86 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.564 -0.962 . . . . 0.0 111.031 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.425 ' N ' HD12 ' A' ' 63' ' ' LEU . 8.0 t-20 -107.44 86.34 2.29 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.421 ' HA ' ' HB3' ' A' ' 84' ' ' SER . . . -42.91 -50.6 5.76 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.48 -44.19 85.4 Favored Glycine 0 N--CA 1.503 3.162 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -74.41 -55.17 6.28 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.707 -0.878 . . . . 0.0 109.585 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.402 ' HB2' ' HB ' ' A' ' 83' ' ' ILE . . . -51.43 -35.88 41.37 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.937 -0.477 . . . . 0.0 111.435 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.95 -40.0 17.48 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.133 -0.979 . . . . 0.0 110.014 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.0 t -65.17 -40.55 94.46 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.473 -0.767 . . . . 0.0 110.826 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.754 HG23 ' SG ' ' A' ' 14' ' ' CYS . 74.7 mt -51.7 -65.19 1.05 Allowed Pre-proline 0 N--CA 1.503 2.224 0 O-C-N 121.845 -0.534 . . . . 0.0 111.934 -178.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.528 ' CD ' ' HB ' ' A' ' 71' ' ' ILE . 41.1 Cg_endo -60.2 -40.54 58.96 Favored 'Trans proline' 0 N--CA 1.482 0.813 0 C-N-CA 121.908 1.739 . . . . 0.0 110.404 -179.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.6 m -55.52 -62.95 1.34 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -63.97 -39.63 94.57 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.893 -0.505 . . . . 0.0 109.84 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 1.3 m -48.28 -33.31 8.57 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.91 -0.494 . . . . 0.0 111.689 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 132.17 50.3 0.09 OUTLIER Glycine 0 N--CA 1.498 2.796 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 176.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.564 HG23 ' CG1' ' A' ' 33' ' ' VAL . 43.8 t -139.98 135.4 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.379 -1.071 . . . . 0.0 110.681 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.8 p -112.11 59.8 0.63 Allowed 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 122.219 1.009 . . . . 0.0 108.695 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.551 HD12 ' CE1' ' A' ' 81' ' ' TYR . 13.5 tt -125.07 122.56 25.39 Favored Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.46 -41.31 78.03 Favored 'Trans proline' 0 N--CA 1.486 1.084 0 C-N-CA 122.66 2.24 . . . . 0.0 112.092 -178.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.551 ' CE1' HD12 ' A' ' 79' ' ' ILE . 6.6 p90 -97.13 128.91 44.49 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.121 -0.987 . . . . 0.0 108.429 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.521 ' C ' HD13 ' A' ' 83' ' ' ILE . 40.2 p -128.59 -94.97 0.42 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.339 -0.851 . . . . 0.0 110.834 -178.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.521 HD13 ' C ' ' A' ' 82' ' ' THR . 1.4 mp -120.12 -51.79 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.265 -0.897 . . . . 0.0 109.639 -177.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.547 ' HA ' HD13 ' A' ' 63' ' ' LEU . 1.4 m -42.63 144.52 0.53 Allowed 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.309 0.576 . . . . 0.0 110.86 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 87' ' ' THR . 41.3 p -72.44 -130.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.7 t 63.03 -58.9 0.15 Allowed 'General case' 0 N--CA 1.508 2.438 0 O-C-N 120.97 -1.081 . . . . 0.0 111.012 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 85' ' ' THR . 3.4 m -61.11 140.62 57.84 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.387 -0.821 . . . . 0.0 109.789 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -83.67 134.35 34.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.578 -0.701 . . . . 0.0 111.025 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.574 ' SG ' ' O ' ' A' ' 50' ' ' CYS . 65.2 m -105.17 54.55 0.71 Allowed 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.836 0.827 . . . . 0.0 110.129 177.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 m -144.06 -40.89 0.28 Allowed 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 113.796 -1.547 . . . . 0.0 109.132 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -99.43 -30.45 12.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.504 -0.748 . . . . 0.0 109.806 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -47.64 142.77 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 121.297 -0.877 . . . . 0.0 110.391 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.49 ' HB3' HG21 ' A' ' 43' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.499 1.992 0 O-C-N 121.711 -0.618 . . . . 0.0 109.529 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.461 HD12 ' HB3' ' A' ' 49' ' ' ALA . 7.4 tp . . . . . 0 N--CA 1.51 2.574 0 CA-C-O 121.806 0.812 . . . . 0.0 111.603 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.8 t -118.59 161.62 19.74 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.878 -1.139 . . . . 0.0 110.268 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.3 t -53.66 -38.02 63.74 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.23 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.16 -37.18 94.08 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -83.93 -43.91 14.77 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.64 -0.918 . . . . 0.0 108.962 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.474 HG23 ' HA ' ' A' ' 49' ' ' ALA . 94.8 t -57.03 -40.58 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.64 -27.46 55.68 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 m -67.76 -22.64 65.21 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.399 -0.813 . . . . 0.0 109.247 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.502 ' C ' ' HD2' ' A' ' 13' ' ' PRO . . . -98.29 -29.23 13.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.517 -0.739 . . . . 0.0 109.075 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 tp -79.37 -41.53 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.487 -0.758 . . . . 0.0 110.515 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.486 ' HB2' ' HD3' ' A' ' 13' ' ' PRO . . . -46.41 -49.78 42.58 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 121.555 -0.716 . . . . 0.0 110.316 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.502 ' HD2' ' C ' ' A' ' 10' ' ' ALA . 22.6 Cg_exo -65.1 -24.61 59.25 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.044 1.829 . . . . 0.0 110.451 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.74 ' SG ' HG22 ' A' ' 71' ' ' ILE . 1.7 m -104.15 14.55 30.25 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 176.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -65.76 -50.68 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.706 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.41 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 0.2 OUTLIER -62.04 -57.31 12.11 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.57 -0.706 . . . . 0.0 109.133 179.02 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.526 ' CE2' HG12 ' A' ' 71' ' ' ILE . 1.1 t80 -54.17 -58.9 5.63 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.77 -35.49 66.31 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.514 -0.741 . . . . 0.0 109.858 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 29.5 ttm180 -74.53 -25.93 59.65 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.471 -0.768 . . . . 0.0 110.18 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.84 3.2 25.14 Favored Glycine 0 N--CA 1.5 2.929 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -103.82 70.7 1.02 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.1 -1.235 . . . . 0.0 109.484 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.05 -145.0 7.64 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.2 t 176.63 -54.29 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.809 -0.818 . . . . 0.0 109.514 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.61 118.4 4.65 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -56.71 132.42 51.63 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 122.568 2.179 . . . . 0.0 110.781 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.2 t -75.05 119.25 18.97 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.515 -0.741 . . . . 0.0 109.208 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.88 -46.01 51.22 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.692 -0.63 . . . . 0.0 109.986 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.98 -42.76 87.41 Favored Glycine 0 N--CA 1.499 2.868 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.449 ' O ' HG22 ' A' ' 33' ' ' VAL . 42.4 t -57.93 -46.08 85.6 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.88 -1.128 . . . . 0.0 109.53 177.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 75' ' ' CYS . 81.3 m -64.91 -41.97 95.12 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 123.855 0.722 . . . . 0.0 112.355 -177.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.5 t -70.68 -42.31 70.9 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 123.993 0.808 . . . . 0.0 110.192 176.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.95 -51.08 56.04 Favored Glycine 0 N--CA 1.498 2.819 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.507 HG11 HG13 ' A' ' 77' ' ' VAL . 4.8 t -70.47 -46.77 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.625 -0.927 . . . . 0.0 109.237 179.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.542 ' HA ' ' CG1' ' A' ' 77' ' ' VAL . 28.2 ttp180 -52.87 -36.66 59.42 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.4 t -74.29 -47.45 34.71 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.463 HD21 ' HA ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -55.83 -37.84 69.22 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.174 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . 0.471 ' HB2' ' CG1' ' A' ' 77' ' ' VAL . 2.6 t-20 -63.34 -33.97 76.68 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.471 -0.768 . . . . 0.0 108.962 178.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -78.12 -38.0 44.9 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -94.85 32.01 1.73 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.706 -0.621 . . . . 0.0 109.724 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.469 ' HA ' ' CB ' ' A' ' 45' ' ' ASP . . . -164.39 -159.51 0.48 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.468 -0.77 . . . . 0.0 110.541 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ARG . . . . . 0.438 ' HA ' ' HD3' ' A' ' 46' ' ' ARG . 1.4 mtp180 78.14 12.03 1.79 Allowed 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.974 -0.453 . . . . 0.0 111.598 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.497 ' O ' ' HB ' ' A' ' 43' ' ' THR . 0.9 OUTLIER -99.64 27.32 5.43 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 120.889 -1.132 . . . . 0.0 110.189 178.869 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.497 ' HB ' ' O ' ' A' ' 42' ' ' THR . 55.2 m 83.83 -67.44 0.06 Allowed 'General case' 0 N--CA 1.51 2.557 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.82 -55.42 34.6 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.683 -0.635 . . . . 0.0 109.427 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.469 ' CB ' ' HA ' ' A' ' 40' ' ' ALA . 8.8 m-20 -54.39 -46.05 73.01 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.438 ' HD3' ' HA ' ' A' ' 41' ' ' ARG . 9.5 mmm-85 -56.81 -44.54 82.06 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.446 ' HA ' ' NH1' ' A' ' 47' ' ' ARG . 0.7 OUTLIER -60.25 -50.52 73.31 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.984 -0.448 . . . . 0.0 110.385 -179.64 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.61 -39.53 80.71 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.78 -0.575 . . . . 0.0 109.727 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.474 ' HA ' HG23 ' A' ' 7' ' ' VAL . . . -71.62 -61.6 1.72 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -44.84 -41.85 7.42 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 176.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.482 ' O ' ' HG3' ' A' ' 54' ' ' LYS . 3.0 t30 -65.53 -56.02 14.62 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.394 177.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 16.8 t -64.39 -26.37 68.43 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 119.139 -1.025 . . . . 0.0 111.146 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.458 ' HG ' HG12 ' A' ' 7' ' ' VAL . 21.7 mt -70.4 -58.9 3.23 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.39 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 51' ' ' ASN . 2.7 pptp? -54.07 -36.18 62.84 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.333 -0.854 . . . . 0.0 110.009 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -64.46 -48.15 76.35 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.435 -0.79 . . . . 0.0 109.092 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.58 -40.05 80.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.541 -0.724 . . . . 0.0 109.563 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.409 ' HA ' ' CD1' ' A' ' 63' ' ' LEU . . . -48.43 -48.32 37.45 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.611 -0.681 . . . . 0.0 110.366 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.55 -6.35 45.97 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.453 -0.78 . . . . 0.0 111.554 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -123.63 8.86 8.76 Favored Glycine 0 N--CA 1.501 3.032 0 O-C-N 120.833 -1.167 . . . . 0.0 110.759 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.405 ' O ' ' CB ' ' A' ' 61' ' ' SER . 0.9 OUTLIER -74.42 -21.11 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.333 -1.098 . . . . 0.0 110.367 -179.739 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 60' ' ' VAL . 0.9 OUTLIER 76.49 107.54 0.08 Allowed 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.279 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.73 -78.63 1.92 Allowed Glycine 0 N--CA 1.498 2.774 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 7.5 tt 59.48 103.09 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 121.953 0.883 . . . . 0.0 111.236 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.432 ' HB3' ' HB2' ' A' ' 67' ' ' ASN . 2.6 m-80 -94.39 81.88 4.01 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -32.87 -55.69 0.37 Allowed 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -52.21 -42.99 56.54 Favored Glycine 0 N--CA 1.506 3.357 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.432 ' HB2' ' HB3' ' A' ' 64' ' ' ASN . 2.0 t30 -72.7 -51.97 17.12 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.439 ' O ' ' CD ' ' A' ' 72' ' ' PRO . . . -57.16 -33.25 67.24 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 122.018 -0.426 . . . . 0.0 111.626 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.43 -45.22 13.91 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.094 -1.004 . . . . 0.0 109.964 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.09 -29.62 69.98 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.347 -0.846 . . . . 0.0 111.055 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.74 HG22 ' SG ' ' A' ' 14' ' ' CYS . 70.2 mt -60.11 -66.09 1.71 Allowed Pre-proline 0 N--CA 1.506 2.329 0 O-C-N 121.243 -0.911 . . . . 0.0 111.291 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.474 ' O ' HG23 ' A' ' 77' ' ' VAL . 23.7 Cg_endo -57.33 -53.62 4.53 Favored 'Trans proline' 0 C--N 1.325 -0.699 0 C-N-CA 121.805 1.67 . . . . 0.0 109.652 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.5 m -45.29 -63.98 0.82 Allowed 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -64.85 -34.05 77.45 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.712 -0.617 . . . . 0.0 109.916 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' CYS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 30' ' ' CYS . 1.1 m -50.98 -31.48 18.07 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.222 -177.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 135.07 53.6 0.07 OUTLIER Glycine 0 N--CA 1.497 2.711 0 C-N-CA 119.657 -1.259 . . . . 0.0 110.81 175.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.542 ' CG1' ' HA ' ' A' ' 34' ' ' ARG . 12.0 m -147.71 124.49 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.184 -1.186 . . . . 0.0 111.172 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 65.2 m -91.45 67.06 5.57 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.47 HD13 ' CE2' ' A' ' 81' ' ' TYR . 2.3 tp -104.02 127.19 29.79 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.553 -0.717 . . . . 0.0 109.854 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.63 -33.88 65.37 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 122.826 2.351 . . . . 0.0 112.394 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' TYR . . . . . 0.47 ' CE2' HD13 ' A' ' 79' ' ' ILE . 5.9 p90 -90.3 143.68 26.54 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.904 -1.122 . . . . 0.0 110.407 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.3 p -104.88 173.37 6.33 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.504 -0.747 . . . . 0.0 110.814 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.4 mm -108.95 92.51 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.536 -0.727 . . . . 0.0 109.357 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.403 ' OG ' ' OG1' ' A' ' 87' ' ' THR . 82.8 p -119.45 -104.91 0.39 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.159 -0.963 . . . . 0.0 109.653 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -164.02 -55.9 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 63.3 m -79.34 -8.26 58.94 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 122.107 -0.371 . . . . 0.0 110.183 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.403 ' OG1' ' OG ' ' A' ' 84' ' ' SER . 8.7 m -50.03 142.67 9.06 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.325 -0.859 . . . . 0.0 109.951 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -82.58 118.46 23.3 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.496 -0.753 . . . . 0.0 109.813 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 11.4 m -109.64 56.11 0.63 Allowed 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.886 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.3 t -128.5 -61.4 1.08 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.571 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.404 ' HG3' HH11 ' A' ' 91' ' ' ARG . 2.9 mtm-85 -97.96 60.61 1.49 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 122.052 0.93 . . . . 0.0 109.629 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.3 t -115.37 81.51 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.482 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 2.1 p-10 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 117.152 -1.404 . . . . 0.0 110.326 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 2' ' ' ILE . . . . . . . . 0 N--CA 1.499 1.989 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.585 ' CG1' ' HB3' ' A' ' 40' ' ' ALA . 5.3 tp 32.13 70.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.407 0 CA-C-O 121.916 0.865 . . . . 0.0 111.579 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 5' ' ' GLY . 1.2 t -156.39 80.19 0.97 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.782 -1.199 . . . . 0.0 110.632 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 11.4 t 66.08 -57.88 0.35 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 3' ' ' SER . . . -44.07 -53.45 6.53 Favored Glycine 0 N--CA 1.505 3.279 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.466 ' CG ' ' HA ' ' A' ' 2' ' ' ILE . 0.0 OUTLIER -81.49 -25.76 35.73 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.514 -0.992 . . . . 0.0 110.482 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 37.6 t -56.07 -41.18 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.47 ' HA ' ' CD1' ' A' ' 11' ' ' ILE . . . -68.42 -39.58 81.54 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.0 p -71.9 -20.84 61.72 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.339 -0.851 . . . . 0.0 109.94 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.73 -49.1 11.61 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.508 -0.745 . . . . 0.0 110.573 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.47 ' CD1' ' HA ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -84.31 -16.7 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.209 -0.932 . . . . 0.0 110.488 -179.7 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.497 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -46.82 -53.98 22.64 Favored Pre-proline 0 N--CA 1.501 2.099 0 O-C-N 121.369 -0.832 . . . . 0.0 109.867 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 27.5 Cg_endo -63.38 -23.1 71.75 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 121.945 1.763 . . . . 0.0 110.585 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.2 m -88.58 -6.52 57.49 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 118.655 -0.688 . . . . 0.0 112.714 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.55 ' O ' ' CB ' ' A' ' 19' ' ' ARG . 1.0 OUTLIER -48.56 -47.07 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-N 118.62 0.646 . . . . 0.0 109.686 -178.096 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.462 ' O ' ' N ' ' A' ' 21' ' ' GLN . 85.2 p -52.81 -63.55 1.11 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.119 -0.988 . . . . 0.0 109.38 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.534 ' CD2' HG12 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -59.5 -59.74 4.97 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.683 -0.636 . . . . 0.0 110.295 179.674 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.82 -27.59 60.24 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.289 -0.882 . . . . 0.0 111.039 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.55 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 16.1 ttm-85 -94.02 11.31 30.19 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.306 -0.872 . . . . 0.0 110.899 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.22 30.12 63.32 Favored Glycine 0 N--CA 1.506 3.307 0 O-C-N 120.784 -1.198 . . . . 0.0 111.33 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.462 ' N ' ' O ' ' A' ' 16' ' ' SER . 69.4 mt-30 -140.79 48.49 1.71 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.335 -1.097 . . . . 0.0 109.461 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -165.28 -52.23 0.02 OUTLIER Glycine 0 N--CA 1.502 3.072 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.3 p 70.87 -47.6 0.65 Allowed 'General case' 0 N--CA 1.51 2.564 0 O-C-N 121.81 -0.818 . . . . 0.0 111.501 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.59 132.11 10.82 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.15 148.83 91.24 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 C-N-CA 122.366 2.044 . . . . 0.0 110.766 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.1 p -104.19 156.14 18.14 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.285 -0.884 . . . . 0.0 109.749 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.34 -47.44 85.86 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.49 -0.756 . . . . 0.0 109.133 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.01 -36.43 93.45 Favored Glycine 0 N--CA 1.501 2.977 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.444 ' O ' HG22 ' A' ' 33' ' ' VAL . 3.9 t -62.38 -59.11 5.45 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 91.5 m -63.65 -36.43 83.81 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 120.184 -0.606 . . . . 0.0 112.15 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.4 m -66.81 -48.18 69.74 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 123.726 0.641 . . . . 0.0 109.753 176.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.36 -53.74 37.18 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.507 HG11 HG22 ' A' ' 77' ' ' VAL . 11.6 t -62.23 -48.33 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.609 -0.936 . . . . 0.0 110.361 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -23.89 63.48 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.988 -1.07 . . . . 0.0 109.66 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.427 ' HA ' ' OD1' ' A' ' 38' ' ' ASN . 21.4 p -73.63 -34.54 65.06 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.301 -0.874 . . . . 0.0 108.818 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.498 HD22 ' HA ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER -67.2 -31.8 72.43 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.495 -0.753 . . . . 0.0 109.861 179.073 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.463 ' HB2' HG12 ' A' ' 77' ' ' VAL . 2.4 t-20 -64.6 -50.23 67.99 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.395 -0.816 . . . . 0.0 110.575 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.427 ' OD1' ' HA ' ' A' ' 35' ' ' SER . 3.8 p-10 -68.76 -27.07 65.58 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.211 -0.93 . . . . 0.0 109.964 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.11 -46.11 12.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.667 -0.646 . . . . 0.0 110.004 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.585 ' HB3' ' CG1' ' A' ' 2' ' ' ILE . . . -88.97 95.99 10.54 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.199 -0.938 . . . . 0.0 109.679 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.539 ' HG2' ' NH1' ' A' ' 46' ' ' ARG . 42.1 mtm180 -152.3 23.74 0.63 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.398 -0.814 . . . . 0.0 110.595 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -128.26 33.95 4.64 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.024 -1.048 . . . . 0.0 110.462 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.451 ' O ' ' N ' ' A' ' 47' ' ' ARG . 53.2 m 67.73 -61.78 0.36 Allowed 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.443 -0.786 . . . . 0.0 109.601 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 42' ' ' THR . . . -55.93 -57.8 10.58 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.632 -0.667 . . . . 0.0 109.713 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -71.1 -35.06 71.67 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.582 ' HG3' ' CE2' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -67.38 -58.9 3.94 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 122.001 -0.437 . . . . 0.0 110.271 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 43' ' ' THR . 80.2 mtt180 -60.6 -43.71 97.12 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.04 -45.71 61.4 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.292 -0.88 . . . . 0.0 108.662 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.6 -49.49 62.86 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.667 ' SG ' HG23 ' A' ' 87' ' ' THR . 0.0 OUTLIER -55.68 -39.87 71.54 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.498 -0.751 . . . . 0.0 112.359 179.266 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.605 ' N ' ' SG ' ' A' ' 89' ' ' CYS . 2.2 t30 -63.44 -56.87 12.72 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.677 177.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 53.7 t -63.93 -26.7 68.71 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.773 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.0 mt -63.42 -51.31 66.28 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 124.183 0.927 . . . . 0.0 109.285 175.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.435 ' HE3' ' HA ' ' A' ' 51' ' ' ASN . 0.4 OUTLIER -55.86 -40.75 73.35 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.19 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.402 ' N ' ' HG2' ' A' ' 54' ' ' LYS . 5.3 m120 -66.48 -46.8 75.09 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.97 -46.02 91.08 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.493 ' HA ' ' HG ' ' A' ' 63' ' ' LEU . . . -61.42 -58.52 7.85 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.27 66.9 6.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.352 -0.843 . . . . 0.0 109.153 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.6 -36.59 0.09 OUTLIER Glycine 0 N--CA 1.498 2.813 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.0 t -51.91 136.4 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.651 -0.911 . . . . 0.0 110.087 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.62 102.0 0.3 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.592 -0.692 . . . . 0.0 109.629 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.28 42.11 19.65 Favored Glycine 0 N--CA 1.5 2.934 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.493 ' HG ' ' HA ' ' A' ' 57' ' ' ALA . 3.3 tm? -64.02 122.72 17.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.463 -1.022 . . . . 0.0 110.251 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -97.57 83.94 3.32 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -36.24 -53.08 0.82 Allowed 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.89 -0.506 . . . . 0.0 111.506 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -51.71 -50.96 41.14 Favored Glycine 0 N--CA 1.504 3.201 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -67.2 -53.28 31.68 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.694 -0.886 . . . . 0.0 108.949 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.404 ' O ' ' CD ' ' A' ' 72' ' ' PRO . . . -54.03 -32.77 55.41 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 122.038 -0.414 . . . . 0.0 111.235 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.3 -48.19 8.72 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.196 -0.94 . . . . 0.0 110.299 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.462 ' HA ' ' HZ2' ' A' ' 74' ' ' LYS . 1.9 t -65.4 -27.98 68.93 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.326 -0.859 . . . . 0.0 110.967 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.534 HG12 ' CD2' ' A' ' 17' ' ' TYR . 55.8 mt -58.48 -65.17 2.09 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.253 -0.904 . . . . 0.0 110.451 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.495 ' HB3' HG13 ' A' ' 33' ' ' VAL . 9.5 Cg_endo -53.75 -52.1 9.28 Favored 'Trans proline' 0 N--CA 1.482 0.828 0 C-N-CA 122.217 1.945 . . . . 0.0 110.838 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.7 p -44.63 -70.62 0.1 Allowed 'General case' 0 N--CA 1.504 2.232 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.317 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.462 ' HZ2' ' HA ' ' A' ' 70' ' ' SER . 1.1 mppt? -64.06 -39.37 93.92 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.972 -0.455 . . . . 0.0 111.106 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 1.1 m -47.5 -35.14 8.34 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.502 -0.749 . . . . 0.0 111.505 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 135.16 46.69 0.09 OUTLIER Glycine 0 N--CA 1.496 2.658 0 O-C-N 124.655 1.222 . . . . 0.0 110.05 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.507 HG22 HG11 ' A' ' 33' ' ' VAL . 59.8 t -119.13 86.33 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.31 -1.112 . . . . 0.0 110.071 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.1 m -75.92 62.49 1.6 Allowed 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.433 ' CG1' ' HD2' ' A' ' 46' ' ' ARG . 8.9 tt -111.14 142.98 27.43 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.373 -0.83 . . . . 0.0 109.287 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.418 ' HD2' ' CG1' ' A' ' 79' ' ' ILE . 11.4 Cg_endo -53.37 -39.2 82.33 Favored 'Trans proline' 0 N--CA 1.485 0.973 0 C-N-CA 122.873 2.382 . . . . 0.0 112.942 -177.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.582 ' CE2' ' HG3' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -96.63 159.94 14.66 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.661 -1.275 . . . . 0.0 111.144 -179.572 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.437 ' C ' HD13 ' A' ' 83' ' ' ILE . 1.3 m -96.11 -170.25 2.08 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.437 HD13 ' C ' ' A' ' 82' ' ' THR . 2.0 mp -120.65 92.68 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.154 -0.967 . . . . 0.0 108.48 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.3 p -142.83 172.29 12.9 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.574 -0.704 . . . . 0.0 110.292 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.6 p -59.69 -50.14 75.01 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.698 -0.626 . . . . 0.0 109.546 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 38.8 m -84.96 48.54 1.58 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.761 -0.587 . . . . 0.0 110.559 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.667 HG23 ' SG ' ' A' ' 50' ' ' CYS . 22.2 m -74.6 117.25 16.21 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.055 -1.028 . . . . 0.0 108.569 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -83.21 136.36 34.44 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.332 -0.855 . . . . 0.0 110.968 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.605 ' SG ' ' N ' ' A' ' 51' ' ' ASN . 58.6 m -117.08 56.04 0.82 Allowed 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.286 176.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.67 -38.7 0.47 Allowed 'General case' 0 N--CA 1.497 1.925 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.227 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.32 2.76 48.4 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.317 -0.864 . . . . 0.0 111.199 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.549 HG12 ' CD2' ' A' ' 81' ' ' TYR . 17.1 t -105.82 136.17 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 120.889 -1.132 . . . . 0.0 110.007 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.5 m120 . . . . . 0 N--CA 1.494 1.772 0 O-C-N 121.289 -0.882 . . . . 0.0 108.738 179.153 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 121.419 0.628 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.557 ' HB ' ' NE2' ' A' ' 6' ' ' GLN . 1.2 pp -84.52 100.64 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.073 -1.017 . . . . 0.0 108.434 179.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.3 t -90.18 174.56 7.55 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.002 -1.061 . . . . 0.0 111.215 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.9 t -62.23 -25.83 68.03 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.672 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.63 -46.39 94.08 Favored Glycine 0 N--CA 1.5 2.93 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.557 ' NE2' ' HB ' ' A' ' 2' ' ' ILE . 1.2 pt20 -78.03 -35.27 49.99 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.327 -1.102 . . . . 0.0 109.719 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.458 ' N ' ' HG3' ' A' ' 6' ' ' GLN . 95.9 t -59.74 -47.41 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.532 ' HA ' ' CD1' ' A' ' 11' ' ' ILE . . . -69.98 -35.05 74.12 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 72.4 m -70.59 -21.16 62.7 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.139 -0.976 . . . . 0.0 109.92 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.55 -41.94 12.39 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.384 -0.822 . . . . 0.0 111.128 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.532 ' CD1' ' HA ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -83.28 -17.81 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 120.813 -1.179 . . . . 0.0 110.307 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.514 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -48.05 -52.97 36.66 Favored Pre-proline 0 N--CA 1.502 2.13 0 O-C-N 121.249 -0.907 . . . . 0.0 109.596 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.514 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 17.8 Cg_endo -61.68 -25.03 78.49 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 121.899 1.732 . . . . 0.0 110.011 178.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.6 m -88.39 -1.67 58.17 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.501 ' O ' ' CB ' ' A' ' 19' ' ' ARG . 0.5 OUTLIER -55.39 -50.79 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.505 ' O ' ' N ' ' A' ' 21' ' ' GLN . 5.8 m -54.1 -53.17 56.83 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.292 -0.88 . . . . 0.0 108.797 178.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.476 ' CD1' HD13 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -59.97 -65.33 0.7 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.127 -0.983 . . . . 0.0 110.042 179.053 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.406 ' N ' HD13 ' A' ' 71' ' ' ILE . . . -55.08 -34.0 63.26 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.606 -0.684 . . . . 0.0 110.97 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.501 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 1.7 ttm-85 -80.35 5.58 14.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.718 -0.614 . . . . 0.0 111.539 -178.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.72 23.68 45.35 Favored Glycine 0 N--CA 1.504 3.226 0 O-C-N 120.618 -1.301 . . . . 0.0 111.803 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 16' ' ' SER . 6.3 mm-40 -141.22 59.76 1.51 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.18 -1.188 . . . . 0.0 109.515 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.61 -58.99 0.02 OUTLIER Glycine 0 N--CA 1.503 3.12 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.7 p 74.42 -51.34 0.68 Allowed 'General case' 0 N--CA 1.511 2.596 0 O-C-N 122.054 -0.674 . . . . 0.0 111.479 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.78 139.99 14.66 Favored Glycine 0 N--CA 1.501 2.981 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.634 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 27.3 Cg_endo -61.9 121.77 9.99 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 122.173 1.915 . . . . 0.0 110.238 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 p -75.96 152.95 36.91 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.201 -0.937 . . . . 0.0 110.313 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.01 -51.91 66.1 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.363 -0.835 . . . . 0.0 108.828 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.19 -36.63 91.21 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.434 ' HA ' ' HG2' ' A' ' 13' ' ' PRO . 7.3 t -63.98 -53.95 42.03 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.634 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 93.4 m -67.52 -39.27 85.09 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 118.635 -0.698 . . . . 0.0 111.389 -177.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.0 t -65.62 -47.9 74.08 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 124.19 0.931 . . . . 0.0 109.5 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.31 -53.09 48.5 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.541 HG11 HG23 ' A' ' 77' ' ' VAL . 12.5 t -63.36 -50.63 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.382 -1.069 . . . . 0.0 110.072 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.469 ' O ' ' CB ' ' A' ' 38' ' ' ASN . 7.1 ttp180 -56.24 -35.63 67.6 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 m -73.92 -43.69 57.5 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.465 HD22 ' HA ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -64.4 -44.89 89.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.752 -0.593 . . . . 0.0 109.663 179.628 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.497 ' HB3' HG11 ' A' ' 77' ' ' VAL . 7.3 m-80 -80.8 -28.9 36.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -0.904 . . . . 0.0 110.509 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 8.7 t30 -63.6 -35.19 79.69 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.7 -38.23 29.26 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.532 ' N ' HG23 ' A' ' 2' ' ' ILE . . . -83.17 93.5 7.66 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.503 -0.748 . . . . 0.0 110.651 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.452 ' HA ' ' HD3' ' A' ' 46' ' ' ARG . 43.3 mtt180 -143.0 9.18 1.7 Allowed 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.95 -1.094 . . . . 0.0 110.584 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 58.0 m -87.53 -65.74 0.98 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.223 -0.923 . . . . 0.0 110.337 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 m 160.15 -56.98 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.86 -47.64 70.79 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.544 ' HB3' ' CG1' ' A' ' 2' ' ' ILE . 18.2 m-20 -68.58 -49.92 55.69 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.452 ' HD3' ' HA ' ' A' ' 41' ' ' ARG . 22.2 mtm180 -62.47 -46.27 89.27 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.526 -0.734 . . . . 0.0 110.46 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -59.06 -46.29 88.63 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.378 -0.826 . . . . 0.0 108.879 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.56 -39.68 91.95 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.507 ' HB1' HD13 ' A' ' 2' ' ' ILE . . . -57.24 -51.13 70.6 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.46 ' SG ' ' N ' ' A' ' 89' ' ' CYS . 19.1 t -58.05 -38.11 75.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.809 -0.557 . . . . 0.0 110.866 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -63.7 -63.21 1.23 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 123.711 0.632 . . . . 0.0 109.305 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 8.6 t -53.7 -33.92 57.09 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.336 -0.852 . . . . 0.0 112.036 176.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.476 HD23 HG21 ' A' ' 83' ' ' ILE . 25.1 mt -61.81 -44.83 96.07 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 114.961 -1.018 . . . . 0.0 108.821 176.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.516 ' HD2' ' SG ' ' A' ' 89' ' ' CYS . 3.3 tttp -56.77 -42.96 80.32 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.639 -0.663 . . . . 0.0 109.269 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -55.89 -44.94 78.65 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.764 -0.585 . . . . 0.0 109.73 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.476 ' O ' HG22 ' A' ' 60' ' ' VAL . . . -76.63 -53.98 7.29 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.567 -0.708 . . . . 0.0 109.565 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.446 ' HB3' ' HA ' ' A' ' 85' ' ' THR . . . -52.36 -55.31 22.46 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.536 -0.728 . . . . 0.0 109.679 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -87.95 62.18 6.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.288 -0.883 . . . . 0.0 108.74 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.98 -34.14 0.07 OUTLIER Glycine 0 N--CA 1.498 2.787 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.476 HG22 ' O ' ' A' ' 56' ' ' ALA . 24.3 t -47.54 133.78 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.672 -0.899 . . . . 0.0 109.86 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.41 97.93 0.1 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.706 -0.621 . . . . 0.0 110.191 -179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.59 73.37 0.61 Allowed Glycine 0 N--CA 1.5 2.928 0 N-CA-C 110.014 -1.235 . . . . 0.0 110.014 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 1.7 pt? -102.5 159.28 15.57 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.346 -1.091 . . . . 0.0 110.713 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -116.26 114.71 24.76 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -49.57 -53.3 24.49 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.753 -0.592 . . . . 0.0 110.423 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.76 -45.35 85.85 Favored Glycine 0 N--CA 1.5 2.904 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -62.37 -55.33 28.95 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.728 -0.866 . . . . 0.0 109.474 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.452 ' O ' ' CD ' ' A' ' 72' ' ' PRO . . . -58.36 -33.04 69.12 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.921 -0.487 . . . . 0.0 110.76 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.61 -51.15 8.52 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.217 -0.927 . . . . 0.0 110.215 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.3 t -60.62 -31.13 70.33 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.543 -0.723 . . . . 0.0 110.738 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.482 ' HB ' ' CD ' ' A' ' 72' ' ' PRO . 51.6 mt -56.94 -69.63 0.43 Allowed Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.518 -0.739 . . . . 0.0 111.072 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.482 ' CD ' ' HB ' ' A' ' 71' ' ' ILE . 17.7 Cg_endo -56.06 -52.56 7.03 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 122.485 2.123 . . . . 0.0 111.762 -178.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.4 t -49.36 -69.5 0.11 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.78 -0.575 . . . . 0.0 110.521 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -63.56 -35.83 81.8 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 122.107 -0.37 . . . . 0.0 111.166 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -48.66 -35.98 14.98 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.398 -0.814 . . . . 0.0 111.419 -178.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 133.92 50.14 0.08 OUTLIER Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.541 HG23 HG11 ' A' ' 33' ' ' VAL . 2.4 t -119.52 110.99 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.423 -1.045 . . . . 0.0 109.951 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 83.8 p -81.32 68.24 7.56 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.296 -0.878 . . . . 0.0 108.918 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.499 HG12 ' CE2' ' A' ' 81' ' ' TYR . 0.7 OUTLIER -133.92 134.26 23.0 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.589 -0.694 . . . . 0.0 109.739 -178.943 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.413 ' HD2' HG13 ' A' ' 79' ' ' ILE . 47.3 Cg_endo -67.11 -35.37 25.43 Favored 'Trans proline' 0 N--CA 1.486 1.048 0 C-N-CA 122.958 2.439 . . . . 0.0 113.278 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.499 ' CE2' HG12 ' A' ' 79' ' ' ILE . 54.8 p90 -80.54 132.26 35.64 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.698 -1.251 . . . . 0.0 110.755 -178.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.55 154.51 20.28 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.468 0.651 . . . . 0.0 110.38 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.476 HG21 HD23 ' A' ' 53' ' ' LEU . 1.9 mp -98.33 83.16 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 121.41 0.624 . . . . 0.0 109.739 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 99.8 p -128.99 171.26 12.52 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.116 -0.99 . . . . 0.0 110.07 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.446 ' HA ' ' HB3' ' A' ' 57' ' ' ALA . 1.7 m -58.37 101.14 0.07 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.335 -0.853 . . . . 0.0 109.375 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.406 ' HA ' ' CG ' ' A' ' 54' ' ' LYS . 34.2 t 60.36 60.53 2.0 Allowed 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 121.493 0.663 . . . . 0.0 109.513 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 56.0 m -63.8 -69.23 0.29 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.434 -0.791 . . . . 0.0 110.684 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -150.87 -72.46 0.16 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.061 -1.024 . . . . 0.0 110.149 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.516 ' SG ' ' HD2' ' A' ' 54' ' ' LYS . 38.5 m 58.82 55.01 4.83 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-O 121.621 0.724 . . . . 0.0 111.626 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 97.6 p -162.75 -42.35 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 114.427 -1.261 . . . . 0.0 109.705 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -100.17 12.43 37.02 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.458 -0.777 . . . . 0.0 109.719 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.473 HG21 ' HB3' ' A' ' 81' ' ' TYR . 85.7 t -79.54 117.14 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.268 -0.895 . . . . 0.0 109.659 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.936 0 CA-C-O 117.267 -1.349 . . . . 0.0 109.542 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.996 0 CA-C-O 121.812 0.815 . . . . 0.0 109.651 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.599 HD13 ' HB1' ' A' ' 49' ' ' ALA . 0.6 OUTLIER -135.94 100.88 2.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.2 t -119.05 -173.3 2.47 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.527 -1.358 . . . . 0.0 110.632 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.493 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 1.9 t -52.2 -28.16 17.34 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 177.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -57.23 -51.75 55.67 Favored Glycine 0 N--CA 1.501 2.987 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.479 ' HG3' ' N ' ' A' ' 7' ' ' VAL . 3.1 pt20 -89.33 -34.16 16.65 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.387 -1.067 . . . . 0.0 109.666 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.493 ' HB ' ' HA ' ' A' ' 4' ' ' CYS . 40.7 t -56.16 -37.74 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.32 -37.7 68.86 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.7 p -77.15 -22.11 53.04 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.011 -1.056 . . . . 0.0 110.02 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.63 -48.86 23.98 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.473 -0.767 . . . . 0.0 110.29 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -83.98 -16.02 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 O-C-N 121.13 -0.981 . . . . 0.0 110.812 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.498 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -45.61 -54.78 14.27 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.455 -0.778 . . . . 0.0 109.759 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.631 ' HG2' ' SG ' ' A' ' 29' ' ' CYS . 19.2 Cg_endo -62.0 -24.76 77.09 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.186 1.924 . . . . 0.0 110.565 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.614 ' SG ' HG22 ' A' ' 71' ' ' ILE . 72.1 m -86.61 -16.81 35.57 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 178.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.429 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -47.58 -24.53 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.904 -0.497 . . . . 0.0 111.255 -177.462 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.423 ' HA ' ' NH2' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -91.21 -61.93 1.55 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.017 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.454 ' CD2' HG12 ' A' ' 71' ' ' ILE . 1.1 t80 -55.19 -57.42 11.87 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 14' ' ' CYS . . . -52.36 -32.38 38.15 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-O 121.42 0.629 . . . . 0.0 110.144 178.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.469 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 9.3 tmm_? -90.01 7.9 35.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.798 -0.564 . . . . 0.0 110.86 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.18 9.31 59.45 Favored Glycine 0 N--CA 1.502 3.075 0 O-C-N 120.713 -1.242 . . . . 0.0 111.976 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.417 ' N ' ' O ' ' A' ' 16' ' ' SER . 5.5 tp60 -114.75 81.91 1.64 Allowed 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 118.768 1.284 . . . . 0.0 109.699 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 157.48 -148.95 19.26 Favored Glycine 0 N--CA 1.5 2.905 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.3 t -175.24 -45.71 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.596 -0.943 . . . . 0.0 109.918 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -97.84 141.75 15.76 Favored Glycine 0 N--CA 1.499 2.886 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.551 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 27.9 Cg_endo -62.31 121.91 10.11 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 122.362 2.041 . . . . 0.0 111.051 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.5 t -60.77 134.62 57.27 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.548 -0.72 . . . . 0.0 110.045 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.91 -52.9 37.53 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.65 -0.656 . . . . 0.0 110.109 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -52.76 -45.93 60.27 Favored Glycine 0 N--CA 1.502 3.06 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.631 ' SG ' ' HG2' ' A' ' 13' ' ' PRO . 1.1 m -60.02 -43.84 95.02 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.016 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.551 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 3.6 m -63.56 -57.33 10.47 Favored 'General case' 0 C--O 1.201 -1.473 0 CA-C-O 117.556 -1.211 . . . . 0.0 109.574 -176.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.3 t -65.79 -39.78 91.28 Favored 'General case' 0 N--CA 1.505 2.296 0 CA-C-N 118.804 0.729 . . . . 0.0 110.683 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -57.98 -44.78 94.38 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.565 ' CG1' HG22 ' A' ' 77' ' ' VAL . 5.3 t -84.06 -46.41 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.425 -1.044 . . . . 0.0 110.169 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -54.62 -35.06 63.02 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.491 -0.756 . . . . 0.0 109.14 179.676 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 90.9 p -78.49 -44.42 24.56 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.306 -0.871 . . . . 0.0 110.027 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.437 ' C ' HD13 ' A' ' 36' ' ' LEU . 0.4 OUTLIER -52.67 -35.82 55.91 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.513 -0.742 . . . . 0.0 109.665 179.786 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.455 ' HB2' HG12 ' A' ' 77' ' ' VAL . 4.3 t-20 -62.39 -26.21 68.35 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.259 -0.9 . . . . 0.0 109.917 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -91.65 -40.56 11.23 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.317 -0.864 . . . . 0.0 108.98 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.06 -36.44 69.58 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.572 ' HB1' HG12 ' A' ' 2' ' ' ILE . . . -91.51 -131.21 0.11 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.873 -0.517 . . . . 0.0 109.926 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 8.1 mtt-85 56.95 38.92 29.67 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.294 -0.879 . . . . 0.0 110.064 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.409 ' O ' ' HB ' ' A' ' 43' ' ' THR . 9.0 t -136.1 19.02 3.2 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.822 -0.549 . . . . 0.0 109.867 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.702 ' HA ' ' C ' ' A' ' 93' ' ' ASN . 99.5 m 78.17 -60.73 0.4 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.755 -0.591 . . . . 0.0 110.327 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.51 -55.67 32.06 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.445 -0.785 . . . . 0.0 110.613 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.41 ' HB3' HG13 ' A' ' 2' ' ' ILE . 54.5 m-20 -67.44 -37.14 82.54 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.575 -0.703 . . . . 0.0 110.889 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.497 ' HD2' HD12 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -67.5 -57.08 7.14 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.879 -1.138 . . . . 0.0 110.778 -179.145 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -55.31 -44.17 75.56 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.226 -0.921 . . . . 0.0 109.419 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.46 -45.76 80.72 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.599 ' HB1' HD13 ' A' ' 2' ' ' ILE 0.27 . . -61.59 -52.87 62.61 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.4 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.471 ' C ' ' SG ' ' A' ' 89' ' ' CYS . 44.7 t -54.84 -34.26 62.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.996 -1.065 . . . . 0.0 111.809 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -68.92 -59.5 3.02 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 123.676 0.61 . . . . 0.0 109.988 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.5 t -61.73 -33.36 73.91 Favored 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.526 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.448 HD21 HG13 ' A' ' 83' ' ' ILE . 17.8 mt -67.65 -51.39 50.45 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.636 176.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -59.04 -38.92 80.48 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -61.13 -53.43 57.1 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 122.077 -0.39 . . . . 0.0 110.381 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.29 -44.42 52.77 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.286 -0.884 . . . . 0.0 110.357 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.57 -44.31 76.75 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.526 -0.734 . . . . 0.0 110.112 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.54 68.66 2.88 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.321 -0.862 . . . . 0.0 109.379 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 149.13 -12.21 1.06 Allowed Glycine 0 N--CA 1.5 2.933 0 C-N-CA 120.117 -1.039 . . . . 0.0 111.719 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.3 t -40.09 -60.33 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.566 0 CA-C-N 118.962 1.381 . . . . 0.0 110.776 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.0 m 160.45 77.9 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.512 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.54 -65.21 3.45 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 107.456 -2.257 . . . . 0.0 107.456 -177.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.469 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 8.4 tt 68.99 138.13 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 121.821 0.82 . . . . 0.0 111.413 177.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.401 ' O ' ' N ' ' A' ' 67' ' ' ASN . 17.3 m120 -121.38 92.26 3.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.427 -0.796 . . . . 0.0 109.192 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.46 -41.4 4.3 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.764 -0.585 . . . . 0.0 110.07 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -53.11 -32.18 42.38 Favored Glycine 0 N--CA 1.502 3.076 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 64' ' ' ASN . 83.1 m-20 -97.49 -53.49 3.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.788 -0.831 . . . . 0.0 108.95 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -54.69 -32.42 59.37 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.871 -0.518 . . . . 0.0 111.221 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.422 ' CB ' ' HB ' ' A' ' 82' ' ' THR . . . -86.7 -44.01 12.14 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.232 -0.917 . . . . 0.0 109.534 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 65.5 m -64.05 -39.36 93.91 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.677 -0.639 . . . . 0.0 111.139 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.614 HG22 ' SG ' ' A' ' 14' ' ' CYS . 68.5 mt -51.18 -64.35 1.43 Allowed Pre-proline 0 N--CA 1.499 2.008 0 O-C-N 121.628 -0.67 . . . . 0.0 111.479 -178.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.47 ' CB ' HG13 ' A' ' 33' ' ' VAL . 36.8 Cg_endo -59.56 -50.14 8.82 Favored 'Trans proline' 0 N--CA 1.48 0.678 0 C-N-CA 121.85 1.7 . . . . 0.0 110.549 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.7 t -55.82 -60.74 3.03 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.843 -0.536 . . . . 0.0 110.186 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -63.04 -40.01 96.44 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 122.04 -0.413 . . . . 0.0 110.317 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 1.2 m -49.86 -37.59 31.64 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.377 -0.827 . . . . 0.0 111.176 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 136.21 55.99 0.06 OUTLIER Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 176.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.565 HG22 ' CG1' ' A' ' 33' ' ' VAL . 37.4 t -132.07 114.36 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.515 -0.991 . . . . 0.0 110.139 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.2 m -82.57 56.53 3.36 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.467 -0.77 . . . . 0.0 109.215 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.497 HD12 ' HD2' ' A' ' 46' ' ' ARG . 2.1 tt -117.49 125.51 28.06 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.433 -0.792 . . . . 0.0 109.581 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -64.46 -37.13 40.33 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 122.786 2.324 . . . . 0.0 111.79 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.488 ' C ' ' CD1' ' A' ' 81' ' ' TYR . 0.8 OUTLIER -77.83 138.83 39.17 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.995 -1.066 . . . . 0.0 109.76 -179.396 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.422 ' HB ' ' CB ' ' A' ' 69' ' ' ALA . 30.0 p -107.79 168.21 9.42 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.499 -0.751 . . . . 0.0 110.327 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.454 ' N ' ' CD1' ' A' ' 83' ' ' ILE . 1.2 mp -84.6 58.31 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.9 m -136.49 40.4 2.61 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.541 -0.725 . . . . 0.0 109.149 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 87' ' ' THR . 66.9 p 39.72 -115.69 0.2 Allowed 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -178.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.1 m 62.75 -60.87 0.13 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.389 -0.819 . . . . 0.0 111.416 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 85' ' ' THR . 3.7 t -75.76 158.61 32.01 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.247 -0.908 . . . . 0.0 111.181 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -104.52 6.72 34.93 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.476 -0.765 . . . . 0.0 110.418 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.471 ' SG ' ' C ' ' A' ' 50' ' ' CYS . 3.9 m 52.42 49.27 20.82 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.933 -0.479 . . . . 0.0 111.611 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.7 t -111.05 -37.85 5.24 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.981 -178.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -138.71 36.68 2.2 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.486 -0.759 . . . . 0.0 109.507 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.4 p -98.78 11.86 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 O-C-N 121.323 -0.861 . . . . 0.0 110.464 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.702 ' C ' ' HA ' ' A' ' 43' ' ' THR . 27.6 m-20 . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 117.186 -1.388 . . . . 0.0 108.78 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.87 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.522 HG23 ' HB3' ' A' ' 45' ' ' ASP . 10.6 tp 35.12 71.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.351 0 CA-C-O 122.092 0.948 . . . . 0.0 111.655 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.6 t -144.59 59.74 1.33 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.72 -1.237 . . . . 0.0 110.521 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.3 t 67.3 -52.5 0.48 Allowed 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -47.32 -48.91 20.69 Favored Glycine 0 N--CA 1.506 3.321 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 177.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.411 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -82.46 -31.05 29.63 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.422 -1.046 . . . . 0.0 110.479 179.531 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.401 ' N ' ' CD ' ' A' ' 6' ' ' GLN . 1.7 t -60.72 -46.15 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.446 ' HA ' HG13 ' A' ' 11' ' ' ILE . . . -72.64 -26.33 61.62 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.9 m -68.57 -20.37 64.52 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.323 -0.861 . . . . 0.0 110.34 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -98.24 -36.42 10.03 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.248 -0.908 . . . . 0.0 110.477 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.446 HG13 ' HA ' ' A' ' 8' ' ' ALA . 2.6 pp -80.0 -31.7 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.378 -0.826 . . . . 0.0 110.541 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.51 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -46.76 -50.89 41.3 Favored Pre-proline 0 N--CA 1.501 2.107 0 O-C-N 121.45 -0.782 . . . . 0.0 109.897 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 19.3 Cg_endo -63.08 -13.02 32.76 Favored 'Trans proline' 0 CA--C 1.548 1.178 0 C-N-CA 122.23 1.953 . . . . 0.0 111.412 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.2 m -125.45 24.06 7.37 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 175.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 16' ' ' SER . 0.3 OUTLIER -60.06 -50.16 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 118.684 0.674 . . . . 0.0 111.019 177.18 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 21' ' ' GLN . 1.5 m -67.58 -45.73 74.69 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.251 -0.906 . . . . 0.0 109.726 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.521 ' CE2' HG12 ' A' ' 71' ' ' ILE . 1.2 t80 -58.69 -48.5 80.9 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.38 -28.98 66.66 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.592 -0.692 . . . . 0.0 109.375 178.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.433 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 9.9 ttm180 -75.34 -18.24 60.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.653 -0.654 . . . . 0.0 109.864 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.46 20.83 11.34 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.42 ' O ' ' HB3' ' A' ' 16' ' ' SER . 26.7 tt0 -123.06 82.34 1.98 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 158.88 -153.75 24.86 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.4 t 170.17 60.45 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.795 -0.827 . . . . 0.0 109.233 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 160.06 123.12 0.68 Allowed Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.547 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 32.0 Cg_endo -63.1 124.8 14.57 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 122.571 2.18 . . . . 0.0 110.918 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.2 p -77.36 154.43 32.79 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.484 -0.76 . . . . 0.0 109.612 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.31 -57.76 10.88 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.461 -0.775 . . . . 0.0 110.245 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -53.94 -37.96 59.2 Favored Glycine 0 N--CA 1.501 3.011 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.487 ' HA ' ' HG2' ' A' ' 13' ' ' PRO . 6.4 t -66.63 -73.24 0.14 Allowed 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.749 177.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.547 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 0.5 OUTLIER -44.81 -41.52 7.06 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.238 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.8 t -73.15 -52.03 15.68 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.414 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.21 -41.24 96.62 Favored Glycine 0 N--CA 1.5 2.913 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.527 ' HA ' HD21 ' A' ' 36' ' ' LEU . 57.7 t -72.54 -50.23 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.339 -1.094 . . . . 0.0 109.85 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -62.1 -23.04 66.29 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.5 -0.75 . . . . 0.0 110.351 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 57.6 p -88.4 -42.3 12.26 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.314 -0.866 . . . . 0.0 109.373 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.527 HD21 ' HA ' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -52.24 -32.89 39.04 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.322 -0.861 . . . . 0.0 109.344 178.794 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -74.78 -8.56 56.81 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.932 -0.48 . . . . 0.0 111.168 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -105.44 -26.95 11.72 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.501 -1.375 . . . . 0.0 110.855 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.41 -13.86 61.98 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.287 -0.883 . . . . 0.0 110.219 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.635 ' HB2' ' HB3' ' A' ' 45' ' ' ASP . . . -163.1 139.54 7.23 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.51 -0.743 . . . . 0.0 110.297 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.448 ' HA ' ' HD3' ' A' ' 46' ' ' ARG . 4.4 mtm180 -172.62 51.32 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.228 -0.92 . . . . 0.0 110.613 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.596 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.9 OUTLIER -133.6 57.99 1.79 Allowed 'General case' 0 N--CA 1.508 2.466 0 O-C-N 120.987 -1.07 . . . . 0.0 109.979 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.545 ' CB ' ' HA ' ' A' ' 93' ' ' ASN . 12.6 t 54.66 -53.8 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.105 0 C-N-CA 123.988 0.915 . . . . 0.0 111.775 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.596 ' N ' ' O ' ' A' ' 42' ' ' THR . . . -61.37 -51.86 67.03 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.635 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 6.3 m-20 -66.87 -42.86 84.91 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.486 ' HD2' HG13 ' A' ' 79' ' ' ILE . 1.0 OUTLIER -62.01 -48.35 80.7 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.411 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.553 ' HA ' ' SG ' ' A' ' 50' ' ' CYS . 72.0 mtt180 -67.43 -37.13 82.53 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.247 -0.908 . . . . 0.0 109.213 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.47 -50.21 74.54 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 177.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.74 -42.65 97.77 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.553 ' SG ' ' HA ' ' A' ' 47' ' ' ARG . 4.3 p -66.23 -33.15 75.1 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.591 -0.693 . . . . 0.0 110.509 -177.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.5 ' N ' ' SG ' ' A' ' 50' ' ' CYS . 1.7 t30 -62.93 -54.15 43.0 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 124.06 0.85 . . . . 0.0 109.334 176.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 18.6 t -68.41 -38.79 81.59 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 119.166 -1.014 . . . . 0.0 111.314 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.4 mt -56.03 -41.97 75.81 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 124.377 1.048 . . . . 0.0 108.619 176.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.417 ' HG2' ' HB ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -58.61 -50.22 74.61 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.109 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -59.34 -41.51 89.34 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.78 -55.86 8.72 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.477 -0.764 . . . . 0.0 109.403 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.59 -47.67 73.05 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.586 -0.696 . . . . 0.0 110.297 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.11 7.34 7.64 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.319 -0.863 . . . . 0.0 110.726 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -132.99 7.52 5.14 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 t -79.73 133.92 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.128 -1.219 . . . . 0.0 109.382 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.8 p -65.57 94.21 0.18 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.514 -0.741 . . . . 0.0 109.284 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 112.93 -78.52 0.25 Allowed Glycine 0 N--CA 1.497 2.715 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 16.7 tp 69.12 134.43 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 122.2 1.0 . . . . 0.0 111.316 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.417 ' HB3' ' HB2' ' A' ' 67' ' ' ASN . 6.8 t-20 -135.84 106.09 6.37 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.0 -57.82 8.35 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.623 -0.673 . . . . 0.0 111.463 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.45 -47.69 68.22 Favored Glycine 0 N--CA 1.504 3.18 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.417 ' HB2' ' HB3' ' A' ' 64' ' ' ASN . 1.8 m-20 -69.84 -58.94 3.28 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.625 -0.926 . . . . 0.0 110.25 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.449 ' O ' ' CD ' ' A' ' 72' ' ' PRO . . . -57.35 -32.4 66.72 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.474 -0.766 . . . . 0.0 112.273 -178.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.46 -52.57 7.88 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.879 -1.138 . . . . 0.0 110.189 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 90.6 p -68.3 -34.25 75.81 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.653 -0.654 . . . . 0.0 111.122 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.521 HG12 ' CE2' ' A' ' 17' ' ' TYR . 28.1 mt -47.83 -65.33 0.77 Allowed Pre-proline 0 N--CA 1.503 2.215 0 O-C-N 121.516 -0.74 . . . . 0.0 110.357 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.487 ' HB3' HG12 ' A' ' 33' ' ' VAL . 28.3 Cg_endo -61.65 -50.23 5.8 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 122.218 1.945 . . . . 0.0 110.557 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 40.6 t -51.52 -60.84 2.7 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.828 -0.545 . . . . 0.0 110.151 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.437 ' NZ ' ' O ' ' A' ' 74' ' ' LYS . 3.2 tptp -64.36 -41.28 96.81 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.721 -0.612 . . . . 0.0 110.1 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -48.16 -50.44 28.9 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 120.019 -0.673 . . . . 0.0 111.707 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.61 46.99 0.01 OUTLIER Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 176.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.491 HG23 HG13 ' A' ' 33' ' ' VAL . 53.5 t -129.23 125.65 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.643 -0.916 . . . . 0.0 110.106 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.5 t -112.45 81.0 1.4 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.486 HG13 ' HD2' ' A' ' 46' ' ' ARG . 11.1 tt -121.3 137.38 26.76 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.652 -0.655 . . . . 0.0 109.27 -178.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.409 ' HD2' HG13 ' A' ' 79' ' ' ILE . 50.9 Cg_exo -52.75 -41.74 67.66 Favored 'Trans proline' 0 N--CA 1.483 0.889 0 C-N-CA 122.785 2.324 . . . . 0.0 113.114 -178.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.417 ' HB3' HG22 ' A' ' 92' ' ' VAL . 5.9 p90 -93.6 147.91 22.57 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 120.626 -1.296 . . . . 0.0 110.824 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -84.1 152.91 24.05 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.598 -0.688 . . . . 0.0 109.503 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 2.0 mp -85.38 93.74 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.487 -0.758 . . . . 0.0 109.951 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.9 p -170.89 -175.65 1.82 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.417 -0.802 . . . . 0.0 109.827 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.417 HG21 ' CD2' ' A' ' 63' ' ' LEU . 0.6 OUTLIER -62.88 -28.91 70.36 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.807 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 32.9 m -83.93 45.76 1.12 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.527 -0.733 . . . . 0.0 109.819 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.417 ' HB ' ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -77.01 139.0 39.94 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.341 -0.849 . . . . 0.0 109.977 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -95.4 134.63 37.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.449 -0.782 . . . . 0.0 109.872 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 94.5 m -143.47 53.57 1.33 Allowed 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.675 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 89.7 p -159.15 -48.48 0.06 Allowed 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.732 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -113.41 21.16 15.46 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.417 HG22 ' HB3' ' A' ' 81' ' ' TYR . 3.3 p -101.9 129.99 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-O 121.638 0.733 . . . . 0.0 109.794 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.545 ' HA ' ' CB ' ' A' ' 43' ' ' THR . 72.4 m-20 . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 116.506 -1.711 . . . . 0.0 108.969 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.798 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.545 HG22 ' HB3' ' A' ' 45' ' ' ASP . 3.5 tp -69.12 82.56 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 CA-C-O 121.757 0.789 . . . . 0.0 109.82 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.1 t -115.81 169.54 9.14 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.244 -0.91 . . . . 0.0 109.994 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 26.5 t -62.33 -33.64 75.09 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.665 -0.814 . . . . 0.0 112.65 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -50.56 -51.09 33.92 Favored Glycine 0 N--CA 1.502 3.062 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.24 -36.05 54.94 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.279 -1.13 . . . . 0.0 110.308 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.421 HG22 ' HA ' ' A' ' 49' ' ' ALA . 83.2 t -56.52 -46.66 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.74 -35.59 72.74 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.6 t -69.0 -21.86 64.12 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.272 -0.893 . . . . 0.0 109.825 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.28 -27.93 21.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.509 -0.744 . . . . 0.0 109.018 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.415 HD13 HG22 ' A' ' 83' ' ' ILE . 1.2 tp -79.5 -40.63 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.356 -0.84 . . . . 0.0 110.023 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.492 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -44.26 -51.46 19.23 Favored Pre-proline 0 N--CA 1.504 2.225 0 O-C-N 121.646 -0.659 . . . . 0.0 110.977 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 32.9 Cg_endo -65.79 -28.17 51.47 Favored 'Trans proline' 0 N--CA 1.483 0.911 0 C-N-CA 122.281 1.987 . . . . 0.0 110.592 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.685 ' SG ' HG22 ' A' ' 71' ' ' ILE . 1.3 m -101.28 16.79 24.39 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 177.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.523 HD11 HG11 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -65.79 -51.1 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.507 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.1 p -59.76 -57.79 11.38 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.324 -0.86 . . . . 0.0 109.302 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.641 ' CD1' HD13 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -55.3 -54.45 43.38 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' A' ' 64' ' ' ASN . . . -65.11 -25.37 67.74 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.416 -0.802 . . . . 0.0 110.003 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.474 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 10.5 ttp180 -79.02 -26.03 43.23 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.319 -0.863 . . . . 0.0 110.006 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 148.32 -12.95 1.23 Allowed Glycine 0 N--CA 1.5 2.916 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.9 mp0 -82.53 64.38 7.15 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.923 -1.34 . . . . 0.0 108.875 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.518 ' HA2' ' CD1' ' A' ' 17' ' ' TYR . . . -76.34 75.69 1.56 Allowed Glycine 0 N--CA 1.5 2.904 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.62 36.05 0.06 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.717 -0.873 . . . . 0.0 110.05 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 178.11 78.78 0.06 OUTLIER Glycine 0 N--CA 1.499 2.836 0 C-N-CA 120.075 -1.059 . . . . 0.0 110.51 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -59.91 131.88 41.94 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 122.17 1.913 . . . . 0.0 109.928 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.1 t -90.06 120.17 31.03 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.268 -0.895 . . . . 0.0 110.602 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.87 -45.2 74.56 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.38 -46.0 87.93 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.5 t -54.07 -42.28 69.11 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.301 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 80.4 m -61.76 -47.6 84.47 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.926 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.1 t -65.19 -40.55 94.38 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 124.259 0.974 . . . . 0.0 110.906 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.25 -57.07 12.43 Favored Glycine 0 N--CA 1.5 2.908 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.567 HG13 ' CB ' ' A' ' 72' ' ' PRO . 16.4 t -62.94 -46.54 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.488 -1.007 . . . . 0.0 109.442 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.564 ' N ' HG23 ' A' ' 77' ' ' VAL . 0.5 OUTLIER -54.54 -31.08 55.76 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.694 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.7 m -78.86 -44.09 23.62 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -56.86 -43.7 81.45 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.632 -0.668 . . . . 0.0 109.995 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.545 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 51.3 t30 -74.72 -35.48 62.69 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.167 -0.958 . . . . 0.0 109.912 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -63.83 -37.72 88.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.039 -1.038 . . . . 0.0 108.395 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.29 -43.53 13.65 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.786 -0.571 . . . . 0.0 110.617 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.471 ' CB ' HG12 ' A' ' 2' ' ' ILE . . . -103.9 111.44 23.97 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.06 -1.025 . . . . 0.0 111.441 -178.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.545 ' HG3' ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -157.84 26.48 0.27 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.781 -0.575 . . . . 0.0 110.0 179.044 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -127.64 34.7 4.62 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.127 -0.983 . . . . 0.0 109.624 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.427 ' OG1' ' HA ' ' A' ' 93' ' ' ASN . 27.9 m 70.09 -66.08 0.29 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.562 -0.711 . . . . 0.0 109.924 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.91 -57.06 10.5 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.707 -0.62 . . . . 0.0 110.677 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.545 ' HB3' HG22 ' A' ' 2' ' ' ILE . 6.5 m-20 -67.2 -36.89 82.67 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.463 ' NH1' HG12 ' A' ' 79' ' ' ILE . 5.6 mmm180 -67.95 -39.45 83.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.629 -0.669 . . . . 0.0 109.684 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.82 -41.89 87.9 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.428 -0.795 . . . . 0.0 108.995 178.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.42 -46.49 86.34 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.433 ' HB1' HD13 ' A' ' 2' ' ' ILE . . . -64.14 -41.58 97.14 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 50.0 t -66.31 -35.83 81.39 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.613 -0.68 . . . . 0.0 110.569 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -66.54 -55.76 14.0 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 124.152 0.908 . . . . 0.0 109.813 176.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.403 ' SG ' ' HB ' ' A' ' 7' ' ' VAL . 42.1 t -61.63 -35.7 78.66 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.862 178.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.486 HD21 HG21 ' A' ' 83' ' ' ILE . 12.1 mt -61.15 -53.19 60.15 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 124.336 1.022 . . . . 0.0 109.011 176.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.476 ' NZ ' ' O ' ' A' ' 85' ' ' THR . 43.8 tttp -55.82 -37.64 68.94 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.78 -29.77 69.05 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.532 -0.73 . . . . 0.0 110.817 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.448 ' O ' HG21 ' A' ' 60' ' ' VAL . . . -94.96 -49.3 5.62 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.271 -0.893 . . . . 0.0 110.378 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.435 ' HA ' HD11 ' A' ' 63' ' ' LEU . . . -53.65 -49.59 67.59 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.36 -0.838 . . . . 0.0 109.522 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.462 ' HB3' ' HG1' ' A' ' 85' ' ' THR . . . -73.46 67.05 1.02 Allowed 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 61' ' ' SER . . . 165.16 -22.87 0.14 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.523 HG11 HD11 ' A' ' 15' ' ' ILE . 24.7 t -64.52 69.85 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 121.29 -1.124 . . . . 0.0 109.942 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.44 ' N ' ' O ' ' A' ' 59' ' ' GLY . 43.3 m 54.38 -102.68 0.15 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.222 -0.924 . . . . 0.0 110.022 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -100.0 -29.11 6.99 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.435 HD11 ' HA ' ' A' ' 57' ' ' ALA . 21.7 tp 63.54 99.98 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.807 -0.82 . . . . 0.0 111.047 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.558 ' N ' ' O ' ' A' ' 18' ' ' ALA . 12.2 m-80 -98.62 95.43 7.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.205 -0.934 . . . . 0.0 108.643 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -49.31 -50.44 39.38 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.734 -0.604 . . . . 0.0 111.042 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.07 -32.7 50.2 Favored Glycine 0 N--CA 1.505 3.261 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -82.87 -48.98 10.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.52 -0.988 . . . . 0.0 109.435 179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.25 -21.42 63.91 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.687 -0.633 . . . . 0.0 111.408 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.44 -41.35 12.13 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.011 -1.056 . . . . 0.0 110.253 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 76.6 p -68.99 -45.39 70.71 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.499 -0.751 . . . . 0.0 110.954 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.685 HG22 ' SG ' ' A' ' 14' ' ' CYS . 44.0 mt -47.95 -64.55 1.03 Allowed Pre-proline 0 N--CA 1.503 2.208 0 O-C-N 121.647 -0.658 . . . . 0.0 111.589 -178.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.567 ' CB ' HG13 ' A' ' 33' ' ' VAL . 28.4 Cg_endo -59.27 -48.87 12.28 Favored 'Trans proline' 0 N--CA 1.48 0.677 0 C-N-CA 121.745 1.63 . . . . 0.0 110.566 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.1 m -49.45 -68.96 0.13 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -33.59 75.62 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -47.78 -35.43 9.99 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.794 -0.566 . . . . 0.0 110.453 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 124.74 54.4 0.18 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.011 -2.036 . . . . 0.0 108.011 177.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.564 HG23 ' N ' ' A' ' 34' ' ' ARG . 85.2 t -111.09 -48.57 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.205 -178.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 19.7 m 68.33 33.59 4.15 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.677 -0.639 . . . . 0.0 110.149 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.614 HG12 ' CD1' ' A' ' 81' ' ' TYR . 9.7 tt -95.78 121.35 61.44 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.059 -1.026 . . . . 0.0 109.06 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 79' ' ' ILE . 16.2 Cg_exo -65.31 56.6 0.31 Allowed 'Trans proline' 0 CA--C 1.55 1.294 0 C-N-CA 122.51 2.14 . . . . 0.0 112.711 -178.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.614 ' CD1' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -178.54 152.31 0.64 Allowed 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.332 -0.855 . . . . 0.0 110.271 177.443 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.6 p -108.64 171.37 7.46 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.65 0.738 . . . . 0.0 110.592 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.486 HG21 HD21 ' A' ' 53' ' ' LEU . 2.0 mp -104.44 67.12 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 122.012 0.911 . . . . 0.0 108.702 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.419 ' O ' ' CB ' ' A' ' 85' ' ' THR . 86.2 p -98.37 -18.39 18.33 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.494 -0.754 . . . . 0.0 110.627 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.476 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . 0.5 OUTLIER 81.04 -16.44 0.65 Allowed 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.781 -0.574 . . . . 0.0 110.995 -179.282 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.9 m -76.17 -21.88 56.02 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.017 -1.052 . . . . 0.0 109.013 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -47.74 145.8 2.61 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.621 0.724 . . . . 0.0 111.1 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -88.93 -13.23 39.5 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.995 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 54.6 m 52.87 51.25 16.29 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.465 0.65 . . . . 0.0 111.291 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.96 -42.64 0.27 Allowed 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.552 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.8 31.74 4.83 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.3 p -109.48 118.84 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.768 -0.582 . . . . 0.0 109.462 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.427 ' HA ' ' OG1' ' A' ' 43' ' ' THR . 2.9 p-10 . . . . . 0 N--CA 1.497 1.912 0 CA-C-O 114.6 -2.619 . . . . 0.0 110.17 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.782 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.47 HD12 ' HB1' ' A' ' 49' ' ' ALA . 4.2 tp -71.68 99.26 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.319 -0.863 . . . . 0.0 109.828 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.8 t -135.17 172.61 12.76 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.314 -0.867 . . . . 0.0 110.205 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.8 t -67.86 -20.78 65.17 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -56.7 -54.48 36.12 Favored Glycine 0 N--CA 1.504 3.176 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.401 ' NE2' ' HB3' ' A' ' 36' ' ' LEU . 8.4 tt0 -67.66 -40.65 84.48 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.456 -1.026 . . . . 0.0 108.516 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 77.5 t -53.78 -44.91 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.87 -35.95 75.09 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.7 t -69.39 -22.2 63.73 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.44 -0.788 . . . . 0.0 109.241 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.51 ' C ' ' HD2' ' A' ' 13' ' ' PRO . . . -98.05 -25.43 14.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.51 -0.744 . . . . 0.0 109.236 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.8 tp -78.77 -42.31 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.218 -0.926 . . . . 0.0 110.072 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.503 ' HB2' ' HD3' ' A' ' 13' ' ' PRO . . . -46.43 -51.16 36.92 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.588 -0.695 . . . . 0.0 110.432 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.51 ' HD2' ' C ' ' A' ' 10' ' ' ALA . 11.2 Cg_exo -67.26 -28.76 39.7 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.136 1.891 . . . . 0.0 110.992 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.553 ' SG ' HG22 ' A' ' 71' ' ' ILE . 1.3 m -103.07 14.38 31.99 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 178.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.461 ' O ' ' CB ' ' A' ' 19' ' ' ARG . 0.4 OUTLIER -74.16 -44.5 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -178.474 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.1 p -65.74 -56.84 9.89 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.619 ' CG ' HD13 ' A' ' 71' ' ' ILE . 0.5 OUTLIER -54.82 -55.35 31.12 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.579 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 64' ' ' ASN . . . -60.01 -32.05 70.51 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.313 -0.867 . . . . 0.0 109.439 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.461 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 11.9 ttt180 -78.42 -5.89 53.69 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.647 -0.658 . . . . 0.0 110.623 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.56 -12.43 39.21 Favored Glycine 0 N--CA 1.501 3.025 0 O-C-N 120.666 -1.272 . . . . 0.0 111.412 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -105.06 81.38 1.72 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.136 -1.214 . . . . 0.0 109.333 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -146.44 -177.03 20.76 Favored Glycine 0 N--CA 1.499 2.838 0 C-N-CA 119.686 -1.245 . . . . 0.0 111.356 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -176.38 49.98 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.13 136.93 3.73 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 108.504 -1.839 . . . . 0.0 108.504 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -60.98 130.22 31.84 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 122.158 1.905 . . . . 0.0 111.136 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.1 t -74.04 123.81 25.07 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.507 -0.746 . . . . 0.0 109.718 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.51 -46.43 73.5 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.502 -0.749 . . . . 0.0 109.879 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.1 -48.3 86.57 Favored Glycine 0 N--CA 1.503 3.164 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.442 ' O ' HG21 ' A' ' 33' ' ' VAL . 1.0 OUTLIER -58.74 -55.19 38.24 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.095 178.328 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 96.2 m -58.76 -27.17 64.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 124.027 0.829 . . . . 0.0 112.033 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.2 m -74.23 -47.7 33.6 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 123.825 0.703 . . . . 0.0 109.296 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.43 ' HA3' ' HB1' ' A' ' 10' ' ' ALA . . . -65.0 -28.26 73.29 Favored Glycine 0 N--CA 1.5 2.953 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.613 ' CG1' HG23 ' A' ' 77' ' ' VAL . 21.2 t -81.91 -48.22 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.269 -1.136 . . . . 0.0 108.762 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.423 ' HA ' HG21 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -61.9 -25.78 67.77 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.358 -0.839 . . . . 0.0 109.05 179.071 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 79.6 p -74.0 -46.38 44.03 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.514 HD21 ' HA ' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -63.24 -30.86 71.93 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.671 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.549 ' HB2' HG12 ' A' ' 77' ' ' VAL . 3.1 t-20 -63.39 -36.17 82.84 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.025 -1.047 . . . . 0.0 110.215 179.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -90.38 -36.33 14.68 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.463 -0.773 . . . . 0.0 110.099 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.26 -18.48 25.56 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.538 -0.727 . . . . 0.0 111.076 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.628 ' HA ' ' CB ' ' A' ' 45' ' ' ASP . . . -123.56 110.49 15.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.011 -1.055 . . . . 0.0 110.508 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -163.32 -20.19 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.411 -0.806 . . . . 0.0 112.081 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 44' ' ' ALA . 89.7 m -78.28 50.02 0.88 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.648 -1.283 . . . . 0.0 110.292 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.515 HG21 ' HA ' ' A' ' 93' ' ' ASN . 97.9 m 62.4 -64.6 0.09 Allowed 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.846 -0.534 . . . . 0.0 110.015 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 42' ' ' THR . . . -48.45 -57.29 6.32 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 122.067 -0.396 . . . . 0.0 110.419 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.628 ' CB ' ' HA ' ' A' ' 40' ' ' ALA . 3.1 m-20 -55.26 -45.45 76.09 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.525 HH11 ' HB2' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -57.51 -55.23 37.52 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.738 178.825 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -59.92 -44.14 94.48 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.15 -50.88 71.39 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.535 -0.728 . . . . 0.0 109.317 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.47 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -63.56 -55.27 25.11 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.413 ' HA ' ' HB2' ' A' ' 53' ' ' LEU . 3.7 t -48.63 -39.42 24.03 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 174.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.419 ' N ' ' SG ' ' A' ' 89' ' ' CYS . 2.8 t30 -60.35 -53.09 61.81 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 176.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.6 t -68.54 -32.26 72.07 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 119.766 -0.774 . . . . 0.0 111.598 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.413 ' HB2' ' HA ' ' A' ' 50' ' ' CYS . 13.6 mt -63.0 -57.56 10.29 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.072 178.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.468 ' NZ ' ' O ' ' A' ' 85' ' ' THR . 54.7 tttp -54.73 -39.4 68.21 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -54.51 -50.75 67.1 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.465 ' O ' HG22 ' A' ' 60' ' ' VAL . . . -72.03 -44.17 63.82 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.507 -0.746 . . . . 0.0 109.205 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.5 ' HA ' ' CD1' ' A' ' 63' ' ' LEU . . . -54.88 -37.79 66.73 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.629 -0.669 . . . . 0.0 110.297 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.89 8.03 21.83 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.237 -0.914 . . . . 0.0 110.43 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -140.3 11.56 3.02 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 56' ' ' ALA . 3.8 t -79.04 -28.01 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.234 -1.157 . . . . 0.0 109.937 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 77.25 113.26 0.07 Allowed 'General case' 0 N--CA 1.506 2.369 0 CA-C-O 121.275 0.559 . . . . 0.0 109.946 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.48 34.22 87.1 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.5 ' CD1' ' HA ' ' A' ' 57' ' ' ALA . 10.0 tt -64.68 121.86 15.5 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.463 -1.022 . . . . 0.0 110.406 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 18' ' ' ALA . 10.7 m-80 -97.09 90.05 5.02 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -44.28 -48.47 9.5 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.912 -0.492 . . . . 0.0 110.494 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -50.68 -40.52 40.92 Favored Glycine 0 N--CA 1.502 3.07 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -76.46 -56.4 4.66 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.703 -0.88 . . . . 0.0 109.344 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.44 -24.7 63.74 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.906 -0.496 . . . . 0.0 111.769 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.01 -47.48 7.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.956 -1.09 . . . . 0.0 110.419 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 t -64.54 -31.27 72.42 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.445 -0.784 . . . . 0.0 111.056 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.619 HD13 ' CG ' ' A' ' 17' ' ' TYR . 78.0 mt -60.43 -70.38 0.44 Allowed Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 121.204 -0.935 . . . . 0.0 111.007 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.601 ' CB ' HG13 ' A' ' 33' ' ' VAL . 38.0 Cg_endo -60.07 -51.67 5.33 Favored 'Trans proline' 0 N--CA 1.484 0.944 0 C-N-CA 122.328 2.019 . . . . 0.0 112.077 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.2 p -51.45 -63.67 1.06 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.692 -0.63 . . . . 0.0 110.487 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.7 mmtt -63.11 -42.33 99.53 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 122.15 -0.343 . . . . 0.0 110.604 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 71' ' ' ILE . 0.4 OUTLIER -47.36 -55.22 9.27 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.506 -0.746 . . . . 0.0 112.12 -177.502 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 164.9 50.97 0.02 OUTLIER Glycine 0 N--CA 1.496 2.653 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.613 HG23 ' CG1' ' A' ' 33' ' ' VAL . 46.8 t -130.85 93.59 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.756 -0.85 . . . . 0.0 110.323 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 56.7 p -70.1 66.44 0.27 Allowed 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.6 0.714 . . . . 0.0 110.365 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.591 HG12 ' CE1' ' A' ' 81' ' ' TYR . 0.4 OUTLIER -124.94 120.36 25.49 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.173 -0.954 . . . . 0.0 108.79 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.91 -27.5 74.76 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 C-N-CA 122.955 2.436 . . . . 0.0 113.679 -177.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.591 ' CE1' HG12 ' A' ' 79' ' ' ILE . 12.9 p90 -89.59 130.12 35.94 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.794 -1.191 . . . . 0.0 111.063 -178.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.1 p -102.68 155.51 18.26 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.738 0.78 . . . . 0.0 110.655 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.502 ' N ' HD13 ' A' ' 83' ' ' ILE . 2.0 mp -86.92 85.21 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.402 ' O ' ' N ' ' A' ' 86' ' ' SER . 59.5 p -114.39 13.79 17.8 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.526 -0.734 . . . . 0.0 111.866 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.468 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . 86.0 m 68.78 -56.82 0.52 Allowed 'General case' 0 N--CA 1.51 2.567 0 O-C-N 121.211 -0.93 . . . . 0.0 108.86 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 84' ' ' SER . 42.0 m -68.43 -25.6 65.1 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.289 -0.882 . . . . 0.0 109.167 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.439 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . 94.4 m -38.48 140.92 0.29 Allowed 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 121.362 0.601 . . . . 0.0 110.697 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -85.3 139.9 31.24 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.594 -0.691 . . . . 0.0 110.56 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 51' ' ' ASN . 0.5 OUTLIER -122.73 56.26 1.15 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.934 0.873 . . . . 0.0 110.61 176.448 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.1 m -151.34 -41.15 0.12 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.092 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.06 -1.09 37.8 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.264 -0.897 . . . . 0.0 110.311 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.9 t -73.26 136.51 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 O-C-N 121.049 -1.032 . . . . 0.0 109.714 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.515 ' HA ' HG21 ' A' ' 43' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 114.0 -2.905 . . . . 0.0 110.05 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 121.291 0.567 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.64 ' CD1' ' HB3' ' A' ' 49' ' ' ALA . 1.3 pp -90.49 101.81 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.413 ' O ' ' HG3' ' A' ' 6' ' ' GLN . 27.7 t -96.13 -167.73 1.63 Allowed 'General case' 0 N--CA 1.503 2.211 0 O-C-N 120.894 -1.129 . . . . 0.0 111.199 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 33.5 t -74.96 -29.05 60.81 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -54.5 -50.57 56.46 Favored Glycine 0 N--CA 1.504 3.226 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 177.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.42 ' HG3' ' N ' ' A' ' 7' ' ' VAL . 0.5 OUTLIER -66.67 -34.93 78.95 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.486 -1.009 . . . . 0.0 109.415 179.111 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.513 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 61.6 t -59.05 -38.27 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 177.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.41 ' HA ' HG13 ' A' ' 11' ' ' ILE . . . -68.97 -34.84 75.97 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.56 -16.36 63.84 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.531 -0.731 . . . . 0.0 109.573 178.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.534 ' CB ' HG23 ' A' ' 33' ' ' VAL . . . -94.11 -31.84 14.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.505 -0.747 . . . . 0.0 110.145 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.466 HD13 ' N ' ' A' ' 12' ' ' ALA . 2.4 pp -95.18 -30.79 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.31 -0.869 . . . . 0.0 111.443 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.466 ' N ' HD13 ' A' ' 11' ' ' ILE . . . -50.87 -52.84 53.69 Favored Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.133 -0.979 . . . . 0.0 110.449 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.465 ' HD3' ' HB1' ' A' ' 12' ' ' ALA . 71.5 Cg_endo -73.46 -10.05 23.48 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.405 2.07 . . . . 0.0 111.019 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.561 ' SG ' ' HB3' ' A' ' 25' ' ' PRO . 15.6 m -124.61 21.0 8.56 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.452 ' CD1' HG11 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -67.04 -50.69 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.548 -179.129 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.436 ' HA ' ' HB3' ' A' ' 19' ' ' ARG . 20.2 m -62.48 -46.91 86.34 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.278 -0.889 . . . . 0.0 110.091 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.537 ' CD2' HG12 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -59.31 -56.14 25.92 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 64' ' ' ASN . . . -57.96 -28.21 64.13 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.436 ' HB3' ' HA ' ' A' ' 16' ' ' SER . 0.0 OUTLIER -75.09 -5.21 42.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.904 -0.497 . . . . 0.0 110.568 179.153 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.04 -5.73 27.2 Favored Glycine 0 N--CA 1.5 2.953 0 O-C-N 120.599 -1.313 . . . . 0.0 111.846 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.46 97.52 3.71 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 118.991 1.395 . . . . 0.0 110.091 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.421 ' HA3' ' CB ' ' A' ' 17' ' ' TYR . . . -153.54 -66.28 0.01 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.7 t 58.65 43.64 18.62 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.507 -0.996 . . . . 0.0 109.037 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 132.37 95.31 0.61 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 107.977 -2.049 . . . . 0.0 107.977 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.561 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 17.1 Cg_exo -59.95 -78.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 122.381 2.054 . . . . 0.0 111.089 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 25' ' ' PRO . 10.8 t 161.83 149.79 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.581 -0.7 . . . . 0.0 109.635 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.35 -36.69 78.6 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.93 -45.01 87.41 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.413 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 35.3 t -64.63 -52.42 57.54 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.655 -1.218 . . . . 0.0 109.638 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 83.4 m -59.18 -46.94 87.08 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.5 m -68.89 -50.12 52.37 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 124.119 0.887 . . . . 0.0 110.468 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.55 -54.76 33.82 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.578 HG11 ' CG2' ' A' ' 77' ' ' VAL . 38.3 t -60.61 -47.27 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.972 -0.722 . . . . 0.0 109.241 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.491 ' O ' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -56.34 -31.2 63.51 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.41 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.1 m -80.23 -55.12 5.14 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.778 -0.576 . . . . 0.0 109.647 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.483 ' CG ' ' HA ' ' A' ' 33' ' ' VAL . 1.7 pp -58.37 -42.46 87.05 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.254 -0.904 . . . . 0.0 109.133 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.461 ' HB3' HG11 ' A' ' 77' ' ' VAL . 18.4 m120 -70.92 -20.14 62.51 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.449 -0.782 . . . . 0.0 109.194 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 34' ' ' ARG . 52.1 t30 -67.69 -37.52 82.4 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.15 -24.87 30.02 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.96 -0.462 . . . . 0.0 110.89 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.486 ' N ' HG23 ' A' ' 2' ' ' ILE . . . -82.46 86.88 6.68 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.117 -0.99 . . . . 0.0 110.104 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.593 ' HA ' ' NE ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -152.55 38.19 0.54 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.121 -0.987 . . . . 0.0 110.314 -179.713 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.472 ' O ' ' N ' ' A' ' 44' ' ' ALA . 12.4 p -139.08 35.57 2.12 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 120.935 -1.103 . . . . 0.0 110.805 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.446 HG21 ' HB3' ' A' ' 93' ' ' ASN . 1.1 p 65.19 -60.92 0.24 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.424 -0.798 . . . . 0.0 109.6 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 42' ' ' THR . . . -58.72 -58.16 9.83 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.5 ' O ' HD13 ' A' ' 2' ' ' ILE . 21.8 m-20 -66.1 -45.21 82.01 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.835 0.826 . . . . 0.0 108.83 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.593 ' NE ' ' HA ' ' A' ' 41' ' ' ARG . 1.8 tpp180 -59.63 -57.63 12.1 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.752 -0.593 . . . . 0.0 110.95 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 -61.6 -38.69 88.54 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.282 -0.886 . . . . 0.0 109.986 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.13 -50.79 70.11 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.64 ' HB3' ' CD1' ' A' ' 2' ' ' ILE . . . -62.4 -46.68 87.49 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.489 ' C ' ' SG ' ' A' ' 89' ' ' CYS . 42.9 t -55.12 -42.19 72.66 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.998 -0.439 . . . . 0.0 111.05 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -67.69 -60.45 2.53 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 124.117 0.885 . . . . 0.0 110.206 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.513 ' SG ' ' HB ' ' A' ' 7' ' ' VAL . 10.8 t -55.36 -29.33 58.2 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.05 178.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.487 HD21 HG13 ' A' ' 83' ' ' ILE . 15.8 mt -70.44 -50.65 36.14 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.13 175.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.5 tttm -56.67 -41.03 76.56 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -56.34 -46.19 80.05 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.05 -41.01 62.42 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.558 -0.714 . . . . 0.0 109.238 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.474 ' HA ' HD11 ' A' ' 63' ' ' LEU . . . -52.92 -43.74 66.47 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.664 -0.647 . . . . 0.0 109.963 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -90.05 18.2 6.09 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.293 -0.879 . . . . 0.0 110.133 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -127.95 -31.48 0.69 Allowed Glycine 0 N--CA 1.501 2.969 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.452 HG11 ' CD1' ' A' ' 15' ' ' ILE . 7.6 t -52.87 135.34 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.54 -0.977 . . . . 0.0 110.272 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.7 t -64.12 107.68 1.35 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.596 -0.69 . . . . 0.0 109.191 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.93 50.09 43.47 Favored Glycine 0 N--CA 1.499 2.88 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.474 HD11 ' HA ' ' A' ' 57' ' ' ALA . 4.0 tp -61.41 126.31 26.89 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.369 -1.077 . . . . 0.0 110.372 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.405 ' N ' ' O ' ' A' ' 18' ' ' ALA . 2.0 m-80 -103.48 93.48 4.97 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -41.49 -46.21 3.42 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.853 -0.53 . . . . 0.0 110.691 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.06 -31.34 48.27 Favored Glycine 0 N--CA 1.502 3.064 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -94.59 -49.5 5.61 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.464 -1.021 . . . . 0.0 109.257 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.414 ' HB3' ' CG2' ' A' ' 83' ' ' ILE . . . -57.88 -34.26 69.59 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.702 -0.624 . . . . 0.0 111.049 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.493 ' HA ' ' HB ' ' A' ' 82' ' ' THR . . . -83.79 -47.76 10.79 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.945 -1.097 . . . . 0.0 109.934 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.6 p -68.66 -36.78 78.99 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.537 -0.727 . . . . 0.0 110.984 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.537 HG12 ' CD2' ' A' ' 17' ' ' TYR . 22.4 mt -46.07 -62.44 1.84 Allowed Pre-proline 0 N--CA 1.504 2.271 0 O-C-N 121.436 -0.79 . . . . 0.0 110.584 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 71' ' ' ILE . 37.9 Cg_endo -62.35 -52.62 2.45 Favored 'Trans proline' 0 C--N 1.321 -0.869 0 C-N-CA 121.907 1.738 . . . . 0.0 110.048 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.6 m -52.46 -60.81 2.78 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.518 -0.739 . . . . 0.0 110.183 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -61.41 -44.65 96.78 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -47.56 -32.78 5.74 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.554 -0.716 . . . . 0.0 111.264 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.407 ' O ' ' CD ' ' A' ' 34' ' ' ARG . . . 126.55 41.47 0.32 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 177.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.578 ' CG2' HG11 ' A' ' 33' ' ' VAL . 12.8 t -92.43 -32.95 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -1.121 . . . . 0.0 110.851 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.8 m 45.25 58.82 3.87 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.536 -0.728 . . . . 0.0 109.435 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.557 ' CG1' HH11 ' A' ' 46' ' ' ARG . 0.2 OUTLIER -140.8 136.71 16.51 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.443 -0.786 . . . . 0.0 109.449 -178.683 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -58.76 -43.97 39.92 Favored 'Trans proline' 0 C--N 1.318 -1.054 0 C-N-CA 122.842 2.361 . . . . 0.0 112.184 -178.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.47 ' CD1' ' HG3' ' A' ' 46' ' ' ARG . 42.7 p90 -79.7 134.28 36.39 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 122.026 0.917 . . . . 0.0 109.988 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.493 ' HB ' ' HA ' ' A' ' 69' ' ' ALA . 32.4 p -123.21 -175.84 3.28 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.363 0.601 . . . . 0.0 109.916 -178.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.555 ' N ' ' CD1' ' A' ' 83' ' ' ILE . 0.3 OUTLIER -84.48 59.27 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 178.553 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.6 p -102.2 136.13 42.57 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.972 -177.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.9 p -61.66 -56.01 24.41 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.514 -0.741 . . . . 0.0 109.014 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 55.9 p -93.32 53.53 1.93 Allowed 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.491 ' CG2' ' SG ' ' A' ' 89' ' ' CYS . 2.4 t -75.7 -170.96 1.42 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.518 -0.739 . . . . 0.0 110.867 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.407 ' N ' HG22 ' A' ' 87' ' ' THR . 22.8 t70 -83.13 -71.74 0.48 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.305 -0.872 . . . . 0.0 109.99 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.491 ' SG ' ' CG2' ' A' ' 87' ' ' THR . 85.1 m 52.19 51.52 16.16 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.274 0.559 . . . . 0.0 112.228 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.2 t -170.12 -49.24 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.492 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -99.54 -22.2 15.58 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.527 -0.733 . . . . 0.0 110.865 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.518 HG11 ' HG2' ' A' ' 46' ' ' ARG . 21.5 t -59.09 138.32 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.001 -1.062 . . . . 0.0 110.065 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.446 ' HB3' HG21 ' A' ' 43' ' ' THR . 61.8 m-20 . . . . . 0 N--CA 1.496 1.852 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.579 HD12 ' HB1' ' A' ' 49' ' ' ALA . 0.9 OUTLIER -117.58 85.5 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-O 121.988 0.899 . . . . 0.0 109.272 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.0 t -146.97 171.22 15.58 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.224 -0.922 . . . . 0.0 110.846 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -56.4 -35.96 68.37 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -58.52 -42.11 95.79 Favored Glycine 0 N--CA 1.502 3.037 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 175.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.472 ' CG ' ' HB2' ' A' ' 36' ' ' LEU . 0.8 OUTLIER -79.83 -41.43 26.39 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.574 -0.956 . . . . 0.0 109.168 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 77.0 t -56.33 -42.44 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.66 -36.27 75.9 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.2 t -69.35 -21.24 63.83 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.315 -0.866 . . . . 0.0 108.973 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.49 -52.26 14.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.437 -0.789 . . . . 0.0 110.651 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.425 HD12 ' N ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -80.54 -20.21 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 121.184 -0.948 . . . . 0.0 110.978 -178.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.456 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -45.5 -55.36 12.28 Favored Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 121.262 -0.899 . . . . 0.0 110.385 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 64.4 Cg_endo -70.49 -21.95 29.39 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.251 1.968 . . . . 0.0 110.994 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.544 ' SG ' ' CG2' ' A' ' 71' ' ' ILE . 1.1 m -111.73 27.99 9.16 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.464 ' O ' ' CB ' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -63.24 -44.92 99.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 177.208 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.413 ' O ' ' N ' ' A' ' 21' ' ' GLN . 0.4 OUTLIER -61.72 -53.83 50.72 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.392 -0.817 . . . . 0.0 108.807 178.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.544 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 0.5 OUTLIER -53.77 -60.66 3.02 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.662 -0.648 . . . . 0.0 109.566 178.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.555 ' N ' HD13 ' A' ' 71' ' ' ILE . . . -60.1 -31.92 70.49 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.612 -0.68 . . . . 0.0 111.084 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.464 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 9.5 tmm_? -83.84 18.49 1.99 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.453 -0.779 . . . . 0.0 111.602 -178.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.49 14.65 75.65 Favored Glycine 0 N--CA 1.503 3.137 0 O-C-N 120.541 -1.349 . . . . 0.0 112.032 178.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.544 ' O ' ' HA ' ' A' ' 17' ' ' TYR . 1.6 mm-40 -124.8 -176.7 3.61 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.113 -1.228 . . . . 0.0 109.92 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.08 -62.1 0.54 Allowed Glycine 0 N--CA 1.504 3.171 0 O-C-N 121.096 -1.003 . . . . 0.0 110.992 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 76.16 -51.82 0.61 Allowed 'General case' 0 N--CA 1.508 2.461 0 O-C-N 121.557 -0.967 . . . . 0.0 110.372 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.5 134.28 12.46 Favored Glycine 0 N--CA 1.501 2.974 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -62.38 134.3 47.64 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 122.394 2.063 . . . . 0.0 111.017 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 t -79.93 134.56 36.28 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.299 -0.875 . . . . 0.0 109.407 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.28 -50.11 72.32 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.367 -0.833 . . . . 0.0 109.112 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.26 -46.17 94.76 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.5 t -56.79 -39.68 74.54 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.994 178.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 82.0 m -71.22 -44.81 64.62 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.597 -175.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 46.7 t -65.65 -40.01 92.0 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 124.048 0.842 . . . . 0.0 109.916 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.76 -60.3 6.29 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.535 ' HA ' ' CG ' ' A' ' 36' ' ' LEU . 17.3 t -59.38 -47.85 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.581 -0.952 . . . . 0.0 110.946 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.476 ' HA ' HG23 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -57.94 -26.87 62.81 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.237 -0.914 . . . . 0.0 109.537 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.0 m -86.12 -51.07 6.54 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.394 -0.816 . . . . 0.0 109.697 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.535 ' CG ' ' HA ' ' A' ' 33' ' ' VAL . 2.7 pp -60.69 -49.2 78.47 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.676 -0.64 . . . . 0.0 110.51 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.505 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . 2.6 m-80 -66.83 -32.55 73.9 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.1 -1.0 . . . . 0.0 108.696 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.455 ' HA ' ' HD2' ' A' ' 41' ' ' ARG . 10.0 t30 -63.79 -38.96 93.07 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.48 -30.37 71.4 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.485 ' HA ' ' CB ' ' A' ' 45' ' ' ASP . . . -94.16 88.46 5.63 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.508 -0.745 . . . . 0.0 109.82 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.455 ' HD2' ' HA ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -143.1 20.49 1.93 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.937 -1.102 . . . . 0.0 111.922 -179.653 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.4 m -115.55 31.96 6.38 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.817 -1.177 . . . . 0.0 109.939 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.462 HG21 ' HA ' ' A' ' 93' ' ' ASN . 58.0 m 69.63 -61.54 0.44 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.456 -0.777 . . . . 0.0 109.297 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.24 -45.56 72.38 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.485 ' CB ' ' HA ' ' A' ' 40' ' ' ALA . 8.9 m-20 -73.44 -39.69 64.78 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.462 ' HG3' ' CE1' ' A' ' 81' ' ' TYR . 0.3 OUTLIER -65.14 -47.13 78.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.901 -0.499 . . . . 0.0 111.552 -178.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.402 ' NE ' ' O ' ' A' ' 90' ' ' SER . 51.9 mtt180 -65.49 -40.67 93.34 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.009 -1.057 . . . . 0.0 109.517 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.89 -43.19 99.36 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.579 ' HB1' HD12 ' A' ' 2' ' ' ILE 0.268 . . -65.15 -49.69 68.88 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.234 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.495 ' C ' ' SG ' ' A' ' 89' ' ' CYS . 50.2 t -55.26 -40.73 71.3 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.289 -0.882 . . . . 0.0 110.126 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.499 ' O ' ' HG3' ' A' ' 54' ' ' LYS . 1.8 t30 -62.69 -53.41 54.87 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 124.035 0.834 . . . . 0.0 110.481 177.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.9 t -72.2 -20.01 61.64 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.817 -1.153 . . . . 0.0 111.609 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.461 HD11 ' CG1' ' A' ' 83' ' ' ILE . 18.1 mt -68.85 -57.86 4.98 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 124.092 0.87 . . . . 0.0 109.012 175.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -57.17 -28.79 63.11 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.436 ' OD1' ' NZ ' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -73.63 -45.33 53.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.688 -0.632 . . . . 0.0 109.569 178.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.98 -49.84 47.6 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.418 -0.801 . . . . 0.0 109.75 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.412 ' O ' HD12 ' A' ' 63' ' ' LEU . . . -59.74 -62.23 2.03 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.439 -0.788 . . . . 0.0 109.334 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.529 ' HA ' HD12 ' A' ' 63' ' ' LEU . . . -70.75 77.28 0.61 Allowed 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.73 -16.21 0.94 Allowed Glycine 0 N--CA 1.497 2.749 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.433 HG11 HD12 ' A' ' 15' ' ' ILE . 0.9 OUTLIER -47.7 -58.58 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 CA-C-N 118.54 1.17 . . . . 0.0 110.477 -179.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.5 m 162.79 -62.74 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.513 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -128.28 46.97 1.05 Allowed Glycine 0 N--CA 1.498 2.784 0 N-CA-C 107.462 -2.255 . . . . 0.0 107.462 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.529 HD12 ' HA ' ' A' ' 58' ' ' ALA . 2.5 pt? -50.54 129.48 22.36 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.883 0.849 . . . . 0.0 111.431 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.452 ' CB ' ' HB2' ' A' ' 67' ' ' ASN . 1.6 m-80 -109.27 103.14 12.04 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -36.06 -57.48 0.7 Allowed 'General case' 0 N--CA 1.506 2.349 0 O-C-N 122.028 -0.42 . . . . 0.0 111.775 -178.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.23 -52.41 44.34 Favored Glycine 0 N--CA 1.502 3.074 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.452 ' HB2' ' CB ' ' A' ' 64' ' ' ASN . 2.9 m120 -54.9 -45.39 74.71 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.669 -0.9 . . . . 0.0 110.626 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.431 ' O ' ' HD2' ' A' ' 72' ' ' PRO . . . -55.45 -55.42 31.97 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.783 -0.573 . . . . 0.0 110.252 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.517 ' HB3' HG21 ' A' ' 82' ' ' THR . . . -70.66 -36.98 73.65 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.476 -0.765 . . . . 0.0 110.784 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.487 ' OG ' ' NZ ' ' A' ' 74' ' ' LYS . 4.5 t -62.12 -28.07 69.37 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.361 -0.837 . . . . 0.0 111.087 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.555 HD13 ' N ' ' A' ' 18' ' ' ALA . 38.4 mt -61.36 -69.67 0.55 Allowed Pre-proline 0 N--CA 1.502 2.15 0 O-C-N 121.243 -0.911 . . . . 0.0 111.442 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.505 ' CD ' ' HB ' ' A' ' 71' ' ' ILE . 19.5 Cg_endo -58.81 -50.27 9.54 Favored 'Trans proline' 0 N--CA 1.481 0.787 0 C-N-CA 122.141 1.894 . . . . 0.0 110.929 -178.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.0 m -48.51 -70.91 0.08 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 122.099 -0.376 . . . . 0.0 110.478 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.487 ' NZ ' ' OG ' ' A' ' 70' ' ' SER . 27.9 mtmm -60.33 -43.14 96.68 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-N 116.965 -0.107 . . . . 0.0 110.746 -178.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 1.5 m -45.48 -35.98 4.17 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.823 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 34' ' ' ARG . . . 122.37 49.88 0.24 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 175.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.505 ' CG1' ' HB3' ' A' ' 37' ' ' ASN . 90.6 t -90.07 -27.66 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 C-N-CA 118.365 -1.334 . . . . 0.0 112.029 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 77' ' ' VAL . 24.9 p 65.47 16.75 10.67 Favored 'General case' 0 N--CA 1.51 2.56 0 O-C-N 121.103 -0.998 . . . . 0.0 110.564 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.493 ' HB ' HG11 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -89.06 124.75 64.26 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.008 -1.058 . . . . 0.0 108.504 179.341 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.23 -35.86 60.72 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 122.519 2.146 . . . . 0.0 112.214 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.462 ' CE1' ' HG3' ' A' ' 46' ' ' ARG . 17.9 p90 -82.65 142.15 31.93 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.098 -1.001 . . . . 0.0 110.515 -179.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.517 HG21 ' HB3' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -96.38 150.65 20.35 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.489 -0.757 . . . . 0.0 110.633 -178.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.461 ' CG1' HD11 ' A' ' 53' ' ' LEU . 4.4 mp -99.71 128.91 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.428 -0.795 . . . . 0.0 109.196 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 62.4 p -150.61 -85.3 0.08 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.236 -0.915 . . . . 0.0 110.379 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.8 p -152.62 -61.11 0.15 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.588 -0.695 . . . . 0.0 109.486 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.6 t -109.5 59.83 0.6 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.617 -0.677 . . . . 0.0 110.088 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.5 m -75.28 164.5 26.38 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.345 -0.847 . . . . 0.0 109.116 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -83.83 80.19 9.23 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.95 -1.094 . . . . 0.0 110.172 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.495 ' SG ' ' C ' ' A' ' 50' ' ' CYS . 14.9 m -82.55 53.31 2.3 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.119 176.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.402 ' O ' ' NE ' ' A' ' 47' ' ' ARG . 41.4 t -144.98 -50.66 0.26 Allowed 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.024 -177.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -99.5 -23.82 14.97 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.331 -0.855 . . . . 0.0 110.414 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.2 t -49.54 142.09 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 O-C-N 121.402 -0.811 . . . . 0.0 111.038 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.462 ' HA ' HG21 ' A' ' 43' ' ' THR . 33.4 m-80 . . . . . 0 N--CA 1.5 2.073 0 CA-C-O 117.039 -1.458 . . . . 0.0 109.134 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.832 0 CA-C-O 121.088 0.47 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.5 ' CD1' ' HB1' ' A' ' 40' ' ' ALA . 3.0 tp -128.23 77.02 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 121.723 0.773 . . . . 0.0 109.569 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.6 p -125.95 177.75 6.15 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.156 -0.965 . . . . 0.0 110.198 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.459 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 70.5 m -56.97 -19.17 16.67 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 119.879 -0.728 . . . . 0.0 112.467 177.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.58 -43.44 99.28 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -85.68 -35.04 21.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.432 -1.04 . . . . 0.0 108.824 178.603 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.459 ' HB ' ' HA ' ' A' ' 4' ' ' CYS . 58.7 t -54.7 -43.22 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.09 -37.68 61.45 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.484 ' HB2' ' HA ' ' A' ' 6' ' ' GLN . 69.0 m -69.61 -21.09 63.61 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.221 -0.924 . . . . 0.0 109.806 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.5 ' N ' ' O ' ' A' ' 6' ' ' GLN . . . -85.65 -30.29 23.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.428 -0.795 . . . . 0.0 109.629 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.439 HD13 ' N ' ' A' ' 12' ' ' ALA . 2.4 pp -96.57 -26.71 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.463 -0.773 . . . . 0.0 110.813 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.504 ' HB2' ' HD3' ' A' ' 13' ' ' PRO . . . -49.33 -53.45 39.66 Favored Pre-proline 0 N--CA 1.504 2.244 0 O-C-N 121.207 -0.933 . . . . 0.0 110.783 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.504 ' HD3' ' HB2' ' A' ' 12' ' ' ALA . 73.4 Cg_endo -72.78 -9.6 23.98 Favored 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 122.29 1.993 . . . . 0.0 110.969 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.7 m -117.41 6.33 12.62 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.525 ' O ' ' CB ' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -58.09 -50.43 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 118.109 0.413 . . . . 0.0 110.632 -178.606 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.414 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -61.2 -63.49 1.27 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.952 -1.092 . . . . 0.0 109.618 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.51 ' CD2' HG12 ' A' ' 71' ' ' ILE . 1.1 t80 -51.66 -58.8 5.33 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.644 -0.66 . . . . 0.0 109.922 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.471 ' O ' ' N ' ' A' ' 64' ' ' ASN . . . -57.22 -29.25 63.59 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.603 -0.686 . . . . 0.0 110.556 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.525 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 9.1 tmm_? -89.93 8.67 31.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.368 -0.833 . . . . 0.0 110.944 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.28 1.1 44.32 Favored Glycine 0 N--CA 1.503 3.123 0 O-C-N 120.714 -1.241 . . . . 0.0 111.922 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -117.59 72.12 0.83 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.014 -1.286 . . . . 0.0 110.115 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.72 174.61 45.82 Favored Glycine 0 N--CA 1.498 2.793 0 C-N-CA 120.197 -1.001 . . . . 0.0 110.826 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.9 p -151.23 -60.8 0.18 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -97.83 126.77 8.99 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.642 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 37.1 Cg_endo -62.49 125.45 16.23 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 C-N-CA 122.393 2.062 . . . . 0.0 111.008 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.3 t -76.57 159.89 29.92 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.418 -0.801 . . . . 0.0 110.99 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.57 -41.44 76.92 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.644 -0.66 . . . . 0.0 110.552 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.62 -48.46 77.35 Favored Glycine 0 N--CA 1.503 3.127 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.55 ' SG ' ' CG2' ' A' ' 71' ' ' ILE . 42.4 t -58.3 -43.0 87.88 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.661 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.642 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 88.2 m -73.69 -35.18 65.15 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.154 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 61.9 m -71.81 -40.7 68.99 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 124.533 1.146 . . . . 0.0 109.725 175.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.33 -51.75 57.29 Favored Glycine 0 N--CA 1.5 2.953 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.61 HG13 ' CB ' ' A' ' 72' ' ' PRO . 47.4 t -69.3 -45.69 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.441 -1.035 . . . . 0.0 109.125 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.555 ' HA ' ' CG1' ' A' ' 77' ' ' VAL . 2.4 tpt180 -54.15 -28.42 39.89 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.4 m -73.76 -44.0 57.38 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER -61.32 -33.94 74.43 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.409 -0.807 . . . . 0.0 109.771 179.338 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.465 ' HB2' ' CG1' ' A' ' 77' ' ' VAL . 0.6 OUTLIER -59.69 -32.68 70.72 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.299 -0.876 . . . . 0.0 110.015 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -88.71 -33.51 17.5 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.526 -0.734 . . . . 0.0 109.415 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.11 -32.29 22.87 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.506 -0.746 . . . . 0.0 110.878 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.559 ' HA ' ' CB ' ' A' ' 45' ' ' ASP . . . -111.47 101.52 9.94 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.169 -0.957 . . . . 0.0 110.474 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.511 ' CZ ' ' HB3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -161.06 20.27 0.12 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.402 -0.811 . . . . 0.0 111.692 179.59 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 44' ' ' ALA . 5.8 m -116.87 35.31 4.67 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.848 -1.158 . . . . 0.0 109.384 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 44.6 m 67.95 -59.82 0.42 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.595 -0.691 . . . . 0.0 109.649 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 42' ' ' THR . . . -57.35 -54.63 44.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.551 -0.718 . . . . 0.0 109.179 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.559 ' CB ' ' HA ' ' A' ' 40' ' ' ALA . 8.3 m-20 -55.61 -44.04 76.65 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.707 0.765 . . . . 0.0 109.199 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.44 ' NH1' HG13 ' A' ' 79' ' ' ILE . 0.5 OUTLIER -67.39 -47.12 71.25 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.978 -178.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -60.84 -48.58 81.16 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.5 -48.72 80.53 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.777 -0.577 . . . . 0.0 109.498 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.442 ' HB1' HD12 ' A' ' 2' ' ' ILE . . . -57.16 -46.37 82.8 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.459 ' SG ' HG23 ' A' ' 87' ' ' THR . 0.1 OUTLIER -63.86 -38.81 92.48 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.112 -0.368 . . . . 0.0 110.872 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.44 ' N ' ' SG ' ' A' ' 89' ' ' CYS . 2.2 t30 -60.01 -57.38 13.1 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 123.869 0.731 . . . . 0.0 109.701 176.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 12.9 t -66.76 -31.08 71.49 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.357 178.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.485 HD21 HG21 ' A' ' 83' ' ' ILE . 15.1 mt -64.01 -44.47 92.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 123.902 0.751 . . . . 0.0 109.446 175.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -58.54 -41.18 84.98 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -64.18 -54.01 40.35 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.74 -43.39 90.2 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.643 -0.661 . . . . 0.0 109.608 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.463 ' HA ' HD11 ' A' ' 63' ' ' LEU . . . -60.55 -51.9 67.44 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.87 64.86 1.33 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.489 ' O ' ' N ' ' A' ' 61' ' ' SER . . . 167.88 -22.48 0.1 Allowed Glycine 0 N--CA 1.499 2.879 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.202 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.474 HG11 ' CD1' ' A' ' 15' ' ' ILE . 6.5 t -64.9 62.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 CA-C-N 118.699 1.25 . . . . 0.0 110.595 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 59' ' ' GLY . 67.9 m 36.02 57.32 0.99 Allowed 'General case' 0 N--CA 1.507 2.409 0 O-C-N 121.309 -0.869 . . . . 0.0 111.888 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.76 57.81 3.69 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.463 HD11 ' HA ' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -56.94 132.04 51.51 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.677 -0.896 . . . . 0.0 110.463 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 18' ' ' ALA . 1.8 m-80 -96.7 89.78 5.06 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -39.54 -45.87 1.65 Allowed 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.907 -0.495 . . . . 0.0 111.021 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -51.7 -38.16 43.93 Favored Glycine 0 N--CA 1.503 3.136 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -83.7 -55.5 4.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.635 -0.921 . . . . 0.0 108.913 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 83' ' ' ILE . . . -55.72 -25.21 39.16 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.826 -0.546 . . . . 0.0 111.932 -178.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.25 -49.27 6.82 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.949 -1.094 . . . . 0.0 109.818 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.04 -32.37 72.68 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.47 -0.769 . . . . 0.0 110.409 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.55 ' CG2' ' SG ' ' A' ' 29' ' ' CYS . 30.8 mt -52.07 -61.51 4.32 Favored Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 121.643 -0.66 . . . . 0.0 110.528 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.61 ' CB ' HG13 ' A' ' 33' ' ' VAL . 38.4 Cg_endo -61.88 -57.08 0.58 Allowed 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 122.028 1.819 . . . . 0.0 110.465 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.9 t -44.35 -63.64 0.84 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 120.681 0.277 . . . . 0.0 110.38 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -63.61 -39.1 93.52 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 122.034 -0.416 . . . . 0.0 109.982 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.593 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 0.8 OUTLIER -48.01 -35.04 10.28 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.823 -0.751 . . . . 0.0 112.092 -178.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.422 ' O ' ' HD2' ' A' ' 34' ' ' ARG . . . 137.7 44.53 0.08 OUTLIER Glycine 0 N--CA 1.496 2.659 0 C-N-CA 119.243 -1.456 . . . . 0.0 111.339 176.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.555 ' CG1' ' HA ' ' A' ' 34' ' ' ARG . 16.1 m -135.34 129.76 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 120.828 -1.395 . . . . 0.0 111.021 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.1 p -99.97 78.38 2.1 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.557 HD13 ' CE2' ' A' ' 81' ' ' TYR . 11.0 tt -132.38 128.41 21.14 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.514 -0.741 . . . . 0.0 109.723 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.77 -45.33 41.76 Favored 'Trans proline' 0 N--CA 1.484 0.936 0 C-N-CA 123.28 2.653 . . . . 0.0 112.736 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.557 ' CE2' HD13 ' A' ' 79' ' ' ILE . 26.5 p90 -81.7 143.28 31.98 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.938 -1.101 . . . . 0.0 109.911 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 69.5 p -98.67 166.49 11.3 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.908 0.861 . . . . 0.0 110.692 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.485 HG21 HD21 ' A' ' 53' ' ' LEU . 1.5 mp -90.16 63.81 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 82.4 p -161.49 170.34 20.13 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.022 -1.049 . . . . 0.0 110.701 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.5 p -60.71 -30.0 69.69 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.575 -0.703 . . . . 0.0 109.748 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.0 t -82.49 79.74 8.84 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.459 HG23 ' SG ' ' A' ' 50' ' ' CYS . 0.6 OUTLIER -162.63 149.15 12.87 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.842 -179.37 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -91.77 154.65 18.79 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 122.18 0.991 . . . . 0.0 112.329 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 51' ' ' ASN . 1.2 m -137.03 53.4 1.89 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.142 176.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 95.8 p -159.3 -51.42 0.06 Allowed 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.355 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.0 mmm-85 -97.1 -6.78 34.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.223 -0.923 . . . . 0.0 109.245 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.1 t -70.48 119.73 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.391 -0.818 . . . . 0.0 109.231 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.43 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 1.7 p30 . . . . . 0 N--CA 1.497 1.915 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.46 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 39' ' ' ALA . . . . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 121.518 0.675 . . . . 0.0 110.074 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.519 HG22 ' HB1' ' A' ' 49' ' ' ALA . 0.8 OUTLIER -103.97 101.9 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.391 -0.818 . . . . 0.0 108.927 179.76 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.0 t -118.19 167.19 11.73 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.305 -0.872 . . . . 0.0 111.504 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -63.94 -35.98 82.44 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -56.39 -51.49 55.88 Favored Glycine 0 N--CA 1.503 3.122 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 177.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.23 -41.87 84.95 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.455 -1.026 . . . . 0.0 109.087 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.8 t -54.8 -46.14 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.36 -36.38 74.15 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.3 t -68.83 -20.53 64.3 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.318 -0.864 . . . . 0.0 110.099 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.39 -41.65 9.29 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.316 -0.865 . . . . 0.0 109.862 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.5 pp -79.98 -33.79 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.214 -0.929 . . . . 0.0 111.099 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.505 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -46.95 -51.76 37.69 Favored Pre-proline 0 N--CA 1.504 2.229 0 O-C-N 121.213 -0.929 . . . . 0.0 110.417 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 33.5 Cg_endo -65.89 -15.65 49.74 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.163 1.909 . . . . 0.0 110.831 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.61 ' SG ' HG22 ' A' ' 71' ' ' ILE . 1.3 m -114.14 18.94 16.8 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 176.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.406 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -62.72 -49.58 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-N 118.16 0.437 . . . . 0.0 110.473 178.047 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.4 p -68.88 -49.27 59.66 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.429 -0.794 . . . . 0.0 109.323 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.568 ' CG ' HD13 ' A' ' 71' ' ' ILE . 0.4 OUTLIER -55.42 -54.3 45.46 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.084 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.524 ' O ' ' N ' ' A' ' 64' ' ' ASN . . . -60.69 -27.99 68.28 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.406 ' HB3' ' O ' ' A' ' 15' ' ' ILE . 1.3 tpt180 -82.46 -13.24 57.06 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.864 -0.522 . . . . 0.0 109.953 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.24 14.3 42.36 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -118.16 78.18 1.23 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.251 -1.146 . . . . 0.0 109.527 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 177.15 -151.68 11.33 Favored Glycine 0 N--CA 1.5 2.918 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.6 p -168.88 -58.71 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.632 -0.923 . . . . 0.0 109.511 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.74 145.98 17.95 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.64 152.09 82.74 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 C-N-CA 122.536 2.158 . . . . 0.0 110.356 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.4 p -102.18 146.79 27.46 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.311 -0.868 . . . . 0.0 110.431 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.95 -47.08 71.67 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.793 -0.567 . . . . 0.0 110.848 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.79 -41.31 95.92 Favored Glycine 0 N--CA 1.502 3.037 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 42.1 t -61.64 -55.98 24.8 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.405 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -62.6 -39.59 94.25 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.735 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.7 m -67.18 -50.76 59.83 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 123.932 0.77 . . . . 0.0 110.24 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.43 -47.33 91.67 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.514 ' HA ' HD21 ' A' ' 36' ' ' LEU . 59.2 t -67.86 -53.07 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.773 -0.839 . . . . 0.0 110.891 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 76' ' ' GLY . 0.4 OUTLIER -56.04 -21.19 20.26 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.175 -0.953 . . . . 0.0 110.295 -179.569 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.8 p -81.32 -43.8 18.57 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.402 -0.811 . . . . 0.0 109.523 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.517 ' HB2' HD13 ' A' ' 2' ' ' ILE . 0.6 OUTLIER -55.85 -36.01 67.07 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.891 -0.506 . . . . 0.0 110.646 -179.411 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 76' ' ' GLY . 31.9 t30 -56.44 -49.55 74.24 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.323 -0.861 . . . . 0.0 109.821 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -81.36 -29.39 34.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.604 -0.685 . . . . 0.0 109.776 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.494 ' O ' ' N ' ' A' ' 1' ' ' ALA . . . -65.2 -26.9 68.34 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.697 -0.627 . . . . 0.0 110.451 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.504 ' CB ' ' CG1' ' A' ' 2' ' ' ILE . . . -139.92 -110.79 0.15 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.091 -1.005 . . . . 0.0 111.109 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.442 ' CB ' ' CZ ' ' A' ' 41' ' ' ARG . 0.0 OUTLIER 64.5 32.23 11.87 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.403 -0.811 . . . . 0.0 111.082 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.461 ' O ' ' HB ' ' A' ' 43' ' ' THR . 14.9 t -128.57 17.54 6.39 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 120.829 -1.169 . . . . 0.0 111.382 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.589 ' HA ' ' C ' ' A' ' 93' ' ' ASN . 86.5 m 84.8 -67.76 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.696 -0.627 . . . . 0.0 109.799 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.49 -61.43 2.02 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.302 -0.874 . . . . 0.0 109.708 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.491 ' HB3' ' HB ' ' A' ' 2' ' ' ILE . 1.0 OUTLIER -70.28 -36.55 74.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.682 -0.636 . . . . 0.0 109.367 179.321 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.455 ' NH1' ' HD2' ' A' ' 80' ' ' PRO . 5.8 mtm180 -59.28 -53.12 61.89 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.436 -0.79 . . . . 0.0 110.249 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.463 ' NH1' ' HA ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -54.12 -47.48 71.81 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.473 -0.767 . . . . 0.0 109.337 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.91 -41.38 87.08 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.519 ' HB1' HG22 ' A' ' 2' ' ' ILE . . . -58.28 -48.32 80.83 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.498 ' C ' ' SG ' ' A' ' 89' ' ' CYS . 0.8 OUTLIER -55.4 -33.66 63.7 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.498 178.566 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.444 ' N ' ' SG ' ' A' ' 89' ' ' CYS . 1.3 t30 -65.56 -61.98 1.78 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.035 0.445 . . . . 0.0 110.056 177.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.6 t -63.49 -33.58 75.88 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.253 -0.979 . . . . 0.0 111.342 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.458 HD23 HG21 ' A' ' 83' ' ' ILE . 20.8 mt -68.4 -57.82 5.29 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.373 178.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 58' ' ' ALA . 24.6 tttp -57.9 -36.2 72.1 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.465 -0.772 . . . . 0.0 109.354 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.84 -39.05 87.63 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.474 -0.766 . . . . 0.0 110.606 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.443 ' O ' HG22 ' A' ' 60' ' ' VAL . . . -94.39 -53.43 3.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.235 -0.916 . . . . 0.0 110.009 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.536 ' HB2' ' HA ' ' A' ' 84' ' ' SER . . . -60.09 -53.74 54.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.484 -0.76 . . . . 0.0 109.702 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 54' ' ' LYS . . . -80.79 63.18 5.1 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.52 -32.43 0.06 OUTLIER Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 56' ' ' ALA . 24.4 t -47.23 148.67 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 121.68 -0.894 . . . . 0.0 110.199 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.8 m -64.29 90.85 0.07 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.576 -0.702 . . . . 0.0 110.123 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.99 64.89 1.69 Allowed Glycine 0 N--CA 1.499 2.854 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.522 HD13 ' HB2' ' A' ' 84' ' ' SER . 3.0 tm? -74.68 118.73 17.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.667 -0.902 . . . . 0.0 109.791 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.524 ' N ' ' O ' ' A' ' 18' ' ' ALA . 11.7 m120 -94.52 85.36 4.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.891 . . . . 0.0 108.726 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.453 ' HA ' ' HB2' ' A' ' 84' ' ' SER . . . -48.31 -37.95 17.74 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.858 -0.526 . . . . 0.0 110.719 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -53.97 -38.71 60.97 Favored Glycine 0 N--CA 1.502 3.099 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -89.7 -45.38 9.36 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.478 -1.013 . . . . 0.0 109.961 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.458 ' HB1' ' CB ' ' A' ' 18' ' ' ALA . . . -71.74 -20.34 61.91 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.594 -0.691 . . . . 0.0 111.946 -178.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.23 -40.95 10.16 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.867 -1.146 . . . . 0.0 110.244 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 92.5 p -71.17 -43.27 67.8 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.57 -0.706 . . . . 0.0 110.847 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.61 HG22 ' SG ' ' A' ' 14' ' ' CYS . 87.0 mt -50.63 -64.59 1.23 Allowed Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.485 -0.76 . . . . 0.0 110.89 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.511 ' CA ' HG13 ' A' ' 33' ' ' VAL . 30.7 Cg_endo -59.74 -52.52 4.37 Favored 'Trans proline' 0 C--N 1.326 -0.636 0 C-N-CA 121.868 1.712 . . . . 0.0 110.773 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.2 t -38.5 -68.07 0.18 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 122.271 -0.268 . . . . 0.0 110.62 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.4 pttt -70.38 -32.45 70.11 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.551 -0.718 . . . . 0.0 109.888 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.4 ' HB2' ' HA ' ' A' ' 72' ' ' PRO . 1.1 m -49.72 -47.57 50.49 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.27 -0.893 . . . . 0.0 111.985 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 34' ' ' ARG . . . 169.03 47.03 0.03 OUTLIER Glycine 0 N--CA 1.5 2.927 0 C-N-CA 118.365 -1.874 . . . . 0.0 111.527 175.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.42 HG13 ' HB2' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -150.65 91.04 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.191 -1.182 . . . . 0.0 110.353 179.323 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.6 t -80.18 77.78 6.89 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.509 HD11 ' CZ ' ' A' ' 81' ' ' TYR . 3.3 pt -130.98 135.68 27.71 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.6 -0.687 . . . . 0.0 110.306 -178.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . 0.455 ' HD2' ' NH1' ' A' ' 46' ' ' ARG . 77.4 Cg_exo -49.19 -43.2 37.86 Favored 'Trans proline' 0 N--CA 1.483 0.908 0 C-N-CA 122.682 2.255 . . . . 0.0 111.533 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.509 ' CZ ' HD11 ' A' ' 79' ' ' ILE . 1.5 p90 -81.03 143.98 32.11 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.06 -1.025 . . . . 0.0 109.41 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.7 p -100.4 165.75 11.3 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.213 -0.929 . . . . 0.0 109.849 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.458 HG21 HD23 ' A' ' 53' ' ' LEU . 1.5 mp -89.93 62.91 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.536 ' HA ' ' HB2' ' A' ' 57' ' ' ALA . 80.5 p -158.68 -106.68 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.362 -0.836 . . . . 0.0 109.808 -178.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.5 p -122.4 -24.71 4.94 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.96 -1.088 . . . . 0.0 109.792 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.2 p -74.12 64.24 1.04 Allowed 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.423 HG21 ' HB2' ' A' ' 81' ' ' TYR . 13.1 m -162.43 128.71 3.53 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -125.73 138.46 53.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.244 -0.91 . . . . 0.0 110.762 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.498 ' SG ' ' C ' ' A' ' 50' ' ' CYS . 89.4 m -90.9 57.89 3.65 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.267 -0.973 . . . . 0.0 111.473 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.3 t -155.42 -42.34 0.08 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.865 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.8 mtm-85 -99.68 -37.01 9.29 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.28 -0.888 . . . . 0.0 110.332 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.495 HG22 ' HB3' ' A' ' 81' ' ' TYR . 1.2 t -60.69 158.74 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 121.451 -0.78 . . . . 0.0 111.254 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.589 ' C ' ' HA ' ' A' ' 43' ' ' THR . 58.9 m-80 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 176.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 2' ' ' ILE . . . . . . . . 0 N--CA 1.5 2.064 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.592 HG22 ' HB3' ' A' ' 45' ' ' ASP . 10.4 tp 30.54 65.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 CA-C-O 121.803 0.811 . . . . 0.0 111.714 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.4 t -123.16 -74.88 0.6 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.134 -0.979 . . . . 0.0 109.931 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.7 t -151.51 -46.31 0.11 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -53.47 -44.11 66.84 Favored Glycine 0 N--CA 1.506 3.302 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 177.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.52 -41.99 23.26 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.304 -1.115 . . . . 0.0 108.452 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 91.5 t -54.1 -44.13 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.454 ' HA ' ' CG1' ' A' ' 11' ' ' ILE . . . -69.12 -34.82 75.65 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.8 m -71.37 -20.12 62.19 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.513 -0.742 . . . . 0.0 109.608 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.57 -35.45 10.61 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.275 -0.89 . . . . 0.0 109.923 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.454 ' CG1' ' HA ' ' A' ' 8' ' ' ALA . 2.6 pp -79.94 -33.61 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.254 -0.904 . . . . 0.0 110.54 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.502 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -47.85 -51.67 45.05 Favored Pre-proline 0 N--CA 1.503 2.187 0 O-C-N 121.28 -0.888 . . . . 0.0 110.206 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 31.0 Cg_endo -65.21 -12.22 33.77 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.238 1.959 . . . . 0.0 110.938 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.427 ' HB3' HD11 ' A' ' 71' ' ' ILE . 2.7 m -121.85 17.33 11.01 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 176.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.446 ' O ' ' CB ' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -62.73 -50.1 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 121.381 -0.128 . . . . 0.0 110.802 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.433 ' O ' ' N ' ' A' ' 21' ' ' GLN . 18.7 m -57.46 -46.84 83.19 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.338 -0.851 . . . . 0.0 109.33 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.517 ' CD2' HG12 ' A' ' 71' ' ' ILE . 0.9 OUTLIER -61.26 -62.0 2.15 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.787 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.486 ' N ' HD12 ' A' ' 71' ' ' ILE . . . -55.78 -35.46 66.28 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.153 -0.967 . . . . 0.0 110.436 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.46 ' HB2' ' CG1' ' A' ' 60' ' ' VAL . 0.0 OUTLIER -73.85 -1.69 20.54 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.587 -0.696 . . . . 0.0 111.3 -179.151 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.88 21.24 47.39 Favored Glycine 0 N--CA 1.501 3.009 0 O-C-N 120.678 -1.264 . . . . 0.0 110.902 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.433 ' N ' ' O ' ' A' ' 16' ' ' SER . 34.3 mm-40 -140.41 50.01 1.7 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.201 -1.176 . . . . 0.0 109.612 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -150.38 -64.75 0.01 OUTLIER Glycine 0 N--CA 1.501 2.975 0 O-C-N 121.019 -1.051 . . . . 0.0 110.833 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 71.8 -58.02 0.6 Allowed 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.642 -0.916 . . . . 0.0 109.485 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.59 112.06 3.64 Favored Glycine 0 N--CA 1.498 2.779 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.75 173.63 12.36 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 122.611 2.207 . . . . 0.0 110.751 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.1 p -110.25 134.93 51.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.57 -0.706 . . . . 0.0 109.362 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -45.99 -54.77 7.8 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.776 -0.578 . . . . 0.0 110.887 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.97 -39.43 89.29 Favored Glycine 0 N--CA 1.503 3.103 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 44.1 t -63.55 -49.48 73.31 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 118.764 -1.174 . . . . 0.0 109.828 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.422 ' HA ' ' HB3' ' A' ' 75' ' ' CYS . 68.2 m -69.07 -42.99 75.47 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.483 -176.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.494 ' O ' ' HG2' ' A' ' 34' ' ' ARG . 72.5 p -68.31 -47.26 68.03 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 124.355 1.034 . . . . 0.0 110.012 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -53.91 -55.19 27.01 Favored Glycine 0 N--CA 1.498 2.782 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.473 ' HA ' ' HG ' ' A' ' 36' ' ' LEU . 17.4 t -63.81 -44.59 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.486 -1.008 . . . . 0.0 110.257 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 31' ' ' SER . 7.8 ptm180 -57.71 -22.61 47.38 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.111 -0.993 . . . . 0.0 109.694 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.1 t -92.65 -55.14 3.49 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.3 -0.875 . . . . 0.0 109.461 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.473 ' HG ' ' HA ' ' A' ' 33' ' ' VAL . 3.5 pp -58.25 -28.43 64.89 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.497 -0.752 . . . . 0.0 110.89 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.488 ' CB ' HG11 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -64.85 -42.69 94.69 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.945 -1.097 . . . . 0.0 108.719 179.523 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -63.5 -29.2 70.51 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.93 8.83 35.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.679 -0.638 . . . . 0.0 110.102 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.508 ' CB ' ' HB ' ' A' ' 2' ' ' ILE . . . -166.91 51.5 0.07 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.763 -1.21 . . . . 0.0 111.454 -179.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.463 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 2.3 mpt_? -135.27 44.7 2.55 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.527 -0.733 . . . . 0.0 109.596 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.421 ' O ' ' OG1' ' A' ' 43' ' ' THR . 6.7 m -95.38 -45.96 6.91 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.344 -0.847 . . . . 0.0 109.278 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 42' ' ' THR . 1.4 m 160.52 -51.48 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.453 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.73 -45.81 84.91 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 177.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.592 ' HB3' HG22 ' A' ' 2' ' ' ILE . 3.1 m-20 -63.69 -50.93 67.27 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.575 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.407 ' HD3' ' HG3' ' A' ' 41' ' ' ARG . 8.9 mtm180 -59.94 -39.07 84.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.738 -0.601 . . . . 0.0 109.792 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.431 ' NH1' ' HG2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -62.2 -44.45 96.56 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.227 -0.92 . . . . 0.0 108.957 179.165 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.55 -46.62 75.5 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.539 ' HB1' ' CG1' ' A' ' 2' ' ' ILE 0.252 . . -61.45 -55.36 32.18 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.865 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.537 ' C ' ' SG ' ' A' ' 89' ' ' CYS . 12.0 t -48.23 -36.86 14.69 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 174.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -58.55 -56.33 23.48 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 42.3 t -70.06 -31.12 68.57 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 118.388 -1.325 . . . . 0.0 111.621 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.52 HD23 HG21 ' A' ' 83' ' ' ILE . 75.5 mt -58.83 -48.61 80.72 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 124.101 0.876 . . . . 0.0 109.598 176.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.573 ' HD3' ' SG ' ' A' ' 89' ' ' CYS . 7.5 mtpp -61.12 -38.25 85.67 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -65.71 -47.49 75.2 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.822 -0.548 . . . . 0.0 109.706 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.79 -44.75 63.46 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.416 -0.803 . . . . 0.0 109.977 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.53 -55.36 29.94 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.74 62.56 1.08 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.392 -0.818 . . . . 0.0 108.912 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 61' ' ' SER . . . -179.75 -28.91 0.05 OUTLIER Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.46 ' CG1' ' HB2' ' A' ' 19' ' ' ARG . 74.5 t -65.92 53.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.507 0 O-C-N 121.254 -1.145 . . . . 0.0 110.992 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 59' ' ' GLY . 56.5 p 49.12 -138.11 0.92 Allowed 'General case' 0 N--CA 1.504 2.244 0 O-C-N 120.6 -1.312 . . . . 0.0 110.093 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.96 71.65 2.82 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 108.496 -1.842 . . . . 0.0 108.496 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 1.8 pp -63.13 158.96 18.47 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 122.01 -0.7 . . . . 0.0 110.582 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -106.62 107.87 19.09 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.36 -55.22 4.21 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.743 -0.598 . . . . 0.0 110.152 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -57.69 -41.9 94.02 Favored Glycine 0 N--CA 1.498 2.799 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.43 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 3.2 m120 -60.31 -57.5 12.51 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.313 -1.11 . . . . 0.0 109.309 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.424 ' O ' ' HD2' ' A' ' 72' ' ' PRO . . . -58.71 -41.19 85.75 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.788 -0.57 . . . . 0.0 110.173 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.471 ' HB1' ' HB ' ' A' ' 82' ' ' THR . . . -71.64 -46.01 60.33 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.313 -0.867 . . . . 0.0 110.235 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 94.1 p -61.16 -36.25 79.31 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.623 -0.673 . . . . 0.0 110.802 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.517 HG12 ' CD2' ' A' ' 17' ' ' TYR . 18.7 mt -47.83 -74.23 0.08 OUTLIER Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 121.611 -0.681 . . . . 0.0 111.364 -178.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.519 ' HG3' ' CG1' ' A' ' 83' ' ' ILE . 28.6 Cg_endo -58.82 -49.75 10.78 Favored 'Trans proline' 0 N--CA 1.481 0.779 0 C-N-CA 121.681 1.587 . . . . 0.0 111.499 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.4 p -51.66 -68.71 0.15 Allowed 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.525 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.4 pttt -64.25 -37.95 89.29 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.621 -0.674 . . . . 0.0 110.973 -179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 30' ' ' CYS . 1.7 m -47.11 -35.54 7.22 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.325 -0.859 . . . . 0.0 111.888 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.79 40.84 0.16 Allowed Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 177.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.488 HG11 ' CB ' ' A' ' 37' ' ' ASN . 4.0 t -131.16 106.89 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.521 -0.988 . . . . 0.0 109.313 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.53 73.4 0.75 Allowed 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.691 0.758 . . . . 0.0 109.716 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.48 HD12 ' HB2' ' A' ' 72' ' ' PRO . 0.8 OUTLIER -121.66 109.49 34.31 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.296 -0.877 . . . . 0.0 109.319 179.735 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.14 -23.58 45.45 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 123.105 2.537 . . . . 0.0 112.618 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.45 ' C ' ' CD1' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -82.43 171.13 14.51 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.378 -0.826 . . . . 0.0 109.922 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.471 ' HB ' ' HB1' ' A' ' 69' ' ' ALA . 51.9 p -122.81 164.67 17.94 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.118 -0.989 . . . . 0.0 110.137 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.52 HG21 HD23 ' A' ' 53' ' ' LEU . 5.3 mm -93.24 40.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.88 162.41 15.85 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.384 0.611 . . . . 0.0 110.032 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 68.6 p -62.03 -33.17 73.88 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.5 p -70.22 64.95 0.26 Allowed 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.648 0.737 . . . . 0.0 109.439 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.6 m -168.08 155.22 8.01 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.345 -0.847 . . . . 0.0 109.0 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -132.95 152.91 51.86 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.002 -1.061 . . . . 0.0 111.285 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.573 ' SG ' ' HD3' ' A' ' 54' ' ' LYS . 4.2 m -94.82 60.89 2.52 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.409 178.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 37.2 p -135.62 -51.5 0.74 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.551 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -98.78 5.91 47.22 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.647 -0.658 . . . . 0.0 110.792 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 94.3 t -82.84 106.33 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 120.997 -1.064 . . . . 0.0 108.785 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.8 m120 . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 117.053 -1.451 . . . . 0.0 109.32 -179.752 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.885 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.493 HG12 ' CA ' ' A' ' 40' ' ' ALA . 5.1 tp 37.98 43.99 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.48 0 CA-C-O 121.666 0.745 . . . . 0.0 111.37 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 5' ' ' GLY . 23.4 t -124.08 66.9 1.05 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.023 -1.048 . . . . 0.0 109.485 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.0 t 62.8 -56.29 0.16 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 3' ' ' SER . . . -49.6 -43.91 37.3 Favored Glycine 0 N--CA 1.506 3.312 0 CA-C-N 119.458 1.026 . . . . 0.0 110.556 177.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.473 ' NE2' ' HB3' ' A' ' 36' ' ' LEU . 0.4 OUTLIER -78.99 -39.73 33.43 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.414 -1.051 . . . . 0.0 108.856 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 56.6 t -55.24 -46.6 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.64 -31.31 65.01 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.435 ' HB2' ' HA ' ' A' ' 6' ' ' GLN . 58.6 m -68.35 -22.12 64.69 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.132 -0.98 . . . . 0.0 109.463 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.77 -29.71 14.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.515 -0.741 . . . . 0.0 109.071 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 tp -82.83 -41.0 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.514 -0.741 . . . . 0.0 110.527 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.493 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -42.42 -52.06 10.64 Favored Pre-proline 0 N--CA 1.504 2.268 0 O-C-N 121.757 -0.589 . . . . 0.0 111.399 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 36.9 Cg_endo -64.23 -23.76 66.01 Favored 'Trans proline' 0 N--CA 1.484 0.923 0 C-N-CA 121.977 1.785 . . . . 0.0 110.386 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.588 ' SG ' HG22 ' A' ' 71' ' ' ILE . 1.4 m -109.36 19.37 19.43 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 176.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 16' ' ' SER . 0.4 OUTLIER -66.07 -50.24 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.86 177.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.426 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 51.4 p -55.73 -50.94 69.0 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.39 -0.818 . . . . 0.0 108.875 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.422 ' CG ' HD13 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -57.29 -57.76 11.19 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.393 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' A' ' 64' ' ' ASN . . . -67.76 -5.99 18.92 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.58 -0.7 . . . . 0.0 110.172 178.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.8 ttt-85 -100.05 -18.01 17.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.406 -0.809 . . . . 0.0 109.999 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 133.8 -20.82 4.04 Favored Glycine 0 N--CA 1.503 3.108 0 O-C-N 120.859 -1.151 . . . . 0.0 111.577 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -123.01 92.46 3.71 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.03 -1.277 . . . . 0.0 110.463 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 17' ' ' TYR . . . -156.12 -60.18 0.01 OUTLIER Glycine 0 N--CA 1.504 3.176 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.3 p 73.91 -62.65 0.46 Allowed 'General case' 0 N--CA 1.507 2.409 0 O-C-N 122.061 -0.67 . . . . 0.0 111.278 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -114.82 139.44 15.59 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 110.476 -1.049 . . . . 0.0 110.476 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.01 173.14 9.77 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 122.552 2.168 . . . . 0.0 110.911 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 69.3 p -124.48 149.6 46.66 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.303 -0.873 . . . . 0.0 110.321 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.38 -45.62 69.32 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.608 -0.683 . . . . 0.0 110.115 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.16 -39.06 97.16 Favored Glycine 0 N--CA 1.5 2.931 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 40.2 t -66.43 -45.57 79.41 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 119.016 -1.074 . . . . 0.0 110.589 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 88.7 m -71.36 -38.49 71.57 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.343 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.6 p -68.7 -39.81 80.32 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 124.166 0.916 . . . . 0.0 109.668 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.41 -52.98 38.78 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.533 HG13 ' CB ' ' A' ' 72' ' ' PRO . 43.2 t -62.5 -44.88 99.73 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.367 -1.079 . . . . 0.0 109.134 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.579 ' HA ' ' CG1' ' A' ' 77' ' ' VAL . 6.4 tpm_? -54.78 -32.39 60.01 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.5 m -75.17 -45.89 37.77 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' A' ' 40' ' ' ALA . 0.4 OUTLIER -62.99 -39.68 95.48 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.482 -0.761 . . . . 0.0 110.062 179.602 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -60.42 -42.35 95.86 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.326 -0.859 . . . . 0.0 109.684 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -64.1 -44.39 92.42 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.513 -0.742 . . . . 0.0 109.004 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.42 ' HB1' ' HB ' ' A' ' 2' ' ' ILE . . . -75.94 -50.3 15.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.777 -0.577 . . . . 0.0 110.349 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.493 ' N ' ' O ' ' A' ' 36' ' ' LEU . . . -74.35 59.43 0.79 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.058 -1.026 . . . . 0.0 109.792 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.486 ' HA ' ' HD3' ' A' ' 46' ' ' ARG . 7.0 mtt-85 -147.94 18.48 1.12 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.036 -1.04 . . . . 0.0 111.082 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.453 ' O ' ' HB ' ' A' ' 43' ' ' THR . 9.9 t -111.26 28.14 9.01 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.116 -0.99 . . . . 0.0 109.652 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.504 ' CG2' ' HB3' ' A' ' 93' ' ' ASN . 46.3 m 70.95 -61.77 0.47 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.76 -0.588 . . . . 0.0 110.127 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.48 -60.12 3.61 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.786 -0.571 . . . . 0.0 111.118 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -72.54 -28.93 63.15 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.586 -0.696 . . . . 0.0 110.775 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.486 ' HD3' ' HA ' ' A' ' 41' ' ' ARG . 7.6 mmm-85 -53.13 -51.75 60.93 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.396 -0.815 . . . . 0.0 109.47 179.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.519 ' HD2' ' HB2' ' A' ' 93' ' ' ASN . 1.0 OUTLIER -62.12 -51.62 67.17 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.411 -0.805 . . . . 0.0 110.361 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.83 -44.74 90.95 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.63 -0.669 . . . . 0.0 109.733 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.52 -47.67 85.14 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.435 ' C ' ' SG ' ' A' ' 89' ' ' CYS . 37.9 t -59.37 -38.48 80.59 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.018 177.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -64.46 -54.16 36.85 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 123.772 0.67 . . . . 0.0 109.596 176.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . 0.429 ' HA ' ' ND2' ' A' ' 55' ' ' ASN . 39.3 t -63.65 -31.04 72.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.896 -1.127 . . . . 0.0 110.566 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.476 HD12 HG12 ' A' ' 83' ' ' ILE . 26.3 mt -63.67 -46.56 85.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 124.365 1.041 . . . . 0.0 109.008 175.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.5 ttpt -55.04 -49.93 70.36 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.429 ' ND2' ' HA ' ' A' ' 52' ' ' CYS . 1.3 p30 -65.66 -33.61 76.3 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.247 -0.908 . . . . 0.0 109.489 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.423 ' O ' HG22 ' A' ' 60' ' ' VAL . . . -66.92 -56.78 8.75 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.327 -0.858 . . . . 0.0 108.743 178.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.62 -56.9 15.74 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.572 -0.705 . . . . 0.0 109.167 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.9 66.45 1.15 Allowed 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.17 -28.05 0.1 OUTLIER Glycine 0 N--CA 1.501 3.014 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -178.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 56' ' ' ALA . 2.8 t -46.92 -21.92 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.736 -0.861 . . . . 0.0 111.06 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.6 m 74.8 83.45 0.1 Allowed 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.82 36.82 7.61 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.474 HD11 ' O ' ' A' ' 84' ' ' SER . 3.7 pp -56.02 138.87 48.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.661 -0.905 . . . . 0.0 110.22 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 18' ' ' ALA . 1.6 m-80 -109.25 88.27 2.69 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -48.28 -41.8 28.93 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.654 -0.654 . . . . 0.0 109.983 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -52.3 -47.23 56.47 Favored Glycine 0 N--CA 1.501 2.999 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 30.7 m-20 -82.14 -50.2 9.3 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.568 -0.96 . . . . 0.0 109.262 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.422 ' O ' ' CD ' ' A' ' 72' ' ' PRO . . . -51.2 -43.0 61.27 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.996 -0.44 . . . . 0.0 111.987 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.75 -45.95 19.98 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.141 -0.975 . . . . 0.0 110.217 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.4 m -61.92 -43.47 98.78 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.618 -0.676 . . . . 0.0 110.619 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.588 HG22 ' SG ' ' A' ' 14' ' ' CYS . 44.0 mt -42.58 -64.3 0.74 Allowed Pre-proline 0 N--CA 1.504 2.273 0 O-C-N 121.864 -0.522 . . . . 0.0 111.109 -179.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.533 ' CB ' HG13 ' A' ' 33' ' ' VAL . 46.0 Cg_endo -62.69 -60.33 0.19 Allowed 'Trans proline' 0 C--N 1.322 -0.816 0 C-N-CA 122.124 1.882 . . . . 0.0 110.682 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.4 m -45.2 -61.22 1.74 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.942 -0.474 . . . . 0.0 109.919 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.87 -39.98 95.46 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 1.2 m -50.11 -34.66 22.75 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.826 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.415 ' O ' ' HD2' ' A' ' 34' ' ' ARG . . . 135.36 46.62 0.09 OUTLIER Glycine 0 N--CA 1.494 2.553 0 C-N-CA 119.584 -1.293 . . . . 0.0 111.344 175.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.579 ' CG1' ' HA ' ' A' ' 34' ' ' ARG . 16.4 m -135.57 126.47 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 CA-C-N 118.776 1.288 . . . . 0.0 111.084 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.3 p -99.92 70.96 1.63 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.366 0.603 . . . . 0.0 109.707 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.7 tp -92.97 138.24 23.41 Favored Pre-proline 0 N--CA 1.505 2.31 0 O-C-N 121.213 -0.929 . . . . 0.0 109.456 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -59.49 -44.81 29.85 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 122.38 2.053 . . . . 0.0 111.555 -179.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -94.6 135.98 35.43 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.014 -1.054 . . . . 0.0 110.906 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.1 m -91.91 163.12 14.14 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.476 HG12 HD12 ' A' ' 53' ' ' LEU . 4.5 mp -121.27 118.18 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.819 -1.175 . . . . 0.0 110.99 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.474 ' O ' HD11 ' A' ' 63' ' ' LEU . 2.5 t -123.47 -72.19 0.69 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 98.2 m -133.13 -69.32 0.56 Allowed 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.8 m -113.43 -24.46 9.29 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.444 HG23 ' N ' ' A' ' 88' ' ' ASP . 54.6 m 54.63 -100.18 0.1 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.801 -0.562 . . . . 0.0 110.806 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.444 ' N ' HG23 ' A' ' 87' ' ' THR . 20.7 t0 -157.97 -70.74 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.272 -0.893 . . . . 0.0 110.062 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.435 ' SG ' ' C ' ' A' ' 50' ' ' CYS . 14.0 m 58.92 50.99 7.74 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 121.339 0.59 . . . . 0.0 111.645 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.2 t -161.37 -38.15 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.282 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 91' ' ' ARG . 0.1 OUTLIER -94.16 9.26 38.57 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.684 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 10.9 t -109.0 139.49 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.519 ' HB2' ' HD2' ' A' ' 47' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.499 2.007 0 O-C-N 121.556 -0.715 . . . . 0.0 109.635 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.92 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.501 HD11 ' HB2' ' A' ' 36' ' ' LEU . 0.6 OUTLIER -135.17 70.13 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 CA-C-O 121.716 0.77 . . . . 0.0 109.167 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.6 t -152.06 82.35 1.26 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.675 -1.265 . . . . 0.0 111.168 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.4 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 2.6 t 66.43 -59.85 0.34 Allowed 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 177.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -46.01 -58.51 5.57 Favored Glycine 0 N--CA 1.506 3.366 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 178.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -78.49 -34.11 47.72 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.54 -0.976 . . . . 0.0 108.93 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.43 HG11 ' CD2' ' A' ' 53' ' ' LEU . 8.3 t -53.39 -39.93 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.421 ' HA ' ' CD1' ' A' ' 11' ' ' ILE . . . -68.81 -35.23 76.75 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.1 p -71.75 -21.37 61.75 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.431 -0.793 . . . . 0.0 109.778 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.1 -46.74 13.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.525 -0.734 . . . . 0.0 110.429 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.421 ' CD1' ' HA ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -79.96 -25.63 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 O-C-N 121.09 -1.006 . . . . 0.0 110.984 -178.956 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.458 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -47.45 -55.02 17.98 Favored Pre-proline 0 N--CA 1.502 2.15 0 O-C-N 121.132 -0.98 . . . . 0.0 110.1 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 57.8 Cg_endo -70.9 -26.71 21.89 Favored 'Trans proline' 0 C--N 1.322 -0.84 0 C-N-CA 122.106 1.871 . . . . 0.0 110.555 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.603 ' SG ' HG23 ' A' ' 71' ' ' ILE . 1.1 m -97.4 15.46 22.99 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.744 -0.783 . . . . 0.0 112.442 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.445 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 0.4 OUTLIER -63.19 -45.03 99.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.712 179.082 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.404 ' OG ' ' N ' ' A' ' 17' ' ' TYR . 39.1 p -65.26 -59.29 4.22 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.343 -0.848 . . . . 0.0 109.549 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.404 ' N ' ' OG ' ' A' ' 16' ' ' SER . 1.5 t80 -53.82 -56.08 20.78 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.76 -33.38 68.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.577 -0.702 . . . . 0.0 110.036 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.445 ' HB3' ' O ' ' A' ' 15' ' ' ILE . 24.2 ttm180 -76.7 -32.39 57.83 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.562 -0.711 . . . . 0.0 109.838 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.24 -20.81 3.16 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -85.48 77.24 9.93 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.305 -1.115 . . . . 0.0 109.352 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.7 -158.08 28.77 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.15 -43.74 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.676 -0.896 . . . . 0.0 109.089 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -102.14 141.24 15.2 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.683 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 27.0 Cg_endo -61.03 127.98 23.92 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 121.945 1.763 . . . . 0.0 110.894 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.7 t -62.33 142.16 57.93 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.704 -0.622 . . . . 0.0 110.134 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.52 -61.04 2.57 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.608 -0.682 . . . . 0.0 109.805 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.57 -41.06 80.62 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.527 ' SG ' ' CG2' ' A' ' 71' ' ' ILE . 42.8 t -57.56 -49.36 76.62 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.859 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.683 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 24.9 m -60.5 -34.8 74.59 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 120.674 0.273 . . . . 0.0 110.687 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.9 t -68.75 -50.86 47.13 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.102 175.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.59 -38.26 95.55 Favored Glycine 0 N--CA 1.501 3.013 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.5 HG12 ' HA ' ' A' ' 72' ' ' PRO . 12.8 t -83.57 -52.68 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.403 -1.057 . . . . 0.0 110.707 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.524 ' HA ' ' CG1' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -57.77 -18.23 20.37 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.472 -0.768 . . . . 0.0 110.861 -179.685 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 89.9 p -94.97 -40.69 9.54 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.223 -0.923 . . . . 0.0 109.278 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.501 ' HB2' HD11 ' A' ' 2' ' ' ILE . 0.8 OUTLIER -54.15 -35.89 62.74 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.052 -1.03 . . . . 0.0 109.675 179.265 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.33 -19.2 64.41 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.44 -0.788 . . . . 0.0 109.668 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -87.44 -27.62 22.6 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.46 -30.3 18.4 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.652 -0.655 . . . . 0.0 110.385 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.473 ' HB1' HG12 ' A' ' 2' ' ' ILE . . . -84.41 -148.27 0.1 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.299 -0.876 . . . . 0.0 110.744 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 69.43 23.15 6.19 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.25 -0.906 . . . . 0.0 111.055 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.439 ' O ' ' HB ' ' A' ' 43' ' ' THR . 6.3 t -123.77 15.44 9.41 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.998 -1.064 . . . . 0.0 110.533 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 85.4 m 76.7 -66.94 0.23 Allowed 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.22 -0.925 . . . . 0.0 109.973 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.99 -58.51 6.29 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.213 0.53 . . . . 0.0 110.509 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.467 ' HB3' HG21 ' A' ' 2' ' ' ILE . 24.8 m-20 -70.77 -33.01 70.33 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.453 -0.779 . . . . 0.0 109.184 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.588 ' HG3' ' CE1' ' A' ' 81' ' ' TYR . 0.2 OUTLIER -56.32 -54.8 41.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.543 -0.723 . . . . 0.0 109.858 179.621 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -68.26 -43.0 78.76 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.492 -0.755 . . . . 0.0 109.574 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.36 -48.41 74.29 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.407 ' HB1' HG13 ' A' ' 2' ' ' ILE . . . -66.23 -49.4 67.35 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.476 ' SG ' ' O ' ' A' ' 88' ' ' ASP . 1.6 t -56.53 -41.14 76.26 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -57.61 -58.3 8.94 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 124.231 0.957 . . . . 0.0 110.285 177.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 48.6 t -67.91 -34.35 76.45 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 118.724 -1.19 . . . . 0.0 111.749 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.572 HD23 HD11 ' A' ' 83' ' ' ILE . 15.3 mt -59.22 -41.46 88.71 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.525 175.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.7 ttmt -64.63 -38.58 91.49 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -54.85 -36.27 64.88 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.43 -55.84 4.76 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.521 ' HB3' HG21 ' A' ' 83' ' ' ILE . . . -56.26 -36.02 68.09 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.309 -0.869 . . . . 0.0 110.814 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -93.04 17.02 11.46 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.34 -0.85 . . . . 0.0 110.856 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -143.68 -25.63 0.15 Allowed Glycine 0 N--CA 1.507 3.374 0 O-C-N 121.061 -1.024 . . . . 0.0 111.631 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.8 t -55.53 123.91 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.199 -1.177 . . . . 0.0 110.46 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.8 t -64.67 114.61 4.54 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.563 -0.711 . . . . 0.0 109.611 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 63' ' ' LEU . . . 103.1 -49.94 0.93 Allowed Glycine 0 N--CA 1.499 2.849 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 57' ' ' ALA . 3.4 tm? 19.86 100.65 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.764 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.406 ' O ' ' N ' ' A' ' 67' ' ' ASN . 1.0 OUTLIER -97.32 87.52 4.17 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.475 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -38.61 -45.85 1.13 Allowed 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.605 -0.684 . . . . 0.0 111.192 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.41 -35.36 55.91 Favored Glycine 0 N--CA 1.504 3.19 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 64' ' ' ASN . 7.0 m-20 -89.57 -46.58 8.56 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.776 -0.838 . . . . 0.0 109.063 178.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.514 ' HB2' ' HB ' ' A' ' 83' ' ' ILE . . . -51.24 -49.85 60.32 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.95 -0.469 . . . . 0.0 110.347 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.77 -26.8 60.83 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.333 -0.855 . . . . 0.0 109.835 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.9 m -68.83 -36.89 78.74 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.379 -0.825 . . . . 0.0 110.698 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.603 HG23 ' SG ' ' A' ' 14' ' ' CYS . 10.6 mt -53.45 -61.93 4.34 Favored Pre-proline 0 N--CA 1.5 2.034 0 O-C-N 121.675 -0.641 . . . . 0.0 110.465 -179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.5 ' HA ' HG12 ' A' ' 33' ' ' VAL . 28.3 Cg_endo -61.26 -60.96 0.19 Allowed 'Trans proline' 0 C--N 1.323 -0.785 0 C-N-CA 121.794 1.663 . . . . 0.0 111.032 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 77.7 p -46.77 -64.09 0.86 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.966 -0.459 . . . . 0.0 111.057 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -62.67 -44.69 95.62 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 119.571 -0.252 . . . . 0.0 111.346 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 1.6 m -46.88 -43.99 19.26 Favored 'General case' 0 N--CA 1.506 2.335 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.673 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 146.86 50.44 0.03 OUTLIER Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.186 -1.483 . . . . 0.0 111.52 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.524 ' CG1' ' HA ' ' A' ' 34' ' ' ARG . 32.9 m -135.07 136.46 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-N 119.243 1.521 . . . . 0.0 111.064 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.3 p -106.82 62.65 0.63 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.504 HG12 ' CE1' ' A' ' 81' ' ' TYR . 3.2 tp -116.64 126.24 27.7 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.426 -0.796 . . . . 0.0 109.354 -179.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -57.97 -38.11 93.41 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 C-N-CA 122.662 2.241 . . . . 0.0 112.083 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.588 ' CE1' ' HG3' ' A' ' 46' ' ' ARG . 14.0 p90 -90.27 113.99 25.93 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.879 -1.138 . . . . 0.0 109.941 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.5 ' C ' HD12 ' A' ' 83' ' ' ILE . 81.9 p -113.71 -135.55 0.36 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.532 -0.73 . . . . 0.0 109.119 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.572 HD11 HD23 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -123.51 51.59 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.111 -0.993 . . . . 0.0 108.648 -179.53 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.7 p -89.45 9.83 24.96 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.858 -0.526 . . . . 0.0 111.794 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 63.5 m 72.07 -59.89 0.54 Allowed 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.285 -0.884 . . . . 0.0 110.104 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.7 p -73.14 -58.08 3.56 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.1 m 31.58 -144.63 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.941 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.996 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.476 ' O ' ' SG ' ' A' ' 50' ' ' CYS . 31.6 t70 -155.51 142.55 19.16 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.609 -1.307 . . . . 0.0 110.58 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.2 m -137.06 54.69 1.85 Allowed 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.964 0.888 . . . . 0.0 110.421 176.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.0 t -164.08 -51.52 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.58 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.27 26.06 6.32 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.575 HG23 ' HB3' ' A' ' 81' ' ' TYR . 5.0 p -110.32 15.75 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.82 -0.55 . . . . 0.0 110.842 -178.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 1.9 p-10 . . . . . 0 N--CA 1.505 2.291 0 CA-C-O 115.308 -2.282 . . . . 0.0 111.078 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.016 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.507 ' CD1' ' HB3' ' A' ' 49' ' ' ALA . 2.9 tp 33.9 46.41 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 CA-C-O 121.735 0.778 . . . . 0.0 111.74 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.7 t -95.72 152.9 18.05 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.996 -1.065 . . . . 0.0 110.279 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.411 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 13.0 t -53.63 -27.69 28.49 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 115.407 -0.815 . . . . 0.0 113.113 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.34 -55.85 27.79 Favored Glycine 0 N--CA 1.502 3.034 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 176.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.473 ' HG3' ' N ' ' A' ' 7' ' ' VAL . 5.5 pt20 -71.39 -34.99 70.9 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.209 -1.171 . . . . 0.0 109.442 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.493 ' CG1' ' HG ' ' A' ' 53' ' ' LEU . 37.6 t -56.62 -49.16 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.492 ' HA ' ' CD1' ' A' ' 11' ' ' ILE . . . -70.09 -34.29 72.95 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 t -73.03 -22.26 60.67 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.116 -0.99 . . . . 0.0 110.149 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.21 -43.73 23.27 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.298 -0.876 . . . . 0.0 110.427 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.492 ' CD1' ' HA ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -85.59 -16.73 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.038 -1.039 . . . . 0.0 110.413 -179.691 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.47 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -48.62 -54.98 21.89 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.38 -0.825 . . . . 0.0 110.167 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 41.4 Cg_endo -67.56 -22.84 43.91 Favored 'Trans proline' 0 N--CA 1.481 0.763 0 C-N-CA 122.142 1.894 . . . . 0.0 110.585 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.754 ' SG ' HG23 ' A' ' 71' ' ' ILE . 10.6 m -102.28 11.7 37.76 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.607 178.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.518 ' O ' ' CB ' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -59.94 -39.54 80.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.049 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.68 -57.97 5.46 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.59 -0.694 . . . . 0.0 109.558 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.565 ' CD1' ' HA2' ' A' ' 22' ' ' GLY . 0.9 OUTLIER -58.37 -57.21 13.93 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.62 -0.675 . . . . 0.0 109.272 179.594 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.31 -22.98 21.1 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.335 -0.853 . . . . 0.0 109.916 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.518 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 9.2 tmm_? -95.19 0.02 53.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.619 -0.676 . . . . 0.0 110.75 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 123.16 -17.86 7.95 Favored Glycine 0 N--CA 1.501 2.988 0 O-C-N 120.339 -1.475 . . . . 0.0 112.166 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -83.06 69.48 9.85 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-N 119.084 1.442 . . . . 0.0 109.476 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.565 ' HA2' ' CD1' ' A' ' 17' ' ' TYR . . . -74.05 77.19 1.0 Allowed Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.2 p -101.25 -37.06 8.68 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.68 -0.894 . . . . 0.0 109.755 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 172.97 131.64 1.41 Allowed Glycine 0 N--CA 1.501 3.021 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -60.72 119.02 5.96 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 C-N-CA 122.272 1.982 . . . . 0.0 110.442 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.25 135.38 48.92 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.377 -0.827 . . . . 0.0 110.707 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.68 -48.87 71.86 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.783 -0.573 . . . . 0.0 109.587 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.95 -43.75 92.81 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 30.5 t -60.1 -46.52 89.31 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.53 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 96.5 m -64.63 -39.32 93.5 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.283 -177.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.77 -42.24 77.7 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 124.462 1.101 . . . . 0.0 110.031 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.36 -53.94 37.6 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.564 ' CG1' HG23 ' A' ' 77' ' ' VAL . 2.8 t -68.6 -44.83 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.572 -0.957 . . . . 0.0 109.21 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.432 ' HD2' ' O ' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -53.23 -35.71 60.24 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.956 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.4 m -73.53 -48.31 34.07 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -59.77 -34.13 72.59 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.736 -1.227 . . . . 0.0 107.938 177.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.435 ' HB2' HG12 ' A' ' 77' ' ' VAL . 66.0 t30 -52.28 -42.87 64.09 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.601 -0.687 . . . . 0.0 110.212 178.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -93.12 -24.06 18.4 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.18 -0.95 . . . . 0.0 110.703 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.464 ' O ' ' HB ' ' A' ' 2' ' ' ILE . . . -106.63 33.85 3.7 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.956 -1.09 . . . . 0.0 110.372 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.464 ' HB1' HD11 ' A' ' 2' ' ' ILE . . . -168.62 85.78 0.18 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.165 -0.959 . . . . 0.0 110.669 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.467 ' HA ' ' CD ' ' A' ' 46' ' ' ARG . 15.2 mtt180 -158.86 24.31 0.22 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.204 -0.935 . . . . 0.0 111.028 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.419 ' O ' ' HB ' ' A' ' 43' ' ' THR . 8.9 m -110.82 42.16 1.66 Allowed 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.973 -1.079 . . . . 0.0 110.796 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.49 HG21 ' HB3' ' A' ' 93' ' ' ASN . 52.0 m 68.8 -65.72 0.27 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.158 -0.964 . . . . 0.0 109.469 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 42' ' ' THR . . . -56.82 -51.9 67.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.902 -0.499 . . . . 0.0 109.731 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.465 ' HB3' HG23 ' A' ' 2' ' ' ILE . 12.6 m-20 -58.42 -48.61 80.12 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.273 0.558 . . . . 0.0 109.797 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.467 ' CD ' ' HA ' ' A' ' 41' ' ' ARG . 13.5 mtm180 -67.39 -48.66 66.74 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.943 -0.473 . . . . 0.0 111.145 -178.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -63.39 -50.86 68.22 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.081 -1.012 . . . . 0.0 109.145 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.97 -47.7 77.16 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.507 ' HB3' ' CD1' ' A' ' 2' ' ' ILE . . . -63.7 -44.06 94.76 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.538 -0.726 . . . . 0.0 109.186 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.574 ' O ' ' SG ' ' A' ' 89' ' ' CYS . 38.4 t -57.39 -39.03 75.24 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 120.364 -0.534 . . . . 0.0 109.736 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -61.37 -56.12 23.94 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 124.03 0.832 . . . . 0.0 109.788 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 8.4 t -64.26 -35.16 79.94 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.544 178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.493 ' HG ' ' CG1' ' A' ' 7' ' ' VAL . 8.0 mt -63.39 -44.47 94.61 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.061 176.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.0 ttpp -59.67 -40.62 88.41 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -56.11 -47.23 78.46 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.65 -47.16 42.05 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.87 -41.66 64.52 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.59 -0.694 . . . . 0.0 110.136 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.98 1.53 39.35 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.541 -0.724 . . . . 0.0 110.199 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -125.63 9.48 7.68 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.405 ' O ' ' CB ' ' A' ' 61' ' ' SER . 4.9 t -73.58 -5.69 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.579 -0.953 . . . . 0.0 110.07 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER 76.59 -71.03 0.12 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.34 -0.85 . . . . 0.0 109.598 179.777 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 19' ' ' ARG . . . -109.48 59.33 0.36 Allowed Glycine 0 N--CA 1.499 2.859 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.547 HD13 ' HA ' ' A' ' 84' ' ' SER . 1.4 tm? -54.79 117.99 3.86 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.564 -0.962 . . . . 0.0 111.031 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.425 ' N ' HD12 ' A' ' 63' ' ' LEU . 8.0 t-20 -107.44 86.34 2.29 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.421 ' HA ' ' HB3' ' A' ' 84' ' ' SER . . . -42.91 -50.6 5.76 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.48 -44.19 85.4 Favored Glycine 0 N--CA 1.503 3.162 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -74.41 -55.17 6.28 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.707 -0.878 . . . . 0.0 109.585 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.402 ' HB2' ' HB ' ' A' ' 83' ' ' ILE . . . -51.43 -35.88 41.37 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.937 -0.477 . . . . 0.0 111.435 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.95 -40.0 17.48 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.133 -0.979 . . . . 0.0 110.014 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.0 t -65.17 -40.55 94.46 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.473 -0.767 . . . . 0.0 110.826 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.754 HG23 ' SG ' ' A' ' 14' ' ' CYS . 74.7 mt -51.7 -65.19 1.05 Allowed Pre-proline 0 N--CA 1.503 2.224 0 O-C-N 121.845 -0.534 . . . . 0.0 111.934 -178.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.528 ' CD ' ' HB ' ' A' ' 71' ' ' ILE . 41.1 Cg_endo -60.2 -40.54 58.96 Favored 'Trans proline' 0 N--CA 1.482 0.813 0 C-N-CA 121.908 1.739 . . . . 0.0 110.404 -179.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.6 m -55.52 -62.95 1.34 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -63.97 -39.63 94.57 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.893 -0.505 . . . . 0.0 109.84 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 1.3 m -48.28 -33.31 8.57 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.91 -0.494 . . . . 0.0 111.689 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 132.17 50.3 0.09 OUTLIER Glycine 0 N--CA 1.498 2.796 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 176.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.564 HG23 ' CG1' ' A' ' 33' ' ' VAL . 43.8 t -139.98 135.4 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.379 -1.071 . . . . 0.0 110.681 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.8 p -112.11 59.8 0.63 Allowed 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 122.219 1.009 . . . . 0.0 108.695 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.551 HD12 ' CE1' ' A' ' 81' ' ' TYR . 13.5 tt -125.07 122.56 25.39 Favored Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.46 -41.31 78.03 Favored 'Trans proline' 0 N--CA 1.486 1.084 0 C-N-CA 122.66 2.24 . . . . 0.0 112.092 -178.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.551 ' CE1' HD12 ' A' ' 79' ' ' ILE . 6.6 p90 -97.13 128.91 44.49 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.121 -0.987 . . . . 0.0 108.429 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.521 ' C ' HD13 ' A' ' 83' ' ' ILE . 40.2 p -128.59 -94.97 0.42 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.339 -0.851 . . . . 0.0 110.834 -178.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.521 HD13 ' C ' ' A' ' 82' ' ' THR . 1.4 mp -120.12 -51.79 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.265 -0.897 . . . . 0.0 109.639 -177.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.547 ' HA ' HD13 ' A' ' 63' ' ' LEU . 1.4 m -42.63 144.52 0.53 Allowed 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.309 0.576 . . . . 0.0 110.86 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 87' ' ' THR . 41.3 p -72.44 -130.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.7 t 63.03 -58.9 0.15 Allowed 'General case' 0 N--CA 1.508 2.438 0 O-C-N 120.97 -1.081 . . . . 0.0 111.012 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 85' ' ' THR . 3.4 m -61.11 140.62 57.84 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.387 -0.821 . . . . 0.0 109.789 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -83.67 134.35 34.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.578 -0.701 . . . . 0.0 111.025 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.574 ' SG ' ' O ' ' A' ' 50' ' ' CYS . 65.2 m -105.17 54.55 0.71 Allowed 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.836 0.827 . . . . 0.0 110.129 177.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 m -144.06 -40.89 0.28 Allowed 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 113.796 -1.547 . . . . 0.0 109.132 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -99.43 -30.45 12.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.504 -0.748 . . . . 0.0 109.806 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -47.64 142.77 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 121.297 -0.877 . . . . 0.0 110.391 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.49 ' HB3' HG21 ' A' ' 43' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.499 1.992 0 O-C-N 121.711 -0.618 . . . . 0.0 109.529 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.455 ' HB2' ' HB3' ' A' ' 39' ' ' ALA . . . . . . . . 0 N--CA 1.497 1.9 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.461 HD12 ' HB3' ' A' ' 49' ' ' ALA . 7.4 tp 32.11 59.04 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.574 0 CA-C-O 121.806 0.812 . . . . 0.0 111.603 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.8 t -118.59 161.62 19.74 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.878 -1.139 . . . . 0.0 110.268 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.3 t -53.66 -38.02 63.74 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.23 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.16 -37.18 94.08 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -83.93 -43.91 14.77 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.64 -0.918 . . . . 0.0 108.962 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.474 HG23 ' HA ' ' A' ' 49' ' ' ALA . 94.8 t -57.03 -40.58 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.64 -27.46 55.68 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 m -67.76 -22.64 65.21 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.399 -0.813 . . . . 0.0 109.247 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.502 ' C ' ' HD2' ' A' ' 13' ' ' PRO . . . -98.29 -29.23 13.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.517 -0.739 . . . . 0.0 109.075 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 tp -79.37 -41.53 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.487 -0.758 . . . . 0.0 110.515 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.486 ' HB2' ' HD3' ' A' ' 13' ' ' PRO . . . -46.41 -49.78 42.58 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 121.555 -0.716 . . . . 0.0 110.316 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.502 ' HD2' ' C ' ' A' ' 10' ' ' ALA . 22.6 Cg_exo -65.1 -24.61 59.25 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.044 1.829 . . . . 0.0 110.451 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.74 ' SG ' HG22 ' A' ' 71' ' ' ILE . 1.7 m -104.15 14.55 30.25 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 176.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -65.76 -50.68 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.706 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.41 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 0.2 OUTLIER -62.04 -57.31 12.11 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.57 -0.706 . . . . 0.0 109.133 179.02 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.526 ' CE2' HG12 ' A' ' 71' ' ' ILE . 1.1 t80 -54.17 -58.9 5.63 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.77 -35.49 66.31 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.514 -0.741 . . . . 0.0 109.858 178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.427 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 29.5 ttm180 -74.53 -25.93 59.65 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.471 -0.768 . . . . 0.0 110.18 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.84 3.2 25.14 Favored Glycine 0 N--CA 1.5 2.929 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -103.82 70.7 1.02 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.1 -1.235 . . . . 0.0 109.484 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.05 -145.0 7.64 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.2 t 176.63 -54.29 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.809 -0.818 . . . . 0.0 109.514 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.61 118.4 4.65 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -56.71 132.42 51.63 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 122.568 2.179 . . . . 0.0 110.781 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.2 t -75.05 119.25 18.97 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.515 -0.741 . . . . 0.0 109.208 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.88 -46.01 51.22 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.692 -0.63 . . . . 0.0 109.986 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.98 -42.76 87.41 Favored Glycine 0 N--CA 1.499 2.868 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.449 ' O ' HG22 ' A' ' 33' ' ' VAL . 42.4 t -57.93 -46.08 85.6 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.88 -1.128 . . . . 0.0 109.53 177.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 75' ' ' CYS . 81.3 m -64.91 -41.97 95.12 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 123.855 0.722 . . . . 0.0 112.355 -177.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.5 t -70.68 -42.31 70.9 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 123.993 0.808 . . . . 0.0 110.192 176.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.95 -51.08 56.04 Favored Glycine 0 N--CA 1.498 2.819 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.507 HG11 HG13 ' A' ' 77' ' ' VAL . 4.8 t -70.47 -46.77 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.625 -0.927 . . . . 0.0 109.237 179.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.542 ' HA ' ' CG1' ' A' ' 77' ' ' VAL . 28.2 ttp180 -52.87 -36.66 59.42 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.4 t -74.29 -47.45 34.71 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.463 HD21 ' HA ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -55.83 -37.84 69.22 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.174 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.471 ' HB2' ' CG1' ' A' ' 77' ' ' VAL . 2.6 t-20 -63.34 -33.97 76.68 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.471 -0.768 . . . . 0.0 108.962 178.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -78.12 -38.0 44.9 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.455 ' HB3' ' HB2' ' A' ' 1' ' ' ALA . . . -94.85 32.01 1.73 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.706 -0.621 . . . . 0.0 109.724 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.469 ' HA ' ' CB ' ' A' ' 45' ' ' ASP . . . -164.39 -159.51 0.48 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.468 -0.77 . . . . 0.0 110.541 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ARG . . . . . 0.438 ' HA ' ' HD3' ' A' ' 46' ' ' ARG . 1.4 mtp180 78.14 12.03 1.79 Allowed 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.974 -0.453 . . . . 0.0 111.598 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.497 ' O ' ' HB ' ' A' ' 43' ' ' THR . 0.9 OUTLIER -99.64 27.32 5.43 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 120.889 -1.132 . . . . 0.0 110.189 178.869 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.497 ' HB ' ' O ' ' A' ' 42' ' ' THR . 55.2 m 83.83 -67.44 0.06 Allowed 'General case' 0 N--CA 1.51 2.557 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.82 -55.42 34.6 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.683 -0.635 . . . . 0.0 109.427 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.469 ' CB ' ' HA ' ' A' ' 40' ' ' ALA . 8.8 m-20 -54.39 -46.05 73.01 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.438 ' HD3' ' HA ' ' A' ' 41' ' ' ARG . 9.5 mmm-85 -56.81 -44.54 82.06 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.446 ' HA ' ' NH1' ' A' ' 47' ' ' ARG . 0.7 OUTLIER -60.25 -50.52 73.31 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.984 -0.448 . . . . 0.0 110.385 -179.64 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.61 -39.53 80.71 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.78 -0.575 . . . . 0.0 109.727 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.474 ' HA ' HG23 ' A' ' 7' ' ' VAL . . . -71.62 -61.6 1.72 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -44.84 -41.85 7.42 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 176.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.482 ' O ' ' HG3' ' A' ' 54' ' ' LYS . 3.0 t30 -65.53 -56.02 14.62 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.394 177.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 16.8 t -64.39 -26.37 68.43 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 119.139 -1.025 . . . . 0.0 111.146 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.458 ' HG ' HG12 ' A' ' 7' ' ' VAL . 21.7 mt -70.4 -58.9 3.23 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.39 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 51' ' ' ASN . 2.7 pptp? -54.07 -36.18 62.84 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.333 -0.854 . . . . 0.0 110.009 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -64.46 -48.15 76.35 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.435 -0.79 . . . . 0.0 109.092 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.58 -40.05 80.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.541 -0.724 . . . . 0.0 109.563 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.409 ' HA ' ' CD1' ' A' ' 63' ' ' LEU . . . -48.43 -48.32 37.45 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.611 -0.681 . . . . 0.0 110.366 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.55 -6.35 45.97 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.453 -0.78 . . . . 0.0 111.554 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -123.63 8.86 8.76 Favored Glycine 0 N--CA 1.501 3.032 0 O-C-N 120.833 -1.167 . . . . 0.0 110.759 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.405 ' O ' ' CB ' ' A' ' 61' ' ' SER . 0.9 OUTLIER -74.42 -21.11 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.333 -1.098 . . . . 0.0 110.367 -179.739 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 60' ' ' VAL . 0.9 OUTLIER 76.49 107.54 0.08 Allowed 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.279 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.73 -78.63 1.92 Allowed Glycine 0 N--CA 1.498 2.774 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 7.5 tt 59.48 103.09 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 121.953 0.883 . . . . 0.0 111.236 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.432 ' HB3' ' HB2' ' A' ' 67' ' ' ASN . 2.6 m-80 -94.39 81.88 4.01 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -32.87 -55.69 0.37 Allowed 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -52.21 -42.99 56.54 Favored Glycine 0 N--CA 1.506 3.357 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.432 ' HB2' ' HB3' ' A' ' 64' ' ' ASN . 2.0 t30 -72.7 -51.97 17.12 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.439 ' O ' ' CD ' ' A' ' 72' ' ' PRO . . . -57.16 -33.25 67.24 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 122.018 -0.426 . . . . 0.0 111.626 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.43 -45.22 13.91 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.094 -1.004 . . . . 0.0 109.964 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.09 -29.62 69.98 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.347 -0.846 . . . . 0.0 111.055 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.74 HG22 ' SG ' ' A' ' 14' ' ' CYS . 70.2 mt -60.11 -66.09 1.71 Allowed Pre-proline 0 N--CA 1.506 2.329 0 O-C-N 121.243 -0.911 . . . . 0.0 111.291 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.474 ' O ' HG23 ' A' ' 77' ' ' VAL . 23.7 Cg_endo -57.33 -53.62 4.53 Favored 'Trans proline' 0 C--N 1.325 -0.699 0 C-N-CA 121.805 1.67 . . . . 0.0 109.652 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.5 m -45.29 -63.98 0.82 Allowed 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -64.85 -34.05 77.45 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.712 -0.617 . . . . 0.0 109.916 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' CYS . . . . . 0.414 ' HB3' ' HA ' ' A' ' 30' ' ' CYS . 1.1 m -50.98 -31.48 18.07 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.222 -177.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 135.07 53.6 0.07 OUTLIER Glycine 0 N--CA 1.497 2.711 0 C-N-CA 119.657 -1.259 . . . . 0.0 110.81 175.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.542 ' CG1' ' HA ' ' A' ' 34' ' ' ARG . 12.0 m -147.71 124.49 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.184 -1.186 . . . . 0.0 111.172 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 65.2 m -91.45 67.06 5.57 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.47 HD13 ' CE2' ' A' ' 81' ' ' TYR . 2.3 tp -104.02 127.19 29.79 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.553 -0.717 . . . . 0.0 109.854 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.63 -33.88 65.37 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 122.826 2.351 . . . . 0.0 112.394 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' TYR . . . . . 0.47 ' CE2' HD13 ' A' ' 79' ' ' ILE . 5.9 p90 -90.3 143.68 26.54 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.904 -1.122 . . . . 0.0 110.407 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.3 p -104.88 173.37 6.33 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.504 -0.747 . . . . 0.0 110.814 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 5.4 mm -108.95 92.51 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.536 -0.727 . . . . 0.0 109.357 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.403 ' OG ' ' OG1' ' A' ' 87' ' ' THR . 82.8 p -119.45 -104.91 0.39 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.159 -0.963 . . . . 0.0 109.653 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -164.02 -55.9 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 63.3 m -79.34 -8.26 58.94 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 122.107 -0.371 . . . . 0.0 110.183 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.403 ' OG1' ' OG ' ' A' ' 84' ' ' SER . 8.7 m -50.03 142.67 9.06 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.325 -0.859 . . . . 0.0 109.951 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -82.58 118.46 23.3 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.496 -0.753 . . . . 0.0 109.813 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 11.4 m -109.64 56.11 0.63 Allowed 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.886 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.3 t -128.5 -61.4 1.08 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.571 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.404 ' HG3' HH11 ' A' ' 91' ' ' ARG . 2.9 mtm-85 -97.96 60.61 1.49 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 122.052 0.93 . . . . 0.0 109.629 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.3 t -115.37 81.51 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.482 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 2.1 p-10 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 117.152 -1.404 . . . . 0.0 110.326 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.71 ' CG1' ' HB2' ' A' ' 40' ' ' ALA . 5.3 tp . . . . . 0 N--CA 1.507 2.407 0 CA-C-O 121.916 0.865 . . . . 0.0 111.579 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 5' ' ' GLY . 1.2 t -156.39 80.19 0.97 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.782 -1.199 . . . . 0.0 110.632 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.431 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 11.4 t 66.08 -57.88 0.35 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 3' ' ' SER . . . -44.07 -53.45 6.53 Favored Glycine 0 N--CA 1.505 3.279 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.493 ' OE1' HG23 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -81.49 -25.76 35.73 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.514 -0.992 . . . . 0.0 110.482 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.506 HG21 ' HA ' ' A' ' 49' ' ' ALA . 37.6 t -56.07 -41.18 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.489 ' HA ' ' CD1' ' A' ' 11' ' ' ILE . . . -68.42 -39.58 81.54 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.0 p -71.9 -20.84 61.72 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.339 -0.851 . . . . 0.0 109.94 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.73 -49.1 11.61 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.508 -0.745 . . . . 0.0 110.573 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.489 ' CD1' ' HA ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -84.31 -16.7 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.209 -0.932 . . . . 0.0 110.488 -179.7 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.524 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -46.82 -53.98 22.64 Favored Pre-proline 0 N--CA 1.501 2.099 0 O-C-N 121.369 -0.832 . . . . 0.0 109.867 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 27.5 Cg_endo -63.38 -23.1 71.75 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 121.945 1.763 . . . . 0.0 110.585 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.2 m -88.58 -6.52 57.49 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 118.655 -0.688 . . . . 0.0 112.714 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.55 ' O ' ' CB ' ' A' ' 19' ' ' ARG . 1.0 OUTLIER -48.56 -47.07 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-N 118.62 0.646 . . . . 0.0 109.686 -178.096 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 21' ' ' GLN . 85.2 p -52.81 -63.55 1.11 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.119 -0.988 . . . . 0.0 109.38 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.591 ' CD2' HG12 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -59.5 -59.74 4.97 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.683 -0.636 . . . . 0.0 110.295 179.674 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.82 -27.59 60.24 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.289 -0.882 . . . . 0.0 111.039 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.55 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 16.1 ttm-85 -94.02 11.31 30.19 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.306 -0.872 . . . . 0.0 110.899 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.22 30.12 63.32 Favored Glycine 0 N--CA 1.506 3.307 0 O-C-N 120.784 -1.198 . . . . 0.0 111.33 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 16' ' ' SER . 69.4 mt-30 -140.79 48.49 1.71 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.335 -1.097 . . . . 0.0 109.461 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -165.28 -52.23 0.02 OUTLIER Glycine 0 N--CA 1.502 3.072 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.3 p 70.87 -47.6 0.65 Allowed 'General case' 0 N--CA 1.51 2.564 0 O-C-N 121.81 -0.818 . . . . 0.0 111.501 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.59 132.11 10.82 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.15 148.83 91.24 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 C-N-CA 122.366 2.044 . . . . 0.0 110.766 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.1 p -104.19 156.14 18.14 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.285 -0.884 . . . . 0.0 109.749 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.34 -47.44 85.86 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.49 -0.756 . . . . 0.0 109.133 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.01 -36.43 93.45 Favored Glycine 0 N--CA 1.501 2.977 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.448 ' HA ' ' HG2' ' A' ' 13' ' ' PRO . 3.9 t -62.38 -59.11 5.45 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 91.5 m -63.65 -36.43 83.81 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 120.184 -0.606 . . . . 0.0 112.15 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.4 m -66.81 -48.18 69.74 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 123.726 0.641 . . . . 0.0 109.753 176.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.36 -53.74 37.18 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.806 HG12 HG21 ' A' ' 77' ' ' VAL . 11.6 t -62.23 -48.33 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.609 -0.936 . . . . 0.0 110.361 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -23.89 63.48 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.988 -1.07 . . . . 0.0 109.66 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.444 ' HA ' ' OD1' ' A' ' 38' ' ' ASN . 21.4 p -73.63 -34.54 65.06 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.301 -0.874 . . . . 0.0 108.818 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.549 HD23 ' HA ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER -67.2 -31.8 72.43 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.495 -0.753 . . . . 0.0 109.861 179.073 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.629 ' HB2' HG13 ' A' ' 77' ' ' VAL . 2.4 t-20 -64.6 -50.23 67.99 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.395 -0.816 . . . . 0.0 110.575 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.444 ' OD1' ' HA ' ' A' ' 35' ' ' SER . 3.8 p-10 -68.76 -27.07 65.58 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.211 -0.93 . . . . 0.0 109.964 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.11 -46.11 12.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.667 -0.646 . . . . 0.0 110.004 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.71 ' HB2' ' CG1' ' A' ' 2' ' ' ILE . . . -88.97 95.99 10.54 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.199 -0.938 . . . . 0.0 109.679 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.583 ' HG2' ' NH1' ' A' ' 46' ' ' ARG . 42.1 mtm180 -152.3 23.74 0.63 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.398 -0.814 . . . . 0.0 110.595 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -128.26 33.95 4.64 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.024 -1.048 . . . . 0.0 110.462 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.43 HG23 ' HE ' ' A' ' 47' ' ' ARG . 53.2 m 67.73 -61.78 0.36 Allowed 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.443 -0.786 . . . . 0.0 109.601 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 42' ' ' THR . . . -55.93 -57.8 10.58 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.632 -0.667 . . . . 0.0 109.713 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.466 ' HB3' HG23 ' A' ' 2' ' ' ILE . 2.7 m-20 -71.1 -35.06 71.67 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.709 ' HG3' ' CE2' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -67.38 -58.9 3.94 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 122.001 -0.437 . . . . 0.0 110.271 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.43 ' HE ' HG23 ' A' ' 43' ' ' THR . 80.2 mtt180 -60.6 -43.71 97.12 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.04 -45.71 61.4 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.292 -0.88 . . . . 0.0 108.662 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.506 ' HA ' HG21 ' A' ' 7' ' ' VAL . . . -67.6 -49.49 62.86 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.67 ' SG ' HG22 ' A' ' 87' ' ' THR . 0.0 OUTLIER -55.68 -39.87 71.54 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.498 -0.751 . . . . 0.0 112.359 179.266 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.605 ' N ' ' SG ' ' A' ' 89' ' ' CYS . 2.2 t30 -63.44 -56.87 12.72 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.677 177.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 53.7 t -63.93 -26.7 68.71 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.773 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.451 HD22 HG23 ' A' ' 83' ' ' ILE . 21.0 mt -63.42 -51.31 66.28 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 124.183 0.927 . . . . 0.0 109.285 175.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.535 ' HE3' ' HA ' ' A' ' 51' ' ' ASN . 0.4 OUTLIER -55.86 -40.75 73.35 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.19 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.433 ' N ' ' HG2' ' A' ' 54' ' ' LYS . 5.3 m120 -66.48 -46.8 75.09 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.412 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -61.97 -46.02 91.08 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.527 ' HA ' ' HG ' ' A' ' 63' ' ' LEU . . . -61.42 -58.52 7.85 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.27 66.9 6.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.352 -0.843 . . . . 0.0 109.153 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.6 -36.59 0.09 OUTLIER Glycine 0 N--CA 1.498 2.813 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.474 ' HB ' ' HB2' ' A' ' 63' ' ' LEU . 4.0 t -51.91 136.4 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.651 -0.911 . . . . 0.0 110.087 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.444 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 0.4 OUTLIER -62.62 102.0 0.3 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.592 -0.692 . . . . 0.0 109.629 -179.786 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.28 42.11 19.65 Favored Glycine 0 N--CA 1.5 2.934 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.527 ' HG ' ' HA ' ' A' ' 57' ' ' ALA . 3.3 tm? -64.02 122.72 17.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.463 -1.022 . . . . 0.0 110.251 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.428 ' N ' HD13 ' A' ' 63' ' ' LEU . 2.4 m-80 -97.57 83.94 3.32 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -36.24 -53.08 0.82 Allowed 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.89 -0.506 . . . . 0.0 111.506 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -51.71 -50.96 41.14 Favored Glycine 0 N--CA 1.504 3.201 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -67.2 -53.28 31.68 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.694 -0.886 . . . . 0.0 108.949 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.404 ' O ' ' CD ' ' A' ' 72' ' ' PRO . . . -54.03 -32.77 55.41 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 122.038 -0.414 . . . . 0.0 111.235 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.3 -48.19 8.72 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.196 -0.94 . . . . 0.0 110.299 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.9 t -65.4 -27.98 68.93 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.326 -0.859 . . . . 0.0 110.967 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.591 HG12 ' CD2' ' A' ' 17' ' ' TYR . 55.8 mt -58.48 -65.17 2.09 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.253 -0.904 . . . . 0.0 110.451 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.651 ' HB3' HG11 ' A' ' 33' ' ' VAL . 9.5 Cg_endo -53.75 -52.1 9.28 Favored 'Trans proline' 0 N--CA 1.482 0.828 0 C-N-CA 122.217 1.945 . . . . 0.0 110.838 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.7 p -44.63 -70.62 0.1 Allowed 'General case' 0 N--CA 1.504 2.232 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.317 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.411 ' N ' ' HD3' ' A' ' 74' ' ' LYS . 1.1 mppt? -64.06 -39.37 93.92 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.972 -0.455 . . . . 0.0 111.106 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 1.1 m -47.5 -35.14 8.34 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.502 -0.749 . . . . 0.0 111.505 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 135.16 46.69 0.09 OUTLIER Glycine 0 N--CA 1.496 2.658 0 O-C-N 124.655 1.222 . . . . 0.0 110.05 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.806 HG21 HG12 ' A' ' 33' ' ' VAL . 59.8 t -119.13 86.33 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.31 -1.112 . . . . 0.0 110.071 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.1 m -75.92 62.49 1.6 Allowed 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.549 HG13 ' HD2' ' A' ' 80' ' ' PRO . 8.9 tt -111.14 142.98 27.43 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.373 -0.83 . . . . 0.0 109.287 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.549 ' HD2' HG13 ' A' ' 79' ' ' ILE . 11.4 Cg_endo -53.37 -39.2 82.33 Favored 'Trans proline' 0 N--CA 1.485 0.973 0 C-N-CA 122.873 2.382 . . . . 0.0 112.942 -177.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.73 ' HB3' HG21 ' A' ' 92' ' ' VAL . 0.2 OUTLIER -96.63 159.94 14.66 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.661 -1.275 . . . . 0.0 111.144 -179.572 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.545 ' C ' HD12 ' A' ' 83' ' ' ILE . 1.3 m -96.11 -170.25 2.08 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.545 HD12 ' C ' ' A' ' 82' ' ' THR . 2.0 mp -120.65 92.68 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.154 -0.967 . . . . 0.0 108.48 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.3 p -142.83 172.29 12.9 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.574 -0.704 . . . . 0.0 110.292 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.6 p -59.69 -50.14 75.01 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.698 -0.626 . . . . 0.0 109.546 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 38.8 m -84.96 48.54 1.58 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.761 -0.587 . . . . 0.0 110.559 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.67 HG22 ' SG ' ' A' ' 50' ' ' CYS . 22.2 m -74.6 117.25 16.21 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.055 -1.028 . . . . 0.0 108.569 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -83.21 136.36 34.44 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.332 -0.855 . . . . 0.0 110.968 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.605 ' SG ' ' N ' ' A' ' 51' ' ' ASN . 58.6 m -117.08 56.04 0.82 Allowed 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.286 176.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.67 -38.7 0.47 Allowed 'General case' 0 N--CA 1.497 1.925 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.227 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.469 ' HG2' ' NH1' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -98.32 2.76 48.4 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.317 -0.864 . . . . 0.0 111.199 -179.176 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.73 HG21 ' HB3' ' A' ' 81' ' ' TYR . 17.1 t -105.82 136.17 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 120.889 -1.132 . . . . 0.0 110.007 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.5 m120 . . . . . 0 N--CA 1.494 1.772 0 O-C-N 121.289 -0.882 . . . . 0.0 108.738 179.153 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.876 HD11 ' HB2' ' A' ' 49' ' ' ALA . 1.2 pp . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.3 t -90.18 174.56 7.55 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.002 -1.061 . . . . 0.0 111.215 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.9 t -62.23 -25.83 68.03 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.672 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.63 -46.39 94.08 Favored Glycine 0 N--CA 1.5 2.93 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.508 ' HG3' ' N ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -78.03 -35.27 49.99 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.327 -1.102 . . . . 0.0 109.719 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.508 ' N ' ' HG3' ' A' ' 6' ' ' GLN . 95.9 t -59.74 -47.41 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.582 ' HA ' ' CD1' ' A' ' 11' ' ' ILE . . . -69.98 -35.05 74.12 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 72.4 m -70.59 -21.16 62.7 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.139 -0.976 . . . . 0.0 109.92 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.55 -41.94 12.39 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.384 -0.822 . . . . 0.0 111.128 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.582 ' CD1' ' HA ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -83.28 -17.81 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 120.813 -1.179 . . . . 0.0 110.307 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.539 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -48.05 -52.97 36.66 Favored Pre-proline 0 N--CA 1.502 2.13 0 O-C-N 121.249 -0.907 . . . . 0.0 109.596 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 17.8 Cg_endo -61.68 -25.03 78.49 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 121.899 1.732 . . . . 0.0 110.011 178.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.467 ' HB3' HD13 ' A' ' 71' ' ' ILE . 6.6 m -88.39 -1.67 58.17 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 176.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.501 ' O ' ' CB ' ' A' ' 19' ' ' ARG . 0.5 OUTLIER -55.39 -50.79 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' A' ' 21' ' ' GLN . 5.8 m -54.1 -53.17 56.83 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.292 -0.88 . . . . 0.0 108.797 178.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.505 ' CD1' HD11 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -59.97 -65.33 0.7 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.127 -0.983 . . . . 0.0 110.042 179.053 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.479 ' HA ' ' HB3' ' A' ' 67' ' ' ASN . . . -55.08 -34.0 63.26 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.606 -0.684 . . . . 0.0 110.97 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.509 ' HG3' HH11 ' A' ' 19' ' ' ARG . 1.7 ttm-85 -80.35 5.58 14.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.718 -0.614 . . . . 0.0 111.539 -178.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.72 23.68 45.35 Favored Glycine 0 N--CA 1.504 3.226 0 O-C-N 120.618 -1.301 . . . . 0.0 111.803 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.49 ' O ' ' HB3' ' A' ' 16' ' ' SER . 6.3 mm-40 -141.22 59.76 1.51 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.18 -1.188 . . . . 0.0 109.515 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.61 -58.99 0.02 OUTLIER Glycine 0 N--CA 1.503 3.12 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.7 p 74.42 -51.34 0.68 Allowed 'General case' 0 N--CA 1.511 2.596 0 O-C-N 122.054 -0.674 . . . . 0.0 111.479 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.78 139.99 14.66 Favored Glycine 0 N--CA 1.501 2.981 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.718 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 27.3 Cg_endo -61.9 121.77 9.99 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 122.173 1.915 . . . . 0.0 110.238 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 p -75.96 152.95 36.91 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.201 -0.937 . . . . 0.0 110.313 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.01 -51.91 66.1 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.363 -0.835 . . . . 0.0 108.828 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.19 -36.63 91.21 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.572 ' O ' HG23 ' A' ' 33' ' ' VAL . 7.3 t -63.98 -53.95 42.03 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.718 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 93.4 m -67.52 -39.27 85.09 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 118.635 -0.698 . . . . 0.0 111.389 -177.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.0 t -65.62 -47.9 74.08 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 124.19 0.931 . . . . 0.0 109.5 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.31 -53.09 48.5 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.789 HG12 HG21 ' A' ' 77' ' ' VAL . 12.5 t -63.36 -50.63 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.382 -1.069 . . . . 0.0 110.072 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.469 ' O ' ' CB ' ' A' ' 38' ' ' ASN . 7.1 ttp180 -56.24 -35.63 67.6 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 m -73.92 -43.69 57.5 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.531 HD23 ' HA ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -64.4 -44.89 89.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.752 -0.593 . . . . 0.0 109.663 179.628 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.615 ' HB3' HG13 ' A' ' 77' ' ' VAL . 7.3 m-80 -80.8 -28.9 36.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -0.904 . . . . 0.0 110.509 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 8.7 t30 -63.6 -35.19 79.69 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.7 -38.23 29.26 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.585 ' HB2' HG12 ' A' ' 2' ' ' ILE . . . -83.17 93.5 7.66 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.503 -0.748 . . . . 0.0 110.651 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.517 ' HA ' ' HD3' ' A' ' 46' ' ' ARG . 43.3 mtt180 -143.0 9.18 1.7 Allowed 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.95 -1.094 . . . . 0.0 110.584 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 58.0 m -87.53 -65.74 0.98 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.223 -0.923 . . . . 0.0 110.337 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 m 160.15 -56.98 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.86 -47.64 70.79 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.596 ' HB3' ' CG1' ' A' ' 2' ' ' ILE . 18.2 m-20 -68.58 -49.92 55.69 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.517 ' HD3' ' HA ' ' A' ' 41' ' ' ARG . 22.2 mtm180 -62.47 -46.27 89.27 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.526 -0.734 . . . . 0.0 110.46 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -59.06 -46.29 88.63 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.378 -0.826 . . . . 0.0 108.879 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.56 -39.68 91.95 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.876 ' HB2' HD11 ' A' ' 2' ' ' ILE . . . -57.24 -51.13 70.6 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.46 ' SG ' ' N ' ' A' ' 89' ' ' CYS . 19.1 t -58.05 -38.11 75.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.809 -0.557 . . . . 0.0 110.866 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -63.7 -63.21 1.23 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 123.711 0.632 . . . . 0.0 109.305 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 8.6 t -53.7 -33.92 57.09 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.336 -0.852 . . . . 0.0 112.036 176.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.666 HD22 HG23 ' A' ' 83' ' ' ILE . 25.1 mt -61.81 -44.83 96.07 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 114.961 -1.018 . . . . 0.0 108.821 176.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.532 ' HD2' ' SG ' ' A' ' 89' ' ' CYS . 3.3 tttp -56.77 -42.96 80.32 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.639 -0.663 . . . . 0.0 109.269 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -55.89 -44.94 78.65 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.764 -0.585 . . . . 0.0 109.73 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.526 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -76.63 -53.98 7.29 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.567 -0.708 . . . . 0.0 109.565 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.611 ' HB1' ' HA ' ' A' ' 85' ' ' THR . . . -52.36 -55.31 22.46 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.536 -0.728 . . . . 0.0 109.679 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -87.95 62.18 6.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.288 -0.883 . . . . 0.0 108.74 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.98 -34.14 0.07 OUTLIER Glycine 0 N--CA 1.498 2.787 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 56' ' ' ALA . 24.3 t -47.54 133.78 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.672 -0.899 . . . . 0.0 109.86 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.405 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 0.5 OUTLIER -62.41 97.93 0.1 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.706 -0.621 . . . . 0.0 110.191 -179.187 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.59 73.37 0.61 Allowed Glycine 0 N--CA 1.5 2.928 0 N-CA-C 110.014 -1.235 . . . . 0.0 110.014 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.493 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 1.7 pt? -102.5 159.28 15.57 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.346 -1.091 . . . . 0.0 110.713 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -116.26 114.71 24.76 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -49.57 -53.3 24.49 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.753 -0.592 . . . . 0.0 110.423 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.76 -45.35 85.85 Favored Glycine 0 N--CA 1.5 2.904 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.479 ' HB3' ' HA ' ' A' ' 18' ' ' ALA . 2.9 m120 -62.37 -55.33 28.95 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.728 -0.866 . . . . 0.0 109.474 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.468 ' O ' ' HD2' ' A' ' 72' ' ' PRO . . . -58.36 -33.04 69.12 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.921 -0.487 . . . . 0.0 110.76 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.61 -51.15 8.52 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.217 -0.927 . . . . 0.0 110.215 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.3 t -60.62 -31.13 70.33 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.543 -0.723 . . . . 0.0 110.738 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.531 ' HB ' ' CD ' ' A' ' 72' ' ' PRO . 51.6 mt -56.94 -69.63 0.43 Allowed Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.518 -0.739 . . . . 0.0 111.072 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.739 ' HB3' HG11 ' A' ' 33' ' ' VAL . 17.7 Cg_endo -56.06 -52.56 7.03 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 122.485 2.123 . . . . 0.0 111.762 -178.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.4 t -49.36 -69.5 0.11 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.78 -0.575 . . . . 0.0 110.521 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -63.56 -35.83 81.8 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 122.107 -0.37 . . . . 0.0 111.166 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 71' ' ' ILE . 0.9 OUTLIER -48.66 -35.98 14.98 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.398 -0.814 . . . . 0.0 111.419 -178.447 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 133.92 50.14 0.08 OUTLIER Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.789 HG21 HG12 ' A' ' 33' ' ' VAL . 2.4 t -119.52 110.99 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.423 -1.045 . . . . 0.0 109.951 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 83.8 p -81.32 68.24 7.56 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.296 -0.878 . . . . 0.0 108.918 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.565 HG12 ' CE2' ' A' ' 81' ' ' TYR . 0.7 OUTLIER -133.92 134.26 23.0 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.589 -0.694 . . . . 0.0 109.739 -178.943 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.495 ' HD2' HG13 ' A' ' 79' ' ' ILE . 47.3 Cg_endo -67.11 -35.37 25.43 Favored 'Trans proline' 0 N--CA 1.486 1.048 0 C-N-CA 122.958 2.439 . . . . 0.0 113.278 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.706 ' HB3' HG22 ' A' ' 92' ' ' VAL . 54.8 p90 -80.54 132.26 35.64 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.698 -1.251 . . . . 0.0 110.755 -178.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.55 154.51 20.28 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.468 0.651 . . . . 0.0 110.38 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.666 HG23 HD22 ' A' ' 53' ' ' LEU . 1.9 mp -98.33 83.16 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 121.41 0.624 . . . . 0.0 109.739 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 99.8 p -128.99 171.26 12.52 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.116 -0.99 . . . . 0.0 110.07 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.611 ' HA ' ' HB1' ' A' ' 57' ' ' ALA . 1.7 m -58.37 101.14 0.07 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.335 -0.853 . . . . 0.0 109.375 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.4 ' HA ' ' CG ' ' A' ' 54' ' ' LYS . 34.2 t 60.36 60.53 2.0 Allowed 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 121.493 0.663 . . . . 0.0 109.513 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 56.0 m -63.8 -69.23 0.29 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.434 -0.791 . . . . 0.0 110.684 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -150.87 -72.46 0.16 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.061 -1.024 . . . . 0.0 110.149 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.532 ' SG ' ' HD2' ' A' ' 54' ' ' LYS . 38.5 m 58.82 55.01 4.83 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-O 121.621 0.724 . . . . 0.0 111.626 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 97.6 p -162.75 -42.35 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 114.427 -1.261 . . . . 0.0 109.705 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -100.17 12.43 37.02 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.458 -0.777 . . . . 0.0 109.719 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.706 HG22 ' HB3' ' A' ' 81' ' ' TYR . 85.7 t -79.54 117.14 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.268 -0.895 . . . . 0.0 109.659 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.936 0 CA-C-O 117.267 -1.349 . . . . 0.0 109.542 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 1.019 HD11 ' HB2' ' A' ' 49' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.3 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.2 t -119.05 -173.3 2.47 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.527 -1.358 . . . . 0.0 110.632 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.568 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 1.9 t -52.2 -28.16 17.34 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 177.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -57.23 -51.75 55.67 Favored Glycine 0 N--CA 1.501 2.987 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.543 ' HG3' ' N ' ' A' ' 7' ' ' VAL . 3.1 pt20 -89.33 -34.16 16.65 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.387 -1.067 . . . . 0.0 109.666 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 49' ' ' ALA . 40.7 t -56.16 -37.74 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.32 -37.7 68.86 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.7 p -77.15 -22.11 53.04 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.011 -1.056 . . . . 0.0 110.02 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.63 -48.86 23.98 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.473 -0.767 . . . . 0.0 110.29 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.435 HG21 ' CD2' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -83.98 -16.02 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 O-C-N 121.13 -0.981 . . . . 0.0 110.812 -179.412 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.541 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -45.61 -54.78 14.27 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.455 -0.778 . . . . 0.0 109.759 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.74 ' HG2' ' SG ' ' A' ' 29' ' ' CYS . 19.2 Cg_endo -62.0 -24.76 77.09 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.186 1.924 . . . . 0.0 110.565 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.724 ' SG ' HG21 ' A' ' 71' ' ' ILE . 72.1 m -86.61 -16.81 35.57 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 178.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.453 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -47.58 -24.53 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.904 -0.497 . . . . 0.0 111.255 -177.462 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.447 ' HA ' ' NH2' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -91.21 -61.93 1.55 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.017 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.508 ' CE2' HG12 ' A' ' 71' ' ' ILE . 1.1 t80 -55.19 -57.42 11.87 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 14' ' ' CYS . . . -52.36 -32.38 38.15 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-O 121.42 0.629 . . . . 0.0 110.144 178.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 9.3 tmm_? -90.01 7.9 35.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.798 -0.564 . . . . 0.0 110.86 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.18 9.31 59.45 Favored Glycine 0 N--CA 1.502 3.075 0 O-C-N 120.713 -1.242 . . . . 0.0 111.976 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -114.75 81.91 1.64 Allowed 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 118.768 1.284 . . . . 0.0 109.699 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 157.48 -148.95 19.26 Favored Glycine 0 N--CA 1.5 2.905 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.3 t -175.24 -45.71 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.596 -0.943 . . . . 0.0 109.918 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -97.84 141.75 15.76 Favored Glycine 0 N--CA 1.499 2.886 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.633 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . 27.9 Cg_endo -62.31 121.91 10.11 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 122.362 2.041 . . . . 0.0 111.051 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.5 t -60.77 134.62 57.27 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.548 -0.72 . . . . 0.0 110.045 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.91 -52.9 37.53 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.65 -0.656 . . . . 0.0 110.109 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -52.76 -45.93 60.27 Favored Glycine 0 N--CA 1.502 3.06 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.74 ' SG ' ' HG2' ' A' ' 13' ' ' PRO . 1.1 m -60.02 -43.84 95.02 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.016 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.558 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 3.6 m -63.56 -57.33 10.47 Favored 'General case' 0 C--O 1.201 -1.473 0 CA-C-O 117.556 -1.211 . . . . 0.0 109.574 -176.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.3 t -65.79 -39.78 91.28 Favored 'General case' 0 N--CA 1.505 2.296 0 CA-C-N 118.804 0.729 . . . . 0.0 110.683 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -57.98 -44.78 94.38 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.743 HG12 HG21 ' A' ' 77' ' ' VAL . 5.3 t -84.06 -46.41 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.425 -1.044 . . . . 0.0 110.169 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.542 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -54.62 -35.06 63.02 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.491 -0.756 . . . . 0.0 109.14 179.676 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 90.9 p -78.49 -44.42 24.56 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.306 -0.871 . . . . 0.0 110.027 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.599 ' C ' HD12 ' A' ' 36' ' ' LEU . 0.4 OUTLIER -52.67 -35.82 55.91 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.513 -0.742 . . . . 0.0 109.665 179.786 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.56 ' HB2' HG13 ' A' ' 77' ' ' VAL . 4.3 t-20 -62.39 -26.21 68.35 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.259 -0.9 . . . . 0.0 109.917 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -91.65 -40.56 11.23 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.317 -0.864 . . . . 0.0 108.98 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.06 -36.44 69.58 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.861 ' HB2' HG12 ' A' ' 2' ' ' ILE . . . -91.51 -131.21 0.11 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.873 -0.517 . . . . 0.0 109.926 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.475 ' H ' ' HG2' ' A' ' 46' ' ' ARG . 8.1 mtt-85 56.95 38.92 29.67 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.294 -0.879 . . . . 0.0 110.064 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.465 ' O ' ' HB ' ' A' ' 43' ' ' THR . 9.0 t -136.1 19.02 3.2 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.822 -0.549 . . . . 0.0 109.867 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.768 ' HA ' ' C ' ' A' ' 93' ' ' ASN . 99.5 m 78.17 -60.73 0.4 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.755 -0.591 . . . . 0.0 110.327 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.51 -55.67 32.06 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.445 -0.785 . . . . 0.0 110.613 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.42 ' HB3' ' CG1' ' A' ' 2' ' ' ILE . 54.5 m-20 -67.44 -37.14 82.54 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.575 -0.703 . . . . 0.0 110.889 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.661 ' HD2' HD11 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -67.5 -57.08 7.14 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.879 -1.138 . . . . 0.0 110.778 -179.145 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -55.31 -44.17 75.56 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.226 -0.921 . . . . 0.0 109.419 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.46 -45.76 80.72 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 1.019 ' HB2' HD11 ' A' ' 2' ' ' ILE 0.27 . . -61.59 -52.87 62.61 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.4 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.471 ' C ' ' SG ' ' A' ' 89' ' ' CYS . 44.7 t -54.84 -34.26 62.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.996 -1.065 . . . . 0.0 111.809 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -68.92 -59.5 3.02 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 123.676 0.61 . . . . 0.0 109.988 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.5 t -61.73 -33.36 73.91 Favored 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.526 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.613 HD22 HG13 ' A' ' 83' ' ' ILE . 17.8 mt -67.65 -51.39 50.45 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.636 176.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -59.04 -38.92 80.48 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -61.13 -53.43 57.1 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 122.077 -0.39 . . . . 0.0 110.381 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.29 -44.42 52.77 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.286 -0.884 . . . . 0.0 110.357 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.57 -44.31 76.75 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.526 -0.734 . . . . 0.0 110.112 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.422 ' HB2' HG21 ' A' ' 85' ' ' THR . . . -76.54 68.66 2.88 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.321 -0.862 . . . . 0.0 109.379 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 149.13 -12.21 1.06 Allowed Glycine 0 N--CA 1.5 2.933 0 C-N-CA 120.117 -1.039 . . . . 0.0 111.719 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.3 t -40.09 -60.33 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.566 0 CA-C-N 118.962 1.381 . . . . 0.0 110.776 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.0 m 160.45 77.9 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.512 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.54 -65.21 3.45 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 107.456 -2.257 . . . . 0.0 107.456 -177.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 8.4 tt 68.99 138.13 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 121.821 0.82 . . . . 0.0 111.413 177.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -121.38 92.26 3.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.427 -0.796 . . . . 0.0 109.192 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.46 -41.4 4.3 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.764 -0.585 . . . . 0.0 110.07 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -53.11 -32.18 42.38 Favored Glycine 0 N--CA 1.502 3.076 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -97.49 -53.49 3.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.788 -0.831 . . . . 0.0 108.95 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.407 ' HB2' ' HB1' ' A' ' 18' ' ' ALA . . . -54.69 -32.42 59.37 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.871 -0.518 . . . . 0.0 111.221 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.418 ' CB ' ' HB ' ' A' ' 82' ' ' THR . . . -86.7 -44.01 12.14 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.232 -0.917 . . . . 0.0 109.534 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 65.5 m -64.05 -39.36 93.91 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.677 -0.639 . . . . 0.0 111.139 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.724 HG21 ' SG ' ' A' ' 14' ' ' CYS . 68.5 mt -51.18 -64.35 1.43 Allowed Pre-proline 0 N--CA 1.499 2.008 0 O-C-N 121.628 -0.67 . . . . 0.0 111.479 -178.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.592 ' HG3' HD13 ' A' ' 83' ' ' ILE . 36.8 Cg_endo -59.56 -50.14 8.82 Favored 'Trans proline' 0 N--CA 1.48 0.678 0 C-N-CA 121.85 1.7 . . . . 0.0 110.549 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.7 t -55.82 -60.74 3.03 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.843 -0.536 . . . . 0.0 110.186 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -63.04 -40.01 96.44 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 122.04 -0.413 . . . . 0.0 110.317 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.633 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 1.2 m -49.86 -37.59 31.64 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.377 -0.827 . . . . 0.0 111.176 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 136.21 55.99 0.06 OUTLIER Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 176.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.743 HG21 HG12 ' A' ' 33' ' ' VAL . 37.4 t -132.07 114.36 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.515 -0.991 . . . . 0.0 110.139 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.2 m -82.57 56.53 3.36 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.467 -0.77 . . . . 0.0 109.215 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.661 HD11 ' HD2' ' A' ' 46' ' ' ARG . 2.1 tt -117.49 125.51 28.06 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.433 -0.792 . . . . 0.0 109.581 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 79' ' ' ILE . 21.9 Cg_exo -64.46 -37.13 40.33 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 122.786 2.324 . . . . 0.0 111.79 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.488 ' C ' ' CD1' ' A' ' 81' ' ' TYR . 0.8 OUTLIER -77.83 138.83 39.17 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.995 -1.066 . . . . 0.0 109.76 -179.396 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.418 ' HB ' ' CB ' ' A' ' 69' ' ' ALA . 30.0 p -107.79 168.21 9.42 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.499 -0.751 . . . . 0.0 110.327 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.613 HG13 HD22 ' A' ' 53' ' ' LEU . 1.2 mp -84.6 58.31 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.9 m -136.49 40.4 2.61 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.541 -0.725 . . . . 0.0 109.149 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 87' ' ' THR . 66.9 p 39.72 -115.69 0.2 Allowed 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -178.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.1 m 62.75 -60.87 0.13 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.389 -0.819 . . . . 0.0 111.416 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 85' ' ' THR . 3.7 t -75.76 158.61 32.01 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.247 -0.908 . . . . 0.0 111.181 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -104.52 6.72 34.93 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.476 -0.765 . . . . 0.0 110.418 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.471 ' SG ' ' C ' ' A' ' 50' ' ' CYS . 3.9 m 52.42 49.27 20.82 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.933 -0.479 . . . . 0.0 111.611 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.7 t -111.05 -37.85 5.24 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.981 -178.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -138.71 36.68 2.2 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.486 -0.759 . . . . 0.0 109.507 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.4 p -98.78 11.86 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 O-C-N 121.323 -0.861 . . . . 0.0 110.464 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.768 ' C ' ' HA ' ' A' ' 43' ' ' THR . 27.6 m-20 . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 117.186 -1.388 . . . . 0.0 108.78 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 2' ' ' ILE . 10.6 tp . . . . . 0 N--CA 1.506 2.351 0 CA-C-O 122.092 0.948 . . . . 0.0 111.655 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.6 t -144.59 59.74 1.33 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.72 -1.237 . . . . 0.0 110.521 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.413 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 6.3 t 67.3 -52.5 0.48 Allowed 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -47.32 -48.91 20.69 Favored Glycine 0 N--CA 1.506 3.321 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 177.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.428 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -82.46 -31.05 29.63 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.422 -1.046 . . . . 0.0 110.479 179.531 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.474 HG21 ' HA ' ' A' ' 49' ' ' ALA . 1.7 t -60.72 -46.15 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.596 ' HA ' HG13 ' A' ' 11' ' ' ILE . . . -72.64 -26.33 61.62 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.9 m -68.57 -20.37 64.52 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.323 -0.861 . . . . 0.0 110.34 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.429 ' HB1' ' CA ' ' A' ' 33' ' ' VAL . . . -98.24 -36.42 10.03 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.248 -0.908 . . . . 0.0 110.477 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.596 HG13 ' HA ' ' A' ' 8' ' ' ALA . 2.6 pp -80.0 -31.7 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.378 -0.826 . . . . 0.0 110.541 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.543 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -46.76 -50.89 41.3 Favored Pre-proline 0 N--CA 1.501 2.107 0 O-C-N 121.45 -0.782 . . . . 0.0 109.897 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.555 ' HG2' ' HA ' ' A' ' 29' ' ' CYS . 19.3 Cg_endo -63.08 -13.02 32.76 Favored 'Trans proline' 0 CA--C 1.548 1.178 0 C-N-CA 122.23 1.953 . . . . 0.0 111.412 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.2 m -125.45 24.06 7.37 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 175.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.446 ' CD1' HG13 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -60.06 -50.16 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 118.684 0.674 . . . . 0.0 111.019 177.18 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.474 ' HA ' ' HB3' ' A' ' 19' ' ' ARG . 1.5 m -67.58 -45.73 74.69 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.251 -0.906 . . . . 0.0 109.726 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.551 ' CE2' HG12 ' A' ' 71' ' ' ILE . 1.2 t80 -58.69 -48.5 80.9 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.475 ' HB1' ' HB2' ' A' ' 68' ' ' ALA . . . -69.38 -28.98 66.66 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.592 -0.692 . . . . 0.0 109.375 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.487 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 9.9 ttm180 -75.34 -18.24 60.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.653 -0.654 . . . . 0.0 109.864 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.46 20.83 11.34 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.451 ' O ' ' HB3' ' A' ' 16' ' ' SER . 26.7 tt0 -123.06 82.34 1.98 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . 158.88 -153.75 24.86 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 46.4 t 170.17 60.45 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.795 -0.827 . . . . 0.0 109.233 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 160.06 123.12 0.68 Allowed Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.597 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 32.0 Cg_endo -63.1 124.8 14.57 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 122.571 2.18 . . . . 0.0 110.918 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.2 p -77.36 154.43 32.79 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.484 -0.76 . . . . 0.0 109.612 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.31 -57.76 10.88 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.461 -0.775 . . . . 0.0 110.245 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -53.94 -37.96 59.2 Favored Glycine 0 N--CA 1.501 3.011 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.555 ' HA ' ' HG2' ' A' ' 13' ' ' PRO . 6.4 t -66.63 -73.24 0.14 Allowed 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.749 177.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.597 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 0.5 OUTLIER -44.81 -41.52 7.06 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.238 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.438 ' HA ' ' HG2' ' A' ' 34' ' ' ARG . 35.8 t -73.15 -52.03 15.68 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.414 178.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.21 -41.24 96.62 Favored Glycine 0 N--CA 1.5 2.913 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.792 HG12 HG21 ' A' ' 77' ' ' VAL . 57.7 t -72.54 -50.23 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.339 -1.094 . . . . 0.0 109.85 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.438 ' HG2' ' HA ' ' A' ' 31' ' ' SER . 11.6 ptm180 -62.1 -23.04 66.29 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.5 -0.75 . . . . 0.0 110.351 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 57.6 p -88.4 -42.3 12.26 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.314 -0.866 . . . . 0.0 109.373 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.712 HD23 ' HA ' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -52.24 -32.89 39.04 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.322 -0.861 . . . . 0.0 109.344 178.794 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.498 ' HB2' HG13 ' A' ' 77' ' ' VAL . 8.9 t-20 -74.78 -8.56 56.81 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.932 -0.48 . . . . 0.0 111.168 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -105.44 -26.95 11.72 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.501 -1.375 . . . . 0.0 110.855 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.41 -13.86 61.98 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.287 -0.883 . . . . 0.0 110.219 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 1.05 ' HB1' ' HB3' ' A' ' 45' ' ' ASP . . . -163.1 139.54 7.23 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.51 -0.743 . . . . 0.0 110.297 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.51 ' HG2' HH11 ' A' ' 46' ' ' ARG . 4.4 mtm180 -172.62 51.32 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.228 -0.92 . . . . 0.0 110.613 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.569 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.9 OUTLIER -133.6 57.99 1.79 Allowed 'General case' 0 N--CA 1.508 2.466 0 O-C-N 120.987 -1.07 . . . . 0.0 109.979 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.61 ' CB ' ' HA ' ' A' ' 93' ' ' ASN . 12.6 t 54.66 -53.8 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.105 0 C-N-CA 123.988 0.915 . . . . 0.0 111.775 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 42' ' ' THR . . . -61.37 -51.86 67.03 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 1.05 ' HB3' ' HB1' ' A' ' 40' ' ' ALA . 6.3 m-20 -66.87 -42.86 84.91 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.567 ' HD2' HG13 ' A' ' 79' ' ' ILE . 1.0 OUTLIER -62.01 -48.35 80.7 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.411 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.553 ' HA ' ' SG ' ' A' ' 50' ' ' CYS . 72.0 mtt180 -67.43 -37.13 82.53 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.247 -0.908 . . . . 0.0 109.213 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.47 -50.21 74.54 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 177.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.513 ' HB2' HD11 ' A' ' 2' ' ' ILE . . . -60.74 -42.65 97.77 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.553 ' SG ' ' HA ' ' A' ' 47' ' ' ARG . 4.3 p -66.23 -33.15 75.1 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.591 -0.693 . . . . 0.0 110.509 -177.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.5 ' N ' ' SG ' ' A' ' 50' ' ' CYS . 1.7 t30 -62.93 -54.15 43.0 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 124.06 0.85 . . . . 0.0 109.334 176.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 18.6 t -68.41 -38.79 81.59 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 119.166 -1.014 . . . . 0.0 111.314 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 53' ' ' LEU . 12.4 mt -56.03 -41.97 75.81 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 124.377 1.048 . . . . 0.0 108.619 176.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.419 ' HG2' ' CB ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -58.61 -50.22 74.61 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.109 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -59.34 -41.51 89.34 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.404 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -69.78 -55.86 8.72 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.477 -0.764 . . . . 0.0 109.403 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.467 ' O ' HD22 ' A' ' 63' ' ' LEU . . . -54.59 -47.67 73.05 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.586 -0.696 . . . . 0.0 110.297 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.11 7.34 7.64 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.319 -0.863 . . . . 0.0 110.726 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -132.99 7.52 5.14 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.446 HG13 ' CD1' ' A' ' 15' ' ' ILE . 2.5 t -79.73 133.92 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.128 -1.219 . . . . 0.0 109.382 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.8 p -65.57 94.21 0.18 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.514 -0.741 . . . . 0.0 109.284 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 112.93 -78.52 0.25 Allowed Glycine 0 N--CA 1.497 2.715 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.491 ' CD2' HG23 ' A' ' 85' ' ' THR . 16.7 tp 69.12 134.43 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 122.2 1.0 . . . . 0.0 111.316 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.477 ' HB3' ' HB2' ' A' ' 67' ' ' ASN . 6.8 t-20 -135.84 106.09 6.37 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.0 -57.82 8.35 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.623 -0.673 . . . . 0.0 111.463 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.45 -47.69 68.22 Favored Glycine 0 N--CA 1.504 3.18 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 64' ' ' ASN . 1.8 m-20 -69.84 -58.94 3.28 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.625 -0.926 . . . . 0.0 110.25 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.475 ' HB2' ' HB1' ' A' ' 18' ' ' ALA . . . -57.35 -32.4 66.72 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.474 -0.766 . . . . 0.0 112.273 -178.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.46 -52.57 7.88 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.879 -1.138 . . . . 0.0 110.189 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 90.6 p -68.3 -34.25 75.81 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.653 -0.654 . . . . 0.0 111.122 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.551 HG12 ' CE2' ' A' ' 17' ' ' TYR . 28.1 mt -47.83 -65.33 0.77 Allowed Pre-proline 0 N--CA 1.503 2.215 0 O-C-N 121.516 -0.74 . . . . 0.0 110.357 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.577 ' HB3' HG11 ' A' ' 33' ' ' VAL . 28.3 Cg_endo -61.65 -50.23 5.8 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 122.218 1.945 . . . . 0.0 110.557 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 40.6 t -51.52 -60.84 2.7 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.828 -0.545 . . . . 0.0 110.151 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.2 tptp -64.36 -41.28 96.81 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.721 -0.612 . . . . 0.0 110.1 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -48.16 -50.44 28.9 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 120.019 -0.673 . . . . 0.0 111.707 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.61 46.99 0.01 OUTLIER Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 176.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.792 HG21 HG12 ' A' ' 33' ' ' VAL . 53.5 t -129.23 125.65 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.643 -0.916 . . . . 0.0 110.106 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.5 t -112.45 81.0 1.4 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.567 HG13 ' HD2' ' A' ' 46' ' ' ARG . 11.1 tt -121.3 137.38 26.76 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.652 -0.655 . . . . 0.0 109.27 -178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 79' ' ' ILE . 50.9 Cg_exo -52.75 -41.74 67.66 Favored 'Trans proline' 0 N--CA 1.483 0.889 0 C-N-CA 122.785 2.324 . . . . 0.0 113.114 -178.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.478 ' HH ' ' HB3' ' A' ' 49' ' ' ALA . 5.9 p90 -93.6 147.91 22.57 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 120.626 -1.296 . . . . 0.0 110.824 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -84.1 152.91 24.05 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.598 -0.688 . . . . 0.0 109.503 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.501 HD12 ' N ' ' A' ' 83' ' ' ILE . 2.0 mp -85.38 93.74 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.487 -0.758 . . . . 0.0 109.951 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.9 p -170.89 -175.65 1.82 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.417 -0.802 . . . . 0.0 109.827 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.491 HG23 ' CD2' ' A' ' 63' ' ' LEU . 0.6 OUTLIER -62.88 -28.91 70.36 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.807 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 32.9 m -83.93 45.76 1.12 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.527 -0.733 . . . . 0.0 109.819 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.419 ' CB ' ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -77.01 139.0 39.94 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.341 -0.849 . . . . 0.0 109.977 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -95.4 134.63 37.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.449 -0.782 . . . . 0.0 109.872 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 94.5 m -143.47 53.57 1.33 Allowed 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.675 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 89.7 p -159.15 -48.48 0.06 Allowed 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.732 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.579 ' HB2' ' CZ ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -113.41 21.16 15.46 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.954 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.462 HG21 ' HD2' ' A' ' 81' ' ' TYR . 3.3 p -101.9 129.99 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-O 121.638 0.733 . . . . 0.0 109.794 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.61 ' HA ' ' CB ' ' A' ' 43' ' ' THR . 72.4 m-20 . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 116.506 -1.711 . . . . 0.0 108.969 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.803 HG21 ' HB3' ' A' ' 45' ' ' ASP . 3.5 tp . . . . . 0 N--CA 1.5 2.032 0 CA-C-O 121.757 0.789 . . . . 0.0 109.82 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.4 ' O ' ' HG3' ' A' ' 6' ' ' GLN . 46.1 t -115.81 169.54 9.14 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.244 -0.91 . . . . 0.0 109.994 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 26.5 t -62.33 -33.64 75.09 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.665 -0.814 . . . . 0.0 112.65 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -50.56 -51.09 33.92 Favored Glycine 0 N--CA 1.502 3.062 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -77.24 -36.05 54.94 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.279 -1.13 . . . . 0.0 110.308 -179.635 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.479 HG21 ' HA ' ' A' ' 49' ' ' ALA . 83.2 t -56.52 -46.66 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.74 -35.59 72.74 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.6 t -69.0 -21.86 64.12 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.272 -0.893 . . . . 0.0 109.825 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.28 -27.93 21.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.509 -0.744 . . . . 0.0 109.018 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.512 HD11 HG21 ' A' ' 83' ' ' ILE . 1.2 tp -79.5 -40.63 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.356 -0.84 . . . . 0.0 110.023 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.536 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -44.26 -51.46 19.23 Favored Pre-proline 0 N--CA 1.504 2.225 0 O-C-N 121.646 -0.659 . . . . 0.0 110.977 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 32.9 Cg_endo -65.79 -28.17 51.47 Favored 'Trans proline' 0 N--CA 1.483 0.911 0 C-N-CA 122.281 1.987 . . . . 0.0 110.592 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.841 ' SG ' HG21 ' A' ' 71' ' ' ILE . 1.3 m -101.28 16.79 24.39 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 177.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.787 HD13 HG13 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -65.79 -51.1 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.507 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.1 p -59.76 -57.79 11.38 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.324 -0.86 . . . . 0.0 109.302 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.716 ' CD1' HD11 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -55.3 -54.45 43.38 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.522 ' HB1' ' HB2' ' A' ' 68' ' ' ALA . . . -65.11 -25.37 67.74 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.416 -0.802 . . . . 0.0 110.003 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.474 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 10.5 ttp180 -79.02 -26.03 43.23 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.319 -0.863 . . . . 0.0 110.006 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 148.32 -12.95 1.23 Allowed Glycine 0 N--CA 1.5 2.916 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.9 mp0 -82.53 64.38 7.15 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.923 -1.34 . . . . 0.0 108.875 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.556 ' HA2' ' CD1' ' A' ' 17' ' ' TYR . . . -76.34 75.69 1.56 Allowed Glycine 0 N--CA 1.5 2.904 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.62 36.05 0.06 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.717 -0.873 . . . . 0.0 110.05 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 178.11 78.78 0.06 OUTLIER Glycine 0 N--CA 1.499 2.836 0 C-N-CA 120.075 -1.059 . . . . 0.0 110.51 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -59.91 131.88 41.94 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 122.17 1.913 . . . . 0.0 109.928 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.1 t -90.06 120.17 31.03 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.268 -0.895 . . . . 0.0 110.602 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.87 -45.2 74.56 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.38 -46.0 87.93 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.5 t -54.07 -42.28 69.11 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.301 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 80.4 m -61.76 -47.6 84.47 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.926 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.1 t -65.19 -40.55 94.38 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 124.259 0.974 . . . . 0.0 110.906 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.25 -57.07 12.43 Favored Glycine 0 N--CA 1.5 2.908 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.647 HG11 ' CB ' ' A' ' 72' ' ' PRO . 16.4 t -62.94 -46.54 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.488 -1.007 . . . . 0.0 109.442 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.576 ' N ' HG22 ' A' ' 77' ' ' VAL . 0.5 OUTLIER -54.54 -31.08 55.76 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.694 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.7 m -78.86 -44.09 23.62 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.536 HD23 ' HA ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -56.86 -43.7 81.45 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.632 -0.668 . . . . 0.0 109.995 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.636 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 51.3 t30 -74.72 -35.48 62.69 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.167 -0.958 . . . . 0.0 109.912 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -63.83 -37.72 88.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.039 -1.038 . . . . 0.0 108.395 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.29 -43.53 13.65 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.786 -0.571 . . . . 0.0 110.617 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.596 ' HB2' HG12 ' A' ' 2' ' ' ILE . . . -103.9 111.44 23.97 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.06 -1.025 . . . . 0.0 111.441 -178.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.636 ' HG3' ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -157.84 26.48 0.27 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.781 -0.575 . . . . 0.0 110.0 179.044 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.423 ' O ' ' HB ' ' A' ' 43' ' ' THR . 0.2 OUTLIER -127.64 34.7 4.62 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.127 -0.983 . . . . 0.0 109.624 -179.441 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.453 ' OG1' ' HA ' ' A' ' 93' ' ' ASN . 27.9 m 70.09 -66.08 0.29 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.562 -0.711 . . . . 0.0 109.924 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.91 -57.06 10.5 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.707 -0.62 . . . . 0.0 110.677 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.803 ' HB3' HG21 ' A' ' 2' ' ' ILE . 6.5 m-20 -67.2 -36.89 82.67 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.495 HH12 ' HB3' ' A' ' 81' ' ' TYR . 5.6 mmm180 -67.95 -39.45 83.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.629 -0.669 . . . . 0.0 109.684 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.444 ' HG2' ' NH1' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -58.82 -41.89 87.9 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.428 -0.795 . . . . 0.0 108.995 178.977 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.42 -46.49 86.34 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.577 ' HB2' HD11 ' A' ' 2' ' ' ILE . . . -64.14 -41.58 97.14 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 50.0 t -66.31 -35.83 81.39 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.613 -0.68 . . . . 0.0 110.569 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -66.54 -55.76 14.0 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 124.152 0.908 . . . . 0.0 109.813 176.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 42.1 t -61.63 -35.7 78.66 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.862 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.601 HD22 HG23 ' A' ' 83' ' ' ILE . 12.1 mt -61.15 -53.19 60.15 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 124.336 1.022 . . . . 0.0 109.011 176.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 43.8 tttp -55.82 -37.64 68.94 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.78 -29.77 69.05 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.532 -0.73 . . . . 0.0 110.817 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.513 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -94.96 -49.3 5.62 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.271 -0.893 . . . . 0.0 110.378 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.603 ' HA ' HD13 ' A' ' 63' ' ' LEU . . . -53.65 -49.59 67.59 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.36 -0.838 . . . . 0.0 109.522 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.46 67.05 1.02 Allowed 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 61' ' ' SER . . . 165.16 -22.87 0.14 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.787 HG13 HD13 ' A' ' 15' ' ' ILE . 24.7 t -64.52 69.85 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 121.29 -1.124 . . . . 0.0 109.942 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.456 ' CB ' ' HD2' ' A' ' 19' ' ' ARG . 43.3 m 54.38 -102.68 0.15 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.222 -0.924 . . . . 0.0 110.022 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -100.0 -29.11 6.99 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.603 HD13 ' HA ' ' A' ' 57' ' ' ALA . 21.7 tp 63.54 99.98 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.807 -0.82 . . . . 0.0 111.047 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -98.62 95.43 7.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.205 -0.934 . . . . 0.0 108.643 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -49.31 -50.44 39.38 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.734 -0.604 . . . . 0.0 111.042 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.07 -32.7 50.2 Favored Glycine 0 N--CA 1.505 3.261 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.441 ' O ' HG13 ' A' ' 71' ' ' ILE . 3.7 m-20 -82.87 -48.98 10.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.52 -0.988 . . . . 0.0 109.435 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.522 ' HB2' ' HB1' ' A' ' 18' ' ' ALA . . . -69.25 -21.42 63.91 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.687 -0.633 . . . . 0.0 111.408 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.441 ' HB2' ' HB ' ' A' ' 82' ' ' THR . . . -89.44 -41.35 12.13 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.011 -1.056 . . . . 0.0 110.253 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 76.6 p -68.99 -45.39 70.71 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.499 -0.751 . . . . 0.0 110.954 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.841 HG21 ' SG ' ' A' ' 14' ' ' CYS . 44.0 mt -47.95 -64.55 1.03 Allowed Pre-proline 0 N--CA 1.503 2.208 0 O-C-N 121.647 -0.658 . . . . 0.0 111.589 -178.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.647 ' CB ' HG11 ' A' ' 33' ' ' VAL . 28.4 Cg_endo -59.27 -48.87 12.28 Favored 'Trans proline' 0 N--CA 1.48 0.677 0 C-N-CA 121.745 1.63 . . . . 0.0 110.566 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.1 m -49.45 -68.96 0.13 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -33.59 75.62 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -47.78 -35.43 9.99 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.794 -0.566 . . . . 0.0 110.453 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 124.74 54.4 0.18 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.011 -2.036 . . . . 0.0 108.011 177.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.576 HG22 ' N ' ' A' ' 34' ' ' ARG . 85.2 t -111.09 -48.57 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.205 -178.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 77' ' ' VAL . 19.7 m 68.33 33.59 4.15 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.677 -0.639 . . . . 0.0 110.149 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.657 HG12 ' CD1' ' A' ' 81' ' ' TYR . 9.7 tt -95.78 121.35 61.44 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.059 -1.026 . . . . 0.0 109.06 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -65.31 56.6 0.31 Allowed 'Trans proline' 0 CA--C 1.55 1.294 0 C-N-CA 122.51 2.14 . . . . 0.0 112.711 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.657 ' CD1' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -178.54 152.31 0.64 Allowed 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.332 -0.855 . . . . 0.0 110.271 177.443 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.441 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 53.6 p -108.64 171.37 7.46 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.65 0.738 . . . . 0.0 110.592 -178.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.601 HG23 HD22 ' A' ' 53' ' ' LEU . 2.0 mp -104.44 67.12 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 122.012 0.911 . . . . 0.0 108.702 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.419 ' O ' ' CB ' ' A' ' 85' ' ' THR . 86.2 p -98.37 -18.39 18.33 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.494 -0.754 . . . . 0.0 110.627 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.419 ' CB ' ' O ' ' A' ' 84' ' ' SER . 0.5 OUTLIER 81.04 -16.44 0.65 Allowed 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.781 -0.574 . . . . 0.0 110.995 -179.282 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.9 m -76.17 -21.88 56.02 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.017 -1.052 . . . . 0.0 109.013 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -47.74 145.8 2.61 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.621 0.724 . . . . 0.0 111.1 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -88.93 -13.23 39.5 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.995 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 54.6 m 52.87 51.25 16.29 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.465 0.65 . . . . 0.0 111.291 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.96 -42.64 0.27 Allowed 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.552 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.8 31.74 4.83 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.3 p -109.48 118.84 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.768 -0.582 . . . . 0.0 109.462 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.453 ' HA ' ' OG1' ' A' ' 43' ' ' THR . 2.9 p-10 . . . . . 0 N--CA 1.497 1.912 0 CA-C-O 114.6 -2.619 . . . . 0.0 110.17 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.694 HG21 ' HA ' ' A' ' 45' ' ' ASP . 4.2 tp . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 121.899 0.857 . . . . 0.0 109.828 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.8 t -135.17 172.61 12.76 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.314 -0.867 . . . . 0.0 110.205 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.8 t -67.86 -20.78 65.17 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -56.7 -54.48 36.12 Favored Glycine 0 N--CA 1.504 3.176 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.441 ' NE2' ' HB3' ' A' ' 36' ' ' LEU . 8.4 tt0 -67.66 -40.65 84.48 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.456 -1.026 . . . . 0.0 108.516 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.442 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 77.5 t -53.78 -44.91 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.87 -35.95 75.09 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.7 t -69.39 -22.2 63.73 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.44 -0.788 . . . . 0.0 109.241 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.561 ' C ' ' HD2' ' A' ' 13' ' ' PRO . . . -98.05 -25.43 14.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.51 -0.744 . . . . 0.0 109.236 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.442 ' HB ' ' O ' ' A' ' 7' ' ' VAL . 1.8 tp -78.77 -42.31 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.218 -0.926 . . . . 0.0 110.072 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.638 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -46.43 -51.16 36.92 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.588 -0.695 . . . . 0.0 110.432 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.638 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 11.2 Cg_exo -67.26 -28.76 39.7 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.136 1.891 . . . . 0.0 110.992 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.659 ' SG ' HG21 ' A' ' 71' ' ' ILE . 1.3 m -103.07 14.38 31.99 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 178.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.461 ' O ' ' CB ' ' A' ' 19' ' ' ARG . 0.4 OUTLIER -74.16 -44.5 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -178.474 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.1 p -65.74 -56.84 9.89 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.718 ' CG ' HD11 ' A' ' 71' ' ' ILE . 0.5 OUTLIER -54.82 -55.35 31.12 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.579 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.495 ' HB1' ' HB2' ' A' ' 68' ' ' ALA . . . -60.01 -32.05 70.51 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.313 -0.867 . . . . 0.0 109.439 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.461 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 11.9 ttt180 -78.42 -5.89 53.69 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.647 -0.658 . . . . 0.0 110.623 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.56 -12.43 39.21 Favored Glycine 0 N--CA 1.501 3.025 0 O-C-N 120.666 -1.272 . . . . 0.0 111.412 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -105.06 81.38 1.72 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.136 -1.214 . . . . 0.0 109.333 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -146.44 -177.03 20.76 Favored Glycine 0 N--CA 1.499 2.838 0 C-N-CA 119.686 -1.245 . . . . 0.0 111.356 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -176.38 49.98 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.13 136.93 3.73 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 108.504 -1.839 . . . . 0.0 108.504 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.452 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . 30.4 Cg_endo -60.98 130.22 31.84 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 122.158 1.905 . . . . 0.0 111.136 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.1 t -74.04 123.81 25.07 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.507 -0.746 . . . . 0.0 109.718 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.51 -46.43 73.5 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.502 -0.749 . . . . 0.0 109.879 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.1 -48.3 86.57 Favored Glycine 0 N--CA 1.503 3.164 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.0 OUTLIER -58.74 -55.19 38.24 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.095 178.328 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 96.2 m -58.76 -27.17 64.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 124.027 0.829 . . . . 0.0 112.033 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.2 m -74.23 -47.7 33.6 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 123.825 0.703 . . . . 0.0 109.296 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.531 ' HA3' ' HB2' ' A' ' 10' ' ' ALA . . . -65.0 -28.26 73.29 Favored Glycine 0 N--CA 1.5 2.953 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.754 HG12 HG11 ' A' ' 77' ' ' VAL . 21.2 t -81.91 -48.22 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.269 -1.136 . . . . 0.0 108.762 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.494 ' HA ' HG22 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -61.9 -25.78 67.77 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.358 -0.839 . . . . 0.0 109.05 179.071 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.437 ' HB3' ' NH2' ' A' ' 34' ' ' ARG . 79.6 p -74.0 -46.38 44.03 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.673 HD23 ' HA ' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -63.24 -30.86 71.93 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.671 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.785 ' HB2' HG13 ' A' ' 77' ' ' VAL . 3.1 t-20 -63.39 -36.17 82.84 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.025 -1.047 . . . . 0.0 110.215 179.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -90.38 -36.33 14.68 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.463 -0.773 . . . . 0.0 110.099 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.26 -18.48 25.56 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.538 -0.727 . . . . 0.0 111.076 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.683 ' HA ' ' CB ' ' A' ' 45' ' ' ASP . . . -123.56 110.49 15.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.011 -1.055 . . . . 0.0 110.508 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -163.32 -20.19 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.411 -0.806 . . . . 0.0 112.081 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 44' ' ' ALA . 89.7 m -78.28 50.02 0.88 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.648 -1.283 . . . . 0.0 110.292 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.705 HG23 ' HA ' ' A' ' 93' ' ' ASN . 97.9 m 62.4 -64.6 0.09 Allowed 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.846 -0.534 . . . . 0.0 110.015 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 42' ' ' THR . . . -48.45 -57.29 6.32 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 122.067 -0.396 . . . . 0.0 110.419 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.694 ' HA ' HG21 ' A' ' 2' ' ' ILE . 3.1 m-20 -55.26 -45.45 76.09 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.575 HH11 ' HB2' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -57.51 -55.23 37.52 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.738 178.825 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -59.92 -44.14 94.48 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.15 -50.88 71.39 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.535 -0.728 . . . . 0.0 109.317 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.629 ' HB2' HD11 ' A' ' 2' ' ' ILE . . . -63.56 -55.27 25.11 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.515 ' HA ' ' HB2' ' A' ' 53' ' ' LEU . 3.7 t -48.63 -39.42 24.03 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 174.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.419 ' N ' ' SG ' ' A' ' 89' ' ' CYS . 2.8 t30 -60.35 -53.09 61.81 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 176.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.6 t -68.54 -32.26 72.07 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 119.766 -0.774 . . . . 0.0 111.598 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.563 HD22 HG12 ' A' ' 83' ' ' ILE . 13.6 mt -63.0 -57.56 10.29 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.072 178.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -54.73 -39.4 68.21 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -54.51 -50.75 67.1 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.538 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -72.03 -44.17 63.82 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.507 -0.746 . . . . 0.0 109.205 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.551 ' HA ' ' CD1' ' A' ' 63' ' ' LEU . . . -54.88 -37.79 66.73 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.629 -0.669 . . . . 0.0 110.297 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.445 ' HA ' HG23 ' A' ' 85' ' ' THR . . . -85.89 8.03 21.83 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.237 -0.914 . . . . 0.0 110.43 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -140.3 11.56 3.02 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 56' ' ' ALA . 3.8 t -79.04 -28.01 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.234 -1.157 . . . . 0.0 109.937 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 60' ' ' VAL . 0.6 OUTLIER 77.25 113.26 0.07 Allowed 'General case' 0 N--CA 1.506 2.369 0 CA-C-O 121.275 0.559 . . . . 0.0 109.946 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.48 34.22 87.1 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.551 ' CD1' ' HA ' ' A' ' 57' ' ' ALA . 10.0 tt -64.68 121.86 15.5 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.463 -1.022 . . . . 0.0 110.406 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -97.09 90.05 5.02 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -44.28 -48.47 9.5 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.912 -0.492 . . . . 0.0 110.494 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -50.68 -40.52 40.92 Favored Glycine 0 N--CA 1.502 3.07 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -76.46 -56.4 4.66 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.703 -0.88 . . . . 0.0 109.344 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.495 ' HB2' ' HB1' ' A' ' 18' ' ' ALA . . . -59.44 -24.7 63.74 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.906 -0.496 . . . . 0.0 111.769 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.01 -47.48 7.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.956 -1.09 . . . . 0.0 110.419 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 t -64.54 -31.27 72.42 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.445 -0.784 . . . . 0.0 111.056 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.718 HD11 ' CG ' ' A' ' 17' ' ' TYR . 78.0 mt -60.43 -70.38 0.44 Allowed Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 121.204 -0.935 . . . . 0.0 111.007 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.694 ' CB ' HG11 ' A' ' 33' ' ' VAL . 38.0 Cg_endo -60.07 -51.67 5.33 Favored 'Trans proline' 0 N--CA 1.484 0.944 0 C-N-CA 122.328 2.019 . . . . 0.0 112.077 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.2 p -51.45 -63.67 1.06 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.692 -0.63 . . . . 0.0 110.487 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.7 mmtt -63.11 -42.33 99.53 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 122.15 -0.343 . . . . 0.0 110.604 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 71' ' ' ILE . 0.4 OUTLIER -47.36 -55.22 9.27 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.506 -0.746 . . . . 0.0 112.12 -177.502 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 164.9 50.97 0.02 OUTLIER Glycine 0 N--CA 1.496 2.653 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.785 HG13 ' HB2' ' A' ' 37' ' ' ASN . 46.8 t -130.85 93.59 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.756 -0.85 . . . . 0.0 110.323 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 56.7 p -70.1 66.44 0.27 Allowed 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.6 0.714 . . . . 0.0 110.365 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.618 HG12 ' CE1' ' A' ' 81' ' ' TYR . 0.4 OUTLIER -124.94 120.36 25.49 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.173 -0.954 . . . . 0.0 108.79 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.91 -27.5 74.76 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 C-N-CA 122.955 2.436 . . . . 0.0 113.679 -177.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.618 ' CE1' HG12 ' A' ' 79' ' ' ILE . 12.9 p90 -89.59 130.12 35.94 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.794 -1.191 . . . . 0.0 111.063 -178.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.1 p -102.68 155.51 18.26 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.738 0.78 . . . . 0.0 110.655 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.607 HD12 ' N ' ' A' ' 83' ' ' ILE . 2.0 mp -86.92 85.21 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.412 ' O ' ' HB ' ' A' ' 85' ' ' THR . 59.5 p -114.39 13.79 17.8 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.526 -0.734 . . . . 0.0 111.866 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.445 HG23 ' HA ' ' A' ' 58' ' ' ALA . 86.0 m 68.78 -56.82 0.52 Allowed 'General case' 0 N--CA 1.51 2.567 0 O-C-N 121.211 -0.93 . . . . 0.0 108.86 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 84' ' ' SER . 42.0 m -68.43 -25.6 65.1 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.289 -0.882 . . . . 0.0 109.167 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 94.4 m -38.48 140.92 0.29 Allowed 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 121.362 0.601 . . . . 0.0 110.697 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -85.3 139.9 31.24 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.594 -0.691 . . . . 0.0 110.56 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 51' ' ' ASN . 0.5 OUTLIER -122.73 56.26 1.15 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.934 0.873 . . . . 0.0 110.61 176.448 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.1 m -151.34 -41.15 0.12 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.092 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.06 -1.09 37.8 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.264 -0.897 . . . . 0.0 110.311 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.9 t -73.26 136.51 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 O-C-N 121.049 -1.032 . . . . 0.0 109.714 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.705 ' HA ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 114.0 -2.905 . . . . 0.0 110.05 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.777 ' CD1' ' HB2' ' A' ' 49' ' ' ALA . 1.3 pp . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.429 ' O ' ' HG3' ' A' ' 6' ' ' GLN . 27.7 t -96.13 -167.73 1.63 Allowed 'General case' 0 N--CA 1.503 2.211 0 O-C-N 120.894 -1.129 . . . . 0.0 111.199 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 33.5 t -74.96 -29.05 60.81 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -54.5 -50.57 56.46 Favored Glycine 0 N--CA 1.504 3.226 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 177.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.468 ' CD ' ' HB2' ' A' ' 36' ' ' LEU . 0.5 OUTLIER -66.67 -34.93 78.95 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.486 -1.009 . . . . 0.0 109.415 179.111 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.507 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 61.6 t -59.05 -38.27 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 177.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.511 ' HA ' HG13 ' A' ' 11' ' ' ILE . . . -68.97 -34.84 75.97 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.56 -16.36 63.84 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.531 -0.731 . . . . 0.0 109.573 178.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.698 ' HB1' HG22 ' A' ' 33' ' ' VAL . . . -94.11 -31.84 14.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.505 -0.747 . . . . 0.0 110.145 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.532 HD12 ' N ' ' A' ' 12' ' ' ALA . 2.4 pp -95.18 -30.79 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.31 -0.869 . . . . 0.0 111.443 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.574 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -50.87 -52.84 53.69 Favored Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.133 -0.979 . . . . 0.0 110.449 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.574 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 71.5 Cg_endo -73.46 -10.05 23.48 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.405 2.07 . . . . 0.0 111.019 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.634 ' SG ' ' HB3' ' A' ' 25' ' ' PRO . 15.6 m -124.61 21.0 8.56 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.56 ' CD1' HG13 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -67.04 -50.69 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.548 -179.129 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.494 ' HA ' ' HB3' ' A' ' 19' ' ' ARG . 20.2 m -62.48 -46.91 86.34 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.278 -0.889 . . . . 0.0 110.091 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.608 ' CD2' HG12 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -59.31 -56.14 25.92 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.835 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.96 -28.21 64.13 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.494 ' HB3' ' HA ' ' A' ' 16' ' ' SER . 0.0 OUTLIER -75.09 -5.21 42.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.904 -0.497 . . . . 0.0 110.568 179.153 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.04 -5.73 27.2 Favored Glycine 0 N--CA 1.5 2.953 0 O-C-N 120.599 -1.313 . . . . 0.0 111.846 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.46 97.52 3.71 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 118.991 1.395 . . . . 0.0 110.091 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.449 ' HA3' ' CB ' ' A' ' 17' ' ' TYR . . . -153.54 -66.28 0.01 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.7 t 58.65 43.64 18.62 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.507 -0.996 . . . . 0.0 109.037 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 132.37 95.31 0.61 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 107.977 -2.049 . . . . 0.0 107.977 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.634 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 17.1 Cg_exo -59.95 -78.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 122.381 2.054 . . . . 0.0 111.089 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 25' ' ' PRO . 10.8 t 161.83 149.79 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.581 -0.7 . . . . 0.0 109.635 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.35 -36.69 78.6 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.93 -45.01 87.41 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.61 ' O ' HG23 ' A' ' 33' ' ' VAL . 35.3 t -64.63 -52.42 57.54 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.655 -1.218 . . . . 0.0 109.638 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 83.4 m -59.18 -46.94 87.08 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.5 m -68.89 -50.12 52.37 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 124.119 0.887 . . . . 0.0 110.468 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.55 -54.76 33.82 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.698 HG22 ' HB1' ' A' ' 10' ' ' ALA . 38.3 t -60.61 -47.27 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.972 -0.722 . . . . 0.0 109.241 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.549 ' O ' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -56.34 -31.2 63.51 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.41 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.1 m -80.23 -55.12 5.14 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.778 -0.576 . . . . 0.0 109.647 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.539 ' CG ' ' HA ' ' A' ' 33' ' ' VAL . 1.7 pp -58.37 -42.46 87.05 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.254 -0.904 . . . . 0.0 109.133 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.547 ' HB3' HG13 ' A' ' 77' ' ' VAL . 57.8 m-80 -70.92 -20.14 62.51 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.449 -0.782 . . . . 0.0 109.194 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.549 ' HB2' ' O ' ' A' ' 34' ' ' ARG . 52.1 t30 -67.69 -37.52 82.4 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.474 ' HB3' HG22 ' A' ' 2' ' ' ILE . . . -84.15 -24.87 30.02 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.96 -0.462 . . . . 0.0 110.89 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.577 ' N ' HG21 ' A' ' 2' ' ' ILE . . . -82.46 86.88 6.68 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.117 -0.99 . . . . 0.0 110.104 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.618 ' HA ' ' NE ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -152.55 38.19 0.54 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.121 -0.987 . . . . 0.0 110.314 -179.713 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.472 ' O ' ' N ' ' A' ' 44' ' ' ALA . 12.4 p -139.08 35.57 2.12 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 120.935 -1.103 . . . . 0.0 110.805 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.627 HG22 ' HB3' ' A' ' 93' ' ' ASN . 1.1 p 65.19 -60.92 0.24 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.424 -0.798 . . . . 0.0 109.6 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 42' ' ' THR . . . -58.72 -58.16 9.83 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.56 ' O ' HD11 ' A' ' 2' ' ' ILE . 21.8 m-20 -66.1 -45.21 82.01 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.835 0.826 . . . . 0.0 108.83 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.67 ' HG2' HG12 ' A' ' 92' ' ' VAL . 1.8 tpp180 -59.63 -57.63 12.1 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.752 -0.593 . . . . 0.0 110.95 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 -61.6 -38.69 88.54 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.282 -0.886 . . . . 0.0 109.986 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.13 -50.79 70.11 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.777 ' HB2' ' CD1' ' A' ' 2' ' ' ILE . . . -62.4 -46.68 87.49 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.489 ' C ' ' SG ' ' A' ' 89' ' ' CYS . 42.9 t -55.12 -42.19 72.66 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.998 -0.439 . . . . 0.0 111.05 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -67.69 -60.45 2.53 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 124.117 0.885 . . . . 0.0 110.206 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.507 ' SG ' ' HB ' ' A' ' 7' ' ' VAL . 10.8 t -55.36 -29.33 58.2 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.05 178.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.665 HD22 HG13 ' A' ' 83' ' ' ILE . 15.8 mt -70.44 -50.65 36.14 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.13 175.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.5 tttm -56.67 -41.03 76.56 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -56.34 -46.19 80.05 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.05 -41.01 62.42 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.558 -0.714 . . . . 0.0 109.238 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.618 ' HA ' HD13 ' A' ' 63' ' ' LEU . . . -52.92 -43.74 66.47 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.664 -0.647 . . . . 0.0 109.963 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -90.05 18.2 6.09 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.293 -0.879 . . . . 0.0 110.133 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -127.95 -31.48 0.69 Allowed Glycine 0 N--CA 1.501 2.969 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.56 HG13 ' CD1' ' A' ' 15' ' ' ILE . 7.6 t -52.87 135.34 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.54 -0.977 . . . . 0.0 110.272 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.7 t -64.12 107.68 1.35 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.596 -0.69 . . . . 0.0 109.191 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.93 50.09 43.47 Favored Glycine 0 N--CA 1.499 2.88 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.618 HD13 ' HA ' ' A' ' 57' ' ' ALA . 4.0 tp -61.41 126.31 26.89 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.369 -1.077 . . . . 0.0 110.372 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -103.48 93.48 4.97 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -41.49 -46.21 3.42 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.853 -0.53 . . . . 0.0 110.691 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.06 -31.34 48.27 Favored Glycine 0 N--CA 1.502 3.064 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.448 ' O ' HG13 ' A' ' 71' ' ' ILE . 95.4 m-20 -94.59 -49.5 5.61 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.464 -1.021 . . . . 0.0 109.257 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.444 ' HB1' ' CG2' ' A' ' 83' ' ' ILE . . . -57.88 -34.26 69.59 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.702 -0.624 . . . . 0.0 111.049 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.581 ' HA ' ' HB ' ' A' ' 82' ' ' THR . . . -83.79 -47.76 10.79 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.945 -1.097 . . . . 0.0 109.934 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.6 p -68.66 -36.78 78.99 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.537 -0.727 . . . . 0.0 110.984 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.608 HG12 ' CD2' ' A' ' 17' ' ' TYR . 22.4 mt -46.07 -62.44 1.84 Allowed Pre-proline 0 N--CA 1.504 2.271 0 O-C-N 121.436 -0.79 . . . . 0.0 110.584 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.499 ' HG3' HD13 ' A' ' 83' ' ' ILE . 37.9 Cg_endo -62.35 -52.62 2.45 Favored 'Trans proline' 0 C--N 1.321 -0.869 0 C-N-CA 121.907 1.738 . . . . 0.0 110.048 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.6 m -52.46 -60.81 2.78 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.518 -0.739 . . . . 0.0 110.183 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -61.41 -44.65 96.78 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 71' ' ' ILE . 0.9 OUTLIER -47.56 -32.78 5.74 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.554 -0.716 . . . . 0.0 111.264 178.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.54 ' O ' ' HD3' ' A' ' 34' ' ' ARG . . . 126.55 41.47 0.32 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 177.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.68 HG12 ' HB ' ' A' ' 79' ' ' ILE . 12.8 t -92.43 -32.95 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -1.121 . . . . 0.0 110.851 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.8 m 45.25 58.82 3.87 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.536 -0.728 . . . . 0.0 109.435 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.68 ' HB ' HG12 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -140.8 136.71 16.51 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.443 -0.786 . . . . 0.0 109.449 -178.683 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 79' ' ' ILE . 29.2 Cg_exo -58.76 -43.97 39.92 Favored 'Trans proline' 0 C--N 1.318 -1.054 0 C-N-CA 122.842 2.361 . . . . 0.0 112.184 -178.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.483 ' CD1' ' HG3' ' A' ' 46' ' ' ARG . 42.7 p90 -79.7 134.28 36.39 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 122.026 0.917 . . . . 0.0 109.988 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.581 ' HB ' ' HA ' ' A' ' 69' ' ' ALA . 32.4 p -123.21 -175.84 3.28 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.363 0.601 . . . . 0.0 109.916 -178.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.665 HG13 HD22 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -84.48 59.27 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 178.553 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.438 ' O ' ' HB ' ' A' ' 87' ' ' THR . 1.6 p -102.2 136.13 42.57 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.972 -177.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.9 p -61.66 -56.01 24.41 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.514 -0.741 . . . . 0.0 109.014 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 55.9 p -93.32 53.53 1.93 Allowed 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.491 ' CG2' ' SG ' ' A' ' 89' ' ' CYS . 2.4 t -75.7 -170.96 1.42 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.518 -0.739 . . . . 0.0 110.867 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.483 ' N ' HG23 ' A' ' 87' ' ' THR . 22.8 t70 -83.13 -71.74 0.48 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.305 -0.872 . . . . 0.0 109.99 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.491 ' SG ' ' CG2' ' A' ' 87' ' ' THR . 85.1 m 52.19 51.52 16.16 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.274 0.559 . . . . 0.0 112.228 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.2 t -170.12 -49.24 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.492 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -99.54 -22.2 15.58 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.527 -0.733 . . . . 0.0 110.865 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.67 HG12 ' HG2' ' A' ' 46' ' ' ARG . 21.5 t -59.09 138.32 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.001 -1.062 . . . . 0.0 110.065 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.627 ' HB3' HG22 ' A' ' 43' ' ' THR . 61.8 m-20 . . . . . 0 N--CA 1.496 1.852 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.86 HD11 ' HB2' ' A' ' 49' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 121.988 0.899 . . . . 0.0 109.272 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.0 t -146.97 171.22 15.58 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.224 -0.922 . . . . 0.0 110.846 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -56.4 -35.96 68.37 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -58.52 -42.11 95.79 Favored Glycine 0 N--CA 1.502 3.037 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 175.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.63 HE21 HD13 ' A' ' 36' ' ' LEU . 0.8 OUTLIER -79.83 -41.43 26.39 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.574 -0.956 . . . . 0.0 109.168 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 77.0 t -56.33 -42.44 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.442 ' O ' HD13 ' A' ' 11' ' ' ILE . . . -69.66 -36.27 75.9 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.2 t -69.35 -21.24 63.83 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.315 -0.866 . . . . 0.0 108.973 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.464 ' HB2' ' CD2' ' A' ' 36' ' ' LEU . . . -73.49 -52.26 14.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.437 -0.789 . . . . 0.0 110.651 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.443 HD13 ' N ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -80.54 -20.21 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 121.184 -0.948 . . . . 0.0 110.978 -178.879 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.565 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -45.5 -55.36 12.28 Favored Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 121.262 -0.899 . . . . 0.0 110.385 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.565 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 64.4 Cg_endo -70.49 -21.95 29.39 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.251 1.968 . . . . 0.0 110.994 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.544 ' SG ' ' CG2' ' A' ' 71' ' ' ILE . 1.1 m -111.73 27.99 9.16 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.509 HD11 HG13 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -63.24 -44.92 99.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 177.208 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.72 -53.83 50.72 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.392 -0.817 . . . . 0.0 108.807 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.591 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 0.5 OUTLIER -53.77 -60.66 3.02 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.662 -0.648 . . . . 0.0 109.566 178.929 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.642 ' N ' HD11 ' A' ' 71' ' ' ILE . . . -60.1 -31.92 70.49 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.612 -0.68 . . . . 0.0 111.084 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.464 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 9.5 tmm_? -83.84 18.49 1.99 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.453 -0.779 . . . . 0.0 111.602 -178.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.49 14.65 75.65 Favored Glycine 0 N--CA 1.503 3.137 0 O-C-N 120.541 -1.349 . . . . 0.0 112.032 178.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.591 ' O ' ' HA ' ' A' ' 17' ' ' TYR . 1.6 mm-40 -124.8 -176.7 3.61 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.113 -1.228 . . . . 0.0 109.92 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.08 -62.1 0.54 Allowed Glycine 0 N--CA 1.504 3.171 0 O-C-N 121.096 -1.003 . . . . 0.0 110.992 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 76.16 -51.82 0.61 Allowed 'General case' 0 N--CA 1.508 2.461 0 O-C-N 121.557 -0.967 . . . . 0.0 110.372 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.5 134.28 12.46 Favored Glycine 0 N--CA 1.501 2.974 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.43 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 27.6 Cg_endo -62.38 134.3 47.64 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 122.394 2.063 . . . . 0.0 111.017 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 t -79.93 134.56 36.28 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.299 -0.875 . . . . 0.0 109.407 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.28 -50.11 72.32 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.367 -0.833 . . . . 0.0 109.112 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.26 -46.17 94.76 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.496 ' O ' HG23 ' A' ' 33' ' ' VAL . 8.5 t -56.79 -39.68 74.54 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.994 178.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.43 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 82.0 m -71.22 -44.81 64.62 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.597 -175.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 46.7 t -65.65 -40.01 92.0 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 124.048 0.842 . . . . 0.0 109.916 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.76 -60.3 6.29 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.612 HG11 ' HB3' ' A' ' 72' ' ' PRO . 17.3 t -59.38 -47.85 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.581 -0.952 . . . . 0.0 110.946 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.629 ' HA ' HG22 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -57.94 -26.87 62.81 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.237 -0.914 . . . . 0.0 109.537 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.0 m -86.12 -51.07 6.54 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.394 -0.816 . . . . 0.0 109.697 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.63 HD13 HE21 ' A' ' 6' ' ' GLN . 2.7 pp -60.69 -49.2 78.47 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.676 -0.64 . . . . 0.0 110.51 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.595 ' N ' HD12 ' A' ' 36' ' ' LEU . 2.6 m-80 -66.83 -32.55 73.9 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.1 -1.0 . . . . 0.0 108.696 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.528 ' HA ' ' HD2' ' A' ' 41' ' ' ARG . 10.0 t30 -63.79 -38.96 93.07 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.48 -30.37 71.4 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.573 ' HB2' HD13 ' A' ' 2' ' ' ILE . . . -94.16 88.46 5.63 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.508 -0.745 . . . . 0.0 109.82 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.528 ' HD2' ' HA ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -143.1 20.49 1.93 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.937 -1.102 . . . . 0.0 111.922 -179.653 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.421 ' O ' ' HB ' ' A' ' 43' ' ' THR . 2.4 m -115.55 31.96 6.38 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.817 -1.177 . . . . 0.0 109.939 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.589 HG23 ' HA ' ' A' ' 93' ' ' ASN . 58.0 m 69.63 -61.54 0.44 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.456 -0.777 . . . . 0.0 109.297 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.24 -45.56 72.38 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.528 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 8.9 m-20 -73.44 -39.69 64.78 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.489 ' HG3' ' CE1' ' A' ' 81' ' ' TYR . 0.3 OUTLIER -65.14 -47.13 78.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.901 -0.499 . . . . 0.0 111.552 -178.886 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.402 ' NE ' ' O ' ' A' ' 90' ' ' SER . 51.9 mtt180 -65.49 -40.67 93.34 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.009 -1.057 . . . . 0.0 109.517 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.89 -43.19 99.36 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.86 ' HB2' HD11 ' A' ' 2' ' ' ILE 0.268 . . -65.15 -49.69 68.88 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.234 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.495 ' C ' ' SG ' ' A' ' 89' ' ' CYS . 50.2 t -55.26 -40.73 71.3 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.289 -0.882 . . . . 0.0 110.126 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.6 ' O ' ' HG3' ' A' ' 54' ' ' LYS . 1.8 t30 -62.69 -53.41 54.87 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 124.035 0.834 . . . . 0.0 110.481 177.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.9 t -72.2 -20.01 61.64 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.817 -1.153 . . . . 0.0 111.609 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.528 HD13 ' CG1' ' A' ' 83' ' ' ILE . 18.1 mt -68.85 -57.86 4.98 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 124.092 0.87 . . . . 0.0 109.012 175.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.6 ' HG3' ' O ' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -57.17 -28.79 63.11 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.899 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.63 -45.33 53.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.688 -0.632 . . . . 0.0 109.569 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.98 -49.84 47.6 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.418 -0.801 . . . . 0.0 109.75 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.419 ' O ' HD13 ' A' ' 63' ' ' LEU . . . -59.74 -62.23 2.03 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.439 -0.788 . . . . 0.0 109.334 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.634 ' HA ' HD13 ' A' ' 63' ' ' LEU . . . -70.75 77.28 0.61 Allowed 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.73 -16.21 0.94 Allowed Glycine 0 N--CA 1.497 2.749 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.509 HG13 HD11 ' A' ' 15' ' ' ILE . 0.9 OUTLIER -47.7 -58.58 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 CA-C-N 118.54 1.17 . . . . 0.0 110.477 -179.796 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.478 ' N ' HG12 ' A' ' 60' ' ' VAL . 1.5 m 162.79 -62.74 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.513 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -128.28 46.97 1.05 Allowed Glycine 0 N--CA 1.498 2.784 0 N-CA-C 107.462 -2.255 . . . . 0.0 107.462 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.634 HD13 ' HA ' ' A' ' 58' ' ' ALA . 2.5 pt? -50.54 129.48 22.36 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.883 0.849 . . . . 0.0 111.431 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.532 ' HB2' ' HB2' ' A' ' 67' ' ' ASN . 1.6 m-80 -109.27 103.14 12.04 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -36.06 -57.48 0.7 Allowed 'General case' 0 N--CA 1.506 2.349 0 O-C-N 122.028 -0.42 . . . . 0.0 111.775 -178.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.23 -52.41 44.34 Favored Glycine 0 N--CA 1.502 3.074 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.532 ' HB2' ' HB2' ' A' ' 64' ' ' ASN . 2.9 m120 -54.9 -45.39 74.71 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.669 -0.9 . . . . 0.0 110.626 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.536 ' O ' ' HD2' ' A' ' 72' ' ' PRO . . . -55.45 -55.42 31.97 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.783 -0.573 . . . . 0.0 110.252 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.705 ' HB1' HG22 ' A' ' 82' ' ' THR . . . -70.66 -36.98 73.65 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.476 -0.765 . . . . 0.0 110.784 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.5 t -62.12 -28.07 69.37 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.361 -0.837 . . . . 0.0 111.087 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.642 HD11 ' N ' ' A' ' 18' ' ' ALA . 38.4 mt -61.36 -69.67 0.55 Allowed Pre-proline 0 N--CA 1.502 2.15 0 O-C-N 121.243 -0.911 . . . . 0.0 111.442 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.612 ' HB3' HG11 ' A' ' 33' ' ' VAL . 19.5 Cg_endo -58.81 -50.27 9.54 Favored 'Trans proline' 0 N--CA 1.481 0.787 0 C-N-CA 122.141 1.894 . . . . 0.0 110.929 -178.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.0 m -48.51 -70.91 0.08 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 122.099 -0.376 . . . . 0.0 110.478 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.9 mtmm -60.33 -43.14 96.68 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-N 116.965 -0.107 . . . . 0.0 110.746 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 1.5 m -45.48 -35.98 4.17 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.823 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 34' ' ' ARG . . . 122.37 49.88 0.24 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 175.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.629 HG22 ' HA ' ' A' ' 34' ' ' ARG . 90.6 t -90.07 -27.66 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 C-N-CA 118.365 -1.334 . . . . 0.0 112.029 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 77' ' ' VAL . 24.9 p 65.47 16.75 10.67 Favored 'General case' 0 N--CA 1.51 2.56 0 O-C-N 121.103 -0.998 . . . . 0.0 110.564 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.563 ' HB ' HG12 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -89.06 124.75 64.26 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.008 -1.058 . . . . 0.0 108.504 179.341 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.456 ' HD2' ' NH1' ' A' ' 46' ' ' ARG . 37.7 Cg_endo -63.23 -35.86 60.72 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 122.519 2.146 . . . . 0.0 112.214 -178.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.489 ' CE1' ' HG3' ' A' ' 46' ' ' ARG . 17.9 p90 -82.65 142.15 31.93 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.098 -1.001 . . . . 0.0 110.515 -179.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.705 HG22 ' HB1' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -96.38 150.65 20.35 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.489 -0.757 . . . . 0.0 110.633 -178.911 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.528 ' CG1' HD13 ' A' ' 53' ' ' LEU . 4.4 mp -99.71 128.91 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.428 -0.795 . . . . 0.0 109.196 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 62.4 p -150.61 -85.3 0.08 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.236 -0.915 . . . . 0.0 110.379 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.8 p -152.62 -61.11 0.15 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.588 -0.695 . . . . 0.0 109.486 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.6 t -109.5 59.83 0.6 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.617 -0.677 . . . . 0.0 110.088 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.5 m -75.28 164.5 26.38 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.345 -0.847 . . . . 0.0 109.116 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -83.83 80.19 9.23 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.95 -1.094 . . . . 0.0 110.172 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.495 ' SG ' ' C ' ' A' ' 50' ' ' CYS . 14.9 m -82.55 53.31 2.3 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.119 176.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.402 ' O ' ' NE ' ' A' ' 47' ' ' ARG . 41.4 t -144.98 -50.66 0.26 Allowed 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.024 -177.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -99.5 -23.82 14.97 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.331 -0.855 . . . . 0.0 110.414 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.2 t -49.54 142.09 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 O-C-N 121.402 -0.811 . . . . 0.0 111.038 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.589 ' HA ' HG23 ' A' ' 43' ' ' THR . 33.4 m-80 . . . . . 0 N--CA 1.5 2.073 0 CA-C-O 117.039 -1.458 . . . . 0.0 109.134 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.625 HD11 ' HB2' ' A' ' 49' ' ' ALA . 3.0 tp . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 121.723 0.773 . . . . 0.0 109.569 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.6 p -125.95 177.75 6.15 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.156 -0.965 . . . . 0.0 110.198 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.539 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 70.5 m -56.97 -19.17 16.67 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 119.879 -0.728 . . . . 0.0 112.467 177.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.58 -43.44 99.28 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.532 ' HA ' ' HB2' ' A' ' 9' ' ' SER . 3.2 pp0? -85.68 -35.04 21.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.432 -1.04 . . . . 0.0 108.824 178.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.539 ' HB ' ' HA ' ' A' ' 4' ' ' CYS . 58.7 t -54.7 -43.22 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.401 ' HA ' HG13 ' A' ' 11' ' ' ILE . . . -75.09 -37.68 61.45 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.532 ' HB2' ' HA ' ' A' ' 6' ' ' GLN . 69.0 m -69.61 -21.09 63.61 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.221 -0.924 . . . . 0.0 109.806 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 6' ' ' GLN . . . -85.65 -30.29 23.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.428 -0.795 . . . . 0.0 109.629 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.497 HD12 ' N ' ' A' ' 12' ' ' ALA . 2.4 pp -96.57 -26.71 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.463 -0.773 . . . . 0.0 110.813 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.61 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -49.33 -53.45 39.66 Favored Pre-proline 0 N--CA 1.504 2.244 0 O-C-N 121.207 -0.933 . . . . 0.0 110.783 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.61 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 73.4 Cg_endo -72.78 -9.6 23.98 Favored 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 122.29 1.993 . . . . 0.0 110.969 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.7 m -117.41 6.33 12.62 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.525 ' O ' ' CB ' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -58.09 -50.43 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 118.109 0.413 . . . . 0.0 110.632 -178.606 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.414 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -61.2 -63.49 1.27 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.952 -1.092 . . . . 0.0 109.618 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.569 ' CD2' HG12 ' A' ' 71' ' ' ILE . 1.1 t80 -51.66 -58.8 5.33 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.644 -0.66 . . . . 0.0 109.922 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.577 ' HB1' ' HB2' ' A' ' 68' ' ' ALA . . . -57.22 -29.25 63.59 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.603 -0.686 . . . . 0.0 110.556 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.525 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 9.1 tmm_? -89.93 8.67 31.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.368 -0.833 . . . . 0.0 110.944 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.28 1.1 44.32 Favored Glycine 0 N--CA 1.503 3.123 0 O-C-N 120.714 -1.241 . . . . 0.0 111.922 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -117.59 72.12 0.83 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.014 -1.286 . . . . 0.0 110.115 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.72 174.61 45.82 Favored Glycine 0 N--CA 1.498 2.793 0 C-N-CA 120.197 -1.001 . . . . 0.0 110.826 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.9 p -151.23 -60.8 0.18 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -97.83 126.77 8.99 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.714 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . 37.1 Cg_endo -62.49 125.45 16.23 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 C-N-CA 122.393 2.062 . . . . 0.0 111.008 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.3 t -76.57 159.89 29.92 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.418 -0.801 . . . . 0.0 110.99 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.57 -41.44 76.92 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.644 -0.66 . . . . 0.0 110.552 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.62 -48.46 77.35 Favored Glycine 0 N--CA 1.503 3.127 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.55 ' SG ' ' CG2' ' A' ' 71' ' ' ILE . 42.4 t -58.3 -43.0 87.88 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.661 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.661 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 88.2 m -73.69 -35.18 65.15 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.154 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 61.9 m -71.81 -40.7 68.99 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 124.533 1.146 . . . . 0.0 109.725 175.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.33 -51.75 57.29 Favored Glycine 0 N--CA 1.5 2.953 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.75 HG11 ' CB ' ' A' ' 72' ' ' PRO . 47.4 t -69.3 -45.69 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.441 -1.035 . . . . 0.0 109.125 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.592 ' HA ' ' CG1' ' A' ' 77' ' ' VAL . 2.4 tpt180 -54.15 -28.42 39.89 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.4 m -73.76 -44.0 57.38 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.613 ' C ' HD12 ' A' ' 36' ' ' LEU . 0.5 OUTLIER -61.32 -33.94 74.43 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.409 -0.807 . . . . 0.0 109.771 179.338 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.538 ' HB2' HG12 ' A' ' 77' ' ' VAL . 0.6 OUTLIER -59.69 -32.68 70.72 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.299 -0.876 . . . . 0.0 110.015 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -88.71 -33.51 17.5 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.526 -0.734 . . . . 0.0 109.415 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.11 -32.29 22.87 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.506 -0.746 . . . . 0.0 110.878 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.586 ' HA ' ' CB ' ' A' ' 45' ' ' ASP . . . -111.47 101.52 9.94 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.169 -0.957 . . . . 0.0 110.474 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.541 ' CZ ' ' HB3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -161.06 20.27 0.12 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.402 -0.811 . . . . 0.0 111.692 179.59 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 44' ' ' ALA . 5.8 m -116.87 35.31 4.67 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.848 -1.158 . . . . 0.0 109.384 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 44.6 m 67.95 -59.82 0.42 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.595 -0.691 . . . . 0.0 109.649 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 42' ' ' THR . . . -57.35 -54.63 44.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.551 -0.718 . . . . 0.0 109.179 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.586 ' CB ' ' HA ' ' A' ' 40' ' ' ALA . 8.3 m-20 -55.61 -44.04 76.65 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.707 0.765 . . . . 0.0 109.199 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.502 ' NH1' HG13 ' A' ' 79' ' ' ILE . 0.5 OUTLIER -67.39 -47.12 71.25 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.978 -178.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -60.84 -48.58 81.16 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.5 -48.72 80.53 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.777 -0.577 . . . . 0.0 109.498 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.625 ' HB2' HD11 ' A' ' 2' ' ' ILE . . . -57.16 -46.37 82.8 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.476 ' SG ' HG22 ' A' ' 87' ' ' THR . 0.1 OUTLIER -63.86 -38.81 92.48 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.112 -0.368 . . . . 0.0 110.872 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.44 ' N ' ' SG ' ' A' ' 89' ' ' CYS . 2.2 t30 -60.01 -57.38 13.1 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 123.869 0.731 . . . . 0.0 109.701 176.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.459 ' HB3' HG21 ' A' ' 7' ' ' VAL . 12.9 t -66.76 -31.08 71.49 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.357 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.615 HD22 HG23 ' A' ' 83' ' ' ILE . 15.1 mt -64.01 -44.47 92.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 123.902 0.751 . . . . 0.0 109.446 175.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -58.54 -41.18 84.98 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -64.18 -54.01 40.35 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.528 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -58.74 -43.39 90.2 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.643 -0.661 . . . . 0.0 109.608 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.545 ' HA ' HD13 ' A' ' 63' ' ' LEU . . . -60.55 -51.9 67.44 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.87 64.86 1.33 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 61' ' ' SER . . . 167.88 -22.48 0.1 Allowed Glycine 0 N--CA 1.499 2.879 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.202 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.607 ' O ' HG12 ' A' ' 60' ' ' VAL . 6.5 t -64.9 62.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 CA-C-N 118.699 1.25 . . . . 0.0 110.595 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 59' ' ' GLY . 67.9 m 36.02 57.32 0.99 Allowed 'General case' 0 N--CA 1.507 2.409 0 O-C-N 121.309 -0.869 . . . . 0.0 111.888 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.76 57.81 3.69 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.545 HD13 ' HA ' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -56.94 132.04 51.51 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.677 -0.896 . . . . 0.0 110.463 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -96.7 89.78 5.06 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -39.54 -45.87 1.65 Allowed 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.907 -0.495 . . . . 0.0 111.021 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -51.7 -38.16 43.93 Favored Glycine 0 N--CA 1.503 3.136 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -83.7 -55.5 4.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.635 -0.921 . . . . 0.0 108.913 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.611 ' HB1' ' O ' ' A' ' 83' ' ' ILE . . . -55.72 -25.21 39.16 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.826 -0.546 . . . . 0.0 111.932 -178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.25 -49.27 6.82 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.949 -1.094 . . . . 0.0 109.818 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.04 -32.37 72.68 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.47 -0.769 . . . . 0.0 110.409 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.569 HG12 ' CD2' ' A' ' 17' ' ' TYR . 30.8 mt -52.07 -61.51 4.32 Favored Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 121.643 -0.66 . . . . 0.0 110.528 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.75 ' CB ' HG11 ' A' ' 33' ' ' VAL . 38.4 Cg_endo -61.88 -57.08 0.58 Allowed 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 122.028 1.819 . . . . 0.0 110.465 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.9 t -44.35 -63.64 0.84 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 120.681 0.277 . . . . 0.0 110.38 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -63.61 -39.1 93.52 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 122.034 -0.416 . . . . 0.0 109.982 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.714 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 0.8 OUTLIER -48.01 -35.04 10.28 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.823 -0.751 . . . . 0.0 112.092 -178.817 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.484 ' O ' ' HD2' ' A' ' 34' ' ' ARG . . . 137.7 44.53 0.08 OUTLIER Glycine 0 N--CA 1.496 2.659 0 C-N-CA 119.243 -1.456 . . . . 0.0 111.339 176.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.702 HG11 HG12 ' A' ' 33' ' ' VAL . 16.1 m -135.34 129.76 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 120.828 -1.395 . . . . 0.0 111.021 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.1 p -99.97 78.38 2.1 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.678 HD11 ' CE2' ' A' ' 81' ' ' TYR . 11.0 tt -132.38 128.41 21.14 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.514 -0.741 . . . . 0.0 109.723 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 79' ' ' ILE . 52.6 Cg_exo -54.77 -45.33 41.76 Favored 'Trans proline' 0 N--CA 1.484 0.936 0 C-N-CA 123.28 2.653 . . . . 0.0 112.736 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.678 ' CE2' HD11 ' A' ' 79' ' ' ILE . 26.5 p90 -81.7 143.28 31.98 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.938 -1.101 . . . . 0.0 109.911 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 69.5 p -98.67 166.49 11.3 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.908 0.861 . . . . 0.0 110.692 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.615 HG23 HD22 ' A' ' 53' ' ' LEU . 1.5 mp -90.16 63.81 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 82.4 p -161.49 170.34 20.13 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.022 -1.049 . . . . 0.0 110.701 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.5 p -60.71 -30.0 69.69 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.575 -0.703 . . . . 0.0 109.748 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.0 t -82.49 79.74 8.84 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.476 HG22 ' SG ' ' A' ' 50' ' ' CYS . 0.6 OUTLIER -162.63 149.15 12.87 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.842 -179.37 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -91.77 154.65 18.79 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 122.18 0.991 . . . . 0.0 112.329 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 51' ' ' ASN . 1.2 m -137.03 53.4 1.89 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.142 176.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 95.8 p -159.3 -51.42 0.06 Allowed 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.355 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.0 mmm-85 -97.1 -6.78 34.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.223 -0.923 . . . . 0.0 109.245 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.1 t -70.48 119.73 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.391 -0.818 . . . . 0.0 109.231 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.531 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 1.7 p30 . . . . . 0 N--CA 1.497 1.915 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.46 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.799 HD11 ' HB2' ' A' ' 36' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.0 t -118.19 167.19 11.73 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.305 -0.872 . . . . 0.0 111.504 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -63.94 -35.98 82.44 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -56.39 -51.49 55.88 Favored Glycine 0 N--CA 1.503 3.122 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 177.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.418 ' OE1' HD13 ' A' ' 2' ' ' ILE . 0.5 OUTLIER -67.23 -41.87 84.95 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.455 -1.026 . . . . 0.0 109.087 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.8 t -54.8 -46.14 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.36 -36.38 74.15 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.3 t -68.83 -20.53 64.3 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.318 -0.864 . . . . 0.0 110.099 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.39 -41.65 9.29 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.316 -0.865 . . . . 0.0 109.862 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.5 pp -79.98 -33.79 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.214 -0.929 . . . . 0.0 111.099 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.55 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -46.95 -51.76 37.69 Favored Pre-proline 0 N--CA 1.504 2.229 0 O-C-N 121.213 -0.929 . . . . 0.0 110.417 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 33.5 Cg_endo -65.89 -15.65 49.74 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.163 1.909 . . . . 0.0 110.831 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.664 ' SG ' HG21 ' A' ' 71' ' ' ILE . 1.3 m -114.14 18.94 16.8 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 176.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.422 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -62.72 -49.58 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-N 118.16 0.437 . . . . 0.0 110.473 178.047 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.4 p -68.88 -49.27 59.66 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.429 -0.794 . . . . 0.0 109.323 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.697 ' CG ' HD11 ' A' ' 71' ' ' ILE . 0.4 OUTLIER -55.42 -54.3 45.46 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.084 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.597 ' HB1' ' HB2' ' A' ' 68' ' ' ALA . . . -60.69 -27.99 68.28 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.422 ' HB3' ' O ' ' A' ' 15' ' ' ILE . 1.3 tpt180 -82.46 -13.24 57.06 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.864 -0.522 . . . . 0.0 109.953 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.24 14.3 42.36 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -118.16 78.18 1.23 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.251 -1.146 . . . . 0.0 109.527 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 177.15 -151.68 11.33 Favored Glycine 0 N--CA 1.5 2.918 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.6 p -168.88 -58.71 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.632 -0.923 . . . . 0.0 109.511 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.74 145.98 17.95 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.64 152.09 82.74 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 C-N-CA 122.536 2.158 . . . . 0.0 110.356 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.4 p -102.18 146.79 27.46 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.311 -0.868 . . . . 0.0 110.431 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.95 -47.08 71.67 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.793 -0.567 . . . . 0.0 110.848 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.79 -41.31 95.92 Favored Glycine 0 N--CA 1.502 3.037 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.401 ' HA ' ' HG2' ' A' ' 13' ' ' PRO . 42.1 t -61.64 -55.98 24.8 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.405 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -62.6 -39.59 94.25 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.735 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.426 ' HA ' ' HG2' ' A' ' 34' ' ' ARG . 48.7 m -67.18 -50.76 59.83 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 123.932 0.77 . . . . 0.0 110.24 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.43 -47.33 91.67 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.668 ' HA ' HD23 ' A' ' 36' ' ' LEU . 59.2 t -67.86 -53.07 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.773 -0.839 . . . . 0.0 110.891 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 76' ' ' GLY . 0.4 OUTLIER -56.04 -21.19 20.26 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.175 -0.953 . . . . 0.0 110.295 -179.569 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.8 p -81.32 -43.8 18.57 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.402 -0.811 . . . . 0.0 109.523 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.799 ' HB2' HD11 ' A' ' 2' ' ' ILE . 0.6 OUTLIER -55.85 -36.01 67.07 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.891 -0.506 . . . . 0.0 110.646 -179.411 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 76' ' ' GLY . 31.9 t30 -56.44 -49.55 74.24 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.323 -0.861 . . . . 0.0 109.821 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -81.36 -29.39 34.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.604 -0.685 . . . . 0.0 109.776 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.456 ' HB3' ' HA ' ' A' ' 36' ' ' LEU . . . -65.2 -26.9 68.34 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.697 -0.627 . . . . 0.0 110.451 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.78 ' HB2' HG12 ' A' ' 2' ' ' ILE . . . -139.92 -110.79 0.15 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.091 -1.005 . . . . 0.0 111.109 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.484 ' HA ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER 64.5 32.23 11.87 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.403 -0.811 . . . . 0.0 111.082 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.514 ' O ' ' HB ' ' A' ' 43' ' ' THR . 14.9 t -128.57 17.54 6.39 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 120.829 -1.169 . . . . 0.0 111.382 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.661 ' HA ' ' C ' ' A' ' 93' ' ' ASN . 86.5 m 84.8 -67.76 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.696 -0.627 . . . . 0.0 109.799 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.49 -61.43 2.02 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.302 -0.874 . . . . 0.0 109.708 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.505 ' HB3' ' CB ' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -70.28 -36.55 74.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.682 -0.636 . . . . 0.0 109.367 179.321 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.484 ' HD3' ' HA ' ' A' ' 41' ' ' ARG . 5.8 mtm180 -59.28 -53.12 61.89 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.436 -0.79 . . . . 0.0 110.249 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.5 ' NH1' ' HA ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -54.12 -47.48 71.81 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.473 -0.767 . . . . 0.0 109.337 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 51' ' ' ASN . . . -58.91 -41.38 87.08 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.598 ' HB2' HG21 ' A' ' 2' ' ' ILE . . . -58.28 -48.32 80.83 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.498 ' C ' ' SG ' ' A' ' 89' ' ' CYS . 0.8 OUTLIER -55.4 -33.66 63.7 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.498 178.566 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.444 ' N ' ' SG ' ' A' ' 89' ' ' CYS . 1.3 t30 -65.56 -61.98 1.78 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.035 0.445 . . . . 0.0 110.056 177.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.6 t -63.49 -33.58 75.88 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.253 -0.979 . . . . 0.0 111.342 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.564 HD22 HG23 ' A' ' 83' ' ' ILE . 20.8 mt -68.4 -57.82 5.29 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.373 178.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 24.6 tttp -57.9 -36.2 72.1 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.465 -0.772 . . . . 0.0 109.354 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.84 -39.05 87.63 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.474 -0.766 . . . . 0.0 110.606 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.476 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -94.39 -53.43 3.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.235 -0.916 . . . . 0.0 110.009 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.722 ' HB1' ' HA ' ' A' ' 84' ' ' SER . . . -60.09 -53.74 54.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.484 -0.76 . . . . 0.0 109.702 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 54' ' ' LYS . . . -80.79 63.18 5.1 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.52 -32.43 0.06 OUTLIER Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 56' ' ' ALA . 24.4 t -47.23 148.67 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 121.68 -0.894 . . . . 0.0 110.199 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.8 m -64.29 90.85 0.07 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.576 -0.702 . . . . 0.0 110.123 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.99 64.89 1.69 Allowed Glycine 0 N--CA 1.499 2.854 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.62 ' C ' HD13 ' A' ' 63' ' ' LEU . 3.0 tm? -74.68 118.73 17.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.667 -0.902 . . . . 0.0 109.791 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -94.52 85.36 4.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.891 . . . . 0.0 108.726 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.522 ' HA ' ' HB2' ' A' ' 84' ' ' SER . . . -48.31 -37.95 17.74 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.858 -0.526 . . . . 0.0 110.719 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -53.97 -38.71 60.97 Favored Glycine 0 N--CA 1.502 3.099 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -89.7 -45.38 9.36 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.478 -1.013 . . . . 0.0 109.961 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.597 ' HB2' ' HB1' ' A' ' 18' ' ' ALA . . . -71.74 -20.34 61.91 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.594 -0.691 . . . . 0.0 111.946 -178.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.23 -40.95 10.16 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.867 -1.146 . . . . 0.0 110.244 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 92.5 p -71.17 -43.27 67.8 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.57 -0.706 . . . . 0.0 110.847 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.697 HD11 ' CG ' ' A' ' 17' ' ' TYR . 87.0 mt -50.63 -64.59 1.23 Allowed Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.485 -0.76 . . . . 0.0 110.89 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.612 ' HG3' ' HB ' ' A' ' 83' ' ' ILE . 30.7 Cg_endo -59.74 -52.52 4.37 Favored 'Trans proline' 0 C--N 1.326 -0.636 0 C-N-CA 121.868 1.712 . . . . 0.0 110.773 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.2 t -38.5 -68.07 0.18 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 122.271 -0.268 . . . . 0.0 110.62 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.4 pttt -70.38 -32.45 70.11 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.551 -0.718 . . . . 0.0 109.888 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 72' ' ' PRO . 1.1 m -49.72 -47.57 50.49 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.27 -0.893 . . . . 0.0 111.985 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 37' ' ' ASN . . . 169.03 47.03 0.03 OUTLIER Glycine 0 N--CA 1.5 2.927 0 C-N-CA 118.365 -1.874 . . . . 0.0 111.527 175.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.473 HG12 ' HB2' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -150.65 91.04 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.191 -1.182 . . . . 0.0 110.353 179.323 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.6 t -80.18 77.78 6.89 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.538 HD12 ' CZ ' ' A' ' 81' ' ' TYR . 3.3 pt -130.98 135.68 27.71 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.6 -0.687 . . . . 0.0 110.306 -178.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.475 ' HD2' ' NH1' ' A' ' 46' ' ' ARG . 77.4 Cg_exo -49.19 -43.2 37.86 Favored 'Trans proline' 0 N--CA 1.483 0.908 0 C-N-CA 122.682 2.255 . . . . 0.0 111.533 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.699 ' HB3' HG21 ' A' ' 92' ' ' VAL . 1.5 p90 -81.03 143.98 32.11 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.06 -1.025 . . . . 0.0 109.41 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.7 p -100.4 165.75 11.3 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.213 -0.929 . . . . 0.0 109.849 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.612 ' HB ' ' HG3' ' A' ' 72' ' ' PRO . 1.5 mp -89.93 62.91 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.722 ' HA ' ' HB1' ' A' ' 57' ' ' ALA . 80.5 p -158.68 -106.68 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.362 -0.836 . . . . 0.0 109.808 -178.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.5 p -122.4 -24.71 4.94 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.96 -1.088 . . . . 0.0 109.792 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.2 p -74.12 64.24 1.04 Allowed 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.526 HG23 ' HB2' ' A' ' 81' ' ' TYR . 13.1 m -162.43 128.71 3.53 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -125.73 138.46 53.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.244 -0.91 . . . . 0.0 110.762 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.5 ' HA ' ' NH1' ' A' ' 47' ' ' ARG . 89.4 m -90.9 57.89 3.65 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.267 -0.973 . . . . 0.0 111.473 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.3 t -155.42 -42.34 0.08 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.865 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.8 mtm-85 -99.68 -37.01 9.29 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.28 -0.888 . . . . 0.0 110.332 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.699 HG21 ' HB3' ' A' ' 81' ' ' TYR . 1.2 t -60.69 158.74 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 121.451 -0.78 . . . . 0.0 111.254 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.661 ' C ' ' HA ' ' A' ' 43' ' ' THR . 58.9 m-80 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 176.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.813 HG13 ' HB2' ' A' ' 49' ' ' ALA . 10.4 tp . . . . . 0 N--CA 1.503 2.194 0 CA-C-O 121.803 0.811 . . . . 0.0 111.714 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.4 t -123.16 -74.88 0.6 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.134 -0.979 . . . . 0.0 109.931 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.7 t -151.51 -46.31 0.11 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -53.47 -44.11 66.84 Favored Glycine 0 N--CA 1.506 3.302 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 177.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.52 -41.99 23.26 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.304 -1.115 . . . . 0.0 108.452 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 91.5 t -54.1 -44.13 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.511 ' HA ' HG13 ' A' ' 11' ' ' ILE . . . -69.12 -34.82 75.65 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.8 m -71.37 -20.12 62.19 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.513 -0.742 . . . . 0.0 109.608 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.57 -35.45 10.61 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.275 -0.89 . . . . 0.0 109.923 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.511 HG13 ' HA ' ' A' ' 8' ' ' ALA . 2.6 pp -79.94 -33.61 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.254 -0.904 . . . . 0.0 110.54 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.55 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -47.85 -51.67 45.05 Favored Pre-proline 0 N--CA 1.503 2.187 0 O-C-N 121.28 -0.888 . . . . 0.0 110.206 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 31.0 Cg_endo -65.21 -12.22 33.77 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.238 1.959 . . . . 0.0 110.938 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.567 ' HB3' HD13 ' A' ' 71' ' ' ILE . 2.7 m -121.85 17.33 11.01 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 176.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.487 HD11 HG13 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -62.73 -50.1 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 121.381 -0.128 . . . . 0.0 110.802 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 21' ' ' GLN . 18.7 m -57.46 -46.84 83.19 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.338 -0.851 . . . . 0.0 109.33 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.538 ' CD2' HG12 ' A' ' 71' ' ' ILE . 0.9 OUTLIER -61.26 -62.0 2.15 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.787 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.591 ' N ' HD11 ' A' ' 71' ' ' ILE . . . -55.78 -35.46 66.28 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.153 -0.967 . . . . 0.0 110.436 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -73.85 -1.69 20.54 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.587 -0.696 . . . . 0.0 111.3 -179.151 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.88 21.24 47.39 Favored Glycine 0 N--CA 1.501 3.009 0 O-C-N 120.678 -1.264 . . . . 0.0 110.902 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.42 ' O ' ' HB3' ' A' ' 16' ' ' SER . 34.3 mm-40 -140.41 50.01 1.7 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.201 -1.176 . . . . 0.0 109.612 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -150.38 -64.75 0.01 OUTLIER Glycine 0 N--CA 1.501 2.975 0 O-C-N 121.019 -1.051 . . . . 0.0 110.833 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 71.8 -58.02 0.6 Allowed 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.642 -0.916 . . . . 0.0 109.485 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.59 112.06 3.64 Favored Glycine 0 N--CA 1.498 2.779 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.75 173.63 12.36 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 122.611 2.207 . . . . 0.0 110.751 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.1 p -110.25 134.93 51.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.57 -0.706 . . . . 0.0 109.362 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -45.99 -54.77 7.8 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.776 -0.578 . . . . 0.0 110.887 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.97 -39.43 89.29 Favored Glycine 0 N--CA 1.503 3.103 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.403 ' O ' HG23 ' A' ' 33' ' ' VAL . 44.1 t -63.55 -49.48 73.31 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 118.764 -1.174 . . . . 0.0 109.828 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.471 ' HA ' ' HB3' ' A' ' 75' ' ' CYS . 68.2 m -69.07 -42.99 75.47 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.483 -176.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.544 ' HA ' ' HG2' ' A' ' 34' ' ' ARG . 72.5 p -68.31 -47.26 68.03 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 124.355 1.034 . . . . 0.0 110.012 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -53.91 -55.19 27.01 Favored Glycine 0 N--CA 1.498 2.782 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.6 HG12 HG21 ' A' ' 77' ' ' VAL . 17.4 t -63.81 -44.59 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.486 -1.008 . . . . 0.0 110.257 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.648 ' HA ' HG22 ' A' ' 77' ' ' VAL . 7.8 ptm180 -57.71 -22.61 47.38 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.111 -0.993 . . . . 0.0 109.694 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.1 t -92.65 -55.14 3.49 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.3 -0.875 . . . . 0.0 109.461 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.592 ' HG ' ' HA ' ' A' ' 33' ' ' VAL . 3.5 pp -58.25 -28.43 64.89 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.497 -0.752 . . . . 0.0 110.89 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.599 ' CB ' HG13 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -64.85 -42.69 94.69 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.945 -1.097 . . . . 0.0 108.719 179.523 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -63.5 -29.2 70.51 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.93 8.83 35.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.679 -0.638 . . . . 0.0 110.102 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.677 ' HB1' HG21 ' A' ' 2' ' ' ILE . . . -166.91 51.5 0.07 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.763 -1.21 . . . . 0.0 111.454 -179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.652 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 2.3 mpt_? -135.27 44.7 2.55 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.527 -0.733 . . . . 0.0 109.596 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.7 m -95.38 -45.96 6.91 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.344 -0.847 . . . . 0.0 109.278 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.4 m 160.52 -51.48 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.453 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.73 -45.81 84.91 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 177.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.756 ' HB3' HG21 ' A' ' 2' ' ' ILE . 3.1 m-20 -63.69 -50.93 67.27 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.575 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.505 ' HD3' ' HG3' ' A' ' 41' ' ' ARG . 8.9 mtm180 -59.94 -39.07 84.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.738 -0.601 . . . . 0.0 109.792 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.54 ' HG2' ' NH1' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -62.2 -44.45 96.56 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.227 -0.92 . . . . 0.0 108.957 179.165 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.427 ' O ' ' HB3' ' A' ' 51' ' ' ASN . . . -66.55 -46.62 75.5 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.813 ' HB2' HG13 ' A' ' 2' ' ' ILE 0.252 . . -61.45 -55.36 32.18 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.865 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.54 ' HA ' ' HB2' ' A' ' 53' ' ' LEU . 12.0 t -48.23 -36.86 14.69 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 174.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.427 ' HB3' ' O ' ' A' ' 48' ' ' ALA . 1.7 t30 -58.55 -56.33 23.48 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 42.3 t -70.06 -31.12 68.57 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 118.388 -1.325 . . . . 0.0 111.621 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.84 HD22 HG23 ' A' ' 83' ' ' ILE . 75.5 mt -58.83 -48.61 80.72 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 124.101 0.876 . . . . 0.0 109.598 176.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.599 ' HD3' ' SG ' ' A' ' 89' ' ' CYS . 7.5 mtpp -61.12 -38.25 85.67 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -65.71 -47.49 75.2 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.822 -0.548 . . . . 0.0 109.706 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -71.79 -44.75 63.46 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.416 -0.803 . . . . 0.0 109.977 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.53 -55.36 29.94 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.74 62.56 1.08 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.392 -0.818 . . . . 0.0 108.912 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 61' ' ' SER . . . -179.75 -28.91 0.05 OUTLIER Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.619 ' O ' HG12 ' A' ' 60' ' ' VAL . 74.5 t -65.92 53.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.507 0 O-C-N 121.254 -1.145 . . . . 0.0 110.992 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 59' ' ' GLY . 56.5 p 49.12 -138.11 0.92 Allowed 'General case' 0 N--CA 1.504 2.244 0 O-C-N 120.6 -1.312 . . . . 0.0 110.093 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.96 71.65 2.82 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 108.496 -1.842 . . . . 0.0 108.496 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 1.8 pp -63.13 158.96 18.47 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 122.01 -0.7 . . . . 0.0 110.582 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -106.62 107.87 19.09 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.36 -55.22 4.21 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.743 -0.598 . . . . 0.0 110.152 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -57.69 -41.9 94.02 Favored Glycine 0 N--CA 1.498 2.799 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.473 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 3.2 m120 -60.31 -57.5 12.51 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.313 -1.11 . . . . 0.0 109.309 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.518 ' O ' ' HD2' ' A' ' 72' ' ' PRO . . . -58.71 -41.19 85.75 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.788 -0.57 . . . . 0.0 110.173 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.666 ' HB2' ' HB ' ' A' ' 82' ' ' THR . . . -71.64 -46.01 60.33 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.313 -0.867 . . . . 0.0 110.235 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.424 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 94.1 p -61.16 -36.25 79.31 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.623 -0.673 . . . . 0.0 110.802 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.591 HD11 ' N ' ' A' ' 18' ' ' ALA . 18.7 mt -47.83 -74.23 0.08 OUTLIER Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 121.611 -0.681 . . . . 0.0 111.364 -178.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.838 ' HB2' HD11 ' A' ' 79' ' ' ILE . 28.6 Cg_endo -58.82 -49.75 10.78 Favored 'Trans proline' 0 N--CA 1.481 0.779 0 C-N-CA 121.681 1.587 . . . . 0.0 111.499 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.4 p -51.66 -68.71 0.15 Allowed 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.525 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 70' ' ' SER . 7.4 pttt -64.25 -37.95 89.29 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.621 -0.674 . . . . 0.0 110.973 -179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.471 ' HB3' ' HA ' ' A' ' 30' ' ' CYS . 1.7 m -47.11 -35.54 7.22 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.325 -0.859 . . . . 0.0 111.888 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.79 40.84 0.16 Allowed Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 177.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.648 HG22 ' HA ' ' A' ' 34' ' ' ARG . 4.0 t -131.16 106.89 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.521 -0.988 . . . . 0.0 109.313 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.53 73.4 0.75 Allowed 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.691 0.758 . . . . 0.0 109.716 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.838 HD11 ' HB2' ' A' ' 72' ' ' PRO . 0.8 OUTLIER -121.66 109.49 34.31 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.296 -0.877 . . . . 0.0 109.319 179.735 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.14 -23.58 45.45 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 123.105 2.537 . . . . 0.0 112.618 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.685 ' HE1' HD12 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -82.43 171.13 14.51 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.378 -0.826 . . . . 0.0 109.922 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.666 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 51.9 p -122.81 164.67 17.94 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.118 -0.989 . . . . 0.0 110.137 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.84 HG23 HD22 ' A' ' 53' ' ' LEU . 5.3 mm -93.24 40.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.88 162.41 15.85 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.384 0.611 . . . . 0.0 110.032 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 68.6 p -62.03 -33.17 73.88 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.5 p -70.22 64.95 0.26 Allowed 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.648 0.737 . . . . 0.0 109.439 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.6 m -168.08 155.22 8.01 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.345 -0.847 . . . . 0.0 109.0 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -132.95 152.91 51.86 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.002 -1.061 . . . . 0.0 111.285 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.599 ' SG ' ' HD3' ' A' ' 54' ' ' LYS . 4.2 m -94.82 60.89 2.52 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.409 178.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 37.2 p -135.62 -51.5 0.74 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.551 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -98.78 5.91 47.22 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.647 -0.658 . . . . 0.0 110.792 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 94.3 t -82.84 106.33 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 120.997 -1.064 . . . . 0.0 108.785 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.8 m120 . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 117.053 -1.451 . . . . 0.0 109.32 -179.752 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.535 HG12 ' HB2' ' A' ' 40' ' ' ALA . 5.1 tp . . . . . 0 N--CA 1.509 2.48 0 CA-C-O 121.666 0.745 . . . . 0.0 111.37 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 5' ' ' GLY . 23.4 t -124.08 66.9 1.05 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.023 -1.048 . . . . 0.0 109.485 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.0 t 62.8 -56.29 0.16 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 3' ' ' SER . . . -49.6 -43.91 37.3 Favored Glycine 0 N--CA 1.506 3.312 0 CA-C-N 119.458 1.026 . . . . 0.0 110.556 177.057 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.493 ' HA ' ' HB2' ' A' ' 9' ' ' SER . 0.0 OUTLIER -78.99 -39.73 33.43 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.414 -1.051 . . . . 0.0 108.856 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 56.6 t -55.24 -46.6 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.64 -31.31 65.01 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.493 ' HB2' ' HA ' ' A' ' 6' ' ' GLN . 58.6 m -68.35 -22.12 64.69 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.132 -0.98 . . . . 0.0 109.463 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.77 -29.71 14.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.515 -0.741 . . . . 0.0 109.071 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 tp -82.83 -41.0 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.514 -0.741 . . . . 0.0 110.527 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.535 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -42.42 -52.06 10.64 Favored Pre-proline 0 N--CA 1.504 2.268 0 O-C-N 121.757 -0.589 . . . . 0.0 111.399 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 36.9 Cg_endo -64.23 -23.76 66.01 Favored 'Trans proline' 0 N--CA 1.484 0.923 0 C-N-CA 121.977 1.785 . . . . 0.0 110.386 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.584 ' SG ' HG21 ' A' ' 71' ' ' ILE . 1.4 m -109.36 19.37 19.43 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 176.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 16' ' ' SER . 0.4 OUTLIER -66.07 -50.24 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.86 177.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.426 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 51.4 p -55.73 -50.94 69.0 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.39 -0.818 . . . . 0.0 108.875 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.505 ' CG ' HD11 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -57.29 -57.76 11.19 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.393 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.76 -5.99 18.92 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.58 -0.7 . . . . 0.0 110.172 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.8 ttt-85 -100.05 -18.01 17.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.406 -0.809 . . . . 0.0 109.999 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 133.8 -20.82 4.04 Favored Glycine 0 N--CA 1.503 3.108 0 O-C-N 120.859 -1.151 . . . . 0.0 111.577 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -123.01 92.46 3.71 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.03 -1.277 . . . . 0.0 110.463 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.457 ' HA3' ' HA ' ' A' ' 17' ' ' TYR . . . -156.12 -60.18 0.01 OUTLIER Glycine 0 N--CA 1.504 3.176 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.3 p 73.91 -62.65 0.46 Allowed 'General case' 0 N--CA 1.507 2.409 0 O-C-N 122.061 -0.67 . . . . 0.0 111.278 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -114.82 139.44 15.59 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 110.476 -1.049 . . . . 0.0 110.476 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.01 173.14 9.77 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 122.552 2.168 . . . . 0.0 110.911 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 69.3 p -124.48 149.6 46.66 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.303 -0.873 . . . . 0.0 110.321 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.38 -45.62 69.32 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.608 -0.683 . . . . 0.0 110.115 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.16 -39.06 97.16 Favored Glycine 0 N--CA 1.5 2.931 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 40.2 t -66.43 -45.57 79.41 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 119.016 -1.074 . . . . 0.0 110.589 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 88.7 m -71.36 -38.49 71.57 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.343 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.6 p -68.7 -39.81 80.32 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 124.166 0.916 . . . . 0.0 109.668 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.41 -52.98 38.78 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.677 HG11 ' CB ' ' A' ' 72' ' ' PRO . 43.2 t -62.5 -44.88 99.73 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.367 -1.079 . . . . 0.0 109.134 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.627 ' HA ' ' CG1' ' A' ' 77' ' ' VAL . 6.4 tpm_? -54.78 -32.39 60.01 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.5 m -75.17 -45.89 37.77 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.57 HD23 ' HA ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -62.99 -39.68 95.48 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.482 -0.761 . . . . 0.0 110.062 179.602 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.403 ' HB2' ' CG1' ' A' ' 77' ' ' VAL . 53.4 t30 -60.42 -42.35 95.86 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.326 -0.859 . . . . 0.0 109.684 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -64.1 -44.39 92.42 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.513 -0.742 . . . . 0.0 109.004 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.459 ' HB3' ' HB ' ' A' ' 2' ' ' ILE . . . -75.94 -50.3 15.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.777 -0.577 . . . . 0.0 110.349 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.535 ' HB2' HG12 ' A' ' 2' ' ' ILE . . . -74.35 59.43 0.79 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.058 -1.026 . . . . 0.0 109.792 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.62 ' HA ' ' HD3' ' A' ' 46' ' ' ARG . 7.0 mtt-85 -147.94 18.48 1.12 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.036 -1.04 . . . . 0.0 111.082 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.534 ' O ' ' HB ' ' A' ' 43' ' ' THR . 9.9 t -111.26 28.14 9.01 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.116 -0.99 . . . . 0.0 109.652 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.684 HG23 ' HB3' ' A' ' 93' ' ' ASN . 46.3 m 70.95 -61.77 0.47 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.76 -0.588 . . . . 0.0 110.127 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.48 -60.12 3.61 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.786 -0.571 . . . . 0.0 111.118 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -72.54 -28.93 63.15 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.586 -0.696 . . . . 0.0 110.775 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.62 ' HD3' ' HA ' ' A' ' 41' ' ' ARG . 7.6 mmm-85 -53.13 -51.75 60.93 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.396 -0.815 . . . . 0.0 109.47 179.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.574 ' HD2' ' HB2' ' A' ' 93' ' ' ASN . 1.0 OUTLIER -62.12 -51.62 67.17 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.411 -0.805 . . . . 0.0 110.361 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.83 -44.74 90.95 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.63 -0.669 . . . . 0.0 109.733 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.52 -47.67 85.14 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.435 ' C ' ' SG ' ' A' ' 89' ' ' CYS . 37.9 t -59.37 -38.48 80.59 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.018 177.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.456 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 1.9 t30 -64.46 -54.16 36.85 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 123.772 0.67 . . . . 0.0 109.596 176.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.437 ' HA ' ' ND2' ' A' ' 55' ' ' ASN . 39.3 t -63.65 -31.04 72.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.896 -1.127 . . . . 0.0 110.566 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.618 HD13 HG12 ' A' ' 83' ' ' ILE . 26.3 mt -63.67 -46.56 85.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 124.365 1.041 . . . . 0.0 109.008 175.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.456 ' HE2' ' O ' ' A' ' 51' ' ' ASN . 12.5 ttpt -55.04 -49.93 70.36 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.437 ' ND2' ' HA ' ' A' ' 52' ' ' CYS . 1.3 p30 -65.66 -33.61 76.3 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.247 -0.908 . . . . 0.0 109.489 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.45 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -66.92 -56.78 8.75 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.327 -0.858 . . . . 0.0 108.743 178.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.422 ' HB1' ' O ' ' A' ' 84' ' ' SER . . . -60.62 -56.9 15.74 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.572 -0.705 . . . . 0.0 109.167 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.9 66.45 1.15 Allowed 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.17 -28.05 0.1 OUTLIER Glycine 0 N--CA 1.501 3.014 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -178.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 56' ' ' ALA . 2.8 t -46.92 -21.92 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.736 -0.861 . . . . 0.0 111.06 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 60' ' ' VAL . 47.6 m 74.8 83.45 0.1 Allowed 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.82 36.82 7.61 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.566 HD13 ' O ' ' A' ' 84' ' ' SER . 3.7 pp -56.02 138.87 48.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.661 -0.905 . . . . 0.0 110.22 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -109.25 88.27 2.69 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -48.28 -41.8 28.93 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.654 -0.654 . . . . 0.0 109.983 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -52.3 -47.23 56.47 Favored Glycine 0 N--CA 1.501 2.999 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 30.7 m-20 -82.14 -50.2 9.3 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.568 -0.96 . . . . 0.0 109.262 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.422 ' O ' ' CD ' ' A' ' 72' ' ' PRO . . . -51.2 -43.0 61.27 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.996 -0.44 . . . . 0.0 111.987 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.75 -45.95 19.98 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.141 -0.975 . . . . 0.0 110.217 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.4 m -61.92 -43.47 98.78 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.618 -0.676 . . . . 0.0 110.619 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.584 HG21 ' SG ' ' A' ' 14' ' ' CYS . 44.0 mt -42.58 -64.3 0.74 Allowed Pre-proline 0 N--CA 1.504 2.273 0 O-C-N 121.864 -0.522 . . . . 0.0 111.109 -179.044 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.677 ' CB ' HG11 ' A' ' 33' ' ' VAL . 46.0 Cg_endo -62.69 -60.33 0.19 Allowed 'Trans proline' 0 C--N 1.322 -0.816 0 C-N-CA 122.124 1.882 . . . . 0.0 110.682 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.4 m -45.2 -61.22 1.74 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.942 -0.474 . . . . 0.0 109.919 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.87 -39.98 95.46 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 1.2 m -50.11 -34.66 22.75 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.826 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.465 ' O ' ' HD2' ' A' ' 34' ' ' ARG . . . 135.36 46.62 0.09 OUTLIER Glycine 0 N--CA 1.494 2.553 0 C-N-CA 119.584 -1.293 . . . . 0.0 111.344 175.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.64 HG11 HG12 ' A' ' 33' ' ' VAL . 16.4 m -135.57 126.47 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 CA-C-N 118.776 1.288 . . . . 0.0 111.084 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.3 p -99.92 70.96 1.63 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.366 0.603 . . . . 0.0 109.707 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.476 HD12 ' HD2' ' A' ' 80' ' ' PRO . 2.7 tp -92.97 138.24 23.41 Favored Pre-proline 0 N--CA 1.505 2.31 0 O-C-N 121.213 -0.929 . . . . 0.0 109.456 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.476 ' HD2' HD12 ' A' ' 79' ' ' ILE . 23.9 Cg_endo -59.49 -44.81 29.85 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 122.38 2.053 . . . . 0.0 111.555 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.454 ' HD2' HG11 ' A' ' 92' ' ' VAL . 22.3 p90 -94.6 135.98 35.43 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.014 -1.054 . . . . 0.0 110.906 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.1 m -91.91 163.12 14.14 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.618 HG12 HD13 ' A' ' 53' ' ' LEU . 4.5 mp -121.27 118.18 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.819 -1.175 . . . . 0.0 110.99 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.566 ' O ' HD13 ' A' ' 63' ' ' LEU . 2.5 t -123.47 -72.19 0.69 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.204 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.513 HG23 HD21 ' A' ' 63' ' ' LEU . 98.2 m -133.13 -69.32 0.56 Allowed 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.8 m -113.43 -24.46 9.29 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.492 HG22 ' N ' ' A' ' 88' ' ' ASP . 54.6 m 54.63 -100.18 0.1 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.801 -0.562 . . . . 0.0 110.806 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.492 ' N ' HG22 ' A' ' 87' ' ' THR . 20.7 t0 -157.97 -70.74 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.272 -0.893 . . . . 0.0 110.062 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.435 ' SG ' ' C ' ' A' ' 50' ' ' CYS . 14.0 m 58.92 50.99 7.74 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 121.339 0.59 . . . . 0.0 111.645 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.2 t -161.37 -38.15 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.282 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.443 ' HG3' HH11 ' A' ' 91' ' ' ARG . 0.1 OUTLIER -94.16 9.26 38.57 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.684 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.454 HG11 ' HD2' ' A' ' 81' ' ' TYR . 10.9 t -109.0 139.49 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.684 ' HB3' HG23 ' A' ' 43' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.499 2.007 0 O-C-N 121.556 -0.715 . . . . 0.0 109.635 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.67 HD13 ' HB2' ' A' ' 36' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.502 2.148 0 CA-C-O 121.716 0.77 . . . . 0.0 109.167 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.6 t -152.06 82.35 1.26 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.675 -1.265 . . . . 0.0 111.168 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.469 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 2.6 t 66.43 -59.85 0.34 Allowed 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 177.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -46.01 -58.51 5.57 Favored Glycine 0 N--CA 1.506 3.366 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 178.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -78.49 -34.11 47.72 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.54 -0.976 . . . . 0.0 108.93 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.494 HG13 ' CD2' ' A' ' 53' ' ' LEU . 8.3 t -53.39 -39.93 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.448 ' HA ' ' CD1' ' A' ' 11' ' ' ILE . . . -68.81 -35.23 76.75 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.1 p -71.75 -21.37 61.75 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.431 -0.793 . . . . 0.0 109.778 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.1 -46.74 13.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.525 -0.734 . . . . 0.0 110.429 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.448 ' CD1' ' HA ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -79.96 -25.63 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 O-C-N 121.09 -1.006 . . . . 0.0 110.984 -178.956 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.601 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -47.45 -55.02 17.98 Favored Pre-proline 0 N--CA 1.502 2.15 0 O-C-N 121.132 -0.98 . . . . 0.0 110.1 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.601 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 57.8 Cg_endo -70.9 -26.71 21.89 Favored 'Trans proline' 0 C--N 1.322 -0.84 0 C-N-CA 122.106 1.871 . . . . 0.0 110.555 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.643 ' SG ' HG21 ' A' ' 71' ' ' ILE . 1.1 m -97.4 15.46 22.99 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.744 -0.783 . . . . 0.0 112.442 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.484 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 0.4 OUTLIER -63.19 -45.03 99.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.712 179.082 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.404 ' OG ' ' N ' ' A' ' 17' ' ' TYR . 39.1 p -65.26 -59.29 4.22 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.343 -0.848 . . . . 0.0 109.549 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.404 ' N ' ' OG ' ' A' ' 16' ' ' SER . 1.5 t80 -53.82 -56.08 20.78 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.76 -33.38 68.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.577 -0.702 . . . . 0.0 110.036 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.484 ' HB3' ' O ' ' A' ' 15' ' ' ILE . 24.2 ttm180 -76.7 -32.39 57.83 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.562 -0.711 . . . . 0.0 109.838 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.24 -20.81 3.16 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -85.48 77.24 9.93 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.305 -1.115 . . . . 0.0 109.352 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.7 -158.08 28.77 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.15 -43.74 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.676 -0.896 . . . . 0.0 109.089 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -102.14 141.24 15.2 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.706 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 27.0 Cg_endo -61.03 127.98 23.92 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 121.945 1.763 . . . . 0.0 110.894 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.7 t -62.33 142.16 57.93 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.704 -0.622 . . . . 0.0 110.134 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.52 -61.04 2.57 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.608 -0.682 . . . . 0.0 109.805 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.57 -41.06 80.62 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.527 ' SG ' ' CG2' ' A' ' 71' ' ' ILE . 42.8 t -57.56 -49.36 76.62 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.859 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.706 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 24.9 m -60.5 -34.8 74.59 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 120.674 0.273 . . . . 0.0 110.687 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.9 t -68.75 -50.86 47.13 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.102 175.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.59 -38.26 95.55 Favored Glycine 0 N--CA 1.501 3.013 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.739 HG11 ' HA ' ' A' ' 72' ' ' PRO . 12.8 t -83.57 -52.68 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.403 -1.057 . . . . 0.0 110.707 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.572 ' HA ' ' CG1' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -57.77 -18.23 20.37 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.472 -0.768 . . . . 0.0 110.861 -179.685 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 89.9 p -94.97 -40.69 9.54 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.223 -0.923 . . . . 0.0 109.278 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.67 ' HB2' HD13 ' A' ' 2' ' ' ILE . 0.8 OUTLIER -54.15 -35.89 62.74 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.052 -1.03 . . . . 0.0 109.675 179.265 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.33 -19.2 64.41 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.44 -0.788 . . . . 0.0 109.668 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -87.44 -27.62 22.6 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.46 -30.3 18.4 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.652 -0.655 . . . . 0.0 110.385 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.527 ' HB2' HG12 ' A' ' 2' ' ' ILE . . . -84.41 -148.27 0.1 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.299 -0.876 . . . . 0.0 110.744 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 69.43 23.15 6.19 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.25 -0.906 . . . . 0.0 111.055 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.497 ' O ' ' HB ' ' A' ' 43' ' ' THR . 6.3 t -123.77 15.44 9.41 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.998 -1.064 . . . . 0.0 110.533 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.618 HG23 ' HB3' ' A' ' 93' ' ' ASN . 85.4 m 76.7 -66.94 0.23 Allowed 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.22 -0.925 . . . . 0.0 109.973 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.99 -58.51 6.29 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.213 0.53 . . . . 0.0 110.509 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.596 ' HB3' HG23 ' A' ' 2' ' ' ILE . 24.8 m-20 -70.77 -33.01 70.33 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.453 -0.779 . . . . 0.0 109.184 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.599 ' HG3' ' CE1' ' A' ' 81' ' ' TYR . 0.2 OUTLIER -56.32 -54.8 41.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.543 -0.723 . . . . 0.0 109.858 179.621 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -68.26 -43.0 78.76 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.492 -0.755 . . . . 0.0 109.574 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.36 -48.41 74.29 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.469 ' HB2' HG13 ' A' ' 2' ' ' ILE . . . -66.23 -49.4 67.35 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.476 ' SG ' ' O ' ' A' ' 88' ' ' ASP . 1.6 t -56.53 -41.14 76.26 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -57.61 -58.3 8.94 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 124.231 0.957 . . . . 0.0 110.285 177.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 48.6 t -67.91 -34.35 76.45 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 118.724 -1.19 . . . . 0.0 111.749 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.618 HD22 HD12 ' A' ' 83' ' ' ILE . 15.3 mt -59.22 -41.46 88.71 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.525 175.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.456 ' HB2' ' HE3' ' A' ' 54' ' ' LYS . 18.7 ttmt -64.63 -38.58 91.49 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -54.85 -36.27 64.88 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.43 -55.84 4.76 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.628 ' HB2' HG22 ' A' ' 83' ' ' ILE . . . -56.26 -36.02 68.09 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.309 -0.869 . . . . 0.0 110.814 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.509 ' HA ' HG23 ' A' ' 85' ' ' THR . . . -93.04 17.02 11.46 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.34 -0.85 . . . . 0.0 110.856 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -143.68 -25.63 0.15 Allowed Glycine 0 N--CA 1.507 3.374 0 O-C-N 121.061 -1.024 . . . . 0.0 111.631 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.8 t -55.53 123.91 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.199 -1.177 . . . . 0.0 110.46 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.8 t -64.67 114.61 4.54 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.563 -0.711 . . . . 0.0 109.611 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 63' ' ' LEU . . . 103.1 -49.94 0.93 Allowed Glycine 0 N--CA 1.499 2.849 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.486 ' C ' HD13 ' A' ' 63' ' ' LEU . 3.4 tm? 19.86 100.65 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.764 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -97.32 87.52 4.17 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -38.61 -45.85 1.13 Allowed 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.605 -0.684 . . . . 0.0 111.192 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.41 -35.36 55.91 Favored Glycine 0 N--CA 1.504 3.19 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -89.57 -46.58 8.56 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.776 -0.838 . . . . 0.0 109.063 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.504 ' HB1' ' HB ' ' A' ' 83' ' ' ILE . . . -51.24 -49.85 60.32 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.95 -0.469 . . . . 0.0 110.347 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.77 -26.8 60.83 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.333 -0.855 . . . . 0.0 109.835 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.9 m -68.83 -36.89 78.74 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.379 -0.825 . . . . 0.0 110.698 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.643 HG21 ' SG ' ' A' ' 14' ' ' CYS . 10.6 mt -53.45 -61.93 4.34 Favored Pre-proline 0 N--CA 1.5 2.034 0 O-C-N 121.675 -0.641 . . . . 0.0 110.465 -179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.739 ' HA ' HG11 ' A' ' 33' ' ' VAL . 28.3 Cg_endo -61.26 -60.96 0.19 Allowed 'Trans proline' 0 C--N 1.323 -0.785 0 C-N-CA 121.794 1.663 . . . . 0.0 111.032 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 77.7 p -46.77 -64.09 0.86 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.966 -0.459 . . . . 0.0 111.057 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -62.67 -44.69 95.62 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 119.571 -0.252 . . . . 0.0 111.346 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.621 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 1.6 m -46.88 -43.99 19.26 Favored 'General case' 0 N--CA 1.506 2.335 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.673 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 146.86 50.44 0.03 OUTLIER Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.186 -1.483 . . . . 0.0 111.52 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.667 HG22 ' O ' ' A' ' 72' ' ' PRO . 32.9 m -135.07 136.46 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-N 119.243 1.521 . . . . 0.0 111.064 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.3 p -106.82 62.65 0.63 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.505 HG12 ' CE1' ' A' ' 81' ' ' TYR . 3.2 tp -116.64 126.24 27.7 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.426 -0.796 . . . . 0.0 109.354 -179.067 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 79' ' ' ILE . 18.4 Cg_endo -57.97 -38.11 93.41 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 C-N-CA 122.662 2.241 . . . . 0.0 112.083 -178.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.75 ' HB3' HG21 ' A' ' 92' ' ' VAL . 14.0 p90 -90.27 113.99 25.93 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.879 -1.138 . . . . 0.0 109.941 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.663 ' C ' HD13 ' A' ' 83' ' ' ILE . 81.9 p -113.71 -135.55 0.36 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.532 -0.73 . . . . 0.0 109.119 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.663 HD13 ' C ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -123.51 51.59 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.111 -0.993 . . . . 0.0 108.648 -179.53 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.412 ' O ' ' HB ' ' A' ' 85' ' ' THR . 41.7 p -89.45 9.83 24.96 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.858 -0.526 . . . . 0.0 111.794 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.509 HG23 ' HA ' ' A' ' 58' ' ' ALA . 63.5 m 72.07 -59.89 0.54 Allowed 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.285 -0.884 . . . . 0.0 110.104 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.7 p -73.14 -58.08 3.56 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.1 m 31.58 -144.63 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.941 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.996 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.476 ' O ' ' SG ' ' A' ' 50' ' ' CYS . 31.6 t70 -155.51 142.55 19.16 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.609 -1.307 . . . . 0.0 110.58 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.2 m -137.06 54.69 1.85 Allowed 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.964 0.888 . . . . 0.0 110.421 176.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.0 t -164.08 -51.52 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.58 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.455 ' HG2' ' NH1' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -99.27 26.06 6.32 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.476 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.75 HG21 ' HB3' ' A' ' 81' ' ' TYR . 5.0 p -110.32 15.75 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.82 -0.55 . . . . 0.0 110.842 -178.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.618 ' HB3' HG23 ' A' ' 43' ' ' THR . 1.9 p-10 . . . . . 0 N--CA 1.505 2.291 0 CA-C-O 115.308 -2.282 . . . . 0.0 111.078 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.607 HD13 ' HB2' ' A' ' 40' ' ' ALA . 2.9 tp . . . . . 0 N--CA 1.509 2.479 0 CA-C-O 121.735 0.778 . . . . 0.0 111.74 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.7 t -95.72 152.9 18.05 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.996 -1.065 . . . . 0.0 110.279 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.482 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 13.0 t -53.63 -27.69 28.49 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 115.407 -0.815 . . . . 0.0 113.113 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.34 -55.85 27.79 Favored Glycine 0 N--CA 1.502 3.034 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 176.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.539 ' HG3' ' N ' ' A' ' 7' ' ' VAL . 5.6 pt20 -71.39 -34.99 70.9 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.209 -1.171 . . . . 0.0 109.442 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.617 HG13 ' HG ' ' A' ' 53' ' ' LEU . 37.6 t -56.62 -49.16 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.525 ' HA ' ' CD1' ' A' ' 11' ' ' ILE . . . -70.09 -34.29 72.95 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 t -73.03 -22.26 60.67 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.116 -0.99 . . . . 0.0 110.149 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.21 -43.73 23.27 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.298 -0.876 . . . . 0.0 110.427 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.525 ' CD1' ' HA ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -85.59 -16.73 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.038 -1.039 . . . . 0.0 110.413 -179.691 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.582 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -48.62 -54.98 21.89 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.38 -0.825 . . . . 0.0 110.167 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 41.4 Cg_endo -67.56 -22.84 43.91 Favored 'Trans proline' 0 N--CA 1.481 0.763 0 C-N-CA 122.142 1.894 . . . . 0.0 110.585 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.849 ' SG ' HG21 ' A' ' 71' ' ' ILE . 10.6 m -102.28 11.7 37.76 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.607 178.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.518 ' O ' ' CB ' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -59.94 -39.54 80.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.049 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.68 -57.97 5.46 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.59 -0.694 . . . . 0.0 109.558 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.612 ' CD1' ' HA2' ' A' ' 22' ' ' GLY . 0.9 OUTLIER -58.37 -57.21 13.93 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.62 -0.675 . . . . 0.0 109.272 179.594 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.31 -22.98 21.1 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.335 -0.853 . . . . 0.0 109.916 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.518 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 9.2 tmm_? -95.19 0.02 53.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.619 -0.676 . . . . 0.0 110.75 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 123.16 -17.86 7.95 Favored Glycine 0 N--CA 1.501 2.988 0 O-C-N 120.339 -1.475 . . . . 0.0 112.166 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -83.06 69.48 9.85 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-N 119.084 1.442 . . . . 0.0 109.476 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.612 ' HA2' ' CD1' ' A' ' 17' ' ' TYR . . . -74.05 77.19 1.0 Allowed Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.2 p -101.25 -37.06 8.68 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.68 -0.894 . . . . 0.0 109.755 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.441 ' HA2' ' HD3' ' A' ' 25' ' ' PRO . . . 172.97 131.64 1.41 Allowed Glycine 0 N--CA 1.501 3.021 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.441 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 26.5 Cg_exo -60.72 119.02 5.96 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 C-N-CA 122.272 1.982 . . . . 0.0 110.442 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.25 135.38 48.92 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.377 -0.827 . . . . 0.0 110.707 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.68 -48.87 71.86 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.783 -0.573 . . . . 0.0 109.587 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.95 -43.75 92.81 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 30.5 t -60.1 -46.52 89.31 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.53 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.425 ' HA ' ' HB3' ' A' ' 75' ' ' CYS . 96.5 m -64.63 -39.32 93.5 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.283 -177.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.77 -42.24 77.7 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 124.462 1.101 . . . . 0.0 110.031 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.36 -53.94 37.6 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.681 HG12 HG21 ' A' ' 77' ' ' VAL . 2.8 t -68.6 -44.83 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.572 -0.957 . . . . 0.0 109.21 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.547 ' O ' ' HD2' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -53.23 -35.71 60.24 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.956 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.4 m -73.53 -48.31 34.07 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.52 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 0.9 OUTLIER -59.77 -34.13 72.59 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.736 -1.227 . . . . 0.0 107.938 177.921 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.477 ' HB2' HG13 ' A' ' 77' ' ' VAL . 66.0 t30 -52.28 -42.87 64.09 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.601 -0.687 . . . . 0.0 110.212 178.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -93.12 -24.06 18.4 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.18 -0.95 . . . . 0.0 110.703 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.507 ' O ' ' HB ' ' A' ' 2' ' ' ILE . . . -106.63 33.85 3.7 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.956 -1.09 . . . . 0.0 110.372 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.607 ' HB2' HD13 ' A' ' 2' ' ' ILE . . . -168.62 85.78 0.18 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.165 -0.959 . . . . 0.0 110.669 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.492 ' HA ' ' CD ' ' A' ' 46' ' ' ARG . 15.2 mtt180 -158.86 24.31 0.22 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.204 -0.935 . . . . 0.0 111.028 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.461 ' O ' ' HB ' ' A' ' 43' ' ' THR . 8.9 m -110.82 42.16 1.66 Allowed 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.973 -1.079 . . . . 0.0 110.796 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.689 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 52.0 m 68.8 -65.72 0.27 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.158 -0.964 . . . . 0.0 109.469 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 42' ' ' THR . . . -56.82 -51.9 67.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.902 -0.499 . . . . 0.0 109.731 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.518 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 12.6 m-20 -58.42 -48.61 80.12 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.273 0.558 . . . . 0.0 109.797 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.492 ' CD ' ' HA ' ' A' ' 41' ' ' ARG . 13.5 mtm180 -67.39 -48.66 66.74 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.943 -0.473 . . . . 0.0 111.145 -178.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -63.39 -50.86 68.22 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.081 -1.012 . . . . 0.0 109.145 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.97 -47.7 77.16 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.591 ' CB ' HD11 ' A' ' 2' ' ' ILE . . . -63.7 -44.06 94.76 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.538 -0.726 . . . . 0.0 109.186 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.574 ' O ' ' SG ' ' A' ' 89' ' ' CYS . 38.4 t -57.39 -39.03 75.24 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 120.364 -0.534 . . . . 0.0 109.736 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -61.37 -56.12 23.94 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 124.03 0.832 . . . . 0.0 109.788 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' CYS . . . . . 0.445 ' HA ' HD22 ' A' ' 55' ' ' ASN . 8.4 t -64.26 -35.16 79.94 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.544 178.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.646 HD13 ' O ' ' A' ' 82' ' ' THR . 8.0 mt -63.39 -44.47 94.61 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.061 176.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.428 ' HE3' ' HB3' ' A' ' 54' ' ' LYS . 14.0 ttpp -59.67 -40.62 88.41 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.445 HD22 ' HA ' ' A' ' 52' ' ' CYS . 86.1 m-20 -56.11 -47.23 78.46 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.473 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -73.65 -47.16 42.05 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.203 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 83' ' ' ILE . . . -52.87 -41.66 64.52 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.59 -0.694 . . . . 0.0 110.136 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.98 1.53 39.35 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.541 -0.724 . . . . 0.0 110.199 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -125.63 9.48 7.68 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 56' ' ' ALA . 4.9 t -73.58 -5.69 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.579 -0.953 . . . . 0.0 110.07 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER 76.59 -71.03 0.12 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.34 -0.85 . . . . 0.0 109.598 179.777 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 19' ' ' ARG . . . -109.48 59.33 0.36 Allowed Glycine 0 N--CA 1.499 2.859 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.636 HD11 ' HA ' ' A' ' 84' ' ' SER . 1.4 tm? -54.79 117.99 3.86 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.564 -0.962 . . . . 0.0 111.031 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.543 ' N ' HD13 ' A' ' 63' ' ' LEU . 8.0 t-20 -107.44 86.34 2.29 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.439 ' HA ' ' HB3' ' A' ' 84' ' ' SER . . . -42.91 -50.6 5.76 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.48 -44.19 85.4 Favored Glycine 0 N--CA 1.503 3.162 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -74.41 -55.17 6.28 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.707 -0.878 . . . . 0.0 109.585 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.445 ' HB1' ' HB ' ' A' ' 83' ' ' ILE . . . -51.43 -35.88 41.37 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.937 -0.477 . . . . 0.0 111.435 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.95 -40.0 17.48 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.133 -0.979 . . . . 0.0 110.014 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.0 t -65.17 -40.55 94.46 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.473 -0.767 . . . . 0.0 110.826 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.849 HG21 ' SG ' ' A' ' 14' ' ' CYS . 74.7 mt -51.7 -65.19 1.05 Allowed Pre-proline 0 N--CA 1.503 2.224 0 O-C-N 121.845 -0.534 . . . . 0.0 111.934 -178.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.661 ' HG3' ' HB ' ' A' ' 82' ' ' THR . 41.1 Cg_endo -60.2 -40.54 58.96 Favored 'Trans proline' 0 N--CA 1.482 0.813 0 C-N-CA 121.908 1.739 . . . . 0.0 110.404 -179.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.6 m -55.52 -62.95 1.34 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -63.97 -39.63 94.57 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.893 -0.505 . . . . 0.0 109.84 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.425 ' HB3' ' HA ' ' A' ' 30' ' ' CYS . 1.3 m -48.28 -33.31 8.57 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.91 -0.494 . . . . 0.0 111.689 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 132.17 50.3 0.09 OUTLIER Glycine 0 N--CA 1.498 2.796 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 176.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.681 HG21 HG12 ' A' ' 33' ' ' VAL . 43.8 t -139.98 135.4 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.379 -1.071 . . . . 0.0 110.681 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.8 p -112.11 59.8 0.63 Allowed 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 122.219 1.009 . . . . 0.0 108.695 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.661 HG22 HG12 ' A' ' 77' ' ' VAL . 13.5 tt -125.07 122.56 25.39 Favored Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.46 -41.31 78.03 Favored 'Trans proline' 0 N--CA 1.486 1.084 0 C-N-CA 122.66 2.24 . . . . 0.0 112.092 -178.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.564 ' CE1' HD11 ' A' ' 79' ' ' ILE . 6.6 p90 -97.13 128.91 44.49 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.121 -0.987 . . . . 0.0 108.429 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.662 ' C ' HD12 ' A' ' 83' ' ' ILE . 40.2 p -128.59 -94.97 0.42 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.339 -0.851 . . . . 0.0 110.834 -178.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.662 HD12 ' C ' ' A' ' 82' ' ' THR . 1.4 mp -120.12 -51.79 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.265 -0.897 . . . . 0.0 109.639 -177.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.636 ' HA ' HD11 ' A' ' 63' ' ' LEU . 1.4 m -42.63 144.52 0.53 Allowed 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.309 0.576 . . . . 0.0 110.86 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 87' ' ' THR . 41.3 p -72.44 -130.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.7 t 63.03 -58.9 0.15 Allowed 'General case' 0 N--CA 1.508 2.438 0 O-C-N 120.97 -1.081 . . . . 0.0 111.012 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 85' ' ' THR . 3.4 m -61.11 140.62 57.84 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.387 -0.821 . . . . 0.0 109.789 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -83.67 134.35 34.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.578 -0.701 . . . . 0.0 111.025 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.574 ' SG ' ' O ' ' A' ' 50' ' ' CYS . 65.2 m -105.17 54.55 0.71 Allowed 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.836 0.827 . . . . 0.0 110.129 177.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 m -144.06 -40.89 0.28 Allowed 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 113.796 -1.547 . . . . 0.0 109.132 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -99.43 -30.45 12.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.504 -0.748 . . . . 0.0 109.806 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -47.64 142.77 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 121.297 -0.877 . . . . 0.0 110.391 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.689 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.499 1.992 0 O-C-N 121.711 -0.618 . . . . 0.0 109.529 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.747 HD11 ' HB2' ' A' ' 49' ' ' ALA . 7.4 tp . . . . . 0 N--CA 1.51 2.574 0 CA-C-O 121.806 0.812 . . . . 0.0 111.603 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.8 t -118.59 161.62 19.74 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.878 -1.139 . . . . 0.0 110.268 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.3 t -53.66 -38.02 63.74 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.23 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.16 -37.18 94.08 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -83.93 -43.91 14.77 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.64 -0.918 . . . . 0.0 108.962 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.563 HG21 ' HA ' ' A' ' 49' ' ' ALA . 94.8 t -57.03 -40.58 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.64 -27.46 55.68 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 m -67.76 -22.64 65.21 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.399 -0.813 . . . . 0.0 109.247 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.546 ' C ' ' HD2' ' A' ' 13' ' ' PRO . . . -98.29 -29.23 13.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.517 -0.739 . . . . 0.0 109.075 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 tp -79.37 -41.53 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.487 -0.758 . . . . 0.0 110.515 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.626 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -46.41 -49.78 42.58 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 121.555 -0.716 . . . . 0.0 110.316 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.626 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 22.6 Cg_exo -65.1 -24.61 59.25 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.044 1.829 . . . . 0.0 110.451 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.789 ' SG ' HG21 ' A' ' 71' ' ' ILE . 1.7 m -104.15 14.55 30.25 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 176.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -65.76 -50.68 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.706 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.41 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 0.2 OUTLIER -62.04 -57.31 12.11 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.57 -0.706 . . . . 0.0 109.133 179.02 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.557 ' CE2' HG12 ' A' ' 71' ' ' ILE . 1.1 t80 -54.17 -58.9 5.63 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.452 ' HB1' ' HB2' ' A' ' 68' ' ' ALA . . . -55.77 -35.49 66.31 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.514 -0.741 . . . . 0.0 109.858 178.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.478 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 29.5 ttm180 -74.53 -25.93 59.65 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.471 -0.768 . . . . 0.0 110.18 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.84 3.2 25.14 Favored Glycine 0 N--CA 1.5 2.929 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -103.82 70.7 1.02 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.1 -1.235 . . . . 0.0 109.484 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.05 -145.0 7.64 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.2 t 176.63 -54.29 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.809 -0.818 . . . . 0.0 109.514 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.61 118.4 4.65 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -56.71 132.42 51.63 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 122.568 2.179 . . . . 0.0 110.781 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.2 t -75.05 119.25 18.97 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.515 -0.741 . . . . 0.0 109.208 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.88 -46.01 51.22 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.692 -0.63 . . . . 0.0 109.986 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.98 -42.76 87.41 Favored Glycine 0 N--CA 1.499 2.868 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.446 ' O ' HG23 ' A' ' 33' ' ' VAL . 42.4 t -57.93 -46.08 85.6 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.88 -1.128 . . . . 0.0 109.53 177.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 75' ' ' CYS . 81.3 m -64.91 -41.97 95.12 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 123.855 0.722 . . . . 0.0 112.355 -177.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.443 ' HA ' ' HE ' ' A' ' 34' ' ' ARG . 9.5 t -70.68 -42.31 70.9 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 123.993 0.808 . . . . 0.0 110.192 176.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.95 -51.08 56.04 Favored Glycine 0 N--CA 1.498 2.819 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.662 HG12 HG11 ' A' ' 77' ' ' VAL . 4.8 t -70.47 -46.77 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.625 -0.927 . . . . 0.0 109.237 179.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.59 ' HA ' ' CG1' ' A' ' 77' ' ' VAL . 28.2 ttp180 -52.87 -36.66 59.42 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.4 t -74.29 -47.45 34.71 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.563 HD23 ' HA ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -55.83 -37.84 69.22 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.174 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.585 ' HB2' HG12 ' A' ' 77' ' ' VAL . 2.6 t-20 -63.34 -33.97 76.68 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.471 -0.768 . . . . 0.0 108.962 178.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -78.12 -38.0 44.9 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.417 ' O ' ' HB ' ' A' ' 2' ' ' ILE . . . -94.85 32.01 1.73 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.706 -0.621 . . . . 0.0 109.724 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.493 ' HA ' ' CB ' ' A' ' 45' ' ' ASP . . . -164.39 -159.51 0.48 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.468 -0.77 . . . . 0.0 110.541 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ARG . . . . . 0.542 ' HA ' ' HD3' ' A' ' 46' ' ' ARG . 1.4 mtp180 78.14 12.03 1.79 Allowed 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.974 -0.453 . . . . 0.0 111.598 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.599 ' O ' ' HB ' ' A' ' 43' ' ' THR . 0.9 OUTLIER -99.64 27.32 5.43 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 120.889 -1.132 . . . . 0.0 110.189 178.869 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.64 HG23 ' HB3' ' A' ' 93' ' ' ASN . 55.2 m 83.83 -67.44 0.06 Allowed 'General case' 0 N--CA 1.51 2.557 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.82 -55.42 34.6 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.683 -0.635 . . . . 0.0 109.427 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.567 ' HB3' HG12 ' A' ' 2' ' ' ILE . 8.8 m-20 -54.39 -46.05 73.01 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.542 ' HD3' ' HA ' ' A' ' 41' ' ' ARG . 9.5 mmm-85 -56.81 -44.54 82.06 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.49 ' HA ' ' NH1' ' A' ' 47' ' ' ARG . 0.7 OUTLIER -60.25 -50.52 73.31 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.984 -0.448 . . . . 0.0 110.385 -179.64 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.61 -39.53 80.71 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.78 -0.575 . . . . 0.0 109.727 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.747 ' HB2' HD11 ' A' ' 2' ' ' ILE . . . -71.62 -61.6 1.72 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -44.84 -41.85 7.42 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 176.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.53 ' O ' ' HG3' ' A' ' 54' ' ' LYS . 3.0 t30 -65.53 -56.02 14.62 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.394 177.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 16.8 t -64.39 -26.37 68.43 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 119.139 -1.025 . . . . 0.0 111.146 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.542 ' HG ' HG11 ' A' ' 7' ' ' VAL . 21.7 mt -70.4 -58.9 3.23 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.39 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' A' ' 51' ' ' ASN . 2.7 pptp? -54.07 -36.18 62.84 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.333 -0.854 . . . . 0.0 110.009 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -64.46 -48.15 76.35 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.435 -0.79 . . . . 0.0 109.092 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.58 -40.05 80.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.541 -0.724 . . . . 0.0 109.563 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.443 ' HA ' ' CD1' ' A' ' 63' ' ' LEU . . . -48.43 -48.32 37.45 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.611 -0.681 . . . . 0.0 110.366 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.55 -6.35 45.97 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.453 -0.78 . . . . 0.0 111.554 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -123.63 8.86 8.76 Favored Glycine 0 N--CA 1.501 3.032 0 O-C-N 120.833 -1.167 . . . . 0.0 110.759 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.405 ' O ' ' CB ' ' A' ' 61' ' ' SER . 0.9 OUTLIER -74.42 -21.11 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.333 -1.098 . . . . 0.0 110.367 -179.739 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 60' ' ' VAL . 0.9 OUTLIER 76.49 107.54 0.08 Allowed 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.279 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.73 -78.63 1.92 Allowed Glycine 0 N--CA 1.498 2.774 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 7.5 tt 59.48 103.09 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 121.953 0.883 . . . . 0.0 111.236 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.512 ' HB3' ' HB2' ' A' ' 67' ' ' ASN . 2.6 m-80 -94.39 81.88 4.01 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -32.87 -55.69 0.37 Allowed 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 70' ' ' SER . . . -52.21 -42.99 56.54 Favored Glycine 0 N--CA 1.506 3.357 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.512 ' HB2' ' HB3' ' A' ' 64' ' ' ASN . 2.0 t30 -72.7 -51.97 17.12 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.452 ' HB2' ' HB1' ' A' ' 18' ' ' ALA . . . -57.16 -33.25 67.24 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 122.018 -0.426 . . . . 0.0 111.626 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.43 -45.22 13.91 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.094 -1.004 . . . . 0.0 109.964 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 66' ' ' GLY . 0.4 OUTLIER -66.09 -29.62 69.98 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.347 -0.846 . . . . 0.0 111.055 -179.619 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.789 HG21 ' SG ' ' A' ' 14' ' ' CYS . 70.2 mt -60.11 -66.09 1.71 Allowed Pre-proline 0 N--CA 1.506 2.329 0 O-C-N 121.243 -0.911 . . . . 0.0 111.291 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.564 ' O ' HG22 ' A' ' 77' ' ' VAL . 23.7 Cg_endo -57.33 -53.62 4.53 Favored 'Trans proline' 0 C--N 1.325 -0.699 0 C-N-CA 121.805 1.67 . . . . 0.0 109.652 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.5 m -45.29 -63.98 0.82 Allowed 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -64.85 -34.05 77.45 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.712 -0.617 . . . . 0.0 109.916 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' CYS . . . . . 0.448 ' HB3' ' HA ' ' A' ' 30' ' ' CYS . 1.1 m -50.98 -31.48 18.07 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.222 -177.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 135.07 53.6 0.07 OUTLIER Glycine 0 N--CA 1.497 2.711 0 C-N-CA 119.657 -1.259 . . . . 0.0 110.81 175.608 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.662 HG11 HG12 ' A' ' 33' ' ' VAL . 12.0 m -147.71 124.49 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.184 -1.186 . . . . 0.0 111.172 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.411 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 65.2 m -91.45 67.06 5.57 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.531 HD11 ' CE2' ' A' ' 81' ' ' TYR . 2.3 tp -104.02 127.19 29.79 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.553 -0.717 . . . . 0.0 109.854 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.63 -33.88 65.37 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 122.826 2.351 . . . . 0.0 112.394 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' TYR . . . . . 0.531 ' CE2' HD11 ' A' ' 79' ' ' ILE . 5.9 p90 -90.3 143.68 26.54 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.904 -1.122 . . . . 0.0 110.407 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.3 p -104.88 173.37 6.33 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.504 -0.747 . . . . 0.0 110.814 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.468 HD12 HD13 ' A' ' 53' ' ' LEU . 5.4 mm -108.95 92.51 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.536 -0.727 . . . . 0.0 109.357 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 82.8 p -119.45 -104.91 0.39 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.159 -0.963 . . . . 0.0 109.653 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -164.02 -55.9 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 63.3 m -79.34 -8.26 58.94 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 122.107 -0.371 . . . . 0.0 110.183 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.7 m -50.03 142.67 9.06 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.325 -0.859 . . . . 0.0 109.951 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -82.58 118.46 23.3 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.496 -0.753 . . . . 0.0 109.813 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 11.4 m -109.64 56.11 0.63 Allowed 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.886 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.3 t -128.5 -61.4 1.08 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.571 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.475 ' NH1' ' HG3' ' A' ' 91' ' ' ARG . 2.9 mtm-85 -97.96 60.61 1.49 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 122.052 0.93 . . . . 0.0 109.629 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.3 t -115.37 81.51 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.64 ' HB3' HG23 ' A' ' 43' ' ' THR . 2.1 p-10 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 117.152 -1.404 . . . . 0.0 110.326 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 2' ' ' ILE . . . . . . . . 0 N--CA 1.499 1.989 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.71 ' CG1' ' HB2' ' A' ' 40' ' ' ALA . 5.3 tp 32.13 70.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.407 0 CA-C-O 121.916 0.865 . . . . 0.0 111.579 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 5' ' ' GLY . 1.2 t -156.39 80.19 0.97 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.782 -1.199 . . . . 0.0 110.632 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.431 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 11.4 t 66.08 -57.88 0.35 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 3' ' ' SER . . . -44.07 -53.45 6.53 Favored Glycine 0 N--CA 1.505 3.279 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.493 ' OE1' HG23 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -81.49 -25.76 35.73 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.514 -0.992 . . . . 0.0 110.482 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.506 HG21 ' HA ' ' A' ' 49' ' ' ALA . 37.6 t -56.07 -41.18 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.489 ' HA ' ' CD1' ' A' ' 11' ' ' ILE . . . -68.42 -39.58 81.54 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.0 p -71.9 -20.84 61.72 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.339 -0.851 . . . . 0.0 109.94 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.73 -49.1 11.61 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.508 -0.745 . . . . 0.0 110.573 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.489 ' CD1' ' HA ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -84.31 -16.7 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.209 -0.932 . . . . 0.0 110.488 -179.7 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.524 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -46.82 -53.98 22.64 Favored Pre-proline 0 N--CA 1.501 2.099 0 O-C-N 121.369 -0.832 . . . . 0.0 109.867 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 27.5 Cg_endo -63.38 -23.1 71.75 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 121.945 1.763 . . . . 0.0 110.585 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.2 m -88.58 -6.52 57.49 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 118.655 -0.688 . . . . 0.0 112.714 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.55 ' O ' ' CB ' ' A' ' 19' ' ' ARG . 1.0 OUTLIER -48.56 -47.07 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-N 118.62 0.646 . . . . 0.0 109.686 -178.096 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 21' ' ' GLN . 85.2 p -52.81 -63.55 1.11 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.119 -0.988 . . . . 0.0 109.38 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.591 ' CD2' HG12 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -59.5 -59.74 4.97 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.683 -0.636 . . . . 0.0 110.295 179.674 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.82 -27.59 60.24 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.289 -0.882 . . . . 0.0 111.039 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.55 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 16.1 ttm-85 -94.02 11.31 30.19 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.306 -0.872 . . . . 0.0 110.899 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.22 30.12 63.32 Favored Glycine 0 N--CA 1.506 3.307 0 O-C-N 120.784 -1.198 . . . . 0.0 111.33 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 16' ' ' SER . 69.4 mt-30 -140.79 48.49 1.71 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.335 -1.097 . . . . 0.0 109.461 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -165.28 -52.23 0.02 OUTLIER Glycine 0 N--CA 1.502 3.072 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.3 p 70.87 -47.6 0.65 Allowed 'General case' 0 N--CA 1.51 2.564 0 O-C-N 121.81 -0.818 . . . . 0.0 111.501 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.59 132.11 10.82 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.15 148.83 91.24 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 C-N-CA 122.366 2.044 . . . . 0.0 110.766 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.1 p -104.19 156.14 18.14 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.285 -0.884 . . . . 0.0 109.749 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.34 -47.44 85.86 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.49 -0.756 . . . . 0.0 109.133 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.01 -36.43 93.45 Favored Glycine 0 N--CA 1.501 2.977 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.448 ' HA ' ' HG2' ' A' ' 13' ' ' PRO . 3.9 t -62.38 -59.11 5.45 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 91.5 m -63.65 -36.43 83.81 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 120.184 -0.606 . . . . 0.0 112.15 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.4 m -66.81 -48.18 69.74 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 123.726 0.641 . . . . 0.0 109.753 176.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.36 -53.74 37.18 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.806 HG12 HG21 ' A' ' 77' ' ' VAL . 11.6 t -62.23 -48.33 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.609 -0.936 . . . . 0.0 110.361 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -23.89 63.48 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.988 -1.07 . . . . 0.0 109.66 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.444 ' HA ' ' OD1' ' A' ' 38' ' ' ASN . 21.4 p -73.63 -34.54 65.06 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.301 -0.874 . . . . 0.0 108.818 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.549 HD23 ' HA ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER -67.2 -31.8 72.43 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.495 -0.753 . . . . 0.0 109.861 179.073 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.629 ' HB2' HG13 ' A' ' 77' ' ' VAL . 2.4 t-20 -64.6 -50.23 67.99 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.395 -0.816 . . . . 0.0 110.575 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.444 ' OD1' ' HA ' ' A' ' 35' ' ' SER . 3.8 p-10 -68.76 -27.07 65.58 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.211 -0.93 . . . . 0.0 109.964 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.11 -46.11 12.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.667 -0.646 . . . . 0.0 110.004 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.71 ' HB2' ' CG1' ' A' ' 2' ' ' ILE . . . -88.97 95.99 10.54 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.199 -0.938 . . . . 0.0 109.679 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.583 ' HG2' ' NH1' ' A' ' 46' ' ' ARG . 42.1 mtm180 -152.3 23.74 0.63 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.398 -0.814 . . . . 0.0 110.595 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -128.26 33.95 4.64 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.024 -1.048 . . . . 0.0 110.462 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.43 HG23 ' HE ' ' A' ' 47' ' ' ARG . 53.2 m 67.73 -61.78 0.36 Allowed 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.443 -0.786 . . . . 0.0 109.601 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 42' ' ' THR . . . -55.93 -57.8 10.58 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.632 -0.667 . . . . 0.0 109.713 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.466 ' HB3' HG23 ' A' ' 2' ' ' ILE . 2.7 m-20 -71.1 -35.06 71.67 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.709 ' HG3' ' CE2' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -67.38 -58.9 3.94 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 122.001 -0.437 . . . . 0.0 110.271 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.43 ' HE ' HG23 ' A' ' 43' ' ' THR . 80.2 mtt180 -60.6 -43.71 97.12 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.04 -45.71 61.4 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.292 -0.88 . . . . 0.0 108.662 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.506 ' HA ' HG21 ' A' ' 7' ' ' VAL . . . -67.6 -49.49 62.86 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.67 ' SG ' HG22 ' A' ' 87' ' ' THR . 0.0 OUTLIER -55.68 -39.87 71.54 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.498 -0.751 . . . . 0.0 112.359 179.266 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.605 ' N ' ' SG ' ' A' ' 89' ' ' CYS . 2.2 t30 -63.44 -56.87 12.72 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.677 177.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 53.7 t -63.93 -26.7 68.71 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.773 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.451 HD22 HG23 ' A' ' 83' ' ' ILE . 21.0 mt -63.42 -51.31 66.28 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 124.183 0.927 . . . . 0.0 109.285 175.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.535 ' HE3' ' HA ' ' A' ' 51' ' ' ASN . 0.4 OUTLIER -55.86 -40.75 73.35 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.19 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.433 ' N ' ' HG2' ' A' ' 54' ' ' LYS . 5.3 m120 -66.48 -46.8 75.09 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.412 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -61.97 -46.02 91.08 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.527 ' HA ' ' HG ' ' A' ' 63' ' ' LEU . . . -61.42 -58.52 7.85 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.27 66.9 6.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.352 -0.843 . . . . 0.0 109.153 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.6 -36.59 0.09 OUTLIER Glycine 0 N--CA 1.498 2.813 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.474 ' HB ' ' HB2' ' A' ' 63' ' ' LEU . 4.0 t -51.91 136.4 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.651 -0.911 . . . . 0.0 110.087 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.444 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 0.4 OUTLIER -62.62 102.0 0.3 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.592 -0.692 . . . . 0.0 109.629 -179.786 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.28 42.11 19.65 Favored Glycine 0 N--CA 1.5 2.934 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.527 ' HG ' ' HA ' ' A' ' 57' ' ' ALA . 3.3 tm? -64.02 122.72 17.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.463 -1.022 . . . . 0.0 110.251 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.428 ' N ' HD13 ' A' ' 63' ' ' LEU . 2.4 m-80 -97.57 83.94 3.32 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -36.24 -53.08 0.82 Allowed 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.89 -0.506 . . . . 0.0 111.506 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -51.71 -50.96 41.14 Favored Glycine 0 N--CA 1.504 3.201 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -67.2 -53.28 31.68 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.694 -0.886 . . . . 0.0 108.949 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.404 ' O ' ' CD ' ' A' ' 72' ' ' PRO . . . -54.03 -32.77 55.41 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 122.038 -0.414 . . . . 0.0 111.235 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.3 -48.19 8.72 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.196 -0.94 . . . . 0.0 110.299 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.9 t -65.4 -27.98 68.93 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.326 -0.859 . . . . 0.0 110.967 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.591 HG12 ' CD2' ' A' ' 17' ' ' TYR . 55.8 mt -58.48 -65.17 2.09 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.253 -0.904 . . . . 0.0 110.451 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.651 ' HB3' HG11 ' A' ' 33' ' ' VAL . 9.5 Cg_endo -53.75 -52.1 9.28 Favored 'Trans proline' 0 N--CA 1.482 0.828 0 C-N-CA 122.217 1.945 . . . . 0.0 110.838 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.7 p -44.63 -70.62 0.1 Allowed 'General case' 0 N--CA 1.504 2.232 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.317 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.411 ' N ' ' HD3' ' A' ' 74' ' ' LYS . 1.1 mppt? -64.06 -39.37 93.92 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.972 -0.455 . . . . 0.0 111.106 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 1.1 m -47.5 -35.14 8.34 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.502 -0.749 . . . . 0.0 111.505 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 135.16 46.69 0.09 OUTLIER Glycine 0 N--CA 1.496 2.658 0 O-C-N 124.655 1.222 . . . . 0.0 110.05 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.806 HG21 HG12 ' A' ' 33' ' ' VAL . 59.8 t -119.13 86.33 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.31 -1.112 . . . . 0.0 110.071 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.1 m -75.92 62.49 1.6 Allowed 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.549 HG13 ' HD2' ' A' ' 80' ' ' PRO . 8.9 tt -111.14 142.98 27.43 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.373 -0.83 . . . . 0.0 109.287 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.549 ' HD2' HG13 ' A' ' 79' ' ' ILE . 11.4 Cg_endo -53.37 -39.2 82.33 Favored 'Trans proline' 0 N--CA 1.485 0.973 0 C-N-CA 122.873 2.382 . . . . 0.0 112.942 -177.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.73 ' HB3' HG21 ' A' ' 92' ' ' VAL . 0.2 OUTLIER -96.63 159.94 14.66 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.661 -1.275 . . . . 0.0 111.144 -179.572 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.545 ' C ' HD12 ' A' ' 83' ' ' ILE . 1.3 m -96.11 -170.25 2.08 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.545 HD12 ' C ' ' A' ' 82' ' ' THR . 2.0 mp -120.65 92.68 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.154 -0.967 . . . . 0.0 108.48 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.3 p -142.83 172.29 12.9 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.574 -0.704 . . . . 0.0 110.292 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.6 p -59.69 -50.14 75.01 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.698 -0.626 . . . . 0.0 109.546 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 38.8 m -84.96 48.54 1.58 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.761 -0.587 . . . . 0.0 110.559 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.67 HG22 ' SG ' ' A' ' 50' ' ' CYS . 22.2 m -74.6 117.25 16.21 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.055 -1.028 . . . . 0.0 108.569 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -83.21 136.36 34.44 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.332 -0.855 . . . . 0.0 110.968 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.605 ' SG ' ' N ' ' A' ' 51' ' ' ASN . 58.6 m -117.08 56.04 0.82 Allowed 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.286 176.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.67 -38.7 0.47 Allowed 'General case' 0 N--CA 1.497 1.925 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.227 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.469 ' HG2' ' NH1' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -98.32 2.76 48.4 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.317 -0.864 . . . . 0.0 111.199 -179.176 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.73 HG21 ' HB3' ' A' ' 81' ' ' TYR . 17.1 t -105.82 136.17 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 120.889 -1.132 . . . . 0.0 110.007 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.5 m120 . . . . . 0 N--CA 1.494 1.772 0 O-C-N 121.289 -0.882 . . . . 0.0 108.738 179.153 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 121.419 0.628 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.876 HD11 ' HB2' ' A' ' 49' ' ' ALA . 1.2 pp -84.52 100.64 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.073 -1.017 . . . . 0.0 108.434 179.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.3 t -90.18 174.56 7.55 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.002 -1.061 . . . . 0.0 111.215 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.9 t -62.23 -25.83 68.03 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.672 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.63 -46.39 94.08 Favored Glycine 0 N--CA 1.5 2.93 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.508 ' HG3' ' N ' ' A' ' 7' ' ' VAL . 0.1 OUTLIER -78.03 -35.27 49.99 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.327 -1.102 . . . . 0.0 109.719 179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.508 ' N ' ' HG3' ' A' ' 6' ' ' GLN . 95.9 t -59.74 -47.41 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.582 ' HA ' ' CD1' ' A' ' 11' ' ' ILE . . . -69.98 -35.05 74.12 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 72.4 m -70.59 -21.16 62.7 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.139 -0.976 . . . . 0.0 109.92 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.55 -41.94 12.39 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.384 -0.822 . . . . 0.0 111.128 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.582 ' CD1' ' HA ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -83.28 -17.81 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 120.813 -1.179 . . . . 0.0 110.307 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.539 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -48.05 -52.97 36.66 Favored Pre-proline 0 N--CA 1.502 2.13 0 O-C-N 121.249 -0.907 . . . . 0.0 109.596 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 17.8 Cg_endo -61.68 -25.03 78.49 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 121.899 1.732 . . . . 0.0 110.011 178.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.467 ' HB3' HD13 ' A' ' 71' ' ' ILE . 6.6 m -88.39 -1.67 58.17 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 176.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.501 ' O ' ' CB ' ' A' ' 19' ' ' ARG . 0.5 OUTLIER -55.39 -50.79 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' A' ' 21' ' ' GLN . 5.8 m -54.1 -53.17 56.83 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.292 -0.88 . . . . 0.0 108.797 178.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.505 ' CD1' HD11 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -59.97 -65.33 0.7 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.127 -0.983 . . . . 0.0 110.042 179.053 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.479 ' HA ' ' HB3' ' A' ' 67' ' ' ASN . . . -55.08 -34.0 63.26 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.606 -0.684 . . . . 0.0 110.97 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.509 ' HG3' HH11 ' A' ' 19' ' ' ARG . 1.7 ttm-85 -80.35 5.58 14.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.718 -0.614 . . . . 0.0 111.539 -178.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.72 23.68 45.35 Favored Glycine 0 N--CA 1.504 3.226 0 O-C-N 120.618 -1.301 . . . . 0.0 111.803 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.49 ' O ' ' HB3' ' A' ' 16' ' ' SER . 6.3 mm-40 -141.22 59.76 1.51 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.18 -1.188 . . . . 0.0 109.515 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.61 -58.99 0.02 OUTLIER Glycine 0 N--CA 1.503 3.12 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.7 p 74.42 -51.34 0.68 Allowed 'General case' 0 N--CA 1.511 2.596 0 O-C-N 122.054 -0.674 . . . . 0.0 111.479 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.78 139.99 14.66 Favored Glycine 0 N--CA 1.501 2.981 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.718 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 27.3 Cg_endo -61.9 121.77 9.99 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 122.173 1.915 . . . . 0.0 110.238 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 p -75.96 152.95 36.91 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.201 -0.937 . . . . 0.0 110.313 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.01 -51.91 66.1 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.363 -0.835 . . . . 0.0 108.828 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.19 -36.63 91.21 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.572 ' O ' HG23 ' A' ' 33' ' ' VAL . 7.3 t -63.98 -53.95 42.03 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.718 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 93.4 m -67.52 -39.27 85.09 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 118.635 -0.698 . . . . 0.0 111.389 -177.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.0 t -65.62 -47.9 74.08 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 124.19 0.931 . . . . 0.0 109.5 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.31 -53.09 48.5 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.789 HG12 HG21 ' A' ' 77' ' ' VAL . 12.5 t -63.36 -50.63 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.382 -1.069 . . . . 0.0 110.072 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.469 ' O ' ' CB ' ' A' ' 38' ' ' ASN . 7.1 ttp180 -56.24 -35.63 67.6 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 m -73.92 -43.69 57.5 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.531 HD23 ' HA ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -64.4 -44.89 89.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.752 -0.593 . . . . 0.0 109.663 179.628 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.615 ' HB3' HG13 ' A' ' 77' ' ' VAL . 7.3 m-80 -80.8 -28.9 36.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -0.904 . . . . 0.0 110.509 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 8.7 t30 -63.6 -35.19 79.69 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.7 -38.23 29.26 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.585 ' HB2' HG12 ' A' ' 2' ' ' ILE . . . -83.17 93.5 7.66 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.503 -0.748 . . . . 0.0 110.651 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.517 ' HA ' ' HD3' ' A' ' 46' ' ' ARG . 43.3 mtt180 -143.0 9.18 1.7 Allowed 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.95 -1.094 . . . . 0.0 110.584 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 58.0 m -87.53 -65.74 0.98 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.223 -0.923 . . . . 0.0 110.337 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 m 160.15 -56.98 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.86 -47.64 70.79 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.596 ' HB3' ' CG1' ' A' ' 2' ' ' ILE . 18.2 m-20 -68.58 -49.92 55.69 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.517 ' HD3' ' HA ' ' A' ' 41' ' ' ARG . 22.2 mtm180 -62.47 -46.27 89.27 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.526 -0.734 . . . . 0.0 110.46 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -59.06 -46.29 88.63 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.378 -0.826 . . . . 0.0 108.879 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.56 -39.68 91.95 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.876 ' HB2' HD11 ' A' ' 2' ' ' ILE . . . -57.24 -51.13 70.6 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.46 ' SG ' ' N ' ' A' ' 89' ' ' CYS . 19.1 t -58.05 -38.11 75.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.809 -0.557 . . . . 0.0 110.866 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -63.7 -63.21 1.23 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 123.711 0.632 . . . . 0.0 109.305 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 8.6 t -53.7 -33.92 57.09 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.336 -0.852 . . . . 0.0 112.036 176.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.666 HD22 HG23 ' A' ' 83' ' ' ILE . 25.1 mt -61.81 -44.83 96.07 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 114.961 -1.018 . . . . 0.0 108.821 176.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.532 ' HD2' ' SG ' ' A' ' 89' ' ' CYS . 3.3 tttp -56.77 -42.96 80.32 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.639 -0.663 . . . . 0.0 109.269 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -55.89 -44.94 78.65 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.764 -0.585 . . . . 0.0 109.73 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.526 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -76.63 -53.98 7.29 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.567 -0.708 . . . . 0.0 109.565 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.611 ' HB1' ' HA ' ' A' ' 85' ' ' THR . . . -52.36 -55.31 22.46 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.536 -0.728 . . . . 0.0 109.679 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -87.95 62.18 6.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.288 -0.883 . . . . 0.0 108.74 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.98 -34.14 0.07 OUTLIER Glycine 0 N--CA 1.498 2.787 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 56' ' ' ALA . 24.3 t -47.54 133.78 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.672 -0.899 . . . . 0.0 109.86 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.405 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 0.5 OUTLIER -62.41 97.93 0.1 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.706 -0.621 . . . . 0.0 110.191 -179.187 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.59 73.37 0.61 Allowed Glycine 0 N--CA 1.5 2.928 0 N-CA-C 110.014 -1.235 . . . . 0.0 110.014 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.493 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 1.7 pt? -102.5 159.28 15.57 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.346 -1.091 . . . . 0.0 110.713 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -116.26 114.71 24.76 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -49.57 -53.3 24.49 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.753 -0.592 . . . . 0.0 110.423 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.76 -45.35 85.85 Favored Glycine 0 N--CA 1.5 2.904 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.479 ' HB3' ' HA ' ' A' ' 18' ' ' ALA . 2.9 m120 -62.37 -55.33 28.95 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.728 -0.866 . . . . 0.0 109.474 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.468 ' O ' ' HD2' ' A' ' 72' ' ' PRO . . . -58.36 -33.04 69.12 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.921 -0.487 . . . . 0.0 110.76 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.61 -51.15 8.52 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.217 -0.927 . . . . 0.0 110.215 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.3 t -60.62 -31.13 70.33 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.543 -0.723 . . . . 0.0 110.738 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.531 ' HB ' ' CD ' ' A' ' 72' ' ' PRO . 51.6 mt -56.94 -69.63 0.43 Allowed Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.518 -0.739 . . . . 0.0 111.072 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.739 ' HB3' HG11 ' A' ' 33' ' ' VAL . 17.7 Cg_endo -56.06 -52.56 7.03 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 122.485 2.123 . . . . 0.0 111.762 -178.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.4 t -49.36 -69.5 0.11 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.78 -0.575 . . . . 0.0 110.521 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -63.56 -35.83 81.8 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 122.107 -0.37 . . . . 0.0 111.166 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 71' ' ' ILE . 0.9 OUTLIER -48.66 -35.98 14.98 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.398 -0.814 . . . . 0.0 111.419 -178.447 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 133.92 50.14 0.08 OUTLIER Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.789 HG21 HG12 ' A' ' 33' ' ' VAL . 2.4 t -119.52 110.99 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.423 -1.045 . . . . 0.0 109.951 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 83.8 p -81.32 68.24 7.56 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.296 -0.878 . . . . 0.0 108.918 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.565 HG12 ' CE2' ' A' ' 81' ' ' TYR . 0.7 OUTLIER -133.92 134.26 23.0 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.589 -0.694 . . . . 0.0 109.739 -178.943 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.495 ' HD2' HG13 ' A' ' 79' ' ' ILE . 47.3 Cg_endo -67.11 -35.37 25.43 Favored 'Trans proline' 0 N--CA 1.486 1.048 0 C-N-CA 122.958 2.439 . . . . 0.0 113.278 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.706 ' HB3' HG22 ' A' ' 92' ' ' VAL . 54.8 p90 -80.54 132.26 35.64 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.698 -1.251 . . . . 0.0 110.755 -178.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.55 154.51 20.28 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.468 0.651 . . . . 0.0 110.38 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.666 HG23 HD22 ' A' ' 53' ' ' LEU . 1.9 mp -98.33 83.16 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 121.41 0.624 . . . . 0.0 109.739 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 99.8 p -128.99 171.26 12.52 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.116 -0.99 . . . . 0.0 110.07 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.611 ' HA ' ' HB1' ' A' ' 57' ' ' ALA . 1.7 m -58.37 101.14 0.07 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.335 -0.853 . . . . 0.0 109.375 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.4 ' HA ' ' CG ' ' A' ' 54' ' ' LYS . 34.2 t 60.36 60.53 2.0 Allowed 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 121.493 0.663 . . . . 0.0 109.513 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 56.0 m -63.8 -69.23 0.29 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.434 -0.791 . . . . 0.0 110.684 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -150.87 -72.46 0.16 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.061 -1.024 . . . . 0.0 110.149 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.532 ' SG ' ' HD2' ' A' ' 54' ' ' LYS . 38.5 m 58.82 55.01 4.83 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-O 121.621 0.724 . . . . 0.0 111.626 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 97.6 p -162.75 -42.35 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 114.427 -1.261 . . . . 0.0 109.705 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -100.17 12.43 37.02 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.458 -0.777 . . . . 0.0 109.719 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.706 HG22 ' HB3' ' A' ' 81' ' ' TYR . 85.7 t -79.54 117.14 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.268 -0.895 . . . . 0.0 109.659 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.936 0 CA-C-O 117.267 -1.349 . . . . 0.0 109.542 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.996 0 CA-C-O 121.812 0.815 . . . . 0.0 109.651 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 1.019 HD11 ' HB2' ' A' ' 49' ' ' ALA . 0.6 OUTLIER -135.94 100.88 2.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.2 t -119.05 -173.3 2.47 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.527 -1.358 . . . . 0.0 110.632 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.568 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 1.9 t -52.2 -28.16 17.34 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 177.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -57.23 -51.75 55.67 Favored Glycine 0 N--CA 1.501 2.987 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.543 ' HG3' ' N ' ' A' ' 7' ' ' VAL . 3.1 pt20 -89.33 -34.16 16.65 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.387 -1.067 . . . . 0.0 109.666 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 49' ' ' ALA . 40.7 t -56.16 -37.74 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.32 -37.7 68.86 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.7 p -77.15 -22.11 53.04 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.011 -1.056 . . . . 0.0 110.02 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.63 -48.86 23.98 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.473 -0.767 . . . . 0.0 110.29 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.435 HG21 ' CD2' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -83.98 -16.02 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 O-C-N 121.13 -0.981 . . . . 0.0 110.812 -179.412 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.541 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -45.61 -54.78 14.27 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.455 -0.778 . . . . 0.0 109.759 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.74 ' HG2' ' SG ' ' A' ' 29' ' ' CYS . 19.2 Cg_endo -62.0 -24.76 77.09 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.186 1.924 . . . . 0.0 110.565 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.724 ' SG ' HG21 ' A' ' 71' ' ' ILE . 72.1 m -86.61 -16.81 35.57 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 178.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.453 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -47.58 -24.53 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.904 -0.497 . . . . 0.0 111.255 -177.462 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.447 ' HA ' ' NH2' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -91.21 -61.93 1.55 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.017 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.508 ' CE2' HG12 ' A' ' 71' ' ' ILE . 1.1 t80 -55.19 -57.42 11.87 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 14' ' ' CYS . . . -52.36 -32.38 38.15 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-O 121.42 0.629 . . . . 0.0 110.144 178.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 9.3 tmm_? -90.01 7.9 35.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.798 -0.564 . . . . 0.0 110.86 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.18 9.31 59.45 Favored Glycine 0 N--CA 1.502 3.075 0 O-C-N 120.713 -1.242 . . . . 0.0 111.976 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -114.75 81.91 1.64 Allowed 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 118.768 1.284 . . . . 0.0 109.699 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 157.48 -148.95 19.26 Favored Glycine 0 N--CA 1.5 2.905 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.3 t -175.24 -45.71 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.596 -0.943 . . . . 0.0 109.918 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -97.84 141.75 15.76 Favored Glycine 0 N--CA 1.499 2.886 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.633 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . 27.9 Cg_endo -62.31 121.91 10.11 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 122.362 2.041 . . . . 0.0 111.051 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.5 t -60.77 134.62 57.27 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.548 -0.72 . . . . 0.0 110.045 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.91 -52.9 37.53 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.65 -0.656 . . . . 0.0 110.109 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -52.76 -45.93 60.27 Favored Glycine 0 N--CA 1.502 3.06 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.74 ' SG ' ' HG2' ' A' ' 13' ' ' PRO . 1.1 m -60.02 -43.84 95.02 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.016 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.558 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 3.6 m -63.56 -57.33 10.47 Favored 'General case' 0 C--O 1.201 -1.473 0 CA-C-O 117.556 -1.211 . . . . 0.0 109.574 -176.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.3 t -65.79 -39.78 91.28 Favored 'General case' 0 N--CA 1.505 2.296 0 CA-C-N 118.804 0.729 . . . . 0.0 110.683 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -57.98 -44.78 94.38 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.743 HG12 HG21 ' A' ' 77' ' ' VAL . 5.3 t -84.06 -46.41 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.425 -1.044 . . . . 0.0 110.169 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.542 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -54.62 -35.06 63.02 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.491 -0.756 . . . . 0.0 109.14 179.676 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 90.9 p -78.49 -44.42 24.56 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.306 -0.871 . . . . 0.0 110.027 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.599 ' C ' HD12 ' A' ' 36' ' ' LEU . 0.4 OUTLIER -52.67 -35.82 55.91 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.513 -0.742 . . . . 0.0 109.665 179.786 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.56 ' HB2' HG13 ' A' ' 77' ' ' VAL . 4.3 t-20 -62.39 -26.21 68.35 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.259 -0.9 . . . . 0.0 109.917 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -91.65 -40.56 11.23 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.317 -0.864 . . . . 0.0 108.98 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.06 -36.44 69.58 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.861 ' HB2' HG12 ' A' ' 2' ' ' ILE . . . -91.51 -131.21 0.11 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.873 -0.517 . . . . 0.0 109.926 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.475 ' H ' ' HG2' ' A' ' 46' ' ' ARG . 8.1 mtt-85 56.95 38.92 29.67 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.294 -0.879 . . . . 0.0 110.064 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.465 ' O ' ' HB ' ' A' ' 43' ' ' THR . 9.0 t -136.1 19.02 3.2 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.822 -0.549 . . . . 0.0 109.867 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.768 ' HA ' ' C ' ' A' ' 93' ' ' ASN . 99.5 m 78.17 -60.73 0.4 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.755 -0.591 . . . . 0.0 110.327 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.51 -55.67 32.06 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.445 -0.785 . . . . 0.0 110.613 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.42 ' HB3' ' CG1' ' A' ' 2' ' ' ILE . 54.5 m-20 -67.44 -37.14 82.54 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.575 -0.703 . . . . 0.0 110.889 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.661 ' HD2' HD11 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -67.5 -57.08 7.14 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.879 -1.138 . . . . 0.0 110.778 -179.145 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -55.31 -44.17 75.56 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.226 -0.921 . . . . 0.0 109.419 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.46 -45.76 80.72 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 1.019 ' HB2' HD11 ' A' ' 2' ' ' ILE 0.27 . . -61.59 -52.87 62.61 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.4 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.471 ' C ' ' SG ' ' A' ' 89' ' ' CYS . 44.7 t -54.84 -34.26 62.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.996 -1.065 . . . . 0.0 111.809 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -68.92 -59.5 3.02 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 123.676 0.61 . . . . 0.0 109.988 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.5 t -61.73 -33.36 73.91 Favored 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.526 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.613 HD22 HG13 ' A' ' 83' ' ' ILE . 17.8 mt -67.65 -51.39 50.45 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.636 176.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -59.04 -38.92 80.48 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -61.13 -53.43 57.1 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 122.077 -0.39 . . . . 0.0 110.381 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.29 -44.42 52.77 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.286 -0.884 . . . . 0.0 110.357 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.57 -44.31 76.75 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.526 -0.734 . . . . 0.0 110.112 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.422 ' HB2' HG21 ' A' ' 85' ' ' THR . . . -76.54 68.66 2.88 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.321 -0.862 . . . . 0.0 109.379 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 149.13 -12.21 1.06 Allowed Glycine 0 N--CA 1.5 2.933 0 C-N-CA 120.117 -1.039 . . . . 0.0 111.719 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.3 t -40.09 -60.33 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.566 0 CA-C-N 118.962 1.381 . . . . 0.0 110.776 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.0 m 160.45 77.9 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.512 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.54 -65.21 3.45 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 107.456 -2.257 . . . . 0.0 107.456 -177.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 8.4 tt 68.99 138.13 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 121.821 0.82 . . . . 0.0 111.413 177.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -121.38 92.26 3.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.427 -0.796 . . . . 0.0 109.192 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.46 -41.4 4.3 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.764 -0.585 . . . . 0.0 110.07 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -53.11 -32.18 42.38 Favored Glycine 0 N--CA 1.502 3.076 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -97.49 -53.49 3.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.788 -0.831 . . . . 0.0 108.95 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.407 ' HB2' ' HB1' ' A' ' 18' ' ' ALA . . . -54.69 -32.42 59.37 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.871 -0.518 . . . . 0.0 111.221 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.418 ' CB ' ' HB ' ' A' ' 82' ' ' THR . . . -86.7 -44.01 12.14 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.232 -0.917 . . . . 0.0 109.534 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 65.5 m -64.05 -39.36 93.91 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.677 -0.639 . . . . 0.0 111.139 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.724 HG21 ' SG ' ' A' ' 14' ' ' CYS . 68.5 mt -51.18 -64.35 1.43 Allowed Pre-proline 0 N--CA 1.499 2.008 0 O-C-N 121.628 -0.67 . . . . 0.0 111.479 -178.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.592 ' HG3' HD13 ' A' ' 83' ' ' ILE . 36.8 Cg_endo -59.56 -50.14 8.82 Favored 'Trans proline' 0 N--CA 1.48 0.678 0 C-N-CA 121.85 1.7 . . . . 0.0 110.549 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.7 t -55.82 -60.74 3.03 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.843 -0.536 . . . . 0.0 110.186 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -63.04 -40.01 96.44 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 122.04 -0.413 . . . . 0.0 110.317 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.633 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 1.2 m -49.86 -37.59 31.64 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.377 -0.827 . . . . 0.0 111.176 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 136.21 55.99 0.06 OUTLIER Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 176.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.743 HG21 HG12 ' A' ' 33' ' ' VAL . 37.4 t -132.07 114.36 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.515 -0.991 . . . . 0.0 110.139 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.2 m -82.57 56.53 3.36 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.467 -0.77 . . . . 0.0 109.215 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.661 HD11 ' HD2' ' A' ' 46' ' ' ARG . 2.1 tt -117.49 125.51 28.06 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.433 -0.792 . . . . 0.0 109.581 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 79' ' ' ILE . 21.9 Cg_exo -64.46 -37.13 40.33 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 122.786 2.324 . . . . 0.0 111.79 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.488 ' C ' ' CD1' ' A' ' 81' ' ' TYR . 0.8 OUTLIER -77.83 138.83 39.17 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.995 -1.066 . . . . 0.0 109.76 -179.396 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.418 ' HB ' ' CB ' ' A' ' 69' ' ' ALA . 30.0 p -107.79 168.21 9.42 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.499 -0.751 . . . . 0.0 110.327 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.613 HG13 HD22 ' A' ' 53' ' ' LEU . 1.2 mp -84.6 58.31 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.9 m -136.49 40.4 2.61 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.541 -0.725 . . . . 0.0 109.149 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 87' ' ' THR . 66.9 p 39.72 -115.69 0.2 Allowed 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -178.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.1 m 62.75 -60.87 0.13 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.389 -0.819 . . . . 0.0 111.416 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 85' ' ' THR . 3.7 t -75.76 158.61 32.01 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.247 -0.908 . . . . 0.0 111.181 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -104.52 6.72 34.93 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.476 -0.765 . . . . 0.0 110.418 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.471 ' SG ' ' C ' ' A' ' 50' ' ' CYS . 3.9 m 52.42 49.27 20.82 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.933 -0.479 . . . . 0.0 111.611 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.7 t -111.05 -37.85 5.24 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.981 -178.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -138.71 36.68 2.2 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.486 -0.759 . . . . 0.0 109.507 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.4 p -98.78 11.86 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 O-C-N 121.323 -0.861 . . . . 0.0 110.464 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.768 ' C ' ' HA ' ' A' ' 43' ' ' THR . 27.6 m-20 . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 117.186 -1.388 . . . . 0.0 108.78 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.87 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 2' ' ' ILE . 10.6 tp 35.12 71.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.351 0 CA-C-O 122.092 0.948 . . . . 0.0 111.655 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.6 t -144.59 59.74 1.33 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.72 -1.237 . . . . 0.0 110.521 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.413 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 6.3 t 67.3 -52.5 0.48 Allowed 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -47.32 -48.91 20.69 Favored Glycine 0 N--CA 1.506 3.321 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 177.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.428 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -82.46 -31.05 29.63 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.422 -1.046 . . . . 0.0 110.479 179.531 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.474 HG21 ' HA ' ' A' ' 49' ' ' ALA . 1.7 t -60.72 -46.15 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.596 ' HA ' HG13 ' A' ' 11' ' ' ILE . . . -72.64 -26.33 61.62 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.9 m -68.57 -20.37 64.52 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.323 -0.861 . . . . 0.0 110.34 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.429 ' HB1' ' CA ' ' A' ' 33' ' ' VAL . . . -98.24 -36.42 10.03 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.248 -0.908 . . . . 0.0 110.477 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.596 HG13 ' HA ' ' A' ' 8' ' ' ALA . 2.6 pp -80.0 -31.7 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.378 -0.826 . . . . 0.0 110.541 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.543 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -46.76 -50.89 41.3 Favored Pre-proline 0 N--CA 1.501 2.107 0 O-C-N 121.45 -0.782 . . . . 0.0 109.897 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.555 ' HG2' ' HA ' ' A' ' 29' ' ' CYS . 19.3 Cg_endo -63.08 -13.02 32.76 Favored 'Trans proline' 0 CA--C 1.548 1.178 0 C-N-CA 122.23 1.953 . . . . 0.0 111.412 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.2 m -125.45 24.06 7.37 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 175.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.446 ' CD1' HG13 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -60.06 -50.16 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 118.684 0.674 . . . . 0.0 111.019 177.18 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.474 ' HA ' ' HB3' ' A' ' 19' ' ' ARG . 1.5 m -67.58 -45.73 74.69 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.251 -0.906 . . . . 0.0 109.726 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.551 ' CE2' HG12 ' A' ' 71' ' ' ILE . 1.2 t80 -58.69 -48.5 80.9 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.475 ' HB1' ' HB2' ' A' ' 68' ' ' ALA . . . -69.38 -28.98 66.66 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.592 -0.692 . . . . 0.0 109.375 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.487 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 9.9 ttm180 -75.34 -18.24 60.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.653 -0.654 . . . . 0.0 109.864 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.46 20.83 11.34 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.451 ' O ' ' HB3' ' A' ' 16' ' ' SER . 26.7 tt0 -123.06 82.34 1.98 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . 158.88 -153.75 24.86 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 46.4 t 170.17 60.45 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.795 -0.827 . . . . 0.0 109.233 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 160.06 123.12 0.68 Allowed Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.597 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 32.0 Cg_endo -63.1 124.8 14.57 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 122.571 2.18 . . . . 0.0 110.918 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.2 p -77.36 154.43 32.79 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.484 -0.76 . . . . 0.0 109.612 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.31 -57.76 10.88 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.461 -0.775 . . . . 0.0 110.245 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -53.94 -37.96 59.2 Favored Glycine 0 N--CA 1.501 3.011 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.555 ' HA ' ' HG2' ' A' ' 13' ' ' PRO . 6.4 t -66.63 -73.24 0.14 Allowed 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.749 177.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.597 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 0.5 OUTLIER -44.81 -41.52 7.06 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.238 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.438 ' HA ' ' HG2' ' A' ' 34' ' ' ARG . 35.8 t -73.15 -52.03 15.68 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.414 178.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.21 -41.24 96.62 Favored Glycine 0 N--CA 1.5 2.913 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.792 HG12 HG21 ' A' ' 77' ' ' VAL . 57.7 t -72.54 -50.23 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.339 -1.094 . . . . 0.0 109.85 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.438 ' HG2' ' HA ' ' A' ' 31' ' ' SER . 11.6 ptm180 -62.1 -23.04 66.29 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.5 -0.75 . . . . 0.0 110.351 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 57.6 p -88.4 -42.3 12.26 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.314 -0.866 . . . . 0.0 109.373 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.712 HD23 ' HA ' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -52.24 -32.89 39.04 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.322 -0.861 . . . . 0.0 109.344 178.794 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.498 ' HB2' HG13 ' A' ' 77' ' ' VAL . 8.9 t-20 -74.78 -8.56 56.81 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.932 -0.48 . . . . 0.0 111.168 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -105.44 -26.95 11.72 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.501 -1.375 . . . . 0.0 110.855 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.41 -13.86 61.98 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.287 -0.883 . . . . 0.0 110.219 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 1.05 ' HB1' ' HB3' ' A' ' 45' ' ' ASP . . . -163.1 139.54 7.23 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.51 -0.743 . . . . 0.0 110.297 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.51 ' HG2' HH11 ' A' ' 46' ' ' ARG . 4.4 mtm180 -172.62 51.32 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.228 -0.92 . . . . 0.0 110.613 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.569 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.9 OUTLIER -133.6 57.99 1.79 Allowed 'General case' 0 N--CA 1.508 2.466 0 O-C-N 120.987 -1.07 . . . . 0.0 109.979 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.61 ' CB ' ' HA ' ' A' ' 93' ' ' ASN . 12.6 t 54.66 -53.8 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.105 0 C-N-CA 123.988 0.915 . . . . 0.0 111.775 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 42' ' ' THR . . . -61.37 -51.86 67.03 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 1.05 ' HB3' ' HB1' ' A' ' 40' ' ' ALA . 6.3 m-20 -66.87 -42.86 84.91 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.567 ' HD2' HG13 ' A' ' 79' ' ' ILE . 1.0 OUTLIER -62.01 -48.35 80.7 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.411 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.553 ' HA ' ' SG ' ' A' ' 50' ' ' CYS . 72.0 mtt180 -67.43 -37.13 82.53 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.247 -0.908 . . . . 0.0 109.213 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.47 -50.21 74.54 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 177.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.513 ' HB2' HD11 ' A' ' 2' ' ' ILE . . . -60.74 -42.65 97.77 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.553 ' SG ' ' HA ' ' A' ' 47' ' ' ARG . 4.3 p -66.23 -33.15 75.1 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.591 -0.693 . . . . 0.0 110.509 -177.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.5 ' N ' ' SG ' ' A' ' 50' ' ' CYS . 1.7 t30 -62.93 -54.15 43.0 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 124.06 0.85 . . . . 0.0 109.334 176.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 18.6 t -68.41 -38.79 81.59 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 119.166 -1.014 . . . . 0.0 111.314 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 53' ' ' LEU . 12.4 mt -56.03 -41.97 75.81 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 124.377 1.048 . . . . 0.0 108.619 176.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.419 ' HG2' ' CB ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -58.61 -50.22 74.61 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.109 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -59.34 -41.51 89.34 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.404 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -69.78 -55.86 8.72 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.477 -0.764 . . . . 0.0 109.403 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.467 ' O ' HD22 ' A' ' 63' ' ' LEU . . . -54.59 -47.67 73.05 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.586 -0.696 . . . . 0.0 110.297 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.11 7.34 7.64 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.319 -0.863 . . . . 0.0 110.726 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -132.99 7.52 5.14 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.446 HG13 ' CD1' ' A' ' 15' ' ' ILE . 2.5 t -79.73 133.92 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.128 -1.219 . . . . 0.0 109.382 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.8 p -65.57 94.21 0.18 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.514 -0.741 . . . . 0.0 109.284 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 112.93 -78.52 0.25 Allowed Glycine 0 N--CA 1.497 2.715 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.491 ' CD2' HG23 ' A' ' 85' ' ' THR . 16.7 tp 69.12 134.43 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 122.2 1.0 . . . . 0.0 111.316 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.477 ' HB3' ' HB2' ' A' ' 67' ' ' ASN . 6.8 t-20 -135.84 106.09 6.37 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.0 -57.82 8.35 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.623 -0.673 . . . . 0.0 111.463 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.45 -47.69 68.22 Favored Glycine 0 N--CA 1.504 3.18 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 64' ' ' ASN . 1.8 m-20 -69.84 -58.94 3.28 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.625 -0.926 . . . . 0.0 110.25 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.475 ' HB2' ' HB1' ' A' ' 18' ' ' ALA . . . -57.35 -32.4 66.72 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.474 -0.766 . . . . 0.0 112.273 -178.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.46 -52.57 7.88 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.879 -1.138 . . . . 0.0 110.189 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 90.6 p -68.3 -34.25 75.81 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.653 -0.654 . . . . 0.0 111.122 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.551 HG12 ' CE2' ' A' ' 17' ' ' TYR . 28.1 mt -47.83 -65.33 0.77 Allowed Pre-proline 0 N--CA 1.503 2.215 0 O-C-N 121.516 -0.74 . . . . 0.0 110.357 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.577 ' HB3' HG11 ' A' ' 33' ' ' VAL . 28.3 Cg_endo -61.65 -50.23 5.8 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 122.218 1.945 . . . . 0.0 110.557 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 40.6 t -51.52 -60.84 2.7 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.828 -0.545 . . . . 0.0 110.151 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.2 tptp -64.36 -41.28 96.81 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.721 -0.612 . . . . 0.0 110.1 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -48.16 -50.44 28.9 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 120.019 -0.673 . . . . 0.0 111.707 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.61 46.99 0.01 OUTLIER Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 176.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.792 HG21 HG12 ' A' ' 33' ' ' VAL . 53.5 t -129.23 125.65 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.643 -0.916 . . . . 0.0 110.106 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.5 t -112.45 81.0 1.4 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.567 HG13 ' HD2' ' A' ' 46' ' ' ARG . 11.1 tt -121.3 137.38 26.76 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.652 -0.655 . . . . 0.0 109.27 -178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 79' ' ' ILE . 50.9 Cg_exo -52.75 -41.74 67.66 Favored 'Trans proline' 0 N--CA 1.483 0.889 0 C-N-CA 122.785 2.324 . . . . 0.0 113.114 -178.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.478 ' HH ' ' HB3' ' A' ' 49' ' ' ALA . 5.9 p90 -93.6 147.91 22.57 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 120.626 -1.296 . . . . 0.0 110.824 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -84.1 152.91 24.05 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.598 -0.688 . . . . 0.0 109.503 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.501 HD12 ' N ' ' A' ' 83' ' ' ILE . 2.0 mp -85.38 93.74 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.487 -0.758 . . . . 0.0 109.951 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.9 p -170.89 -175.65 1.82 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.417 -0.802 . . . . 0.0 109.827 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.491 HG23 ' CD2' ' A' ' 63' ' ' LEU . 0.6 OUTLIER -62.88 -28.91 70.36 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.807 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 32.9 m -83.93 45.76 1.12 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.527 -0.733 . . . . 0.0 109.819 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.419 ' CB ' ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -77.01 139.0 39.94 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.341 -0.849 . . . . 0.0 109.977 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -95.4 134.63 37.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.449 -0.782 . . . . 0.0 109.872 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 94.5 m -143.47 53.57 1.33 Allowed 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.675 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 89.7 p -159.15 -48.48 0.06 Allowed 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.732 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.579 ' HB2' ' CZ ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -113.41 21.16 15.46 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.462 HG21 ' HD2' ' A' ' 81' ' ' TYR . 3.3 p -101.9 129.99 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-O 121.638 0.733 . . . . 0.0 109.794 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.61 ' HA ' ' CB ' ' A' ' 43' ' ' THR . 72.4 m-20 . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 116.506 -1.711 . . . . 0.0 108.969 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.798 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.803 HG21 ' HB3' ' A' ' 45' ' ' ASP . 3.5 tp -69.12 82.56 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 CA-C-O 121.757 0.789 . . . . 0.0 109.82 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.4 ' O ' ' HG3' ' A' ' 6' ' ' GLN . 46.1 t -115.81 169.54 9.14 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.244 -0.91 . . . . 0.0 109.994 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 26.5 t -62.33 -33.64 75.09 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.665 -0.814 . . . . 0.0 112.65 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -50.56 -51.09 33.92 Favored Glycine 0 N--CA 1.502 3.062 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -77.24 -36.05 54.94 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.279 -1.13 . . . . 0.0 110.308 -179.635 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.479 HG21 ' HA ' ' A' ' 49' ' ' ALA . 83.2 t -56.52 -46.66 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.74 -35.59 72.74 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.6 t -69.0 -21.86 64.12 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.272 -0.893 . . . . 0.0 109.825 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.28 -27.93 21.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.509 -0.744 . . . . 0.0 109.018 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.512 HD11 HG21 ' A' ' 83' ' ' ILE . 1.2 tp -79.5 -40.63 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.356 -0.84 . . . . 0.0 110.023 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.536 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -44.26 -51.46 19.23 Favored Pre-proline 0 N--CA 1.504 2.225 0 O-C-N 121.646 -0.659 . . . . 0.0 110.977 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 32.9 Cg_endo -65.79 -28.17 51.47 Favored 'Trans proline' 0 N--CA 1.483 0.911 0 C-N-CA 122.281 1.987 . . . . 0.0 110.592 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.841 ' SG ' HG21 ' A' ' 71' ' ' ILE . 1.3 m -101.28 16.79 24.39 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 177.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.787 HD13 HG13 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -65.79 -51.1 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.507 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.1 p -59.76 -57.79 11.38 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.324 -0.86 . . . . 0.0 109.302 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.716 ' CD1' HD11 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -55.3 -54.45 43.38 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.522 ' HB1' ' HB2' ' A' ' 68' ' ' ALA . . . -65.11 -25.37 67.74 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.416 -0.802 . . . . 0.0 110.003 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.474 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 10.5 ttp180 -79.02 -26.03 43.23 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.319 -0.863 . . . . 0.0 110.006 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 148.32 -12.95 1.23 Allowed Glycine 0 N--CA 1.5 2.916 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.9 mp0 -82.53 64.38 7.15 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.923 -1.34 . . . . 0.0 108.875 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.556 ' HA2' ' CD1' ' A' ' 17' ' ' TYR . . . -76.34 75.69 1.56 Allowed Glycine 0 N--CA 1.5 2.904 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.62 36.05 0.06 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.717 -0.873 . . . . 0.0 110.05 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 178.11 78.78 0.06 OUTLIER Glycine 0 N--CA 1.499 2.836 0 C-N-CA 120.075 -1.059 . . . . 0.0 110.51 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -59.91 131.88 41.94 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 122.17 1.913 . . . . 0.0 109.928 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.1 t -90.06 120.17 31.03 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.268 -0.895 . . . . 0.0 110.602 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.87 -45.2 74.56 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.38 -46.0 87.93 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.5 t -54.07 -42.28 69.11 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.301 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 80.4 m -61.76 -47.6 84.47 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.926 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.1 t -65.19 -40.55 94.38 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 124.259 0.974 . . . . 0.0 110.906 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.25 -57.07 12.43 Favored Glycine 0 N--CA 1.5 2.908 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.647 HG11 ' CB ' ' A' ' 72' ' ' PRO . 16.4 t -62.94 -46.54 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.488 -1.007 . . . . 0.0 109.442 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.576 ' N ' HG22 ' A' ' 77' ' ' VAL . 0.5 OUTLIER -54.54 -31.08 55.76 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.694 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.7 m -78.86 -44.09 23.62 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.536 HD23 ' HA ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -56.86 -43.7 81.45 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.632 -0.668 . . . . 0.0 109.995 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.636 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 51.3 t30 -74.72 -35.48 62.69 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.167 -0.958 . . . . 0.0 109.912 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -63.83 -37.72 88.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.039 -1.038 . . . . 0.0 108.395 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.29 -43.53 13.65 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.786 -0.571 . . . . 0.0 110.617 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.596 ' HB2' HG12 ' A' ' 2' ' ' ILE . . . -103.9 111.44 23.97 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.06 -1.025 . . . . 0.0 111.441 -178.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.636 ' HG3' ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -157.84 26.48 0.27 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.781 -0.575 . . . . 0.0 110.0 179.044 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.423 ' O ' ' HB ' ' A' ' 43' ' ' THR . 0.2 OUTLIER -127.64 34.7 4.62 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.127 -0.983 . . . . 0.0 109.624 -179.441 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.453 ' OG1' ' HA ' ' A' ' 93' ' ' ASN . 27.9 m 70.09 -66.08 0.29 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.562 -0.711 . . . . 0.0 109.924 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.91 -57.06 10.5 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.707 -0.62 . . . . 0.0 110.677 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.803 ' HB3' HG21 ' A' ' 2' ' ' ILE . 6.5 m-20 -67.2 -36.89 82.67 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.495 HH12 ' HB3' ' A' ' 81' ' ' TYR . 5.6 mmm180 -67.95 -39.45 83.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.629 -0.669 . . . . 0.0 109.684 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.444 ' HG2' ' NH1' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -58.82 -41.89 87.9 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.428 -0.795 . . . . 0.0 108.995 178.977 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.42 -46.49 86.34 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.577 ' HB2' HD11 ' A' ' 2' ' ' ILE . . . -64.14 -41.58 97.14 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 50.0 t -66.31 -35.83 81.39 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.613 -0.68 . . . . 0.0 110.569 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -66.54 -55.76 14.0 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 124.152 0.908 . . . . 0.0 109.813 176.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 42.1 t -61.63 -35.7 78.66 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.862 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.601 HD22 HG23 ' A' ' 83' ' ' ILE . 12.1 mt -61.15 -53.19 60.15 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 124.336 1.022 . . . . 0.0 109.011 176.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 43.8 tttp -55.82 -37.64 68.94 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.78 -29.77 69.05 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.532 -0.73 . . . . 0.0 110.817 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.513 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -94.96 -49.3 5.62 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.271 -0.893 . . . . 0.0 110.378 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.603 ' HA ' HD13 ' A' ' 63' ' ' LEU . . . -53.65 -49.59 67.59 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.36 -0.838 . . . . 0.0 109.522 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.46 67.05 1.02 Allowed 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 61' ' ' SER . . . 165.16 -22.87 0.14 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.787 HG13 HD13 ' A' ' 15' ' ' ILE . 24.7 t -64.52 69.85 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 121.29 -1.124 . . . . 0.0 109.942 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.456 ' CB ' ' HD2' ' A' ' 19' ' ' ARG . 43.3 m 54.38 -102.68 0.15 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.222 -0.924 . . . . 0.0 110.022 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -100.0 -29.11 6.99 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.603 HD13 ' HA ' ' A' ' 57' ' ' ALA . 21.7 tp 63.54 99.98 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.807 -0.82 . . . . 0.0 111.047 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -98.62 95.43 7.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.205 -0.934 . . . . 0.0 108.643 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -49.31 -50.44 39.38 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.734 -0.604 . . . . 0.0 111.042 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.07 -32.7 50.2 Favored Glycine 0 N--CA 1.505 3.261 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.441 ' O ' HG13 ' A' ' 71' ' ' ILE . 3.7 m-20 -82.87 -48.98 10.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.52 -0.988 . . . . 0.0 109.435 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.522 ' HB2' ' HB1' ' A' ' 18' ' ' ALA . . . -69.25 -21.42 63.91 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.687 -0.633 . . . . 0.0 111.408 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.441 ' HB2' ' HB ' ' A' ' 82' ' ' THR . . . -89.44 -41.35 12.13 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.011 -1.056 . . . . 0.0 110.253 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 76.6 p -68.99 -45.39 70.71 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.499 -0.751 . . . . 0.0 110.954 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.841 HG21 ' SG ' ' A' ' 14' ' ' CYS . 44.0 mt -47.95 -64.55 1.03 Allowed Pre-proline 0 N--CA 1.503 2.208 0 O-C-N 121.647 -0.658 . . . . 0.0 111.589 -178.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.647 ' CB ' HG11 ' A' ' 33' ' ' VAL . 28.4 Cg_endo -59.27 -48.87 12.28 Favored 'Trans proline' 0 N--CA 1.48 0.677 0 C-N-CA 121.745 1.63 . . . . 0.0 110.566 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.1 m -49.45 -68.96 0.13 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -33.59 75.62 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -47.78 -35.43 9.99 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.794 -0.566 . . . . 0.0 110.453 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 124.74 54.4 0.18 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.011 -2.036 . . . . 0.0 108.011 177.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.576 HG22 ' N ' ' A' ' 34' ' ' ARG . 85.2 t -111.09 -48.57 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.205 -178.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 77' ' ' VAL . 19.7 m 68.33 33.59 4.15 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.677 -0.639 . . . . 0.0 110.149 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.657 HG12 ' CD1' ' A' ' 81' ' ' TYR . 9.7 tt -95.78 121.35 61.44 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.059 -1.026 . . . . 0.0 109.06 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -65.31 56.6 0.31 Allowed 'Trans proline' 0 CA--C 1.55 1.294 0 C-N-CA 122.51 2.14 . . . . 0.0 112.711 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.657 ' CD1' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -178.54 152.31 0.64 Allowed 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.332 -0.855 . . . . 0.0 110.271 177.443 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.441 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 53.6 p -108.64 171.37 7.46 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.65 0.738 . . . . 0.0 110.592 -178.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.601 HG23 HD22 ' A' ' 53' ' ' LEU . 2.0 mp -104.44 67.12 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 122.012 0.911 . . . . 0.0 108.702 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.419 ' O ' ' CB ' ' A' ' 85' ' ' THR . 86.2 p -98.37 -18.39 18.33 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.494 -0.754 . . . . 0.0 110.627 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.419 ' CB ' ' O ' ' A' ' 84' ' ' SER . 0.5 OUTLIER 81.04 -16.44 0.65 Allowed 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.781 -0.574 . . . . 0.0 110.995 -179.282 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.9 m -76.17 -21.88 56.02 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.017 -1.052 . . . . 0.0 109.013 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -47.74 145.8 2.61 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.621 0.724 . . . . 0.0 111.1 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -88.93 -13.23 39.5 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.995 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 54.6 m 52.87 51.25 16.29 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.465 0.65 . . . . 0.0 111.291 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.96 -42.64 0.27 Allowed 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.552 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.8 31.74 4.83 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.3 p -109.48 118.84 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.768 -0.582 . . . . 0.0 109.462 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.453 ' HA ' ' OG1' ' A' ' 43' ' ' THR . 2.9 p-10 . . . . . 0 N--CA 1.497 1.912 0 CA-C-O 114.6 -2.619 . . . . 0.0 110.17 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.782 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.694 HG21 ' HA ' ' A' ' 45' ' ' ASP . 4.2 tp -71.68 99.26 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.319 -0.863 . . . . 0.0 109.828 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.8 t -135.17 172.61 12.76 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.314 -0.867 . . . . 0.0 110.205 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.8 t -67.86 -20.78 65.17 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -56.7 -54.48 36.12 Favored Glycine 0 N--CA 1.504 3.176 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.441 ' NE2' ' HB3' ' A' ' 36' ' ' LEU . 8.4 tt0 -67.66 -40.65 84.48 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.456 -1.026 . . . . 0.0 108.516 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.442 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 77.5 t -53.78 -44.91 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.87 -35.95 75.09 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.7 t -69.39 -22.2 63.73 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.44 -0.788 . . . . 0.0 109.241 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.561 ' C ' ' HD2' ' A' ' 13' ' ' PRO . . . -98.05 -25.43 14.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.51 -0.744 . . . . 0.0 109.236 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.442 ' HB ' ' O ' ' A' ' 7' ' ' VAL . 1.8 tp -78.77 -42.31 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.218 -0.926 . . . . 0.0 110.072 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.638 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -46.43 -51.16 36.92 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.588 -0.695 . . . . 0.0 110.432 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.638 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 11.2 Cg_exo -67.26 -28.76 39.7 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.136 1.891 . . . . 0.0 110.992 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.659 ' SG ' HG21 ' A' ' 71' ' ' ILE . 1.3 m -103.07 14.38 31.99 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 178.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.461 ' O ' ' CB ' ' A' ' 19' ' ' ARG . 0.4 OUTLIER -74.16 -44.5 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -178.474 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.1 p -65.74 -56.84 9.89 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.718 ' CG ' HD11 ' A' ' 71' ' ' ILE . 0.5 OUTLIER -54.82 -55.35 31.12 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.579 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.495 ' HB1' ' HB2' ' A' ' 68' ' ' ALA . . . -60.01 -32.05 70.51 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.313 -0.867 . . . . 0.0 109.439 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.461 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 11.9 ttt180 -78.42 -5.89 53.69 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.647 -0.658 . . . . 0.0 110.623 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.56 -12.43 39.21 Favored Glycine 0 N--CA 1.501 3.025 0 O-C-N 120.666 -1.272 . . . . 0.0 111.412 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -105.06 81.38 1.72 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.136 -1.214 . . . . 0.0 109.333 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -146.44 -177.03 20.76 Favored Glycine 0 N--CA 1.499 2.838 0 C-N-CA 119.686 -1.245 . . . . 0.0 111.356 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -176.38 49.98 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.13 136.93 3.73 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 108.504 -1.839 . . . . 0.0 108.504 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.452 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . 30.4 Cg_endo -60.98 130.22 31.84 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 122.158 1.905 . . . . 0.0 111.136 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.1 t -74.04 123.81 25.07 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.507 -0.746 . . . . 0.0 109.718 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.51 -46.43 73.5 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.502 -0.749 . . . . 0.0 109.879 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.1 -48.3 86.57 Favored Glycine 0 N--CA 1.503 3.164 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.0 OUTLIER -58.74 -55.19 38.24 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.095 178.328 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 96.2 m -58.76 -27.17 64.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 124.027 0.829 . . . . 0.0 112.033 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.2 m -74.23 -47.7 33.6 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 123.825 0.703 . . . . 0.0 109.296 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.531 ' HA3' ' HB2' ' A' ' 10' ' ' ALA . . . -65.0 -28.26 73.29 Favored Glycine 0 N--CA 1.5 2.953 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.754 HG12 HG11 ' A' ' 77' ' ' VAL . 21.2 t -81.91 -48.22 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.269 -1.136 . . . . 0.0 108.762 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.494 ' HA ' HG22 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -61.9 -25.78 67.77 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.358 -0.839 . . . . 0.0 109.05 179.071 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.437 ' HB3' ' NH2' ' A' ' 34' ' ' ARG . 79.6 p -74.0 -46.38 44.03 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.673 HD23 ' HA ' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -63.24 -30.86 71.93 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.671 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.785 ' HB2' HG13 ' A' ' 77' ' ' VAL . 3.1 t-20 -63.39 -36.17 82.84 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.025 -1.047 . . . . 0.0 110.215 179.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -90.38 -36.33 14.68 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.463 -0.773 . . . . 0.0 110.099 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.26 -18.48 25.56 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.538 -0.727 . . . . 0.0 111.076 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.683 ' HA ' ' CB ' ' A' ' 45' ' ' ASP . . . -123.56 110.49 15.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.011 -1.055 . . . . 0.0 110.508 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -163.32 -20.19 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.411 -0.806 . . . . 0.0 112.081 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 44' ' ' ALA . 89.7 m -78.28 50.02 0.88 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.648 -1.283 . . . . 0.0 110.292 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.705 HG23 ' HA ' ' A' ' 93' ' ' ASN . 97.9 m 62.4 -64.6 0.09 Allowed 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.846 -0.534 . . . . 0.0 110.015 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 42' ' ' THR . . . -48.45 -57.29 6.32 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 122.067 -0.396 . . . . 0.0 110.419 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.694 ' HA ' HG21 ' A' ' 2' ' ' ILE . 3.1 m-20 -55.26 -45.45 76.09 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.575 HH11 ' HB2' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -57.51 -55.23 37.52 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.738 178.825 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -59.92 -44.14 94.48 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.15 -50.88 71.39 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.535 -0.728 . . . . 0.0 109.317 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.629 ' HB2' HD11 ' A' ' 2' ' ' ILE . . . -63.56 -55.27 25.11 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.515 ' HA ' ' HB2' ' A' ' 53' ' ' LEU . 3.7 t -48.63 -39.42 24.03 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 174.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.419 ' N ' ' SG ' ' A' ' 89' ' ' CYS . 2.8 t30 -60.35 -53.09 61.81 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 176.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.6 t -68.54 -32.26 72.07 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 119.766 -0.774 . . . . 0.0 111.598 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.563 HD22 HG12 ' A' ' 83' ' ' ILE . 13.6 mt -63.0 -57.56 10.29 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.072 178.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -54.73 -39.4 68.21 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -54.51 -50.75 67.1 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.538 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -72.03 -44.17 63.82 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.507 -0.746 . . . . 0.0 109.205 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.551 ' HA ' ' CD1' ' A' ' 63' ' ' LEU . . . -54.88 -37.79 66.73 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.629 -0.669 . . . . 0.0 110.297 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.445 ' HA ' HG23 ' A' ' 85' ' ' THR . . . -85.89 8.03 21.83 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.237 -0.914 . . . . 0.0 110.43 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -140.3 11.56 3.02 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 56' ' ' ALA . 3.8 t -79.04 -28.01 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.234 -1.157 . . . . 0.0 109.937 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 60' ' ' VAL . 0.6 OUTLIER 77.25 113.26 0.07 Allowed 'General case' 0 N--CA 1.506 2.369 0 CA-C-O 121.275 0.559 . . . . 0.0 109.946 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.48 34.22 87.1 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.551 ' CD1' ' HA ' ' A' ' 57' ' ' ALA . 10.0 tt -64.68 121.86 15.5 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.463 -1.022 . . . . 0.0 110.406 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -97.09 90.05 5.02 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -44.28 -48.47 9.5 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.912 -0.492 . . . . 0.0 110.494 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -50.68 -40.52 40.92 Favored Glycine 0 N--CA 1.502 3.07 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -76.46 -56.4 4.66 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.703 -0.88 . . . . 0.0 109.344 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.495 ' HB2' ' HB1' ' A' ' 18' ' ' ALA . . . -59.44 -24.7 63.74 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.906 -0.496 . . . . 0.0 111.769 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.01 -47.48 7.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.956 -1.09 . . . . 0.0 110.419 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 t -64.54 -31.27 72.42 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.445 -0.784 . . . . 0.0 111.056 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.718 HD11 ' CG ' ' A' ' 17' ' ' TYR . 78.0 mt -60.43 -70.38 0.44 Allowed Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 121.204 -0.935 . . . . 0.0 111.007 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.694 ' CB ' HG11 ' A' ' 33' ' ' VAL . 38.0 Cg_endo -60.07 -51.67 5.33 Favored 'Trans proline' 0 N--CA 1.484 0.944 0 C-N-CA 122.328 2.019 . . . . 0.0 112.077 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.2 p -51.45 -63.67 1.06 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.692 -0.63 . . . . 0.0 110.487 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.7 mmtt -63.11 -42.33 99.53 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 122.15 -0.343 . . . . 0.0 110.604 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 71' ' ' ILE . 0.4 OUTLIER -47.36 -55.22 9.27 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.506 -0.746 . . . . 0.0 112.12 -177.502 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 164.9 50.97 0.02 OUTLIER Glycine 0 N--CA 1.496 2.653 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.785 HG13 ' HB2' ' A' ' 37' ' ' ASN . 46.8 t -130.85 93.59 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.756 -0.85 . . . . 0.0 110.323 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 56.7 p -70.1 66.44 0.27 Allowed 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.6 0.714 . . . . 0.0 110.365 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.618 HG12 ' CE1' ' A' ' 81' ' ' TYR . 0.4 OUTLIER -124.94 120.36 25.49 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.173 -0.954 . . . . 0.0 108.79 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.91 -27.5 74.76 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 C-N-CA 122.955 2.436 . . . . 0.0 113.679 -177.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.618 ' CE1' HG12 ' A' ' 79' ' ' ILE . 12.9 p90 -89.59 130.12 35.94 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.794 -1.191 . . . . 0.0 111.063 -178.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.1 p -102.68 155.51 18.26 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.738 0.78 . . . . 0.0 110.655 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.607 HD12 ' N ' ' A' ' 83' ' ' ILE . 2.0 mp -86.92 85.21 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.412 ' O ' ' HB ' ' A' ' 85' ' ' THR . 59.5 p -114.39 13.79 17.8 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.526 -0.734 . . . . 0.0 111.866 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.445 HG23 ' HA ' ' A' ' 58' ' ' ALA . 86.0 m 68.78 -56.82 0.52 Allowed 'General case' 0 N--CA 1.51 2.567 0 O-C-N 121.211 -0.93 . . . . 0.0 108.86 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 84' ' ' SER . 42.0 m -68.43 -25.6 65.1 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.289 -0.882 . . . . 0.0 109.167 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 94.4 m -38.48 140.92 0.29 Allowed 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 121.362 0.601 . . . . 0.0 110.697 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -85.3 139.9 31.24 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.594 -0.691 . . . . 0.0 110.56 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 51' ' ' ASN . 0.5 OUTLIER -122.73 56.26 1.15 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.934 0.873 . . . . 0.0 110.61 176.448 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.1 m -151.34 -41.15 0.12 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.092 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.06 -1.09 37.8 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.264 -0.897 . . . . 0.0 110.311 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.9 t -73.26 136.51 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 O-C-N 121.049 -1.032 . . . . 0.0 109.714 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.705 ' HA ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 114.0 -2.905 . . . . 0.0 110.05 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 121.291 0.567 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.777 ' CD1' ' HB2' ' A' ' 49' ' ' ALA . 1.3 pp -90.49 101.81 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.429 ' O ' ' HG3' ' A' ' 6' ' ' GLN . 27.7 t -96.13 -167.73 1.63 Allowed 'General case' 0 N--CA 1.503 2.211 0 O-C-N 120.894 -1.129 . . . . 0.0 111.199 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 33.5 t -74.96 -29.05 60.81 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -54.5 -50.57 56.46 Favored Glycine 0 N--CA 1.504 3.226 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 177.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.468 ' CD ' ' HB2' ' A' ' 36' ' ' LEU . 0.5 OUTLIER -66.67 -34.93 78.95 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.486 -1.009 . . . . 0.0 109.415 179.111 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.507 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 61.6 t -59.05 -38.27 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 177.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.511 ' HA ' HG13 ' A' ' 11' ' ' ILE . . . -68.97 -34.84 75.97 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.56 -16.36 63.84 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.531 -0.731 . . . . 0.0 109.573 178.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.698 ' HB1' HG22 ' A' ' 33' ' ' VAL . . . -94.11 -31.84 14.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.505 -0.747 . . . . 0.0 110.145 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.532 HD12 ' N ' ' A' ' 12' ' ' ALA . 2.4 pp -95.18 -30.79 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.31 -0.869 . . . . 0.0 111.443 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.574 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -50.87 -52.84 53.69 Favored Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.133 -0.979 . . . . 0.0 110.449 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.574 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 71.5 Cg_endo -73.46 -10.05 23.48 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.405 2.07 . . . . 0.0 111.019 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.634 ' SG ' ' HB3' ' A' ' 25' ' ' PRO . 15.6 m -124.61 21.0 8.56 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.56 ' CD1' HG13 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -67.04 -50.69 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.548 -179.129 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.494 ' HA ' ' HB3' ' A' ' 19' ' ' ARG . 20.2 m -62.48 -46.91 86.34 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.278 -0.889 . . . . 0.0 110.091 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.608 ' CD2' HG12 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -59.31 -56.14 25.92 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.835 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.96 -28.21 64.13 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.494 ' HB3' ' HA ' ' A' ' 16' ' ' SER . 0.0 OUTLIER -75.09 -5.21 42.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.904 -0.497 . . . . 0.0 110.568 179.153 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.04 -5.73 27.2 Favored Glycine 0 N--CA 1.5 2.953 0 O-C-N 120.599 -1.313 . . . . 0.0 111.846 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.46 97.52 3.71 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 118.991 1.395 . . . . 0.0 110.091 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.449 ' HA3' ' CB ' ' A' ' 17' ' ' TYR . . . -153.54 -66.28 0.01 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.7 t 58.65 43.64 18.62 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.507 -0.996 . . . . 0.0 109.037 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 132.37 95.31 0.61 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 107.977 -2.049 . . . . 0.0 107.977 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.634 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 17.1 Cg_exo -59.95 -78.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 122.381 2.054 . . . . 0.0 111.089 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 25' ' ' PRO . 10.8 t 161.83 149.79 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.581 -0.7 . . . . 0.0 109.635 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.35 -36.69 78.6 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.93 -45.01 87.41 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.61 ' O ' HG23 ' A' ' 33' ' ' VAL . 35.3 t -64.63 -52.42 57.54 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.655 -1.218 . . . . 0.0 109.638 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 83.4 m -59.18 -46.94 87.08 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.5 m -68.89 -50.12 52.37 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 124.119 0.887 . . . . 0.0 110.468 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.55 -54.76 33.82 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.698 HG22 ' HB1' ' A' ' 10' ' ' ALA . 38.3 t -60.61 -47.27 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.972 -0.722 . . . . 0.0 109.241 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.549 ' O ' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -56.34 -31.2 63.51 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.41 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.1 m -80.23 -55.12 5.14 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.778 -0.576 . . . . 0.0 109.647 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.539 ' CG ' ' HA ' ' A' ' 33' ' ' VAL . 1.7 pp -58.37 -42.46 87.05 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.254 -0.904 . . . . 0.0 109.133 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.547 ' HB3' HG13 ' A' ' 77' ' ' VAL . 57.8 m-80 -70.92 -20.14 62.51 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.449 -0.782 . . . . 0.0 109.194 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.549 ' HB2' ' O ' ' A' ' 34' ' ' ARG . 52.1 t30 -67.69 -37.52 82.4 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.474 ' HB3' HG22 ' A' ' 2' ' ' ILE . . . -84.15 -24.87 30.02 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.96 -0.462 . . . . 0.0 110.89 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.577 ' N ' HG21 ' A' ' 2' ' ' ILE . . . -82.46 86.88 6.68 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.117 -0.99 . . . . 0.0 110.104 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.618 ' HA ' ' NE ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -152.55 38.19 0.54 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.121 -0.987 . . . . 0.0 110.314 -179.713 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.472 ' O ' ' N ' ' A' ' 44' ' ' ALA . 12.4 p -139.08 35.57 2.12 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 120.935 -1.103 . . . . 0.0 110.805 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.627 HG22 ' HB3' ' A' ' 93' ' ' ASN . 1.1 p 65.19 -60.92 0.24 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.424 -0.798 . . . . 0.0 109.6 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 42' ' ' THR . . . -58.72 -58.16 9.83 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.56 ' O ' HD11 ' A' ' 2' ' ' ILE . 21.8 m-20 -66.1 -45.21 82.01 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.835 0.826 . . . . 0.0 108.83 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.67 ' HG2' HG12 ' A' ' 92' ' ' VAL . 1.8 tpp180 -59.63 -57.63 12.1 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.752 -0.593 . . . . 0.0 110.95 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 -61.6 -38.69 88.54 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.282 -0.886 . . . . 0.0 109.986 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.13 -50.79 70.11 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.777 ' HB2' ' CD1' ' A' ' 2' ' ' ILE . . . -62.4 -46.68 87.49 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.489 ' C ' ' SG ' ' A' ' 89' ' ' CYS . 42.9 t -55.12 -42.19 72.66 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.998 -0.439 . . . . 0.0 111.05 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -67.69 -60.45 2.53 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 124.117 0.885 . . . . 0.0 110.206 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.507 ' SG ' ' HB ' ' A' ' 7' ' ' VAL . 10.8 t -55.36 -29.33 58.2 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.05 178.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.665 HD22 HG13 ' A' ' 83' ' ' ILE . 15.8 mt -70.44 -50.65 36.14 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.13 175.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.5 tttm -56.67 -41.03 76.56 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -56.34 -46.19 80.05 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.05 -41.01 62.42 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.558 -0.714 . . . . 0.0 109.238 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.618 ' HA ' HD13 ' A' ' 63' ' ' LEU . . . -52.92 -43.74 66.47 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.664 -0.647 . . . . 0.0 109.963 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -90.05 18.2 6.09 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.293 -0.879 . . . . 0.0 110.133 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -127.95 -31.48 0.69 Allowed Glycine 0 N--CA 1.501 2.969 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.56 HG13 ' CD1' ' A' ' 15' ' ' ILE . 7.6 t -52.87 135.34 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.54 -0.977 . . . . 0.0 110.272 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.7 t -64.12 107.68 1.35 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.596 -0.69 . . . . 0.0 109.191 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.93 50.09 43.47 Favored Glycine 0 N--CA 1.499 2.88 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.618 HD13 ' HA ' ' A' ' 57' ' ' ALA . 4.0 tp -61.41 126.31 26.89 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.369 -1.077 . . . . 0.0 110.372 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -103.48 93.48 4.97 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -41.49 -46.21 3.42 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.853 -0.53 . . . . 0.0 110.691 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.06 -31.34 48.27 Favored Glycine 0 N--CA 1.502 3.064 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.448 ' O ' HG13 ' A' ' 71' ' ' ILE . 95.4 m-20 -94.59 -49.5 5.61 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.464 -1.021 . . . . 0.0 109.257 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.444 ' HB1' ' CG2' ' A' ' 83' ' ' ILE . . . -57.88 -34.26 69.59 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.702 -0.624 . . . . 0.0 111.049 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.581 ' HA ' ' HB ' ' A' ' 82' ' ' THR . . . -83.79 -47.76 10.79 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.945 -1.097 . . . . 0.0 109.934 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.6 p -68.66 -36.78 78.99 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.537 -0.727 . . . . 0.0 110.984 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.608 HG12 ' CD2' ' A' ' 17' ' ' TYR . 22.4 mt -46.07 -62.44 1.84 Allowed Pre-proline 0 N--CA 1.504 2.271 0 O-C-N 121.436 -0.79 . . . . 0.0 110.584 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.499 ' HG3' HD13 ' A' ' 83' ' ' ILE . 37.9 Cg_endo -62.35 -52.62 2.45 Favored 'Trans proline' 0 C--N 1.321 -0.869 0 C-N-CA 121.907 1.738 . . . . 0.0 110.048 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.6 m -52.46 -60.81 2.78 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.518 -0.739 . . . . 0.0 110.183 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -61.41 -44.65 96.78 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 71' ' ' ILE . 0.9 OUTLIER -47.56 -32.78 5.74 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.554 -0.716 . . . . 0.0 111.264 178.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.54 ' O ' ' HD3' ' A' ' 34' ' ' ARG . . . 126.55 41.47 0.32 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 177.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.68 HG12 ' HB ' ' A' ' 79' ' ' ILE . 12.8 t -92.43 -32.95 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -1.121 . . . . 0.0 110.851 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.8 m 45.25 58.82 3.87 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.536 -0.728 . . . . 0.0 109.435 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.68 ' HB ' HG12 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -140.8 136.71 16.51 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.443 -0.786 . . . . 0.0 109.449 -178.683 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 79' ' ' ILE . 29.2 Cg_exo -58.76 -43.97 39.92 Favored 'Trans proline' 0 C--N 1.318 -1.054 0 C-N-CA 122.842 2.361 . . . . 0.0 112.184 -178.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.483 ' CD1' ' HG3' ' A' ' 46' ' ' ARG . 42.7 p90 -79.7 134.28 36.39 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 122.026 0.917 . . . . 0.0 109.988 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.581 ' HB ' ' HA ' ' A' ' 69' ' ' ALA . 32.4 p -123.21 -175.84 3.28 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.363 0.601 . . . . 0.0 109.916 -178.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.665 HG13 HD22 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -84.48 59.27 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 178.553 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.438 ' O ' ' HB ' ' A' ' 87' ' ' THR . 1.6 p -102.2 136.13 42.57 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.972 -177.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.9 p -61.66 -56.01 24.41 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.514 -0.741 . . . . 0.0 109.014 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 55.9 p -93.32 53.53 1.93 Allowed 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.491 ' CG2' ' SG ' ' A' ' 89' ' ' CYS . 2.4 t -75.7 -170.96 1.42 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.518 -0.739 . . . . 0.0 110.867 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.483 ' N ' HG23 ' A' ' 87' ' ' THR . 22.8 t70 -83.13 -71.74 0.48 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.305 -0.872 . . . . 0.0 109.99 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.491 ' SG ' ' CG2' ' A' ' 87' ' ' THR . 85.1 m 52.19 51.52 16.16 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.274 0.559 . . . . 0.0 112.228 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.2 t -170.12 -49.24 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.492 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -99.54 -22.2 15.58 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.527 -0.733 . . . . 0.0 110.865 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.67 HG12 ' HG2' ' A' ' 46' ' ' ARG . 21.5 t -59.09 138.32 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.001 -1.062 . . . . 0.0 110.065 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.627 ' HB3' HG22 ' A' ' 43' ' ' THR . 61.8 m-20 . . . . . 0 N--CA 1.496 1.852 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.86 HD11 ' HB2' ' A' ' 49' ' ' ALA . 0.9 OUTLIER -117.58 85.5 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-O 121.988 0.899 . . . . 0.0 109.272 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.0 t -146.97 171.22 15.58 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.224 -0.922 . . . . 0.0 110.846 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -56.4 -35.96 68.37 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -58.52 -42.11 95.79 Favored Glycine 0 N--CA 1.502 3.037 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 175.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.63 HE21 HD13 ' A' ' 36' ' ' LEU . 0.8 OUTLIER -79.83 -41.43 26.39 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.574 -0.956 . . . . 0.0 109.168 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 77.0 t -56.33 -42.44 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.442 ' O ' HD13 ' A' ' 11' ' ' ILE . . . -69.66 -36.27 75.9 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.2 t -69.35 -21.24 63.83 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.315 -0.866 . . . . 0.0 108.973 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.464 ' HB2' ' CD2' ' A' ' 36' ' ' LEU . . . -73.49 -52.26 14.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.437 -0.789 . . . . 0.0 110.651 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.443 HD13 ' N ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -80.54 -20.21 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 121.184 -0.948 . . . . 0.0 110.978 -178.879 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.565 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -45.5 -55.36 12.28 Favored Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 121.262 -0.899 . . . . 0.0 110.385 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.565 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 64.4 Cg_endo -70.49 -21.95 29.39 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.251 1.968 . . . . 0.0 110.994 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.544 ' SG ' ' CG2' ' A' ' 71' ' ' ILE . 1.1 m -111.73 27.99 9.16 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.509 HD11 HG13 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -63.24 -44.92 99.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 177.208 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.72 -53.83 50.72 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.392 -0.817 . . . . 0.0 108.807 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.591 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 0.5 OUTLIER -53.77 -60.66 3.02 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.662 -0.648 . . . . 0.0 109.566 178.929 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.642 ' N ' HD11 ' A' ' 71' ' ' ILE . . . -60.1 -31.92 70.49 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.612 -0.68 . . . . 0.0 111.084 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.464 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 9.5 tmm_? -83.84 18.49 1.99 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.453 -0.779 . . . . 0.0 111.602 -178.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.49 14.65 75.65 Favored Glycine 0 N--CA 1.503 3.137 0 O-C-N 120.541 -1.349 . . . . 0.0 112.032 178.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.591 ' O ' ' HA ' ' A' ' 17' ' ' TYR . 1.6 mm-40 -124.8 -176.7 3.61 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.113 -1.228 . . . . 0.0 109.92 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.08 -62.1 0.54 Allowed Glycine 0 N--CA 1.504 3.171 0 O-C-N 121.096 -1.003 . . . . 0.0 110.992 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 76.16 -51.82 0.61 Allowed 'General case' 0 N--CA 1.508 2.461 0 O-C-N 121.557 -0.967 . . . . 0.0 110.372 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.5 134.28 12.46 Favored Glycine 0 N--CA 1.501 2.974 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.43 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 27.6 Cg_endo -62.38 134.3 47.64 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 122.394 2.063 . . . . 0.0 111.017 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 t -79.93 134.56 36.28 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.299 -0.875 . . . . 0.0 109.407 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.28 -50.11 72.32 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.367 -0.833 . . . . 0.0 109.112 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.26 -46.17 94.76 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.496 ' O ' HG23 ' A' ' 33' ' ' VAL . 8.5 t -56.79 -39.68 74.54 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.994 178.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.43 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 82.0 m -71.22 -44.81 64.62 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.597 -175.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 46.7 t -65.65 -40.01 92.0 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 124.048 0.842 . . . . 0.0 109.916 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.76 -60.3 6.29 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.612 HG11 ' HB3' ' A' ' 72' ' ' PRO . 17.3 t -59.38 -47.85 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.581 -0.952 . . . . 0.0 110.946 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.629 ' HA ' HG22 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -57.94 -26.87 62.81 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.237 -0.914 . . . . 0.0 109.537 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.0 m -86.12 -51.07 6.54 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.394 -0.816 . . . . 0.0 109.697 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.63 HD13 HE21 ' A' ' 6' ' ' GLN . 2.7 pp -60.69 -49.2 78.47 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.676 -0.64 . . . . 0.0 110.51 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.595 ' N ' HD12 ' A' ' 36' ' ' LEU . 2.6 m-80 -66.83 -32.55 73.9 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.1 -1.0 . . . . 0.0 108.696 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.528 ' HA ' ' HD2' ' A' ' 41' ' ' ARG . 10.0 t30 -63.79 -38.96 93.07 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.48 -30.37 71.4 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.573 ' HB2' HD13 ' A' ' 2' ' ' ILE . . . -94.16 88.46 5.63 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.508 -0.745 . . . . 0.0 109.82 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.528 ' HD2' ' HA ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -143.1 20.49 1.93 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.937 -1.102 . . . . 0.0 111.922 -179.653 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.421 ' O ' ' HB ' ' A' ' 43' ' ' THR . 2.4 m -115.55 31.96 6.38 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.817 -1.177 . . . . 0.0 109.939 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.589 HG23 ' HA ' ' A' ' 93' ' ' ASN . 58.0 m 69.63 -61.54 0.44 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.456 -0.777 . . . . 0.0 109.297 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.24 -45.56 72.38 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.528 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 8.9 m-20 -73.44 -39.69 64.78 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.489 ' HG3' ' CE1' ' A' ' 81' ' ' TYR . 0.3 OUTLIER -65.14 -47.13 78.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.901 -0.499 . . . . 0.0 111.552 -178.886 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.402 ' NE ' ' O ' ' A' ' 90' ' ' SER . 51.9 mtt180 -65.49 -40.67 93.34 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.009 -1.057 . . . . 0.0 109.517 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.89 -43.19 99.36 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.86 ' HB2' HD11 ' A' ' 2' ' ' ILE 0.268 . . -65.15 -49.69 68.88 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.234 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.495 ' C ' ' SG ' ' A' ' 89' ' ' CYS . 50.2 t -55.26 -40.73 71.3 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.289 -0.882 . . . . 0.0 110.126 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.6 ' O ' ' HG3' ' A' ' 54' ' ' LYS . 1.8 t30 -62.69 -53.41 54.87 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 124.035 0.834 . . . . 0.0 110.481 177.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.9 t -72.2 -20.01 61.64 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.817 -1.153 . . . . 0.0 111.609 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.528 HD13 ' CG1' ' A' ' 83' ' ' ILE . 18.1 mt -68.85 -57.86 4.98 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 124.092 0.87 . . . . 0.0 109.012 175.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.6 ' HG3' ' O ' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -57.17 -28.79 63.11 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.899 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.63 -45.33 53.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.688 -0.632 . . . . 0.0 109.569 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.98 -49.84 47.6 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.418 -0.801 . . . . 0.0 109.75 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.419 ' O ' HD13 ' A' ' 63' ' ' LEU . . . -59.74 -62.23 2.03 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.439 -0.788 . . . . 0.0 109.334 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.634 ' HA ' HD13 ' A' ' 63' ' ' LEU . . . -70.75 77.28 0.61 Allowed 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.73 -16.21 0.94 Allowed Glycine 0 N--CA 1.497 2.749 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.509 HG13 HD11 ' A' ' 15' ' ' ILE . 0.9 OUTLIER -47.7 -58.58 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 CA-C-N 118.54 1.17 . . . . 0.0 110.477 -179.796 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.478 ' N ' HG12 ' A' ' 60' ' ' VAL . 1.5 m 162.79 -62.74 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.513 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -128.28 46.97 1.05 Allowed Glycine 0 N--CA 1.498 2.784 0 N-CA-C 107.462 -2.255 . . . . 0.0 107.462 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.634 HD13 ' HA ' ' A' ' 58' ' ' ALA . 2.5 pt? -50.54 129.48 22.36 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.883 0.849 . . . . 0.0 111.431 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.532 ' HB2' ' HB2' ' A' ' 67' ' ' ASN . 1.6 m-80 -109.27 103.14 12.04 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -36.06 -57.48 0.7 Allowed 'General case' 0 N--CA 1.506 2.349 0 O-C-N 122.028 -0.42 . . . . 0.0 111.775 -178.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.23 -52.41 44.34 Favored Glycine 0 N--CA 1.502 3.074 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.532 ' HB2' ' HB2' ' A' ' 64' ' ' ASN . 2.9 m120 -54.9 -45.39 74.71 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.669 -0.9 . . . . 0.0 110.626 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.536 ' O ' ' HD2' ' A' ' 72' ' ' PRO . . . -55.45 -55.42 31.97 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.783 -0.573 . . . . 0.0 110.252 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.705 ' HB1' HG22 ' A' ' 82' ' ' THR . . . -70.66 -36.98 73.65 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.476 -0.765 . . . . 0.0 110.784 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.5 t -62.12 -28.07 69.37 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.361 -0.837 . . . . 0.0 111.087 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.642 HD11 ' N ' ' A' ' 18' ' ' ALA . 38.4 mt -61.36 -69.67 0.55 Allowed Pre-proline 0 N--CA 1.502 2.15 0 O-C-N 121.243 -0.911 . . . . 0.0 111.442 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.612 ' HB3' HG11 ' A' ' 33' ' ' VAL . 19.5 Cg_endo -58.81 -50.27 9.54 Favored 'Trans proline' 0 N--CA 1.481 0.787 0 C-N-CA 122.141 1.894 . . . . 0.0 110.929 -178.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.0 m -48.51 -70.91 0.08 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 122.099 -0.376 . . . . 0.0 110.478 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.9 mtmm -60.33 -43.14 96.68 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-N 116.965 -0.107 . . . . 0.0 110.746 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 1.5 m -45.48 -35.98 4.17 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.823 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 34' ' ' ARG . . . 122.37 49.88 0.24 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 175.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.629 HG22 ' HA ' ' A' ' 34' ' ' ARG . 90.6 t -90.07 -27.66 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 C-N-CA 118.365 -1.334 . . . . 0.0 112.029 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 77' ' ' VAL . 24.9 p 65.47 16.75 10.67 Favored 'General case' 0 N--CA 1.51 2.56 0 O-C-N 121.103 -0.998 . . . . 0.0 110.564 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.563 ' HB ' HG12 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -89.06 124.75 64.26 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.008 -1.058 . . . . 0.0 108.504 179.341 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.456 ' HD2' ' NH1' ' A' ' 46' ' ' ARG . 37.7 Cg_endo -63.23 -35.86 60.72 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 122.519 2.146 . . . . 0.0 112.214 -178.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.489 ' CE1' ' HG3' ' A' ' 46' ' ' ARG . 17.9 p90 -82.65 142.15 31.93 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.098 -1.001 . . . . 0.0 110.515 -179.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.705 HG22 ' HB1' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -96.38 150.65 20.35 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.489 -0.757 . . . . 0.0 110.633 -178.911 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.528 ' CG1' HD13 ' A' ' 53' ' ' LEU . 4.4 mp -99.71 128.91 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.428 -0.795 . . . . 0.0 109.196 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 62.4 p -150.61 -85.3 0.08 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.236 -0.915 . . . . 0.0 110.379 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.8 p -152.62 -61.11 0.15 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.588 -0.695 . . . . 0.0 109.486 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.6 t -109.5 59.83 0.6 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.617 -0.677 . . . . 0.0 110.088 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.5 m -75.28 164.5 26.38 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.345 -0.847 . . . . 0.0 109.116 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -83.83 80.19 9.23 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.95 -1.094 . . . . 0.0 110.172 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.495 ' SG ' ' C ' ' A' ' 50' ' ' CYS . 14.9 m -82.55 53.31 2.3 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.119 176.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.402 ' O ' ' NE ' ' A' ' 47' ' ' ARG . 41.4 t -144.98 -50.66 0.26 Allowed 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.024 -177.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -99.5 -23.82 14.97 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.331 -0.855 . . . . 0.0 110.414 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.2 t -49.54 142.09 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 O-C-N 121.402 -0.811 . . . . 0.0 111.038 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.589 ' HA ' HG23 ' A' ' 43' ' ' THR . 33.4 m-80 . . . . . 0 N--CA 1.5 2.073 0 CA-C-O 117.039 -1.458 . . . . 0.0 109.134 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.832 0 CA-C-O 121.088 0.47 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.625 HD11 ' HB2' ' A' ' 49' ' ' ALA . 3.0 tp -128.23 77.02 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 121.723 0.773 . . . . 0.0 109.569 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.6 p -125.95 177.75 6.15 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.156 -0.965 . . . . 0.0 110.198 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.539 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 70.5 m -56.97 -19.17 16.67 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 119.879 -0.728 . . . . 0.0 112.467 177.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.58 -43.44 99.28 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.532 ' HA ' ' HB2' ' A' ' 9' ' ' SER . 3.2 pp0? -85.68 -35.04 21.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.432 -1.04 . . . . 0.0 108.824 178.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.539 ' HB ' ' HA ' ' A' ' 4' ' ' CYS . 58.7 t -54.7 -43.22 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.401 ' HA ' HG13 ' A' ' 11' ' ' ILE . . . -75.09 -37.68 61.45 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.532 ' HB2' ' HA ' ' A' ' 6' ' ' GLN . 69.0 m -69.61 -21.09 63.61 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.221 -0.924 . . . . 0.0 109.806 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 6' ' ' GLN . . . -85.65 -30.29 23.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.428 -0.795 . . . . 0.0 109.629 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.497 HD12 ' N ' ' A' ' 12' ' ' ALA . 2.4 pp -96.57 -26.71 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.463 -0.773 . . . . 0.0 110.813 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.61 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -49.33 -53.45 39.66 Favored Pre-proline 0 N--CA 1.504 2.244 0 O-C-N 121.207 -0.933 . . . . 0.0 110.783 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.61 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 73.4 Cg_endo -72.78 -9.6 23.98 Favored 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 122.29 1.993 . . . . 0.0 110.969 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.7 m -117.41 6.33 12.62 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.525 ' O ' ' CB ' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -58.09 -50.43 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 118.109 0.413 . . . . 0.0 110.632 -178.606 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.414 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -61.2 -63.49 1.27 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.952 -1.092 . . . . 0.0 109.618 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.569 ' CD2' HG12 ' A' ' 71' ' ' ILE . 1.1 t80 -51.66 -58.8 5.33 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.644 -0.66 . . . . 0.0 109.922 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.577 ' HB1' ' HB2' ' A' ' 68' ' ' ALA . . . -57.22 -29.25 63.59 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.603 -0.686 . . . . 0.0 110.556 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.525 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 9.1 tmm_? -89.93 8.67 31.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.368 -0.833 . . . . 0.0 110.944 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.28 1.1 44.32 Favored Glycine 0 N--CA 1.503 3.123 0 O-C-N 120.714 -1.241 . . . . 0.0 111.922 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -117.59 72.12 0.83 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.014 -1.286 . . . . 0.0 110.115 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.72 174.61 45.82 Favored Glycine 0 N--CA 1.498 2.793 0 C-N-CA 120.197 -1.001 . . . . 0.0 110.826 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.9 p -151.23 -60.8 0.18 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -97.83 126.77 8.99 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.714 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . 37.1 Cg_endo -62.49 125.45 16.23 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 C-N-CA 122.393 2.062 . . . . 0.0 111.008 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.3 t -76.57 159.89 29.92 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.418 -0.801 . . . . 0.0 110.99 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.57 -41.44 76.92 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.644 -0.66 . . . . 0.0 110.552 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.62 -48.46 77.35 Favored Glycine 0 N--CA 1.503 3.127 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.55 ' SG ' ' CG2' ' A' ' 71' ' ' ILE . 42.4 t -58.3 -43.0 87.88 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.661 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.661 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 88.2 m -73.69 -35.18 65.15 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.154 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 61.9 m -71.81 -40.7 68.99 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 124.533 1.146 . . . . 0.0 109.725 175.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.33 -51.75 57.29 Favored Glycine 0 N--CA 1.5 2.953 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.75 HG11 ' CB ' ' A' ' 72' ' ' PRO . 47.4 t -69.3 -45.69 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.441 -1.035 . . . . 0.0 109.125 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.592 ' HA ' ' CG1' ' A' ' 77' ' ' VAL . 2.4 tpt180 -54.15 -28.42 39.89 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.4 m -73.76 -44.0 57.38 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.613 ' C ' HD12 ' A' ' 36' ' ' LEU . 0.5 OUTLIER -61.32 -33.94 74.43 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.409 -0.807 . . . . 0.0 109.771 179.338 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.538 ' HB2' HG12 ' A' ' 77' ' ' VAL . 0.6 OUTLIER -59.69 -32.68 70.72 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.299 -0.876 . . . . 0.0 110.015 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -88.71 -33.51 17.5 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.526 -0.734 . . . . 0.0 109.415 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.11 -32.29 22.87 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.506 -0.746 . . . . 0.0 110.878 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.586 ' HA ' ' CB ' ' A' ' 45' ' ' ASP . . . -111.47 101.52 9.94 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.169 -0.957 . . . . 0.0 110.474 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.541 ' CZ ' ' HB3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -161.06 20.27 0.12 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.402 -0.811 . . . . 0.0 111.692 179.59 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 44' ' ' ALA . 5.8 m -116.87 35.31 4.67 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.848 -1.158 . . . . 0.0 109.384 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 44.6 m 67.95 -59.82 0.42 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.595 -0.691 . . . . 0.0 109.649 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 42' ' ' THR . . . -57.35 -54.63 44.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.551 -0.718 . . . . 0.0 109.179 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.586 ' CB ' ' HA ' ' A' ' 40' ' ' ALA . 8.3 m-20 -55.61 -44.04 76.65 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.707 0.765 . . . . 0.0 109.199 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.502 ' NH1' HG13 ' A' ' 79' ' ' ILE . 0.5 OUTLIER -67.39 -47.12 71.25 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.978 -178.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -60.84 -48.58 81.16 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.5 -48.72 80.53 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.777 -0.577 . . . . 0.0 109.498 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.625 ' HB2' HD11 ' A' ' 2' ' ' ILE . . . -57.16 -46.37 82.8 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.476 ' SG ' HG22 ' A' ' 87' ' ' THR . 0.1 OUTLIER -63.86 -38.81 92.48 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.112 -0.368 . . . . 0.0 110.872 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.44 ' N ' ' SG ' ' A' ' 89' ' ' CYS . 2.2 t30 -60.01 -57.38 13.1 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 123.869 0.731 . . . . 0.0 109.701 176.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.459 ' HB3' HG21 ' A' ' 7' ' ' VAL . 12.9 t -66.76 -31.08 71.49 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.357 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.615 HD22 HG23 ' A' ' 83' ' ' ILE . 15.1 mt -64.01 -44.47 92.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 123.902 0.751 . . . . 0.0 109.446 175.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -58.54 -41.18 84.98 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -64.18 -54.01 40.35 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.528 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -58.74 -43.39 90.2 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.643 -0.661 . . . . 0.0 109.608 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.545 ' HA ' HD13 ' A' ' 63' ' ' LEU . . . -60.55 -51.9 67.44 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.87 64.86 1.33 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 61' ' ' SER . . . 167.88 -22.48 0.1 Allowed Glycine 0 N--CA 1.499 2.879 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.202 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.607 ' O ' HG12 ' A' ' 60' ' ' VAL . 6.5 t -64.9 62.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 CA-C-N 118.699 1.25 . . . . 0.0 110.595 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 59' ' ' GLY . 67.9 m 36.02 57.32 0.99 Allowed 'General case' 0 N--CA 1.507 2.409 0 O-C-N 121.309 -0.869 . . . . 0.0 111.888 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.76 57.81 3.69 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.545 HD13 ' HA ' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -56.94 132.04 51.51 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.677 -0.896 . . . . 0.0 110.463 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -96.7 89.78 5.06 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -39.54 -45.87 1.65 Allowed 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.907 -0.495 . . . . 0.0 111.021 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -51.7 -38.16 43.93 Favored Glycine 0 N--CA 1.503 3.136 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -83.7 -55.5 4.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.635 -0.921 . . . . 0.0 108.913 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.611 ' HB1' ' O ' ' A' ' 83' ' ' ILE . . . -55.72 -25.21 39.16 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.826 -0.546 . . . . 0.0 111.932 -178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.25 -49.27 6.82 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.949 -1.094 . . . . 0.0 109.818 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.04 -32.37 72.68 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.47 -0.769 . . . . 0.0 110.409 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.569 HG12 ' CD2' ' A' ' 17' ' ' TYR . 30.8 mt -52.07 -61.51 4.32 Favored Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 121.643 -0.66 . . . . 0.0 110.528 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.75 ' CB ' HG11 ' A' ' 33' ' ' VAL . 38.4 Cg_endo -61.88 -57.08 0.58 Allowed 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 122.028 1.819 . . . . 0.0 110.465 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.9 t -44.35 -63.64 0.84 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 120.681 0.277 . . . . 0.0 110.38 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -63.61 -39.1 93.52 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 122.034 -0.416 . . . . 0.0 109.982 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.714 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 0.8 OUTLIER -48.01 -35.04 10.28 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.823 -0.751 . . . . 0.0 112.092 -178.817 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.484 ' O ' ' HD2' ' A' ' 34' ' ' ARG . . . 137.7 44.53 0.08 OUTLIER Glycine 0 N--CA 1.496 2.659 0 C-N-CA 119.243 -1.456 . . . . 0.0 111.339 176.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.702 HG11 HG12 ' A' ' 33' ' ' VAL . 16.1 m -135.34 129.76 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 120.828 -1.395 . . . . 0.0 111.021 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.1 p -99.97 78.38 2.1 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.678 HD11 ' CE2' ' A' ' 81' ' ' TYR . 11.0 tt -132.38 128.41 21.14 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.514 -0.741 . . . . 0.0 109.723 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 79' ' ' ILE . 52.6 Cg_exo -54.77 -45.33 41.76 Favored 'Trans proline' 0 N--CA 1.484 0.936 0 C-N-CA 123.28 2.653 . . . . 0.0 112.736 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.678 ' CE2' HD11 ' A' ' 79' ' ' ILE . 26.5 p90 -81.7 143.28 31.98 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.938 -1.101 . . . . 0.0 109.911 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 69.5 p -98.67 166.49 11.3 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.908 0.861 . . . . 0.0 110.692 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.615 HG23 HD22 ' A' ' 53' ' ' LEU . 1.5 mp -90.16 63.81 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 82.4 p -161.49 170.34 20.13 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.022 -1.049 . . . . 0.0 110.701 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.5 p -60.71 -30.0 69.69 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.575 -0.703 . . . . 0.0 109.748 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.0 t -82.49 79.74 8.84 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.476 HG22 ' SG ' ' A' ' 50' ' ' CYS . 0.6 OUTLIER -162.63 149.15 12.87 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.842 -179.37 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -91.77 154.65 18.79 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 122.18 0.991 . . . . 0.0 112.329 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 51' ' ' ASN . 1.2 m -137.03 53.4 1.89 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.142 176.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 95.8 p -159.3 -51.42 0.06 Allowed 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.355 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.0 mmm-85 -97.1 -6.78 34.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.223 -0.923 . . . . 0.0 109.245 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.1 t -70.48 119.73 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.391 -0.818 . . . . 0.0 109.231 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.531 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 1.7 p30 . . . . . 0 N--CA 1.497 1.915 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.46 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 121.518 0.675 . . . . 0.0 110.074 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.799 HD11 ' HB2' ' A' ' 36' ' ' LEU . 0.8 OUTLIER -103.97 101.9 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.391 -0.818 . . . . 0.0 108.927 179.76 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.0 t -118.19 167.19 11.73 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.305 -0.872 . . . . 0.0 111.504 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -63.94 -35.98 82.44 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -56.39 -51.49 55.88 Favored Glycine 0 N--CA 1.503 3.122 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 177.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.418 ' OE1' HD13 ' A' ' 2' ' ' ILE . 0.5 OUTLIER -67.23 -41.87 84.95 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.455 -1.026 . . . . 0.0 109.087 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.8 t -54.8 -46.14 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.36 -36.38 74.15 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.3 t -68.83 -20.53 64.3 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.318 -0.864 . . . . 0.0 110.099 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.39 -41.65 9.29 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.316 -0.865 . . . . 0.0 109.862 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.5 pp -79.98 -33.79 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.214 -0.929 . . . . 0.0 111.099 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.55 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -46.95 -51.76 37.69 Favored Pre-proline 0 N--CA 1.504 2.229 0 O-C-N 121.213 -0.929 . . . . 0.0 110.417 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 33.5 Cg_endo -65.89 -15.65 49.74 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.163 1.909 . . . . 0.0 110.831 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.664 ' SG ' HG21 ' A' ' 71' ' ' ILE . 1.3 m -114.14 18.94 16.8 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 176.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.422 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -62.72 -49.58 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-N 118.16 0.437 . . . . 0.0 110.473 178.047 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.4 p -68.88 -49.27 59.66 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.429 -0.794 . . . . 0.0 109.323 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.697 ' CG ' HD11 ' A' ' 71' ' ' ILE . 0.4 OUTLIER -55.42 -54.3 45.46 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.084 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.597 ' HB1' ' HB2' ' A' ' 68' ' ' ALA . . . -60.69 -27.99 68.28 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.422 ' HB3' ' O ' ' A' ' 15' ' ' ILE . 1.3 tpt180 -82.46 -13.24 57.06 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.864 -0.522 . . . . 0.0 109.953 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.24 14.3 42.36 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -118.16 78.18 1.23 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.251 -1.146 . . . . 0.0 109.527 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 177.15 -151.68 11.33 Favored Glycine 0 N--CA 1.5 2.918 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.6 p -168.88 -58.71 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.632 -0.923 . . . . 0.0 109.511 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.74 145.98 17.95 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.64 152.09 82.74 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 C-N-CA 122.536 2.158 . . . . 0.0 110.356 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.4 p -102.18 146.79 27.46 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.311 -0.868 . . . . 0.0 110.431 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.95 -47.08 71.67 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.793 -0.567 . . . . 0.0 110.848 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.79 -41.31 95.92 Favored Glycine 0 N--CA 1.502 3.037 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.401 ' HA ' ' HG2' ' A' ' 13' ' ' PRO . 42.1 t -61.64 -55.98 24.8 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.405 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -62.6 -39.59 94.25 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.735 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.426 ' HA ' ' HG2' ' A' ' 34' ' ' ARG . 48.7 m -67.18 -50.76 59.83 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 123.932 0.77 . . . . 0.0 110.24 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.43 -47.33 91.67 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.668 ' HA ' HD23 ' A' ' 36' ' ' LEU . 59.2 t -67.86 -53.07 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.773 -0.839 . . . . 0.0 110.891 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 76' ' ' GLY . 0.4 OUTLIER -56.04 -21.19 20.26 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.175 -0.953 . . . . 0.0 110.295 -179.569 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.8 p -81.32 -43.8 18.57 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.402 -0.811 . . . . 0.0 109.523 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.799 ' HB2' HD11 ' A' ' 2' ' ' ILE . 0.6 OUTLIER -55.85 -36.01 67.07 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.891 -0.506 . . . . 0.0 110.646 -179.411 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 76' ' ' GLY . 31.9 t30 -56.44 -49.55 74.24 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.323 -0.861 . . . . 0.0 109.821 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -81.36 -29.39 34.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.604 -0.685 . . . . 0.0 109.776 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.456 ' HB3' ' HA ' ' A' ' 36' ' ' LEU . . . -65.2 -26.9 68.34 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.697 -0.627 . . . . 0.0 110.451 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.78 ' HB2' HG12 ' A' ' 2' ' ' ILE . . . -139.92 -110.79 0.15 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.091 -1.005 . . . . 0.0 111.109 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.484 ' HA ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER 64.5 32.23 11.87 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.403 -0.811 . . . . 0.0 111.082 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.514 ' O ' ' HB ' ' A' ' 43' ' ' THR . 14.9 t -128.57 17.54 6.39 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 120.829 -1.169 . . . . 0.0 111.382 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.661 ' HA ' ' C ' ' A' ' 93' ' ' ASN . 86.5 m 84.8 -67.76 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.696 -0.627 . . . . 0.0 109.799 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.49 -61.43 2.02 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.302 -0.874 . . . . 0.0 109.708 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.505 ' HB3' ' CB ' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -70.28 -36.55 74.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.682 -0.636 . . . . 0.0 109.367 179.321 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.484 ' HD3' ' HA ' ' A' ' 41' ' ' ARG . 5.8 mtm180 -59.28 -53.12 61.89 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.436 -0.79 . . . . 0.0 110.249 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.5 ' NH1' ' HA ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -54.12 -47.48 71.81 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.473 -0.767 . . . . 0.0 109.337 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 51' ' ' ASN . . . -58.91 -41.38 87.08 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.598 ' HB2' HG21 ' A' ' 2' ' ' ILE . . . -58.28 -48.32 80.83 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.498 ' C ' ' SG ' ' A' ' 89' ' ' CYS . 0.8 OUTLIER -55.4 -33.66 63.7 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.498 178.566 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.444 ' N ' ' SG ' ' A' ' 89' ' ' CYS . 1.3 t30 -65.56 -61.98 1.78 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.035 0.445 . . . . 0.0 110.056 177.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.6 t -63.49 -33.58 75.88 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.253 -0.979 . . . . 0.0 111.342 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.564 HD22 HG23 ' A' ' 83' ' ' ILE . 20.8 mt -68.4 -57.82 5.29 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.373 178.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 24.6 tttp -57.9 -36.2 72.1 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.465 -0.772 . . . . 0.0 109.354 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.84 -39.05 87.63 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.474 -0.766 . . . . 0.0 110.606 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.476 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -94.39 -53.43 3.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.235 -0.916 . . . . 0.0 110.009 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.722 ' HB1' ' HA ' ' A' ' 84' ' ' SER . . . -60.09 -53.74 54.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.484 -0.76 . . . . 0.0 109.702 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 54' ' ' LYS . . . -80.79 63.18 5.1 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.52 -32.43 0.06 OUTLIER Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 56' ' ' ALA . 24.4 t -47.23 148.67 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 121.68 -0.894 . . . . 0.0 110.199 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.8 m -64.29 90.85 0.07 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.576 -0.702 . . . . 0.0 110.123 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.99 64.89 1.69 Allowed Glycine 0 N--CA 1.499 2.854 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.62 ' C ' HD13 ' A' ' 63' ' ' LEU . 3.0 tm? -74.68 118.73 17.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.667 -0.902 . . . . 0.0 109.791 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -94.52 85.36 4.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.891 . . . . 0.0 108.726 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.522 ' HA ' ' HB2' ' A' ' 84' ' ' SER . . . -48.31 -37.95 17.74 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.858 -0.526 . . . . 0.0 110.719 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -53.97 -38.71 60.97 Favored Glycine 0 N--CA 1.502 3.099 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -89.7 -45.38 9.36 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.478 -1.013 . . . . 0.0 109.961 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.597 ' HB2' ' HB1' ' A' ' 18' ' ' ALA . . . -71.74 -20.34 61.91 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.594 -0.691 . . . . 0.0 111.946 -178.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.23 -40.95 10.16 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.867 -1.146 . . . . 0.0 110.244 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 92.5 p -71.17 -43.27 67.8 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.57 -0.706 . . . . 0.0 110.847 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.697 HD11 ' CG ' ' A' ' 17' ' ' TYR . 87.0 mt -50.63 -64.59 1.23 Allowed Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.485 -0.76 . . . . 0.0 110.89 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.612 ' HG3' ' HB ' ' A' ' 83' ' ' ILE . 30.7 Cg_endo -59.74 -52.52 4.37 Favored 'Trans proline' 0 C--N 1.326 -0.636 0 C-N-CA 121.868 1.712 . . . . 0.0 110.773 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.2 t -38.5 -68.07 0.18 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 122.271 -0.268 . . . . 0.0 110.62 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.4 pttt -70.38 -32.45 70.11 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.551 -0.718 . . . . 0.0 109.888 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 72' ' ' PRO . 1.1 m -49.72 -47.57 50.49 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.27 -0.893 . . . . 0.0 111.985 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 37' ' ' ASN . . . 169.03 47.03 0.03 OUTLIER Glycine 0 N--CA 1.5 2.927 0 C-N-CA 118.365 -1.874 . . . . 0.0 111.527 175.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.473 HG12 ' HB2' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -150.65 91.04 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.191 -1.182 . . . . 0.0 110.353 179.323 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.6 t -80.18 77.78 6.89 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.538 HD12 ' CZ ' ' A' ' 81' ' ' TYR . 3.3 pt -130.98 135.68 27.71 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.6 -0.687 . . . . 0.0 110.306 -178.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.475 ' HD2' ' NH1' ' A' ' 46' ' ' ARG . 77.4 Cg_exo -49.19 -43.2 37.86 Favored 'Trans proline' 0 N--CA 1.483 0.908 0 C-N-CA 122.682 2.255 . . . . 0.0 111.533 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.699 ' HB3' HG21 ' A' ' 92' ' ' VAL . 1.5 p90 -81.03 143.98 32.11 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.06 -1.025 . . . . 0.0 109.41 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.7 p -100.4 165.75 11.3 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.213 -0.929 . . . . 0.0 109.849 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.612 ' HB ' ' HG3' ' A' ' 72' ' ' PRO . 1.5 mp -89.93 62.91 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.722 ' HA ' ' HB1' ' A' ' 57' ' ' ALA . 80.5 p -158.68 -106.68 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.362 -0.836 . . . . 0.0 109.808 -178.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.5 p -122.4 -24.71 4.94 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.96 -1.088 . . . . 0.0 109.792 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.2 p -74.12 64.24 1.04 Allowed 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.526 HG23 ' HB2' ' A' ' 81' ' ' TYR . 13.1 m -162.43 128.71 3.53 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -125.73 138.46 53.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.244 -0.91 . . . . 0.0 110.762 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.5 ' HA ' ' NH1' ' A' ' 47' ' ' ARG . 89.4 m -90.9 57.89 3.65 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.267 -0.973 . . . . 0.0 111.473 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.3 t -155.42 -42.34 0.08 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.865 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.8 mtm-85 -99.68 -37.01 9.29 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.28 -0.888 . . . . 0.0 110.332 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.699 HG21 ' HB3' ' A' ' 81' ' ' TYR . 1.2 t -60.69 158.74 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 121.451 -0.78 . . . . 0.0 111.254 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.661 ' C ' ' HA ' ' A' ' 43' ' ' THR . 58.9 m-80 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 176.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 2' ' ' ILE . . . . . . . . 0 N--CA 1.5 2.064 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.813 HG13 ' HB2' ' A' ' 49' ' ' ALA . 10.4 tp 30.54 65.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 CA-C-O 121.803 0.811 . . . . 0.0 111.714 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.4 t -123.16 -74.88 0.6 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.134 -0.979 . . . . 0.0 109.931 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.7 t -151.51 -46.31 0.11 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -53.47 -44.11 66.84 Favored Glycine 0 N--CA 1.506 3.302 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 177.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.52 -41.99 23.26 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.304 -1.115 . . . . 0.0 108.452 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 91.5 t -54.1 -44.13 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.511 ' HA ' HG13 ' A' ' 11' ' ' ILE . . . -69.12 -34.82 75.65 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.8 m -71.37 -20.12 62.19 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.513 -0.742 . . . . 0.0 109.608 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.57 -35.45 10.61 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.275 -0.89 . . . . 0.0 109.923 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.511 HG13 ' HA ' ' A' ' 8' ' ' ALA . 2.6 pp -79.94 -33.61 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.254 -0.904 . . . . 0.0 110.54 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.55 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -47.85 -51.67 45.05 Favored Pre-proline 0 N--CA 1.503 2.187 0 O-C-N 121.28 -0.888 . . . . 0.0 110.206 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 31.0 Cg_endo -65.21 -12.22 33.77 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.238 1.959 . . . . 0.0 110.938 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.567 ' HB3' HD13 ' A' ' 71' ' ' ILE . 2.7 m -121.85 17.33 11.01 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 176.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.487 HD11 HG13 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -62.73 -50.1 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 121.381 -0.128 . . . . 0.0 110.802 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 21' ' ' GLN . 18.7 m -57.46 -46.84 83.19 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.338 -0.851 . . . . 0.0 109.33 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.538 ' CD2' HG12 ' A' ' 71' ' ' ILE . 0.9 OUTLIER -61.26 -62.0 2.15 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.787 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.591 ' N ' HD11 ' A' ' 71' ' ' ILE . . . -55.78 -35.46 66.28 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.153 -0.967 . . . . 0.0 110.436 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -73.85 -1.69 20.54 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.587 -0.696 . . . . 0.0 111.3 -179.151 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.88 21.24 47.39 Favored Glycine 0 N--CA 1.501 3.009 0 O-C-N 120.678 -1.264 . . . . 0.0 110.902 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.42 ' O ' ' HB3' ' A' ' 16' ' ' SER . 34.3 mm-40 -140.41 50.01 1.7 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.201 -1.176 . . . . 0.0 109.612 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -150.38 -64.75 0.01 OUTLIER Glycine 0 N--CA 1.501 2.975 0 O-C-N 121.019 -1.051 . . . . 0.0 110.833 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 71.8 -58.02 0.6 Allowed 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.642 -0.916 . . . . 0.0 109.485 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.59 112.06 3.64 Favored Glycine 0 N--CA 1.498 2.779 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.75 173.63 12.36 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 122.611 2.207 . . . . 0.0 110.751 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.1 p -110.25 134.93 51.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.57 -0.706 . . . . 0.0 109.362 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -45.99 -54.77 7.8 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.776 -0.578 . . . . 0.0 110.887 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.97 -39.43 89.29 Favored Glycine 0 N--CA 1.503 3.103 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.403 ' O ' HG23 ' A' ' 33' ' ' VAL . 44.1 t -63.55 -49.48 73.31 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 118.764 -1.174 . . . . 0.0 109.828 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.471 ' HA ' ' HB3' ' A' ' 75' ' ' CYS . 68.2 m -69.07 -42.99 75.47 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.483 -176.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.544 ' HA ' ' HG2' ' A' ' 34' ' ' ARG . 72.5 p -68.31 -47.26 68.03 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 124.355 1.034 . . . . 0.0 110.012 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -53.91 -55.19 27.01 Favored Glycine 0 N--CA 1.498 2.782 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.6 HG12 HG21 ' A' ' 77' ' ' VAL . 17.4 t -63.81 -44.59 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.486 -1.008 . . . . 0.0 110.257 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.648 ' HA ' HG22 ' A' ' 77' ' ' VAL . 7.8 ptm180 -57.71 -22.61 47.38 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.111 -0.993 . . . . 0.0 109.694 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.1 t -92.65 -55.14 3.49 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.3 -0.875 . . . . 0.0 109.461 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.592 ' HG ' ' HA ' ' A' ' 33' ' ' VAL . 3.5 pp -58.25 -28.43 64.89 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.497 -0.752 . . . . 0.0 110.89 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.599 ' CB ' HG13 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -64.85 -42.69 94.69 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.945 -1.097 . . . . 0.0 108.719 179.523 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -63.5 -29.2 70.51 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.93 8.83 35.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.679 -0.638 . . . . 0.0 110.102 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.677 ' HB1' HG21 ' A' ' 2' ' ' ILE . . . -166.91 51.5 0.07 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.763 -1.21 . . . . 0.0 111.454 -179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.652 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 2.3 mpt_? -135.27 44.7 2.55 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.527 -0.733 . . . . 0.0 109.596 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.7 m -95.38 -45.96 6.91 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.344 -0.847 . . . . 0.0 109.278 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.4 m 160.52 -51.48 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.453 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.73 -45.81 84.91 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 177.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.756 ' HB3' HG21 ' A' ' 2' ' ' ILE . 3.1 m-20 -63.69 -50.93 67.27 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.575 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.505 ' HD3' ' HG3' ' A' ' 41' ' ' ARG . 8.9 mtm180 -59.94 -39.07 84.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.738 -0.601 . . . . 0.0 109.792 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.54 ' HG2' ' NH1' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -62.2 -44.45 96.56 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.227 -0.92 . . . . 0.0 108.957 179.165 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.427 ' O ' ' HB3' ' A' ' 51' ' ' ASN . . . -66.55 -46.62 75.5 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.813 ' HB2' HG13 ' A' ' 2' ' ' ILE 0.252 . . -61.45 -55.36 32.18 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.865 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.54 ' HA ' ' HB2' ' A' ' 53' ' ' LEU . 12.0 t -48.23 -36.86 14.69 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 174.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.427 ' HB3' ' O ' ' A' ' 48' ' ' ALA . 1.7 t30 -58.55 -56.33 23.48 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 42.3 t -70.06 -31.12 68.57 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 118.388 -1.325 . . . . 0.0 111.621 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.84 HD22 HG23 ' A' ' 83' ' ' ILE . 75.5 mt -58.83 -48.61 80.72 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 124.101 0.876 . . . . 0.0 109.598 176.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.599 ' HD3' ' SG ' ' A' ' 89' ' ' CYS . 7.5 mtpp -61.12 -38.25 85.67 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -65.71 -47.49 75.2 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.822 -0.548 . . . . 0.0 109.706 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -71.79 -44.75 63.46 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.416 -0.803 . . . . 0.0 109.977 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.53 -55.36 29.94 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.74 62.56 1.08 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.392 -0.818 . . . . 0.0 108.912 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 61' ' ' SER . . . -179.75 -28.91 0.05 OUTLIER Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.619 ' O ' HG12 ' A' ' 60' ' ' VAL . 74.5 t -65.92 53.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.507 0 O-C-N 121.254 -1.145 . . . . 0.0 110.992 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 59' ' ' GLY . 56.5 p 49.12 -138.11 0.92 Allowed 'General case' 0 N--CA 1.504 2.244 0 O-C-N 120.6 -1.312 . . . . 0.0 110.093 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.96 71.65 2.82 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 108.496 -1.842 . . . . 0.0 108.496 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 1.8 pp -63.13 158.96 18.47 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 122.01 -0.7 . . . . 0.0 110.582 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -106.62 107.87 19.09 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.36 -55.22 4.21 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.743 -0.598 . . . . 0.0 110.152 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -57.69 -41.9 94.02 Favored Glycine 0 N--CA 1.498 2.799 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.473 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 3.2 m120 -60.31 -57.5 12.51 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.313 -1.11 . . . . 0.0 109.309 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.518 ' O ' ' HD2' ' A' ' 72' ' ' PRO . . . -58.71 -41.19 85.75 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.788 -0.57 . . . . 0.0 110.173 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.666 ' HB2' ' HB ' ' A' ' 82' ' ' THR . . . -71.64 -46.01 60.33 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.313 -0.867 . . . . 0.0 110.235 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.424 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 94.1 p -61.16 -36.25 79.31 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.623 -0.673 . . . . 0.0 110.802 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.591 HD11 ' N ' ' A' ' 18' ' ' ALA . 18.7 mt -47.83 -74.23 0.08 OUTLIER Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 121.611 -0.681 . . . . 0.0 111.364 -178.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.838 ' HB2' HD11 ' A' ' 79' ' ' ILE . 28.6 Cg_endo -58.82 -49.75 10.78 Favored 'Trans proline' 0 N--CA 1.481 0.779 0 C-N-CA 121.681 1.587 . . . . 0.0 111.499 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.4 p -51.66 -68.71 0.15 Allowed 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.525 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 70' ' ' SER . 7.4 pttt -64.25 -37.95 89.29 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.621 -0.674 . . . . 0.0 110.973 -179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.471 ' HB3' ' HA ' ' A' ' 30' ' ' CYS . 1.7 m -47.11 -35.54 7.22 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.325 -0.859 . . . . 0.0 111.888 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.79 40.84 0.16 Allowed Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 177.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.648 HG22 ' HA ' ' A' ' 34' ' ' ARG . 4.0 t -131.16 106.89 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.521 -0.988 . . . . 0.0 109.313 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.53 73.4 0.75 Allowed 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.691 0.758 . . . . 0.0 109.716 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.838 HD11 ' HB2' ' A' ' 72' ' ' PRO . 0.8 OUTLIER -121.66 109.49 34.31 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.296 -0.877 . . . . 0.0 109.319 179.735 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.14 -23.58 45.45 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 123.105 2.537 . . . . 0.0 112.618 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.685 ' HE1' HD12 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -82.43 171.13 14.51 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.378 -0.826 . . . . 0.0 109.922 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.666 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 51.9 p -122.81 164.67 17.94 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.118 -0.989 . . . . 0.0 110.137 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.84 HG23 HD22 ' A' ' 53' ' ' LEU . 5.3 mm -93.24 40.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.88 162.41 15.85 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.384 0.611 . . . . 0.0 110.032 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 68.6 p -62.03 -33.17 73.88 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.5 p -70.22 64.95 0.26 Allowed 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.648 0.737 . . . . 0.0 109.439 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.6 m -168.08 155.22 8.01 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.345 -0.847 . . . . 0.0 109.0 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -132.95 152.91 51.86 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.002 -1.061 . . . . 0.0 111.285 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.599 ' SG ' ' HD3' ' A' ' 54' ' ' LYS . 4.2 m -94.82 60.89 2.52 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.409 178.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 37.2 p -135.62 -51.5 0.74 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.551 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -98.78 5.91 47.22 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.647 -0.658 . . . . 0.0 110.792 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 94.3 t -82.84 106.33 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 120.997 -1.064 . . . . 0.0 108.785 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.8 m120 . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 117.053 -1.451 . . . . 0.0 109.32 -179.752 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.885 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.535 HG12 ' HB2' ' A' ' 40' ' ' ALA . 5.1 tp 37.98 43.99 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.48 0 CA-C-O 121.666 0.745 . . . . 0.0 111.37 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 5' ' ' GLY . 23.4 t -124.08 66.9 1.05 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.023 -1.048 . . . . 0.0 109.485 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.0 t 62.8 -56.29 0.16 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 3' ' ' SER . . . -49.6 -43.91 37.3 Favored Glycine 0 N--CA 1.506 3.312 0 CA-C-N 119.458 1.026 . . . . 0.0 110.556 177.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.493 ' HA ' ' HB2' ' A' ' 9' ' ' SER . 0.0 OUTLIER -78.99 -39.73 33.43 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.414 -1.051 . . . . 0.0 108.856 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 56.6 t -55.24 -46.6 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.64 -31.31 65.01 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.493 ' HB2' ' HA ' ' A' ' 6' ' ' GLN . 58.6 m -68.35 -22.12 64.69 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.132 -0.98 . . . . 0.0 109.463 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.77 -29.71 14.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.515 -0.741 . . . . 0.0 109.071 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 tp -82.83 -41.0 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.514 -0.741 . . . . 0.0 110.527 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.535 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -42.42 -52.06 10.64 Favored Pre-proline 0 N--CA 1.504 2.268 0 O-C-N 121.757 -0.589 . . . . 0.0 111.399 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 36.9 Cg_endo -64.23 -23.76 66.01 Favored 'Trans proline' 0 N--CA 1.484 0.923 0 C-N-CA 121.977 1.785 . . . . 0.0 110.386 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.584 ' SG ' HG21 ' A' ' 71' ' ' ILE . 1.4 m -109.36 19.37 19.43 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 176.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 16' ' ' SER . 0.4 OUTLIER -66.07 -50.24 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.86 177.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.426 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 51.4 p -55.73 -50.94 69.0 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.39 -0.818 . . . . 0.0 108.875 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.505 ' CG ' HD11 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -57.29 -57.76 11.19 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.393 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.76 -5.99 18.92 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.58 -0.7 . . . . 0.0 110.172 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.8 ttt-85 -100.05 -18.01 17.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.406 -0.809 . . . . 0.0 109.999 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 133.8 -20.82 4.04 Favored Glycine 0 N--CA 1.503 3.108 0 O-C-N 120.859 -1.151 . . . . 0.0 111.577 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -123.01 92.46 3.71 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.03 -1.277 . . . . 0.0 110.463 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.457 ' HA3' ' HA ' ' A' ' 17' ' ' TYR . . . -156.12 -60.18 0.01 OUTLIER Glycine 0 N--CA 1.504 3.176 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.3 p 73.91 -62.65 0.46 Allowed 'General case' 0 N--CA 1.507 2.409 0 O-C-N 122.061 -0.67 . . . . 0.0 111.278 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -114.82 139.44 15.59 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 110.476 -1.049 . . . . 0.0 110.476 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.01 173.14 9.77 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 122.552 2.168 . . . . 0.0 110.911 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 69.3 p -124.48 149.6 46.66 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.303 -0.873 . . . . 0.0 110.321 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.38 -45.62 69.32 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.608 -0.683 . . . . 0.0 110.115 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.16 -39.06 97.16 Favored Glycine 0 N--CA 1.5 2.931 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 40.2 t -66.43 -45.57 79.41 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 119.016 -1.074 . . . . 0.0 110.589 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 88.7 m -71.36 -38.49 71.57 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.343 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.6 p -68.7 -39.81 80.32 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 124.166 0.916 . . . . 0.0 109.668 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.41 -52.98 38.78 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.677 HG11 ' CB ' ' A' ' 72' ' ' PRO . 43.2 t -62.5 -44.88 99.73 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.367 -1.079 . . . . 0.0 109.134 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.627 ' HA ' ' CG1' ' A' ' 77' ' ' VAL . 6.4 tpm_? -54.78 -32.39 60.01 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.5 m -75.17 -45.89 37.77 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.57 HD23 ' HA ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -62.99 -39.68 95.48 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.482 -0.761 . . . . 0.0 110.062 179.602 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.403 ' HB2' ' CG1' ' A' ' 77' ' ' VAL . 53.4 t30 -60.42 -42.35 95.86 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.326 -0.859 . . . . 0.0 109.684 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -64.1 -44.39 92.42 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.513 -0.742 . . . . 0.0 109.004 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.459 ' HB3' ' HB ' ' A' ' 2' ' ' ILE . . . -75.94 -50.3 15.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.777 -0.577 . . . . 0.0 110.349 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.535 ' HB2' HG12 ' A' ' 2' ' ' ILE . . . -74.35 59.43 0.79 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.058 -1.026 . . . . 0.0 109.792 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.62 ' HA ' ' HD3' ' A' ' 46' ' ' ARG . 7.0 mtt-85 -147.94 18.48 1.12 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.036 -1.04 . . . . 0.0 111.082 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.534 ' O ' ' HB ' ' A' ' 43' ' ' THR . 9.9 t -111.26 28.14 9.01 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.116 -0.99 . . . . 0.0 109.652 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.684 HG23 ' HB3' ' A' ' 93' ' ' ASN . 46.3 m 70.95 -61.77 0.47 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.76 -0.588 . . . . 0.0 110.127 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.48 -60.12 3.61 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.786 -0.571 . . . . 0.0 111.118 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -72.54 -28.93 63.15 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.586 -0.696 . . . . 0.0 110.775 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.62 ' HD3' ' HA ' ' A' ' 41' ' ' ARG . 7.6 mmm-85 -53.13 -51.75 60.93 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.396 -0.815 . . . . 0.0 109.47 179.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.574 ' HD2' ' HB2' ' A' ' 93' ' ' ASN . 1.0 OUTLIER -62.12 -51.62 67.17 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.411 -0.805 . . . . 0.0 110.361 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.83 -44.74 90.95 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.63 -0.669 . . . . 0.0 109.733 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.52 -47.67 85.14 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.435 ' C ' ' SG ' ' A' ' 89' ' ' CYS . 37.9 t -59.37 -38.48 80.59 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.018 177.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.456 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 1.9 t30 -64.46 -54.16 36.85 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 123.772 0.67 . . . . 0.0 109.596 176.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.437 ' HA ' ' ND2' ' A' ' 55' ' ' ASN . 39.3 t -63.65 -31.04 72.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.896 -1.127 . . . . 0.0 110.566 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.618 HD13 HG12 ' A' ' 83' ' ' ILE . 26.3 mt -63.67 -46.56 85.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 124.365 1.041 . . . . 0.0 109.008 175.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.456 ' HE2' ' O ' ' A' ' 51' ' ' ASN . 12.5 ttpt -55.04 -49.93 70.36 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.437 ' ND2' ' HA ' ' A' ' 52' ' ' CYS . 1.3 p30 -65.66 -33.61 76.3 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.247 -0.908 . . . . 0.0 109.489 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.45 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -66.92 -56.78 8.75 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.327 -0.858 . . . . 0.0 108.743 178.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.422 ' HB1' ' O ' ' A' ' 84' ' ' SER . . . -60.62 -56.9 15.74 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.572 -0.705 . . . . 0.0 109.167 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.9 66.45 1.15 Allowed 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.17 -28.05 0.1 OUTLIER Glycine 0 N--CA 1.501 3.014 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -178.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 56' ' ' ALA . 2.8 t -46.92 -21.92 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.736 -0.861 . . . . 0.0 111.06 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 60' ' ' VAL . 47.6 m 74.8 83.45 0.1 Allowed 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.82 36.82 7.61 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.566 HD13 ' O ' ' A' ' 84' ' ' SER . 3.7 pp -56.02 138.87 48.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.661 -0.905 . . . . 0.0 110.22 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -109.25 88.27 2.69 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -48.28 -41.8 28.93 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.654 -0.654 . . . . 0.0 109.983 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -52.3 -47.23 56.47 Favored Glycine 0 N--CA 1.501 2.999 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 30.7 m-20 -82.14 -50.2 9.3 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.568 -0.96 . . . . 0.0 109.262 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.422 ' O ' ' CD ' ' A' ' 72' ' ' PRO . . . -51.2 -43.0 61.27 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.996 -0.44 . . . . 0.0 111.987 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.75 -45.95 19.98 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.141 -0.975 . . . . 0.0 110.217 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.4 m -61.92 -43.47 98.78 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.618 -0.676 . . . . 0.0 110.619 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.584 HG21 ' SG ' ' A' ' 14' ' ' CYS . 44.0 mt -42.58 -64.3 0.74 Allowed Pre-proline 0 N--CA 1.504 2.273 0 O-C-N 121.864 -0.522 . . . . 0.0 111.109 -179.044 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.677 ' CB ' HG11 ' A' ' 33' ' ' VAL . 46.0 Cg_endo -62.69 -60.33 0.19 Allowed 'Trans proline' 0 C--N 1.322 -0.816 0 C-N-CA 122.124 1.882 . . . . 0.0 110.682 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.4 m -45.2 -61.22 1.74 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.942 -0.474 . . . . 0.0 109.919 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.87 -39.98 95.46 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 1.2 m -50.11 -34.66 22.75 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.826 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.465 ' O ' ' HD2' ' A' ' 34' ' ' ARG . . . 135.36 46.62 0.09 OUTLIER Glycine 0 N--CA 1.494 2.553 0 C-N-CA 119.584 -1.293 . . . . 0.0 111.344 175.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.64 HG11 HG12 ' A' ' 33' ' ' VAL . 16.4 m -135.57 126.47 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 CA-C-N 118.776 1.288 . . . . 0.0 111.084 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.3 p -99.92 70.96 1.63 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.366 0.603 . . . . 0.0 109.707 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.476 HD12 ' HD2' ' A' ' 80' ' ' PRO . 2.7 tp -92.97 138.24 23.41 Favored Pre-proline 0 N--CA 1.505 2.31 0 O-C-N 121.213 -0.929 . . . . 0.0 109.456 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.476 ' HD2' HD12 ' A' ' 79' ' ' ILE . 23.9 Cg_endo -59.49 -44.81 29.85 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 122.38 2.053 . . . . 0.0 111.555 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.454 ' HD2' HG11 ' A' ' 92' ' ' VAL . 22.3 p90 -94.6 135.98 35.43 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.014 -1.054 . . . . 0.0 110.906 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.1 m -91.91 163.12 14.14 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.618 HG12 HD13 ' A' ' 53' ' ' LEU . 4.5 mp -121.27 118.18 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.819 -1.175 . . . . 0.0 110.99 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.566 ' O ' HD13 ' A' ' 63' ' ' LEU . 2.5 t -123.47 -72.19 0.69 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.513 HG23 HD21 ' A' ' 63' ' ' LEU . 98.2 m -133.13 -69.32 0.56 Allowed 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.8 m -113.43 -24.46 9.29 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.492 HG22 ' N ' ' A' ' 88' ' ' ASP . 54.6 m 54.63 -100.18 0.1 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.801 -0.562 . . . . 0.0 110.806 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.492 ' N ' HG22 ' A' ' 87' ' ' THR . 20.7 t0 -157.97 -70.74 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.272 -0.893 . . . . 0.0 110.062 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.435 ' SG ' ' C ' ' A' ' 50' ' ' CYS . 14.0 m 58.92 50.99 7.74 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 121.339 0.59 . . . . 0.0 111.645 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.2 t -161.37 -38.15 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.282 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.443 ' HG3' HH11 ' A' ' 91' ' ' ARG . 0.1 OUTLIER -94.16 9.26 38.57 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.684 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.454 HG11 ' HD2' ' A' ' 81' ' ' TYR . 10.9 t -109.0 139.49 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.684 ' HB3' HG23 ' A' ' 43' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.499 2.007 0 O-C-N 121.556 -0.715 . . . . 0.0 109.635 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.92 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.67 HD13 ' HB2' ' A' ' 36' ' ' LEU . 0.6 OUTLIER -135.17 70.13 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 CA-C-O 121.716 0.77 . . . . 0.0 109.167 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.6 t -152.06 82.35 1.26 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.675 -1.265 . . . . 0.0 111.168 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.469 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 2.6 t 66.43 -59.85 0.34 Allowed 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 177.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -46.01 -58.51 5.57 Favored Glycine 0 N--CA 1.506 3.366 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 178.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -78.49 -34.11 47.72 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.54 -0.976 . . . . 0.0 108.93 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.494 HG13 ' CD2' ' A' ' 53' ' ' LEU . 8.3 t -53.39 -39.93 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.448 ' HA ' ' CD1' ' A' ' 11' ' ' ILE . . . -68.81 -35.23 76.75 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.1 p -71.75 -21.37 61.75 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.431 -0.793 . . . . 0.0 109.778 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.1 -46.74 13.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.525 -0.734 . . . . 0.0 110.429 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.448 ' CD1' ' HA ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -79.96 -25.63 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 O-C-N 121.09 -1.006 . . . . 0.0 110.984 -178.956 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.601 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -47.45 -55.02 17.98 Favored Pre-proline 0 N--CA 1.502 2.15 0 O-C-N 121.132 -0.98 . . . . 0.0 110.1 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.601 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 57.8 Cg_endo -70.9 -26.71 21.89 Favored 'Trans proline' 0 C--N 1.322 -0.84 0 C-N-CA 122.106 1.871 . . . . 0.0 110.555 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.643 ' SG ' HG21 ' A' ' 71' ' ' ILE . 1.1 m -97.4 15.46 22.99 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.744 -0.783 . . . . 0.0 112.442 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.484 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 0.4 OUTLIER -63.19 -45.03 99.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.712 179.082 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.404 ' OG ' ' N ' ' A' ' 17' ' ' TYR . 39.1 p -65.26 -59.29 4.22 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.343 -0.848 . . . . 0.0 109.549 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.404 ' N ' ' OG ' ' A' ' 16' ' ' SER . 1.5 t80 -53.82 -56.08 20.78 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.76 -33.38 68.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.577 -0.702 . . . . 0.0 110.036 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.484 ' HB3' ' O ' ' A' ' 15' ' ' ILE . 24.2 ttm180 -76.7 -32.39 57.83 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.562 -0.711 . . . . 0.0 109.838 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.24 -20.81 3.16 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -85.48 77.24 9.93 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.305 -1.115 . . . . 0.0 109.352 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.7 -158.08 28.77 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.15 -43.74 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.676 -0.896 . . . . 0.0 109.089 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -102.14 141.24 15.2 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.706 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 27.0 Cg_endo -61.03 127.98 23.92 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 121.945 1.763 . . . . 0.0 110.894 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.7 t -62.33 142.16 57.93 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.704 -0.622 . . . . 0.0 110.134 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.52 -61.04 2.57 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.608 -0.682 . . . . 0.0 109.805 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.57 -41.06 80.62 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.527 ' SG ' ' CG2' ' A' ' 71' ' ' ILE . 42.8 t -57.56 -49.36 76.62 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.859 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.706 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 24.9 m -60.5 -34.8 74.59 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 120.674 0.273 . . . . 0.0 110.687 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.9 t -68.75 -50.86 47.13 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.102 175.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.59 -38.26 95.55 Favored Glycine 0 N--CA 1.501 3.013 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.739 HG11 ' HA ' ' A' ' 72' ' ' PRO . 12.8 t -83.57 -52.68 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.403 -1.057 . . . . 0.0 110.707 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.572 ' HA ' ' CG1' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -57.77 -18.23 20.37 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.472 -0.768 . . . . 0.0 110.861 -179.685 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 89.9 p -94.97 -40.69 9.54 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.223 -0.923 . . . . 0.0 109.278 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.67 ' HB2' HD13 ' A' ' 2' ' ' ILE . 0.8 OUTLIER -54.15 -35.89 62.74 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.052 -1.03 . . . . 0.0 109.675 179.265 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.33 -19.2 64.41 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.44 -0.788 . . . . 0.0 109.668 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -87.44 -27.62 22.6 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.46 -30.3 18.4 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.652 -0.655 . . . . 0.0 110.385 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.527 ' HB2' HG12 ' A' ' 2' ' ' ILE . . . -84.41 -148.27 0.1 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.299 -0.876 . . . . 0.0 110.744 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 69.43 23.15 6.19 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.25 -0.906 . . . . 0.0 111.055 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.497 ' O ' ' HB ' ' A' ' 43' ' ' THR . 6.3 t -123.77 15.44 9.41 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.998 -1.064 . . . . 0.0 110.533 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.618 HG23 ' HB3' ' A' ' 93' ' ' ASN . 85.4 m 76.7 -66.94 0.23 Allowed 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.22 -0.925 . . . . 0.0 109.973 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.99 -58.51 6.29 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.213 0.53 . . . . 0.0 110.509 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.596 ' HB3' HG23 ' A' ' 2' ' ' ILE . 24.8 m-20 -70.77 -33.01 70.33 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.453 -0.779 . . . . 0.0 109.184 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.599 ' HG3' ' CE1' ' A' ' 81' ' ' TYR . 0.2 OUTLIER -56.32 -54.8 41.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.543 -0.723 . . . . 0.0 109.858 179.621 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -68.26 -43.0 78.76 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.492 -0.755 . . . . 0.0 109.574 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.36 -48.41 74.29 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.469 ' HB2' HG13 ' A' ' 2' ' ' ILE . . . -66.23 -49.4 67.35 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.476 ' SG ' ' O ' ' A' ' 88' ' ' ASP . 1.6 t -56.53 -41.14 76.26 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -57.61 -58.3 8.94 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 124.231 0.957 . . . . 0.0 110.285 177.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 48.6 t -67.91 -34.35 76.45 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 118.724 -1.19 . . . . 0.0 111.749 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.618 HD22 HD12 ' A' ' 83' ' ' ILE . 15.3 mt -59.22 -41.46 88.71 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.525 175.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.456 ' HB2' ' HE3' ' A' ' 54' ' ' LYS . 18.7 ttmt -64.63 -38.58 91.49 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -54.85 -36.27 64.88 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.43 -55.84 4.76 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.628 ' HB2' HG22 ' A' ' 83' ' ' ILE . . . -56.26 -36.02 68.09 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.309 -0.869 . . . . 0.0 110.814 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.509 ' HA ' HG23 ' A' ' 85' ' ' THR . . . -93.04 17.02 11.46 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.34 -0.85 . . . . 0.0 110.856 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -143.68 -25.63 0.15 Allowed Glycine 0 N--CA 1.507 3.374 0 O-C-N 121.061 -1.024 . . . . 0.0 111.631 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.8 t -55.53 123.91 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.199 -1.177 . . . . 0.0 110.46 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.8 t -64.67 114.61 4.54 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.563 -0.711 . . . . 0.0 109.611 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 63' ' ' LEU . . . 103.1 -49.94 0.93 Allowed Glycine 0 N--CA 1.499 2.849 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.486 ' C ' HD13 ' A' ' 63' ' ' LEU . 3.4 tm? 19.86 100.65 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.764 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -97.32 87.52 4.17 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -38.61 -45.85 1.13 Allowed 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.605 -0.684 . . . . 0.0 111.192 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.41 -35.36 55.91 Favored Glycine 0 N--CA 1.504 3.19 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -89.57 -46.58 8.56 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.776 -0.838 . . . . 0.0 109.063 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.504 ' HB1' ' HB ' ' A' ' 83' ' ' ILE . . . -51.24 -49.85 60.32 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.95 -0.469 . . . . 0.0 110.347 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.77 -26.8 60.83 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.333 -0.855 . . . . 0.0 109.835 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.9 m -68.83 -36.89 78.74 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.379 -0.825 . . . . 0.0 110.698 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.643 HG21 ' SG ' ' A' ' 14' ' ' CYS . 10.6 mt -53.45 -61.93 4.34 Favored Pre-proline 0 N--CA 1.5 2.034 0 O-C-N 121.675 -0.641 . . . . 0.0 110.465 -179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.739 ' HA ' HG11 ' A' ' 33' ' ' VAL . 28.3 Cg_endo -61.26 -60.96 0.19 Allowed 'Trans proline' 0 C--N 1.323 -0.785 0 C-N-CA 121.794 1.663 . . . . 0.0 111.032 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 77.7 p -46.77 -64.09 0.86 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.966 -0.459 . . . . 0.0 111.057 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -62.67 -44.69 95.62 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 119.571 -0.252 . . . . 0.0 111.346 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.621 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 1.6 m -46.88 -43.99 19.26 Favored 'General case' 0 N--CA 1.506 2.335 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.673 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 146.86 50.44 0.03 OUTLIER Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.186 -1.483 . . . . 0.0 111.52 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.667 HG22 ' O ' ' A' ' 72' ' ' PRO . 32.9 m -135.07 136.46 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-N 119.243 1.521 . . . . 0.0 111.064 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.3 p -106.82 62.65 0.63 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.505 HG12 ' CE1' ' A' ' 81' ' ' TYR . 3.2 tp -116.64 126.24 27.7 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.426 -0.796 . . . . 0.0 109.354 -179.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 79' ' ' ILE . 18.4 Cg_endo -57.97 -38.11 93.41 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 C-N-CA 122.662 2.241 . . . . 0.0 112.083 -178.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.75 ' HB3' HG21 ' A' ' 92' ' ' VAL . 14.0 p90 -90.27 113.99 25.93 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.879 -1.138 . . . . 0.0 109.941 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.663 ' C ' HD13 ' A' ' 83' ' ' ILE . 81.9 p -113.71 -135.55 0.36 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.532 -0.73 . . . . 0.0 109.119 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.663 HD13 ' C ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -123.51 51.59 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.111 -0.993 . . . . 0.0 108.648 -179.53 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.412 ' O ' ' HB ' ' A' ' 85' ' ' THR . 41.7 p -89.45 9.83 24.96 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.858 -0.526 . . . . 0.0 111.794 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.509 HG23 ' HA ' ' A' ' 58' ' ' ALA . 63.5 m 72.07 -59.89 0.54 Allowed 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.285 -0.884 . . . . 0.0 110.104 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.7 p -73.14 -58.08 3.56 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.1 m 31.58 -144.63 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.941 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.996 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.476 ' O ' ' SG ' ' A' ' 50' ' ' CYS . 31.6 t70 -155.51 142.55 19.16 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.609 -1.307 . . . . 0.0 110.58 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.2 m -137.06 54.69 1.85 Allowed 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.964 0.888 . . . . 0.0 110.421 176.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.0 t -164.08 -51.52 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.58 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.455 ' HG2' ' NH1' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -99.27 26.06 6.32 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.476 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.75 HG21 ' HB3' ' A' ' 81' ' ' TYR . 5.0 p -110.32 15.75 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.82 -0.55 . . . . 0.0 110.842 -178.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.618 ' HB3' HG23 ' A' ' 43' ' ' THR . 1.9 p-10 . . . . . 0 N--CA 1.505 2.291 0 CA-C-O 115.308 -2.282 . . . . 0.0 111.078 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.016 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.607 HD13 ' HB2' ' A' ' 40' ' ' ALA . 2.9 tp 33.9 46.41 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 CA-C-O 121.735 0.778 . . . . 0.0 111.74 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.7 t -95.72 152.9 18.05 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.996 -1.065 . . . . 0.0 110.279 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.482 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 13.0 t -53.63 -27.69 28.49 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 115.407 -0.815 . . . . 0.0 113.113 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.34 -55.85 27.79 Favored Glycine 0 N--CA 1.502 3.034 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 176.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.539 ' HG3' ' N ' ' A' ' 7' ' ' VAL . 5.6 pt20 -71.39 -34.99 70.9 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.209 -1.171 . . . . 0.0 109.442 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.617 HG13 ' HG ' ' A' ' 53' ' ' LEU . 37.6 t -56.62 -49.16 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.525 ' HA ' ' CD1' ' A' ' 11' ' ' ILE . . . -70.09 -34.29 72.95 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 t -73.03 -22.26 60.67 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.116 -0.99 . . . . 0.0 110.149 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.21 -43.73 23.27 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.298 -0.876 . . . . 0.0 110.427 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.525 ' CD1' ' HA ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -85.59 -16.73 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.038 -1.039 . . . . 0.0 110.413 -179.691 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.582 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -48.62 -54.98 21.89 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.38 -0.825 . . . . 0.0 110.167 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 41.4 Cg_endo -67.56 -22.84 43.91 Favored 'Trans proline' 0 N--CA 1.481 0.763 0 C-N-CA 122.142 1.894 . . . . 0.0 110.585 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.849 ' SG ' HG21 ' A' ' 71' ' ' ILE . 10.6 m -102.28 11.7 37.76 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.607 178.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.518 ' O ' ' CB ' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -59.94 -39.54 80.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.049 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.68 -57.97 5.46 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.59 -0.694 . . . . 0.0 109.558 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.612 ' CD1' ' HA2' ' A' ' 22' ' ' GLY . 0.9 OUTLIER -58.37 -57.21 13.93 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.62 -0.675 . . . . 0.0 109.272 179.594 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.31 -22.98 21.1 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.335 -0.853 . . . . 0.0 109.916 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.518 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 9.2 tmm_? -95.19 0.02 53.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.619 -0.676 . . . . 0.0 110.75 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 123.16 -17.86 7.95 Favored Glycine 0 N--CA 1.501 2.988 0 O-C-N 120.339 -1.475 . . . . 0.0 112.166 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -83.06 69.48 9.85 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-N 119.084 1.442 . . . . 0.0 109.476 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.612 ' HA2' ' CD1' ' A' ' 17' ' ' TYR . . . -74.05 77.19 1.0 Allowed Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.2 p -101.25 -37.06 8.68 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.68 -0.894 . . . . 0.0 109.755 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.441 ' HA2' ' HD3' ' A' ' 25' ' ' PRO . . . 172.97 131.64 1.41 Allowed Glycine 0 N--CA 1.501 3.021 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.441 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 26.5 Cg_exo -60.72 119.02 5.96 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 C-N-CA 122.272 1.982 . . . . 0.0 110.442 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.25 135.38 48.92 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.377 -0.827 . . . . 0.0 110.707 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.68 -48.87 71.86 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.783 -0.573 . . . . 0.0 109.587 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.95 -43.75 92.81 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 30.5 t -60.1 -46.52 89.31 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.53 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.425 ' HA ' ' HB3' ' A' ' 75' ' ' CYS . 96.5 m -64.63 -39.32 93.5 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.283 -177.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.77 -42.24 77.7 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 124.462 1.101 . . . . 0.0 110.031 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.36 -53.94 37.6 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.681 HG12 HG21 ' A' ' 77' ' ' VAL . 2.8 t -68.6 -44.83 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.572 -0.957 . . . . 0.0 109.21 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.547 ' O ' ' HD2' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -53.23 -35.71 60.24 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.956 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.4 m -73.53 -48.31 34.07 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.52 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 0.9 OUTLIER -59.77 -34.13 72.59 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.736 -1.227 . . . . 0.0 107.938 177.921 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.477 ' HB2' HG13 ' A' ' 77' ' ' VAL . 66.0 t30 -52.28 -42.87 64.09 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.601 -0.687 . . . . 0.0 110.212 178.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -93.12 -24.06 18.4 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.18 -0.95 . . . . 0.0 110.703 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.507 ' O ' ' HB ' ' A' ' 2' ' ' ILE . . . -106.63 33.85 3.7 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.956 -1.09 . . . . 0.0 110.372 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.607 ' HB2' HD13 ' A' ' 2' ' ' ILE . . . -168.62 85.78 0.18 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.165 -0.959 . . . . 0.0 110.669 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.492 ' HA ' ' CD ' ' A' ' 46' ' ' ARG . 15.2 mtt180 -158.86 24.31 0.22 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.204 -0.935 . . . . 0.0 111.028 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.461 ' O ' ' HB ' ' A' ' 43' ' ' THR . 8.9 m -110.82 42.16 1.66 Allowed 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.973 -1.079 . . . . 0.0 110.796 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.689 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 52.0 m 68.8 -65.72 0.27 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.158 -0.964 . . . . 0.0 109.469 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 42' ' ' THR . . . -56.82 -51.9 67.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.902 -0.499 . . . . 0.0 109.731 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.518 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 12.6 m-20 -58.42 -48.61 80.12 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.273 0.558 . . . . 0.0 109.797 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.492 ' CD ' ' HA ' ' A' ' 41' ' ' ARG . 13.5 mtm180 -67.39 -48.66 66.74 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.943 -0.473 . . . . 0.0 111.145 -178.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -63.39 -50.86 68.22 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.081 -1.012 . . . . 0.0 109.145 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.97 -47.7 77.16 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.591 ' CB ' HD11 ' A' ' 2' ' ' ILE . . . -63.7 -44.06 94.76 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.538 -0.726 . . . . 0.0 109.186 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.574 ' O ' ' SG ' ' A' ' 89' ' ' CYS . 38.4 t -57.39 -39.03 75.24 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 120.364 -0.534 . . . . 0.0 109.736 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -61.37 -56.12 23.94 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 124.03 0.832 . . . . 0.0 109.788 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' CYS . . . . . 0.445 ' HA ' HD22 ' A' ' 55' ' ' ASN . 8.4 t -64.26 -35.16 79.94 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.544 178.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.646 HD13 ' O ' ' A' ' 82' ' ' THR . 8.0 mt -63.39 -44.47 94.61 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.061 176.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.428 ' HE3' ' HB3' ' A' ' 54' ' ' LYS . 14.0 ttpp -59.67 -40.62 88.41 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.445 HD22 ' HA ' ' A' ' 52' ' ' CYS . 86.1 m-20 -56.11 -47.23 78.46 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.473 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -73.65 -47.16 42.05 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.203 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 83' ' ' ILE . . . -52.87 -41.66 64.52 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.59 -0.694 . . . . 0.0 110.136 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.98 1.53 39.35 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.541 -0.724 . . . . 0.0 110.199 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -125.63 9.48 7.68 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 56' ' ' ALA . 4.9 t -73.58 -5.69 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.579 -0.953 . . . . 0.0 110.07 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER 76.59 -71.03 0.12 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.34 -0.85 . . . . 0.0 109.598 179.777 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 19' ' ' ARG . . . -109.48 59.33 0.36 Allowed Glycine 0 N--CA 1.499 2.859 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.636 HD11 ' HA ' ' A' ' 84' ' ' SER . 1.4 tm? -54.79 117.99 3.86 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.564 -0.962 . . . . 0.0 111.031 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.543 ' N ' HD13 ' A' ' 63' ' ' LEU . 8.0 t-20 -107.44 86.34 2.29 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.439 ' HA ' ' HB3' ' A' ' 84' ' ' SER . . . -42.91 -50.6 5.76 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.48 -44.19 85.4 Favored Glycine 0 N--CA 1.503 3.162 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -74.41 -55.17 6.28 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.707 -0.878 . . . . 0.0 109.585 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.445 ' HB1' ' HB ' ' A' ' 83' ' ' ILE . . . -51.43 -35.88 41.37 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.937 -0.477 . . . . 0.0 111.435 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.95 -40.0 17.48 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.133 -0.979 . . . . 0.0 110.014 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.0 t -65.17 -40.55 94.46 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.473 -0.767 . . . . 0.0 110.826 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.849 HG21 ' SG ' ' A' ' 14' ' ' CYS . 74.7 mt -51.7 -65.19 1.05 Allowed Pre-proline 0 N--CA 1.503 2.224 0 O-C-N 121.845 -0.534 . . . . 0.0 111.934 -178.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.661 ' HG3' ' HB ' ' A' ' 82' ' ' THR . 41.1 Cg_endo -60.2 -40.54 58.96 Favored 'Trans proline' 0 N--CA 1.482 0.813 0 C-N-CA 121.908 1.739 . . . . 0.0 110.404 -179.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.6 m -55.52 -62.95 1.34 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -63.97 -39.63 94.57 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.893 -0.505 . . . . 0.0 109.84 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.425 ' HB3' ' HA ' ' A' ' 30' ' ' CYS . 1.3 m -48.28 -33.31 8.57 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.91 -0.494 . . . . 0.0 111.689 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 132.17 50.3 0.09 OUTLIER Glycine 0 N--CA 1.498 2.796 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 176.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.681 HG21 HG12 ' A' ' 33' ' ' VAL . 43.8 t -139.98 135.4 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.379 -1.071 . . . . 0.0 110.681 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.8 p -112.11 59.8 0.63 Allowed 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 122.219 1.009 . . . . 0.0 108.695 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.661 HG22 HG12 ' A' ' 77' ' ' VAL . 13.5 tt -125.07 122.56 25.39 Favored Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.46 -41.31 78.03 Favored 'Trans proline' 0 N--CA 1.486 1.084 0 C-N-CA 122.66 2.24 . . . . 0.0 112.092 -178.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.564 ' CE1' HD11 ' A' ' 79' ' ' ILE . 6.6 p90 -97.13 128.91 44.49 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.121 -0.987 . . . . 0.0 108.429 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.662 ' C ' HD12 ' A' ' 83' ' ' ILE . 40.2 p -128.59 -94.97 0.42 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.339 -0.851 . . . . 0.0 110.834 -178.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.662 HD12 ' C ' ' A' ' 82' ' ' THR . 1.4 mp -120.12 -51.79 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.265 -0.897 . . . . 0.0 109.639 -177.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.636 ' HA ' HD11 ' A' ' 63' ' ' LEU . 1.4 m -42.63 144.52 0.53 Allowed 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.309 0.576 . . . . 0.0 110.86 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 87' ' ' THR . 41.3 p -72.44 -130.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.7 t 63.03 -58.9 0.15 Allowed 'General case' 0 N--CA 1.508 2.438 0 O-C-N 120.97 -1.081 . . . . 0.0 111.012 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 85' ' ' THR . 3.4 m -61.11 140.62 57.84 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.387 -0.821 . . . . 0.0 109.789 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -83.67 134.35 34.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.578 -0.701 . . . . 0.0 111.025 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.574 ' SG ' ' O ' ' A' ' 50' ' ' CYS . 65.2 m -105.17 54.55 0.71 Allowed 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.836 0.827 . . . . 0.0 110.129 177.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 m -144.06 -40.89 0.28 Allowed 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 113.796 -1.547 . . . . 0.0 109.132 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -99.43 -30.45 12.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.504 -0.748 . . . . 0.0 109.806 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -47.64 142.77 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 121.297 -0.877 . . . . 0.0 110.391 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.689 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.499 1.992 0 O-C-N 121.711 -0.618 . . . . 0.0 109.529 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.615 ' HB1' ' HB1' ' A' ' 39' ' ' ALA . . . . . . . . 0 N--CA 1.497 1.9 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.747 HD11 ' HB2' ' A' ' 49' ' ' ALA . 7.4 tp 32.11 59.04 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.574 0 CA-C-O 121.806 0.812 . . . . 0.0 111.603 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.8 t -118.59 161.62 19.74 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.878 -1.139 . . . . 0.0 110.268 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.3 t -53.66 -38.02 63.74 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.23 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.16 -37.18 94.08 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -83.93 -43.91 14.77 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.64 -0.918 . . . . 0.0 108.962 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.563 HG21 ' HA ' ' A' ' 49' ' ' ALA . 94.8 t -57.03 -40.58 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.64 -27.46 55.68 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 m -67.76 -22.64 65.21 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.399 -0.813 . . . . 0.0 109.247 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.546 ' C ' ' HD2' ' A' ' 13' ' ' PRO . . . -98.29 -29.23 13.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.517 -0.739 . . . . 0.0 109.075 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 tp -79.37 -41.53 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.487 -0.758 . . . . 0.0 110.515 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.626 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -46.41 -49.78 42.58 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 121.555 -0.716 . . . . 0.0 110.316 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.626 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 22.6 Cg_exo -65.1 -24.61 59.25 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.044 1.829 . . . . 0.0 110.451 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.789 ' SG ' HG21 ' A' ' 71' ' ' ILE . 1.7 m -104.15 14.55 30.25 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 176.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -65.76 -50.68 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.706 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.41 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 0.2 OUTLIER -62.04 -57.31 12.11 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.57 -0.706 . . . . 0.0 109.133 179.02 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.557 ' CE2' HG12 ' A' ' 71' ' ' ILE . 1.1 t80 -54.17 -58.9 5.63 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.452 ' HB1' ' HB2' ' A' ' 68' ' ' ALA . . . -55.77 -35.49 66.31 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.514 -0.741 . . . . 0.0 109.858 178.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.478 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 29.5 ttm180 -74.53 -25.93 59.65 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.471 -0.768 . . . . 0.0 110.18 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.84 3.2 25.14 Favored Glycine 0 N--CA 1.5 2.929 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -103.82 70.7 1.02 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.1 -1.235 . . . . 0.0 109.484 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.05 -145.0 7.64 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.2 t 176.63 -54.29 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.809 -0.818 . . . . 0.0 109.514 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.61 118.4 4.65 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -56.71 132.42 51.63 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 122.568 2.179 . . . . 0.0 110.781 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.2 t -75.05 119.25 18.97 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.515 -0.741 . . . . 0.0 109.208 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.88 -46.01 51.22 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.692 -0.63 . . . . 0.0 109.986 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.98 -42.76 87.41 Favored Glycine 0 N--CA 1.499 2.868 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.446 ' O ' HG23 ' A' ' 33' ' ' VAL . 42.4 t -57.93 -46.08 85.6 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.88 -1.128 . . . . 0.0 109.53 177.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 75' ' ' CYS . 81.3 m -64.91 -41.97 95.12 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 123.855 0.722 . . . . 0.0 112.355 -177.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.443 ' HA ' ' HE ' ' A' ' 34' ' ' ARG . 9.5 t -70.68 -42.31 70.9 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 123.993 0.808 . . . . 0.0 110.192 176.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.95 -51.08 56.04 Favored Glycine 0 N--CA 1.498 2.819 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.662 HG12 HG11 ' A' ' 77' ' ' VAL . 4.8 t -70.47 -46.77 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.625 -0.927 . . . . 0.0 109.237 179.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.59 ' HA ' ' CG1' ' A' ' 77' ' ' VAL . 28.2 ttp180 -52.87 -36.66 59.42 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.4 t -74.29 -47.45 34.71 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.563 HD23 ' HA ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -55.83 -37.84 69.22 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.174 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.585 ' HB2' HG12 ' A' ' 77' ' ' VAL . 2.6 t-20 -63.34 -33.97 76.68 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.471 -0.768 . . . . 0.0 108.962 178.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -78.12 -38.0 44.9 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.615 ' HB1' ' HB1' ' A' ' 1' ' ' ALA . . . -94.85 32.01 1.73 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.706 -0.621 . . . . 0.0 109.724 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.493 ' HA ' ' CB ' ' A' ' 45' ' ' ASP . . . -164.39 -159.51 0.48 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.468 -0.77 . . . . 0.0 110.541 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ARG . . . . . 0.542 ' HA ' ' HD3' ' A' ' 46' ' ' ARG . 1.4 mtp180 78.14 12.03 1.79 Allowed 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.974 -0.453 . . . . 0.0 111.598 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.599 ' O ' ' HB ' ' A' ' 43' ' ' THR . 0.9 OUTLIER -99.64 27.32 5.43 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 120.889 -1.132 . . . . 0.0 110.189 178.869 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.64 HG23 ' HB3' ' A' ' 93' ' ' ASN . 55.2 m 83.83 -67.44 0.06 Allowed 'General case' 0 N--CA 1.51 2.557 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.82 -55.42 34.6 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.683 -0.635 . . . . 0.0 109.427 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.567 ' HB3' HG12 ' A' ' 2' ' ' ILE . 8.8 m-20 -54.39 -46.05 73.01 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.542 ' HD3' ' HA ' ' A' ' 41' ' ' ARG . 9.5 mmm-85 -56.81 -44.54 82.06 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.49 ' HA ' ' NH1' ' A' ' 47' ' ' ARG . 0.7 OUTLIER -60.25 -50.52 73.31 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.984 -0.448 . . . . 0.0 110.385 -179.64 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.61 -39.53 80.71 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.78 -0.575 . . . . 0.0 109.727 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.747 ' HB2' HD11 ' A' ' 2' ' ' ILE . . . -71.62 -61.6 1.72 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -44.84 -41.85 7.42 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 176.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.53 ' O ' ' HG3' ' A' ' 54' ' ' LYS . 3.0 t30 -65.53 -56.02 14.62 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.394 177.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 16.8 t -64.39 -26.37 68.43 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 119.139 -1.025 . . . . 0.0 111.146 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.542 ' HG ' HG11 ' A' ' 7' ' ' VAL . 21.7 mt -70.4 -58.9 3.23 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.39 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' A' ' 51' ' ' ASN . 2.7 pptp? -54.07 -36.18 62.84 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.333 -0.854 . . . . 0.0 110.009 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -64.46 -48.15 76.35 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.435 -0.79 . . . . 0.0 109.092 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.58 -40.05 80.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.541 -0.724 . . . . 0.0 109.563 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.443 ' HA ' ' CD1' ' A' ' 63' ' ' LEU . . . -48.43 -48.32 37.45 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.611 -0.681 . . . . 0.0 110.366 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.55 -6.35 45.97 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.453 -0.78 . . . . 0.0 111.554 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -123.63 8.86 8.76 Favored Glycine 0 N--CA 1.501 3.032 0 O-C-N 120.833 -1.167 . . . . 0.0 110.759 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.405 ' O ' ' CB ' ' A' ' 61' ' ' SER . 0.9 OUTLIER -74.42 -21.11 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.333 -1.098 . . . . 0.0 110.367 -179.739 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 60' ' ' VAL . 0.9 OUTLIER 76.49 107.54 0.08 Allowed 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.279 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.73 -78.63 1.92 Allowed Glycine 0 N--CA 1.498 2.774 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 7.5 tt 59.48 103.09 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 121.953 0.883 . . . . 0.0 111.236 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.512 ' HB3' ' HB2' ' A' ' 67' ' ' ASN . 2.6 m-80 -94.39 81.88 4.01 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -32.87 -55.69 0.37 Allowed 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 70' ' ' SER . . . -52.21 -42.99 56.54 Favored Glycine 0 N--CA 1.506 3.357 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.512 ' HB2' ' HB3' ' A' ' 64' ' ' ASN . 2.0 t30 -72.7 -51.97 17.12 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.452 ' HB2' ' HB1' ' A' ' 18' ' ' ALA . . . -57.16 -33.25 67.24 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 122.018 -0.426 . . . . 0.0 111.626 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.43 -45.22 13.91 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.094 -1.004 . . . . 0.0 109.964 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 66' ' ' GLY . 0.4 OUTLIER -66.09 -29.62 69.98 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.347 -0.846 . . . . 0.0 111.055 -179.619 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.789 HG21 ' SG ' ' A' ' 14' ' ' CYS . 70.2 mt -60.11 -66.09 1.71 Allowed Pre-proline 0 N--CA 1.506 2.329 0 O-C-N 121.243 -0.911 . . . . 0.0 111.291 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.564 ' O ' HG22 ' A' ' 77' ' ' VAL . 23.7 Cg_endo -57.33 -53.62 4.53 Favored 'Trans proline' 0 C--N 1.325 -0.699 0 C-N-CA 121.805 1.67 . . . . 0.0 109.652 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.5 m -45.29 -63.98 0.82 Allowed 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -64.85 -34.05 77.45 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.712 -0.617 . . . . 0.0 109.916 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' CYS . . . . . 0.448 ' HB3' ' HA ' ' A' ' 30' ' ' CYS . 1.1 m -50.98 -31.48 18.07 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.222 -177.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 135.07 53.6 0.07 OUTLIER Glycine 0 N--CA 1.497 2.711 0 C-N-CA 119.657 -1.259 . . . . 0.0 110.81 175.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.662 HG11 HG12 ' A' ' 33' ' ' VAL . 12.0 m -147.71 124.49 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.184 -1.186 . . . . 0.0 111.172 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.411 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 65.2 m -91.45 67.06 5.57 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.531 HD11 ' CE2' ' A' ' 81' ' ' TYR . 2.3 tp -104.02 127.19 29.79 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.553 -0.717 . . . . 0.0 109.854 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.63 -33.88 65.37 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 122.826 2.351 . . . . 0.0 112.394 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' TYR . . . . . 0.531 ' CE2' HD11 ' A' ' 79' ' ' ILE . 5.9 p90 -90.3 143.68 26.54 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.904 -1.122 . . . . 0.0 110.407 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.3 p -104.88 173.37 6.33 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.504 -0.747 . . . . 0.0 110.814 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.468 HD12 HD13 ' A' ' 53' ' ' LEU . 5.4 mm -108.95 92.51 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.536 -0.727 . . . . 0.0 109.357 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 82.8 p -119.45 -104.91 0.39 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.159 -0.963 . . . . 0.0 109.653 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -164.02 -55.9 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 63.3 m -79.34 -8.26 58.94 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 122.107 -0.371 . . . . 0.0 110.183 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.7 m -50.03 142.67 9.06 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.325 -0.859 . . . . 0.0 109.951 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -82.58 118.46 23.3 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.496 -0.753 . . . . 0.0 109.813 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 11.4 m -109.64 56.11 0.63 Allowed 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.886 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.3 t -128.5 -61.4 1.08 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.571 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.475 ' NH1' ' HG3' ' A' ' 91' ' ' ARG . 2.9 mtm-85 -97.96 60.61 1.49 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 122.052 0.93 . . . . 0.0 109.629 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.3 t -115.37 81.51 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.64 ' HB3' HG23 ' A' ' 43' ' ' THR . 2.1 p-10 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 117.152 -1.404 . . . . 0.0 110.326 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.71 ' CG1' ' HB2' ' A' ' 40' ' ' ALA . 5.3 tp . . . . . 0 N--CA 1.507 2.407 0 CA-C-O 121.916 0.865 . . . . 0.0 111.579 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 5' ' ' GLY . 1.2 t -156.39 80.19 0.97 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.782 -1.199 . . . . 0.0 110.632 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.431 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 11.4 t 66.08 -57.88 0.35 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 3' ' ' SER . . . -44.07 -53.45 6.53 Favored Glycine 0 N--CA 1.505 3.279 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.493 ' OE1' HG23 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -81.49 -25.76 35.73 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.514 -0.992 . . . . 0.0 110.482 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.506 HG21 ' HA ' ' A' ' 49' ' ' ALA . 37.6 t -56.07 -41.18 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.489 ' HA ' ' CD1' ' A' ' 11' ' ' ILE . . . -68.42 -39.58 81.54 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.0 p -71.9 -20.84 61.72 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.339 -0.851 . . . . 0.0 109.94 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.73 -49.1 11.61 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.508 -0.745 . . . . 0.0 110.573 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.489 ' CD1' ' HA ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -84.31 -16.7 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.209 -0.932 . . . . 0.0 110.488 -179.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.524 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -46.82 -53.98 22.64 Favored Pre-proline 0 N--CA 1.501 2.099 0 O-C-N 121.369 -0.832 . . . . 0.0 109.867 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 27.5 Cg_endo -63.38 -23.1 71.75 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 121.945 1.763 . . . . 0.0 110.585 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.2 m -88.58 -6.52 57.49 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 118.655 -0.688 . . . . 0.0 112.714 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.55 ' O ' ' CB ' ' A' ' 19' ' ' ARG . 1.0 OUTLIER -48.56 -47.07 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-N 118.62 0.646 . . . . 0.0 109.686 -178.096 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 21' ' ' GLN . 85.2 p -52.81 -63.55 1.11 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.119 -0.988 . . . . 0.0 109.38 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.591 ' CD2' HG12 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -59.5 -59.74 4.97 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.683 -0.636 . . . . 0.0 110.295 179.674 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.82 -27.59 60.24 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.289 -0.882 . . . . 0.0 111.039 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.55 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 16.1 ttm-85 -94.02 11.31 30.19 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.306 -0.872 . . . . 0.0 110.899 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.22 30.12 63.32 Favored Glycine 0 N--CA 1.506 3.307 0 O-C-N 120.784 -1.198 . . . . 0.0 111.33 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 16' ' ' SER . 69.4 mt-30 -140.79 48.49 1.71 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.335 -1.097 . . . . 0.0 109.461 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -165.28 -52.23 0.02 OUTLIER Glycine 0 N--CA 1.502 3.072 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.3 p 70.87 -47.6 0.65 Allowed 'General case' 0 N--CA 1.51 2.564 0 O-C-N 121.81 -0.818 . . . . 0.0 111.501 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.59 132.11 10.82 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.15 148.83 91.24 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 C-N-CA 122.366 2.044 . . . . 0.0 110.766 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.1 p -104.19 156.14 18.14 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.285 -0.884 . . . . 0.0 109.749 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.34 -47.44 85.86 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.49 -0.756 . . . . 0.0 109.133 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.01 -36.43 93.45 Favored Glycine 0 N--CA 1.501 2.977 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.448 ' HA ' ' HG2' ' A' ' 13' ' ' PRO . 3.9 t -62.38 -59.11 5.45 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 91.5 m -63.65 -36.43 83.81 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 120.184 -0.606 . . . . 0.0 112.15 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.4 m -66.81 -48.18 69.74 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 123.726 0.641 . . . . 0.0 109.753 176.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.36 -53.74 37.18 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.806 HG12 HG21 ' A' ' 77' ' ' VAL . 11.6 t -62.23 -48.33 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.609 -0.936 . . . . 0.0 110.361 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -23.89 63.48 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.988 -1.07 . . . . 0.0 109.66 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.444 ' HA ' ' OD1' ' A' ' 38' ' ' ASN . 21.4 p -73.63 -34.54 65.06 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.301 -0.874 . . . . 0.0 108.818 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.549 HD23 ' HA ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER -67.2 -31.8 72.43 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.495 -0.753 . . . . 0.0 109.861 179.073 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.629 ' HB2' HG13 ' A' ' 77' ' ' VAL . 2.4 t-20 -64.6 -50.23 67.99 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.395 -0.816 . . . . 0.0 110.575 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.444 ' OD1' ' HA ' ' A' ' 35' ' ' SER . 3.8 p-10 -68.76 -27.07 65.58 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.211 -0.93 . . . . 0.0 109.964 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.11 -46.11 12.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.667 -0.646 . . . . 0.0 110.004 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.71 ' HB2' ' CG1' ' A' ' 2' ' ' ILE . . . -88.97 95.99 10.54 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.199 -0.938 . . . . 0.0 109.679 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.583 ' HG2' ' NH1' ' A' ' 46' ' ' ARG . 42.1 mtm180 -152.3 23.74 0.63 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.398 -0.814 . . . . 0.0 110.595 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -128.26 33.95 4.64 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.024 -1.048 . . . . 0.0 110.462 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.43 HG23 ' HE ' ' A' ' 47' ' ' ARG . 53.2 m 67.73 -61.78 0.36 Allowed 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.443 -0.786 . . . . 0.0 109.601 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 42' ' ' THR . . . -55.93 -57.8 10.58 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.632 -0.667 . . . . 0.0 109.713 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.466 ' HB3' HG23 ' A' ' 2' ' ' ILE . 2.7 m-20 -71.1 -35.06 71.67 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.709 ' HG3' ' CE2' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -67.38 -58.9 3.94 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 122.001 -0.437 . . . . 0.0 110.271 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.43 ' HE ' HG23 ' A' ' 43' ' ' THR . 80.2 mtt180 -60.6 -43.71 97.12 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.04 -45.71 61.4 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.292 -0.88 . . . . 0.0 108.662 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.506 ' HA ' HG21 ' A' ' 7' ' ' VAL . . . -67.6 -49.49 62.86 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.67 ' SG ' HG22 ' A' ' 87' ' ' THR . 0.0 OUTLIER -55.68 -39.87 71.54 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.498 -0.751 . . . . 0.0 112.359 179.266 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.605 ' N ' ' SG ' ' A' ' 89' ' ' CYS . 2.2 t30 -63.44 -56.87 12.72 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.677 177.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 53.7 t -63.93 -26.7 68.71 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.773 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.451 HD22 HG23 ' A' ' 83' ' ' ILE . 21.0 mt -63.42 -51.31 66.28 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 124.183 0.927 . . . . 0.0 109.285 175.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.535 ' HE3' ' HA ' ' A' ' 51' ' ' ASN . 0.4 OUTLIER -55.86 -40.75 73.35 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.19 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.433 ' N ' ' HG2' ' A' ' 54' ' ' LYS . 5.3 m120 -66.48 -46.8 75.09 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.412 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -61.97 -46.02 91.08 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.527 ' HA ' ' HG ' ' A' ' 63' ' ' LEU . . . -61.42 -58.52 7.85 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.27 66.9 6.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.352 -0.843 . . . . 0.0 109.153 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.6 -36.59 0.09 OUTLIER Glycine 0 N--CA 1.498 2.813 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.474 ' HB ' ' HB2' ' A' ' 63' ' ' LEU . 4.0 t -51.91 136.4 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.651 -0.911 . . . . 0.0 110.087 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.444 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 0.4 OUTLIER -62.62 102.0 0.3 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.592 -0.692 . . . . 0.0 109.629 -179.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.28 42.11 19.65 Favored Glycine 0 N--CA 1.5 2.934 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.527 ' HG ' ' HA ' ' A' ' 57' ' ' ALA . 3.3 tm? -64.02 122.72 17.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.463 -1.022 . . . . 0.0 110.251 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.428 ' N ' HD13 ' A' ' 63' ' ' LEU . 2.4 m-80 -97.57 83.94 3.32 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -36.24 -53.08 0.82 Allowed 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.89 -0.506 . . . . 0.0 111.506 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -51.71 -50.96 41.14 Favored Glycine 0 N--CA 1.504 3.201 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -67.2 -53.28 31.68 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.694 -0.886 . . . . 0.0 108.949 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.404 ' O ' ' CD ' ' A' ' 72' ' ' PRO . . . -54.03 -32.77 55.41 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 122.038 -0.414 . . . . 0.0 111.235 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.3 -48.19 8.72 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.196 -0.94 . . . . 0.0 110.299 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.9 t -65.4 -27.98 68.93 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.326 -0.859 . . . . 0.0 110.967 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.591 HG12 ' CD2' ' A' ' 17' ' ' TYR . 55.8 mt -58.48 -65.17 2.09 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.253 -0.904 . . . . 0.0 110.451 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.651 ' HB3' HG11 ' A' ' 33' ' ' VAL . 9.5 Cg_endo -53.75 -52.1 9.28 Favored 'Trans proline' 0 N--CA 1.482 0.828 0 C-N-CA 122.217 1.945 . . . . 0.0 110.838 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.7 p -44.63 -70.62 0.1 Allowed 'General case' 0 N--CA 1.504 2.232 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.317 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.411 ' N ' ' HD3' ' A' ' 74' ' ' LYS . 1.1 mppt? -64.06 -39.37 93.92 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.972 -0.455 . . . . 0.0 111.106 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 1.1 m -47.5 -35.14 8.34 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.502 -0.749 . . . . 0.0 111.505 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 135.16 46.69 0.09 OUTLIER Glycine 0 N--CA 1.496 2.658 0 O-C-N 124.655 1.222 . . . . 0.0 110.05 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.806 HG21 HG12 ' A' ' 33' ' ' VAL . 59.8 t -119.13 86.33 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.31 -1.112 . . . . 0.0 110.071 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.1 m -75.92 62.49 1.6 Allowed 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.549 HG13 ' HD2' ' A' ' 80' ' ' PRO . 8.9 tt -111.14 142.98 27.43 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.373 -0.83 . . . . 0.0 109.287 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.549 ' HD2' HG13 ' A' ' 79' ' ' ILE . 11.4 Cg_endo -53.37 -39.2 82.33 Favored 'Trans proline' 0 N--CA 1.485 0.973 0 C-N-CA 122.873 2.382 . . . . 0.0 112.942 -177.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.73 ' HB3' HG21 ' A' ' 92' ' ' VAL . 0.2 OUTLIER -96.63 159.94 14.66 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.661 -1.275 . . . . 0.0 111.144 -179.572 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.545 ' C ' HD12 ' A' ' 83' ' ' ILE . 1.3 m -96.11 -170.25 2.08 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.545 HD12 ' C ' ' A' ' 82' ' ' THR . 2.0 mp -120.65 92.68 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.154 -0.967 . . . . 0.0 108.48 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.3 p -142.83 172.29 12.9 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.574 -0.704 . . . . 0.0 110.292 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.6 p -59.69 -50.14 75.01 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.698 -0.626 . . . . 0.0 109.546 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 38.8 m -84.96 48.54 1.58 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.761 -0.587 . . . . 0.0 110.559 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.67 HG22 ' SG ' ' A' ' 50' ' ' CYS . 22.2 m -74.6 117.25 16.21 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.055 -1.028 . . . . 0.0 108.569 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -83.21 136.36 34.44 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.332 -0.855 . . . . 0.0 110.968 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.605 ' SG ' ' N ' ' A' ' 51' ' ' ASN . 58.6 m -117.08 56.04 0.82 Allowed 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.286 176.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.67 -38.7 0.47 Allowed 'General case' 0 N--CA 1.497 1.925 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.227 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.469 ' HG2' ' NH1' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -98.32 2.76 48.4 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.317 -0.864 . . . . 0.0 111.199 -179.176 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.73 HG21 ' HB3' ' A' ' 81' ' ' TYR . 17.1 t -105.82 136.17 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 120.889 -1.132 . . . . 0.0 110.007 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.5 m120 . . . . . 0 N--CA 1.494 1.772 0 O-C-N 121.289 -0.882 . . . . 0.0 108.738 179.153 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.876 HD11 ' HB2' ' A' ' 49' ' ' ALA . 1.2 pp . . . . . 0 N--CA 1.492 1.674 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.3 t -90.18 174.56 7.55 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.002 -1.061 . . . . 0.0 111.215 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.9 t -62.23 -25.83 68.03 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.672 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.63 -46.39 94.08 Favored Glycine 0 N--CA 1.5 2.93 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.577 ' NE2' ' HB ' ' A' ' 2' ' ' ILE . 1.2 pt20 -78.03 -35.27 49.99 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.327 -1.102 . . . . 0.0 109.719 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.508 ' N ' ' HG3' ' A' ' 6' ' ' GLN . 95.9 t -59.74 -47.41 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.582 ' HA ' ' CD1' ' A' ' 11' ' ' ILE . . . -69.98 -35.05 74.12 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 72.4 m -70.59 -21.16 62.7 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.139 -0.976 . . . . 0.0 109.92 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.55 -41.94 12.39 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.384 -0.822 . . . . 0.0 111.128 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.582 ' CD1' ' HA ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -83.28 -17.81 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 120.813 -1.179 . . . . 0.0 110.307 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.539 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -48.05 -52.97 36.66 Favored Pre-proline 0 N--CA 1.502 2.13 0 O-C-N 121.249 -0.907 . . . . 0.0 109.596 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 17.8 Cg_endo -61.68 -25.03 78.49 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 121.899 1.732 . . . . 0.0 110.011 178.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.467 ' HB3' HD13 ' A' ' 71' ' ' ILE . 6.6 m -88.39 -1.67 58.17 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 176.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.501 ' O ' ' CB ' ' A' ' 19' ' ' ARG . 0.5 OUTLIER -55.39 -50.79 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' A' ' 21' ' ' GLN . 5.8 m -54.1 -53.17 56.83 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.292 -0.88 . . . . 0.0 108.797 178.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.505 ' CD1' HD11 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -59.97 -65.33 0.7 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.127 -0.983 . . . . 0.0 110.042 179.053 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.479 ' HA ' ' HB3' ' A' ' 67' ' ' ASN . . . -55.08 -34.0 63.26 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.606 -0.684 . . . . 0.0 110.97 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.509 ' HG3' HH11 ' A' ' 19' ' ' ARG . 1.7 ttm-85 -80.35 5.58 14.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.718 -0.614 . . . . 0.0 111.539 -178.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.72 23.68 45.35 Favored Glycine 0 N--CA 1.504 3.226 0 O-C-N 120.618 -1.301 . . . . 0.0 111.803 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.49 ' O ' ' HB3' ' A' ' 16' ' ' SER . 6.3 mm-40 -141.22 59.76 1.51 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.18 -1.188 . . . . 0.0 109.515 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.61 -58.99 0.02 OUTLIER Glycine 0 N--CA 1.503 3.12 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.7 p 74.42 -51.34 0.68 Allowed 'General case' 0 N--CA 1.511 2.596 0 O-C-N 122.054 -0.674 . . . . 0.0 111.479 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.78 139.99 14.66 Favored Glycine 0 N--CA 1.501 2.981 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.718 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 27.3 Cg_endo -61.9 121.77 9.99 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 122.173 1.915 . . . . 0.0 110.238 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 p -75.96 152.95 36.91 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.201 -0.937 . . . . 0.0 110.313 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.01 -51.91 66.1 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.363 -0.835 . . . . 0.0 108.828 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.19 -36.63 91.21 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.572 ' O ' HG23 ' A' ' 33' ' ' VAL . 7.3 t -63.98 -53.95 42.03 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.718 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 93.4 m -67.52 -39.27 85.09 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 118.635 -0.698 . . . . 0.0 111.389 -177.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.0 t -65.62 -47.9 74.08 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 124.19 0.931 . . . . 0.0 109.5 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.31 -53.09 48.5 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.789 HG12 HG21 ' A' ' 77' ' ' VAL . 12.5 t -63.36 -50.63 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.382 -1.069 . . . . 0.0 110.072 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.469 ' O ' ' CB ' ' A' ' 38' ' ' ASN . 7.1 ttp180 -56.24 -35.63 67.6 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 m -73.92 -43.69 57.5 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.531 HD23 ' HA ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -64.4 -44.89 89.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.752 -0.593 . . . . 0.0 109.663 179.628 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.615 ' HB3' HG13 ' A' ' 77' ' ' VAL . 7.3 m-80 -80.8 -28.9 36.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -0.904 . . . . 0.0 110.509 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 8.7 t30 -63.6 -35.19 79.69 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.7 -38.23 29.26 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.585 ' HB2' HG12 ' A' ' 2' ' ' ILE . . . -83.17 93.5 7.66 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.503 -0.748 . . . . 0.0 110.651 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.517 ' HA ' ' HD3' ' A' ' 46' ' ' ARG . 43.3 mtt180 -143.0 9.18 1.7 Allowed 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.95 -1.094 . . . . 0.0 110.584 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 58.0 m -87.53 -65.74 0.98 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.223 -0.923 . . . . 0.0 110.337 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 m 160.15 -56.98 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.86 -47.64 70.79 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.596 ' HB3' ' CG1' ' A' ' 2' ' ' ILE . 18.2 m-20 -68.58 -49.92 55.69 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.517 ' HD3' ' HA ' ' A' ' 41' ' ' ARG . 22.2 mtm180 -62.47 -46.27 89.27 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.526 -0.734 . . . . 0.0 110.46 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -59.06 -46.29 88.63 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.378 -0.826 . . . . 0.0 108.879 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.56 -39.68 91.95 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.876 ' HB2' HD11 ' A' ' 2' ' ' ILE . . . -57.24 -51.13 70.6 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.46 ' SG ' ' N ' ' A' ' 89' ' ' CYS . 19.1 t -58.05 -38.11 75.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.809 -0.557 . . . . 0.0 110.866 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -63.7 -63.21 1.23 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 123.711 0.632 . . . . 0.0 109.305 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 8.6 t -53.7 -33.92 57.09 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.336 -0.852 . . . . 0.0 112.036 176.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.666 HD22 HG23 ' A' ' 83' ' ' ILE . 25.1 mt -61.81 -44.83 96.07 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 114.961 -1.018 . . . . 0.0 108.821 176.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.532 ' HD2' ' SG ' ' A' ' 89' ' ' CYS . 3.3 tttp -56.77 -42.96 80.32 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.639 -0.663 . . . . 0.0 109.269 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -55.89 -44.94 78.65 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.764 -0.585 . . . . 0.0 109.73 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.526 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -76.63 -53.98 7.29 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.567 -0.708 . . . . 0.0 109.565 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.611 ' HB1' ' HA ' ' A' ' 85' ' ' THR . . . -52.36 -55.31 22.46 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.536 -0.728 . . . . 0.0 109.679 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -87.95 62.18 6.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.288 -0.883 . . . . 0.0 108.74 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.98 -34.14 0.07 OUTLIER Glycine 0 N--CA 1.498 2.787 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 56' ' ' ALA . 24.3 t -47.54 133.78 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.672 -0.899 . . . . 0.0 109.86 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.405 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 0.5 OUTLIER -62.41 97.93 0.1 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.706 -0.621 . . . . 0.0 110.191 -179.187 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.59 73.37 0.61 Allowed Glycine 0 N--CA 1.5 2.928 0 N-CA-C 110.014 -1.235 . . . . 0.0 110.014 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.493 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 1.7 pt? -102.5 159.28 15.57 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.346 -1.091 . . . . 0.0 110.713 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -116.26 114.71 24.76 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -49.57 -53.3 24.49 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.753 -0.592 . . . . 0.0 110.423 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.76 -45.35 85.85 Favored Glycine 0 N--CA 1.5 2.904 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.479 ' HB3' ' HA ' ' A' ' 18' ' ' ALA . 2.9 m120 -62.37 -55.33 28.95 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.728 -0.866 . . . . 0.0 109.474 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.468 ' O ' ' HD2' ' A' ' 72' ' ' PRO . . . -58.36 -33.04 69.12 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.921 -0.487 . . . . 0.0 110.76 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.61 -51.15 8.52 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.217 -0.927 . . . . 0.0 110.215 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.3 t -60.62 -31.13 70.33 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.543 -0.723 . . . . 0.0 110.738 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.531 ' HB ' ' CD ' ' A' ' 72' ' ' PRO . 51.6 mt -56.94 -69.63 0.43 Allowed Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.518 -0.739 . . . . 0.0 111.072 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.739 ' HB3' HG11 ' A' ' 33' ' ' VAL . 17.7 Cg_endo -56.06 -52.56 7.03 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 122.485 2.123 . . . . 0.0 111.762 -178.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.4 t -49.36 -69.5 0.11 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.78 -0.575 . . . . 0.0 110.521 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -63.56 -35.83 81.8 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 122.107 -0.37 . . . . 0.0 111.166 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 71' ' ' ILE . 0.9 OUTLIER -48.66 -35.98 14.98 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.398 -0.814 . . . . 0.0 111.419 -178.447 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 133.92 50.14 0.08 OUTLIER Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.789 HG21 HG12 ' A' ' 33' ' ' VAL . 2.4 t -119.52 110.99 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.423 -1.045 . . . . 0.0 109.951 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 83.8 p -81.32 68.24 7.56 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.296 -0.878 . . . . 0.0 108.918 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.565 HG12 ' CE2' ' A' ' 81' ' ' TYR . 0.7 OUTLIER -133.92 134.26 23.0 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.589 -0.694 . . . . 0.0 109.739 -178.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.495 ' HD2' HG13 ' A' ' 79' ' ' ILE . 47.3 Cg_endo -67.11 -35.37 25.43 Favored 'Trans proline' 0 N--CA 1.486 1.048 0 C-N-CA 122.958 2.439 . . . . 0.0 113.278 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.706 ' HB3' HG22 ' A' ' 92' ' ' VAL . 54.8 p90 -80.54 132.26 35.64 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.698 -1.251 . . . . 0.0 110.755 -178.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.55 154.51 20.28 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.468 0.651 . . . . 0.0 110.38 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.666 HG23 HD22 ' A' ' 53' ' ' LEU . 1.9 mp -98.33 83.16 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 121.41 0.624 . . . . 0.0 109.739 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 99.8 p -128.99 171.26 12.52 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.116 -0.99 . . . . 0.0 110.07 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.611 ' HA ' ' HB1' ' A' ' 57' ' ' ALA . 1.7 m -58.37 101.14 0.07 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.335 -0.853 . . . . 0.0 109.375 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.4 ' HA ' ' CG ' ' A' ' 54' ' ' LYS . 34.2 t 60.36 60.53 2.0 Allowed 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 121.493 0.663 . . . . 0.0 109.513 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 56.0 m -63.8 -69.23 0.29 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.434 -0.791 . . . . 0.0 110.684 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -150.87 -72.46 0.16 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.061 -1.024 . . . . 0.0 110.149 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.532 ' SG ' ' HD2' ' A' ' 54' ' ' LYS . 38.5 m 58.82 55.01 4.83 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-O 121.621 0.724 . . . . 0.0 111.626 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 97.6 p -162.75 -42.35 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 114.427 -1.261 . . . . 0.0 109.705 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -100.17 12.43 37.02 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.458 -0.777 . . . . 0.0 109.719 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.706 HG22 ' HB3' ' A' ' 81' ' ' TYR . 85.7 t -79.54 117.14 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.268 -0.895 . . . . 0.0 109.659 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.936 0 CA-C-O 117.267 -1.349 . . . . 0.0 109.542 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 1.019 HD11 ' HB2' ' A' ' 49' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.485 1.3 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.2 t -119.05 -173.3 2.47 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.527 -1.358 . . . . 0.0 110.632 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.568 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 1.9 t -52.2 -28.16 17.34 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 177.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -57.23 -51.75 55.67 Favored Glycine 0 N--CA 1.501 2.987 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.543 ' HG3' ' N ' ' A' ' 7' ' ' VAL . 3.1 pt20 -89.33 -34.16 16.65 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.387 -1.067 . . . . 0.0 109.666 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 49' ' ' ALA . 40.7 t -56.16 -37.74 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.32 -37.7 68.86 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.7 p -77.15 -22.11 53.04 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.011 -1.056 . . . . 0.0 110.02 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.63 -48.86 23.98 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.473 -0.767 . . . . 0.0 110.29 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.435 HG21 ' CD2' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -83.98 -16.02 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 O-C-N 121.13 -0.981 . . . . 0.0 110.812 -179.412 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.541 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -45.61 -54.78 14.27 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.455 -0.778 . . . . 0.0 109.759 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.74 ' HG2' ' SG ' ' A' ' 29' ' ' CYS . 19.2 Cg_endo -62.0 -24.76 77.09 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.186 1.924 . . . . 0.0 110.565 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.724 ' SG ' HG21 ' A' ' 71' ' ' ILE . 72.1 m -86.61 -16.81 35.57 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 178.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.453 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -47.58 -24.53 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.904 -0.497 . . . . 0.0 111.255 -177.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.447 ' HA ' ' NH2' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -91.21 -61.93 1.55 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.017 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.508 ' CE2' HG12 ' A' ' 71' ' ' ILE . 1.1 t80 -55.19 -57.42 11.87 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 14' ' ' CYS . . . -52.36 -32.38 38.15 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-O 121.42 0.629 . . . . 0.0 110.144 178.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 9.3 tmm_? -90.01 7.9 35.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.798 -0.564 . . . . 0.0 110.86 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.18 9.31 59.45 Favored Glycine 0 N--CA 1.502 3.075 0 O-C-N 120.713 -1.242 . . . . 0.0 111.976 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -114.75 81.91 1.64 Allowed 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 118.768 1.284 . . . . 0.0 109.699 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 157.48 -148.95 19.26 Favored Glycine 0 N--CA 1.5 2.905 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.3 t -175.24 -45.71 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.596 -0.943 . . . . 0.0 109.918 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -97.84 141.75 15.76 Favored Glycine 0 N--CA 1.499 2.886 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.633 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . 27.9 Cg_endo -62.31 121.91 10.11 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 122.362 2.041 . . . . 0.0 111.051 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.5 t -60.77 134.62 57.27 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.548 -0.72 . . . . 0.0 110.045 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.91 -52.9 37.53 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.65 -0.656 . . . . 0.0 110.109 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -52.76 -45.93 60.27 Favored Glycine 0 N--CA 1.502 3.06 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.74 ' SG ' ' HG2' ' A' ' 13' ' ' PRO . 1.1 m -60.02 -43.84 95.02 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.016 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.558 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 3.6 m -63.56 -57.33 10.47 Favored 'General case' 0 C--O 1.201 -1.473 0 CA-C-O 117.556 -1.211 . . . . 0.0 109.574 -176.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.3 t -65.79 -39.78 91.28 Favored 'General case' 0 N--CA 1.505 2.296 0 CA-C-N 118.804 0.729 . . . . 0.0 110.683 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -57.98 -44.78 94.38 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.743 HG12 HG21 ' A' ' 77' ' ' VAL . 5.3 t -84.06 -46.41 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.425 -1.044 . . . . 0.0 110.169 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.542 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -54.62 -35.06 63.02 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.491 -0.756 . . . . 0.0 109.14 179.676 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 90.9 p -78.49 -44.42 24.56 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.306 -0.871 . . . . 0.0 110.027 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.599 ' C ' HD12 ' A' ' 36' ' ' LEU . 0.4 OUTLIER -52.67 -35.82 55.91 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.513 -0.742 . . . . 0.0 109.665 179.786 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.56 ' HB2' HG13 ' A' ' 77' ' ' VAL . 4.3 t-20 -62.39 -26.21 68.35 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.259 -0.9 . . . . 0.0 109.917 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -91.65 -40.56 11.23 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.317 -0.864 . . . . 0.0 108.98 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.06 -36.44 69.58 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.861 ' HB2' HG12 ' A' ' 2' ' ' ILE . . . -91.51 -131.21 0.11 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.873 -0.517 . . . . 0.0 109.926 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.475 ' H ' ' HG2' ' A' ' 46' ' ' ARG . 8.1 mtt-85 56.95 38.92 29.67 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.294 -0.879 . . . . 0.0 110.064 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.465 ' O ' ' HB ' ' A' ' 43' ' ' THR . 9.0 t -136.1 19.02 3.2 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.822 -0.549 . . . . 0.0 109.867 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.768 ' HA ' ' C ' ' A' ' 93' ' ' ASN . 99.5 m 78.17 -60.73 0.4 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.755 -0.591 . . . . 0.0 110.327 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.51 -55.67 32.06 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.445 -0.785 . . . . 0.0 110.613 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.42 ' HB3' ' CG1' ' A' ' 2' ' ' ILE . 54.5 m-20 -67.44 -37.14 82.54 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.575 -0.703 . . . . 0.0 110.889 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.661 ' HD2' HD11 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -67.5 -57.08 7.14 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.879 -1.138 . . . . 0.0 110.778 -179.145 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -55.31 -44.17 75.56 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.226 -0.921 . . . . 0.0 109.419 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.46 -45.76 80.72 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 1.019 ' HB2' HD11 ' A' ' 2' ' ' ILE 0.27 . . -61.59 -52.87 62.61 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.4 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.471 ' C ' ' SG ' ' A' ' 89' ' ' CYS . 44.7 t -54.84 -34.26 62.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.996 -1.065 . . . . 0.0 111.809 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -68.92 -59.5 3.02 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 123.676 0.61 . . . . 0.0 109.988 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.5 t -61.73 -33.36 73.91 Favored 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.526 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.613 HD22 HG13 ' A' ' 83' ' ' ILE . 17.8 mt -67.65 -51.39 50.45 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.636 176.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -59.04 -38.92 80.48 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -61.13 -53.43 57.1 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 122.077 -0.39 . . . . 0.0 110.381 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.29 -44.42 52.77 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.286 -0.884 . . . . 0.0 110.357 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.57 -44.31 76.75 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.526 -0.734 . . . . 0.0 110.112 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.422 ' HB2' HG21 ' A' ' 85' ' ' THR . . . -76.54 68.66 2.88 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.321 -0.862 . . . . 0.0 109.379 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 149.13 -12.21 1.06 Allowed Glycine 0 N--CA 1.5 2.933 0 C-N-CA 120.117 -1.039 . . . . 0.0 111.719 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.3 t -40.09 -60.33 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.566 0 CA-C-N 118.962 1.381 . . . . 0.0 110.776 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.0 m 160.45 77.9 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.512 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.54 -65.21 3.45 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 107.456 -2.257 . . . . 0.0 107.456 -177.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 8.4 tt 68.99 138.13 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 121.821 0.82 . . . . 0.0 111.413 177.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -121.38 92.26 3.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.427 -0.796 . . . . 0.0 109.192 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.46 -41.4 4.3 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.764 -0.585 . . . . 0.0 110.07 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -53.11 -32.18 42.38 Favored Glycine 0 N--CA 1.502 3.076 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -97.49 -53.49 3.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.788 -0.831 . . . . 0.0 108.95 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.407 ' HB2' ' HB1' ' A' ' 18' ' ' ALA . . . -54.69 -32.42 59.37 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.871 -0.518 . . . . 0.0 111.221 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.418 ' CB ' ' HB ' ' A' ' 82' ' ' THR . . . -86.7 -44.01 12.14 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.232 -0.917 . . . . 0.0 109.534 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 65.5 m -64.05 -39.36 93.91 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.677 -0.639 . . . . 0.0 111.139 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.724 HG21 ' SG ' ' A' ' 14' ' ' CYS . 68.5 mt -51.18 -64.35 1.43 Allowed Pre-proline 0 N--CA 1.499 2.008 0 O-C-N 121.628 -0.67 . . . . 0.0 111.479 -178.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.592 ' HG3' HD13 ' A' ' 83' ' ' ILE . 36.8 Cg_endo -59.56 -50.14 8.82 Favored 'Trans proline' 0 N--CA 1.48 0.678 0 C-N-CA 121.85 1.7 . . . . 0.0 110.549 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.7 t -55.82 -60.74 3.03 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.843 -0.536 . . . . 0.0 110.186 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -63.04 -40.01 96.44 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 122.04 -0.413 . . . . 0.0 110.317 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.633 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 1.2 m -49.86 -37.59 31.64 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.377 -0.827 . . . . 0.0 111.176 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 136.21 55.99 0.06 OUTLIER Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 176.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.743 HG21 HG12 ' A' ' 33' ' ' VAL . 37.4 t -132.07 114.36 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.515 -0.991 . . . . 0.0 110.139 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.2 m -82.57 56.53 3.36 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.467 -0.77 . . . . 0.0 109.215 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.661 HD11 ' HD2' ' A' ' 46' ' ' ARG . 2.1 tt -117.49 125.51 28.06 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.433 -0.792 . . . . 0.0 109.581 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 79' ' ' ILE . 21.9 Cg_exo -64.46 -37.13 40.33 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 122.786 2.324 . . . . 0.0 111.79 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.488 ' C ' ' CD1' ' A' ' 81' ' ' TYR . 0.8 OUTLIER -77.83 138.83 39.17 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.995 -1.066 . . . . 0.0 109.76 -179.396 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.418 ' HB ' ' CB ' ' A' ' 69' ' ' ALA . 30.0 p -107.79 168.21 9.42 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.499 -0.751 . . . . 0.0 110.327 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.613 HG13 HD22 ' A' ' 53' ' ' LEU . 1.2 mp -84.6 58.31 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.9 m -136.49 40.4 2.61 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.541 -0.725 . . . . 0.0 109.149 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 87' ' ' THR . 66.9 p 39.72 -115.69 0.2 Allowed 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -178.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.1 m 62.75 -60.87 0.13 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.389 -0.819 . . . . 0.0 111.416 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 85' ' ' THR . 3.7 t -75.76 158.61 32.01 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.247 -0.908 . . . . 0.0 111.181 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -104.52 6.72 34.93 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.476 -0.765 . . . . 0.0 110.418 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.471 ' SG ' ' C ' ' A' ' 50' ' ' CYS . 3.9 m 52.42 49.27 20.82 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.933 -0.479 . . . . 0.0 111.611 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.7 t -111.05 -37.85 5.24 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.981 -178.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -138.71 36.68 2.2 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.486 -0.759 . . . . 0.0 109.507 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.4 p -98.78 11.86 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 O-C-N 121.323 -0.861 . . . . 0.0 110.464 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.768 ' C ' ' HA ' ' A' ' 43' ' ' THR . 27.6 m-20 . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 117.186 -1.388 . . . . 0.0 108.78 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 2' ' ' ILE . 10.6 tp . . . . . 0 N--CA 1.506 2.351 0 CA-C-O 122.092 0.948 . . . . 0.0 111.655 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.6 t -144.59 59.74 1.33 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.72 -1.237 . . . . 0.0 110.521 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.413 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 6.3 t 67.3 -52.5 0.48 Allowed 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -47.32 -48.91 20.69 Favored Glycine 0 N--CA 1.506 3.321 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 177.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.428 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -82.46 -31.05 29.63 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.422 -1.046 . . . . 0.0 110.479 179.531 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.474 HG21 ' HA ' ' A' ' 49' ' ' ALA . 1.7 t -60.72 -46.15 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.596 ' HA ' HG13 ' A' ' 11' ' ' ILE . . . -72.64 -26.33 61.62 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.9 m -68.57 -20.37 64.52 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.323 -0.861 . . . . 0.0 110.34 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.429 ' HB1' ' CA ' ' A' ' 33' ' ' VAL . . . -98.24 -36.42 10.03 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.248 -0.908 . . . . 0.0 110.477 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.596 HG13 ' HA ' ' A' ' 8' ' ' ALA . 2.6 pp -80.0 -31.7 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.378 -0.826 . . . . 0.0 110.541 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.543 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -46.76 -50.89 41.3 Favored Pre-proline 0 N--CA 1.501 2.107 0 O-C-N 121.45 -0.782 . . . . 0.0 109.897 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.555 ' HG2' ' HA ' ' A' ' 29' ' ' CYS . 19.3 Cg_endo -63.08 -13.02 32.76 Favored 'Trans proline' 0 CA--C 1.548 1.178 0 C-N-CA 122.23 1.953 . . . . 0.0 111.412 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.2 m -125.45 24.06 7.37 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 175.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.446 ' CD1' HG13 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -60.06 -50.16 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 118.684 0.674 . . . . 0.0 111.019 177.18 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.474 ' HA ' ' HB3' ' A' ' 19' ' ' ARG . 1.5 m -67.58 -45.73 74.69 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.251 -0.906 . . . . 0.0 109.726 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.551 ' CE2' HG12 ' A' ' 71' ' ' ILE . 1.2 t80 -58.69 -48.5 80.9 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.475 ' HB1' ' HB2' ' A' ' 68' ' ' ALA . . . -69.38 -28.98 66.66 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.592 -0.692 . . . . 0.0 109.375 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.487 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 9.9 ttm180 -75.34 -18.24 60.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.653 -0.654 . . . . 0.0 109.864 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.46 20.83 11.34 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.451 ' O ' ' HB3' ' A' ' 16' ' ' SER . 26.7 tt0 -123.06 82.34 1.98 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . 158.88 -153.75 24.86 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 46.4 t 170.17 60.45 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.795 -0.827 . . . . 0.0 109.233 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 160.06 123.12 0.68 Allowed Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.597 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 32.0 Cg_endo -63.1 124.8 14.57 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 122.571 2.18 . . . . 0.0 110.918 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.2 p -77.36 154.43 32.79 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.484 -0.76 . . . . 0.0 109.612 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.31 -57.76 10.88 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.461 -0.775 . . . . 0.0 110.245 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -53.94 -37.96 59.2 Favored Glycine 0 N--CA 1.501 3.011 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.555 ' HA ' ' HG2' ' A' ' 13' ' ' PRO . 6.4 t -66.63 -73.24 0.14 Allowed 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.749 177.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.597 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 0.5 OUTLIER -44.81 -41.52 7.06 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.238 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.438 ' HA ' ' HG2' ' A' ' 34' ' ' ARG . 35.8 t -73.15 -52.03 15.68 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.414 178.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.21 -41.24 96.62 Favored Glycine 0 N--CA 1.5 2.913 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.792 HG12 HG21 ' A' ' 77' ' ' VAL . 57.7 t -72.54 -50.23 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.339 -1.094 . . . . 0.0 109.85 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.438 ' HG2' ' HA ' ' A' ' 31' ' ' SER . 11.6 ptm180 -62.1 -23.04 66.29 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.5 -0.75 . . . . 0.0 110.351 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 57.6 p -88.4 -42.3 12.26 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.314 -0.866 . . . . 0.0 109.373 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.712 HD23 ' HA ' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -52.24 -32.89 39.04 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.322 -0.861 . . . . 0.0 109.344 178.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.498 ' HB2' HG13 ' A' ' 77' ' ' VAL . 8.9 t-20 -74.78 -8.56 56.81 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.932 -0.48 . . . . 0.0 111.168 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -105.44 -26.95 11.72 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.501 -1.375 . . . . 0.0 110.855 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.41 -13.86 61.98 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.287 -0.883 . . . . 0.0 110.219 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 1.05 ' HB1' ' HB3' ' A' ' 45' ' ' ASP . . . -163.1 139.54 7.23 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.51 -0.743 . . . . 0.0 110.297 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.51 ' HG2' HH11 ' A' ' 46' ' ' ARG . 4.4 mtm180 -172.62 51.32 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.228 -0.92 . . . . 0.0 110.613 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.569 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.9 OUTLIER -133.6 57.99 1.79 Allowed 'General case' 0 N--CA 1.508 2.466 0 O-C-N 120.987 -1.07 . . . . 0.0 109.979 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.61 ' CB ' ' HA ' ' A' ' 93' ' ' ASN . 12.6 t 54.66 -53.8 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.105 0 C-N-CA 123.988 0.915 . . . . 0.0 111.775 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 42' ' ' THR . . . -61.37 -51.86 67.03 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 1.05 ' HB3' ' HB1' ' A' ' 40' ' ' ALA . 6.3 m-20 -66.87 -42.86 84.91 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.567 ' HD2' HG13 ' A' ' 79' ' ' ILE . 1.0 OUTLIER -62.01 -48.35 80.7 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.411 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.553 ' HA ' ' SG ' ' A' ' 50' ' ' CYS . 72.0 mtt180 -67.43 -37.13 82.53 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.247 -0.908 . . . . 0.0 109.213 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.47 -50.21 74.54 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 177.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.513 ' HB2' HD11 ' A' ' 2' ' ' ILE . . . -60.74 -42.65 97.77 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.553 ' SG ' ' HA ' ' A' ' 47' ' ' ARG . 4.3 p -66.23 -33.15 75.1 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.591 -0.693 . . . . 0.0 110.509 -177.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.5 ' N ' ' SG ' ' A' ' 50' ' ' CYS . 1.7 t30 -62.93 -54.15 43.0 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 124.06 0.85 . . . . 0.0 109.334 176.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 18.6 t -68.41 -38.79 81.59 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 119.166 -1.014 . . . . 0.0 111.314 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 53' ' ' LEU . 12.4 mt -56.03 -41.97 75.81 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 124.377 1.048 . . . . 0.0 108.619 176.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.419 ' HG2' ' CB ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -58.61 -50.22 74.61 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.109 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -59.34 -41.51 89.34 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.404 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -69.78 -55.86 8.72 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.477 -0.764 . . . . 0.0 109.403 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.467 ' O ' HD22 ' A' ' 63' ' ' LEU . . . -54.59 -47.67 73.05 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.586 -0.696 . . . . 0.0 110.297 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.11 7.34 7.64 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.319 -0.863 . . . . 0.0 110.726 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -132.99 7.52 5.14 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.446 HG13 ' CD1' ' A' ' 15' ' ' ILE . 2.5 t -79.73 133.92 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.128 -1.219 . . . . 0.0 109.382 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.8 p -65.57 94.21 0.18 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.514 -0.741 . . . . 0.0 109.284 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 112.93 -78.52 0.25 Allowed Glycine 0 N--CA 1.497 2.715 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.491 ' CD2' HG23 ' A' ' 85' ' ' THR . 16.7 tp 69.12 134.43 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 122.2 1.0 . . . . 0.0 111.316 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.477 ' HB3' ' HB2' ' A' ' 67' ' ' ASN . 6.8 t-20 -135.84 106.09 6.37 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.0 -57.82 8.35 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.623 -0.673 . . . . 0.0 111.463 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.45 -47.69 68.22 Favored Glycine 0 N--CA 1.504 3.18 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 64' ' ' ASN . 1.8 m-20 -69.84 -58.94 3.28 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.625 -0.926 . . . . 0.0 110.25 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.475 ' HB2' ' HB1' ' A' ' 18' ' ' ALA . . . -57.35 -32.4 66.72 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.474 -0.766 . . . . 0.0 112.273 -178.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.46 -52.57 7.88 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.879 -1.138 . . . . 0.0 110.189 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 90.6 p -68.3 -34.25 75.81 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.653 -0.654 . . . . 0.0 111.122 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.551 HG12 ' CE2' ' A' ' 17' ' ' TYR . 28.1 mt -47.83 -65.33 0.77 Allowed Pre-proline 0 N--CA 1.503 2.215 0 O-C-N 121.516 -0.74 . . . . 0.0 110.357 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.577 ' HB3' HG11 ' A' ' 33' ' ' VAL . 28.3 Cg_endo -61.65 -50.23 5.8 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 122.218 1.945 . . . . 0.0 110.557 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 40.6 t -51.52 -60.84 2.7 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.828 -0.545 . . . . 0.0 110.151 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.2 tptp -64.36 -41.28 96.81 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.721 -0.612 . . . . 0.0 110.1 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -48.16 -50.44 28.9 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 120.019 -0.673 . . . . 0.0 111.707 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.61 46.99 0.01 OUTLIER Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 176.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.792 HG21 HG12 ' A' ' 33' ' ' VAL . 53.5 t -129.23 125.65 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.643 -0.916 . . . . 0.0 110.106 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.5 t -112.45 81.0 1.4 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.567 HG13 ' HD2' ' A' ' 46' ' ' ARG . 11.1 tt -121.3 137.38 26.76 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.652 -0.655 . . . . 0.0 109.27 -178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 79' ' ' ILE . 50.9 Cg_exo -52.75 -41.74 67.66 Favored 'Trans proline' 0 N--CA 1.483 0.889 0 C-N-CA 122.785 2.324 . . . . 0.0 113.114 -178.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.478 ' HH ' ' HB3' ' A' ' 49' ' ' ALA . 5.9 p90 -93.6 147.91 22.57 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 120.626 -1.296 . . . . 0.0 110.824 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -84.1 152.91 24.05 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.598 -0.688 . . . . 0.0 109.503 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.501 HD12 ' N ' ' A' ' 83' ' ' ILE . 2.0 mp -85.38 93.74 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.487 -0.758 . . . . 0.0 109.951 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.9 p -170.89 -175.65 1.82 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.417 -0.802 . . . . 0.0 109.827 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.491 HG23 ' CD2' ' A' ' 63' ' ' LEU . 0.6 OUTLIER -62.88 -28.91 70.36 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.807 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 32.9 m -83.93 45.76 1.12 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.527 -0.733 . . . . 0.0 109.819 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.419 ' CB ' ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -77.01 139.0 39.94 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.341 -0.849 . . . . 0.0 109.977 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -95.4 134.63 37.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.449 -0.782 . . . . 0.0 109.872 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 94.5 m -143.47 53.57 1.33 Allowed 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.675 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 89.7 p -159.15 -48.48 0.06 Allowed 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.732 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.579 ' HB2' ' CZ ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -113.41 21.16 15.46 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.462 HG21 ' HD2' ' A' ' 81' ' ' TYR . 3.3 p -101.9 129.99 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-O 121.638 0.733 . . . . 0.0 109.794 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.61 ' HA ' ' CB ' ' A' ' 43' ' ' THR . 72.4 m-20 . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 116.506 -1.711 . . . . 0.0 108.969 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.803 HG21 ' HB3' ' A' ' 45' ' ' ASP . 3.5 tp . . . . . 0 N--CA 1.5 2.032 0 CA-C-O 121.757 0.789 . . . . 0.0 109.82 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.4 ' O ' ' HG3' ' A' ' 6' ' ' GLN . 46.1 t -115.81 169.54 9.14 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.244 -0.91 . . . . 0.0 109.994 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 26.5 t -62.33 -33.64 75.09 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.665 -0.814 . . . . 0.0 112.65 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -50.56 -51.09 33.92 Favored Glycine 0 N--CA 1.502 3.062 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -77.24 -36.05 54.94 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.279 -1.13 . . . . 0.0 110.308 -179.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.479 HG21 ' HA ' ' A' ' 49' ' ' ALA . 83.2 t -56.52 -46.66 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.74 -35.59 72.74 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.6 t -69.0 -21.86 64.12 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.272 -0.893 . . . . 0.0 109.825 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.28 -27.93 21.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.509 -0.744 . . . . 0.0 109.018 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.512 HD11 HG21 ' A' ' 83' ' ' ILE . 1.2 tp -79.5 -40.63 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.356 -0.84 . . . . 0.0 110.023 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.536 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -44.26 -51.46 19.23 Favored Pre-proline 0 N--CA 1.504 2.225 0 O-C-N 121.646 -0.659 . . . . 0.0 110.977 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 32.9 Cg_endo -65.79 -28.17 51.47 Favored 'Trans proline' 0 N--CA 1.483 0.911 0 C-N-CA 122.281 1.987 . . . . 0.0 110.592 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.841 ' SG ' HG21 ' A' ' 71' ' ' ILE . 1.3 m -101.28 16.79 24.39 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 177.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.787 HD13 HG13 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -65.79 -51.1 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.507 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.1 p -59.76 -57.79 11.38 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.324 -0.86 . . . . 0.0 109.302 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.716 ' CD1' HD11 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -55.3 -54.45 43.38 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.522 ' HB1' ' HB2' ' A' ' 68' ' ' ALA . . . -65.11 -25.37 67.74 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.416 -0.802 . . . . 0.0 110.003 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.474 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 10.5 ttp180 -79.02 -26.03 43.23 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.319 -0.863 . . . . 0.0 110.006 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 148.32 -12.95 1.23 Allowed Glycine 0 N--CA 1.5 2.916 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.9 mp0 -82.53 64.38 7.15 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.923 -1.34 . . . . 0.0 108.875 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.556 ' HA2' ' CD1' ' A' ' 17' ' ' TYR . . . -76.34 75.69 1.56 Allowed Glycine 0 N--CA 1.5 2.904 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.62 36.05 0.06 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.717 -0.873 . . . . 0.0 110.05 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 178.11 78.78 0.06 OUTLIER Glycine 0 N--CA 1.499 2.836 0 C-N-CA 120.075 -1.059 . . . . 0.0 110.51 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -59.91 131.88 41.94 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 122.17 1.913 . . . . 0.0 109.928 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.1 t -90.06 120.17 31.03 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.268 -0.895 . . . . 0.0 110.602 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.87 -45.2 74.56 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.38 -46.0 87.93 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.5 t -54.07 -42.28 69.11 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.301 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 80.4 m -61.76 -47.6 84.47 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.926 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.1 t -65.19 -40.55 94.38 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 124.259 0.974 . . . . 0.0 110.906 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.25 -57.07 12.43 Favored Glycine 0 N--CA 1.5 2.908 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.647 HG11 ' CB ' ' A' ' 72' ' ' PRO . 16.4 t -62.94 -46.54 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.488 -1.007 . . . . 0.0 109.442 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.576 ' N ' HG22 ' A' ' 77' ' ' VAL . 0.5 OUTLIER -54.54 -31.08 55.76 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.694 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.7 m -78.86 -44.09 23.62 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.536 HD23 ' HA ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -56.86 -43.7 81.45 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.632 -0.668 . . . . 0.0 109.995 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.636 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 51.3 t30 -74.72 -35.48 62.69 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.167 -0.958 . . . . 0.0 109.912 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -63.83 -37.72 88.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.039 -1.038 . . . . 0.0 108.395 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.29 -43.53 13.65 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.786 -0.571 . . . . 0.0 110.617 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.596 ' HB2' HG12 ' A' ' 2' ' ' ILE . . . -103.9 111.44 23.97 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.06 -1.025 . . . . 0.0 111.441 -178.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.636 ' HG3' ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -157.84 26.48 0.27 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.781 -0.575 . . . . 0.0 110.0 179.044 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.423 ' O ' ' HB ' ' A' ' 43' ' ' THR . 0.2 OUTLIER -127.64 34.7 4.62 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.127 -0.983 . . . . 0.0 109.624 -179.441 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.453 ' OG1' ' HA ' ' A' ' 93' ' ' ASN . 27.9 m 70.09 -66.08 0.29 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.562 -0.711 . . . . 0.0 109.924 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.91 -57.06 10.5 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.707 -0.62 . . . . 0.0 110.677 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.803 ' HB3' HG21 ' A' ' 2' ' ' ILE . 6.5 m-20 -67.2 -36.89 82.67 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.495 HH12 ' HB3' ' A' ' 81' ' ' TYR . 5.6 mmm180 -67.95 -39.45 83.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.629 -0.669 . . . . 0.0 109.684 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.444 ' HG2' ' NH1' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -58.82 -41.89 87.9 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.428 -0.795 . . . . 0.0 108.995 178.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.42 -46.49 86.34 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.577 ' HB2' HD11 ' A' ' 2' ' ' ILE . . . -64.14 -41.58 97.14 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 50.0 t -66.31 -35.83 81.39 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.613 -0.68 . . . . 0.0 110.569 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -66.54 -55.76 14.0 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 124.152 0.908 . . . . 0.0 109.813 176.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 42.1 t -61.63 -35.7 78.66 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.862 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.601 HD22 HG23 ' A' ' 83' ' ' ILE . 12.1 mt -61.15 -53.19 60.15 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 124.336 1.022 . . . . 0.0 109.011 176.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 43.8 tttp -55.82 -37.64 68.94 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.78 -29.77 69.05 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.532 -0.73 . . . . 0.0 110.817 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.513 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -94.96 -49.3 5.62 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.271 -0.893 . . . . 0.0 110.378 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.603 ' HA ' HD13 ' A' ' 63' ' ' LEU . . . -53.65 -49.59 67.59 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.36 -0.838 . . . . 0.0 109.522 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.46 67.05 1.02 Allowed 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 61' ' ' SER . . . 165.16 -22.87 0.14 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.787 HG13 HD13 ' A' ' 15' ' ' ILE . 24.7 t -64.52 69.85 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 121.29 -1.124 . . . . 0.0 109.942 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.456 ' CB ' ' HD2' ' A' ' 19' ' ' ARG . 43.3 m 54.38 -102.68 0.15 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.222 -0.924 . . . . 0.0 110.022 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -100.0 -29.11 6.99 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.603 HD13 ' HA ' ' A' ' 57' ' ' ALA . 21.7 tp 63.54 99.98 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.807 -0.82 . . . . 0.0 111.047 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -98.62 95.43 7.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.205 -0.934 . . . . 0.0 108.643 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -49.31 -50.44 39.38 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.734 -0.604 . . . . 0.0 111.042 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.07 -32.7 50.2 Favored Glycine 0 N--CA 1.505 3.261 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.441 ' O ' HG13 ' A' ' 71' ' ' ILE . 3.7 m-20 -82.87 -48.98 10.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.52 -0.988 . . . . 0.0 109.435 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.522 ' HB2' ' HB1' ' A' ' 18' ' ' ALA . . . -69.25 -21.42 63.91 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.687 -0.633 . . . . 0.0 111.408 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.441 ' HB2' ' HB ' ' A' ' 82' ' ' THR . . . -89.44 -41.35 12.13 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.011 -1.056 . . . . 0.0 110.253 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 76.6 p -68.99 -45.39 70.71 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.499 -0.751 . . . . 0.0 110.954 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.841 HG21 ' SG ' ' A' ' 14' ' ' CYS . 44.0 mt -47.95 -64.55 1.03 Allowed Pre-proline 0 N--CA 1.503 2.208 0 O-C-N 121.647 -0.658 . . . . 0.0 111.589 -178.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.647 ' CB ' HG11 ' A' ' 33' ' ' VAL . 28.4 Cg_endo -59.27 -48.87 12.28 Favored 'Trans proline' 0 N--CA 1.48 0.677 0 C-N-CA 121.745 1.63 . . . . 0.0 110.566 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.1 m -49.45 -68.96 0.13 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -33.59 75.62 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -47.78 -35.43 9.99 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.794 -0.566 . . . . 0.0 110.453 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 124.74 54.4 0.18 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.011 -2.036 . . . . 0.0 108.011 177.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.576 HG22 ' N ' ' A' ' 34' ' ' ARG . 85.2 t -111.09 -48.57 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.205 -178.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 77' ' ' VAL . 19.7 m 68.33 33.59 4.15 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.677 -0.639 . . . . 0.0 110.149 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.657 HG12 ' CD1' ' A' ' 81' ' ' TYR . 9.7 tt -95.78 121.35 61.44 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.059 -1.026 . . . . 0.0 109.06 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -65.31 56.6 0.31 Allowed 'Trans proline' 0 CA--C 1.55 1.294 0 C-N-CA 122.51 2.14 . . . . 0.0 112.711 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.657 ' CD1' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -178.54 152.31 0.64 Allowed 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.332 -0.855 . . . . 0.0 110.271 177.443 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.441 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 53.6 p -108.64 171.37 7.46 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.65 0.738 . . . . 0.0 110.592 -178.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.601 HG23 HD22 ' A' ' 53' ' ' LEU . 2.0 mp -104.44 67.12 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 122.012 0.911 . . . . 0.0 108.702 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.419 ' O ' ' CB ' ' A' ' 85' ' ' THR . 86.2 p -98.37 -18.39 18.33 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.494 -0.754 . . . . 0.0 110.627 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.419 ' CB ' ' O ' ' A' ' 84' ' ' SER . 0.5 OUTLIER 81.04 -16.44 0.65 Allowed 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.781 -0.574 . . . . 0.0 110.995 -179.282 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.9 m -76.17 -21.88 56.02 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.017 -1.052 . . . . 0.0 109.013 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -47.74 145.8 2.61 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.621 0.724 . . . . 0.0 111.1 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -88.93 -13.23 39.5 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.995 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 54.6 m 52.87 51.25 16.29 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.465 0.65 . . . . 0.0 111.291 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.96 -42.64 0.27 Allowed 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.552 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.8 31.74 4.83 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.3 p -109.48 118.84 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.768 -0.582 . . . . 0.0 109.462 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.453 ' HA ' ' OG1' ' A' ' 43' ' ' THR . 2.9 p-10 . . . . . 0 N--CA 1.497 1.912 0 CA-C-O 114.6 -2.619 . . . . 0.0 110.17 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.694 HG21 ' HA ' ' A' ' 45' ' ' ASP . 4.2 tp . . . . . 0 N--CA 1.496 1.859 0 CA-C-O 121.899 0.857 . . . . 0.0 109.828 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.8 t -135.17 172.61 12.76 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.314 -0.867 . . . . 0.0 110.205 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.8 t -67.86 -20.78 65.17 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -56.7 -54.48 36.12 Favored Glycine 0 N--CA 1.504 3.176 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.441 ' NE2' ' HB3' ' A' ' 36' ' ' LEU . 8.4 tt0 -67.66 -40.65 84.48 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.456 -1.026 . . . . 0.0 108.516 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.442 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 77.5 t -53.78 -44.91 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.87 -35.95 75.09 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.7 t -69.39 -22.2 63.73 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.44 -0.788 . . . . 0.0 109.241 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.561 ' C ' ' HD2' ' A' ' 13' ' ' PRO . . . -98.05 -25.43 14.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.51 -0.744 . . . . 0.0 109.236 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.442 ' HB ' ' O ' ' A' ' 7' ' ' VAL . 1.8 tp -78.77 -42.31 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.218 -0.926 . . . . 0.0 110.072 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.638 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -46.43 -51.16 36.92 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.588 -0.695 . . . . 0.0 110.432 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.638 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 11.2 Cg_exo -67.26 -28.76 39.7 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.136 1.891 . . . . 0.0 110.992 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.659 ' SG ' HG21 ' A' ' 71' ' ' ILE . 1.3 m -103.07 14.38 31.99 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 178.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.461 ' O ' ' CB ' ' A' ' 19' ' ' ARG . 0.4 OUTLIER -74.16 -44.5 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -178.474 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.1 p -65.74 -56.84 9.89 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.718 ' CG ' HD11 ' A' ' 71' ' ' ILE . 0.5 OUTLIER -54.82 -55.35 31.12 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.579 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.495 ' HB1' ' HB2' ' A' ' 68' ' ' ALA . . . -60.01 -32.05 70.51 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.313 -0.867 . . . . 0.0 109.439 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.461 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 11.9 ttt180 -78.42 -5.89 53.69 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.647 -0.658 . . . . 0.0 110.623 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.56 -12.43 39.21 Favored Glycine 0 N--CA 1.501 3.025 0 O-C-N 120.666 -1.272 . . . . 0.0 111.412 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -105.06 81.38 1.72 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.136 -1.214 . . . . 0.0 109.333 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -146.44 -177.03 20.76 Favored Glycine 0 N--CA 1.499 2.838 0 C-N-CA 119.686 -1.245 . . . . 0.0 111.356 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -176.38 49.98 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.13 136.93 3.73 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 108.504 -1.839 . . . . 0.0 108.504 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.452 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . 30.4 Cg_endo -60.98 130.22 31.84 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 122.158 1.905 . . . . 0.0 111.136 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.1 t -74.04 123.81 25.07 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.507 -0.746 . . . . 0.0 109.718 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.51 -46.43 73.5 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.502 -0.749 . . . . 0.0 109.879 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.1 -48.3 86.57 Favored Glycine 0 N--CA 1.503 3.164 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.0 OUTLIER -58.74 -55.19 38.24 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.095 178.328 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 96.2 m -58.76 -27.17 64.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 124.027 0.829 . . . . 0.0 112.033 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.2 m -74.23 -47.7 33.6 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 123.825 0.703 . . . . 0.0 109.296 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.531 ' HA3' ' HB2' ' A' ' 10' ' ' ALA . . . -65.0 -28.26 73.29 Favored Glycine 0 N--CA 1.5 2.953 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.754 HG12 HG11 ' A' ' 77' ' ' VAL . 21.2 t -81.91 -48.22 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.269 -1.136 . . . . 0.0 108.762 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.494 ' HA ' HG22 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -61.9 -25.78 67.77 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.358 -0.839 . . . . 0.0 109.05 179.071 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.437 ' HB3' ' NH2' ' A' ' 34' ' ' ARG . 79.6 p -74.0 -46.38 44.03 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.673 HD23 ' HA ' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -63.24 -30.86 71.93 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.671 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.785 ' HB2' HG13 ' A' ' 77' ' ' VAL . 3.1 t-20 -63.39 -36.17 82.84 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.025 -1.047 . . . . 0.0 110.215 179.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -90.38 -36.33 14.68 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.463 -0.773 . . . . 0.0 110.099 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.26 -18.48 25.56 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.538 -0.727 . . . . 0.0 111.076 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.683 ' HA ' ' CB ' ' A' ' 45' ' ' ASP . . . -123.56 110.49 15.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.011 -1.055 . . . . 0.0 110.508 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -163.32 -20.19 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.411 -0.806 . . . . 0.0 112.081 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 44' ' ' ALA . 89.7 m -78.28 50.02 0.88 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.648 -1.283 . . . . 0.0 110.292 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.705 HG23 ' HA ' ' A' ' 93' ' ' ASN . 97.9 m 62.4 -64.6 0.09 Allowed 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.846 -0.534 . . . . 0.0 110.015 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 42' ' ' THR . . . -48.45 -57.29 6.32 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 122.067 -0.396 . . . . 0.0 110.419 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.694 ' HA ' HG21 ' A' ' 2' ' ' ILE . 3.1 m-20 -55.26 -45.45 76.09 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.575 HH11 ' HB2' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -57.51 -55.23 37.52 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.738 178.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -59.92 -44.14 94.48 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.15 -50.88 71.39 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.535 -0.728 . . . . 0.0 109.317 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.629 ' HB2' HD11 ' A' ' 2' ' ' ILE . . . -63.56 -55.27 25.11 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.515 ' HA ' ' HB2' ' A' ' 53' ' ' LEU . 3.7 t -48.63 -39.42 24.03 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 174.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.419 ' N ' ' SG ' ' A' ' 89' ' ' CYS . 2.8 t30 -60.35 -53.09 61.81 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 176.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.6 t -68.54 -32.26 72.07 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 119.766 -0.774 . . . . 0.0 111.598 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.563 HD22 HG12 ' A' ' 83' ' ' ILE . 13.6 mt -63.0 -57.56 10.29 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.072 178.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -54.73 -39.4 68.21 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -54.51 -50.75 67.1 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.538 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -72.03 -44.17 63.82 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.507 -0.746 . . . . 0.0 109.205 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.551 ' HA ' ' CD1' ' A' ' 63' ' ' LEU . . . -54.88 -37.79 66.73 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.629 -0.669 . . . . 0.0 110.297 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.445 ' HA ' HG23 ' A' ' 85' ' ' THR . . . -85.89 8.03 21.83 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.237 -0.914 . . . . 0.0 110.43 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -140.3 11.56 3.02 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 56' ' ' ALA . 3.8 t -79.04 -28.01 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.234 -1.157 . . . . 0.0 109.937 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 60' ' ' VAL . 0.6 OUTLIER 77.25 113.26 0.07 Allowed 'General case' 0 N--CA 1.506 2.369 0 CA-C-O 121.275 0.559 . . . . 0.0 109.946 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.48 34.22 87.1 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.551 ' CD1' ' HA ' ' A' ' 57' ' ' ALA . 10.0 tt -64.68 121.86 15.5 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.463 -1.022 . . . . 0.0 110.406 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -97.09 90.05 5.02 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -44.28 -48.47 9.5 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.912 -0.492 . . . . 0.0 110.494 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -50.68 -40.52 40.92 Favored Glycine 0 N--CA 1.502 3.07 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -76.46 -56.4 4.66 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.703 -0.88 . . . . 0.0 109.344 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.495 ' HB2' ' HB1' ' A' ' 18' ' ' ALA . . . -59.44 -24.7 63.74 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.906 -0.496 . . . . 0.0 111.769 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.01 -47.48 7.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.956 -1.09 . . . . 0.0 110.419 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 t -64.54 -31.27 72.42 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.445 -0.784 . . . . 0.0 111.056 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.718 HD11 ' CG ' ' A' ' 17' ' ' TYR . 78.0 mt -60.43 -70.38 0.44 Allowed Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 121.204 -0.935 . . . . 0.0 111.007 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.694 ' CB ' HG11 ' A' ' 33' ' ' VAL . 38.0 Cg_endo -60.07 -51.67 5.33 Favored 'Trans proline' 0 N--CA 1.484 0.944 0 C-N-CA 122.328 2.019 . . . . 0.0 112.077 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.2 p -51.45 -63.67 1.06 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.692 -0.63 . . . . 0.0 110.487 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.7 mmtt -63.11 -42.33 99.53 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 122.15 -0.343 . . . . 0.0 110.604 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 71' ' ' ILE . 0.4 OUTLIER -47.36 -55.22 9.27 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.506 -0.746 . . . . 0.0 112.12 -177.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 164.9 50.97 0.02 OUTLIER Glycine 0 N--CA 1.496 2.653 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.785 HG13 ' HB2' ' A' ' 37' ' ' ASN . 46.8 t -130.85 93.59 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.756 -0.85 . . . . 0.0 110.323 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 56.7 p -70.1 66.44 0.27 Allowed 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.6 0.714 . . . . 0.0 110.365 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.618 HG12 ' CE1' ' A' ' 81' ' ' TYR . 0.4 OUTLIER -124.94 120.36 25.49 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.173 -0.954 . . . . 0.0 108.79 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.91 -27.5 74.76 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 C-N-CA 122.955 2.436 . . . . 0.0 113.679 -177.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.618 ' CE1' HG12 ' A' ' 79' ' ' ILE . 12.9 p90 -89.59 130.12 35.94 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.794 -1.191 . . . . 0.0 111.063 -178.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.1 p -102.68 155.51 18.26 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.738 0.78 . . . . 0.0 110.655 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.607 HD12 ' N ' ' A' ' 83' ' ' ILE . 2.0 mp -86.92 85.21 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.412 ' O ' ' HB ' ' A' ' 85' ' ' THR . 59.5 p -114.39 13.79 17.8 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.526 -0.734 . . . . 0.0 111.866 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.445 HG23 ' HA ' ' A' ' 58' ' ' ALA . 86.0 m 68.78 -56.82 0.52 Allowed 'General case' 0 N--CA 1.51 2.567 0 O-C-N 121.211 -0.93 . . . . 0.0 108.86 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 84' ' ' SER . 42.0 m -68.43 -25.6 65.1 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.289 -0.882 . . . . 0.0 109.167 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 94.4 m -38.48 140.92 0.29 Allowed 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 121.362 0.601 . . . . 0.0 110.697 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -85.3 139.9 31.24 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.594 -0.691 . . . . 0.0 110.56 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 51' ' ' ASN . 0.5 OUTLIER -122.73 56.26 1.15 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.934 0.873 . . . . 0.0 110.61 176.448 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.1 m -151.34 -41.15 0.12 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.092 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.06 -1.09 37.8 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.264 -0.897 . . . . 0.0 110.311 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.9 t -73.26 136.51 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 O-C-N 121.049 -1.032 . . . . 0.0 109.714 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.705 ' HA ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 114.0 -2.905 . . . . 0.0 110.05 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.777 ' CD1' ' HB2' ' A' ' 49' ' ' ALA . 1.3 pp . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.429 ' O ' ' HG3' ' A' ' 6' ' ' GLN . 27.7 t -96.13 -167.73 1.63 Allowed 'General case' 0 N--CA 1.503 2.211 0 O-C-N 120.894 -1.129 . . . . 0.0 111.199 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 33.5 t -74.96 -29.05 60.81 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -54.5 -50.57 56.46 Favored Glycine 0 N--CA 1.504 3.226 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 177.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.468 ' CD ' ' HB2' ' A' ' 36' ' ' LEU . 0.5 OUTLIER -66.67 -34.93 78.95 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.486 -1.009 . . . . 0.0 109.415 179.111 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.507 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 61.6 t -59.05 -38.27 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 177.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.511 ' HA ' HG13 ' A' ' 11' ' ' ILE . . . -68.97 -34.84 75.97 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.56 -16.36 63.84 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.531 -0.731 . . . . 0.0 109.573 178.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.698 ' HB1' HG22 ' A' ' 33' ' ' VAL . . . -94.11 -31.84 14.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.505 -0.747 . . . . 0.0 110.145 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.532 HD12 ' N ' ' A' ' 12' ' ' ALA . 2.4 pp -95.18 -30.79 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.31 -0.869 . . . . 0.0 111.443 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.574 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -50.87 -52.84 53.69 Favored Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.133 -0.979 . . . . 0.0 110.449 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.574 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 71.5 Cg_endo -73.46 -10.05 23.48 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.405 2.07 . . . . 0.0 111.019 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.634 ' SG ' ' HB3' ' A' ' 25' ' ' PRO . 15.6 m -124.61 21.0 8.56 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.56 ' CD1' HG13 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -67.04 -50.69 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.548 -179.129 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.494 ' HA ' ' HB3' ' A' ' 19' ' ' ARG . 20.2 m -62.48 -46.91 86.34 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.278 -0.889 . . . . 0.0 110.091 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.608 ' CD2' HG12 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -59.31 -56.14 25.92 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.96 -28.21 64.13 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.494 ' HB3' ' HA ' ' A' ' 16' ' ' SER . 0.0 OUTLIER -75.09 -5.21 42.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.904 -0.497 . . . . 0.0 110.568 179.153 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.04 -5.73 27.2 Favored Glycine 0 N--CA 1.5 2.953 0 O-C-N 120.599 -1.313 . . . . 0.0 111.846 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.46 97.52 3.71 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 118.991 1.395 . . . . 0.0 110.091 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.449 ' HA3' ' CB ' ' A' ' 17' ' ' TYR . . . -153.54 -66.28 0.01 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.7 t 58.65 43.64 18.62 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.507 -0.996 . . . . 0.0 109.037 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 132.37 95.31 0.61 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 107.977 -2.049 . . . . 0.0 107.977 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.634 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 17.1 Cg_exo -59.95 -78.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 122.381 2.054 . . . . 0.0 111.089 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 25' ' ' PRO . 10.8 t 161.83 149.79 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.581 -0.7 . . . . 0.0 109.635 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.35 -36.69 78.6 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.93 -45.01 87.41 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.61 ' O ' HG23 ' A' ' 33' ' ' VAL . 35.3 t -64.63 -52.42 57.54 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.655 -1.218 . . . . 0.0 109.638 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 83.4 m -59.18 -46.94 87.08 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.5 m -68.89 -50.12 52.37 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 124.119 0.887 . . . . 0.0 110.468 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.55 -54.76 33.82 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.698 HG22 ' HB1' ' A' ' 10' ' ' ALA . 38.3 t -60.61 -47.27 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.972 -0.722 . . . . 0.0 109.241 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.549 ' O ' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -56.34 -31.2 63.51 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.41 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.1 m -80.23 -55.12 5.14 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.778 -0.576 . . . . 0.0 109.647 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.539 ' CG ' ' HA ' ' A' ' 33' ' ' VAL . 1.7 pp -58.37 -42.46 87.05 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.254 -0.904 . . . . 0.0 109.133 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.547 ' HB3' HG13 ' A' ' 77' ' ' VAL . 18.4 m120 -70.92 -20.14 62.51 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.449 -0.782 . . . . 0.0 109.194 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.549 ' HB2' ' O ' ' A' ' 34' ' ' ARG . 52.1 t30 -67.69 -37.52 82.4 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.474 ' HB3' HG22 ' A' ' 2' ' ' ILE . . . -84.15 -24.87 30.02 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.96 -0.462 . . . . 0.0 110.89 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.577 ' N ' HG21 ' A' ' 2' ' ' ILE . . . -82.46 86.88 6.68 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.117 -0.99 . . . . 0.0 110.104 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.618 ' HA ' ' NE ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -152.55 38.19 0.54 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.121 -0.987 . . . . 0.0 110.314 -179.713 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.472 ' O ' ' N ' ' A' ' 44' ' ' ALA . 12.4 p -139.08 35.57 2.12 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 120.935 -1.103 . . . . 0.0 110.805 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.627 HG22 ' HB3' ' A' ' 93' ' ' ASN . 1.1 p 65.19 -60.92 0.24 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.424 -0.798 . . . . 0.0 109.6 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 42' ' ' THR . . . -58.72 -58.16 9.83 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.56 ' O ' HD11 ' A' ' 2' ' ' ILE . 21.8 m-20 -66.1 -45.21 82.01 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.835 0.826 . . . . 0.0 108.83 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.67 ' HG2' HG12 ' A' ' 92' ' ' VAL . 1.8 tpp180 -59.63 -57.63 12.1 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.752 -0.593 . . . . 0.0 110.95 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 -61.6 -38.69 88.54 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.282 -0.886 . . . . 0.0 109.986 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.13 -50.79 70.11 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.777 ' HB2' ' CD1' ' A' ' 2' ' ' ILE . . . -62.4 -46.68 87.49 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.489 ' C ' ' SG ' ' A' ' 89' ' ' CYS . 42.9 t -55.12 -42.19 72.66 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.998 -0.439 . . . . 0.0 111.05 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -67.69 -60.45 2.53 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 124.117 0.885 . . . . 0.0 110.206 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.507 ' SG ' ' HB ' ' A' ' 7' ' ' VAL . 10.8 t -55.36 -29.33 58.2 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.05 178.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.665 HD22 HG13 ' A' ' 83' ' ' ILE . 15.8 mt -70.44 -50.65 36.14 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.13 175.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.5 tttm -56.67 -41.03 76.56 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -56.34 -46.19 80.05 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.05 -41.01 62.42 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.558 -0.714 . . . . 0.0 109.238 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.618 ' HA ' HD13 ' A' ' 63' ' ' LEU . . . -52.92 -43.74 66.47 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.664 -0.647 . . . . 0.0 109.963 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -90.05 18.2 6.09 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.293 -0.879 . . . . 0.0 110.133 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -127.95 -31.48 0.69 Allowed Glycine 0 N--CA 1.501 2.969 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.56 HG13 ' CD1' ' A' ' 15' ' ' ILE . 7.6 t -52.87 135.34 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.54 -0.977 . . . . 0.0 110.272 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.7 t -64.12 107.68 1.35 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.596 -0.69 . . . . 0.0 109.191 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.93 50.09 43.47 Favored Glycine 0 N--CA 1.499 2.88 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.618 HD13 ' HA ' ' A' ' 57' ' ' ALA . 4.0 tp -61.41 126.31 26.89 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.369 -1.077 . . . . 0.0 110.372 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -103.48 93.48 4.97 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -41.49 -46.21 3.42 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.853 -0.53 . . . . 0.0 110.691 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.06 -31.34 48.27 Favored Glycine 0 N--CA 1.502 3.064 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.448 ' O ' HG13 ' A' ' 71' ' ' ILE . 95.4 m-20 -94.59 -49.5 5.61 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.464 -1.021 . . . . 0.0 109.257 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.444 ' HB1' ' CG2' ' A' ' 83' ' ' ILE . . . -57.88 -34.26 69.59 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.702 -0.624 . . . . 0.0 111.049 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.581 ' HA ' ' HB ' ' A' ' 82' ' ' THR . . . -83.79 -47.76 10.79 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.945 -1.097 . . . . 0.0 109.934 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.6 p -68.66 -36.78 78.99 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.537 -0.727 . . . . 0.0 110.984 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.608 HG12 ' CD2' ' A' ' 17' ' ' TYR . 22.4 mt -46.07 -62.44 1.84 Allowed Pre-proline 0 N--CA 1.504 2.271 0 O-C-N 121.436 -0.79 . . . . 0.0 110.584 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.499 ' HG3' HD13 ' A' ' 83' ' ' ILE . 37.9 Cg_endo -62.35 -52.62 2.45 Favored 'Trans proline' 0 C--N 1.321 -0.869 0 C-N-CA 121.907 1.738 . . . . 0.0 110.048 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.6 m -52.46 -60.81 2.78 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.518 -0.739 . . . . 0.0 110.183 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -61.41 -44.65 96.78 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 71' ' ' ILE . 0.9 OUTLIER -47.56 -32.78 5.74 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.554 -0.716 . . . . 0.0 111.264 178.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.54 ' O ' ' HD3' ' A' ' 34' ' ' ARG . . . 126.55 41.47 0.32 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 177.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.68 HG12 ' HB ' ' A' ' 79' ' ' ILE . 12.8 t -92.43 -32.95 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -1.121 . . . . 0.0 110.851 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.8 m 45.25 58.82 3.87 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.536 -0.728 . . . . 0.0 109.435 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.68 ' HB ' HG12 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -140.8 136.71 16.51 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.443 -0.786 . . . . 0.0 109.449 -178.683 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 79' ' ' ILE . 29.2 Cg_exo -58.76 -43.97 39.92 Favored 'Trans proline' 0 C--N 1.318 -1.054 0 C-N-CA 122.842 2.361 . . . . 0.0 112.184 -178.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.483 ' CD1' ' HG3' ' A' ' 46' ' ' ARG . 42.7 p90 -79.7 134.28 36.39 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 122.026 0.917 . . . . 0.0 109.988 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.581 ' HB ' ' HA ' ' A' ' 69' ' ' ALA . 32.4 p -123.21 -175.84 3.28 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.363 0.601 . . . . 0.0 109.916 -178.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.665 HG13 HD22 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -84.48 59.27 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 178.553 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.438 ' O ' ' HB ' ' A' ' 87' ' ' THR . 1.6 p -102.2 136.13 42.57 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.972 -177.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.9 p -61.66 -56.01 24.41 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.514 -0.741 . . . . 0.0 109.014 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 55.9 p -93.32 53.53 1.93 Allowed 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.491 ' CG2' ' SG ' ' A' ' 89' ' ' CYS . 2.4 t -75.7 -170.96 1.42 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.518 -0.739 . . . . 0.0 110.867 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.483 ' N ' HG23 ' A' ' 87' ' ' THR . 22.8 t70 -83.13 -71.74 0.48 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.305 -0.872 . . . . 0.0 109.99 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.491 ' SG ' ' CG2' ' A' ' 87' ' ' THR . 85.1 m 52.19 51.52 16.16 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.274 0.559 . . . . 0.0 112.228 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.2 t -170.12 -49.24 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.492 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -99.54 -22.2 15.58 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.527 -0.733 . . . . 0.0 110.865 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.67 HG12 ' HG2' ' A' ' 46' ' ' ARG . 21.5 t -59.09 138.32 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.001 -1.062 . . . . 0.0 110.065 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.627 ' HB3' HG22 ' A' ' 43' ' ' THR . 61.8 m-20 . . . . . 0 N--CA 1.496 1.852 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.86 HD11 ' HB2' ' A' ' 49' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 121.988 0.899 . . . . 0.0 109.272 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.0 t -146.97 171.22 15.58 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.224 -0.922 . . . . 0.0 110.846 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -56.4 -35.96 68.37 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -58.52 -42.11 95.79 Favored Glycine 0 N--CA 1.502 3.037 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 175.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.63 HE21 HD13 ' A' ' 36' ' ' LEU . 0.8 OUTLIER -79.83 -41.43 26.39 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.574 -0.956 . . . . 0.0 109.168 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 77.0 t -56.33 -42.44 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.442 ' O ' HD13 ' A' ' 11' ' ' ILE . . . -69.66 -36.27 75.9 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.2 t -69.35 -21.24 63.83 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.315 -0.866 . . . . 0.0 108.973 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.464 ' HB2' ' CD2' ' A' ' 36' ' ' LEU . . . -73.49 -52.26 14.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.437 -0.789 . . . . 0.0 110.651 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.443 HD13 ' N ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -80.54 -20.21 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 121.184 -0.948 . . . . 0.0 110.978 -178.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.565 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -45.5 -55.36 12.28 Favored Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 121.262 -0.899 . . . . 0.0 110.385 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.565 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 64.4 Cg_endo -70.49 -21.95 29.39 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.251 1.968 . . . . 0.0 110.994 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.544 ' SG ' ' CG2' ' A' ' 71' ' ' ILE . 1.1 m -111.73 27.99 9.16 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.509 HD11 HG13 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -63.24 -44.92 99.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 177.208 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.72 -53.83 50.72 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.392 -0.817 . . . . 0.0 108.807 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.591 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 0.5 OUTLIER -53.77 -60.66 3.02 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.662 -0.648 . . . . 0.0 109.566 178.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.642 ' N ' HD11 ' A' ' 71' ' ' ILE . . . -60.1 -31.92 70.49 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.612 -0.68 . . . . 0.0 111.084 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.464 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 9.5 tmm_? -83.84 18.49 1.99 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.453 -0.779 . . . . 0.0 111.602 -178.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.49 14.65 75.65 Favored Glycine 0 N--CA 1.503 3.137 0 O-C-N 120.541 -1.349 . . . . 0.0 112.032 178.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.591 ' O ' ' HA ' ' A' ' 17' ' ' TYR . 1.6 mm-40 -124.8 -176.7 3.61 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.113 -1.228 . . . . 0.0 109.92 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.08 -62.1 0.54 Allowed Glycine 0 N--CA 1.504 3.171 0 O-C-N 121.096 -1.003 . . . . 0.0 110.992 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 76.16 -51.82 0.61 Allowed 'General case' 0 N--CA 1.508 2.461 0 O-C-N 121.557 -0.967 . . . . 0.0 110.372 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.5 134.28 12.46 Favored Glycine 0 N--CA 1.501 2.974 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.43 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 27.6 Cg_endo -62.38 134.3 47.64 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 122.394 2.063 . . . . 0.0 111.017 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 t -79.93 134.56 36.28 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.299 -0.875 . . . . 0.0 109.407 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.28 -50.11 72.32 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.367 -0.833 . . . . 0.0 109.112 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.26 -46.17 94.76 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.496 ' O ' HG23 ' A' ' 33' ' ' VAL . 8.5 t -56.79 -39.68 74.54 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.994 178.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.43 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 82.0 m -71.22 -44.81 64.62 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.597 -175.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 46.7 t -65.65 -40.01 92.0 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 124.048 0.842 . . . . 0.0 109.916 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.76 -60.3 6.29 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.612 HG11 ' HB3' ' A' ' 72' ' ' PRO . 17.3 t -59.38 -47.85 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.581 -0.952 . . . . 0.0 110.946 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.629 ' HA ' HG22 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -57.94 -26.87 62.81 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.237 -0.914 . . . . 0.0 109.537 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.0 m -86.12 -51.07 6.54 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.394 -0.816 . . . . 0.0 109.697 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.63 HD13 HE21 ' A' ' 6' ' ' GLN . 2.7 pp -60.69 -49.2 78.47 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.676 -0.64 . . . . 0.0 110.51 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.595 ' N ' HD12 ' A' ' 36' ' ' LEU . 2.6 m-80 -66.83 -32.55 73.9 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.1 -1.0 . . . . 0.0 108.696 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.528 ' HA ' ' HD2' ' A' ' 41' ' ' ARG . 10.0 t30 -63.79 -38.96 93.07 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.48 -30.37 71.4 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.573 ' HB2' HD13 ' A' ' 2' ' ' ILE . . . -94.16 88.46 5.63 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.508 -0.745 . . . . 0.0 109.82 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.528 ' HD2' ' HA ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -143.1 20.49 1.93 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.937 -1.102 . . . . 0.0 111.922 -179.653 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.421 ' O ' ' HB ' ' A' ' 43' ' ' THR . 2.4 m -115.55 31.96 6.38 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.817 -1.177 . . . . 0.0 109.939 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.589 HG23 ' HA ' ' A' ' 93' ' ' ASN . 58.0 m 69.63 -61.54 0.44 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.456 -0.777 . . . . 0.0 109.297 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.24 -45.56 72.38 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.528 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 8.9 m-20 -73.44 -39.69 64.78 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.489 ' HG3' ' CE1' ' A' ' 81' ' ' TYR . 0.3 OUTLIER -65.14 -47.13 78.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.901 -0.499 . . . . 0.0 111.552 -178.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.402 ' NE ' ' O ' ' A' ' 90' ' ' SER . 51.9 mtt180 -65.49 -40.67 93.34 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.009 -1.057 . . . . 0.0 109.517 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.89 -43.19 99.36 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.86 ' HB2' HD11 ' A' ' 2' ' ' ILE 0.268 . . -65.15 -49.69 68.88 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.234 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.495 ' C ' ' SG ' ' A' ' 89' ' ' CYS . 50.2 t -55.26 -40.73 71.3 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.289 -0.882 . . . . 0.0 110.126 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.6 ' O ' ' HG3' ' A' ' 54' ' ' LYS . 1.8 t30 -62.69 -53.41 54.87 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 124.035 0.834 . . . . 0.0 110.481 177.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.9 t -72.2 -20.01 61.64 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.817 -1.153 . . . . 0.0 111.609 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.528 HD13 ' CG1' ' A' ' 83' ' ' ILE . 18.1 mt -68.85 -57.86 4.98 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 124.092 0.87 . . . . 0.0 109.012 175.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.6 ' HG3' ' O ' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -57.17 -28.79 63.11 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.63 -45.33 53.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.688 -0.632 . . . . 0.0 109.569 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.98 -49.84 47.6 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.418 -0.801 . . . . 0.0 109.75 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.419 ' O ' HD13 ' A' ' 63' ' ' LEU . . . -59.74 -62.23 2.03 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.439 -0.788 . . . . 0.0 109.334 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.634 ' HA ' HD13 ' A' ' 63' ' ' LEU . . . -70.75 77.28 0.61 Allowed 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.73 -16.21 0.94 Allowed Glycine 0 N--CA 1.497 2.749 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.509 HG13 HD11 ' A' ' 15' ' ' ILE . 0.9 OUTLIER -47.7 -58.58 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 CA-C-N 118.54 1.17 . . . . 0.0 110.477 -179.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.478 ' N ' HG12 ' A' ' 60' ' ' VAL . 1.5 m 162.79 -62.74 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.513 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -128.28 46.97 1.05 Allowed Glycine 0 N--CA 1.498 2.784 0 N-CA-C 107.462 -2.255 . . . . 0.0 107.462 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.634 HD13 ' HA ' ' A' ' 58' ' ' ALA . 2.5 pt? -50.54 129.48 22.36 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.883 0.849 . . . . 0.0 111.431 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.532 ' HB2' ' HB2' ' A' ' 67' ' ' ASN . 1.6 m-80 -109.27 103.14 12.04 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -36.06 -57.48 0.7 Allowed 'General case' 0 N--CA 1.506 2.349 0 O-C-N 122.028 -0.42 . . . . 0.0 111.775 -178.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.23 -52.41 44.34 Favored Glycine 0 N--CA 1.502 3.074 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.532 ' HB2' ' HB2' ' A' ' 64' ' ' ASN . 2.9 m120 -54.9 -45.39 74.71 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.669 -0.9 . . . . 0.0 110.626 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.536 ' O ' ' HD2' ' A' ' 72' ' ' PRO . . . -55.45 -55.42 31.97 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.783 -0.573 . . . . 0.0 110.252 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.705 ' HB1' HG22 ' A' ' 82' ' ' THR . . . -70.66 -36.98 73.65 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.476 -0.765 . . . . 0.0 110.784 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.5 t -62.12 -28.07 69.37 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.361 -0.837 . . . . 0.0 111.087 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.642 HD11 ' N ' ' A' ' 18' ' ' ALA . 38.4 mt -61.36 -69.67 0.55 Allowed Pre-proline 0 N--CA 1.502 2.15 0 O-C-N 121.243 -0.911 . . . . 0.0 111.442 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.612 ' HB3' HG11 ' A' ' 33' ' ' VAL . 19.5 Cg_endo -58.81 -50.27 9.54 Favored 'Trans proline' 0 N--CA 1.481 0.787 0 C-N-CA 122.141 1.894 . . . . 0.0 110.929 -178.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.0 m -48.51 -70.91 0.08 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 122.099 -0.376 . . . . 0.0 110.478 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.9 mtmm -60.33 -43.14 96.68 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-N 116.965 -0.107 . . . . 0.0 110.746 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 1.5 m -45.48 -35.98 4.17 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.823 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 34' ' ' ARG . . . 122.37 49.88 0.24 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 175.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.629 HG22 ' HA ' ' A' ' 34' ' ' ARG . 90.6 t -90.07 -27.66 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 C-N-CA 118.365 -1.334 . . . . 0.0 112.029 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 77' ' ' VAL . 24.9 p 65.47 16.75 10.67 Favored 'General case' 0 N--CA 1.51 2.56 0 O-C-N 121.103 -0.998 . . . . 0.0 110.564 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.563 ' HB ' HG12 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -89.06 124.75 64.26 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.008 -1.058 . . . . 0.0 108.504 179.341 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.456 ' HD2' ' NH1' ' A' ' 46' ' ' ARG . 37.7 Cg_endo -63.23 -35.86 60.72 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 122.519 2.146 . . . . 0.0 112.214 -178.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.489 ' CE1' ' HG3' ' A' ' 46' ' ' ARG . 17.9 p90 -82.65 142.15 31.93 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.098 -1.001 . . . . 0.0 110.515 -179.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.705 HG22 ' HB1' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -96.38 150.65 20.35 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.489 -0.757 . . . . 0.0 110.633 -178.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.528 ' CG1' HD13 ' A' ' 53' ' ' LEU . 4.4 mp -99.71 128.91 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.428 -0.795 . . . . 0.0 109.196 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 62.4 p -150.61 -85.3 0.08 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.236 -0.915 . . . . 0.0 110.379 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.8 p -152.62 -61.11 0.15 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.588 -0.695 . . . . 0.0 109.486 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.6 t -109.5 59.83 0.6 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.617 -0.677 . . . . 0.0 110.088 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.5 m -75.28 164.5 26.38 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.345 -0.847 . . . . 0.0 109.116 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -83.83 80.19 9.23 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.95 -1.094 . . . . 0.0 110.172 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.495 ' SG ' ' C ' ' A' ' 50' ' ' CYS . 14.9 m -82.55 53.31 2.3 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.119 176.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.402 ' O ' ' NE ' ' A' ' 47' ' ' ARG . 41.4 t -144.98 -50.66 0.26 Allowed 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.024 -177.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -99.5 -23.82 14.97 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.331 -0.855 . . . . 0.0 110.414 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.2 t -49.54 142.09 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 O-C-N 121.402 -0.811 . . . . 0.0 111.038 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.589 ' HA ' HG23 ' A' ' 43' ' ' THR . 33.4 m-80 . . . . . 0 N--CA 1.5 2.073 0 CA-C-O 117.039 -1.458 . . . . 0.0 109.134 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.625 HD11 ' HB2' ' A' ' 49' ' ' ALA . 3.0 tp . . . . . 0 N--CA 1.496 1.829 0 CA-C-O 121.723 0.773 . . . . 0.0 109.569 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.6 p -125.95 177.75 6.15 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.156 -0.965 . . . . 0.0 110.198 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.539 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 70.5 m -56.97 -19.17 16.67 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 119.879 -0.728 . . . . 0.0 112.467 177.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.58 -43.44 99.28 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.532 ' HA ' ' HB2' ' A' ' 9' ' ' SER . 0.0 OUTLIER -85.68 -35.04 21.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.432 -1.04 . . . . 0.0 108.824 178.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.539 ' HB ' ' HA ' ' A' ' 4' ' ' CYS . 58.7 t -54.7 -43.22 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.401 ' HA ' HG13 ' A' ' 11' ' ' ILE . . . -75.09 -37.68 61.45 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.532 ' HB2' ' HA ' ' A' ' 6' ' ' GLN . 69.0 m -69.61 -21.09 63.61 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.221 -0.924 . . . . 0.0 109.806 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 6' ' ' GLN . . . -85.65 -30.29 23.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.428 -0.795 . . . . 0.0 109.629 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.497 HD12 ' N ' ' A' ' 12' ' ' ALA . 2.4 pp -96.57 -26.71 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.463 -0.773 . . . . 0.0 110.813 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.61 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -49.33 -53.45 39.66 Favored Pre-proline 0 N--CA 1.504 2.244 0 O-C-N 121.207 -0.933 . . . . 0.0 110.783 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.61 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 73.4 Cg_endo -72.78 -9.6 23.98 Favored 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 122.29 1.993 . . . . 0.0 110.969 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.7 m -117.41 6.33 12.62 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.525 ' O ' ' CB ' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -58.09 -50.43 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 118.109 0.413 . . . . 0.0 110.632 -178.606 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.414 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -61.2 -63.49 1.27 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.952 -1.092 . . . . 0.0 109.618 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.569 ' CD2' HG12 ' A' ' 71' ' ' ILE . 1.1 t80 -51.66 -58.8 5.33 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.644 -0.66 . . . . 0.0 109.922 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.577 ' HB1' ' HB2' ' A' ' 68' ' ' ALA . . . -57.22 -29.25 63.59 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.603 -0.686 . . . . 0.0 110.556 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.525 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 9.1 tmm_? -89.93 8.67 31.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.368 -0.833 . . . . 0.0 110.944 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.28 1.1 44.32 Favored Glycine 0 N--CA 1.503 3.123 0 O-C-N 120.714 -1.241 . . . . 0.0 111.922 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -117.59 72.12 0.83 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.014 -1.286 . . . . 0.0 110.115 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.72 174.61 45.82 Favored Glycine 0 N--CA 1.498 2.793 0 C-N-CA 120.197 -1.001 . . . . 0.0 110.826 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.9 p -151.23 -60.8 0.18 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -97.83 126.77 8.99 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.714 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . 37.1 Cg_endo -62.49 125.45 16.23 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 C-N-CA 122.393 2.062 . . . . 0.0 111.008 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.3 t -76.57 159.89 29.92 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.418 -0.801 . . . . 0.0 110.99 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.57 -41.44 76.92 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.644 -0.66 . . . . 0.0 110.552 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.62 -48.46 77.35 Favored Glycine 0 N--CA 1.503 3.127 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.55 ' SG ' ' CG2' ' A' ' 71' ' ' ILE . 42.4 t -58.3 -43.0 87.88 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.661 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.661 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 88.2 m -73.69 -35.18 65.15 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.154 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 61.9 m -71.81 -40.7 68.99 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 124.533 1.146 . . . . 0.0 109.725 175.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.33 -51.75 57.29 Favored Glycine 0 N--CA 1.5 2.953 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.75 HG11 ' CB ' ' A' ' 72' ' ' PRO . 47.4 t -69.3 -45.69 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.441 -1.035 . . . . 0.0 109.125 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.592 ' HA ' ' CG1' ' A' ' 77' ' ' VAL . 2.4 tpt180 -54.15 -28.42 39.89 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.4 m -73.76 -44.0 57.38 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.613 ' C ' HD12 ' A' ' 36' ' ' LEU . 0.5 OUTLIER -61.32 -33.94 74.43 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.409 -0.807 . . . . 0.0 109.771 179.338 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.538 ' HB2' HG12 ' A' ' 77' ' ' VAL . 0.6 OUTLIER -59.69 -32.68 70.72 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.299 -0.876 . . . . 0.0 110.015 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -88.71 -33.51 17.5 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.526 -0.734 . . . . 0.0 109.415 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.11 -32.29 22.87 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.506 -0.746 . . . . 0.0 110.878 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.586 ' HA ' ' CB ' ' A' ' 45' ' ' ASP . . . -111.47 101.52 9.94 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.169 -0.957 . . . . 0.0 110.474 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.541 ' CZ ' ' HB3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -161.06 20.27 0.12 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.402 -0.811 . . . . 0.0 111.692 179.59 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 44' ' ' ALA . 5.8 m -116.87 35.31 4.67 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.848 -1.158 . . . . 0.0 109.384 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 44.6 m 67.95 -59.82 0.42 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.595 -0.691 . . . . 0.0 109.649 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 42' ' ' THR . . . -57.35 -54.63 44.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.551 -0.718 . . . . 0.0 109.179 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.586 ' CB ' ' HA ' ' A' ' 40' ' ' ALA . 8.3 m-20 -55.61 -44.04 76.65 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.707 0.765 . . . . 0.0 109.199 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.502 ' NH1' HG13 ' A' ' 79' ' ' ILE . 0.5 OUTLIER -67.39 -47.12 71.25 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.978 -178.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -60.84 -48.58 81.16 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.5 -48.72 80.53 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.777 -0.577 . . . . 0.0 109.498 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.625 ' HB2' HD11 ' A' ' 2' ' ' ILE . . . -57.16 -46.37 82.8 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.476 ' SG ' HG22 ' A' ' 87' ' ' THR . 0.1 OUTLIER -63.86 -38.81 92.48 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.112 -0.368 . . . . 0.0 110.872 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.44 ' N ' ' SG ' ' A' ' 89' ' ' CYS . 2.2 t30 -60.01 -57.38 13.1 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 123.869 0.731 . . . . 0.0 109.701 176.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.459 ' HB3' HG21 ' A' ' 7' ' ' VAL . 12.9 t -66.76 -31.08 71.49 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.357 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.615 HD22 HG23 ' A' ' 83' ' ' ILE . 15.1 mt -64.01 -44.47 92.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 123.902 0.751 . . . . 0.0 109.446 175.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -58.54 -41.18 84.98 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -64.18 -54.01 40.35 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.528 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -58.74 -43.39 90.2 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.643 -0.661 . . . . 0.0 109.608 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.545 ' HA ' HD13 ' A' ' 63' ' ' LEU . . . -60.55 -51.9 67.44 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.87 64.86 1.33 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 61' ' ' SER . . . 167.88 -22.48 0.1 Allowed Glycine 0 N--CA 1.499 2.879 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.202 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.607 ' O ' HG12 ' A' ' 60' ' ' VAL . 6.5 t -64.9 62.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 CA-C-N 118.699 1.25 . . . . 0.0 110.595 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 59' ' ' GLY . 67.9 m 36.02 57.32 0.99 Allowed 'General case' 0 N--CA 1.507 2.409 0 O-C-N 121.309 -0.869 . . . . 0.0 111.888 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.76 57.81 3.69 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.545 HD13 ' HA ' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -56.94 132.04 51.51 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.677 -0.896 . . . . 0.0 110.463 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -96.7 89.78 5.06 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -39.54 -45.87 1.65 Allowed 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.907 -0.495 . . . . 0.0 111.021 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -51.7 -38.16 43.93 Favored Glycine 0 N--CA 1.503 3.136 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -83.7 -55.5 4.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.635 -0.921 . . . . 0.0 108.913 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.611 ' HB1' ' O ' ' A' ' 83' ' ' ILE . . . -55.72 -25.21 39.16 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.826 -0.546 . . . . 0.0 111.932 -178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.25 -49.27 6.82 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.949 -1.094 . . . . 0.0 109.818 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.04 -32.37 72.68 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.47 -0.769 . . . . 0.0 110.409 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.569 HG12 ' CD2' ' A' ' 17' ' ' TYR . 30.8 mt -52.07 -61.51 4.32 Favored Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 121.643 -0.66 . . . . 0.0 110.528 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.75 ' CB ' HG11 ' A' ' 33' ' ' VAL . 38.4 Cg_endo -61.88 -57.08 0.58 Allowed 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 122.028 1.819 . . . . 0.0 110.465 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.9 t -44.35 -63.64 0.84 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 120.681 0.277 . . . . 0.0 110.38 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -63.61 -39.1 93.52 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 122.034 -0.416 . . . . 0.0 109.982 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.714 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 0.8 OUTLIER -48.01 -35.04 10.28 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.823 -0.751 . . . . 0.0 112.092 -178.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.484 ' O ' ' HD2' ' A' ' 34' ' ' ARG . . . 137.7 44.53 0.08 OUTLIER Glycine 0 N--CA 1.496 2.659 0 C-N-CA 119.243 -1.456 . . . . 0.0 111.339 176.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.702 HG11 HG12 ' A' ' 33' ' ' VAL . 16.1 m -135.34 129.76 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 120.828 -1.395 . . . . 0.0 111.021 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.1 p -99.97 78.38 2.1 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.678 HD11 ' CE2' ' A' ' 81' ' ' TYR . 11.0 tt -132.38 128.41 21.14 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.514 -0.741 . . . . 0.0 109.723 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 79' ' ' ILE . 52.6 Cg_exo -54.77 -45.33 41.76 Favored 'Trans proline' 0 N--CA 1.484 0.936 0 C-N-CA 123.28 2.653 . . . . 0.0 112.736 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.678 ' CE2' HD11 ' A' ' 79' ' ' ILE . 26.5 p90 -81.7 143.28 31.98 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.938 -1.101 . . . . 0.0 109.911 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 69.5 p -98.67 166.49 11.3 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.908 0.861 . . . . 0.0 110.692 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.615 HG23 HD22 ' A' ' 53' ' ' LEU . 1.5 mp -90.16 63.81 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 82.4 p -161.49 170.34 20.13 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.022 -1.049 . . . . 0.0 110.701 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.5 p -60.71 -30.0 69.69 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.575 -0.703 . . . . 0.0 109.748 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.0 t -82.49 79.74 8.84 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.476 HG22 ' SG ' ' A' ' 50' ' ' CYS . 0.6 OUTLIER -162.63 149.15 12.87 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.842 -179.37 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -91.77 154.65 18.79 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 122.18 0.991 . . . . 0.0 112.329 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 51' ' ' ASN . 1.2 m -137.03 53.4 1.89 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.142 176.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 95.8 p -159.3 -51.42 0.06 Allowed 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.355 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.0 mmm-85 -97.1 -6.78 34.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.223 -0.923 . . . . 0.0 109.245 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.1 t -70.48 119.73 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.391 -0.818 . . . . 0.0 109.231 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.531 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 1.7 p30 . . . . . 0 N--CA 1.497 1.915 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.46 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.799 HD11 ' HB2' ' A' ' 36' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.0 t -118.19 167.19 11.73 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.305 -0.872 . . . . 0.0 111.504 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -63.94 -35.98 82.44 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -56.39 -51.49 55.88 Favored Glycine 0 N--CA 1.503 3.122 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 177.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.418 ' OE1' HD13 ' A' ' 2' ' ' ILE . 0.5 OUTLIER -67.23 -41.87 84.95 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.455 -1.026 . . . . 0.0 109.087 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.8 t -54.8 -46.14 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.36 -36.38 74.15 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.3 t -68.83 -20.53 64.3 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.318 -0.864 . . . . 0.0 110.099 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.39 -41.65 9.29 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.316 -0.865 . . . . 0.0 109.862 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.5 pp -79.98 -33.79 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.214 -0.929 . . . . 0.0 111.099 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.55 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -46.95 -51.76 37.69 Favored Pre-proline 0 N--CA 1.504 2.229 0 O-C-N 121.213 -0.929 . . . . 0.0 110.417 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 33.5 Cg_endo -65.89 -15.65 49.74 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.163 1.909 . . . . 0.0 110.831 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.664 ' SG ' HG21 ' A' ' 71' ' ' ILE . 1.3 m -114.14 18.94 16.8 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 176.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.422 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -62.72 -49.58 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-N 118.16 0.437 . . . . 0.0 110.473 178.047 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.4 p -68.88 -49.27 59.66 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.429 -0.794 . . . . 0.0 109.323 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.697 ' CG ' HD11 ' A' ' 71' ' ' ILE . 0.4 OUTLIER -55.42 -54.3 45.46 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.084 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.597 ' HB1' ' HB2' ' A' ' 68' ' ' ALA . . . -60.69 -27.99 68.28 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.422 ' HB3' ' O ' ' A' ' 15' ' ' ILE . 1.3 tpt180 -82.46 -13.24 57.06 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.864 -0.522 . . . . 0.0 109.953 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.24 14.3 42.36 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -118.16 78.18 1.23 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.251 -1.146 . . . . 0.0 109.527 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 177.15 -151.68 11.33 Favored Glycine 0 N--CA 1.5 2.918 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.6 p -168.88 -58.71 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.632 -0.923 . . . . 0.0 109.511 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.74 145.98 17.95 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.64 152.09 82.74 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 C-N-CA 122.536 2.158 . . . . 0.0 110.356 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.4 p -102.18 146.79 27.46 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.311 -0.868 . . . . 0.0 110.431 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.95 -47.08 71.67 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.793 -0.567 . . . . 0.0 110.848 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.79 -41.31 95.92 Favored Glycine 0 N--CA 1.502 3.037 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.401 ' HA ' ' HG2' ' A' ' 13' ' ' PRO . 42.1 t -61.64 -55.98 24.8 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.405 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -62.6 -39.59 94.25 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.735 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.426 ' HA ' ' HG2' ' A' ' 34' ' ' ARG . 48.7 m -67.18 -50.76 59.83 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 123.932 0.77 . . . . 0.0 110.24 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.43 -47.33 91.67 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.668 ' HA ' HD23 ' A' ' 36' ' ' LEU . 59.2 t -67.86 -53.07 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.773 -0.839 . . . . 0.0 110.891 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 76' ' ' GLY . 0.4 OUTLIER -56.04 -21.19 20.26 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.175 -0.953 . . . . 0.0 110.295 -179.569 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.8 p -81.32 -43.8 18.57 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.402 -0.811 . . . . 0.0 109.523 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.799 ' HB2' HD11 ' A' ' 2' ' ' ILE . 0.6 OUTLIER -55.85 -36.01 67.07 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.891 -0.506 . . . . 0.0 110.646 -179.411 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 76' ' ' GLY . 31.9 t30 -56.44 -49.55 74.24 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.323 -0.861 . . . . 0.0 109.821 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -81.36 -29.39 34.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.604 -0.685 . . . . 0.0 109.776 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.456 ' HB3' ' HA ' ' A' ' 36' ' ' LEU . . . -65.2 -26.9 68.34 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.697 -0.627 . . . . 0.0 110.451 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.78 ' HB2' HG12 ' A' ' 2' ' ' ILE . . . -139.92 -110.79 0.15 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.091 -1.005 . . . . 0.0 111.109 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.484 ' HA ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER 64.5 32.23 11.87 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.403 -0.811 . . . . 0.0 111.082 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.514 ' O ' ' HB ' ' A' ' 43' ' ' THR . 14.9 t -128.57 17.54 6.39 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 120.829 -1.169 . . . . 0.0 111.382 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.661 ' HA ' ' C ' ' A' ' 93' ' ' ASN . 86.5 m 84.8 -67.76 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.696 -0.627 . . . . 0.0 109.799 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.49 -61.43 2.02 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.302 -0.874 . . . . 0.0 109.708 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.505 ' HB3' ' CB ' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -70.28 -36.55 74.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.682 -0.636 . . . . 0.0 109.367 179.321 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.484 ' HD3' ' HA ' ' A' ' 41' ' ' ARG . 5.8 mtm180 -59.28 -53.12 61.89 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.436 -0.79 . . . . 0.0 110.249 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.5 ' NH1' ' HA ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -54.12 -47.48 71.81 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.473 -0.767 . . . . 0.0 109.337 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 51' ' ' ASN . . . -58.91 -41.38 87.08 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.598 ' HB2' HG21 ' A' ' 2' ' ' ILE . . . -58.28 -48.32 80.83 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.498 ' C ' ' SG ' ' A' ' 89' ' ' CYS . 0.8 OUTLIER -55.4 -33.66 63.7 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.498 178.566 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.444 ' N ' ' SG ' ' A' ' 89' ' ' CYS . 1.3 t30 -65.56 -61.98 1.78 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.035 0.445 . . . . 0.0 110.056 177.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.6 t -63.49 -33.58 75.88 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.253 -0.979 . . . . 0.0 111.342 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.564 HD22 HG23 ' A' ' 83' ' ' ILE . 20.8 mt -68.4 -57.82 5.29 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.373 178.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 24.6 tttp -57.9 -36.2 72.1 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.465 -0.772 . . . . 0.0 109.354 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.84 -39.05 87.63 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.474 -0.766 . . . . 0.0 110.606 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.476 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -94.39 -53.43 3.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.235 -0.916 . . . . 0.0 110.009 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.722 ' HB1' ' HA ' ' A' ' 84' ' ' SER . . . -60.09 -53.74 54.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.484 -0.76 . . . . 0.0 109.702 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 54' ' ' LYS . . . -80.79 63.18 5.1 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.52 -32.43 0.06 OUTLIER Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 56' ' ' ALA . 24.4 t -47.23 148.67 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 121.68 -0.894 . . . . 0.0 110.199 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.8 m -64.29 90.85 0.07 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.576 -0.702 . . . . 0.0 110.123 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.99 64.89 1.69 Allowed Glycine 0 N--CA 1.499 2.854 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.62 ' C ' HD13 ' A' ' 63' ' ' LEU . 3.0 tm? -74.68 118.73 17.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.667 -0.902 . . . . 0.0 109.791 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -94.52 85.36 4.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.891 . . . . 0.0 108.726 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.522 ' HA ' ' HB2' ' A' ' 84' ' ' SER . . . -48.31 -37.95 17.74 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.858 -0.526 . . . . 0.0 110.719 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -53.97 -38.71 60.97 Favored Glycine 0 N--CA 1.502 3.099 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -89.7 -45.38 9.36 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.478 -1.013 . . . . 0.0 109.961 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.597 ' HB2' ' HB1' ' A' ' 18' ' ' ALA . . . -71.74 -20.34 61.91 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.594 -0.691 . . . . 0.0 111.946 -178.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.23 -40.95 10.16 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.867 -1.146 . . . . 0.0 110.244 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 92.5 p -71.17 -43.27 67.8 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.57 -0.706 . . . . 0.0 110.847 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.697 HD11 ' CG ' ' A' ' 17' ' ' TYR . 87.0 mt -50.63 -64.59 1.23 Allowed Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.485 -0.76 . . . . 0.0 110.89 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.612 ' HG3' ' HB ' ' A' ' 83' ' ' ILE . 30.7 Cg_endo -59.74 -52.52 4.37 Favored 'Trans proline' 0 C--N 1.326 -0.636 0 C-N-CA 121.868 1.712 . . . . 0.0 110.773 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.2 t -38.5 -68.07 0.18 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 122.271 -0.268 . . . . 0.0 110.62 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.4 pttt -70.38 -32.45 70.11 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.551 -0.718 . . . . 0.0 109.888 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 72' ' ' PRO . 1.1 m -49.72 -47.57 50.49 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.27 -0.893 . . . . 0.0 111.985 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 37' ' ' ASN . . . 169.03 47.03 0.03 OUTLIER Glycine 0 N--CA 1.5 2.927 0 C-N-CA 118.365 -1.874 . . . . 0.0 111.527 175.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.473 HG12 ' HB2' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -150.65 91.04 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.191 -1.182 . . . . 0.0 110.353 179.323 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.6 t -80.18 77.78 6.89 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.538 HD12 ' CZ ' ' A' ' 81' ' ' TYR . 3.3 pt -130.98 135.68 27.71 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.6 -0.687 . . . . 0.0 110.306 -178.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.475 ' HD2' ' NH1' ' A' ' 46' ' ' ARG . 77.4 Cg_exo -49.19 -43.2 37.86 Favored 'Trans proline' 0 N--CA 1.483 0.908 0 C-N-CA 122.682 2.255 . . . . 0.0 111.533 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.699 ' HB3' HG21 ' A' ' 92' ' ' VAL . 1.5 p90 -81.03 143.98 32.11 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.06 -1.025 . . . . 0.0 109.41 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.7 p -100.4 165.75 11.3 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.213 -0.929 . . . . 0.0 109.849 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.612 ' HB ' ' HG3' ' A' ' 72' ' ' PRO . 1.5 mp -89.93 62.91 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.722 ' HA ' ' HB1' ' A' ' 57' ' ' ALA . 80.5 p -158.68 -106.68 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.362 -0.836 . . . . 0.0 109.808 -178.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.5 p -122.4 -24.71 4.94 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.96 -1.088 . . . . 0.0 109.792 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.2 p -74.12 64.24 1.04 Allowed 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.526 HG23 ' HB2' ' A' ' 81' ' ' TYR . 13.1 m -162.43 128.71 3.53 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -125.73 138.46 53.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.244 -0.91 . . . . 0.0 110.762 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.5 ' HA ' ' NH1' ' A' ' 47' ' ' ARG . 89.4 m -90.9 57.89 3.65 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.267 -0.973 . . . . 0.0 111.473 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.3 t -155.42 -42.34 0.08 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.865 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.8 mtm-85 -99.68 -37.01 9.29 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.28 -0.888 . . . . 0.0 110.332 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.699 HG21 ' HB3' ' A' ' 81' ' ' TYR . 1.2 t -60.69 158.74 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 121.451 -0.78 . . . . 0.0 111.254 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.661 ' C ' ' HA ' ' A' ' 43' ' ' THR . 58.9 m-80 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 176.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.813 HG13 ' HB2' ' A' ' 49' ' ' ALA . 10.4 tp . . . . . 0 N--CA 1.503 2.194 0 CA-C-O 121.803 0.811 . . . . 0.0 111.714 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.4 t -123.16 -74.88 0.6 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.134 -0.979 . . . . 0.0 109.931 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.7 t -151.51 -46.31 0.11 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -53.47 -44.11 66.84 Favored Glycine 0 N--CA 1.506 3.302 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 177.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.52 -41.99 23.26 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.304 -1.115 . . . . 0.0 108.452 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 91.5 t -54.1 -44.13 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.511 ' HA ' HG13 ' A' ' 11' ' ' ILE . . . -69.12 -34.82 75.65 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.8 m -71.37 -20.12 62.19 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.513 -0.742 . . . . 0.0 109.608 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.57 -35.45 10.61 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.275 -0.89 . . . . 0.0 109.923 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.511 HG13 ' HA ' ' A' ' 8' ' ' ALA . 2.6 pp -79.94 -33.61 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.254 -0.904 . . . . 0.0 110.54 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.55 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -47.85 -51.67 45.05 Favored Pre-proline 0 N--CA 1.503 2.187 0 O-C-N 121.28 -0.888 . . . . 0.0 110.206 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 31.0 Cg_endo -65.21 -12.22 33.77 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.238 1.959 . . . . 0.0 110.938 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.567 ' HB3' HD13 ' A' ' 71' ' ' ILE . 2.7 m -121.85 17.33 11.01 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 176.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.487 HD11 HG13 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -62.73 -50.1 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 121.381 -0.128 . . . . 0.0 110.802 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 21' ' ' GLN . 18.7 m -57.46 -46.84 83.19 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.338 -0.851 . . . . 0.0 109.33 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.538 ' CD2' HG12 ' A' ' 71' ' ' ILE . 0.9 OUTLIER -61.26 -62.0 2.15 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.787 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.591 ' N ' HD11 ' A' ' 71' ' ' ILE . . . -55.78 -35.46 66.28 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.153 -0.967 . . . . 0.0 110.436 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -73.85 -1.69 20.54 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.587 -0.696 . . . . 0.0 111.3 -179.151 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.88 21.24 47.39 Favored Glycine 0 N--CA 1.501 3.009 0 O-C-N 120.678 -1.264 . . . . 0.0 110.902 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.42 ' O ' ' HB3' ' A' ' 16' ' ' SER . 34.3 mm-40 -140.41 50.01 1.7 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.201 -1.176 . . . . 0.0 109.612 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -150.38 -64.75 0.01 OUTLIER Glycine 0 N--CA 1.501 2.975 0 O-C-N 121.019 -1.051 . . . . 0.0 110.833 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 71.8 -58.02 0.6 Allowed 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.642 -0.916 . . . . 0.0 109.485 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.59 112.06 3.64 Favored Glycine 0 N--CA 1.498 2.779 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.75 173.63 12.36 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 122.611 2.207 . . . . 0.0 110.751 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.1 p -110.25 134.93 51.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.57 -0.706 . . . . 0.0 109.362 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -45.99 -54.77 7.8 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.776 -0.578 . . . . 0.0 110.887 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.97 -39.43 89.29 Favored Glycine 0 N--CA 1.503 3.103 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.403 ' O ' HG23 ' A' ' 33' ' ' VAL . 44.1 t -63.55 -49.48 73.31 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 118.764 -1.174 . . . . 0.0 109.828 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.471 ' HA ' ' HB3' ' A' ' 75' ' ' CYS . 68.2 m -69.07 -42.99 75.47 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.483 -176.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.544 ' HA ' ' HG2' ' A' ' 34' ' ' ARG . 72.5 p -68.31 -47.26 68.03 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 124.355 1.034 . . . . 0.0 110.012 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -53.91 -55.19 27.01 Favored Glycine 0 N--CA 1.498 2.782 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.6 HG12 HG21 ' A' ' 77' ' ' VAL . 17.4 t -63.81 -44.59 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.486 -1.008 . . . . 0.0 110.257 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.648 ' HA ' HG22 ' A' ' 77' ' ' VAL . 7.8 ptm180 -57.71 -22.61 47.38 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.111 -0.993 . . . . 0.0 109.694 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.1 t -92.65 -55.14 3.49 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.3 -0.875 . . . . 0.0 109.461 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.592 ' HG ' ' HA ' ' A' ' 33' ' ' VAL . 3.5 pp -58.25 -28.43 64.89 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.497 -0.752 . . . . 0.0 110.89 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.599 ' CB ' HG13 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -64.85 -42.69 94.69 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.945 -1.097 . . . . 0.0 108.719 179.523 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -63.5 -29.2 70.51 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.93 8.83 35.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.679 -0.638 . . . . 0.0 110.102 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.677 ' HB1' HG21 ' A' ' 2' ' ' ILE . . . -166.91 51.5 0.07 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.763 -1.21 . . . . 0.0 111.454 -179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.652 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 2.3 mpt_? -135.27 44.7 2.55 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.527 -0.733 . . . . 0.0 109.596 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.7 m -95.38 -45.96 6.91 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.344 -0.847 . . . . 0.0 109.278 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.4 m 160.52 -51.48 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.453 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.73 -45.81 84.91 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 177.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.756 ' HB3' HG21 ' A' ' 2' ' ' ILE . 3.1 m-20 -63.69 -50.93 67.27 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.575 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.505 ' HD3' ' HG3' ' A' ' 41' ' ' ARG . 8.9 mtm180 -59.94 -39.07 84.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.738 -0.601 . . . . 0.0 109.792 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.54 ' HG2' ' NH1' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -62.2 -44.45 96.56 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.227 -0.92 . . . . 0.0 108.957 179.165 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.427 ' O ' ' HB3' ' A' ' 51' ' ' ASN . . . -66.55 -46.62 75.5 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.813 ' HB2' HG13 ' A' ' 2' ' ' ILE 0.252 . . -61.45 -55.36 32.18 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.54 ' HA ' ' HB2' ' A' ' 53' ' ' LEU . 12.0 t -48.23 -36.86 14.69 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 174.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.427 ' HB3' ' O ' ' A' ' 48' ' ' ALA . 1.7 t30 -58.55 -56.33 23.48 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 42.3 t -70.06 -31.12 68.57 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 118.388 -1.325 . . . . 0.0 111.621 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.84 HD22 HG23 ' A' ' 83' ' ' ILE . 75.5 mt -58.83 -48.61 80.72 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 124.101 0.876 . . . . 0.0 109.598 176.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.599 ' HD3' ' SG ' ' A' ' 89' ' ' CYS . 7.5 mtpp -61.12 -38.25 85.67 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -65.71 -47.49 75.2 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.822 -0.548 . . . . 0.0 109.706 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -71.79 -44.75 63.46 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.416 -0.803 . . . . 0.0 109.977 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.53 -55.36 29.94 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.74 62.56 1.08 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.392 -0.818 . . . . 0.0 108.912 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 61' ' ' SER . . . -179.75 -28.91 0.05 OUTLIER Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.619 ' O ' HG12 ' A' ' 60' ' ' VAL . 74.5 t -65.92 53.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.507 0 O-C-N 121.254 -1.145 . . . . 0.0 110.992 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 59' ' ' GLY . 56.5 p 49.12 -138.11 0.92 Allowed 'General case' 0 N--CA 1.504 2.244 0 O-C-N 120.6 -1.312 . . . . 0.0 110.093 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.96 71.65 2.82 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 108.496 -1.842 . . . . 0.0 108.496 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 1.8 pp -63.13 158.96 18.47 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 122.01 -0.7 . . . . 0.0 110.582 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -106.62 107.87 19.09 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.36 -55.22 4.21 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.743 -0.598 . . . . 0.0 110.152 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -57.69 -41.9 94.02 Favored Glycine 0 N--CA 1.498 2.799 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.473 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 3.2 m120 -60.31 -57.5 12.51 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.313 -1.11 . . . . 0.0 109.309 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.518 ' O ' ' HD2' ' A' ' 72' ' ' PRO . . . -58.71 -41.19 85.75 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.788 -0.57 . . . . 0.0 110.173 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.666 ' HB2' ' HB ' ' A' ' 82' ' ' THR . . . -71.64 -46.01 60.33 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.313 -0.867 . . . . 0.0 110.235 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.424 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 94.1 p -61.16 -36.25 79.31 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.623 -0.673 . . . . 0.0 110.802 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.591 HD11 ' N ' ' A' ' 18' ' ' ALA . 18.7 mt -47.83 -74.23 0.08 OUTLIER Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 121.611 -0.681 . . . . 0.0 111.364 -178.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.838 ' HB2' HD11 ' A' ' 79' ' ' ILE . 28.6 Cg_endo -58.82 -49.75 10.78 Favored 'Trans proline' 0 N--CA 1.481 0.779 0 C-N-CA 121.681 1.587 . . . . 0.0 111.499 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.4 p -51.66 -68.71 0.15 Allowed 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.525 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 70' ' ' SER . 7.4 pttt -64.25 -37.95 89.29 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.621 -0.674 . . . . 0.0 110.973 -179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.471 ' HB3' ' HA ' ' A' ' 30' ' ' CYS . 1.7 m -47.11 -35.54 7.22 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.325 -0.859 . . . . 0.0 111.888 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.79 40.84 0.16 Allowed Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 177.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.648 HG22 ' HA ' ' A' ' 34' ' ' ARG . 4.0 t -131.16 106.89 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.521 -0.988 . . . . 0.0 109.313 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.53 73.4 0.75 Allowed 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.691 0.758 . . . . 0.0 109.716 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.838 HD11 ' HB2' ' A' ' 72' ' ' PRO . 0.8 OUTLIER -121.66 109.49 34.31 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.296 -0.877 . . . . 0.0 109.319 179.735 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.14 -23.58 45.45 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 123.105 2.537 . . . . 0.0 112.618 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.685 ' HE1' HD12 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -82.43 171.13 14.51 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.378 -0.826 . . . . 0.0 109.922 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.666 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 51.9 p -122.81 164.67 17.94 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.118 -0.989 . . . . 0.0 110.137 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.84 HG23 HD22 ' A' ' 53' ' ' LEU . 5.3 mm -93.24 40.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.88 162.41 15.85 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.384 0.611 . . . . 0.0 110.032 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 68.6 p -62.03 -33.17 73.88 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.5 p -70.22 64.95 0.26 Allowed 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.648 0.737 . . . . 0.0 109.439 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.6 m -168.08 155.22 8.01 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.345 -0.847 . . . . 0.0 109.0 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -132.95 152.91 51.86 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.002 -1.061 . . . . 0.0 111.285 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.599 ' SG ' ' HD3' ' A' ' 54' ' ' LYS . 4.2 m -94.82 60.89 2.52 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.409 178.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 37.2 p -135.62 -51.5 0.74 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.551 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -98.78 5.91 47.22 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.647 -0.658 . . . . 0.0 110.792 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 94.3 t -82.84 106.33 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 120.997 -1.064 . . . . 0.0 108.785 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.8 m120 . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 117.053 -1.451 . . . . 0.0 109.32 -179.752 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.535 HG12 ' HB2' ' A' ' 40' ' ' ALA . 5.1 tp . . . . . 0 N--CA 1.509 2.48 0 CA-C-O 121.666 0.745 . . . . 0.0 111.37 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 5' ' ' GLY . 23.4 t -124.08 66.9 1.05 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.023 -1.048 . . . . 0.0 109.485 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.0 t 62.8 -56.29 0.16 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 3' ' ' SER . . . -49.6 -43.91 37.3 Favored Glycine 0 N--CA 1.506 3.312 0 CA-C-N 119.458 1.026 . . . . 0.0 110.556 177.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.533 ' NE2' ' HB3' ' A' ' 36' ' ' LEU . 0.4 OUTLIER -78.99 -39.73 33.43 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.414 -1.051 . . . . 0.0 108.856 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 56.6 t -55.24 -46.6 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.64 -31.31 65.01 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.493 ' HB2' ' HA ' ' A' ' 6' ' ' GLN . 58.6 m -68.35 -22.12 64.69 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.132 -0.98 . . . . 0.0 109.463 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.77 -29.71 14.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.515 -0.741 . . . . 0.0 109.071 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 tp -82.83 -41.0 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.514 -0.741 . . . . 0.0 110.527 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.535 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -42.42 -52.06 10.64 Favored Pre-proline 0 N--CA 1.504 2.268 0 O-C-N 121.757 -0.589 . . . . 0.0 111.399 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 36.9 Cg_endo -64.23 -23.76 66.01 Favored 'Trans proline' 0 N--CA 1.484 0.923 0 C-N-CA 121.977 1.785 . . . . 0.0 110.386 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.584 ' SG ' HG21 ' A' ' 71' ' ' ILE . 1.4 m -109.36 19.37 19.43 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 176.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 16' ' ' SER . 0.4 OUTLIER -66.07 -50.24 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.86 177.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.426 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 51.4 p -55.73 -50.94 69.0 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.39 -0.818 . . . . 0.0 108.875 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.505 ' CG ' HD11 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -57.29 -57.76 11.19 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.393 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.76 -5.99 18.92 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.58 -0.7 . . . . 0.0 110.172 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.8 ttt-85 -100.05 -18.01 17.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.406 -0.809 . . . . 0.0 109.999 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 133.8 -20.82 4.04 Favored Glycine 0 N--CA 1.503 3.108 0 O-C-N 120.859 -1.151 . . . . 0.0 111.577 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -123.01 92.46 3.71 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.03 -1.277 . . . . 0.0 110.463 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.457 ' HA3' ' HA ' ' A' ' 17' ' ' TYR . . . -156.12 -60.18 0.01 OUTLIER Glycine 0 N--CA 1.504 3.176 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.3 p 73.91 -62.65 0.46 Allowed 'General case' 0 N--CA 1.507 2.409 0 O-C-N 122.061 -0.67 . . . . 0.0 111.278 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -114.82 139.44 15.59 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 110.476 -1.049 . . . . 0.0 110.476 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.01 173.14 9.77 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 122.552 2.168 . . . . 0.0 110.911 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 69.3 p -124.48 149.6 46.66 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.303 -0.873 . . . . 0.0 110.321 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.38 -45.62 69.32 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.608 -0.683 . . . . 0.0 110.115 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.16 -39.06 97.16 Favored Glycine 0 N--CA 1.5 2.931 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 40.2 t -66.43 -45.57 79.41 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 119.016 -1.074 . . . . 0.0 110.589 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 88.7 m -71.36 -38.49 71.57 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.343 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.6 p -68.7 -39.81 80.32 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 124.166 0.916 . . . . 0.0 109.668 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.41 -52.98 38.78 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.677 HG11 ' CB ' ' A' ' 72' ' ' PRO . 43.2 t -62.5 -44.88 99.73 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.367 -1.079 . . . . 0.0 109.134 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.627 ' HA ' ' CG1' ' A' ' 77' ' ' VAL . 6.4 tpm_? -54.78 -32.39 60.01 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.5 m -75.17 -45.89 37.77 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.57 HD23 ' HA ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -62.99 -39.68 95.48 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.482 -0.761 . . . . 0.0 110.062 179.602 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.403 ' HB2' ' CG1' ' A' ' 77' ' ' VAL . 53.4 t30 -60.42 -42.35 95.86 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.326 -0.859 . . . . 0.0 109.684 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -64.1 -44.39 92.42 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.513 -0.742 . . . . 0.0 109.004 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.459 ' HB3' ' HB ' ' A' ' 2' ' ' ILE . . . -75.94 -50.3 15.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.777 -0.577 . . . . 0.0 110.349 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.535 ' HB2' HG12 ' A' ' 2' ' ' ILE . . . -74.35 59.43 0.79 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.058 -1.026 . . . . 0.0 109.792 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.62 ' HA ' ' HD3' ' A' ' 46' ' ' ARG . 7.0 mtt-85 -147.94 18.48 1.12 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.036 -1.04 . . . . 0.0 111.082 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.534 ' O ' ' HB ' ' A' ' 43' ' ' THR . 9.9 t -111.26 28.14 9.01 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.116 -0.99 . . . . 0.0 109.652 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.684 HG23 ' HB3' ' A' ' 93' ' ' ASN . 46.3 m 70.95 -61.77 0.47 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.76 -0.588 . . . . 0.0 110.127 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.48 -60.12 3.61 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.786 -0.571 . . . . 0.0 111.118 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -72.54 -28.93 63.15 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.586 -0.696 . . . . 0.0 110.775 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.62 ' HD3' ' HA ' ' A' ' 41' ' ' ARG . 7.6 mmm-85 -53.13 -51.75 60.93 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.396 -0.815 . . . . 0.0 109.47 179.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.574 ' HD2' ' HB2' ' A' ' 93' ' ' ASN . 1.0 OUTLIER -62.12 -51.62 67.17 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.411 -0.805 . . . . 0.0 110.361 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.83 -44.74 90.95 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.63 -0.669 . . . . 0.0 109.733 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.52 -47.67 85.14 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.435 ' C ' ' SG ' ' A' ' 89' ' ' CYS . 37.9 t -59.37 -38.48 80.59 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.018 177.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.456 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 1.9 t30 -64.46 -54.16 36.85 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 123.772 0.67 . . . . 0.0 109.596 176.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.437 ' HA ' ' ND2' ' A' ' 55' ' ' ASN . 39.3 t -63.65 -31.04 72.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.896 -1.127 . . . . 0.0 110.566 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.618 HD13 HG12 ' A' ' 83' ' ' ILE . 26.3 mt -63.67 -46.56 85.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 124.365 1.041 . . . . 0.0 109.008 175.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.456 ' HE2' ' O ' ' A' ' 51' ' ' ASN . 12.5 ttpt -55.04 -49.93 70.36 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.437 ' ND2' ' HA ' ' A' ' 52' ' ' CYS . 1.3 p30 -65.66 -33.61 76.3 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.247 -0.908 . . . . 0.0 109.489 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.45 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -66.92 -56.78 8.75 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.327 -0.858 . . . . 0.0 108.743 178.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.422 ' HB1' ' O ' ' A' ' 84' ' ' SER . . . -60.62 -56.9 15.74 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.572 -0.705 . . . . 0.0 109.167 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.9 66.45 1.15 Allowed 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.17 -28.05 0.1 OUTLIER Glycine 0 N--CA 1.501 3.014 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -178.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 56' ' ' ALA . 2.8 t -46.92 -21.92 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.736 -0.861 . . . . 0.0 111.06 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 60' ' ' VAL . 47.6 m 74.8 83.45 0.1 Allowed 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.82 36.82 7.61 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.566 HD13 ' O ' ' A' ' 84' ' ' SER . 3.7 pp -56.02 138.87 48.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.661 -0.905 . . . . 0.0 110.22 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -109.25 88.27 2.69 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -48.28 -41.8 28.93 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.654 -0.654 . . . . 0.0 109.983 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -52.3 -47.23 56.47 Favored Glycine 0 N--CA 1.501 2.999 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 30.7 m-20 -82.14 -50.2 9.3 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.568 -0.96 . . . . 0.0 109.262 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.422 ' O ' ' CD ' ' A' ' 72' ' ' PRO . . . -51.2 -43.0 61.27 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.996 -0.44 . . . . 0.0 111.987 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.75 -45.95 19.98 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.141 -0.975 . . . . 0.0 110.217 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.4 m -61.92 -43.47 98.78 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.618 -0.676 . . . . 0.0 110.619 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.584 HG21 ' SG ' ' A' ' 14' ' ' CYS . 44.0 mt -42.58 -64.3 0.74 Allowed Pre-proline 0 N--CA 1.504 2.273 0 O-C-N 121.864 -0.522 . . . . 0.0 111.109 -179.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.677 ' CB ' HG11 ' A' ' 33' ' ' VAL . 46.0 Cg_endo -62.69 -60.33 0.19 Allowed 'Trans proline' 0 C--N 1.322 -0.816 0 C-N-CA 122.124 1.882 . . . . 0.0 110.682 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.4 m -45.2 -61.22 1.74 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.942 -0.474 . . . . 0.0 109.919 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.87 -39.98 95.46 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 1.2 m -50.11 -34.66 22.75 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.826 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.465 ' O ' ' HD2' ' A' ' 34' ' ' ARG . . . 135.36 46.62 0.09 OUTLIER Glycine 0 N--CA 1.494 2.553 0 C-N-CA 119.584 -1.293 . . . . 0.0 111.344 175.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.64 HG11 HG12 ' A' ' 33' ' ' VAL . 16.4 m -135.57 126.47 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 CA-C-N 118.776 1.288 . . . . 0.0 111.084 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.3 p -99.92 70.96 1.63 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.366 0.603 . . . . 0.0 109.707 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.476 HD12 ' HD2' ' A' ' 80' ' ' PRO . 2.7 tp -92.97 138.24 23.41 Favored Pre-proline 0 N--CA 1.505 2.31 0 O-C-N 121.213 -0.929 . . . . 0.0 109.456 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.476 ' HD2' HD12 ' A' ' 79' ' ' ILE . 23.9 Cg_endo -59.49 -44.81 29.85 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 122.38 2.053 . . . . 0.0 111.555 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.454 ' HD2' HG11 ' A' ' 92' ' ' VAL . 22.3 p90 -94.6 135.98 35.43 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.014 -1.054 . . . . 0.0 110.906 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.1 m -91.91 163.12 14.14 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.618 HG12 HD13 ' A' ' 53' ' ' LEU . 4.5 mp -121.27 118.18 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.819 -1.175 . . . . 0.0 110.99 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.566 ' O ' HD13 ' A' ' 63' ' ' LEU . 2.5 t -123.47 -72.19 0.69 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.513 HG23 HD21 ' A' ' 63' ' ' LEU . 98.2 m -133.13 -69.32 0.56 Allowed 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.8 m -113.43 -24.46 9.29 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.492 HG22 ' N ' ' A' ' 88' ' ' ASP . 54.6 m 54.63 -100.18 0.1 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.801 -0.562 . . . . 0.0 110.806 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.492 ' N ' HG22 ' A' ' 87' ' ' THR . 20.7 t0 -157.97 -70.74 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.272 -0.893 . . . . 0.0 110.062 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.435 ' SG ' ' C ' ' A' ' 50' ' ' CYS . 14.0 m 58.92 50.99 7.74 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 121.339 0.59 . . . . 0.0 111.645 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.2 t -161.37 -38.15 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.282 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.443 ' HG3' HH11 ' A' ' 91' ' ' ARG . 0.1 OUTLIER -94.16 9.26 38.57 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.684 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.454 HG11 ' HD2' ' A' ' 81' ' ' TYR . 10.9 t -109.0 139.49 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.684 ' HB3' HG23 ' A' ' 43' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.499 2.007 0 O-C-N 121.556 -0.715 . . . . 0.0 109.635 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.67 HD13 ' HB2' ' A' ' 36' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.502 2.148 0 CA-C-O 121.716 0.77 . . . . 0.0 109.167 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.6 t -152.06 82.35 1.26 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.675 -1.265 . . . . 0.0 111.168 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.469 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 2.6 t 66.43 -59.85 0.34 Allowed 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 177.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -46.01 -58.51 5.57 Favored Glycine 0 N--CA 1.506 3.366 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 178.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -78.49 -34.11 47.72 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.54 -0.976 . . . . 0.0 108.93 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.494 HG13 ' CD2' ' A' ' 53' ' ' LEU . 8.3 t -53.39 -39.93 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.448 ' HA ' ' CD1' ' A' ' 11' ' ' ILE . . . -68.81 -35.23 76.75 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.1 p -71.75 -21.37 61.75 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.431 -0.793 . . . . 0.0 109.778 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.1 -46.74 13.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.525 -0.734 . . . . 0.0 110.429 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.448 ' CD1' ' HA ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -79.96 -25.63 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 O-C-N 121.09 -1.006 . . . . 0.0 110.984 -178.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.601 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -47.45 -55.02 17.98 Favored Pre-proline 0 N--CA 1.502 2.15 0 O-C-N 121.132 -0.98 . . . . 0.0 110.1 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.601 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 57.8 Cg_endo -70.9 -26.71 21.89 Favored 'Trans proline' 0 C--N 1.322 -0.84 0 C-N-CA 122.106 1.871 . . . . 0.0 110.555 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.643 ' SG ' HG21 ' A' ' 71' ' ' ILE . 1.1 m -97.4 15.46 22.99 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.744 -0.783 . . . . 0.0 112.442 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.484 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 0.4 OUTLIER -63.19 -45.03 99.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.712 179.082 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.404 ' OG ' ' N ' ' A' ' 17' ' ' TYR . 39.1 p -65.26 -59.29 4.22 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.343 -0.848 . . . . 0.0 109.549 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.404 ' N ' ' OG ' ' A' ' 16' ' ' SER . 1.5 t80 -53.82 -56.08 20.78 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.76 -33.38 68.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.577 -0.702 . . . . 0.0 110.036 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.484 ' HB3' ' O ' ' A' ' 15' ' ' ILE . 24.2 ttm180 -76.7 -32.39 57.83 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.562 -0.711 . . . . 0.0 109.838 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.24 -20.81 3.16 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -85.48 77.24 9.93 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.305 -1.115 . . . . 0.0 109.352 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.7 -158.08 28.77 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.15 -43.74 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.676 -0.896 . . . . 0.0 109.089 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -102.14 141.24 15.2 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.706 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 27.0 Cg_endo -61.03 127.98 23.92 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 121.945 1.763 . . . . 0.0 110.894 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.7 t -62.33 142.16 57.93 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.704 -0.622 . . . . 0.0 110.134 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.52 -61.04 2.57 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.608 -0.682 . . . . 0.0 109.805 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.57 -41.06 80.62 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.527 ' SG ' ' CG2' ' A' ' 71' ' ' ILE . 42.8 t -57.56 -49.36 76.62 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.859 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.706 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 24.9 m -60.5 -34.8 74.59 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 120.674 0.273 . . . . 0.0 110.687 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.9 t -68.75 -50.86 47.13 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.102 175.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.59 -38.26 95.55 Favored Glycine 0 N--CA 1.501 3.013 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.739 HG11 ' HA ' ' A' ' 72' ' ' PRO . 12.8 t -83.57 -52.68 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.403 -1.057 . . . . 0.0 110.707 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.572 ' HA ' ' CG1' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -57.77 -18.23 20.37 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.472 -0.768 . . . . 0.0 110.861 -179.685 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 89.9 p -94.97 -40.69 9.54 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.223 -0.923 . . . . 0.0 109.278 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.67 ' HB2' HD13 ' A' ' 2' ' ' ILE . 0.8 OUTLIER -54.15 -35.89 62.74 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.052 -1.03 . . . . 0.0 109.675 179.265 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.33 -19.2 64.41 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.44 -0.788 . . . . 0.0 109.668 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -87.44 -27.62 22.6 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.46 -30.3 18.4 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.652 -0.655 . . . . 0.0 110.385 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.527 ' HB2' HG12 ' A' ' 2' ' ' ILE . . . -84.41 -148.27 0.1 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.299 -0.876 . . . . 0.0 110.744 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 69.43 23.15 6.19 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.25 -0.906 . . . . 0.0 111.055 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.497 ' O ' ' HB ' ' A' ' 43' ' ' THR . 6.3 t -123.77 15.44 9.41 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.998 -1.064 . . . . 0.0 110.533 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.618 HG23 ' HB3' ' A' ' 93' ' ' ASN . 85.4 m 76.7 -66.94 0.23 Allowed 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.22 -0.925 . . . . 0.0 109.973 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.99 -58.51 6.29 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.213 0.53 . . . . 0.0 110.509 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.596 ' HB3' HG23 ' A' ' 2' ' ' ILE . 24.8 m-20 -70.77 -33.01 70.33 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.453 -0.779 . . . . 0.0 109.184 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.599 ' HG3' ' CE1' ' A' ' 81' ' ' TYR . 0.2 OUTLIER -56.32 -54.8 41.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.543 -0.723 . . . . 0.0 109.858 179.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -68.26 -43.0 78.76 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.492 -0.755 . . . . 0.0 109.574 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.36 -48.41 74.29 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.469 ' HB2' HG13 ' A' ' 2' ' ' ILE . . . -66.23 -49.4 67.35 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.476 ' SG ' ' O ' ' A' ' 88' ' ' ASP . 1.6 t -56.53 -41.14 76.26 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -57.61 -58.3 8.94 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 124.231 0.957 . . . . 0.0 110.285 177.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 48.6 t -67.91 -34.35 76.45 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 118.724 -1.19 . . . . 0.0 111.749 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.618 HD22 HD12 ' A' ' 83' ' ' ILE . 15.3 mt -59.22 -41.46 88.71 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.525 175.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.456 ' HB2' ' HE3' ' A' ' 54' ' ' LYS . 18.7 ttmt -64.63 -38.58 91.49 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -54.85 -36.27 64.88 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.43 -55.84 4.76 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.628 ' HB2' HG22 ' A' ' 83' ' ' ILE . . . -56.26 -36.02 68.09 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.309 -0.869 . . . . 0.0 110.814 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.509 ' HA ' HG23 ' A' ' 85' ' ' THR . . . -93.04 17.02 11.46 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.34 -0.85 . . . . 0.0 110.856 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -143.68 -25.63 0.15 Allowed Glycine 0 N--CA 1.507 3.374 0 O-C-N 121.061 -1.024 . . . . 0.0 111.631 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.8 t -55.53 123.91 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.199 -1.177 . . . . 0.0 110.46 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.8 t -64.67 114.61 4.54 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.563 -0.711 . . . . 0.0 109.611 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 63' ' ' LEU . . . 103.1 -49.94 0.93 Allowed Glycine 0 N--CA 1.499 2.849 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.486 ' C ' HD13 ' A' ' 63' ' ' LEU . 3.4 tm? 19.86 100.65 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.764 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -97.32 87.52 4.17 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -38.61 -45.85 1.13 Allowed 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.605 -0.684 . . . . 0.0 111.192 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.41 -35.36 55.91 Favored Glycine 0 N--CA 1.504 3.19 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -89.57 -46.58 8.56 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.776 -0.838 . . . . 0.0 109.063 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.504 ' HB1' ' HB ' ' A' ' 83' ' ' ILE . . . -51.24 -49.85 60.32 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.95 -0.469 . . . . 0.0 110.347 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.77 -26.8 60.83 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.333 -0.855 . . . . 0.0 109.835 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.9 m -68.83 -36.89 78.74 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.379 -0.825 . . . . 0.0 110.698 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.643 HG21 ' SG ' ' A' ' 14' ' ' CYS . 10.6 mt -53.45 -61.93 4.34 Favored Pre-proline 0 N--CA 1.5 2.034 0 O-C-N 121.675 -0.641 . . . . 0.0 110.465 -179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.739 ' HA ' HG11 ' A' ' 33' ' ' VAL . 28.3 Cg_endo -61.26 -60.96 0.19 Allowed 'Trans proline' 0 C--N 1.323 -0.785 0 C-N-CA 121.794 1.663 . . . . 0.0 111.032 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 77.7 p -46.77 -64.09 0.86 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.966 -0.459 . . . . 0.0 111.057 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -62.67 -44.69 95.62 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 119.571 -0.252 . . . . 0.0 111.346 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.621 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 1.6 m -46.88 -43.99 19.26 Favored 'General case' 0 N--CA 1.506 2.335 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.673 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 146.86 50.44 0.03 OUTLIER Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.186 -1.483 . . . . 0.0 111.52 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.667 HG22 ' O ' ' A' ' 72' ' ' PRO . 32.9 m -135.07 136.46 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-N 119.243 1.521 . . . . 0.0 111.064 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.3 p -106.82 62.65 0.63 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.505 HG12 ' CE1' ' A' ' 81' ' ' TYR . 3.2 tp -116.64 126.24 27.7 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.426 -0.796 . . . . 0.0 109.354 -179.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 79' ' ' ILE . 18.4 Cg_endo -57.97 -38.11 93.41 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 C-N-CA 122.662 2.241 . . . . 0.0 112.083 -178.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.75 ' HB3' HG21 ' A' ' 92' ' ' VAL . 14.0 p90 -90.27 113.99 25.93 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.879 -1.138 . . . . 0.0 109.941 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.663 ' C ' HD13 ' A' ' 83' ' ' ILE . 81.9 p -113.71 -135.55 0.36 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.532 -0.73 . . . . 0.0 109.119 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.663 HD13 ' C ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -123.51 51.59 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.111 -0.993 . . . . 0.0 108.648 -179.53 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.412 ' O ' ' HB ' ' A' ' 85' ' ' THR . 41.7 p -89.45 9.83 24.96 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.858 -0.526 . . . . 0.0 111.794 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.509 HG23 ' HA ' ' A' ' 58' ' ' ALA . 63.5 m 72.07 -59.89 0.54 Allowed 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.285 -0.884 . . . . 0.0 110.104 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.7 p -73.14 -58.08 3.56 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.1 m 31.58 -144.63 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.941 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.996 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.476 ' O ' ' SG ' ' A' ' 50' ' ' CYS . 31.6 t70 -155.51 142.55 19.16 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.609 -1.307 . . . . 0.0 110.58 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.2 m -137.06 54.69 1.85 Allowed 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.964 0.888 . . . . 0.0 110.421 176.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.0 t -164.08 -51.52 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.58 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.455 ' HG2' ' NH1' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -99.27 26.06 6.32 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.476 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.75 HG21 ' HB3' ' A' ' 81' ' ' TYR . 5.0 p -110.32 15.75 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.82 -0.55 . . . . 0.0 110.842 -178.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.618 ' HB3' HG23 ' A' ' 43' ' ' THR . 1.9 p-10 . . . . . 0 N--CA 1.505 2.291 0 CA-C-O 115.308 -2.282 . . . . 0.0 111.078 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.607 HD13 ' HB2' ' A' ' 40' ' ' ALA . 2.9 tp . . . . . 0 N--CA 1.509 2.479 0 CA-C-O 121.735 0.778 . . . . 0.0 111.74 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.7 t -95.72 152.9 18.05 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.996 -1.065 . . . . 0.0 110.279 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.482 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 13.0 t -53.63 -27.69 28.49 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 115.407 -0.815 . . . . 0.0 113.113 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.34 -55.85 27.79 Favored Glycine 0 N--CA 1.502 3.034 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 176.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.539 ' HG3' ' N ' ' A' ' 7' ' ' VAL . 5.5 pt20 -71.39 -34.99 70.9 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.209 -1.171 . . . . 0.0 109.442 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.617 HG13 ' HG ' ' A' ' 53' ' ' LEU . 37.6 t -56.62 -49.16 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.525 ' HA ' ' CD1' ' A' ' 11' ' ' ILE . . . -70.09 -34.29 72.95 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 t -73.03 -22.26 60.67 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.116 -0.99 . . . . 0.0 110.149 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.21 -43.73 23.27 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.298 -0.876 . . . . 0.0 110.427 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.525 ' CD1' ' HA ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -85.59 -16.73 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.038 -1.039 . . . . 0.0 110.413 -179.691 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.582 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -48.62 -54.98 21.89 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.38 -0.825 . . . . 0.0 110.167 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 41.4 Cg_endo -67.56 -22.84 43.91 Favored 'Trans proline' 0 N--CA 1.481 0.763 0 C-N-CA 122.142 1.894 . . . . 0.0 110.585 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.849 ' SG ' HG21 ' A' ' 71' ' ' ILE . 10.6 m -102.28 11.7 37.76 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.607 178.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.518 ' O ' ' CB ' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -59.94 -39.54 80.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.049 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.68 -57.97 5.46 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.59 -0.694 . . . . 0.0 109.558 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.612 ' CD1' ' HA2' ' A' ' 22' ' ' GLY . 0.9 OUTLIER -58.37 -57.21 13.93 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.62 -0.675 . . . . 0.0 109.272 179.594 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.31 -22.98 21.1 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.335 -0.853 . . . . 0.0 109.916 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.518 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 9.2 tmm_? -95.19 0.02 53.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.619 -0.676 . . . . 0.0 110.75 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 123.16 -17.86 7.95 Favored Glycine 0 N--CA 1.501 2.988 0 O-C-N 120.339 -1.475 . . . . 0.0 112.166 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -83.06 69.48 9.85 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-N 119.084 1.442 . . . . 0.0 109.476 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.612 ' HA2' ' CD1' ' A' ' 17' ' ' TYR . . . -74.05 77.19 1.0 Allowed Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.2 p -101.25 -37.06 8.68 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.68 -0.894 . . . . 0.0 109.755 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.441 ' HA2' ' HD3' ' A' ' 25' ' ' PRO . . . 172.97 131.64 1.41 Allowed Glycine 0 N--CA 1.501 3.021 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.441 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 26.5 Cg_exo -60.72 119.02 5.96 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 C-N-CA 122.272 1.982 . . . . 0.0 110.442 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.25 135.38 48.92 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.377 -0.827 . . . . 0.0 110.707 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.68 -48.87 71.86 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.783 -0.573 . . . . 0.0 109.587 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.95 -43.75 92.81 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 30.5 t -60.1 -46.52 89.31 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.53 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.425 ' HA ' ' HB3' ' A' ' 75' ' ' CYS . 96.5 m -64.63 -39.32 93.5 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.283 -177.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.77 -42.24 77.7 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 124.462 1.101 . . . . 0.0 110.031 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.36 -53.94 37.6 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.681 HG12 HG21 ' A' ' 77' ' ' VAL . 2.8 t -68.6 -44.83 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.572 -0.957 . . . . 0.0 109.21 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.547 ' O ' ' HD2' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -53.23 -35.71 60.24 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.4 m -73.53 -48.31 34.07 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.52 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 0.9 OUTLIER -59.77 -34.13 72.59 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.736 -1.227 . . . . 0.0 107.938 177.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.477 ' HB2' HG13 ' A' ' 77' ' ' VAL . 66.0 t30 -52.28 -42.87 64.09 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.601 -0.687 . . . . 0.0 110.212 178.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -93.12 -24.06 18.4 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.18 -0.95 . . . . 0.0 110.703 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.507 ' O ' ' HB ' ' A' ' 2' ' ' ILE . . . -106.63 33.85 3.7 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.956 -1.09 . . . . 0.0 110.372 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.607 ' HB2' HD13 ' A' ' 2' ' ' ILE . . . -168.62 85.78 0.18 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.165 -0.959 . . . . 0.0 110.669 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.492 ' HA ' ' CD ' ' A' ' 46' ' ' ARG . 15.2 mtt180 -158.86 24.31 0.22 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.204 -0.935 . . . . 0.0 111.028 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.461 ' O ' ' HB ' ' A' ' 43' ' ' THR . 8.9 m -110.82 42.16 1.66 Allowed 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.973 -1.079 . . . . 0.0 110.796 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.689 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 52.0 m 68.8 -65.72 0.27 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.158 -0.964 . . . . 0.0 109.469 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 42' ' ' THR . . . -56.82 -51.9 67.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.902 -0.499 . . . . 0.0 109.731 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.518 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 12.6 m-20 -58.42 -48.61 80.12 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.273 0.558 . . . . 0.0 109.797 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.492 ' CD ' ' HA ' ' A' ' 41' ' ' ARG . 13.5 mtm180 -67.39 -48.66 66.74 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.943 -0.473 . . . . 0.0 111.145 -178.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -63.39 -50.86 68.22 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.081 -1.012 . . . . 0.0 109.145 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.97 -47.7 77.16 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.591 ' CB ' HD11 ' A' ' 2' ' ' ILE . . . -63.7 -44.06 94.76 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.538 -0.726 . . . . 0.0 109.186 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.574 ' O ' ' SG ' ' A' ' 89' ' ' CYS . 38.4 t -57.39 -39.03 75.24 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 120.364 -0.534 . . . . 0.0 109.736 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -61.37 -56.12 23.94 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 124.03 0.832 . . . . 0.0 109.788 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . 0.445 ' HA ' HD22 ' A' ' 55' ' ' ASN . 8.4 t -64.26 -35.16 79.94 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.544 178.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.646 HD13 ' O ' ' A' ' 82' ' ' THR . 8.0 mt -63.39 -44.47 94.61 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.061 176.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.428 ' HE3' ' HB3' ' A' ' 54' ' ' LYS . 14.0 ttpp -59.67 -40.62 88.41 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.445 HD22 ' HA ' ' A' ' 52' ' ' CYS . 86.1 m-20 -56.11 -47.23 78.46 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.473 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -73.65 -47.16 42.05 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 83' ' ' ILE . . . -52.87 -41.66 64.52 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.59 -0.694 . . . . 0.0 110.136 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.98 1.53 39.35 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.541 -0.724 . . . . 0.0 110.199 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -125.63 9.48 7.68 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 56' ' ' ALA . 4.9 t -73.58 -5.69 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.579 -0.953 . . . . 0.0 110.07 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER 76.59 -71.03 0.12 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.34 -0.85 . . . . 0.0 109.598 179.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 19' ' ' ARG . . . -109.48 59.33 0.36 Allowed Glycine 0 N--CA 1.499 2.859 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.636 HD11 ' HA ' ' A' ' 84' ' ' SER . 1.4 tm? -54.79 117.99 3.86 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.564 -0.962 . . . . 0.0 111.031 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.543 ' N ' HD13 ' A' ' 63' ' ' LEU . 8.0 t-20 -107.44 86.34 2.29 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.439 ' HA ' ' HB3' ' A' ' 84' ' ' SER . . . -42.91 -50.6 5.76 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.48 -44.19 85.4 Favored Glycine 0 N--CA 1.503 3.162 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -74.41 -55.17 6.28 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.707 -0.878 . . . . 0.0 109.585 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.445 ' HB1' ' HB ' ' A' ' 83' ' ' ILE . . . -51.43 -35.88 41.37 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.937 -0.477 . . . . 0.0 111.435 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.95 -40.0 17.48 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.133 -0.979 . . . . 0.0 110.014 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.0 t -65.17 -40.55 94.46 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.473 -0.767 . . . . 0.0 110.826 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.849 HG21 ' SG ' ' A' ' 14' ' ' CYS . 74.7 mt -51.7 -65.19 1.05 Allowed Pre-proline 0 N--CA 1.503 2.224 0 O-C-N 121.845 -0.534 . . . . 0.0 111.934 -178.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.661 ' HG3' ' HB ' ' A' ' 82' ' ' THR . 41.1 Cg_endo -60.2 -40.54 58.96 Favored 'Trans proline' 0 N--CA 1.482 0.813 0 C-N-CA 121.908 1.739 . . . . 0.0 110.404 -179.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.6 m -55.52 -62.95 1.34 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -63.97 -39.63 94.57 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.893 -0.505 . . . . 0.0 109.84 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.425 ' HB3' ' HA ' ' A' ' 30' ' ' CYS . 1.3 m -48.28 -33.31 8.57 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.91 -0.494 . . . . 0.0 111.689 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 132.17 50.3 0.09 OUTLIER Glycine 0 N--CA 1.498 2.796 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 176.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.681 HG21 HG12 ' A' ' 33' ' ' VAL . 43.8 t -139.98 135.4 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.379 -1.071 . . . . 0.0 110.681 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.8 p -112.11 59.8 0.63 Allowed 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 122.219 1.009 . . . . 0.0 108.695 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.661 HG22 HG12 ' A' ' 77' ' ' VAL . 13.5 tt -125.07 122.56 25.39 Favored Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.46 -41.31 78.03 Favored 'Trans proline' 0 N--CA 1.486 1.084 0 C-N-CA 122.66 2.24 . . . . 0.0 112.092 -178.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.564 ' CE1' HD11 ' A' ' 79' ' ' ILE . 6.6 p90 -97.13 128.91 44.49 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.121 -0.987 . . . . 0.0 108.429 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.662 ' C ' HD12 ' A' ' 83' ' ' ILE . 40.2 p -128.59 -94.97 0.42 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.339 -0.851 . . . . 0.0 110.834 -178.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.662 HD12 ' C ' ' A' ' 82' ' ' THR . 1.4 mp -120.12 -51.79 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.265 -0.897 . . . . 0.0 109.639 -177.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.636 ' HA ' HD11 ' A' ' 63' ' ' LEU . 1.4 m -42.63 144.52 0.53 Allowed 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.309 0.576 . . . . 0.0 110.86 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 87' ' ' THR . 41.3 p -72.44 -130.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.7 t 63.03 -58.9 0.15 Allowed 'General case' 0 N--CA 1.508 2.438 0 O-C-N 120.97 -1.081 . . . . 0.0 111.012 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 85' ' ' THR . 3.4 m -61.11 140.62 57.84 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.387 -0.821 . . . . 0.0 109.789 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -83.67 134.35 34.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.578 -0.701 . . . . 0.0 111.025 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.574 ' SG ' ' O ' ' A' ' 50' ' ' CYS . 65.2 m -105.17 54.55 0.71 Allowed 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.836 0.827 . . . . 0.0 110.129 177.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 m -144.06 -40.89 0.28 Allowed 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 113.796 -1.547 . . . . 0.0 109.132 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -99.43 -30.45 12.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.504 -0.748 . . . . 0.0 109.806 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -47.64 142.77 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 121.297 -0.877 . . . . 0.0 110.391 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.689 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.499 1.992 0 O-C-N 121.711 -0.618 . . . . 0.0 109.529 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.747 HD11 ' HB2' ' A' ' 49' ' ' ALA . 7.4 tp . . . . . 0 N--CA 1.51 2.574 0 CA-C-O 121.806 0.812 . . . . 0.0 111.603 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.8 t -118.59 161.62 19.74 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.878 -1.139 . . . . 0.0 110.268 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.3 t -53.66 -38.02 63.74 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.23 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.16 -37.18 94.08 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -83.93 -43.91 14.77 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.64 -0.918 . . . . 0.0 108.962 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.563 HG21 ' HA ' ' A' ' 49' ' ' ALA . 94.8 t -57.03 -40.58 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.64 -27.46 55.68 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 m -67.76 -22.64 65.21 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.399 -0.813 . . . . 0.0 109.247 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.546 ' C ' ' HD2' ' A' ' 13' ' ' PRO . . . -98.29 -29.23 13.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.517 -0.739 . . . . 0.0 109.075 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 tp -79.37 -41.53 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.487 -0.758 . . . . 0.0 110.515 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.626 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -46.41 -49.78 42.58 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 121.555 -0.716 . . . . 0.0 110.316 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.626 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 22.6 Cg_exo -65.1 -24.61 59.25 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.044 1.829 . . . . 0.0 110.451 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.789 ' SG ' HG21 ' A' ' 71' ' ' ILE . 1.7 m -104.15 14.55 30.25 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 176.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -65.76 -50.68 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.706 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.41 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 0.2 OUTLIER -62.04 -57.31 12.11 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.57 -0.706 . . . . 0.0 109.133 179.02 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.557 ' CE2' HG12 ' A' ' 71' ' ' ILE . 1.1 t80 -54.17 -58.9 5.63 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.452 ' HB1' ' HB2' ' A' ' 68' ' ' ALA . . . -55.77 -35.49 66.31 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.514 -0.741 . . . . 0.0 109.858 178.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.478 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 29.5 ttm180 -74.53 -25.93 59.65 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.471 -0.768 . . . . 0.0 110.18 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.84 3.2 25.14 Favored Glycine 0 N--CA 1.5 2.929 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -103.82 70.7 1.02 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.1 -1.235 . . . . 0.0 109.484 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.05 -145.0 7.64 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.2 t 176.63 -54.29 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.809 -0.818 . . . . 0.0 109.514 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.61 118.4 4.65 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -56.71 132.42 51.63 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 122.568 2.179 . . . . 0.0 110.781 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.2 t -75.05 119.25 18.97 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.515 -0.741 . . . . 0.0 109.208 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.88 -46.01 51.22 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.692 -0.63 . . . . 0.0 109.986 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.98 -42.76 87.41 Favored Glycine 0 N--CA 1.499 2.868 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.446 ' O ' HG23 ' A' ' 33' ' ' VAL . 42.4 t -57.93 -46.08 85.6 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.88 -1.128 . . . . 0.0 109.53 177.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 75' ' ' CYS . 81.3 m -64.91 -41.97 95.12 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 123.855 0.722 . . . . 0.0 112.355 -177.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.443 ' HA ' ' HE ' ' A' ' 34' ' ' ARG . 9.5 t -70.68 -42.31 70.9 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 123.993 0.808 . . . . 0.0 110.192 176.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.95 -51.08 56.04 Favored Glycine 0 N--CA 1.498 2.819 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.662 HG12 HG11 ' A' ' 77' ' ' VAL . 4.8 t -70.47 -46.77 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.625 -0.927 . . . . 0.0 109.237 179.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.59 ' HA ' ' CG1' ' A' ' 77' ' ' VAL . 28.2 ttp180 -52.87 -36.66 59.42 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.4 t -74.29 -47.45 34.71 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.563 HD23 ' HA ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -55.83 -37.84 69.22 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.174 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.585 ' HB2' HG12 ' A' ' 77' ' ' VAL . 2.6 t-20 -63.34 -33.97 76.68 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.471 -0.768 . . . . 0.0 108.962 178.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -78.12 -38.0 44.9 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.417 ' O ' ' HB ' ' A' ' 2' ' ' ILE . . . -94.85 32.01 1.73 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.706 -0.621 . . . . 0.0 109.724 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.493 ' HA ' ' CB ' ' A' ' 45' ' ' ASP . . . -164.39 -159.51 0.48 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.468 -0.77 . . . . 0.0 110.541 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ARG . . . . . 0.542 ' HA ' ' HD3' ' A' ' 46' ' ' ARG . 1.4 mtp180 78.14 12.03 1.79 Allowed 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.974 -0.453 . . . . 0.0 111.598 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.599 ' O ' ' HB ' ' A' ' 43' ' ' THR . 0.9 OUTLIER -99.64 27.32 5.43 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 120.889 -1.132 . . . . 0.0 110.189 178.869 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.64 HG23 ' HB3' ' A' ' 93' ' ' ASN . 55.2 m 83.83 -67.44 0.06 Allowed 'General case' 0 N--CA 1.51 2.557 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.82 -55.42 34.6 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.683 -0.635 . . . . 0.0 109.427 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.567 ' HB3' HG12 ' A' ' 2' ' ' ILE . 8.8 m-20 -54.39 -46.05 73.01 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.542 ' HD3' ' HA ' ' A' ' 41' ' ' ARG . 9.5 mmm-85 -56.81 -44.54 82.06 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.49 ' HA ' ' NH1' ' A' ' 47' ' ' ARG . 0.7 OUTLIER -60.25 -50.52 73.31 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.984 -0.448 . . . . 0.0 110.385 -179.64 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.61 -39.53 80.71 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.78 -0.575 . . . . 0.0 109.727 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.747 ' HB2' HD11 ' A' ' 2' ' ' ILE . . . -71.62 -61.6 1.72 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -44.84 -41.85 7.42 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 176.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.53 ' O ' ' HG3' ' A' ' 54' ' ' LYS . 3.0 t30 -65.53 -56.02 14.62 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.394 177.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 16.8 t -64.39 -26.37 68.43 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 119.139 -1.025 . . . . 0.0 111.146 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.542 ' HG ' HG11 ' A' ' 7' ' ' VAL . 21.7 mt -70.4 -58.9 3.23 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.39 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' A' ' 51' ' ' ASN . 2.7 pptp? -54.07 -36.18 62.84 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.333 -0.854 . . . . 0.0 110.009 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -64.46 -48.15 76.35 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.435 -0.79 . . . . 0.0 109.092 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.58 -40.05 80.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.541 -0.724 . . . . 0.0 109.563 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.443 ' HA ' ' CD1' ' A' ' 63' ' ' LEU . . . -48.43 -48.32 37.45 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.611 -0.681 . . . . 0.0 110.366 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.55 -6.35 45.97 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.453 -0.78 . . . . 0.0 111.554 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -123.63 8.86 8.76 Favored Glycine 0 N--CA 1.501 3.032 0 O-C-N 120.833 -1.167 . . . . 0.0 110.759 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.405 ' O ' ' CB ' ' A' ' 61' ' ' SER . 0.9 OUTLIER -74.42 -21.11 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.333 -1.098 . . . . 0.0 110.367 -179.739 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 60' ' ' VAL . 0.9 OUTLIER 76.49 107.54 0.08 Allowed 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.279 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.73 -78.63 1.92 Allowed Glycine 0 N--CA 1.498 2.774 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 7.5 tt 59.48 103.09 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 121.953 0.883 . . . . 0.0 111.236 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.512 ' HB3' ' HB2' ' A' ' 67' ' ' ASN . 2.6 m-80 -94.39 81.88 4.01 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -32.87 -55.69 0.37 Allowed 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 70' ' ' SER . . . -52.21 -42.99 56.54 Favored Glycine 0 N--CA 1.506 3.357 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.512 ' HB2' ' HB3' ' A' ' 64' ' ' ASN . 2.0 t30 -72.7 -51.97 17.12 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.452 ' HB2' ' HB1' ' A' ' 18' ' ' ALA . . . -57.16 -33.25 67.24 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 122.018 -0.426 . . . . 0.0 111.626 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.43 -45.22 13.91 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.094 -1.004 . . . . 0.0 109.964 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 66' ' ' GLY . 0.4 OUTLIER -66.09 -29.62 69.98 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.347 -0.846 . . . . 0.0 111.055 -179.619 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.789 HG21 ' SG ' ' A' ' 14' ' ' CYS . 70.2 mt -60.11 -66.09 1.71 Allowed Pre-proline 0 N--CA 1.506 2.329 0 O-C-N 121.243 -0.911 . . . . 0.0 111.291 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.564 ' O ' HG22 ' A' ' 77' ' ' VAL . 23.7 Cg_endo -57.33 -53.62 4.53 Favored 'Trans proline' 0 C--N 1.325 -0.699 0 C-N-CA 121.805 1.67 . . . . 0.0 109.652 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.5 m -45.29 -63.98 0.82 Allowed 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -64.85 -34.05 77.45 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.712 -0.617 . . . . 0.0 109.916 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' CYS . . . . . 0.448 ' HB3' ' HA ' ' A' ' 30' ' ' CYS . 1.1 m -50.98 -31.48 18.07 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.222 -177.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 135.07 53.6 0.07 OUTLIER Glycine 0 N--CA 1.497 2.711 0 C-N-CA 119.657 -1.259 . . . . 0.0 110.81 175.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.662 HG11 HG12 ' A' ' 33' ' ' VAL . 12.0 m -147.71 124.49 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.184 -1.186 . . . . 0.0 111.172 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.411 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 65.2 m -91.45 67.06 5.57 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.531 HD11 ' CE2' ' A' ' 81' ' ' TYR . 2.3 tp -104.02 127.19 29.79 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.553 -0.717 . . . . 0.0 109.854 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.63 -33.88 65.37 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 122.826 2.351 . . . . 0.0 112.394 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' TYR . . . . . 0.531 ' CE2' HD11 ' A' ' 79' ' ' ILE . 5.9 p90 -90.3 143.68 26.54 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.904 -1.122 . . . . 0.0 110.407 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.3 p -104.88 173.37 6.33 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.504 -0.747 . . . . 0.0 110.814 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.468 HD12 HD13 ' A' ' 53' ' ' LEU . 5.4 mm -108.95 92.51 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.536 -0.727 . . . . 0.0 109.357 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 82.8 p -119.45 -104.91 0.39 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.159 -0.963 . . . . 0.0 109.653 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -164.02 -55.9 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 63.3 m -79.34 -8.26 58.94 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 122.107 -0.371 . . . . 0.0 110.183 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.7 m -50.03 142.67 9.06 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.325 -0.859 . . . . 0.0 109.951 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -82.58 118.46 23.3 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.496 -0.753 . . . . 0.0 109.813 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 11.4 m -109.64 56.11 0.63 Allowed 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.886 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.3 t -128.5 -61.4 1.08 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.571 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.475 ' NH1' ' HG3' ' A' ' 91' ' ' ARG . 2.9 mtm-85 -97.96 60.61 1.49 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 122.052 0.93 . . . . 0.0 109.629 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.3 t -115.37 81.51 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.64 ' HB3' HG23 ' A' ' 43' ' ' THR . 2.1 p-10 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 117.152 -1.404 . . . . 0.0 110.326 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' A' ' 2' ' ' ILE . . . . . . . . 0 N--CA 1.499 1.989 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.71 ' CG1' ' HB2' ' A' ' 40' ' ' ALA . 5.3 tp 32.13 70.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.407 0 CA-C-O 121.916 0.865 . . . . 0.0 111.579 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 5' ' ' GLY . 1.2 t -156.39 80.19 0.97 Allowed 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.782 -1.199 . . . . 0.0 110.632 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.431 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 11.4 t 66.08 -57.88 0.35 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 3' ' ' SER . . . -44.07 -53.45 6.53 Favored Glycine 0 N--CA 1.505 3.279 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.493 ' OE1' HG23 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -81.49 -25.76 35.73 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.514 -0.992 . . . . 0.0 110.482 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.506 HG21 ' HA ' ' A' ' 49' ' ' ALA . 37.6 t -56.07 -41.18 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.489 ' HA ' ' CD1' ' A' ' 11' ' ' ILE . . . -68.42 -39.58 81.54 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 62.0 p -71.9 -20.84 61.72 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.339 -0.851 . . . . 0.0 109.94 179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -80.73 -49.1 11.61 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.508 -0.745 . . . . 0.0 110.573 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.489 ' CD1' ' HA ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -84.31 -16.7 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.209 -0.932 . . . . 0.0 110.488 -179.7 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.524 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -46.82 -53.98 22.64 Favored Pre-proline 0 N--CA 1.501 2.099 0 O-C-N 121.369 -0.832 . . . . 0.0 109.867 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 27.5 Cg_endo -63.38 -23.1 71.75 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 121.945 1.763 . . . . 0.0 110.585 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.2 m -88.58 -6.52 57.49 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 118.655 -0.688 . . . . 0.0 112.714 177.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.55 ' O ' ' CB ' ' A' ' 19' ' ' ARG . 1.0 OUTLIER -48.56 -47.07 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-N 118.62 0.646 . . . . 0.0 109.686 -178.096 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 21' ' ' GLN . 85.2 p -52.81 -63.55 1.11 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.119 -0.988 . . . . 0.0 109.38 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.591 ' CD2' HG12 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -59.5 -59.74 4.97 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.683 -0.636 . . . . 0.0 110.295 179.674 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.82 -27.59 60.24 Favored 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.289 -0.882 . . . . 0.0 111.039 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.55 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 16.1 ttm-85 -94.02 11.31 30.19 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.306 -0.872 . . . . 0.0 110.899 -178.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 73.22 30.12 63.32 Favored Glycine 0 N--CA 1.506 3.307 0 O-C-N 120.784 -1.198 . . . . 0.0 111.33 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.463 ' O ' ' HB2' ' A' ' 16' ' ' SER . 69.4 mt-30 -140.79 48.49 1.71 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.335 -1.097 . . . . 0.0 109.461 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -165.28 -52.23 0.02 OUTLIER Glycine 0 N--CA 1.502 3.072 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.3 p 70.87 -47.6 0.65 Allowed 'General case' 0 N--CA 1.51 2.564 0 O-C-N 121.81 -0.818 . . . . 0.0 111.501 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.59 132.11 10.82 Favored Glycine 0 N--CA 1.5 2.906 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -64.15 148.83 91.24 Favored 'Trans proline' 0 C--N 1.317 -1.1 0 C-N-CA 122.366 2.044 . . . . 0.0 110.766 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.1 p -104.19 156.14 18.14 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.285 -0.884 . . . . 0.0 109.749 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.34 -47.44 85.86 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.49 -0.756 . . . . 0.0 109.133 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.01 -36.43 93.45 Favored Glycine 0 N--CA 1.501 2.977 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.448 ' HA ' ' HG2' ' A' ' 13' ' ' PRO . 3.9 t -62.38 -59.11 5.45 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 91.5 m -63.65 -36.43 83.81 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 120.184 -0.606 . . . . 0.0 112.15 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 67.4 m -66.81 -48.18 69.74 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 123.726 0.641 . . . . 0.0 109.753 176.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.36 -53.74 37.18 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.806 HG12 HG21 ' A' ' 77' ' ' VAL . 11.6 t -62.23 -48.33 88.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.609 -0.936 . . . . 0.0 110.361 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -23.89 63.48 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.988 -1.07 . . . . 0.0 109.66 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.444 ' HA ' ' OD1' ' A' ' 38' ' ' ASN . 21.4 p -73.63 -34.54 65.06 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.301 -0.874 . . . . 0.0 108.818 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.549 HD23 ' HA ' ' A' ' 33' ' ' VAL . 0.5 OUTLIER -67.2 -31.8 72.43 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.495 -0.753 . . . . 0.0 109.861 179.073 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.629 ' HB2' HG13 ' A' ' 77' ' ' VAL . 2.4 t-20 -64.6 -50.23 67.99 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.395 -0.816 . . . . 0.0 110.575 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.444 ' OD1' ' HA ' ' A' ' 35' ' ' SER . 3.8 p-10 -68.76 -27.07 65.58 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.211 -0.93 . . . . 0.0 109.964 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.11 -46.11 12.3 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.667 -0.646 . . . . 0.0 110.004 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.71 ' HB2' ' CG1' ' A' ' 2' ' ' ILE . . . -88.97 95.99 10.54 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.199 -0.938 . . . . 0.0 109.679 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.583 ' HG2' ' NH1' ' A' ' 46' ' ' ARG . 42.1 mtm180 -152.3 23.74 0.63 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.398 -0.814 . . . . 0.0 110.595 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.2 OUTLIER -128.26 33.95 4.64 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.024 -1.048 . . . . 0.0 110.462 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.43 HG23 ' HE ' ' A' ' 47' ' ' ARG . 53.2 m 67.73 -61.78 0.36 Allowed 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.443 -0.786 . . . . 0.0 109.601 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 42' ' ' THR . . . -55.93 -57.8 10.58 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.632 -0.667 . . . . 0.0 109.713 179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.466 ' HB3' HG23 ' A' ' 2' ' ' ILE . 2.7 m-20 -71.1 -35.06 71.67 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.709 ' HG3' ' CE2' ' A' ' 81' ' ' TYR . 0.1 OUTLIER -67.38 -58.9 3.94 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 122.001 -0.437 . . . . 0.0 110.271 -179.799 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.43 ' HE ' HG23 ' A' ' 43' ' ' THR . 80.2 mtt180 -60.6 -43.71 97.12 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.04 -45.71 61.4 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.292 -0.88 . . . . 0.0 108.662 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.506 ' HA ' HG21 ' A' ' 7' ' ' VAL . . . -67.6 -49.49 62.86 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 178.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.67 ' SG ' HG22 ' A' ' 87' ' ' THR . 0.0 OUTLIER -55.68 -39.87 71.54 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.498 -0.751 . . . . 0.0 112.359 179.266 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.605 ' N ' ' SG ' ' A' ' 89' ' ' CYS . 2.2 t30 -63.44 -56.87 12.72 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.677 177.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 53.7 t -63.93 -26.7 68.71 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.773 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.451 HD22 HG23 ' A' ' 83' ' ' ILE . 21.0 mt -63.42 -51.31 66.28 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 124.183 0.927 . . . . 0.0 109.285 175.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.535 ' HE3' ' HA ' ' A' ' 51' ' ' ASN . 0.4 OUTLIER -55.86 -40.75 73.35 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.19 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.433 ' N ' ' HG2' ' A' ' 54' ' ' LYS . 5.3 m120 -66.48 -46.8 75.09 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.412 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -61.97 -46.02 91.08 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.527 ' HA ' ' HG ' ' A' ' 63' ' ' LEU . . . -61.42 -58.52 7.85 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.27 66.9 6.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.352 -0.843 . . . . 0.0 109.153 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.6 -36.59 0.09 OUTLIER Glycine 0 N--CA 1.498 2.813 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.474 ' HB ' ' HB2' ' A' ' 63' ' ' LEU . 4.0 t -51.91 136.4 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.651 -0.911 . . . . 0.0 110.087 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.444 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 0.4 OUTLIER -62.62 102.0 0.3 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.592 -0.692 . . . . 0.0 109.629 -179.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.28 42.11 19.65 Favored Glycine 0 N--CA 1.5 2.934 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.527 ' HG ' ' HA ' ' A' ' 57' ' ' ALA . 3.3 tm? -64.02 122.72 17.21 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.463 -1.022 . . . . 0.0 110.251 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.428 ' N ' HD13 ' A' ' 63' ' ' LEU . 2.4 m-80 -97.57 83.94 3.32 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -36.24 -53.08 0.82 Allowed 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.89 -0.506 . . . . 0.0 111.506 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -51.71 -50.96 41.14 Favored Glycine 0 N--CA 1.504 3.201 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -67.2 -53.28 31.68 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.694 -0.886 . . . . 0.0 108.949 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.404 ' O ' ' CD ' ' A' ' 72' ' ' PRO . . . -54.03 -32.77 55.41 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 122.038 -0.414 . . . . 0.0 111.235 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.3 -48.19 8.72 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.196 -0.94 . . . . 0.0 110.299 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.9 t -65.4 -27.98 68.93 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.326 -0.859 . . . . 0.0 110.967 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.591 HG12 ' CD2' ' A' ' 17' ' ' TYR . 55.8 mt -58.48 -65.17 2.09 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.253 -0.904 . . . . 0.0 110.451 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.651 ' HB3' HG11 ' A' ' 33' ' ' VAL . 9.5 Cg_endo -53.75 -52.1 9.28 Favored 'Trans proline' 0 N--CA 1.482 0.828 0 C-N-CA 122.217 1.945 . . . . 0.0 110.838 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 35.7 p -44.63 -70.62 0.1 Allowed 'General case' 0 N--CA 1.504 2.232 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.317 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.411 ' N ' ' HD3' ' A' ' 74' ' ' LYS . 1.1 mppt? -64.06 -39.37 93.92 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.972 -0.455 . . . . 0.0 111.106 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 1.1 m -47.5 -35.14 8.34 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.502 -0.749 . . . . 0.0 111.505 -177.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 135.16 46.69 0.09 OUTLIER Glycine 0 N--CA 1.496 2.658 0 O-C-N 124.655 1.222 . . . . 0.0 110.05 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.806 HG21 HG12 ' A' ' 33' ' ' VAL . 59.8 t -119.13 86.33 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.31 -1.112 . . . . 0.0 110.071 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.1 m -75.92 62.49 1.6 Allowed 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.549 HG13 ' HD2' ' A' ' 80' ' ' PRO . 8.9 tt -111.14 142.98 27.43 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.373 -0.83 . . . . 0.0 109.287 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.549 ' HD2' HG13 ' A' ' 79' ' ' ILE . 11.4 Cg_endo -53.37 -39.2 82.33 Favored 'Trans proline' 0 N--CA 1.485 0.973 0 C-N-CA 122.873 2.382 . . . . 0.0 112.942 -177.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.73 ' HB3' HG21 ' A' ' 92' ' ' VAL . 0.2 OUTLIER -96.63 159.94 14.66 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.661 -1.275 . . . . 0.0 111.144 -179.572 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.545 ' C ' HD12 ' A' ' 83' ' ' ILE . 1.3 m -96.11 -170.25 2.08 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.545 HD12 ' C ' ' A' ' 82' ' ' THR . 2.0 mp -120.65 92.68 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.154 -0.967 . . . . 0.0 108.48 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.3 p -142.83 172.29 12.9 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.574 -0.704 . . . . 0.0 110.292 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 20.6 p -59.69 -50.14 75.01 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.698 -0.626 . . . . 0.0 109.546 179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 38.8 m -84.96 48.54 1.58 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.761 -0.587 . . . . 0.0 110.559 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.67 HG22 ' SG ' ' A' ' 50' ' ' CYS . 22.2 m -74.6 117.25 16.21 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.055 -1.028 . . . . 0.0 108.569 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -83.21 136.36 34.44 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.332 -0.855 . . . . 0.0 110.968 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.605 ' SG ' ' N ' ' A' ' 51' ' ' ASN . 58.6 m -117.08 56.04 0.82 Allowed 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.286 176.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.67 -38.7 0.47 Allowed 'General case' 0 N--CA 1.497 1.925 0 CA-C-N 114.823 -1.081 . . . . 0.0 110.227 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.469 ' HG2' ' NH1' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -98.32 2.76 48.4 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.317 -0.864 . . . . 0.0 111.199 -179.176 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.73 HG21 ' HB3' ' A' ' 81' ' ' TYR . 17.1 t -105.82 136.17 41.14 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 120.889 -1.132 . . . . 0.0 110.007 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.5 m120 . . . . . 0 N--CA 1.494 1.772 0 O-C-N 121.289 -0.882 . . . . 0.0 108.738 179.153 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.784 0 CA-C-O 121.419 0.628 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.876 HD11 ' HB2' ' A' ' 49' ' ' ALA . 1.2 pp -84.52 100.64 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.073 -1.017 . . . . 0.0 108.434 179.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.3 t -90.18 174.56 7.55 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.002 -1.061 . . . . 0.0 111.215 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 14.9 t -62.23 -25.83 68.03 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.672 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -59.63 -46.39 94.08 Favored Glycine 0 N--CA 1.5 2.93 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.577 ' NE2' ' HB ' ' A' ' 2' ' ' ILE . 1.2 pt20 -78.03 -35.27 49.99 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.327 -1.102 . . . . 0.0 109.719 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.508 ' N ' ' HG3' ' A' ' 6' ' ' GLN . 95.9 t -59.74 -47.41 91.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.582 ' HA ' ' CD1' ' A' ' 11' ' ' ILE . . . -69.98 -35.05 74.12 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 178.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 72.4 m -70.59 -21.16 62.7 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.139 -0.976 . . . . 0.0 109.92 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.55 -41.94 12.39 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.384 -0.822 . . . . 0.0 111.128 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.582 ' CD1' ' HA ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -83.28 -17.81 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 120.813 -1.179 . . . . 0.0 110.307 -179.771 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.539 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -48.05 -52.97 36.66 Favored Pre-proline 0 N--CA 1.502 2.13 0 O-C-N 121.249 -0.907 . . . . 0.0 109.596 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 17.8 Cg_endo -61.68 -25.03 78.49 Favored 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 121.899 1.732 . . . . 0.0 110.011 178.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.467 ' HB3' HD13 ' A' ' 71' ' ' ILE . 6.6 m -88.39 -1.67 58.17 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 176.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.501 ' O ' ' CB ' ' A' ' 19' ' ' ARG . 0.5 OUTLIER -55.39 -50.79 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' A' ' 21' ' ' GLN . 5.8 m -54.1 -53.17 56.83 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.292 -0.88 . . . . 0.0 108.797 178.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.505 ' CD1' HD11 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -59.97 -65.33 0.7 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.127 -0.983 . . . . 0.0 110.042 179.053 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.479 ' HA ' ' HB3' ' A' ' 67' ' ' ASN . . . -55.08 -34.0 63.26 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.606 -0.684 . . . . 0.0 110.97 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.509 ' HG3' HH11 ' A' ' 19' ' ' ARG . 1.7 ttm-85 -80.35 5.58 14.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.718 -0.614 . . . . 0.0 111.539 -178.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 85.72 23.68 45.35 Favored Glycine 0 N--CA 1.504 3.226 0 O-C-N 120.618 -1.301 . . . . 0.0 111.803 178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.49 ' O ' ' HB3' ' A' ' 16' ' ' SER . 6.3 mm-40 -141.22 59.76 1.51 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.18 -1.188 . . . . 0.0 109.515 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -161.61 -58.99 0.02 OUTLIER Glycine 0 N--CA 1.503 3.12 0 N-CA-C 110.144 -1.182 . . . . 0.0 110.144 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.7 p 74.42 -51.34 0.68 Allowed 'General case' 0 N--CA 1.511 2.596 0 O-C-N 122.054 -0.674 . . . . 0.0 111.479 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -101.78 139.99 14.66 Favored Glycine 0 N--CA 1.501 2.981 0 N-CA-C 110.255 -1.138 . . . . 0.0 110.255 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.718 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 27.3 Cg_endo -61.9 121.77 9.99 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 122.173 1.915 . . . . 0.0 110.238 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 p -75.96 152.95 36.91 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.201 -0.937 . . . . 0.0 110.313 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.01 -51.91 66.1 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.363 -0.835 . . . . 0.0 108.828 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.19 -36.63 91.21 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.572 ' O ' HG23 ' A' ' 33' ' ' VAL . 7.3 t -63.98 -53.95 42.03 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.718 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 93.4 m -67.52 -39.27 85.09 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 118.635 -0.698 . . . . 0.0 111.389 -177.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.0 t -65.62 -47.9 74.08 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 124.19 0.931 . . . . 0.0 109.5 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.31 -53.09 48.5 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.789 HG12 HG21 ' A' ' 77' ' ' VAL . 12.5 t -63.36 -50.63 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.178 0 O-C-N 121.382 -1.069 . . . . 0.0 110.072 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.469 ' O ' ' CB ' ' A' ' 38' ' ' ASN . 7.1 ttp180 -56.24 -35.63 67.6 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 m -73.92 -43.69 57.5 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.531 HD23 ' HA ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -64.4 -44.89 89.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.752 -0.593 . . . . 0.0 109.663 179.628 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.615 ' HB3' HG13 ' A' ' 77' ' ' VAL . 7.3 m-80 -80.8 -28.9 36.12 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.254 -0.904 . . . . 0.0 110.509 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.469 ' CB ' ' O ' ' A' ' 34' ' ' ARG . 8.7 t30 -63.6 -35.19 79.69 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.7 -38.23 29.26 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.585 ' HB2' HG12 ' A' ' 2' ' ' ILE . . . -83.17 93.5 7.66 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.503 -0.748 . . . . 0.0 110.651 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.517 ' HA ' ' HD3' ' A' ' 46' ' ' ARG . 43.3 mtt180 -143.0 9.18 1.7 Allowed 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.95 -1.094 . . . . 0.0 110.584 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 58.0 m -87.53 -65.74 0.98 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.223 -0.923 . . . . 0.0 110.337 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.3 m 160.15 -56.98 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 N-CA-C 105.462 -2.051 . . . . 0.0 105.462 -178.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.86 -47.64 70.79 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.596 ' HB3' ' CG1' ' A' ' 2' ' ' ILE . 18.2 m-20 -68.58 -49.92 55.69 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.517 ' HD3' ' HA ' ' A' ' 41' ' ' ARG . 22.2 mtm180 -62.47 -46.27 89.27 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.526 -0.734 . . . . 0.0 110.46 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.9 mmt180 -59.06 -46.29 88.63 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.378 -0.826 . . . . 0.0 108.879 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.56 -39.68 91.95 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 178.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.876 ' HB2' HD11 ' A' ' 2' ' ' ILE . . . -57.24 -51.13 70.6 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.46 ' SG ' ' N ' ' A' ' 89' ' ' CYS . 19.1 t -58.05 -38.11 75.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.809 -0.557 . . . . 0.0 110.866 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -63.7 -63.21 1.23 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 123.711 0.632 . . . . 0.0 109.305 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 8.6 t -53.7 -33.92 57.09 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.336 -0.852 . . . . 0.0 112.036 176.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.666 HD22 HG23 ' A' ' 83' ' ' ILE . 25.1 mt -61.81 -44.83 96.07 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 114.961 -1.018 . . . . 0.0 108.821 176.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.532 ' HD2' ' SG ' ' A' ' 89' ' ' CYS . 3.3 tttp -56.77 -42.96 80.32 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.639 -0.663 . . . . 0.0 109.269 178.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -55.89 -44.94 78.65 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.764 -0.585 . . . . 0.0 109.73 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.526 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -76.63 -53.98 7.29 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.567 -0.708 . . . . 0.0 109.565 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.611 ' HB1' ' HA ' ' A' ' 85' ' ' THR . . . -52.36 -55.31 22.46 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.536 -0.728 . . . . 0.0 109.679 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -87.95 62.18 6.74 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.288 -0.883 . . . . 0.0 108.74 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 178.98 -34.14 0.07 OUTLIER Glycine 0 N--CA 1.498 2.787 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 56' ' ' ALA . 24.3 t -47.54 133.78 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 O-C-N 121.672 -0.899 . . . . 0.0 109.86 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.405 ' O ' ' HG3' ' A' ' 19' ' ' ARG . 0.5 OUTLIER -62.41 97.93 0.1 Allowed 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.706 -0.621 . . . . 0.0 110.191 -179.187 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.59 73.37 0.61 Allowed Glycine 0 N--CA 1.5 2.928 0 N-CA-C 110.014 -1.235 . . . . 0.0 110.014 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.493 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 1.7 pt? -102.5 159.28 15.57 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.346 -1.091 . . . . 0.0 110.713 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -116.26 114.71 24.76 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -49.57 -53.3 24.49 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.753 -0.592 . . . . 0.0 110.423 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.76 -45.35 85.85 Favored Glycine 0 N--CA 1.5 2.904 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.479 ' HB3' ' HA ' ' A' ' 18' ' ' ALA . 2.9 m120 -62.37 -55.33 28.95 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.728 -0.866 . . . . 0.0 109.474 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.468 ' O ' ' HD2' ' A' ' 72' ' ' PRO . . . -58.36 -33.04 69.12 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.921 -0.487 . . . . 0.0 110.76 -179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.61 -51.15 8.52 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.217 -0.927 . . . . 0.0 110.215 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.3 t -60.62 -31.13 70.33 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.543 -0.723 . . . . 0.0 110.738 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.531 ' HB ' ' CD ' ' A' ' 72' ' ' PRO . 51.6 mt -56.94 -69.63 0.43 Allowed Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.518 -0.739 . . . . 0.0 111.072 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.739 ' HB3' HG11 ' A' ' 33' ' ' VAL . 17.7 Cg_endo -56.06 -52.56 7.03 Favored 'Trans proline' 0 N--CA 1.483 0.906 0 C-N-CA 122.485 2.123 . . . . 0.0 111.762 -178.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 41.4 t -49.36 -69.5 0.11 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.78 -0.575 . . . . 0.0 110.521 -178.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -63.56 -35.83 81.8 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 122.107 -0.37 . . . . 0.0 111.166 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 71' ' ' ILE . 0.9 OUTLIER -48.66 -35.98 14.98 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.398 -0.814 . . . . 0.0 111.419 -178.447 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 133.92 50.14 0.08 OUTLIER Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.789 HG21 HG12 ' A' ' 33' ' ' VAL . 2.4 t -119.52 110.99 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.423 -1.045 . . . . 0.0 109.951 -179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 83.8 p -81.32 68.24 7.56 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.296 -0.878 . . . . 0.0 108.918 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.565 HG12 ' CE2' ' A' ' 81' ' ' TYR . 0.7 OUTLIER -133.92 134.26 23.0 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.589 -0.694 . . . . 0.0 109.739 -178.943 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.495 ' HD2' HG13 ' A' ' 79' ' ' ILE . 47.3 Cg_endo -67.11 -35.37 25.43 Favored 'Trans proline' 0 N--CA 1.486 1.048 0 C-N-CA 122.958 2.439 . . . . 0.0 113.278 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.706 ' HB3' HG22 ' A' ' 92' ' ' VAL . 54.8 p90 -80.54 132.26 35.64 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 120.698 -1.251 . . . . 0.0 110.755 -178.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -88.55 154.51 20.28 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.468 0.651 . . . . 0.0 110.38 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.666 HG23 HD22 ' A' ' 53' ' ' LEU . 1.9 mp -98.33 83.16 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 121.41 0.624 . . . . 0.0 109.739 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 99.8 p -128.99 171.26 12.52 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.116 -0.99 . . . . 0.0 110.07 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.611 ' HA ' ' HB1' ' A' ' 57' ' ' ALA . 1.7 m -58.37 101.14 0.07 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.335 -0.853 . . . . 0.0 109.375 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.4 ' HA ' ' CG ' ' A' ' 54' ' ' LYS . 34.2 t 60.36 60.53 2.0 Allowed 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 121.493 0.663 . . . . 0.0 109.513 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 56.0 m -63.8 -69.23 0.29 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.434 -0.791 . . . . 0.0 110.684 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -150.87 -72.46 0.16 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.061 -1.024 . . . . 0.0 110.149 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.532 ' SG ' ' HD2' ' A' ' 54' ' ' LYS . 38.5 m 58.82 55.01 4.83 Favored 'General case' 0 N--CA 1.503 2.18 0 CA-C-O 121.621 0.724 . . . . 0.0 111.626 -179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 97.6 p -162.75 -42.35 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 114.427 -1.261 . . . . 0.0 109.705 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -100.17 12.43 37.02 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.458 -0.777 . . . . 0.0 109.719 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.706 HG22 ' HB3' ' A' ' 81' ' ' TYR . 85.7 t -79.54 117.14 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.268 -0.895 . . . . 0.0 109.659 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.936 0 CA-C-O 117.267 -1.349 . . . . 0.0 109.542 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.996 0 CA-C-O 121.812 0.815 . . . . 0.0 109.651 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 1.019 HD11 ' HB2' ' A' ' 49' ' ' ALA . 0.6 OUTLIER -135.94 100.88 2.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.2 t -119.05 -173.3 2.47 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.527 -1.358 . . . . 0.0 110.632 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.568 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 1.9 t -52.2 -28.16 17.34 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 177.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -57.23 -51.75 55.67 Favored Glycine 0 N--CA 1.501 2.987 0 N-CA-C 109.843 -1.303 . . . . 0.0 109.843 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.543 ' HG3' ' N ' ' A' ' 7' ' ' VAL . 3.1 pt20 -89.33 -34.16 16.65 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.387 -1.067 . . . . 0.0 109.666 179.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' A' ' 49' ' ' ALA . 40.7 t -56.16 -37.74 50.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.32 -37.7 68.86 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.7 p -77.15 -22.11 53.04 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.011 -1.056 . . . . 0.0 110.02 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.63 -48.86 23.98 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.473 -0.767 . . . . 0.0 110.29 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.435 HG21 ' CD2' ' A' ' 53' ' ' LEU . 0.1 OUTLIER -83.98 -16.02 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 O-C-N 121.13 -0.981 . . . . 0.0 110.812 -179.412 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.541 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -45.61 -54.78 14.27 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.455 -0.778 . . . . 0.0 109.759 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.74 ' HG2' ' SG ' ' A' ' 29' ' ' CYS . 19.2 Cg_endo -62.0 -24.76 77.09 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.186 1.924 . . . . 0.0 110.565 178.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.724 ' SG ' HG21 ' A' ' 71' ' ' ILE . 72.1 m -86.61 -16.81 35.57 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 112.894 0.701 . . . . 0.0 112.894 178.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.453 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -47.58 -24.53 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.904 -0.497 . . . . 0.0 111.255 -177.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.447 ' HA ' ' NH2' ' A' ' 19' ' ' ARG . 0.1 OUTLIER -91.21 -61.93 1.55 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.017 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.508 ' CE2' HG12 ' A' ' 71' ' ' ILE . 1.1 t80 -55.19 -57.42 11.87 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 14' ' ' CYS . . . -52.36 -32.38 38.15 Favored 'General case' 0 N--CA 1.504 2.242 0 CA-C-O 121.42 0.629 . . . . 0.0 110.144 178.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 9.3 tmm_? -90.01 7.9 35.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.798 -0.564 . . . . 0.0 110.86 -178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 94.18 9.31 59.45 Favored Glycine 0 N--CA 1.502 3.075 0 O-C-N 120.713 -1.242 . . . . 0.0 111.976 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -114.75 81.91 1.64 Allowed 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 118.768 1.284 . . . . 0.0 109.699 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 157.48 -148.95 19.26 Favored Glycine 0 N--CA 1.5 2.905 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.3 t -175.24 -45.71 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.596 -0.943 . . . . 0.0 109.918 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -97.84 141.75 15.76 Favored Glycine 0 N--CA 1.499 2.886 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.633 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . 27.9 Cg_endo -62.31 121.91 10.11 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 122.362 2.041 . . . . 0.0 111.051 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.5 t -60.77 134.62 57.27 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.548 -0.72 . . . . 0.0 110.045 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -50.91 -52.9 37.53 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.65 -0.656 . . . . 0.0 110.109 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -52.76 -45.93 60.27 Favored Glycine 0 N--CA 1.502 3.06 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.74 ' SG ' ' HG2' ' A' ' 13' ' ' PRO . 1.1 m -60.02 -43.84 95.02 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.016 177.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.558 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 3.6 m -63.56 -57.33 10.47 Favored 'General case' 0 C--O 1.201 -1.473 0 CA-C-O 117.556 -1.211 . . . . 0.0 109.574 -176.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.3 t -65.79 -39.78 91.28 Favored 'General case' 0 N--CA 1.505 2.296 0 CA-C-N 118.804 0.729 . . . . 0.0 110.683 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -57.98 -44.78 94.38 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.743 HG12 HG21 ' A' ' 77' ' ' VAL . 5.3 t -84.06 -46.41 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.425 -1.044 . . . . 0.0 110.169 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.542 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -54.62 -35.06 63.02 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.491 -0.756 . . . . 0.0 109.14 179.676 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 90.9 p -78.49 -44.42 24.56 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.306 -0.871 . . . . 0.0 110.027 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.599 ' C ' HD12 ' A' ' 36' ' ' LEU . 0.4 OUTLIER -52.67 -35.82 55.91 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.513 -0.742 . . . . 0.0 109.665 179.786 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.56 ' HB2' HG13 ' A' ' 77' ' ' VAL . 4.3 t-20 -62.39 -26.21 68.35 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.259 -0.9 . . . . 0.0 109.917 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -91.65 -40.56 11.23 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.317 -0.864 . . . . 0.0 108.98 179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.06 -36.44 69.58 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.861 ' HB2' HG12 ' A' ' 2' ' ' ILE . . . -91.51 -131.21 0.11 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.873 -0.517 . . . . 0.0 109.926 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.475 ' H ' ' HG2' ' A' ' 46' ' ' ARG . 8.1 mtt-85 56.95 38.92 29.67 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.294 -0.879 . . . . 0.0 110.064 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.465 ' O ' ' HB ' ' A' ' 43' ' ' THR . 9.0 t -136.1 19.02 3.2 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.822 -0.549 . . . . 0.0 109.867 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.768 ' HA ' ' C ' ' A' ' 93' ' ' ASN . 99.5 m 78.17 -60.73 0.4 Allowed 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.755 -0.591 . . . . 0.0 110.327 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.51 -55.67 32.06 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.445 -0.785 . . . . 0.0 110.613 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.42 ' HB3' ' CG1' ' A' ' 2' ' ' ILE . 54.5 m-20 -67.44 -37.14 82.54 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.575 -0.703 . . . . 0.0 110.889 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.661 ' HD2' HD11 ' A' ' 79' ' ' ILE . 0.9 OUTLIER -67.5 -57.08 7.14 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.879 -1.138 . . . . 0.0 110.778 -179.145 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -55.31 -44.17 75.56 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.226 -0.921 . . . . 0.0 109.419 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.46 -45.76 80.72 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 1.019 ' HB2' HD11 ' A' ' 2' ' ' ILE 0.27 . . -61.59 -52.87 62.61 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 178.4 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.471 ' C ' ' SG ' ' A' ' 89' ' ' CYS . 44.7 t -54.84 -34.26 62.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.996 -1.065 . . . . 0.0 111.809 179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -68.92 -59.5 3.02 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 123.676 0.61 . . . . 0.0 109.988 176.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.5 t -61.73 -33.36 73.91 Favored 'General case' 0 N--CA 1.5 2.039 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.526 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.613 HD22 HG13 ' A' ' 83' ' ' ILE . 17.8 mt -67.65 -51.39 50.45 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.636 176.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.5 ttmt -59.04 -38.92 80.48 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -61.13 -53.43 57.1 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 122.077 -0.39 . . . . 0.0 110.381 179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.29 -44.42 52.77 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.286 -0.884 . . . . 0.0 110.357 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -55.57 -44.31 76.75 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.526 -0.734 . . . . 0.0 110.112 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.422 ' HB2' HG21 ' A' ' 85' ' ' THR . . . -76.54 68.66 2.88 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.321 -0.862 . . . . 0.0 109.379 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 149.13 -12.21 1.06 Allowed Glycine 0 N--CA 1.5 2.933 0 C-N-CA 120.117 -1.039 . . . . 0.0 111.719 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.3 t -40.09 -60.33 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.566 0 CA-C-N 118.962 1.381 . . . . 0.0 110.776 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.0 m 160.45 77.9 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.512 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.54 -65.21 3.45 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 107.456 -2.257 . . . . 0.0 107.456 -177.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 8.4 tt 68.99 138.13 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 121.821 0.82 . . . . 0.0 111.413 177.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -121.38 92.26 3.71 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.427 -0.796 . . . . 0.0 109.192 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.46 -41.4 4.3 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.764 -0.585 . . . . 0.0 110.07 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -53.11 -32.18 42.38 Favored Glycine 0 N--CA 1.502 3.076 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -97.49 -53.49 3.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.788 -0.831 . . . . 0.0 108.95 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.407 ' HB2' ' HB1' ' A' ' 18' ' ' ALA . . . -54.69 -32.42 59.37 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.871 -0.518 . . . . 0.0 111.221 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.418 ' CB ' ' HB ' ' A' ' 82' ' ' THR . . . -86.7 -44.01 12.14 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.232 -0.917 . . . . 0.0 109.534 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 65.5 m -64.05 -39.36 93.91 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.677 -0.639 . . . . 0.0 111.139 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.724 HG21 ' SG ' ' A' ' 14' ' ' CYS . 68.5 mt -51.18 -64.35 1.43 Allowed Pre-proline 0 N--CA 1.499 2.008 0 O-C-N 121.628 -0.67 . . . . 0.0 111.479 -178.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.592 ' HG3' HD13 ' A' ' 83' ' ' ILE . 36.8 Cg_endo -59.56 -50.14 8.82 Favored 'Trans proline' 0 N--CA 1.48 0.678 0 C-N-CA 121.85 1.7 . . . . 0.0 110.549 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.7 t -55.82 -60.74 3.03 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.843 -0.536 . . . . 0.0 110.186 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm -63.04 -40.01 96.44 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 122.04 -0.413 . . . . 0.0 110.317 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.633 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 1.2 m -49.86 -37.59 31.64 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.377 -0.827 . . . . 0.0 111.176 -178.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 136.21 55.99 0.06 OUTLIER Glycine 0 N--CA 1.496 2.697 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 176.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.743 HG21 HG12 ' A' ' 33' ' ' VAL . 37.4 t -132.07 114.36 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.515 -0.991 . . . . 0.0 110.139 -179.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.2 m -82.57 56.53 3.36 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.467 -0.77 . . . . 0.0 109.215 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.661 HD11 ' HD2' ' A' ' 46' ' ' ARG . 2.1 tt -117.49 125.51 28.06 Favored Pre-proline 0 N--CA 1.493 1.716 0 O-C-N 121.433 -0.792 . . . . 0.0 109.581 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 79' ' ' ILE . 21.9 Cg_exo -64.46 -37.13 40.33 Favored 'Trans proline' 0 C--N 1.317 -1.08 0 C-N-CA 122.786 2.324 . . . . 0.0 111.79 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.488 ' C ' ' CD1' ' A' ' 81' ' ' TYR . 0.8 OUTLIER -77.83 138.83 39.17 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.995 -1.066 . . . . 0.0 109.76 -179.396 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.418 ' HB ' ' CB ' ' A' ' 69' ' ' ALA . 30.0 p -107.79 168.21 9.42 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.499 -0.751 . . . . 0.0 110.327 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.613 HG13 HD22 ' A' ' 53' ' ' LEU . 1.2 mp -84.6 58.31 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.9 m -136.49 40.4 2.61 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.541 -0.725 . . . . 0.0 109.149 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 87' ' ' THR . 66.9 p 39.72 -115.69 0.2 Allowed 'General case' 0 N--CA 1.509 2.492 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -178.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 50.1 m 62.75 -60.87 0.13 Allowed 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.389 -0.819 . . . . 0.0 111.416 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 85' ' ' THR . 3.7 t -75.76 158.61 32.01 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.247 -0.908 . . . . 0.0 111.181 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -104.52 6.72 34.93 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.476 -0.765 . . . . 0.0 110.418 179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.471 ' SG ' ' C ' ' A' ' 50' ' ' CYS . 3.9 m 52.42 49.27 20.82 Favored 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.933 -0.479 . . . . 0.0 111.611 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.7 t -111.05 -37.85 5.24 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.981 -178.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 5.5 mtm180 -138.71 36.68 2.2 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.486 -0.759 . . . . 0.0 109.507 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 5.4 p -98.78 11.86 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 O-C-N 121.323 -0.861 . . . . 0.0 110.464 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.768 ' C ' ' HA ' ' A' ' 43' ' ' THR . 27.6 m-20 . . . . . 0 N--CA 1.498 1.93 0 CA-C-O 117.186 -1.388 . . . . 0.0 108.78 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.87 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.581 HG23 ' O ' ' A' ' 2' ' ' ILE . 10.6 tp 35.12 71.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.351 0 CA-C-O 122.092 0.948 . . . . 0.0 111.655 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.6 t -144.59 59.74 1.33 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.72 -1.237 . . . . 0.0 110.521 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.413 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 6.3 t 67.3 -52.5 0.48 Allowed 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -47.32 -48.91 20.69 Favored Glycine 0 N--CA 1.506 3.321 0 N-CA-C 110.646 -0.982 . . . . 0.0 110.646 177.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.428 ' NE2' ' HB2' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -82.46 -31.05 29.63 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.422 -1.046 . . . . 0.0 110.479 179.531 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.474 HG21 ' HA ' ' A' ' 49' ' ' ALA . 1.7 t -60.72 -46.15 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 178.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.596 ' HA ' HG13 ' A' ' 11' ' ' ILE . . . -72.64 -26.33 61.62 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 178.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.9 m -68.57 -20.37 64.52 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.323 -0.861 . . . . 0.0 110.34 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.429 ' HB1' ' CA ' ' A' ' 33' ' ' VAL . . . -98.24 -36.42 10.03 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.248 -0.908 . . . . 0.0 110.477 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.596 HG13 ' HA ' ' A' ' 8' ' ' ALA . 2.6 pp -80.0 -31.7 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.378 -0.826 . . . . 0.0 110.541 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.543 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -46.76 -50.89 41.3 Favored Pre-proline 0 N--CA 1.501 2.107 0 O-C-N 121.45 -0.782 . . . . 0.0 109.897 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.555 ' HG2' ' HA ' ' A' ' 29' ' ' CYS . 19.3 Cg_endo -63.08 -13.02 32.76 Favored 'Trans proline' 0 CA--C 1.548 1.178 0 C-N-CA 122.23 1.953 . . . . 0.0 111.412 178.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.2 m -125.45 24.06 7.37 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 175.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.446 ' CD1' HG13 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -60.06 -50.16 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 118.684 0.674 . . . . 0.0 111.019 177.18 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.474 ' HA ' ' HB3' ' A' ' 19' ' ' ARG . 1.5 m -67.58 -45.73 74.69 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.251 -0.906 . . . . 0.0 109.726 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.551 ' CE2' HG12 ' A' ' 71' ' ' ILE . 1.2 t80 -58.69 -48.5 80.9 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.475 ' HB1' ' HB2' ' A' ' 68' ' ' ALA . . . -69.38 -28.98 66.66 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.592 -0.692 . . . . 0.0 109.375 178.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.487 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 9.9 ttm180 -75.34 -18.24 60.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.653 -0.654 . . . . 0.0 109.864 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 102.46 20.83 11.34 Favored Glycine 0 N--CA 1.499 2.854 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.451 ' O ' ' HB3' ' A' ' 16' ' ' SER . 26.7 tt0 -123.06 82.34 1.98 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . 158.88 -153.75 24.86 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 46.4 t 170.17 60.45 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.331 0 O-C-N 121.795 -0.827 . . . . 0.0 109.233 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 160.06 123.12 0.68 Allowed Glycine 0 N--CA 1.499 2.864 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.597 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 32.0 Cg_endo -63.1 124.8 14.57 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 122.571 2.18 . . . . 0.0 110.918 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 53.2 p -77.36 154.43 32.79 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.484 -0.76 . . . . 0.0 109.612 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.31 -57.76 10.88 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.461 -0.775 . . . . 0.0 110.245 -179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -53.94 -37.96 59.2 Favored Glycine 0 N--CA 1.501 3.011 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.555 ' HA ' ' HG2' ' A' ' 13' ' ' PRO . 6.4 t -66.63 -73.24 0.14 Allowed 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.749 177.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.597 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 0.5 OUTLIER -44.81 -41.52 7.06 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.238 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.438 ' HA ' ' HG2' ' A' ' 34' ' ' ARG . 35.8 t -73.15 -52.03 15.68 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.414 178.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.21 -41.24 96.62 Favored Glycine 0 N--CA 1.5 2.913 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.792 HG12 HG21 ' A' ' 77' ' ' VAL . 57.7 t -72.54 -50.23 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.339 -1.094 . . . . 0.0 109.85 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.438 ' HG2' ' HA ' ' A' ' 31' ' ' SER . 11.6 ptm180 -62.1 -23.04 66.29 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.5 -0.75 . . . . 0.0 110.351 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 57.6 p -88.4 -42.3 12.26 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.314 -0.866 . . . . 0.0 109.373 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.712 HD23 ' HA ' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -52.24 -32.89 39.04 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.322 -0.861 . . . . 0.0 109.344 178.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.498 ' HB2' HG13 ' A' ' 77' ' ' VAL . 8.9 t-20 -74.78 -8.56 56.81 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.932 -0.48 . . . . 0.0 111.168 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -105.44 -26.95 11.72 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.501 -1.375 . . . . 0.0 110.855 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.41 -13.86 61.98 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.287 -0.883 . . . . 0.0 110.219 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 1.05 ' HB1' ' HB3' ' A' ' 45' ' ' ASP . . . -163.1 139.54 7.23 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.51 -0.743 . . . . 0.0 110.297 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.51 ' HG2' HH11 ' A' ' 46' ' ' ARG . 4.4 mtm180 -172.62 51.32 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.228 -0.92 . . . . 0.0 110.613 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.569 ' O ' ' N ' ' A' ' 44' ' ' ALA . 0.9 OUTLIER -133.6 57.99 1.79 Allowed 'General case' 0 N--CA 1.508 2.466 0 O-C-N 120.987 -1.07 . . . . 0.0 109.979 -179.975 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.61 ' CB ' ' HA ' ' A' ' 93' ' ' ASN . 12.6 t 54.66 -53.8 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.105 0 C-N-CA 123.988 0.915 . . . . 0.0 111.775 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.569 ' N ' ' O ' ' A' ' 42' ' ' THR . . . -61.37 -51.86 67.03 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 1.05 ' HB3' ' HB1' ' A' ' 40' ' ' ALA . 6.3 m-20 -66.87 -42.86 84.91 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.567 ' HD2' HG13 ' A' ' 79' ' ' ILE . 1.0 OUTLIER -62.01 -48.35 80.7 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.411 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.553 ' HA ' ' SG ' ' A' ' 50' ' ' CYS . 72.0 mtt180 -67.43 -37.13 82.53 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.247 -0.908 . . . . 0.0 109.213 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.47 -50.21 74.54 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 177.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.513 ' HB2' HD11 ' A' ' 2' ' ' ILE . . . -60.74 -42.65 97.77 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.553 ' SG ' ' HA ' ' A' ' 47' ' ' ARG . 4.3 p -66.23 -33.15 75.1 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.591 -0.693 . . . . 0.0 110.509 -177.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.5 ' N ' ' SG ' ' A' ' 50' ' ' CYS . 1.7 t30 -62.93 -54.15 43.0 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 124.06 0.85 . . . . 0.0 109.334 176.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 18.6 t -68.41 -38.79 81.59 Favored 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 119.166 -1.014 . . . . 0.0 111.314 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 53' ' ' LEU . 12.4 mt -56.03 -41.97 75.81 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 124.377 1.048 . . . . 0.0 108.619 176.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.419 ' HG2' ' CB ' ' A' ' 87' ' ' THR . 0.0 OUTLIER -58.61 -50.22 74.61 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.109 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -59.34 -41.51 89.34 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.404 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -69.78 -55.86 8.72 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.477 -0.764 . . . . 0.0 109.403 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.467 ' O ' HD22 ' A' ' 63' ' ' LEU . . . -54.59 -47.67 73.05 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.586 -0.696 . . . . 0.0 110.297 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.11 7.34 7.64 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.319 -0.863 . . . . 0.0 110.726 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -132.99 7.52 5.14 Favored Glycine 0 N--CA 1.497 2.736 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.446 HG13 ' CD1' ' A' ' 15' ' ' ILE . 2.5 t -79.73 133.92 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.128 -1.219 . . . . 0.0 109.382 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.8 p -65.57 94.21 0.18 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.514 -0.741 . . . . 0.0 109.284 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 112.93 -78.52 0.25 Allowed Glycine 0 N--CA 1.497 2.715 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.491 ' CD2' HG23 ' A' ' 85' ' ' THR . 16.7 tp 69.12 134.43 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.203 0 CA-C-O 122.2 1.0 . . . . 0.0 111.316 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.477 ' HB3' ' HB2' ' A' ' 67' ' ' ASN . 6.8 t-20 -135.84 106.09 6.37 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -52.0 -57.82 8.35 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.623 -0.673 . . . . 0.0 111.463 -178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.45 -47.69 68.22 Favored Glycine 0 N--CA 1.504 3.18 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 64' ' ' ASN . 1.8 m-20 -69.84 -58.94 3.28 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.625 -0.926 . . . . 0.0 110.25 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.475 ' HB2' ' HB1' ' A' ' 18' ' ' ALA . . . -57.35 -32.4 66.72 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.474 -0.766 . . . . 0.0 112.273 -178.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.46 -52.57 7.88 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.879 -1.138 . . . . 0.0 110.189 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 90.6 p -68.3 -34.25 75.81 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.653 -0.654 . . . . 0.0 111.122 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.551 HG12 ' CE2' ' A' ' 17' ' ' TYR . 28.1 mt -47.83 -65.33 0.77 Allowed Pre-proline 0 N--CA 1.503 2.215 0 O-C-N 121.516 -0.74 . . . . 0.0 110.357 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.577 ' HB3' HG11 ' A' ' 33' ' ' VAL . 28.3 Cg_endo -61.65 -50.23 5.8 Favored 'Trans proline' 0 C--N 1.324 -0.744 0 C-N-CA 122.218 1.945 . . . . 0.0 110.557 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 40.6 t -51.52 -60.84 2.7 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.828 -0.545 . . . . 0.0 110.151 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.2 tptp -64.36 -41.28 96.81 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.721 -0.612 . . . . 0.0 110.1 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -48.16 -50.44 28.9 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 120.019 -0.673 . . . . 0.0 111.707 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.61 46.99 0.01 OUTLIER Glycine 0 N--CA 1.495 2.581 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 176.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.792 HG21 HG12 ' A' ' 33' ' ' VAL . 53.5 t -129.23 125.65 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.643 -0.916 . . . . 0.0 110.106 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.5 t -112.45 81.0 1.4 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.567 HG13 ' HD2' ' A' ' 46' ' ' ARG . 11.1 tt -121.3 137.38 26.76 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.652 -0.655 . . . . 0.0 109.27 -178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 79' ' ' ILE . 50.9 Cg_exo -52.75 -41.74 67.66 Favored 'Trans proline' 0 N--CA 1.483 0.889 0 C-N-CA 122.785 2.324 . . . . 0.0 113.114 -178.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.478 ' HH ' ' HB3' ' A' ' 49' ' ' ALA . 5.9 p90 -93.6 147.91 22.57 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 120.626 -1.296 . . . . 0.0 110.824 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -84.1 152.91 24.05 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.598 -0.688 . . . . 0.0 109.503 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.501 HD12 ' N ' ' A' ' 83' ' ' ILE . 2.0 mp -85.38 93.74 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.487 -0.758 . . . . 0.0 109.951 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.9 p -170.89 -175.65 1.82 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.417 -0.802 . . . . 0.0 109.827 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.491 HG23 ' CD2' ' A' ' 63' ' ' LEU . 0.6 OUTLIER -62.88 -28.91 70.36 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.807 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 32.9 m -83.93 45.76 1.12 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.527 -0.733 . . . . 0.0 109.819 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.419 ' CB ' ' HG2' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -77.01 139.0 39.94 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.341 -0.849 . . . . 0.0 109.977 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -95.4 134.63 37.99 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.449 -0.782 . . . . 0.0 109.872 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 94.5 m -143.47 53.57 1.33 Allowed 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.675 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 89.7 p -159.15 -48.48 0.06 Allowed 'General case' 0 N--CA 1.502 2.13 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.732 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.579 ' HB2' ' CZ ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -113.41 21.16 15.46 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.462 HG21 ' HD2' ' A' ' 81' ' ' TYR . 3.3 p -101.9 129.99 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 CA-C-O 121.638 0.733 . . . . 0.0 109.794 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.61 ' HA ' ' CB ' ' A' ' 43' ' ' THR . 72.4 m-20 . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 116.506 -1.711 . . . . 0.0 108.969 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.798 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.803 HG21 ' HB3' ' A' ' 45' ' ' ASP . 3.5 tp -69.12 82.56 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 CA-C-O 121.757 0.789 . . . . 0.0 109.82 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.4 ' O ' ' HG3' ' A' ' 6' ' ' GLN . 46.1 t -115.81 169.54 9.14 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.244 -0.91 . . . . 0.0 109.994 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 26.5 t -62.33 -33.64 75.09 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.665 -0.814 . . . . 0.0 112.65 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -50.56 -51.09 33.92 Favored Glycine 0 N--CA 1.502 3.062 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -77.24 -36.05 54.94 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.279 -1.13 . . . . 0.0 110.308 -179.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.479 HG21 ' HA ' ' A' ' 49' ' ' ALA . 83.2 t -56.52 -46.66 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.74 -35.59 72.74 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.6 t -69.0 -21.86 64.12 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.272 -0.893 . . . . 0.0 109.825 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.28 -27.93 21.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.509 -0.744 . . . . 0.0 109.018 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.512 HD11 HG21 ' A' ' 83' ' ' ILE . 1.2 tp -79.5 -40.63 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.356 -0.84 . . . . 0.0 110.023 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.536 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -44.26 -51.46 19.23 Favored Pre-proline 0 N--CA 1.504 2.225 0 O-C-N 121.646 -0.659 . . . . 0.0 110.977 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 32.9 Cg_endo -65.79 -28.17 51.47 Favored 'Trans proline' 0 N--CA 1.483 0.911 0 C-N-CA 122.281 1.987 . . . . 0.0 110.592 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.841 ' SG ' HG21 ' A' ' 71' ' ' ILE . 1.3 m -101.28 16.79 24.39 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 177.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.787 HD13 HG13 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -65.79 -51.1 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.507 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.1 p -59.76 -57.79 11.38 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.324 -0.86 . . . . 0.0 109.302 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.716 ' CD1' HD11 ' A' ' 71' ' ' ILE . 0.3 OUTLIER -55.3 -54.45 43.38 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.522 ' HB1' ' HB2' ' A' ' 68' ' ' ALA . . . -65.11 -25.37 67.74 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.416 -0.802 . . . . 0.0 110.003 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.474 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 10.5 ttp180 -79.02 -26.03 43.23 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.319 -0.863 . . . . 0.0 110.006 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 148.32 -12.95 1.23 Allowed Glycine 0 N--CA 1.5 2.916 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 8.9 mp0 -82.53 64.38 7.15 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.923 -1.34 . . . . 0.0 108.875 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.556 ' HA2' ' CD1' ' A' ' 17' ' ' TYR . . . -76.34 75.69 1.56 Allowed Glycine 0 N--CA 1.5 2.904 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -165.62 36.05 0.06 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.717 -0.873 . . . . 0.0 110.05 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 178.11 78.78 0.06 OUTLIER Glycine 0 N--CA 1.499 2.836 0 C-N-CA 120.075 -1.059 . . . . 0.0 110.51 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -59.91 131.88 41.94 Favored 'Trans proline' 0 C--N 1.319 -0.989 0 C-N-CA 122.17 1.913 . . . . 0.0 109.928 179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.1 t -90.06 120.17 31.03 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.268 -0.895 . . . . 0.0 110.602 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.87 -45.2 74.56 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.38 -46.0 87.93 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 108.332 -1.907 . . . . 0.0 108.332 178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 47.5 t -54.07 -42.28 69.11 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.442 -0.903 . . . . 0.0 110.301 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 80.4 m -61.76 -47.6 84.47 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.926 177.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.1 t -65.19 -40.55 94.38 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 124.259 0.974 . . . . 0.0 110.906 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.25 -57.07 12.43 Favored Glycine 0 N--CA 1.5 2.908 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.647 HG11 ' CB ' ' A' ' 72' ' ' PRO . 16.4 t -62.94 -46.54 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.488 -1.007 . . . . 0.0 109.442 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.576 ' N ' HG22 ' A' ' 77' ' ' VAL . 0.5 OUTLIER -54.54 -31.08 55.76 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.694 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.7 m -78.86 -44.09 23.62 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.536 HD23 ' HA ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -56.86 -43.7 81.45 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.632 -0.668 . . . . 0.0 109.995 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.636 ' O ' ' HG3' ' A' ' 41' ' ' ARG . 51.3 t30 -74.72 -35.48 62.69 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.167 -0.958 . . . . 0.0 109.912 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -63.83 -37.72 88.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.039 -1.038 . . . . 0.0 108.395 179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.29 -43.53 13.65 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.786 -0.571 . . . . 0.0 110.617 179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.596 ' HB2' HG12 ' A' ' 2' ' ' ILE . . . -103.9 111.44 23.97 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.06 -1.025 . . . . 0.0 111.441 -178.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.636 ' HG3' ' O ' ' A' ' 37' ' ' ASN . 0.0 OUTLIER -157.84 26.48 0.27 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.781 -0.575 . . . . 0.0 110.0 179.044 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.423 ' O ' ' HB ' ' A' ' 43' ' ' THR . 0.2 OUTLIER -127.64 34.7 4.62 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.127 -0.983 . . . . 0.0 109.624 -179.441 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.453 ' OG1' ' HA ' ' A' ' 93' ' ' ASN . 27.9 m 70.09 -66.08 0.29 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.562 -0.711 . . . . 0.0 109.924 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.91 -57.06 10.5 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.707 -0.62 . . . . 0.0 110.677 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.803 ' HB3' HG21 ' A' ' 2' ' ' ILE . 6.5 m-20 -67.2 -36.89 82.67 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.495 HH12 ' HB3' ' A' ' 81' ' ' TYR . 5.6 mmm180 -67.95 -39.45 83.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.629 -0.669 . . . . 0.0 109.684 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.444 ' HG2' ' NH1' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -58.82 -41.89 87.9 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.428 -0.795 . . . . 0.0 108.995 178.977 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.42 -46.49 86.34 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.577 ' HB2' HD11 ' A' ' 2' ' ' ILE . . . -64.14 -41.58 97.14 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 50.0 t -66.31 -35.83 81.39 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.613 -0.68 . . . . 0.0 110.569 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -66.54 -55.76 14.0 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 124.152 0.908 . . . . 0.0 109.813 176.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 42.1 t -61.63 -35.7 78.66 Favored 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.862 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.601 HD22 HG23 ' A' ' 83' ' ' ILE . 12.1 mt -61.15 -53.19 60.15 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 124.336 1.022 . . . . 0.0 109.011 176.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 43.8 tttp -55.82 -37.64 68.94 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.78 -29.77 69.05 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.532 -0.73 . . . . 0.0 110.817 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.513 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -94.96 -49.3 5.62 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.271 -0.893 . . . . 0.0 110.378 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.603 ' HA ' HD13 ' A' ' 63' ' ' LEU . . . -53.65 -49.59 67.59 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.36 -0.838 . . . . 0.0 109.522 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.46 67.05 1.02 Allowed 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 107.694 -1.224 . . . . 0.0 107.694 178.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.44 ' O ' ' N ' ' A' ' 61' ' ' SER . . . 165.16 -22.87 0.14 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 110.121 -1.191 . . . . 0.0 110.121 -178.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.787 HG13 HD13 ' A' ' 15' ' ' ILE . 24.7 t -64.52 69.85 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.247 0 O-C-N 121.29 -1.124 . . . . 0.0 109.942 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.456 ' CB ' ' HD2' ' A' ' 19' ' ' ARG . 43.3 m 54.38 -102.68 0.15 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.222 -0.924 . . . . 0.0 110.022 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -100.0 -29.11 6.99 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.603 HD13 ' HA ' ' A' ' 57' ' ' ALA . 21.7 tp 63.54 99.98 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.807 -0.82 . . . . 0.0 111.047 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -98.62 95.43 7.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.205 -0.934 . . . . 0.0 108.643 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -49.31 -50.44 39.38 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.734 -0.604 . . . . 0.0 111.042 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.07 -32.7 50.2 Favored Glycine 0 N--CA 1.505 3.261 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.441 ' O ' HG13 ' A' ' 71' ' ' ILE . 3.7 m-20 -82.87 -48.98 10.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.52 -0.988 . . . . 0.0 109.435 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.522 ' HB2' ' HB1' ' A' ' 18' ' ' ALA . . . -69.25 -21.42 63.91 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.687 -0.633 . . . . 0.0 111.408 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.441 ' HB2' ' HB ' ' A' ' 82' ' ' THR . . . -89.44 -41.35 12.13 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.011 -1.056 . . . . 0.0 110.253 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 76.6 p -68.99 -45.39 70.71 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.499 -0.751 . . . . 0.0 110.954 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.841 HG21 ' SG ' ' A' ' 14' ' ' CYS . 44.0 mt -47.95 -64.55 1.03 Allowed Pre-proline 0 N--CA 1.503 2.208 0 O-C-N 121.647 -0.658 . . . . 0.0 111.589 -178.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.647 ' CB ' HG11 ' A' ' 33' ' ' VAL . 28.4 Cg_endo -59.27 -48.87 12.28 Favored 'Trans proline' 0 N--CA 1.48 0.677 0 C-N-CA 121.745 1.63 . . . . 0.0 110.566 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.1 m -49.45 -68.96 0.13 Allowed 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.89 -33.59 75.62 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 110.264 -0.272 . . . . 0.0 110.264 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -47.78 -35.43 9.99 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.794 -0.566 . . . . 0.0 110.453 -179.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 124.74 54.4 0.18 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.011 -2.036 . . . . 0.0 108.011 177.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.576 HG22 ' N ' ' A' ' 34' ' ' ARG . 85.2 t -111.09 -48.57 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 C-N-CA 119.499 -0.88 . . . . 0.0 111.205 -178.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 77' ' ' VAL . 19.7 m 68.33 33.59 4.15 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.677 -0.639 . . . . 0.0 110.149 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.657 HG12 ' CD1' ' A' ' 81' ' ' TYR . 9.7 tt -95.78 121.35 61.44 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 121.059 -1.026 . . . . 0.0 109.06 179.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -65.31 56.6 0.31 Allowed 'Trans proline' 0 CA--C 1.55 1.294 0 C-N-CA 122.51 2.14 . . . . 0.0 112.711 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.657 ' CD1' HG12 ' A' ' 79' ' ' ILE . 0.0 OUTLIER -178.54 152.31 0.64 Allowed 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.332 -0.855 . . . . 0.0 110.271 177.443 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.441 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 53.6 p -108.64 171.37 7.46 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.65 0.738 . . . . 0.0 110.592 -178.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.601 HG23 HD22 ' A' ' 53' ' ' LEU . 2.0 mp -104.44 67.12 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-O 122.012 0.911 . . . . 0.0 108.702 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.419 ' O ' ' CB ' ' A' ' 85' ' ' THR . 86.2 p -98.37 -18.39 18.33 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.494 -0.754 . . . . 0.0 110.627 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.419 ' CB ' ' O ' ' A' ' 84' ' ' SER . 0.5 OUTLIER 81.04 -16.44 0.65 Allowed 'General case' 0 N--CA 1.505 2.296 0 O-C-N 121.781 -0.574 . . . . 0.0 110.995 -179.282 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.9 m -76.17 -21.88 56.02 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.017 -1.052 . . . . 0.0 109.013 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -47.74 145.8 2.61 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.621 0.724 . . . . 0.0 111.1 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -88.93 -13.23 39.5 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.995 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 54.6 m 52.87 51.25 16.29 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.465 0.65 . . . . 0.0 111.291 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.96 -42.64 0.27 Allowed 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 114.787 -1.097 . . . . 0.0 110.552 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.8 31.74 4.83 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 6.3 p -109.48 118.84 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.768 -0.582 . . . . 0.0 109.462 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.453 ' HA ' ' OG1' ' A' ' 43' ' ' THR . 2.9 p-10 . . . . . 0 N--CA 1.497 1.912 0 CA-C-O 114.6 -2.619 . . . . 0.0 110.17 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.782 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.694 HG21 ' HA ' ' A' ' 45' ' ' ASP . 4.2 tp -71.68 99.26 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.319 -0.863 . . . . 0.0 109.828 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.8 t -135.17 172.61 12.76 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.314 -0.867 . . . . 0.0 110.205 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.8 t -67.86 -20.78 65.17 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 177.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -56.7 -54.48 36.12 Favored Glycine 0 N--CA 1.504 3.176 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 178.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.441 ' NE2' ' HB3' ' A' ' 36' ' ' LEU . 8.4 tt0 -67.66 -40.65 84.48 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.456 -1.026 . . . . 0.0 108.516 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.442 ' O ' ' HB ' ' A' ' 11' ' ' ILE . 77.5 t -53.78 -44.91 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 178.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -69.87 -35.95 75.09 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.7 t -69.39 -22.2 63.73 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.44 -0.788 . . . . 0.0 109.241 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.561 ' C ' ' HD2' ' A' ' 13' ' ' PRO . . . -98.05 -25.43 14.95 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.51 -0.744 . . . . 0.0 109.236 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.442 ' HB ' ' O ' ' A' ' 7' ' ' VAL . 1.8 tp -78.77 -42.31 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.218 -0.926 . . . . 0.0 110.072 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.638 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -46.43 -51.16 36.92 Favored Pre-proline 0 N--CA 1.498 1.964 0 O-C-N 121.588 -0.695 . . . . 0.0 110.432 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.638 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 11.2 Cg_exo -67.26 -28.76 39.7 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.136 1.891 . . . . 0.0 110.992 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.659 ' SG ' HG21 ' A' ' 71' ' ' ILE . 1.3 m -103.07 14.38 31.99 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 178.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.461 ' O ' ' CB ' ' A' ' 19' ' ' ARG . 0.4 OUTLIER -74.16 -44.5 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -178.474 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.1 p -65.74 -56.84 9.89 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.718 ' CG ' HD11 ' A' ' 71' ' ' ILE . 0.5 OUTLIER -54.82 -55.35 31.12 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.579 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.495 ' HB1' ' HB2' ' A' ' 68' ' ' ALA . . . -60.01 -32.05 70.51 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.313 -0.867 . . . . 0.0 109.439 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.461 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 11.9 ttt180 -78.42 -5.89 53.69 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.647 -0.658 . . . . 0.0 110.623 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 107.56 -12.43 39.21 Favored Glycine 0 N--CA 1.501 3.025 0 O-C-N 120.666 -1.272 . . . . 0.0 111.412 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -105.06 81.38 1.72 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.136 -1.214 . . . . 0.0 109.333 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -146.44 -177.03 20.76 Favored Glycine 0 N--CA 1.499 2.838 0 C-N-CA 119.686 -1.245 . . . . 0.0 111.356 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -176.38 49.98 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 134.13 136.93 3.73 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 108.504 -1.839 . . . . 0.0 108.504 -178.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.452 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . 30.4 Cg_endo -60.98 130.22 31.84 Favored 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 122.158 1.905 . . . . 0.0 111.136 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.1 t -74.04 123.81 25.07 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.507 -0.746 . . . . 0.0 109.718 179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.51 -46.43 73.5 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.502 -0.749 . . . . 0.0 109.879 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.1 -48.3 86.57 Favored Glycine 0 N--CA 1.503 3.164 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.528 ' HB2' ' HB2' ' A' ' 13' ' ' PRO . 1.0 OUTLIER -58.74 -55.19 38.24 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 119.356 -0.938 . . . . 0.0 110.095 178.328 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 96.2 m -58.76 -27.17 64.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 124.027 0.829 . . . . 0.0 112.033 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 75.2 m -74.23 -47.7 33.6 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 123.825 0.703 . . . . 0.0 109.296 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.531 ' HA3' ' HB2' ' A' ' 10' ' ' ALA . . . -65.0 -28.26 73.29 Favored Glycine 0 N--CA 1.5 2.953 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.754 HG12 HG11 ' A' ' 77' ' ' VAL . 21.2 t -81.91 -48.22 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.269 -1.136 . . . . 0.0 108.762 179.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.494 ' HA ' HG22 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -61.9 -25.78 67.77 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.358 -0.839 . . . . 0.0 109.05 179.071 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.437 ' HB3' ' NH2' ' A' ' 34' ' ' ARG . 79.6 p -74.0 -46.38 44.03 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 177.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.673 HD23 ' HA ' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -63.24 -30.86 71.93 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.671 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.785 ' HB2' HG13 ' A' ' 77' ' ' VAL . 3.1 t-20 -63.39 -36.17 82.84 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.025 -1.047 . . . . 0.0 110.215 179.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -90.38 -36.33 14.68 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.463 -0.773 . . . . 0.0 110.099 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -90.26 -18.48 25.56 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.538 -0.727 . . . . 0.0 111.076 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.683 ' HA ' ' CB ' ' A' ' 45' ' ' ASP . . . -123.56 110.49 15.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.011 -1.055 . . . . 0.0 110.508 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -163.32 -20.19 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.411 -0.806 . . . . 0.0 112.081 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.52 ' O ' ' N ' ' A' ' 44' ' ' ALA . 89.7 m -78.28 50.02 0.88 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.648 -1.283 . . . . 0.0 110.292 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.705 HG23 ' HA ' ' A' ' 93' ' ' ASN . 97.9 m 62.4 -64.6 0.09 Allowed 'General case' 0 N--CA 1.503 2.219 0 O-C-N 121.846 -0.534 . . . . 0.0 110.015 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 42' ' ' THR . . . -48.45 -57.29 6.32 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 122.067 -0.396 . . . . 0.0 110.419 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.694 ' HA ' HG21 ' A' ' 2' ' ' ILE . 3.1 m-20 -55.26 -45.45 76.09 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.575 HH11 ' HB2' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -57.51 -55.23 37.52 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.738 178.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -59.92 -44.14 94.48 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.15 -50.88 71.39 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.535 -0.728 . . . . 0.0 109.317 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.629 ' HB2' HD11 ' A' ' 2' ' ' ILE . . . -63.56 -55.27 25.11 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.515 ' HA ' ' HB2' ' A' ' 53' ' ' LEU . 3.7 t -48.63 -39.42 24.03 Favored 'General case' 0 N--CA 1.504 2.259 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 174.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.419 ' N ' ' SG ' ' A' ' 89' ' ' CYS . 2.8 t30 -60.35 -53.09 61.81 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 176.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 5.6 t -68.54 -32.26 72.07 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 119.766 -0.774 . . . . 0.0 111.598 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.563 HD22 HG12 ' A' ' 83' ' ' ILE . 13.6 mt -63.0 -57.56 10.29 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.072 178.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -54.73 -39.4 68.21 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -54.51 -50.75 67.1 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.538 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -72.03 -44.17 63.82 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.507 -0.746 . . . . 0.0 109.205 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.551 ' HA ' ' CD1' ' A' ' 63' ' ' LEU . . . -54.88 -37.79 66.73 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.629 -0.669 . . . . 0.0 110.297 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.445 ' HA ' HG23 ' A' ' 85' ' ' THR . . . -85.89 8.03 21.83 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.237 -0.914 . . . . 0.0 110.43 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -140.3 11.56 3.02 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 56' ' ' ALA . 3.8 t -79.04 -28.01 13.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.234 -1.157 . . . . 0.0 109.937 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 60' ' ' VAL . 0.6 OUTLIER 77.25 113.26 0.07 Allowed 'General case' 0 N--CA 1.506 2.369 0 CA-C-O 121.275 0.559 . . . . 0.0 109.946 -179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 66.48 34.22 87.1 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 110.139 -1.185 . . . . 0.0 110.139 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.551 ' CD1' ' HA ' ' A' ' 57' ' ' ALA . 10.0 tt -64.68 121.86 15.5 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.463 -1.022 . . . . 0.0 110.406 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -97.09 90.05 5.02 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -44.28 -48.47 9.5 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.912 -0.492 . . . . 0.0 110.494 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -50.68 -40.52 40.92 Favored Glycine 0 N--CA 1.502 3.07 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 16.9 m-20 -76.46 -56.4 4.66 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.703 -0.88 . . . . 0.0 109.344 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.495 ' HB2' ' HB1' ' A' ' 18' ' ' ALA . . . -59.44 -24.7 63.74 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.906 -0.496 . . . . 0.0 111.769 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -90.01 -47.48 7.81 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.956 -1.09 . . . . 0.0 110.419 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 t -64.54 -31.27 72.42 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.445 -0.784 . . . . 0.0 111.056 -179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.718 HD11 ' CG ' ' A' ' 17' ' ' TYR . 78.0 mt -60.43 -70.38 0.44 Allowed Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 121.204 -0.935 . . . . 0.0 111.007 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.694 ' CB ' HG11 ' A' ' 33' ' ' VAL . 38.0 Cg_endo -60.07 -51.67 5.33 Favored 'Trans proline' 0 N--CA 1.484 0.944 0 C-N-CA 122.328 2.019 . . . . 0.0 112.077 -178.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 94.2 p -51.45 -63.67 1.06 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.692 -0.63 . . . . 0.0 110.487 -179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 22.7 mmtt -63.11 -42.33 99.53 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 122.15 -0.343 . . . . 0.0 110.604 -179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 71' ' ' ILE . 0.4 OUTLIER -47.36 -55.22 9.27 Favored 'General case' 0 N--CA 1.506 2.344 0 O-C-N 121.506 -0.746 . . . . 0.0 112.12 -177.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 164.9 50.97 0.02 OUTLIER Glycine 0 N--CA 1.496 2.653 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.785 HG13 ' HB2' ' A' ' 37' ' ' ASN . 46.8 t -130.85 93.59 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.756 -0.85 . . . . 0.0 110.323 -178.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 56.7 p -70.1 66.44 0.27 Allowed 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.6 0.714 . . . . 0.0 110.365 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.618 HG12 ' CE1' ' A' ' 81' ' ' TYR . 0.4 OUTLIER -124.94 120.36 25.49 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 121.173 -0.954 . . . . 0.0 108.79 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -62.91 -27.5 74.76 Favored 'Trans proline' 0 N--CA 1.488 1.189 0 C-N-CA 122.955 2.436 . . . . 0.0 113.679 -177.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.618 ' CE1' HG12 ' A' ' 79' ' ' ILE . 12.9 p90 -89.59 130.12 35.94 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.794 -1.191 . . . . 0.0 111.063 -178.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.1 p -102.68 155.51 18.26 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-O 121.738 0.78 . . . . 0.0 110.655 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.607 HD12 ' N ' ' A' ' 83' ' ' ILE . 2.0 mp -86.92 85.21 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.412 ' O ' ' HB ' ' A' ' 85' ' ' THR . 59.5 p -114.39 13.79 17.8 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.526 -0.734 . . . . 0.0 111.866 -178.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.445 HG23 ' HA ' ' A' ' 58' ' ' ALA . 86.0 m 68.78 -56.82 0.52 Allowed 'General case' 0 N--CA 1.51 2.567 0 O-C-N 121.211 -0.93 . . . . 0.0 108.86 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.402 ' N ' ' O ' ' A' ' 84' ' ' SER . 42.0 m -68.43 -25.6 65.1 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.289 -0.882 . . . . 0.0 109.167 178.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 94.4 m -38.48 140.92 0.29 Allowed 'General case' 0 N--CA 1.506 2.339 0 CA-C-O 121.362 0.601 . . . . 0.0 110.697 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -85.3 139.9 31.24 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.594 -0.691 . . . . 0.0 110.56 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.419 ' SG ' ' N ' ' A' ' 51' ' ' ASN . 0.5 OUTLIER -122.73 56.26 1.15 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-O 121.934 0.873 . . . . 0.0 110.61 176.448 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 4.1 m -151.34 -41.15 0.12 Allowed 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.092 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.06 -1.09 37.8 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.264 -0.897 . . . . 0.0 110.311 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 62.9 t -73.26 136.51 25.31 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 O-C-N 121.049 -1.032 . . . . 0.0 109.714 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.705 ' HA ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 114.0 -2.905 . . . . 0.0 110.05 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.86 0 CA-C-O 121.291 0.567 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.777 ' CD1' ' HB2' ' A' ' 49' ' ' ALA . 1.3 pp -90.49 101.81 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.429 ' O ' ' HG3' ' A' ' 6' ' ' GLN . 27.7 t -96.13 -167.73 1.63 Allowed 'General case' 0 N--CA 1.503 2.211 0 O-C-N 120.894 -1.129 . . . . 0.0 111.199 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 33.5 t -74.96 -29.05 60.81 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -54.5 -50.57 56.46 Favored Glycine 0 N--CA 1.504 3.226 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 177.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.468 ' CD ' ' HB2' ' A' ' 36' ' ' LEU . 0.5 OUTLIER -66.67 -34.93 78.95 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.486 -1.009 . . . . 0.0 109.415 179.111 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.507 ' HB ' ' SG ' ' A' ' 52' ' ' CYS . 61.6 t -59.05 -38.27 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 177.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.511 ' HA ' HG13 ' A' ' 11' ' ' ILE . . . -68.97 -34.84 75.97 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.56 -16.36 63.84 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.531 -0.731 . . . . 0.0 109.573 178.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.698 ' HB1' HG22 ' A' ' 33' ' ' VAL . . . -94.11 -31.84 14.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.505 -0.747 . . . . 0.0 110.145 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.532 HD12 ' N ' ' A' ' 12' ' ' ALA . 2.4 pp -95.18 -30.79 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 O-C-N 121.31 -0.869 . . . . 0.0 111.443 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.574 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -50.87 -52.84 53.69 Favored Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.133 -0.979 . . . . 0.0 110.449 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.574 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 71.5 Cg_endo -73.46 -10.05 23.48 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.405 2.07 . . . . 0.0 111.019 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.634 ' SG ' ' HB3' ' A' ' 25' ' ' PRO . 15.6 m -124.61 21.0 8.56 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.56 ' CD1' HG13 ' A' ' 60' ' ' VAL . 0.4 OUTLIER -67.04 -50.69 61.77 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.548 -179.129 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.494 ' HA ' ' HB3' ' A' ' 19' ' ' ARG . 20.2 m -62.48 -46.91 86.34 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.278 -0.889 . . . . 0.0 110.091 -178.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.608 ' CD2' HG12 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -59.31 -56.14 25.92 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.96 -28.21 64.13 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.494 ' HB3' ' HA ' ' A' ' 16' ' ' SER . 0.0 OUTLIER -75.09 -5.21 42.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.904 -0.497 . . . . 0.0 110.568 179.153 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.04 -5.73 27.2 Favored Glycine 0 N--CA 1.5 2.953 0 O-C-N 120.599 -1.313 . . . . 0.0 111.846 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.46 97.52 3.71 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 118.991 1.395 . . . . 0.0 110.091 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.449 ' HA3' ' CB ' ' A' ' 17' ' ' TYR . . . -153.54 -66.28 0.01 OUTLIER Glycine 0 N--CA 1.495 2.63 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 27.7 t 58.65 43.64 18.62 Favored 'General case' 0 N--CA 1.506 2.355 0 O-C-N 121.507 -0.996 . . . . 0.0 109.037 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 132.37 95.31 0.61 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 107.977 -2.049 . . . . 0.0 107.977 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.634 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 17.1 Cg_exo -59.95 -78.82 0.01 OUTLIER 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 122.381 2.054 . . . . 0.0 111.089 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' A' ' 25' ' ' PRO . 10.8 t 161.83 149.79 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.581 -0.7 . . . . 0.0 109.635 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.35 -36.69 78.6 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.93 -45.01 87.41 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 179.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.61 ' O ' HG23 ' A' ' 33' ' ' VAL . 35.3 t -64.63 -52.42 57.54 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.655 -1.218 . . . . 0.0 109.638 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 83.4 m -59.18 -46.94 87.08 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.5 m -68.89 -50.12 52.37 Favored 'General case' 0 N--CA 1.506 2.36 0 O-C-N 124.119 0.887 . . . . 0.0 110.468 176.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.55 -54.76 33.82 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.698 HG22 ' HB1' ' A' ' 10' ' ' ALA . 38.3 t -60.61 -47.27 93.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.972 -0.722 . . . . 0.0 109.241 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.549 ' O ' ' HB2' ' A' ' 38' ' ' ASN . 0.0 OUTLIER -56.34 -31.2 63.51 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 178.41 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.1 m -80.23 -55.12 5.14 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.778 -0.576 . . . . 0.0 109.647 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.539 ' CG ' ' HA ' ' A' ' 33' ' ' VAL . 1.7 pp -58.37 -42.46 87.05 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.254 -0.904 . . . . 0.0 109.133 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.547 ' HB3' HG13 ' A' ' 77' ' ' VAL . 18.4 m120 -70.92 -20.14 62.51 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.449 -0.782 . . . . 0.0 109.194 177.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.549 ' HB2' ' O ' ' A' ' 34' ' ' ARG . 52.1 t30 -67.69 -37.52 82.4 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.474 ' HB3' HG22 ' A' ' 2' ' ' ILE . . . -84.15 -24.87 30.02 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.96 -0.462 . . . . 0.0 110.89 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.577 ' N ' HG21 ' A' ' 2' ' ' ILE . . . -82.46 86.88 6.68 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.117 -0.99 . . . . 0.0 110.104 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.618 ' HA ' ' NE ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -152.55 38.19 0.54 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.121 -0.987 . . . . 0.0 110.314 -179.713 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.472 ' O ' ' N ' ' A' ' 44' ' ' ALA . 12.4 p -139.08 35.57 2.12 Favored 'General case' 0 N--CA 1.507 2.402 0 O-C-N 120.935 -1.103 . . . . 0.0 110.805 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.627 HG22 ' HB3' ' A' ' 93' ' ' ASN . 1.1 p 65.19 -60.92 0.24 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.424 -0.798 . . . . 0.0 109.6 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.472 ' N ' ' O ' ' A' ' 42' ' ' THR . . . -58.72 -58.16 9.83 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.56 ' O ' HD11 ' A' ' 2' ' ' ILE . 21.8 m-20 -66.1 -45.21 82.01 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.835 0.826 . . . . 0.0 108.83 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.67 ' HG2' HG12 ' A' ' 92' ' ' VAL . 1.8 tpp180 -59.63 -57.63 12.1 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.752 -0.593 . . . . 0.0 110.95 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 -61.6 -38.69 88.54 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.282 -0.886 . . . . 0.0 109.986 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.13 -50.79 70.11 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.777 ' HB2' ' CD1' ' A' ' 2' ' ' ILE . . . -62.4 -46.68 87.49 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.489 ' C ' ' SG ' ' A' ' 89' ' ' CYS . 42.9 t -55.12 -42.19 72.66 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.998 -0.439 . . . . 0.0 111.05 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -67.69 -60.45 2.53 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 124.117 0.885 . . . . 0.0 110.206 178.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.507 ' SG ' ' HB ' ' A' ' 7' ' ' VAL . 10.8 t -55.36 -29.33 58.2 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 119.637 -0.825 . . . . 0.0 111.05 178.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.665 HD22 HG13 ' A' ' 83' ' ' ILE . 15.8 mt -70.44 -50.65 36.14 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.13 175.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.5 tttm -56.67 -41.03 76.56 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -56.34 -46.19 80.05 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.05 -41.01 62.42 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.558 -0.714 . . . . 0.0 109.238 179.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.618 ' HA ' HD13 ' A' ' 63' ' ' LEU . . . -52.92 -43.74 66.47 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.664 -0.647 . . . . 0.0 109.963 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -90.05 18.2 6.09 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.293 -0.879 . . . . 0.0 110.133 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -127.95 -31.48 0.69 Allowed Glycine 0 N--CA 1.501 2.969 0 N-CA-C 110.098 -1.201 . . . . 0.0 110.098 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.56 HG13 ' CD1' ' A' ' 15' ' ' ILE . 7.6 t -52.87 135.34 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.54 -0.977 . . . . 0.0 110.272 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.7 t -64.12 107.68 1.35 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.596 -0.69 . . . . 0.0 109.191 179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.93 50.09 43.47 Favored Glycine 0 N--CA 1.499 2.88 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.618 HD13 ' HA ' ' A' ' 57' ' ' ALA . 4.0 tp -61.41 126.31 26.89 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.369 -1.077 . . . . 0.0 110.372 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -103.48 93.48 4.97 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -41.49 -46.21 3.42 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.853 -0.53 . . . . 0.0 110.691 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.06 -31.34 48.27 Favored Glycine 0 N--CA 1.502 3.064 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.448 ' O ' HG13 ' A' ' 71' ' ' ILE . 95.4 m-20 -94.59 -49.5 5.61 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.464 -1.021 . . . . 0.0 109.257 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.444 ' HB1' ' CG2' ' A' ' 83' ' ' ILE . . . -57.88 -34.26 69.59 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.702 -0.624 . . . . 0.0 111.049 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.581 ' HA ' ' HB ' ' A' ' 82' ' ' THR . . . -83.79 -47.76 10.79 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.945 -1.097 . . . . 0.0 109.934 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.6 p -68.66 -36.78 78.99 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.537 -0.727 . . . . 0.0 110.984 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.608 HG12 ' CD2' ' A' ' 17' ' ' TYR . 22.4 mt -46.07 -62.44 1.84 Allowed Pre-proline 0 N--CA 1.504 2.271 0 O-C-N 121.436 -0.79 . . . . 0.0 110.584 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.499 ' HG3' HD13 ' A' ' 83' ' ' ILE . 37.9 Cg_endo -62.35 -52.62 2.45 Favored 'Trans proline' 0 C--N 1.321 -0.869 0 C-N-CA 121.907 1.738 . . . . 0.0 110.048 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.6 m -52.46 -60.81 2.78 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.518 -0.739 . . . . 0.0 110.183 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -61.41 -44.65 96.78 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.414 ' HB2' ' O ' ' A' ' 71' ' ' ILE . 0.9 OUTLIER -47.56 -32.78 5.74 Favored 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.554 -0.716 . . . . 0.0 111.264 178.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.54 ' O ' ' HD3' ' A' ' 34' ' ' ARG . . . 126.55 41.47 0.32 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 177.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.68 HG12 ' HB ' ' A' ' 79' ' ' ILE . 12.8 t -92.43 -32.95 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.295 -1.121 . . . . 0.0 110.851 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.8 m 45.25 58.82 3.87 Favored 'General case' 0 N--CA 1.505 2.307 0 O-C-N 121.536 -0.728 . . . . 0.0 109.435 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.68 ' HB ' HG12 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -140.8 136.71 16.51 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 121.443 -0.786 . . . . 0.0 109.449 -178.683 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 79' ' ' ILE . 29.2 Cg_exo -58.76 -43.97 39.92 Favored 'Trans proline' 0 C--N 1.318 -1.054 0 C-N-CA 122.842 2.361 . . . . 0.0 112.184 -178.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.483 ' CD1' ' HG3' ' A' ' 46' ' ' ARG . 42.7 p90 -79.7 134.28 36.39 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 122.026 0.917 . . . . 0.0 109.988 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.581 ' HB ' ' HA ' ' A' ' 69' ' ' ALA . 32.4 p -123.21 -175.84 3.28 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.363 0.601 . . . . 0.0 109.916 -178.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.665 HG13 HD22 ' A' ' 53' ' ' LEU . 0.3 OUTLIER -84.48 59.27 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 178.553 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.438 ' O ' ' HB ' ' A' ' 87' ' ' THR . 1.6 p -102.2 136.13 42.57 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.972 -177.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 17.9 p -61.66 -56.01 24.41 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.514 -0.741 . . . . 0.0 109.014 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 55.9 p -93.32 53.53 1.93 Allowed 'General case' 0 N--CA 1.5 2.038 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.491 ' CG2' ' SG ' ' A' ' 89' ' ' CYS . 2.4 t -75.7 -170.96 1.42 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.518 -0.739 . . . . 0.0 110.867 -179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.483 ' N ' HG23 ' A' ' 87' ' ' THR . 22.8 t70 -83.13 -71.74 0.48 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.305 -0.872 . . . . 0.0 109.99 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.491 ' SG ' ' CG2' ' A' ' 87' ' ' THR . 85.1 m 52.19 51.52 16.16 Favored 'General case' 0 N--CA 1.5 2.062 0 CA-C-O 121.274 0.559 . . . . 0.0 112.228 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.2 t -170.12 -49.24 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.492 -178.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -99.54 -22.2 15.58 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.527 -0.733 . . . . 0.0 110.865 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.67 HG12 ' HG2' ' A' ' 46' ' ' ARG . 21.5 t -59.09 138.32 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.001 -1.062 . . . . 0.0 110.065 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.627 ' HB3' HG22 ' A' ' 43' ' ' THR . 61.8 m-20 . . . . . 0 N--CA 1.496 1.852 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.757 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.86 HD11 ' HB2' ' A' ' 49' ' ' ALA . 0.9 OUTLIER -117.58 85.5 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 CA-C-O 121.988 0.899 . . . . 0.0 109.272 179.852 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 41.0 t -146.97 171.22 15.58 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.224 -0.922 . . . . 0.0 110.846 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -56.4 -35.96 68.37 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -58.52 -42.11 95.79 Favored Glycine 0 N--CA 1.502 3.037 0 N-CA-C 109.836 -1.306 . . . . 0.0 109.836 175.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.63 HE21 HD13 ' A' ' 36' ' ' LEU . 0.8 OUTLIER -79.83 -41.43 26.39 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.574 -0.956 . . . . 0.0 109.168 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 77.0 t -56.33 -42.44 74.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.442 ' O ' HD13 ' A' ' 11' ' ' ILE . . . -69.66 -36.27 75.9 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 20.2 t -69.35 -21.24 63.83 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.315 -0.866 . . . . 0.0 108.973 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.464 ' HB2' ' CD2' ' A' ' 36' ' ' LEU . . . -73.49 -52.26 14.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.437 -0.789 . . . . 0.0 110.651 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.443 HD13 ' N ' ' A' ' 12' ' ' ALA . 0.0 OUTLIER -80.54 -20.21 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 121.184 -0.948 . . . . 0.0 110.978 -178.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.565 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -45.5 -55.36 12.28 Favored Pre-proline 0 N--CA 1.503 2.217 0 O-C-N 121.262 -0.899 . . . . 0.0 110.385 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.565 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 64.4 Cg_endo -70.49 -21.95 29.39 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.251 1.968 . . . . 0.0 110.994 179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.544 ' SG ' ' CG2' ' A' ' 71' ' ' ILE . 1.1 m -111.73 27.99 9.16 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.509 HD11 HG13 ' A' ' 60' ' ' VAL . 0.3 OUTLIER -63.24 -44.92 99.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 177.208 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.72 -53.83 50.72 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.392 -0.817 . . . . 0.0 108.807 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.591 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 0.5 OUTLIER -53.77 -60.66 3.02 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.662 -0.648 . . . . 0.0 109.566 178.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.642 ' N ' HD11 ' A' ' 71' ' ' ILE . . . -60.1 -31.92 70.49 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.612 -0.68 . . . . 0.0 111.084 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.464 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 9.5 tmm_? -83.84 18.49 1.99 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.453 -0.779 . . . . 0.0 111.602 -178.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.49 14.65 75.65 Favored Glycine 0 N--CA 1.503 3.137 0 O-C-N 120.541 -1.349 . . . . 0.0 112.032 178.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.591 ' O ' ' HA ' ' A' ' 17' ' ' TYR . 1.6 mm-40 -124.8 -176.7 3.61 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.113 -1.228 . . . . 0.0 109.92 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.08 -62.1 0.54 Allowed Glycine 0 N--CA 1.504 3.171 0 O-C-N 121.096 -1.003 . . . . 0.0 110.992 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 76.16 -51.82 0.61 Allowed 'General case' 0 N--CA 1.508 2.461 0 O-C-N 121.557 -0.967 . . . . 0.0 110.372 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.5 134.28 12.46 Favored Glycine 0 N--CA 1.501 2.974 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.43 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 27.6 Cg_endo -62.38 134.3 47.64 Favored 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 122.394 2.063 . . . . 0.0 111.017 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 t -79.93 134.56 36.28 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.299 -0.875 . . . . 0.0 109.407 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.28 -50.11 72.32 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.367 -0.833 . . . . 0.0 109.112 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.26 -46.17 94.76 Favored Glycine 0 N--CA 1.497 2.735 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.496 ' O ' HG23 ' A' ' 33' ' ' VAL . 8.5 t -56.79 -39.68 74.54 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.994 178.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.43 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 82.0 m -71.22 -44.81 64.62 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.597 -175.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 46.7 t -65.65 -40.01 92.0 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 124.048 0.842 . . . . 0.0 109.916 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.76 -60.3 6.29 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.612 HG11 ' HB3' ' A' ' 72' ' ' PRO . 17.3 t -59.38 -47.85 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.581 -0.952 . . . . 0.0 110.946 -179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.629 ' HA ' HG22 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -57.94 -26.87 62.81 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.237 -0.914 . . . . 0.0 109.537 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.0 m -86.12 -51.07 6.54 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.394 -0.816 . . . . 0.0 109.697 179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.63 HD13 HE21 ' A' ' 6' ' ' GLN . 2.7 pp -60.69 -49.2 78.47 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.676 -0.64 . . . . 0.0 110.51 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.595 ' N ' HD12 ' A' ' 36' ' ' LEU . 2.6 m-80 -66.83 -32.55 73.9 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.1 -1.0 . . . . 0.0 108.696 179.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.528 ' HA ' ' HD2' ' A' ' 41' ' ' ARG . 10.0 t30 -63.79 -38.96 93.07 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.48 -30.37 71.4 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.573 ' HB2' HD13 ' A' ' 2' ' ' ILE . . . -94.16 88.46 5.63 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.508 -0.745 . . . . 0.0 109.82 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.528 ' HD2' ' HA ' ' A' ' 38' ' ' ASN . 0.1 OUTLIER -143.1 20.49 1.93 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.937 -1.102 . . . . 0.0 111.922 -179.653 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.421 ' O ' ' HB ' ' A' ' 43' ' ' THR . 2.4 m -115.55 31.96 6.38 Favored 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.817 -1.177 . . . . 0.0 109.939 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.589 HG23 ' HA ' ' A' ' 93' ' ' ASN . 58.0 m 69.63 -61.54 0.44 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.456 -0.777 . . . . 0.0 109.297 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.24 -45.56 72.38 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.528 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 8.9 m-20 -73.44 -39.69 64.78 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.489 ' HG3' ' CE1' ' A' ' 81' ' ' TYR . 0.3 OUTLIER -65.14 -47.13 78.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.901 -0.499 . . . . 0.0 111.552 -178.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.402 ' NE ' ' O ' ' A' ' 90' ' ' SER . 51.9 mtt180 -65.49 -40.67 93.34 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.009 -1.057 . . . . 0.0 109.517 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.89 -43.19 99.36 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.86 ' HB2' HD11 ' A' ' 2' ' ' ILE 0.268 . . -65.15 -49.69 68.88 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.234 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.495 ' C ' ' SG ' ' A' ' 89' ' ' CYS . 50.2 t -55.26 -40.73 71.3 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.289 -0.882 . . . . 0.0 110.126 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.6 ' O ' ' HG3' ' A' ' 54' ' ' LYS . 1.8 t30 -62.69 -53.41 54.87 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 124.035 0.834 . . . . 0.0 110.481 177.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.9 t -72.2 -20.01 61.64 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.817 -1.153 . . . . 0.0 111.609 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.528 HD13 ' CG1' ' A' ' 83' ' ' ILE . 18.1 mt -68.85 -57.86 4.98 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 124.092 0.87 . . . . 0.0 109.012 175.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.6 ' HG3' ' O ' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -57.17 -28.79 63.11 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 178.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.63 -45.33 53.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.688 -0.632 . . . . 0.0 109.569 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -69.98 -49.84 47.6 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.418 -0.801 . . . . 0.0 109.75 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.419 ' O ' HD13 ' A' ' 63' ' ' LEU . . . -59.74 -62.23 2.03 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.439 -0.788 . . . . 0.0 109.334 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.634 ' HA ' HD13 ' A' ' 63' ' ' LEU . . . -70.75 77.28 0.61 Allowed 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.73 -16.21 0.94 Allowed Glycine 0 N--CA 1.497 2.749 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.509 HG13 HD11 ' A' ' 15' ' ' ILE . 0.9 OUTLIER -47.7 -58.58 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.385 0 CA-C-N 118.54 1.17 . . . . 0.0 110.477 -179.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.478 ' N ' HG12 ' A' ' 60' ' ' VAL . 1.5 m 162.79 -62.74 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.513 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -128.28 46.97 1.05 Allowed Glycine 0 N--CA 1.498 2.784 0 N-CA-C 107.462 -2.255 . . . . 0.0 107.462 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.634 HD13 ' HA ' ' A' ' 58' ' ' ALA . 2.5 pt? -50.54 129.48 22.36 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.883 0.849 . . . . 0.0 111.431 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.532 ' HB2' ' HB2' ' A' ' 67' ' ' ASN . 1.6 m-80 -109.27 103.14 12.04 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -36.06 -57.48 0.7 Allowed 'General case' 0 N--CA 1.506 2.349 0 O-C-N 122.028 -0.42 . . . . 0.0 111.775 -178.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -64.23 -52.41 44.34 Favored Glycine 0 N--CA 1.502 3.074 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.532 ' HB2' ' HB2' ' A' ' 64' ' ' ASN . 2.9 m120 -54.9 -45.39 74.71 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.669 -0.9 . . . . 0.0 110.626 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.536 ' O ' ' HD2' ' A' ' 72' ' ' PRO . . . -55.45 -55.42 31.97 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.783 -0.573 . . . . 0.0 110.252 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.705 ' HB1' HG22 ' A' ' 82' ' ' THR . . . -70.66 -36.98 73.65 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.476 -0.765 . . . . 0.0 110.784 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.5 t -62.12 -28.07 69.37 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.361 -0.837 . . . . 0.0 111.087 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.642 HD11 ' N ' ' A' ' 18' ' ' ALA . 38.4 mt -61.36 -69.67 0.55 Allowed Pre-proline 0 N--CA 1.502 2.15 0 O-C-N 121.243 -0.911 . . . . 0.0 111.442 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.612 ' HB3' HG11 ' A' ' 33' ' ' VAL . 19.5 Cg_endo -58.81 -50.27 9.54 Favored 'Trans proline' 0 N--CA 1.481 0.787 0 C-N-CA 122.141 1.894 . . . . 0.0 110.929 -178.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.0 m -48.51 -70.91 0.08 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 122.099 -0.376 . . . . 0.0 110.478 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 27.9 mtmm -60.33 -43.14 96.68 Favored 'General case' 0 N--CA 1.503 2.214 0 CA-C-N 116.965 -0.107 . . . . 0.0 110.746 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 1.5 m -45.48 -35.98 4.17 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.823 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 34' ' ' ARG . . . 122.37 49.88 0.24 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 175.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.629 HG22 ' HA ' ' A' ' 34' ' ' ARG . 90.6 t -90.07 -27.66 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 C-N-CA 118.365 -1.334 . . . . 0.0 112.029 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 77' ' ' VAL . 24.9 p 65.47 16.75 10.67 Favored 'General case' 0 N--CA 1.51 2.56 0 O-C-N 121.103 -0.998 . . . . 0.0 110.564 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.563 ' HB ' HG12 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -89.06 124.75 64.26 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.008 -1.058 . . . . 0.0 108.504 179.341 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.456 ' HD2' ' NH1' ' A' ' 46' ' ' ARG . 37.7 Cg_endo -63.23 -35.86 60.72 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 122.519 2.146 . . . . 0.0 112.214 -178.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.489 ' CE1' ' HG3' ' A' ' 46' ' ' ARG . 17.9 p90 -82.65 142.15 31.93 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.098 -1.001 . . . . 0.0 110.515 -179.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.705 HG22 ' HB1' ' A' ' 69' ' ' ALA . 0.1 OUTLIER -96.38 150.65 20.35 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.489 -0.757 . . . . 0.0 110.633 -178.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.528 ' CG1' HD13 ' A' ' 53' ' ' LEU . 4.4 mp -99.71 128.91 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.428 -0.795 . . . . 0.0 109.196 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 62.4 p -150.61 -85.3 0.08 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.236 -0.915 . . . . 0.0 110.379 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.8 p -152.62 -61.11 0.15 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.588 -0.695 . . . . 0.0 109.486 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.6 t -109.5 59.83 0.6 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.617 -0.677 . . . . 0.0 110.088 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 17.5 m -75.28 164.5 26.38 Favored 'General case' 0 N--CA 1.503 2.179 0 O-C-N 121.345 -0.847 . . . . 0.0 109.116 179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -83.83 80.19 9.23 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.95 -1.094 . . . . 0.0 110.172 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.495 ' SG ' ' C ' ' A' ' 50' ' ' CYS . 14.9 m -82.55 53.31 2.3 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.119 176.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.402 ' O ' ' NE ' ' A' ' 47' ' ' ARG . 41.4 t -144.98 -50.66 0.26 Allowed 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.024 -177.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -99.5 -23.82 14.97 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.331 -0.855 . . . . 0.0 110.414 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 54.2 t -49.54 142.09 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 O-C-N 121.402 -0.811 . . . . 0.0 111.038 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.589 ' HA ' HG23 ' A' ' 43' ' ' THR . 33.4 m-80 . . . . . 0 N--CA 1.5 2.073 0 CA-C-O 117.039 -1.458 . . . . 0.0 109.134 178.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.832 0 CA-C-O 121.088 0.47 . . . . 0.0 109.82 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.625 HD11 ' HB2' ' A' ' 49' ' ' ALA . 3.0 tp -128.23 77.02 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-O 121.723 0.773 . . . . 0.0 109.569 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.6 p -125.95 177.75 6.15 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.156 -0.965 . . . . 0.0 110.198 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.539 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 70.5 m -56.97 -19.17 16.67 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 119.879 -0.728 . . . . 0.0 112.467 177.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -61.58 -43.44 99.28 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.532 ' HA ' ' HB2' ' A' ' 9' ' ' SER . 0.0 OUTLIER -85.68 -35.04 21.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.432 -1.04 . . . . 0.0 108.824 178.603 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.539 ' HB ' ' HA ' ' A' ' 4' ' ' CYS . 58.7 t -54.7 -43.22 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 178.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.401 ' HA ' HG13 ' A' ' 11' ' ' ILE . . . -75.09 -37.68 61.45 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.532 ' HB2' ' HA ' ' A' ' 6' ' ' GLN . 69.0 m -69.61 -21.09 63.61 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.221 -0.924 . . . . 0.0 109.806 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.481 ' N ' ' O ' ' A' ' 6' ' ' GLN . . . -85.65 -30.29 23.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.428 -0.795 . . . . 0.0 109.629 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.497 HD12 ' N ' ' A' ' 12' ' ' ALA . 2.4 pp -96.57 -26.71 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.463 -0.773 . . . . 0.0 110.813 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.61 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -49.33 -53.45 39.66 Favored Pre-proline 0 N--CA 1.504 2.244 0 O-C-N 121.207 -0.933 . . . . 0.0 110.783 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.61 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 73.4 Cg_endo -72.78 -9.6 23.98 Favored 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 122.29 1.993 . . . . 0.0 110.969 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.7 m -117.41 6.33 12.62 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.525 ' O ' ' CB ' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -58.09 -50.43 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-N 118.109 0.413 . . . . 0.0 110.632 -178.606 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.414 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 0.1 OUTLIER -61.2 -63.49 1.27 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.952 -1.092 . . . . 0.0 109.618 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.569 ' CD2' HG12 ' A' ' 71' ' ' ILE . 1.1 t80 -51.66 -58.8 5.33 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.644 -0.66 . . . . 0.0 109.922 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.577 ' HB1' ' HB2' ' A' ' 68' ' ' ALA . . . -57.22 -29.25 63.59 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.603 -0.686 . . . . 0.0 110.556 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.525 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 9.1 tmm_? -89.93 8.67 31.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.368 -0.833 . . . . 0.0 110.944 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 104.28 1.1 44.32 Favored Glycine 0 N--CA 1.503 3.123 0 O-C-N 120.714 -1.241 . . . . 0.0 111.922 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -117.59 72.12 0.83 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.014 -1.286 . . . . 0.0 110.115 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.72 174.61 45.82 Favored Glycine 0 N--CA 1.498 2.793 0 C-N-CA 120.197 -1.001 . . . . 0.0 110.826 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 56.9 p -151.23 -60.8 0.18 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -97.83 126.77 8.99 Favored Glycine 0 N--CA 1.495 2.591 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.714 ' HB2' ' SG ' ' A' ' 75' ' ' CYS . 37.1 Cg_endo -62.49 125.45 16.23 Favored 'Trans proline' 0 C--N 1.316 -1.173 0 C-N-CA 122.393 2.062 . . . . 0.0 111.008 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.3 t -76.57 159.89 29.92 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.418 -0.801 . . . . 0.0 110.99 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.57 -41.44 76.92 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.644 -0.66 . . . . 0.0 110.552 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.62 -48.46 77.35 Favored Glycine 0 N--CA 1.503 3.127 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.55 ' SG ' ' CG2' ' A' ' 71' ' ' ILE . 42.4 t -58.3 -43.0 87.88 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.661 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.661 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 88.2 m -73.69 -35.18 65.15 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.154 -178.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 61.9 m -71.81 -40.7 68.99 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 124.533 1.146 . . . . 0.0 109.725 175.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.33 -51.75 57.29 Favored Glycine 0 N--CA 1.5 2.953 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.75 HG11 ' CB ' ' A' ' 72' ' ' PRO . 47.4 t -69.3 -45.69 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.441 -1.035 . . . . 0.0 109.125 178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.592 ' HA ' ' CG1' ' A' ' 77' ' ' VAL . 2.4 tpt180 -54.15 -28.42 39.89 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 109.001 -0.741 . . . . 0.0 109.001 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.4 m -73.76 -44.0 57.38 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.613 ' C ' HD12 ' A' ' 36' ' ' LEU . 0.5 OUTLIER -61.32 -33.94 74.43 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.409 -0.807 . . . . 0.0 109.771 179.338 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.538 ' HB2' HG12 ' A' ' 77' ' ' VAL . 0.6 OUTLIER -59.69 -32.68 70.72 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.299 -0.876 . . . . 0.0 110.015 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -88.71 -33.51 17.5 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.526 -0.734 . . . . 0.0 109.415 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.11 -32.29 22.87 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.506 -0.746 . . . . 0.0 110.878 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.586 ' HA ' ' CB ' ' A' ' 45' ' ' ASP . . . -111.47 101.52 9.94 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.169 -0.957 . . . . 0.0 110.474 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.541 ' CZ ' ' HB3' ' A' ' 41' ' ' ARG . 0.0 OUTLIER -161.06 20.27 0.12 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.402 -0.811 . . . . 0.0 111.692 179.59 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 44' ' ' ALA . 5.8 m -116.87 35.31 4.67 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.848 -1.158 . . . . 0.0 109.384 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 44.6 m 67.95 -59.82 0.42 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.595 -0.691 . . . . 0.0 109.649 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 42' ' ' THR . . . -57.35 -54.63 44.61 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.551 -0.718 . . . . 0.0 109.179 178.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.586 ' CB ' ' HA ' ' A' ' 40' ' ' ALA . 8.3 m-20 -55.61 -44.04 76.65 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 121.707 0.765 . . . . 0.0 109.199 179.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.502 ' NH1' HG13 ' A' ' 79' ' ' ILE . 0.5 OUTLIER -67.39 -47.12 71.25 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 116.172 -0.467 . . . . 0.0 109.978 -178.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 81.9 mtt180 -60.84 -48.58 81.16 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.5 -48.72 80.53 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.777 -0.577 . . . . 0.0 109.498 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.625 ' HB2' HD11 ' A' ' 2' ' ' ILE . . . -57.16 -46.37 82.8 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.476 ' SG ' HG22 ' A' ' 87' ' ' THR . 0.1 OUTLIER -63.86 -38.81 92.48 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 122.112 -0.368 . . . . 0.0 110.872 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.44 ' N ' ' SG ' ' A' ' 89' ' ' CYS . 2.2 t30 -60.01 -57.38 13.1 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 123.869 0.731 . . . . 0.0 109.701 176.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.459 ' HB3' HG21 ' A' ' 7' ' ' VAL . 12.9 t -66.76 -31.08 71.49 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 120.179 -0.608 . . . . 0.0 111.357 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.615 HD22 HG23 ' A' ' 83' ' ' ILE . 15.1 mt -64.01 -44.47 92.5 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 123.902 0.751 . . . . 0.0 109.446 175.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.0 mmmt -58.54 -41.18 84.98 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -64.18 -54.01 40.35 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.528 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -58.74 -43.39 90.2 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.643 -0.661 . . . . 0.0 109.608 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.545 ' HA ' HD13 ' A' ' 63' ' ' LEU . . . -60.55 -51.9 67.44 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.87 64.86 1.33 Allowed 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.455 ' O ' ' N ' ' A' ' 61' ' ' SER . . . 167.88 -22.48 0.1 Allowed Glycine 0 N--CA 1.499 2.879 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.202 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.607 ' O ' HG12 ' A' ' 60' ' ' VAL . 6.5 t -64.9 62.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 CA-C-N 118.699 1.25 . . . . 0.0 110.595 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.455 ' N ' ' O ' ' A' ' 59' ' ' GLY . 67.9 m 36.02 57.32 0.99 Allowed 'General case' 0 N--CA 1.507 2.409 0 O-C-N 121.309 -0.869 . . . . 0.0 111.888 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 76.76 57.81 3.69 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.545 HD13 ' HA ' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -56.94 132.04 51.51 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.677 -0.896 . . . . 0.0 110.463 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -96.7 89.78 5.06 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -39.54 -45.87 1.65 Allowed 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.907 -0.495 . . . . 0.0 111.021 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -51.7 -38.16 43.93 Favored Glycine 0 N--CA 1.503 3.136 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -83.7 -55.5 4.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.635 -0.921 . . . . 0.0 108.913 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.611 ' HB1' ' O ' ' A' ' 83' ' ' ILE . . . -55.72 -25.21 39.16 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.826 -0.546 . . . . 0.0 111.932 -178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.25 -49.27 6.82 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.949 -1.094 . . . . 0.0 109.818 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.04 -32.37 72.68 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.47 -0.769 . . . . 0.0 110.409 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.569 HG12 ' CD2' ' A' ' 17' ' ' TYR . 30.8 mt -52.07 -61.51 4.32 Favored Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 121.643 -0.66 . . . . 0.0 110.528 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.75 ' CB ' HG11 ' A' ' 33' ' ' VAL . 38.4 Cg_endo -61.88 -57.08 0.58 Allowed 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 122.028 1.819 . . . . 0.0 110.465 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.9 t -44.35 -63.64 0.84 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 120.681 0.277 . . . . 0.0 110.38 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -63.61 -39.1 93.52 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 122.034 -0.416 . . . . 0.0 109.982 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.714 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 0.8 OUTLIER -48.01 -35.04 10.28 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.823 -0.751 . . . . 0.0 112.092 -178.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.484 ' O ' ' HD2' ' A' ' 34' ' ' ARG . . . 137.7 44.53 0.08 OUTLIER Glycine 0 N--CA 1.496 2.659 0 C-N-CA 119.243 -1.456 . . . . 0.0 111.339 176.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.702 HG11 HG12 ' A' ' 33' ' ' VAL . 16.1 m -135.34 129.76 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 O-C-N 120.828 -1.395 . . . . 0.0 111.021 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 34.1 p -99.97 78.38 2.1 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.678 HD11 ' CE2' ' A' ' 81' ' ' TYR . 11.0 tt -132.38 128.41 21.14 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.514 -0.741 . . . . 0.0 109.723 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 79' ' ' ILE . 52.6 Cg_exo -54.77 -45.33 41.76 Favored 'Trans proline' 0 N--CA 1.484 0.936 0 C-N-CA 123.28 2.653 . . . . 0.0 112.736 -178.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.678 ' CE2' HD11 ' A' ' 79' ' ' ILE . 26.5 p90 -81.7 143.28 31.98 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.938 -1.101 . . . . 0.0 109.911 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 69.5 p -98.67 166.49 11.3 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-O 121.908 0.861 . . . . 0.0 110.692 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.615 HG23 HD22 ' A' ' 53' ' ' LEU . 1.5 mp -90.16 63.81 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 82.4 p -161.49 170.34 20.13 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.022 -1.049 . . . . 0.0 110.701 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 25.5 p -60.71 -30.0 69.69 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.575 -0.703 . . . . 0.0 109.748 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.0 t -82.49 79.74 8.84 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.476 HG22 ' SG ' ' A' ' 50' ' ' CYS . 0.6 OUTLIER -162.63 149.15 12.87 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.842 -179.37 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -91.77 154.65 18.79 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 122.18 0.991 . . . . 0.0 112.329 -178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 51' ' ' ASN . 1.2 m -137.03 53.4 1.89 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 114.675 -1.148 . . . . 0.0 110.142 176.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 95.8 p -159.3 -51.42 0.06 Allowed 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 119.514 -0.874 . . . . 0.0 110.355 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 4.0 mmm-85 -97.1 -6.78 34.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.223 -0.923 . . . . 0.0 109.245 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.1 t -70.48 119.73 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.391 -0.818 . . . . 0.0 109.231 179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.531 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 1.7 p30 . . . . . 0 N--CA 1.497 1.915 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.46 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.904 0 CA-C-O 121.518 0.675 . . . . 0.0 110.074 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.799 HD11 ' HB2' ' A' ' 36' ' ' LEU . 0.8 OUTLIER -103.97 101.9 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.391 -0.818 . . . . 0.0 108.927 179.76 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.0 t -118.19 167.19 11.73 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.305 -0.872 . . . . 0.0 111.504 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 1.3 m -63.94 -35.98 82.44 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -56.39 -51.49 55.88 Favored Glycine 0 N--CA 1.503 3.122 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 177.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.418 ' OE1' HD13 ' A' ' 2' ' ' ILE . 0.5 OUTLIER -67.23 -41.87 84.95 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.455 -1.026 . . . . 0.0 109.087 179.59 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.8 t -54.8 -46.14 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.36 -36.38 74.15 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.3 t -68.83 -20.53 64.3 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.318 -0.864 . . . . 0.0 110.099 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.39 -41.65 9.29 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.316 -0.865 . . . . 0.0 109.862 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.5 pp -79.98 -33.79 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 O-C-N 121.214 -0.929 . . . . 0.0 111.099 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.55 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -46.95 -51.76 37.69 Favored Pre-proline 0 N--CA 1.504 2.229 0 O-C-N 121.213 -0.929 . . . . 0.0 110.417 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 33.5 Cg_endo -65.89 -15.65 49.74 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.163 1.909 . . . . 0.0 110.831 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.664 ' SG ' HG21 ' A' ' 71' ' ' ILE . 1.3 m -114.14 18.94 16.8 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 176.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.422 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 0.3 OUTLIER -62.72 -49.58 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-N 118.16 0.437 . . . . 0.0 110.473 178.047 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 33.4 p -68.88 -49.27 59.66 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.429 -0.794 . . . . 0.0 109.323 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.697 ' CG ' HD11 ' A' ' 71' ' ' ILE . 0.4 OUTLIER -55.42 -54.3 45.46 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.084 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.597 ' HB1' ' HB2' ' A' ' 68' ' ' ALA . . . -60.69 -27.99 68.28 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.422 ' HB3' ' O ' ' A' ' 15' ' ' ILE . 1.3 tpt180 -82.46 -13.24 57.06 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.864 -0.522 . . . . 0.0 109.953 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 97.24 14.3 42.36 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -118.16 78.18 1.23 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.251 -1.146 . . . . 0.0 109.527 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 177.15 -151.68 11.33 Favored Glycine 0 N--CA 1.5 2.918 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 61.6 p -168.88 -58.71 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.632 -0.923 . . . . 0.0 109.511 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.74 145.98 17.95 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.64 152.09 82.74 Favored 'Trans proline' 0 C--N 1.318 -1.078 0 C-N-CA 122.536 2.158 . . . . 0.0 110.356 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.4 p -102.18 146.79 27.46 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.311 -0.868 . . . . 0.0 110.431 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.95 -47.08 71.67 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.793 -0.567 . . . . 0.0 110.848 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.79 -41.31 95.92 Favored Glycine 0 N--CA 1.502 3.037 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.401 ' HA ' ' HG2' ' A' ' 13' ' ' PRO . 42.1 t -61.64 -55.98 24.8 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.405 179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.414 ' O ' ' HG2' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -62.6 -39.59 94.25 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.955 -0.698 . . . . 0.0 111.735 -179.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.426 ' HA ' ' HG2' ' A' ' 34' ' ' ARG . 48.7 m -67.18 -50.76 59.83 Favored 'General case' 0 N--CA 1.504 2.269 0 O-C-N 123.932 0.77 . . . . 0.0 110.24 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.43 -47.33 91.67 Favored Glycine 0 N--CA 1.496 2.693 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.668 ' HA ' HD23 ' A' ' 36' ' ' LEU . 59.2 t -67.86 -53.07 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.773 -0.839 . . . . 0.0 110.891 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 76' ' ' GLY . 0.4 OUTLIER -56.04 -21.19 20.26 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.175 -0.953 . . . . 0.0 110.295 -179.569 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.8 p -81.32 -43.8 18.57 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.402 -0.811 . . . . 0.0 109.523 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.799 ' HB2' HD11 ' A' ' 2' ' ' ILE . 0.6 OUTLIER -55.85 -36.01 67.07 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.891 -0.506 . . . . 0.0 110.646 -179.411 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 76' ' ' GLY . 31.9 t30 -56.44 -49.55 74.24 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.323 -0.861 . . . . 0.0 109.821 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -81.36 -29.39 34.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.604 -0.685 . . . . 0.0 109.776 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.456 ' HB3' ' HA ' ' A' ' 36' ' ' LEU . . . -65.2 -26.9 68.34 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.697 -0.627 . . . . 0.0 110.451 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.78 ' HB2' HG12 ' A' ' 2' ' ' ILE . . . -139.92 -110.79 0.15 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.091 -1.005 . . . . 0.0 111.109 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.484 ' HA ' ' HD3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER 64.5 32.23 11.87 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.403 -0.811 . . . . 0.0 111.082 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.514 ' O ' ' HB ' ' A' ' 43' ' ' THR . 14.9 t -128.57 17.54 6.39 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 120.829 -1.169 . . . . 0.0 111.382 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.661 ' HA ' ' C ' ' A' ' 93' ' ' ASN . 86.5 m 84.8 -67.76 0.04 OUTLIER 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.696 -0.627 . . . . 0.0 109.799 -179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -48.49 -61.43 2.02 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.302 -0.874 . . . . 0.0 109.708 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.505 ' HB3' ' CB ' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -70.28 -36.55 74.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.682 -0.636 . . . . 0.0 109.367 179.321 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.484 ' HD3' ' HA ' ' A' ' 41' ' ' ARG . 5.8 mtm180 -59.28 -53.12 61.89 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 121.436 -0.79 . . . . 0.0 110.249 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.5 ' NH1' ' HA ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -54.12 -47.48 71.81 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.473 -0.767 . . . . 0.0 109.337 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 51' ' ' ASN . . . -58.91 -41.38 87.08 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.598 ' HB2' HG21 ' A' ' 2' ' ' ILE . . . -58.28 -48.32 80.83 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.498 ' C ' ' SG ' ' A' ' 89' ' ' CYS . 0.8 OUTLIER -55.4 -33.66 63.7 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.498 178.566 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.444 ' N ' ' SG ' ' A' ' 89' ' ' CYS . 1.3 t30 -65.56 -61.98 1.78 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 121.035 0.445 . . . . 0.0 110.056 177.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 4.6 t -63.49 -33.58 75.88 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.253 -0.979 . . . . 0.0 111.342 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.564 HD22 HG23 ' A' ' 83' ' ' ILE . 20.8 mt -68.4 -57.82 5.29 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.373 178.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.519 ' O ' ' HB3' ' A' ' 58' ' ' ALA . 24.6 tttp -57.9 -36.2 72.1 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.465 -0.772 . . . . 0.0 109.354 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.84 -39.05 87.63 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.474 -0.766 . . . . 0.0 110.606 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.476 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -94.39 -53.43 3.93 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.235 -0.916 . . . . 0.0 110.009 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.722 ' HB1' ' HA ' ' A' ' 84' ' ' SER . . . -60.09 -53.74 54.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.484 -0.76 . . . . 0.0 109.702 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 54' ' ' LYS . . . -80.79 63.18 5.1 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -179.52 -32.43 0.06 OUTLIER Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 56' ' ' ALA . 24.4 t -47.23 148.67 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 121.68 -0.894 . . . . 0.0 110.199 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.8 m -64.29 90.85 0.07 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.576 -0.702 . . . . 0.0 110.123 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.99 64.89 1.69 Allowed Glycine 0 N--CA 1.499 2.854 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.62 ' C ' HD13 ' A' ' 63' ' ' LEU . 3.0 tm? -74.68 118.73 17.97 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.667 -0.902 . . . . 0.0 109.791 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -94.52 85.36 4.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.274 -0.891 . . . . 0.0 108.726 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.522 ' HA ' ' HB2' ' A' ' 84' ' ' SER . . . -48.31 -37.95 17.74 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.858 -0.526 . . . . 0.0 110.719 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -53.97 -38.71 60.97 Favored Glycine 0 N--CA 1.502 3.099 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.8 m-20 -89.7 -45.38 9.36 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.478 -1.013 . . . . 0.0 109.961 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.597 ' HB2' ' HB1' ' A' ' 18' ' ' ALA . . . -71.74 -20.34 61.91 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.594 -0.691 . . . . 0.0 111.946 -178.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.23 -40.95 10.16 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.867 -1.146 . . . . 0.0 110.244 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 92.5 p -71.17 -43.27 67.8 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.57 -0.706 . . . . 0.0 110.847 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.697 HD11 ' CG ' ' A' ' 17' ' ' TYR . 87.0 mt -50.63 -64.59 1.23 Allowed Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.485 -0.76 . . . . 0.0 110.89 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.612 ' HG3' ' HB ' ' A' ' 83' ' ' ILE . 30.7 Cg_endo -59.74 -52.52 4.37 Favored 'Trans proline' 0 C--N 1.326 -0.636 0 C-N-CA 121.868 1.712 . . . . 0.0 110.773 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 47.2 t -38.5 -68.07 0.18 Allowed 'General case' 0 N--CA 1.502 2.161 0 O-C-N 122.271 -0.268 . . . . 0.0 110.62 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 17.4 pttt -70.38 -32.45 70.11 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.551 -0.718 . . . . 0.0 109.888 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.476 ' HB2' ' HA ' ' A' ' 72' ' ' PRO . 1.1 m -49.72 -47.57 50.49 Favored 'General case' 0 N--CA 1.507 2.399 0 O-C-N 121.27 -0.893 . . . . 0.0 111.985 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 37' ' ' ASN . . . 169.03 47.03 0.03 OUTLIER Glycine 0 N--CA 1.5 2.927 0 C-N-CA 118.365 -1.874 . . . . 0.0 111.527 175.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.473 HG12 ' HB2' ' A' ' 37' ' ' ASN . 0.3 OUTLIER -150.65 91.04 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.191 -1.182 . . . . 0.0 110.353 179.323 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.6 t -80.18 77.78 6.89 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.538 HD12 ' CZ ' ' A' ' 81' ' ' TYR . 3.3 pt -130.98 135.68 27.71 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.6 -0.687 . . . . 0.0 110.306 -178.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.475 ' HD2' ' NH1' ' A' ' 46' ' ' ARG . 77.4 Cg_exo -49.19 -43.2 37.86 Favored 'Trans proline' 0 N--CA 1.483 0.908 0 C-N-CA 122.682 2.255 . . . . 0.0 111.533 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.699 ' HB3' HG21 ' A' ' 92' ' ' VAL . 1.5 p90 -81.03 143.98 32.11 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.06 -1.025 . . . . 0.0 109.41 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 43.7 p -100.4 165.75 11.3 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.213 -0.929 . . . . 0.0 109.849 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.612 ' HB ' ' HG3' ' A' ' 72' ' ' PRO . 1.5 mp -89.93 62.91 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.722 ' HA ' ' HB1' ' A' ' 57' ' ' ALA . 80.5 p -158.68 -106.68 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.362 -0.836 . . . . 0.0 109.808 -178.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 23.5 p -122.4 -24.71 4.94 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.96 -1.088 . . . . 0.0 109.792 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.2 p -74.12 64.24 1.04 Allowed 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 178.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.526 HG23 ' HB2' ' A' ' 81' ' ' TYR . 13.1 m -162.43 128.71 3.53 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -125.73 138.46 53.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.244 -0.91 . . . . 0.0 110.762 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.5 ' HA ' ' NH1' ' A' ' 47' ' ' ARG . 89.4 m -90.9 57.89 3.65 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.267 -0.973 . . . . 0.0 111.473 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 30.3 t -155.42 -42.34 0.08 Allowed 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.865 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 1.8 mtm-85 -99.68 -37.01 9.29 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.28 -0.888 . . . . 0.0 110.332 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.699 HG21 ' HB3' ' A' ' 81' ' ' TYR . 1.2 t -60.69 158.74 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.271 0 O-C-N 121.451 -0.78 . . . . 0.0 111.254 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.661 ' C ' ' HA ' ' A' ' 43' ' ' THR . 58.9 m-80 . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 176.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 2' ' ' ILE . . . . . . . . 0 N--CA 1.5 2.064 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.813 HG13 ' HB2' ' A' ' 49' ' ' ALA . 10.4 tp 30.54 65.42 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 CA-C-O 121.803 0.811 . . . . 0.0 111.714 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.4 t -123.16 -74.88 0.6 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.134 -0.979 . . . . 0.0 109.931 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.7 t -151.51 -46.31 0.11 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -53.47 -44.11 66.84 Favored Glycine 0 N--CA 1.506 3.302 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 177.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.52 -41.99 23.26 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.304 -1.115 . . . . 0.0 108.452 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 91.5 t -54.1 -44.13 62.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.511 ' HA ' HG13 ' A' ' 11' ' ' ILE . . . -69.12 -34.82 75.65 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.8 m -71.37 -20.12 62.19 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.513 -0.742 . . . . 0.0 109.608 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.57 -35.45 10.61 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.275 -0.89 . . . . 0.0 109.923 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.511 HG13 ' HA ' ' A' ' 8' ' ' ALA . 2.6 pp -79.94 -33.61 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.254 -0.904 . . . . 0.0 110.54 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.55 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -47.85 -51.67 45.05 Favored Pre-proline 0 N--CA 1.503 2.187 0 O-C-N 121.28 -0.888 . . . . 0.0 110.206 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 31.0 Cg_endo -65.21 -12.22 33.77 Favored 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 122.238 1.959 . . . . 0.0 110.938 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.567 ' HB3' HD13 ' A' ' 71' ' ' ILE . 2.7 m -121.85 17.33 11.01 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 176.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.487 HD11 HG13 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -62.73 -50.1 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 C-N-CA 121.381 -0.128 . . . . 0.0 110.802 -179.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 21' ' ' GLN . 18.7 m -57.46 -46.84 83.19 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.338 -0.851 . . . . 0.0 109.33 179.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.538 ' CD2' HG12 ' A' ' 71' ' ' ILE . 0.9 OUTLIER -61.26 -62.0 2.15 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.787 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.591 ' N ' HD11 ' A' ' 71' ' ' ILE . . . -55.78 -35.46 66.28 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.153 -0.967 . . . . 0.0 110.436 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -73.85 -1.69 20.54 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.587 -0.696 . . . . 0.0 111.3 -179.151 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 87.88 21.24 47.39 Favored Glycine 0 N--CA 1.501 3.009 0 O-C-N 120.678 -1.264 . . . . 0.0 110.902 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.42 ' O ' ' HB3' ' A' ' 16' ' ' SER . 34.3 mm-40 -140.41 50.01 1.7 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.201 -1.176 . . . . 0.0 109.612 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -150.38 -64.75 0.01 OUTLIER Glycine 0 N--CA 1.501 2.975 0 O-C-N 121.019 -1.051 . . . . 0.0 110.833 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 71.8 -58.02 0.6 Allowed 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.642 -0.916 . . . . 0.0 109.485 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.59 112.06 3.64 Favored Glycine 0 N--CA 1.498 2.779 0 N-CA-C 108.859 -1.696 . . . . 0.0 108.859 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.75 173.63 12.36 Favored 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 122.611 2.207 . . . . 0.0 110.751 -179.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 24.1 p -110.25 134.93 51.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.57 -0.706 . . . . 0.0 109.362 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -45.99 -54.77 7.8 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.776 -0.578 . . . . 0.0 110.887 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.97 -39.43 89.29 Favored Glycine 0 N--CA 1.503 3.103 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.403 ' O ' HG23 ' A' ' 33' ' ' VAL . 44.1 t -63.55 -49.48 73.31 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 118.764 -1.174 . . . . 0.0 109.828 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.471 ' HA ' ' HB3' ' A' ' 75' ' ' CYS . 68.2 m -69.07 -42.99 75.47 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.483 -176.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.544 ' HA ' ' HG2' ' A' ' 34' ' ' ARG . 72.5 p -68.31 -47.26 68.03 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 124.355 1.034 . . . . 0.0 110.012 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -53.91 -55.19 27.01 Favored Glycine 0 N--CA 1.498 2.782 0 N-CA-C 109.899 -1.281 . . . . 0.0 109.899 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.6 HG12 HG21 ' A' ' 77' ' ' VAL . 17.4 t -63.81 -44.59 98.23 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.486 -1.008 . . . . 0.0 110.257 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.648 ' HA ' HG22 ' A' ' 77' ' ' VAL . 7.8 ptm180 -57.71 -22.61 47.38 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.111 -0.993 . . . . 0.0 109.694 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 45.1 t -92.65 -55.14 3.49 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.3 -0.875 . . . . 0.0 109.461 178.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.592 ' HG ' ' HA ' ' A' ' 33' ' ' VAL . 3.5 pp -58.25 -28.43 64.89 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.497 -0.752 . . . . 0.0 110.89 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.599 ' CB ' HG13 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -64.85 -42.69 94.69 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.945 -1.097 . . . . 0.0 108.719 179.523 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -63.5 -29.2 70.51 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.93 8.83 35.63 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.679 -0.638 . . . . 0.0 110.102 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.677 ' HB1' HG21 ' A' ' 2' ' ' ILE . . . -166.91 51.5 0.07 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.763 -1.21 . . . . 0.0 111.454 -179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.652 ' HD2' ' O ' ' A' ' 40' ' ' ALA . 2.3 mpt_? -135.27 44.7 2.55 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 121.527 -0.733 . . . . 0.0 109.596 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.7 m -95.38 -45.96 6.91 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.344 -0.847 . . . . 0.0 109.278 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 1.4 m 160.52 -51.48 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.453 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.73 -45.81 84.91 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 177.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.756 ' HB3' HG21 ' A' ' 2' ' ' ILE . 3.1 m-20 -63.69 -50.93 67.27 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.575 179.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.505 ' HD3' ' HG3' ' A' ' 41' ' ' ARG . 8.9 mtm180 -59.94 -39.07 84.29 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.738 -0.601 . . . . 0.0 109.792 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.54 ' HG2' ' NH1' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -62.2 -44.45 96.56 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.227 -0.92 . . . . 0.0 108.957 179.165 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.427 ' O ' ' HB3' ' A' ' 51' ' ' ASN . . . -66.55 -46.62 75.5 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.813 ' HB2' HG13 ' A' ' 2' ' ' ILE 0.252 . . -61.45 -55.36 32.18 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 178.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.54 ' HA ' ' HB2' ' A' ' 53' ' ' LEU . 12.0 t -48.23 -36.86 14.69 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 174.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.427 ' HB3' ' O ' ' A' ' 48' ' ' ALA . 1.7 t30 -58.55 -56.33 23.48 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 42.3 t -70.06 -31.12 68.57 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 118.388 -1.325 . . . . 0.0 111.621 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.84 HD22 HG23 ' A' ' 83' ' ' ILE . 75.5 mt -58.83 -48.61 80.72 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 124.101 0.876 . . . . 0.0 109.598 176.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.599 ' HD3' ' SG ' ' A' ' 89' ' ' CYS . 7.5 mtpp -61.12 -38.25 85.67 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 48.4 m-80 -65.71 -47.49 75.2 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.822 -0.548 . . . . 0.0 109.706 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.468 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -71.79 -44.75 63.46 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.416 -0.803 . . . . 0.0 109.977 -179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.53 -55.36 29.94 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.74 62.56 1.08 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.392 -0.818 . . . . 0.0 108.912 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.448 ' O ' ' N ' ' A' ' 61' ' ' SER . . . -179.75 -28.91 0.05 OUTLIER Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.737 -0.945 . . . . 0.0 110.737 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.619 ' O ' HG12 ' A' ' 60' ' ' VAL . 74.5 t -65.92 53.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.507 0 O-C-N 121.254 -1.145 . . . . 0.0 110.992 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 59' ' ' GLY . 56.5 p 49.12 -138.11 0.92 Allowed 'General case' 0 N--CA 1.504 2.244 0 O-C-N 120.6 -1.312 . . . . 0.0 110.093 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -85.96 71.65 2.82 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 108.496 -1.842 . . . . 0.0 108.496 179.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 1.8 pp -63.13 158.96 18.47 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 122.01 -0.7 . . . . 0.0 110.582 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -106.62 107.87 19.09 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -43.36 -55.22 4.21 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.743 -0.598 . . . . 0.0 110.152 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -57.69 -41.9 94.02 Favored Glycine 0 N--CA 1.498 2.799 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.473 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 3.2 m120 -60.31 -57.5 12.51 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.313 -1.11 . . . . 0.0 109.309 179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.518 ' O ' ' HD2' ' A' ' 72' ' ' PRO . . . -58.71 -41.19 85.75 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.788 -0.57 . . . . 0.0 110.173 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.666 ' HB2' ' HB ' ' A' ' 82' ' ' THR . . . -71.64 -46.01 60.33 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.313 -0.867 . . . . 0.0 110.235 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.424 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 94.1 p -61.16 -36.25 79.31 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.623 -0.673 . . . . 0.0 110.802 -179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.591 HD11 ' N ' ' A' ' 18' ' ' ALA . 18.7 mt -47.83 -74.23 0.08 OUTLIER Pre-proline 0 N--CA 1.502 2.155 0 O-C-N 121.611 -0.681 . . . . 0.0 111.364 -178.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.838 ' HB2' HD11 ' A' ' 79' ' ' ILE . 28.6 Cg_endo -58.82 -49.75 10.78 Favored 'Trans proline' 0 N--CA 1.481 0.779 0 C-N-CA 121.681 1.587 . . . . 0.0 111.499 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 61.4 p -51.66 -68.71 0.15 Allowed 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.525 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 70' ' ' SER . 7.4 pttt -64.25 -37.95 89.29 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.621 -0.674 . . . . 0.0 110.973 -179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.471 ' HB3' ' HA ' ' A' ' 30' ' ' CYS . 1.7 m -47.11 -35.54 7.22 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.325 -0.859 . . . . 0.0 111.888 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 134.79 40.84 0.16 Allowed Glycine 0 N--CA 1.495 2.623 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 177.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.648 HG22 ' HA ' ' A' ' 34' ' ' ARG . 4.0 t -131.16 106.89 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.521 -0.988 . . . . 0.0 109.313 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -71.53 73.4 0.75 Allowed 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.691 0.758 . . . . 0.0 109.716 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.838 HD11 ' HB2' ' A' ' 72' ' ' PRO . 0.8 OUTLIER -121.66 109.49 34.31 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.296 -0.877 . . . . 0.0 109.319 179.735 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.14 -23.58 45.45 Favored 'Trans proline' 0 N--CA 1.49 1.269 0 C-N-CA 123.105 2.537 . . . . 0.0 112.618 -179.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.685 ' HE1' HD12 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -82.43 171.13 14.51 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.378 -0.826 . . . . 0.0 109.922 -179.752 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.666 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 51.9 p -122.81 164.67 17.94 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.118 -0.989 . . . . 0.0 110.137 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.84 HG23 HD22 ' A' ' 53' ' ' LEU . 5.3 mm -93.24 40.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.88 162.41 15.85 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.384 0.611 . . . . 0.0 110.032 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 68.6 p -62.03 -33.17 73.88 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 178.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.5 p -70.22 64.95 0.26 Allowed 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.648 0.737 . . . . 0.0 109.439 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 1.6 m -168.08 155.22 8.01 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.345 -0.847 . . . . 0.0 109.0 -179.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -132.95 152.91 51.86 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.002 -1.061 . . . . 0.0 111.285 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.599 ' SG ' ' HD3' ' A' ' 54' ' ' LYS . 4.2 m -94.82 60.89 2.52 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.409 178.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 37.2 p -135.62 -51.5 0.74 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.551 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 74.2 mtt180 -98.78 5.91 47.22 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.647 -0.658 . . . . 0.0 110.792 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 94.3 t -82.84 106.33 13.54 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 120.997 -1.064 . . . . 0.0 108.785 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.8 m120 . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 117.053 -1.451 . . . . 0.0 109.32 -179.752 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.885 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.535 HG12 ' HB2' ' A' ' 40' ' ' ALA . 5.1 tp 37.98 43.99 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.48 0 CA-C-O 121.666 0.745 . . . . 0.0 111.37 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 5' ' ' GLY . 23.4 t -124.08 66.9 1.05 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.023 -1.048 . . . . 0.0 109.485 179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.0 t 62.8 -56.29 0.16 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 3' ' ' SER . . . -49.6 -43.91 37.3 Favored Glycine 0 N--CA 1.506 3.312 0 CA-C-N 119.458 1.026 . . . . 0.0 110.556 177.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.533 ' NE2' ' HB3' ' A' ' 36' ' ' LEU . 0.4 OUTLIER -78.99 -39.73 33.43 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.414 -1.051 . . . . 0.0 108.856 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 56.6 t -55.24 -46.6 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -72.64 -31.31 65.01 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.493 ' HB2' ' HA ' ' A' ' 6' ' ' GLN . 58.6 m -68.35 -22.12 64.69 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.132 -0.98 . . . . 0.0 109.463 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.77 -29.71 14.11 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.515 -0.741 . . . . 0.0 109.071 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.1 tp -82.83 -41.0 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.514 -0.741 . . . . 0.0 110.527 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.535 ' N ' ' HD2' ' A' ' 13' ' ' PRO . . . -42.42 -52.06 10.64 Favored Pre-proline 0 N--CA 1.504 2.268 0 O-C-N 121.757 -0.589 . . . . 0.0 111.399 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 12' ' ' ALA . 36.9 Cg_endo -64.23 -23.76 66.01 Favored 'Trans proline' 0 N--CA 1.484 0.923 0 C-N-CA 121.977 1.785 . . . . 0.0 110.386 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.584 ' SG ' HG21 ' A' ' 71' ' ' ILE . 1.4 m -109.36 19.37 19.43 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 176.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 16' ' ' SER . 0.4 OUTLIER -66.07 -50.24 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.86 177.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.426 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 51.4 p -55.73 -50.94 69.0 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.39 -0.818 . . . . 0.0 108.875 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.505 ' CG ' HD11 ' A' ' 71' ' ' ILE . 1.0 OUTLIER -57.29 -57.76 11.19 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 179.393 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.76 -5.99 18.92 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.58 -0.7 . . . . 0.0 110.172 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.8 ttt-85 -100.05 -18.01 17.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.406 -0.809 . . . . 0.0 109.999 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 133.8 -20.82 4.04 Favored Glycine 0 N--CA 1.503 3.108 0 O-C-N 120.859 -1.151 . . . . 0.0 111.577 179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -123.01 92.46 3.71 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.03 -1.277 . . . . 0.0 110.463 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.457 ' HA3' ' HA ' ' A' ' 17' ' ' TYR . . . -156.12 -60.18 0.01 OUTLIER Glycine 0 N--CA 1.504 3.176 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.3 p 73.91 -62.65 0.46 Allowed 'General case' 0 N--CA 1.507 2.409 0 O-C-N 122.061 -0.67 . . . . 0.0 111.278 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -114.82 139.44 15.59 Favored Glycine 0 N--CA 1.497 2.749 0 N-CA-C 110.476 -1.049 . . . . 0.0 110.476 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.01 173.14 9.77 Favored 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 122.552 2.168 . . . . 0.0 110.911 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 69.3 p -124.48 149.6 46.66 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.303 -0.873 . . . . 0.0 110.321 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -53.38 -45.62 69.32 Favored 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.608 -0.683 . . . . 0.0 110.115 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.16 -39.06 97.16 Favored Glycine 0 N--CA 1.5 2.931 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 40.2 t -66.43 -45.57 79.41 Favored 'General case' 0 N--CA 1.496 1.844 0 C-N-CA 119.016 -1.074 . . . . 0.0 110.589 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 88.7 m -71.36 -38.49 71.57 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.343 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.6 p -68.7 -39.81 80.32 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 124.166 0.916 . . . . 0.0 109.668 174.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.41 -52.98 38.78 Favored Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.677 HG11 ' CB ' ' A' ' 72' ' ' PRO . 43.2 t -62.5 -44.88 99.73 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.15 0 O-C-N 121.367 -1.079 . . . . 0.0 109.134 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.627 ' HA ' ' CG1' ' A' ' 77' ' ' VAL . 6.4 tpm_? -54.78 -32.39 60.01 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 69.5 m -75.17 -45.89 37.77 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.57 HD23 ' HA ' ' A' ' 33' ' ' VAL . 0.4 OUTLIER -62.99 -39.68 95.48 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.482 -0.761 . . . . 0.0 110.062 179.602 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.403 ' HB2' ' CG1' ' A' ' 77' ' ' VAL . 53.4 t30 -60.42 -42.35 95.86 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.326 -0.859 . . . . 0.0 109.684 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -64.1 -44.39 92.42 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.513 -0.742 . . . . 0.0 109.004 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.459 ' HB3' ' HB ' ' A' ' 2' ' ' ILE . . . -75.94 -50.3 15.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.777 -0.577 . . . . 0.0 110.349 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.535 ' HB2' HG12 ' A' ' 2' ' ' ILE . . . -74.35 59.43 0.79 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.058 -1.026 . . . . 0.0 109.792 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.62 ' HA ' ' HD3' ' A' ' 46' ' ' ARG . 7.0 mtt-85 -147.94 18.48 1.12 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.036 -1.04 . . . . 0.0 111.082 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.534 ' O ' ' HB ' ' A' ' 43' ' ' THR . 9.9 t -111.26 28.14 9.01 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.116 -0.99 . . . . 0.0 109.652 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.684 HG23 ' HB3' ' A' ' 93' ' ' ASN . 46.3 m 70.95 -61.77 0.47 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.76 -0.588 . . . . 0.0 110.127 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -52.48 -60.12 3.61 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.786 -0.571 . . . . 0.0 111.118 -179.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -72.54 -28.93 63.15 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.586 -0.696 . . . . 0.0 110.775 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.62 ' HD3' ' HA ' ' A' ' 41' ' ' ARG . 7.6 mmm-85 -53.13 -51.75 60.93 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.396 -0.815 . . . . 0.0 109.47 179.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.574 ' HD2' ' HB2' ' A' ' 93' ' ' ASN . 1.0 OUTLIER -62.12 -51.62 67.17 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.411 -0.805 . . . . 0.0 110.361 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.83 -44.74 90.95 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.63 -0.669 . . . . 0.0 109.733 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -60.52 -47.67 85.14 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.435 ' C ' ' SG ' ' A' ' 89' ' ' CYS . 37.9 t -59.37 -38.48 80.59 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 120.573 -0.451 . . . . 0.0 111.018 177.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.456 ' O ' ' HE2' ' A' ' 54' ' ' LYS . 1.9 t30 -64.46 -54.16 36.85 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 123.772 0.67 . . . . 0.0 109.596 176.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.437 ' HA ' ' ND2' ' A' ' 55' ' ' ASN . 39.3 t -63.65 -31.04 72.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.896 -1.127 . . . . 0.0 110.566 179.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.618 HD13 HG12 ' A' ' 83' ' ' ILE . 26.3 mt -63.67 -46.56 85.01 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 124.365 1.041 . . . . 0.0 109.008 175.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.456 ' HE2' ' O ' ' A' ' 51' ' ' ASN . 12.5 ttpt -55.04 -49.93 70.36 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.437 ' ND2' ' HA ' ' A' ' 52' ' ' CYS . 1.3 p30 -65.66 -33.61 76.3 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.247 -0.908 . . . . 0.0 109.489 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.45 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -66.92 -56.78 8.75 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.327 -0.858 . . . . 0.0 108.743 178.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.422 ' HB1' ' O ' ' A' ' 84' ' ' SER . . . -60.62 -56.9 15.74 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.572 -0.705 . . . . 0.0 109.167 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.9 66.45 1.15 Allowed 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.17 -28.05 0.1 OUTLIER Glycine 0 N--CA 1.501 3.014 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -178.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 56' ' ' ALA . 2.8 t -46.92 -21.92 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.736 -0.861 . . . . 0.0 111.06 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 60' ' ' VAL . 47.6 m 74.8 83.45 0.1 Allowed 'General case' 0 N--CA 1.505 2.296 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.82 36.82 7.61 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.566 HD13 ' O ' ' A' ' 84' ' ' SER . 3.7 pp -56.02 138.87 48.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.661 -0.905 . . . . 0.0 110.22 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -109.25 88.27 2.69 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -48.28 -41.8 28.93 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.654 -0.654 . . . . 0.0 109.983 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -52.3 -47.23 56.47 Favored Glycine 0 N--CA 1.501 2.999 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 30.7 m-20 -82.14 -50.2 9.3 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.568 -0.96 . . . . 0.0 109.262 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.422 ' O ' ' CD ' ' A' ' 72' ' ' PRO . . . -51.2 -43.0 61.27 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.996 -0.44 . . . . 0.0 111.987 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.75 -45.95 19.98 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.141 -0.975 . . . . 0.0 110.217 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.4 m -61.92 -43.47 98.78 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.618 -0.676 . . . . 0.0 110.619 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.584 HG21 ' SG ' ' A' ' 14' ' ' CYS . 44.0 mt -42.58 -64.3 0.74 Allowed Pre-proline 0 N--CA 1.504 2.273 0 O-C-N 121.864 -0.522 . . . . 0.0 111.109 -179.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.677 ' CB ' HG11 ' A' ' 33' ' ' VAL . 46.0 Cg_endo -62.69 -60.33 0.19 Allowed 'Trans proline' 0 C--N 1.322 -0.816 0 C-N-CA 122.124 1.882 . . . . 0.0 110.682 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.4 m -45.2 -61.22 1.74 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.942 -0.474 . . . . 0.0 109.919 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.87 -39.98 95.46 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . . . . . . . . . 1.2 m -50.11 -34.66 22.75 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 119.769 -0.772 . . . . 0.0 110.826 -178.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.465 ' O ' ' HD2' ' A' ' 34' ' ' ARG . . . 135.36 46.62 0.09 OUTLIER Glycine 0 N--CA 1.494 2.553 0 C-N-CA 119.584 -1.293 . . . . 0.0 111.344 175.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.64 HG11 HG12 ' A' ' 33' ' ' VAL . 16.4 m -135.57 126.47 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 CA-C-N 118.776 1.288 . . . . 0.0 111.084 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 28.3 p -99.92 70.96 1.63 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.366 0.603 . . . . 0.0 109.707 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.476 HD12 ' HD2' ' A' ' 80' ' ' PRO . 2.7 tp -92.97 138.24 23.41 Favored Pre-proline 0 N--CA 1.505 2.31 0 O-C-N 121.213 -0.929 . . . . 0.0 109.456 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.476 ' HD2' HD12 ' A' ' 79' ' ' ILE . 23.9 Cg_endo -59.49 -44.81 29.85 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 C-N-CA 122.38 2.053 . . . . 0.0 111.555 -179.417 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.454 ' HD2' HG11 ' A' ' 92' ' ' VAL . 22.3 p90 -94.6 135.98 35.43 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.014 -1.054 . . . . 0.0 110.906 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.1 m -91.91 163.12 14.14 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.618 HG12 HD13 ' A' ' 53' ' ' LEU . 4.5 mp -121.27 118.18 55.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.819 -1.175 . . . . 0.0 110.99 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.566 ' O ' HD13 ' A' ' 63' ' ' LEU . 2.5 t -123.47 -72.19 0.69 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.513 HG23 HD21 ' A' ' 63' ' ' LEU . 98.2 m -133.13 -69.32 0.56 Allowed 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.8 m -113.43 -24.46 9.29 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.492 HG22 ' N ' ' A' ' 88' ' ' ASP . 54.6 m 54.63 -100.18 0.1 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.801 -0.562 . . . . 0.0 110.806 179.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.492 ' N ' HG22 ' A' ' 87' ' ' THR . 20.7 t0 -157.97 -70.74 0.09 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.272 -0.893 . . . . 0.0 110.062 -179.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.435 ' SG ' ' C ' ' A' ' 50' ' ' CYS . 14.0 m 58.92 50.99 7.74 Favored 'General case' 0 N--CA 1.503 2.211 0 CA-C-O 121.339 0.59 . . . . 0.0 111.645 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.2 t -161.37 -38.15 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 115.017 -0.992 . . . . 0.0 110.282 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.443 ' HG3' HH11 ' A' ' 91' ' ' ARG . 0.1 OUTLIER -94.16 9.26 38.57 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.684 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.454 HG11 ' HD2' ' A' ' 81' ' ' TYR . 10.9 t -109.0 139.49 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 177.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.684 ' HB3' HG23 ' A' ' 43' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.499 2.007 0 O-C-N 121.556 -0.715 . . . . 0.0 109.635 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.92 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.67 HD13 ' HB2' ' A' ' 36' ' ' LEU . 0.6 OUTLIER -135.17 70.13 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 CA-C-O 121.716 0.77 . . . . 0.0 109.167 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 34.6 t -152.06 82.35 1.26 Allowed 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.675 -1.265 . . . . 0.0 111.168 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.469 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 2.6 t 66.43 -59.85 0.34 Allowed 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 177.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -46.01 -58.51 5.57 Favored Glycine 0 N--CA 1.506 3.366 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 178.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -78.49 -34.11 47.72 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.54 -0.976 . . . . 0.0 108.93 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.494 HG13 ' CD2' ' A' ' 53' ' ' LEU . 8.3 t -53.39 -39.93 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.448 ' HA ' ' CD1' ' A' ' 11' ' ' ILE . . . -68.81 -35.23 76.75 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.1 p -71.75 -21.37 61.75 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.431 -0.793 . . . . 0.0 109.778 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -82.1 -46.74 13.45 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.525 -0.734 . . . . 0.0 110.429 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.448 ' CD1' ' HA ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -79.96 -25.63 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 O-C-N 121.09 -1.006 . . . . 0.0 110.984 -178.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.601 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -47.45 -55.02 17.98 Favored Pre-proline 0 N--CA 1.502 2.15 0 O-C-N 121.132 -0.98 . . . . 0.0 110.1 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.601 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 57.8 Cg_endo -70.9 -26.71 21.89 Favored 'Trans proline' 0 C--N 1.322 -0.84 0 C-N-CA 122.106 1.871 . . . . 0.0 110.555 179.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.643 ' SG ' HG21 ' A' ' 71' ' ' ILE . 1.1 m -97.4 15.46 22.99 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.744 -0.783 . . . . 0.0 112.442 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.484 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 0.4 OUTLIER -63.19 -45.03 99.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.712 179.082 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.404 ' OG ' ' N ' ' A' ' 17' ' ' TYR . 39.1 p -65.26 -59.29 4.22 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.343 -0.848 . . . . 0.0 109.549 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.404 ' N ' ' OG ' ' A' ' 16' ' ' SER . 1.5 t80 -53.82 -56.08 20.78 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.76 -33.38 68.45 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.577 -0.702 . . . . 0.0 110.036 179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.484 ' HB3' ' O ' ' A' ' 15' ' ' ILE . 24.2 ttm180 -76.7 -32.39 57.83 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.562 -0.711 . . . . 0.0 109.838 -179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 138.24 -20.81 3.16 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 110.217 -1.153 . . . . 0.0 110.217 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.6 mm-40 -85.48 77.24 9.93 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.305 -1.115 . . . . 0.0 109.352 179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.7 -158.08 28.77 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.15 -43.74 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.676 -0.896 . . . . 0.0 109.089 -179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -102.14 141.24 15.2 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.706 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 27.0 Cg_endo -61.03 127.98 23.92 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 121.945 1.763 . . . . 0.0 110.894 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.7 t -62.33 142.16 57.93 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.704 -0.622 . . . . 0.0 110.134 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.52 -61.04 2.57 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.608 -0.682 . . . . 0.0 109.805 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.57 -41.06 80.62 Favored Glycine 0 N--CA 1.499 2.899 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.527 ' SG ' ' CG2' ' A' ' 71' ' ' ILE . 42.8 t -57.56 -49.36 76.62 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.859 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.706 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 24.9 m -60.5 -34.8 74.59 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 120.674 0.273 . . . . 0.0 110.687 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.9 t -68.75 -50.86 47.13 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.102 175.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.59 -38.26 95.55 Favored Glycine 0 N--CA 1.501 3.013 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.739 HG11 ' HA ' ' A' ' 72' ' ' PRO . 12.8 t -83.57 -52.68 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.141 0 O-C-N 121.403 -1.057 . . . . 0.0 110.707 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.572 ' HA ' ' CG1' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -57.77 -18.23 20.37 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.472 -0.768 . . . . 0.0 110.861 -179.685 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 89.9 p -94.97 -40.69 9.54 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.223 -0.923 . . . . 0.0 109.278 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.67 ' HB2' HD13 ' A' ' 2' ' ' ILE . 0.8 OUTLIER -54.15 -35.89 62.74 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.052 -1.03 . . . . 0.0 109.675 179.265 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -63.33 -19.2 64.41 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.44 -0.788 . . . . 0.0 109.668 178.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -87.44 -27.62 22.6 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.46 -30.3 18.4 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.652 -0.655 . . . . 0.0 110.385 179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.527 ' HB2' HG12 ' A' ' 2' ' ' ILE . . . -84.41 -148.27 0.1 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.299 -0.876 . . . . 0.0 110.744 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 69.43 23.15 6.19 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 121.25 -0.906 . . . . 0.0 111.055 -179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.497 ' O ' ' HB ' ' A' ' 43' ' ' THR . 6.3 t -123.77 15.44 9.41 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.998 -1.064 . . . . 0.0 110.533 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.618 HG23 ' HB3' ' A' ' 93' ' ' ASN . 85.4 m 76.7 -66.94 0.23 Allowed 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.22 -0.925 . . . . 0.0 109.973 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.99 -58.51 6.29 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.213 0.53 . . . . 0.0 110.509 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.596 ' HB3' HG23 ' A' ' 2' ' ' ILE . 24.8 m-20 -70.77 -33.01 70.33 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.453 -0.779 . . . . 0.0 109.184 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.599 ' HG3' ' CE1' ' A' ' 81' ' ' TYR . 0.2 OUTLIER -56.32 -54.8 41.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.543 -0.723 . . . . 0.0 109.858 179.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -68.26 -43.0 78.76 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.492 -0.755 . . . . 0.0 109.574 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.36 -48.41 74.29 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.469 ' HB2' HG13 ' A' ' 2' ' ' ILE . . . -66.23 -49.4 67.35 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.476 ' SG ' ' O ' ' A' ' 88' ' ' ASP . 1.6 t -56.53 -41.14 76.26 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -57.61 -58.3 8.94 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 124.231 0.957 . . . . 0.0 110.285 177.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 48.6 t -67.91 -34.35 76.45 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 118.724 -1.19 . . . . 0.0 111.749 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.618 HD22 HD12 ' A' ' 83' ' ' ILE . 15.3 mt -59.22 -41.46 88.71 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.525 175.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.456 ' HB2' ' HE3' ' A' ' 54' ' ' LYS . 18.7 ttmt -64.63 -38.58 91.49 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -54.85 -36.27 64.88 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.43 -55.84 4.76 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.628 ' HB2' HG22 ' A' ' 83' ' ' ILE . . . -56.26 -36.02 68.09 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.309 -0.869 . . . . 0.0 110.814 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.509 ' HA ' HG23 ' A' ' 85' ' ' THR . . . -93.04 17.02 11.46 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.34 -0.85 . . . . 0.0 110.856 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -143.68 -25.63 0.15 Allowed Glycine 0 N--CA 1.507 3.374 0 O-C-N 121.061 -1.024 . . . . 0.0 111.631 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.8 t -55.53 123.91 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.199 -1.177 . . . . 0.0 110.46 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.8 t -64.67 114.61 4.54 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.563 -0.711 . . . . 0.0 109.611 179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 63' ' ' LEU . . . 103.1 -49.94 0.93 Allowed Glycine 0 N--CA 1.499 2.849 0 N-CA-C 109.288 -1.525 . . . . 0.0 109.288 -179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.486 ' C ' HD13 ' A' ' 63' ' ' LEU . 3.4 tm? 19.86 100.65 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.764 0 N-CA-C 113.321 0.86 . . . . 0.0 113.321 179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -97.32 87.52 4.17 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -38.61 -45.85 1.13 Allowed 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.605 -0.684 . . . . 0.0 111.192 -178.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -54.41 -35.36 55.91 Favored Glycine 0 N--CA 1.504 3.19 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -89.57 -46.58 8.56 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.776 -0.838 . . . . 0.0 109.063 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.504 ' HB1' ' HB ' ' A' ' 83' ' ' ILE . . . -51.24 -49.85 60.32 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.95 -0.469 . . . . 0.0 110.347 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.77 -26.8 60.83 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.333 -0.855 . . . . 0.0 109.835 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.9 m -68.83 -36.89 78.74 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.379 -0.825 . . . . 0.0 110.698 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.643 HG21 ' SG ' ' A' ' 14' ' ' CYS . 10.6 mt -53.45 -61.93 4.34 Favored Pre-proline 0 N--CA 1.5 2.034 0 O-C-N 121.675 -0.641 . . . . 0.0 110.465 -179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.739 ' HA ' HG11 ' A' ' 33' ' ' VAL . 28.3 Cg_endo -61.26 -60.96 0.19 Allowed 'Trans proline' 0 C--N 1.323 -0.785 0 C-N-CA 121.794 1.663 . . . . 0.0 111.032 -179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 77.7 p -46.77 -64.09 0.86 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.966 -0.459 . . . . 0.0 111.057 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -62.67 -44.69 95.62 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 119.571 -0.252 . . . . 0.0 111.346 -178.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.621 ' SG ' ' HB2' ' A' ' 25' ' ' PRO . 1.6 m -46.88 -43.99 19.26 Favored 'General case' 0 N--CA 1.506 2.335 0 C-N-CA 119.182 -1.007 . . . . 0.0 111.673 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 146.86 50.44 0.03 OUTLIER Glycine 0 N--CA 1.495 2.617 0 C-N-CA 119.186 -1.483 . . . . 0.0 111.52 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.667 HG22 ' O ' ' A' ' 72' ' ' PRO . 32.9 m -135.07 136.46 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-N 119.243 1.521 . . . . 0.0 111.064 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.3 p -106.82 62.65 0.63 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.505 HG12 ' CE1' ' A' ' 81' ' ' TYR . 3.2 tp -116.64 126.24 27.7 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.426 -0.796 . . . . 0.0 109.354 -179.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 79' ' ' ILE . 18.4 Cg_endo -57.97 -38.11 93.41 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 C-N-CA 122.662 2.241 . . . . 0.0 112.083 -178.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.75 ' HB3' HG21 ' A' ' 92' ' ' VAL . 14.0 p90 -90.27 113.99 25.93 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.879 -1.138 . . . . 0.0 109.941 -179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.663 ' C ' HD13 ' A' ' 83' ' ' ILE . 81.9 p -113.71 -135.55 0.36 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.532 -0.73 . . . . 0.0 109.119 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.663 HD13 ' C ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -123.51 51.59 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.111 -0.993 . . . . 0.0 108.648 -179.53 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.412 ' O ' ' HB ' ' A' ' 85' ' ' THR . 41.7 p -89.45 9.83 24.96 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.858 -0.526 . . . . 0.0 111.794 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.509 HG23 ' HA ' ' A' ' 58' ' ' ALA . 63.5 m 72.07 -59.89 0.54 Allowed 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.285 -0.884 . . . . 0.0 110.104 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 27.7 p -73.14 -58.08 3.56 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 2.1 m 31.58 -144.63 0.0 OUTLIER 'General case' 0 N--CA 1.518 2.941 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.996 178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.476 ' O ' ' SG ' ' A' ' 50' ' ' CYS . 31.6 t70 -155.51 142.55 19.16 Favored 'General case' 0 N--CA 1.504 2.237 0 O-C-N 120.609 -1.307 . . . . 0.0 110.58 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 1.2 m -137.06 54.69 1.85 Allowed 'General case' 0 N--CA 1.501 2.101 0 CA-C-O 121.964 0.888 . . . . 0.0 110.421 176.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 32.0 t -164.08 -51.52 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.58 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.455 ' HG2' ' NH1' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -99.27 26.06 6.32 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.476 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.75 HG21 ' HB3' ' A' ' 81' ' ' TYR . 5.0 p -110.32 15.75 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.82 -0.55 . . . . 0.0 110.842 -178.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.618 ' HB3' HG23 ' A' ' 43' ' ' THR . 1.9 p-10 . . . . . 0 N--CA 1.505 2.291 0 CA-C-O 115.308 -2.282 . . . . 0.0 111.078 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.016 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.607 HD13 ' HB2' ' A' ' 40' ' ' ALA . 2.9 tp 33.9 46.41 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.479 0 CA-C-O 121.735 0.778 . . . . 0.0 111.74 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 30.7 t -95.72 152.9 18.05 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.996 -1.065 . . . . 0.0 110.279 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.482 ' HA ' ' HB ' ' A' ' 7' ' ' VAL . 13.0 t -53.63 -27.69 28.49 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 115.407 -0.815 . . . . 0.0 113.113 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.34 -55.85 27.79 Favored Glycine 0 N--CA 1.502 3.034 0 N-CA-C 110.066 -1.213 . . . . 0.0 110.066 176.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.539 ' HG3' ' N ' ' A' ' 7' ' ' VAL . 5.5 pt20 -71.39 -34.99 70.9 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.209 -1.171 . . . . 0.0 109.442 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.617 HG13 ' HG ' ' A' ' 53' ' ' LEU . 37.6 t -56.62 -49.16 79.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 178.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.525 ' HA ' ' CD1' ' A' ' 11' ' ' ILE . . . -70.09 -34.29 72.95 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 t -73.03 -22.26 60.67 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.116 -0.99 . . . . 0.0 110.149 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -79.21 -43.73 23.27 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.298 -0.876 . . . . 0.0 110.427 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.525 ' CD1' ' HA ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -85.59 -16.73 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 O-C-N 121.038 -1.039 . . . . 0.0 110.413 -179.691 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.582 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -48.62 -54.98 21.89 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.38 -0.825 . . . . 0.0 110.167 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 41.4 Cg_endo -67.56 -22.84 43.91 Favored 'Trans proline' 0 N--CA 1.481 0.763 0 C-N-CA 122.142 1.894 . . . . 0.0 110.585 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.849 ' SG ' HG21 ' A' ' 71' ' ' ILE . 10.6 m -102.28 11.7 37.76 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.684 -0.806 . . . . 0.0 112.607 178.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.518 ' O ' ' CB ' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -59.94 -39.54 80.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 178.049 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -67.68 -57.97 5.46 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.59 -0.694 . . . . 0.0 109.558 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.612 ' CD1' ' HA2' ' A' ' 22' ' ' GLY . 0.9 OUTLIER -58.37 -57.21 13.93 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.62 -0.675 . . . . 0.0 109.272 179.594 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.31 -22.98 21.1 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.335 -0.853 . . . . 0.0 109.916 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.518 ' CB ' ' O ' ' A' ' 15' ' ' ILE . 9.2 tmm_? -95.19 0.02 53.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.619 -0.676 . . . . 0.0 110.75 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 123.16 -17.86 7.95 Favored Glycine 0 N--CA 1.501 2.988 0 O-C-N 120.339 -1.475 . . . . 0.0 112.166 178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -83.06 69.48 9.85 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-N 119.084 1.442 . . . . 0.0 109.476 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.612 ' HA2' ' CD1' ' A' ' 17' ' ' TYR . . . -74.05 77.19 1.0 Allowed Glycine 0 N--CA 1.497 2.747 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 87.2 p -101.25 -37.06 8.68 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.68 -0.894 . . . . 0.0 109.755 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.441 ' HA2' ' HD3' ' A' ' 25' ' ' PRO . . . 172.97 131.64 1.41 Allowed Glycine 0 N--CA 1.501 3.021 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.441 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 26.5 Cg_exo -60.72 119.02 5.96 Favored 'Trans proline' 0 C--N 1.321 -0.909 0 C-N-CA 122.272 1.982 . . . . 0.0 110.442 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.25 135.38 48.92 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.377 -0.827 . . . . 0.0 110.707 -179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -54.68 -48.87 71.86 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.783 -0.573 . . . . 0.0 109.587 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -56.95 -43.75 92.81 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 30.5 t -60.1 -46.52 89.31 Favored 'General case' 0 N--CA 1.494 1.773 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.53 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.425 ' HA ' ' HB3' ' A' ' 75' ' ' CYS . 96.5 m -64.63 -39.32 93.5 Favored 'General case' 0 N--CA 1.485 1.309 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.283 -177.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.77 -42.24 77.7 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 124.462 1.101 . . . . 0.0 110.031 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -55.36 -53.94 37.6 Favored Glycine 0 N--CA 1.499 2.891 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.681 HG12 HG21 ' A' ' 77' ' ' VAL . 2.8 t -68.6 -44.83 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.572 -0.957 . . . . 0.0 109.21 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.547 ' O ' ' HD2' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -53.23 -35.71 60.24 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.4 m -73.53 -48.31 34.07 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.52 ' O ' ' HB3' ' A' ' 40' ' ' ALA . 0.9 OUTLIER -59.77 -34.13 72.59 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.736 -1.227 . . . . 0.0 107.938 177.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.477 ' HB2' HG13 ' A' ' 77' ' ' VAL . 66.0 t30 -52.28 -42.87 64.09 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.601 -0.687 . . . . 0.0 110.212 178.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -93.12 -24.06 18.4 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.18 -0.95 . . . . 0.0 110.703 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.507 ' O ' ' HB ' ' A' ' 2' ' ' ILE . . . -106.63 33.85 3.7 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 120.956 -1.09 . . . . 0.0 110.372 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.607 ' HB2' HD13 ' A' ' 2' ' ' ILE . . . -168.62 85.78 0.18 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.165 -0.959 . . . . 0.0 110.669 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.492 ' HA ' ' CD ' ' A' ' 46' ' ' ARG . 15.2 mtt180 -158.86 24.31 0.22 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.204 -0.935 . . . . 0.0 111.028 179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.461 ' O ' ' HB ' ' A' ' 43' ' ' THR . 8.9 m -110.82 42.16 1.66 Allowed 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.973 -1.079 . . . . 0.0 110.796 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.689 ' HA ' ' HA ' ' A' ' 93' ' ' ASN . 52.0 m 68.8 -65.72 0.27 Allowed 'General case' 0 N--CA 1.503 2.185 0 O-C-N 121.158 -0.964 . . . . 0.0 109.469 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 42' ' ' THR . . . -56.82 -51.9 67.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.902 -0.499 . . . . 0.0 109.731 179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.518 ' HB3' ' HA ' ' A' ' 40' ' ' ALA . 12.6 m-20 -58.42 -48.61 80.12 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 121.273 0.558 . . . . 0.0 109.797 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.492 ' CD ' ' HA ' ' A' ' 41' ' ' ARG . 13.5 mtm180 -67.39 -48.66 66.74 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.943 -0.473 . . . . 0.0 111.145 -178.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 28.5 ttm180 -63.39 -50.86 68.22 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.081 -1.012 . . . . 0.0 109.145 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.97 -47.7 77.16 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.591 ' CB ' HD11 ' A' ' 2' ' ' ILE . . . -63.7 -44.06 94.76 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.538 -0.726 . . . . 0.0 109.186 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.574 ' O ' ' SG ' ' A' ' 89' ' ' CYS . 38.4 t -57.39 -39.03 75.24 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 120.364 -0.534 . . . . 0.0 109.736 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -61.37 -56.12 23.94 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 124.03 0.832 . . . . 0.0 109.788 177.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . 0.445 ' HA ' HD22 ' A' ' 55' ' ' ASN . 8.4 t -64.26 -35.16 79.94 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 119.75 -0.78 . . . . 0.0 111.544 178.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.646 HD13 ' O ' ' A' ' 82' ' ' THR . 8.0 mt -63.39 -44.47 94.61 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.061 176.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.428 ' HE3' ' HB3' ' A' ' 54' ' ' LYS . 14.0 ttpp -59.67 -40.62 88.41 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.445 HD22 ' HA ' ' A' ' 52' ' ' CYS . 86.1 m-20 -56.11 -47.23 78.46 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.473 ' O ' HG23 ' A' ' 60' ' ' VAL . . . -73.65 -47.16 42.05 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 83' ' ' ILE . . . -52.87 -41.66 64.52 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.59 -0.694 . . . . 0.0 110.136 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.98 1.53 39.35 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.541 -0.724 . . . . 0.0 110.199 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -125.63 9.48 7.68 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 56' ' ' ALA . 4.9 t -73.58 -5.69 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.579 -0.953 . . . . 0.0 110.07 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 60' ' ' VAL . 0.1 OUTLIER 76.59 -71.03 0.12 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.34 -0.85 . . . . 0.0 109.598 179.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 19' ' ' ARG . . . -109.48 59.33 0.36 Allowed Glycine 0 N--CA 1.499 2.859 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.636 HD11 ' HA ' ' A' ' 84' ' ' SER . 1.4 tm? -54.79 117.99 3.86 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.564 -0.962 . . . . 0.0 111.031 -179.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.543 ' N ' HD13 ' A' ' 63' ' ' LEU . 8.0 t-20 -107.44 86.34 2.29 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.439 ' HA ' ' HB3' ' A' ' 84' ' ' SER . . . -42.91 -50.6 5.76 Favored 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -178.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.48 -44.19 85.4 Favored Glycine 0 N--CA 1.503 3.162 0 N-CA-C 110.224 -1.15 . . . . 0.0 110.224 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -74.41 -55.17 6.28 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.707 -0.878 . . . . 0.0 109.585 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.445 ' HB1' ' HB ' ' A' ' 83' ' ' ILE . . . -51.43 -35.88 41.37 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.937 -0.477 . . . . 0.0 111.435 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -84.95 -40.0 17.48 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 121.133 -0.979 . . . . 0.0 110.014 179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.0 t -65.17 -40.55 94.46 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.473 -0.767 . . . . 0.0 110.826 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.849 HG21 ' SG ' ' A' ' 14' ' ' CYS . 74.7 mt -51.7 -65.19 1.05 Allowed Pre-proline 0 N--CA 1.503 2.224 0 O-C-N 121.845 -0.534 . . . . 0.0 111.934 -178.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.661 ' HG3' ' HB ' ' A' ' 82' ' ' THR . 41.1 Cg_endo -60.2 -40.54 58.96 Favored 'Trans proline' 0 N--CA 1.482 0.813 0 C-N-CA 121.908 1.739 . . . . 0.0 110.404 -179.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.6 m -55.52 -62.95 1.34 Allowed 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -63.97 -39.63 94.57 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.893 -0.505 . . . . 0.0 109.84 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.425 ' HB3' ' HA ' ' A' ' 30' ' ' CYS . 1.3 m -48.28 -33.31 8.57 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.91 -0.494 . . . . 0.0 111.689 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 132.17 50.3 0.09 OUTLIER Glycine 0 N--CA 1.498 2.796 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 176.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.681 HG21 HG12 ' A' ' 33' ' ' VAL . 43.8 t -139.98 135.4 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.379 -1.071 . . . . 0.0 110.681 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.8 p -112.11 59.8 0.63 Allowed 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 122.219 1.009 . . . . 0.0 108.695 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.661 HG22 HG12 ' A' ' 77' ' ' VAL . 13.5 tt -125.07 122.56 25.39 Favored Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.46 -41.31 78.03 Favored 'Trans proline' 0 N--CA 1.486 1.084 0 C-N-CA 122.66 2.24 . . . . 0.0 112.092 -178.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.564 ' CE1' HD11 ' A' ' 79' ' ' ILE . 6.6 p90 -97.13 128.91 44.49 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.121 -0.987 . . . . 0.0 108.429 179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.662 ' C ' HD12 ' A' ' 83' ' ' ILE . 40.2 p -128.59 -94.97 0.42 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.339 -0.851 . . . . 0.0 110.834 -178.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.662 HD12 ' C ' ' A' ' 82' ' ' THR . 1.4 mp -120.12 -51.79 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.265 -0.897 . . . . 0.0 109.639 -177.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.636 ' HA ' HD11 ' A' ' 63' ' ' LEU . 1.4 m -42.63 144.52 0.53 Allowed 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.309 0.576 . . . . 0.0 110.86 179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 87' ' ' THR . 41.3 p -72.44 -130.01 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.7 t 63.03 -58.9 0.15 Allowed 'General case' 0 N--CA 1.508 2.438 0 O-C-N 120.97 -1.081 . . . . 0.0 111.012 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.519 ' N ' ' O ' ' A' ' 85' ' ' THR . 3.4 m -61.11 140.62 57.84 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.387 -0.821 . . . . 0.0 109.789 -179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -83.67 134.35 34.78 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.578 -0.701 . . . . 0.0 111.025 -179.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.574 ' SG ' ' O ' ' A' ' 50' ' ' CYS . 65.2 m -105.17 54.55 0.71 Allowed 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.836 0.827 . . . . 0.0 110.129 177.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.0 m -144.06 -40.89 0.28 Allowed 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 113.796 -1.547 . . . . 0.0 109.132 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -99.43 -30.45 12.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.504 -0.748 . . . . 0.0 109.806 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -47.64 142.77 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 121.297 -0.877 . . . . 0.0 110.391 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.689 ' HA ' ' HA ' ' A' ' 43' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.499 1.992 0 O-C-N 121.711 -0.618 . . . . 0.0 109.529 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.615 ' HB1' ' HB1' ' A' ' 39' ' ' ALA . . . . . . . . 0 N--CA 1.497 1.9 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.747 HD11 ' HB2' ' A' ' 49' ' ' ALA . 7.4 tp 32.11 59.04 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.574 0 CA-C-O 121.806 0.812 . . . . 0.0 111.603 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 40.8 t -118.59 161.62 19.74 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.878 -1.139 . . . . 0.0 110.268 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.3 t -53.66 -38.02 63.74 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.817 -0.753 . . . . 0.0 112.23 178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.16 -37.18 94.08 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -83.93 -43.91 14.77 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.64 -0.918 . . . . 0.0 108.962 179.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.563 HG21 ' HA ' ' A' ' 49' ' ' ALA . 94.8 t -57.03 -40.58 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -76.64 -27.46 55.68 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.1 m -67.76 -22.64 65.21 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.399 -0.813 . . . . 0.0 109.247 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.546 ' C ' ' HD2' ' A' ' 13' ' ' PRO . . . -98.29 -29.23 13.29 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.517 -0.739 . . . . 0.0 109.075 178.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 tp -79.37 -41.53 22.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.487 -0.758 . . . . 0.0 110.515 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.626 ' HB3' ' HD3' ' A' ' 13' ' ' PRO . . . -46.41 -49.78 42.58 Favored Pre-proline 0 N--CA 1.503 2.203 0 O-C-N 121.555 -0.716 . . . . 0.0 110.316 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.626 ' HD3' ' HB3' ' A' ' 12' ' ' ALA . 22.6 Cg_exo -65.1 -24.61 59.25 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 122.044 1.829 . . . . 0.0 110.451 179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.789 ' SG ' HG21 ' A' ' 71' ' ' ILE . 1.7 m -104.15 14.55 30.25 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 176.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.41 ' CG2' ' N ' ' A' ' 16' ' ' SER . 0.2 OUTLIER -65.76 -50.68 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.706 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.41 ' N ' ' CG2' ' A' ' 15' ' ' ILE . 0.2 OUTLIER -62.04 -57.31 12.11 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.57 -0.706 . . . . 0.0 109.133 179.02 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.557 ' CE2' HG12 ' A' ' 71' ' ' ILE . 1.1 t80 -54.17 -58.9 5.63 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.452 ' HB1' ' HB2' ' A' ' 68' ' ' ALA . . . -55.77 -35.49 66.31 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.514 -0.741 . . . . 0.0 109.858 178.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.478 ' HA ' ' HA ' ' A' ' 63' ' ' LEU . 29.5 ttm180 -74.53 -25.93 59.65 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.471 -0.768 . . . . 0.0 110.18 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 112.84 3.2 25.14 Favored Glycine 0 N--CA 1.5 2.929 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -103.82 70.7 1.02 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.1 -1.235 . . . . 0.0 109.484 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.05 -145.0 7.64 Favored Glycine 0 N--CA 1.499 2.862 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.2 t 176.63 -54.29 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.809 -0.818 . . . . 0.0 109.514 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -83.61 118.4 4.65 Favored Glycine 0 N--CA 1.495 2.629 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -56.71 132.42 51.63 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 C-N-CA 122.568 2.179 . . . . 0.0 110.781 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.2 t -75.05 119.25 18.97 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.515 -0.741 . . . . 0.0 109.208 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -49.88 -46.01 51.22 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.692 -0.63 . . . . 0.0 109.986 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -55.98 -42.76 87.41 Favored Glycine 0 N--CA 1.499 2.868 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.446 ' O ' HG23 ' A' ' 33' ' ' VAL . 42.4 t -57.93 -46.08 85.6 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.88 -1.128 . . . . 0.0 109.53 177.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 75' ' ' CYS . 81.3 m -64.91 -41.97 95.12 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 123.855 0.722 . . . . 0.0 112.355 -177.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.443 ' HA ' ' HE ' ' A' ' 34' ' ' ARG . 9.5 t -70.68 -42.31 70.9 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 123.993 0.808 . . . . 0.0 110.192 176.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -54.95 -51.08 56.04 Favored Glycine 0 N--CA 1.498 2.819 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.662 HG12 HG11 ' A' ' 77' ' ' VAL . 4.8 t -70.47 -46.77 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.625 -0.927 . . . . 0.0 109.237 179.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.59 ' HA ' ' CG1' ' A' ' 77' ' ' VAL . 28.2 ttp180 -52.87 -36.66 59.42 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 39.4 t -74.29 -47.45 34.71 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.563 HD23 ' HA ' ' A' ' 33' ' ' VAL . 0.3 OUTLIER -55.83 -37.84 69.22 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.174 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.585 ' HB2' HG12 ' A' ' 77' ' ' VAL . 2.6 t-20 -63.34 -33.97 76.68 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.471 -0.768 . . . . 0.0 108.962 178.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -78.12 -38.0 44.9 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.615 ' HB1' ' HB1' ' A' ' 1' ' ' ALA . . . -94.85 32.01 1.73 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.706 -0.621 . . . . 0.0 109.724 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.493 ' HA ' ' CB ' ' A' ' 45' ' ' ASP . . . -164.39 -159.51 0.48 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.468 -0.77 . . . . 0.0 110.541 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ARG . . . . . 0.542 ' HA ' ' HD3' ' A' ' 46' ' ' ARG . 1.4 mtp180 78.14 12.03 1.79 Allowed 'General case' 0 N--CA 1.505 2.302 0 O-C-N 121.974 -0.453 . . . . 0.0 111.598 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.599 ' O ' ' HB ' ' A' ' 43' ' ' THR . 0.9 OUTLIER -99.64 27.32 5.43 Favored 'General case' 0 N--CA 1.508 2.442 0 O-C-N 120.889 -1.132 . . . . 0.0 110.189 178.869 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.64 HG23 ' HB3' ' A' ' 93' ' ' ASN . 55.2 m 83.83 -67.44 0.06 Allowed 'General case' 0 N--CA 1.51 2.557 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -179.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.82 -55.42 34.6 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.683 -0.635 . . . . 0.0 109.427 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.567 ' HB3' HG12 ' A' ' 2' ' ' ILE . 8.8 m-20 -54.39 -46.05 73.01 Favored 'General case' 0 N--CA 1.5 2.065 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.542 ' HD3' ' HA ' ' A' ' 41' ' ' ARG . 9.5 mmm-85 -56.81 -44.54 82.06 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.49 ' HA ' ' NH1' ' A' ' 47' ' ' ARG . 0.7 OUTLIER -60.25 -50.52 73.31 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.984 -0.448 . . . . 0.0 110.385 -179.64 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.61 -39.53 80.71 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.78 -0.575 . . . . 0.0 109.727 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.747 ' HB2' HD11 ' A' ' 2' ' ' ILE . . . -71.62 -61.6 1.72 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.563 -0.902 . . . . 0.0 108.563 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -44.84 -41.85 7.42 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 176.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.53 ' O ' ' HG3' ' A' ' 54' ' ' LYS . 3.0 t30 -65.53 -56.02 14.62 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.394 177.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 16.8 t -64.39 -26.37 68.43 Favored 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 119.139 -1.025 . . . . 0.0 111.146 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.542 ' HG ' HG11 ' A' ' 7' ' ' VAL . 21.7 mt -70.4 -58.9 3.23 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.39 178.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' A' ' 51' ' ' ASN . 2.7 pptp? -54.07 -36.18 62.84 Favored 'General case' 0 N--CA 1.504 2.271 0 O-C-N 121.333 -0.854 . . . . 0.0 110.009 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -64.46 -48.15 76.35 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.435 -0.79 . . . . 0.0 109.092 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.58 -40.05 80.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.541 -0.724 . . . . 0.0 109.563 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.443 ' HA ' ' CD1' ' A' ' 63' ' ' LEU . . . -48.43 -48.32 37.45 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.611 -0.681 . . . . 0.0 110.366 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -73.55 -6.35 45.97 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.453 -0.78 . . . . 0.0 111.554 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -123.63 8.86 8.76 Favored Glycine 0 N--CA 1.501 3.032 0 O-C-N 120.833 -1.167 . . . . 0.0 110.759 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.405 ' O ' ' CB ' ' A' ' 61' ' ' SER . 0.9 OUTLIER -74.42 -21.11 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.333 -1.098 . . . . 0.0 110.367 -179.739 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 60' ' ' VAL . 0.9 OUTLIER 76.49 107.54 0.08 Allowed 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.279 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.73 -78.63 1.92 Allowed Glycine 0 N--CA 1.498 2.774 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 19' ' ' ARG . 7.5 tt 59.48 103.09 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 121.953 0.883 . . . . 0.0 111.236 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.512 ' HB3' ' HB2' ' A' ' 67' ' ' ASN . 2.6 m-80 -94.39 81.88 4.01 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -32.87 -55.69 0.37 Allowed 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 70' ' ' SER . . . -52.21 -42.99 56.54 Favored Glycine 0 N--CA 1.506 3.357 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.512 ' HB2' ' HB3' ' A' ' 64' ' ' ASN . 2.0 t30 -72.7 -51.97 17.12 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.452 ' HB2' ' HB1' ' A' ' 18' ' ' ALA . . . -57.16 -33.25 67.24 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 122.018 -0.426 . . . . 0.0 111.626 -179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -83.43 -45.22 13.91 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.094 -1.004 . . . . 0.0 109.964 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 66' ' ' GLY . 0.4 OUTLIER -66.09 -29.62 69.98 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.347 -0.846 . . . . 0.0 111.055 -179.619 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.789 HG21 ' SG ' ' A' ' 14' ' ' CYS . 70.2 mt -60.11 -66.09 1.71 Allowed Pre-proline 0 N--CA 1.506 2.329 0 O-C-N 121.243 -0.911 . . . . 0.0 111.291 -178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.564 ' O ' HG22 ' A' ' 77' ' ' VAL . 23.7 Cg_endo -57.33 -53.62 4.53 Favored 'Trans proline' 0 C--N 1.325 -0.699 0 C-N-CA 121.805 1.67 . . . . 0.0 109.652 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 50.5 m -45.29 -63.98 0.82 Allowed 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt -64.85 -34.05 77.45 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.712 -0.617 . . . . 0.0 109.916 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' CYS . . . . . 0.448 ' HB3' ' HA ' ' A' ' 30' ' ' CYS . 1.1 m -50.98 -31.48 18.07 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.222 -177.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 135.07 53.6 0.07 OUTLIER Glycine 0 N--CA 1.497 2.711 0 C-N-CA 119.657 -1.259 . . . . 0.0 110.81 175.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.662 HG11 HG12 ' A' ' 33' ' ' VAL . 12.0 m -147.71 124.49 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.125 0 O-C-N 121.184 -1.186 . . . . 0.0 111.172 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.411 ' O ' ' HD2' ' A' ' 41' ' ' ARG . 65.2 m -91.45 67.06 5.57 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.531 HD11 ' CE2' ' A' ' 81' ' ' TYR . 2.3 tp -104.02 127.19 29.79 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.553 -0.717 . . . . 0.0 109.854 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.63 -33.88 65.37 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 122.826 2.351 . . . . 0.0 112.394 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' TYR . . . . . 0.531 ' CE2' HD11 ' A' ' 79' ' ' ILE . 5.9 p90 -90.3 143.68 26.54 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.904 -1.122 . . . . 0.0 110.407 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.3 p -104.88 173.37 6.33 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.504 -0.747 . . . . 0.0 110.814 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.468 HD12 HD13 ' A' ' 53' ' ' LEU . 5.4 mm -108.95 92.51 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.536 -0.727 . . . . 0.0 109.357 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 82.8 p -119.45 -104.91 0.39 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.159 -0.963 . . . . 0.0 109.653 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -164.02 -55.9 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 63.3 m -79.34 -8.26 58.94 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 122.107 -0.371 . . . . 0.0 110.183 178.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 8.7 m -50.03 142.67 9.06 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 121.325 -0.859 . . . . 0.0 109.951 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -82.58 118.46 23.3 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.496 -0.753 . . . . 0.0 109.813 -179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 11.4 m -109.64 56.11 0.63 Allowed 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 120.037 -0.665 . . . . 0.0 109.886 177.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 9.3 t -128.5 -61.4 1.08 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.571 178.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.475 ' NH1' ' HG3' ' A' ' 91' ' ' ARG . 2.9 mtm-85 -97.96 60.61 1.49 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 122.052 0.93 . . . . 0.0 109.629 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 60.3 t -115.37 81.51 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.64 ' HB3' HG23 ' A' ' 43' ' ' THR . 2.1 p-10 . . . . . 0 N--CA 1.495 1.788 0 CA-C-O 117.152 -1.404 . . . . 0.0 110.326 -179.764 . . . . . . . . 1 1 . 1 stop_ save_